phenotype1;phenotype2;cosOriginal;cosTuned;cosOriginalTrans;cosTunedTrans;lin;deltaOriginal;deltaTuned;deltaOriginalTrans;deltaTunedTrans
Temporomandibular joint ankylosis;Dyslexia;0.8805999308824539;1.0242175;0.5380971118859956;0.49229057384555586;0.9999511492611326;-0.11935121837867868;0.024266337120398163;-0.46185403737513697;-0.5076605754155767
Temporomandibular joint ankylosis;Stippling of the epiphysis of the proximal phalanx of the 4th toe;0.765911877155304;1.0832394;0.5752104269046647;0.47347337361311037;0.7973657807105512;-0.03145390355524724;0.28587365543904597;-0.22215535380588647;-0.3238924070974408
Temporomandibular joint ankylosis;Ankle joint effusion;0.5628409385681152;0.9871273;0.6440153227012925;0.5040976231039759;0.7973657807105512;-0.23452484214243596;0.18976152336659724;-0.15335045800925873;-0.2932681576065753
Temporomandibular joint ankylosis;Reduced C-peptide level;0.902930811047554;1.1086887;0.5309468118786714;0.4653348224918208;0.9999536937290383;-0.09702288268148429;0.10873501839101785;-0.4690068818503669;-0.5346188712372175
Temporomandibular joint ankylosis;Loss of voice;0.8826361000537872;0.7945403;0.5374443891283627;0.5658689435445877;0.9999536937290383;-0.11731759367525108;-0.20541340766489036;-0.46250930460067563;-0.4340847501844506
Temporomandibular joint ankylosis;Elevated circulating growth hormone concentration;0.8456036448478699;1.1048385;0.5493432695523368;0.4665674462666496;0.9999515360511232;-0.15434789120325332;0.10488695443502183;-0.4506082664987864;-0.5333840897844736
Temporomandibular joint ankylosis;Visual acuity no light perception;0.8818609192967415;1.1886709;0.5376928654599227;0.4395820759794279;0.9999090677057578;-0.11804814840901634;0.18876180593620995;-0.46221620224583515;-0.5603269917263299
Temporomandibular joint ankylosis;Spinal hypomyelination;0.8457123637199402;1.0442929;0.5493082435610162;0.4858965212986809;0.9999090677057578;-0.15419670398581764;0.04438385908257225;-0.4506008241447417;-0.5140125464070769
Temporomandibular joint ankylosis;Bladder polyp;0.8867116272449493;1.0700969;0.5361383935665673;0.4776691761685836;0.9999574798349273;-0.11324585258997799;0.0701393705602753;-0.46381908626836;-0.5222883036663437
Temporomandibular joint ankylosis;Aberrant melanosome maturation;0.8955681696534157;1.111767;0.5333024048467544;0.4643489503596563;0.9999574798349273;-0.10438931018151165;0.11180957376919864;-0.46665507498817294;-0.535608529475271
Temporomandibular joint ankylosis;Vertebral artery tortuosity;0.6362626552581787;0.9242423;0.6184994299129825;0.5241375406097808;0.9999574798349273;-0.3636948245767486;-0.07571516215838314;-0.3814580499219449;-0.47581993922514654
Temporomandibular joint ankylosis;Warm reactive autoantibody positivity;0.7791336178779602;1.0488183;0.5708884714991198;0.4844544434276763;0.9999090677057578;-0.22077544982779762;0.04890928213249901;-0.429020596206638;-0.5154546242780815
Temporomandibular joint ankylosis;Right aortic arch with retroesophageal left subclavian artery;0.7116318047046661;0.85960597;0.5931127080523375;0.5448369370958321;0.9999090677057578;-0.2882772630010917;-0.1403030997072532;-0.4067963596534203;-0.4550721306099257
Temporomandibular joint ankylosis;Elevated urine suberic acid level;0.9084556251764297;1.142444;0.5291803337363419;0.45450392761946257;0.9999574798349273;-0.09150185465849758;0.14248653471432804;-0.47077714609858545;-0.5454535522154648
Temporomandibular joint ankylosis;Burkitt lymphoma;0.8233332335948944;0.919981;0.5565314901334046;0.525498100687246;0.9999545338528789;-0.1766213002579845;-0.07997353104526173;-0.4434230437194743;-0.4744564331656329
Temporomandibular joint ankylosis;Snail-like ilia;0.8978788927197456;1.0549601;0.5325629244478087;0.48249682747082756;0.9052477392617277;-0.00736884654198211;0.1497123923834749;-0.372684814813919;-0.4227509117909002
Temporomandibular joint ankylosis;Indurated nodule;0.751797616481781;1.0055692;0.579839799804913;0.4982272691908618;0.9999090677057578;-0.24811145122397682;0.005660151883475573;-0.42006926790084487;-0.501681798514896
Temporomandibular joint ankylosis;Absent leukocyte alkaline phosphatase;0.8317865133285522;1.0403614;0.553799797860233;0.4871490669159425;0.9999574798349273;-0.16817096650637509;0.04040392458401798;-0.4461576819746943;-0.5128084129189848
Temporomandibular joint ankylosis;Hippocampal sclerosis;0.8441032469272614;1.0094098;0.5498267149079534;0.4970047358261285;0.9999090677057578;-0.15580582077849647;0.009500717564933092;-0.4500823527978044;-0.5029043318796294
Temporomandibular joint ankylosis;Decreased sensitivity to hypoxemia;0.8891962990164757;1.094472;0.5353424859469795;0.4698837030457512;0.9999574798349273;-0.11076118081845165;0.09451457083188175;-0.4646149938879478;-0.5300737767891761
Temporomandibular joint ankylosis;Decreased level of tissue plasminogen activator;0.7847938537597656;1.0809985;0.5690423429365179;0.4741890976372428;0.9999090677057578;-0.2151152139459922;0.08108947221886376;-0.43086672476923993;-0.525719970068515
Temporomandibular joint ankylosis;Submandibular lymph node enlargement;0.7907854616641998;0.8566767;0.5670907009223505;0.5457788742844194;0.9999574798349273;-0.2091720181707275;-0.14328078210390927;-0.43286677891257686;-0.45417860555050793
Temporomandibular joint ankylosis;Hepatic hemangioma;0.8278675675392151;1.0615917;0.5550657021592065;0.480382320879713;0.9999556674707869;-0.17208809993157181;0.061636076952125696;-0.4448899653115804;-0.5195733465910739
Temporomandibular joint ankylosis;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7755443602800369;1.0552753;0.5720603883044251;0.482396333772503;0.7973657807105512;-0.02182142043051427;0.2579095402962237;-0.22530539240612613;-0.3149694469380482
Temporomandibular joint ankylosis;Acne inversa;0.7273489832878113;0.9084508;0.5879004382254471;0.5291818746278598;0.9999515360511232;-0.2726025527633119;-0.09150075375208144;-0.41205109782567606;-0.4707696614232634
Temporomandibular joint ankylosis;Dentin dysplasia;0.711320161819458;0.81623864;0.5932163131119678;0.5588273684567959;0.7938909578598223;-0.08257079604036432;0.02234768387906927;-0.20067464474785457;-0.2350635894030264
Temporomandibular joint ankylosis;Aplasia of the inner ear;0.6576802730560303;0.83105755;0.611212597448539;0.5540352036217204;0.9999574798349273;-0.34227720677889706;-0.1688999313119781;-0.3887448823863884;-0.4459222762132069
Temporomandibular joint ankylosis;Polycystic liver disease;0.8562189191579819;0.9407217;0.5459261147377887;0.5188799435863755;0.9999536937290383;-0.14373477457105643;-0.05923200307428367;-0.45402757899124957;-0.48107375014266285
Temporomandibular joint ankylosis;Subungual hyperkeratosis;0.9221666529774666;1.0996221;0.5248002070121809;0.46823660284456003;0.9999524555142131;-0.0777858025367465;0.09966967487976885;-0.4751522485020322;-0.531715852669653
Temporomandibular joint ankylosis;Broad humeral epiphyses;0.7905440628528595;0.921125;0.5671692815892175;0.525132799665512;0.7973657807105512;-0.0068217178576917;0.12375921404424006;-0.23019649912133366;-0.27223298104503924
Temporomandibular joint ankylosis;Autoimmune thrombocytopenia;0.6206146478652954;0.91466475;0.6238645286390052;0.5271961382181416;0.9999469426585951;-0.37933229479329966;-0.08528219732778453;-0.37608241401958986;-0.4727508044404535
Temporomandibular joint ankylosis;Adenomyosis;0.7785395085811615;0.91847444;0.5710823842741057;0.5259792303285273;0.9999574798349273;-0.22141797125376583;-0.08148304402865292;-0.4288750955608216;-0.4739782495064
Temporomandibular joint ankylosis;Elevated leukocyte alkaline phosphatase;0.8241319805383682;1.0770866;0.5562731968032066;0.47543822366590616;0.9999574798349273;-0.1758254992965591;0.07712908804379581;-0.4436842830317207;-0.5245192561690212
Temporomandibular joint ankylosis;Clasp-knife sign;1.0246933959424496;1.0968223;0.49213904892276583;0.4691321618359038;0.8656029960338777;0.15909039990857188;0.23121926577642504;-0.37346394711111186;-0.3964708341979739
Temporomandibular joint ankylosis;Keratosis pilaris;0.8959035277366638;1.1221062;0.5331950720505612;0.4610351565516039;0.9999466809608285;-0.10404315322416469;0.12215951353532628;-0.46675160891026735;-0.5389115244092246
Temporomandibular joint ankylosis;Lamina lucida cleavage;0.8760401606559753;1.1023245;0.5395593988496205;0.4673720020227976;0.9999515360511232;-0.12391137539514785;0.1023729497276854;-0.46039213720150274;-0.5325795340283256
Temporomandibular joint ankylosis;Abnormal central response of multifocal electroretinogram;0.8719126433134079;1.1379032;0.5408837884539386;0.45596368994685876;0.9999090677057578;-0.12799642439234993;0.13799414579521874;-0.45902527925181924;-0.5439453777588991
Temporomandibular joint ankylosis;Atypical or prolonged hepatitis;0.7601792365312576;1.0361097;0.5770886773495689;0.4885034425196305;0.9999574798349273;-0.2397782433036697;0.036152206062899817;-0.4228688024853584;-0.5114540373152968
Temporomandibular joint ankylosis;Cubitus varus;0.8599575161933899;0.9571724;0.544723914492641;0.5136366154133869;0.7973657807105512;0.0625917354828387;0.15980661308827693;-0.2526418662179102;-0.2837291652971643
Temporomandibular joint ankylosis;Nasal regurgitation;0.6601336598396301;0.7202456;0.6103818389021438;0.590253029562714;0.9999556674707869;-0.3398220076311568;-0.2797100677240828;-0.3895738285686431;-0.40970263790807293
Temporomandibular joint ankylosis;Moon facies;0.917488656938076;0.9886304;0.5262940695106586;0.5036191295982085;0.899514961016858;0.017973695921218003;0.08911545299223622;-0.3732208915061994;-0.3958958314186495
Temporomandibular joint ankylosis;Intestinal pseudo-obstruction;0.7499250173568726;0.95157295;0.5804552739733508;0.5154208434878549;0.9999504758588345;-0.2500254585019619;-0.04837752120414085;-0.4194952018854836;-0.48452963237097957
Temporomandibular joint ankylosis;Bilateral renal atrophy;0.6893829703330994;1.0656607;0.6005356638251891;0.47908449791259067;0.9999574798349273;-0.31057450950182797;0.06570323526822208;-0.39942181600973825;-0.5208729819223367
Temporomandibular joint ankylosis;Fractured left clavicle;0.7981786727905273;0.9501684;0.5646860307408241;0.5158684745010562;0.7356548868117849;0.06252378597874242;0.2145134843887766;-0.1709688560709608;-0.2197864123107287
Temporomandibular joint ankylosis;Positive urine norcotinine test;0.9277318120002747;1.0379508;0.5230237494208134;0.48791698151982477;0.9999090677057578;-0.07217725570548317;0.03804168645989159;-0.4768853182849444;-0.5119920861859331
Temporomandibular joint ankylosis;Long fibula;0.7209248840808868;1.0056422;0.5900278472258818;0.4982040298778396;0.8968107519695712;-0.17588586788868432;0.10883142370486731;-0.3067829047436894;-0.39860672209173154
Temporomandibular joint ankylosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7376463115215302;1.0664605;0.5844987091342008;0.4788293713969489;0.7973657807105512;-0.059719469189021046;0.2690947095161944;-0.21286707157635043;-0.3185364093136023
Temporomandibular joint ankylosis;Type II cryptotia;0.9222148805856705;1.149878;0.5247848090050378;0.4521119095902051;0.9999090677057578;-0.07769418712008735;0.14996895734917381;-0.47512425870072006;-0.5477971581155527
Temporomandibular joint ankylosis;Increased variability in muscle fiber diameter;0.7963640838861465;1.064153;0.5652758806795672;0.4795654562537518;0.9153376606986002;-0.11897357681245369;0.1488152953103109;-0.350061780019033;-0.43577220444484843
Temporomandibular joint ankylosis;Widened proximal tibial metaphyses;0.718903124332428;1.1118237;0.59069822543633;0.46433082448072105;0.9052477392617277;-0.18634461492929977;0.20657593875493485;-0.31454951382539775;-0.4409169147810067
Temporomandibular joint ankylosis;Wide anterior fontanel;0.8166299909353256;0.8972271;0.5587006399534702;0.532771486432255;0.8018962303507605;0.014733760584565103;0.09533087812778562;-0.24319559039729033;-0.2691247439185055
Temporomandibular joint ankylosis;Increased circulating oleate level;0.8144879639148712;1.114804;0.5593943704085309;0.4633759703372373;0.9999090677057578;-0.1854211037908866;0.11489496175896385;-0.4405146972972269;-0.5365330973685205
Temporomandibular joint ankylosis;Lozenge-shaped umbilicus;0.8574993312358856;0.97572744;0.5455143062140082;0.5077269585696529;0.9999556674707869;-0.14245633623490128;-0.024228228544090125;-0.4544413612567787;-0.492228708901134
Temporomandibular joint ankylosis;Anti-myelin-associated glycoprotein antibody positivity;0.7770224213600159;1.0216511;0.5715776719838945;0.49310768910405556;0.9999090677057578;-0.22288664634574196;0.021742081090323717;-0.4283313957218633;-0.5068013786017023
Temporomandibular joint ankylosis;Fractured radius;0.7032687664031982;1.078037;0.595896548846623;0.4751347795956036;0.9052477392617277;-0.2019789728585295;0.17278928428258378;-0.3093511904151047;-0.4301129596661242
Temporomandibular joint ankylosis;Abnormal manual kinetic perimetry test;0.7797497063875198;1.1298223;0.5706874131251687;0.4585593171552085;0.9999090677057578;-0.220159361318238;0.12991318647515038;-0.42922165458058914;-0.5413497505505493
Temporomandibular joint ankylosis;Small radial epiphyses;0.9010389149188995;1.0986642;0.5315519349268552;0.4685430545469842;0.7973657807105512;0.10367313420834834;0.30129838383260066;-0.26581384578369605;-0.328822726163567
Temporomandibular joint ankylosis;Generalized keratosis follicularis;0.8788626566529274;1.1362046;0.5386541468295158;0.45650954527013243;0.9999574798349273;-0.12109482318199993;0.13624712049924015;-0.4613033330054115;-0.5434479345647949
Temporomandibular joint ankylosis;Hypoplasia of the calcaneus;0.7942219525575638;1.0123359;0.5659724943928681;0.4960732780124443;0.9012090531633711;-0.1069871006058073;0.11112684332863332;-0.33523655877050296;-0.4051357751509268
Temporomandibular joint ankylosis;2-hydroxyadipic aciduria;0.8226557374000549;1.0289055;0.5567506037088533;0.49079781547984513;0.9999090677057578;-0.1772533303057029;0.02899644319664696;-0.4431584639969045;-0.5091112522259127
Temporomandibular joint ankylosis;Potter facies;1.0386219024658203;1.024481;0.4877032082412094;0.4922066704514644;0.891127884050195;0.14749401841562526;0.1333531740705325;-0.40342467580898567;-0.3989212135987307
Temporomandibular joint ankylosis;Increased heart rate variability;0.7619011998176575;0.97241175;0.5765242062988881;0.5087827359973214;0.9999574798349273;-0.23805628001726986;-0.027545728087795984;-0.4234332735360392;-0.49117474383760595
Temporomandibular joint ankylosis;Aplastic zygomatic arch;0.6688791513442993;0.68884057;0.6074267808839826;0.6007173174070288;0.7555979181251512;-0.08671876678085189;-0.06675735005950789;-0.1481711372411686;-0.15488060071812237
Temporomandibular joint ankylosis;Testicular torsion;0.7172330021858215;0.89872116;0.5912523190466221;0.5322934279770499;0.9999574798349273;-0.2827244776491058;-0.10123632133044125;-0.4087051607883052;-0.4676640518578774
Temporomandibular joint ankylosis;Abolished vibration sense;0.846082329750061;0.9042074;0.5491890560011925;0.5305385628272106;0.9999556674707869;-0.15387333772072587;-0.09574825904259476;-0.4507666114695944;-0.46941710464357633
Temporomandibular joint ankylosis;Fractured metatarsal bone of digit 5;0.7998014986515045;1.0981301;0.5641587060439273;0.4687138674262493;0.7973657807105512;0.002435717940953319;0.30076432621541316;-0.23320707466662394;-0.3286519132843019
Temporomandibular joint ankylosis;Prolonged G2 phase of cell cycle;0.9117243438959122;1.0843631;0.5281356366392249;0.47311442012901495;0.9999536937290383;-0.08822934983312614;0.08440940918386453;-0.4718180570898134;-0.5268392736000234
Temporomandibular joint ankylosis;Single naris;1.0758359506726265;1.1136885;0.47583746916794023;0.4637334189418476;0.8950412366415926;0.18079471403103387;0.21864723229151284;-0.4192037674736524;-0.431307817699745
Temporomandibular joint ankylosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7967395782470703;1.17467;0.5651538039645689;0.44411416582656016;0.9999090677057578;-0.2031694894586875;0.1747609132970498;-0.4347552637411889;-0.5557949018791977
Temporomandibular joint ankylosis;Asymmetry of the thorax;0.6725666224956512;0.99449193;0.6061836987957687;0.5017532721792193;0.865385157817563;-0.19281853532191173;0.12910677695874317;-0.25920145902179426;-0.3636318856383437
Temporomandibular joint ankylosis;Type 2 muscle fiber predominance;0.899474523961544;1.0563315;0.5320523917629558;0.4820596262307143;0.9297297346545392;-0.030255210692995194;0.1266017806576556;-0.3976773428915834;-0.44767010842382493
Temporomandibular joint ankylosis;Dependency on parenteral nutrition;0.9382340461015701;1.0836583;0.5196732363111574;0.4733395807094215;0.9999556674707869;-0.06172162136921677;0.08370267012229171;-0.48028243115962954;-0.5266160867613654
Temporomandibular joint ankylosis;Limited shoulder flexion;0.6644050478935242;0.89057416;0.6089373373761451;0.5349012118325602;0.8100986279188489;-0.14569358002532473;0.08047552931915769;-0.20116129054270382;-0.27519741608628867
Temporomandibular joint ankylosis;Paroxysmal vertigo;0.7259848117828369;0.83235383;0.5883518578581224;0.5536166138398128;0.9999556674707869;-0.27397085568795;-0.1676018371332625;-0.4116038096126645;-0.44633905363097415
Temporomandibular joint ankylosis;Long hallux;0.7122428119182587;1.0513229;0.5929096093738759;0.48365622967232524;0.8862381141603949;-0.17399530224213622;0.16508482285132386;-0.29332850478651895;-0.40258188448806964
Temporomandibular joint ankylosis;Broad medial eyebrow;0.9000152796506882;1.0662761;0.5318793922669204;0.4788881885291466;0.9036229035260553;-0.003607623875367172;0.1626531699297552;-0.37174351125913496;-0.42473471499690874
Temporomandibular joint ankylosis;Myxoid subcutaneous tumors;0.9263775199651718;1.1154236;0.523455985500646;0.4631774645903374;0.9999574798349273;-0.07357995986975552;0.11546608030758976;-0.47650149433428135;-0.53678001524459
Temporomandibular joint ankylosis;Bulbous tips of toes;0.8725061118602753;1.1059948;0.5406933199259081;0.46619728875847544;0.9012090531633711;-0.028702941303095808;0.20478576743141652;-0.360515733237463;-0.43501176440489564
Temporomandibular joint ankylosis;Absent internal genitalia;0.8431545495986938;0.9485397;0.550132455768753;0.5163875686878521;0.9999090677057578;-0.15675451810706398;-0.05136939342368385;-0.4497766119370048;-0.48352149901790575
Temporomandibular joint ankylosis;Hyperphalangy of the 2nd finger;0.749653548002243;1.0332946;0.5805445242799098;0.48940004674230897;0.9052477392617277;-0.1555941912594847;0.1280468192633577;-0.324703214981818;-0.4158476925194188
Temporomandibular joint ankylosis;Renal interstitial hemosiderin;0.8346197754144669;1.1229908;0.5528851288513685;0.4607514315657917;0.9999090677057578;-0.16528929229129097;0.12308177892815331;-0.4470239388543893;-0.5391576361399661
Temporomandibular joint ankylosis;Abnormality of depressor anguli oris muscle;0.6597592234611511;0.597673;0.610508578622197;0.6317985076602212;0.7938909578598223;-0.1341317343986712;-0.19621795895464045;-0.18338237923762535;-0.16209245019960117
Temporomandibular joint ankylosis;Paroxysmal dyspnea;0.7329471707344055;0.9591094;0.5860498222548177;0.5130195135020528;0.9999090677057578;-0.2669618969713523;-0.040799642161019056;-0.4138592454509401;-0.48688955420370506
Temporomandibular joint ankylosis;Phenylpyruvic acidemia;0.8932562470436096;1.1019697;0.5340424497027445;0.46748553113994384;0.9999574798349273;-0.10670123279131771;0.10201223909817814;-0.46591503013218283;-0.5324719486949835
Temporomandibular joint ankylosis;Lateral ventricle dilatation;0.766978919506073;0.9106896;0.5748611161071235;0.5284663192047252;0.9999445600944175;-0.23296564058834446;-0.08925496773296726;-0.4250834439872939;-0.47147824088969226
Temporomandibular joint ankylosis;Neonatal unconjugated hyperbilirubinemia;0.8586929440498352;1.0256927;0.5451304833133626;0.4918208674336274;0.9999574798349273;-0.14126453578509213;0.025735221504794348;-0.4548269965215648;-0.5081366124012999
Temporomandibular joint ankylosis;High maternal circulating alpha-fetoprotein concentration;0.8078737854957581;1.1104249;0.5615382984379715;0.46477883510618856;0.9999090677057578;-0.19203528220999977;0.1105158085073159;-0.4383707692677863;-0.5351302325995693
Temporomandibular joint ankylosis;Prominent nasolabial fold;0.7566721886396408;0.76608324;0.5782390782820914;0.5751543274533959;0.8892738924086724;-0.13260170376903158;-0.12319065189963918;-0.31103481412658096;-0.3141195649552765
Temporomandibular joint ankylosis;Abnormality of inferior alveolar nerve;0.6160152852535248;0.6371406;0.6254484698157032;0.6181994859803306;0.9999090677057578;-0.38389378245223305;-0.3627684956346824;-0.3744605978900546;-0.38170958172542724
Temporomandibular joint ankylosis;Unilateral conductive hearing impairment;0.8156108260154724;0.8571363;0.5590306777882885;0.5456310542353056;0.9999574798349273;-0.18434665381945492;-0.14282117068804623;-0.4409268020466388;-0.4543264255996218
Temporomandibular joint ankylosis;Macular hypopigmented whorls, streaks, and patches;0.8663764446973801;1.1478113;0.542661301637575;0.45277716232149123;0.9999574798349273;-0.13358103513754727;0.14785381376706241;-0.45729617819735235;-0.5471803175134361
Temporomandibular joint ankylosis;Delayed ossification of pubic rami;0.6202253699302673;0.78713036;0.6239984634837819;0.5682809761039396;0.9012090531633711;-0.28098368323310374;-0.11407869732841014;-0.2772105896795892;-0.3329280770594315
Temporomandibular joint ankylosis;Hyperphenylalaninemia;0.8132969290018082;1.0091478;0.5597802298259094;0.49708813709365973;0.9999530203863651;-0.18665609138455697;0.009194742865893168;-0.4401727905604558;-0.5028648832927054
Temporomandibular joint ankylosis;Ureteropelvic junction obstruction;0.7112678587436676;1.0217692;0.5932337021620087;0.4930701088701054;0.9999491674684583;-0.2886813087247907;0.021819998524278517;-0.40671546530644964;-0.5068790585983529
Temporomandibular joint ankylosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8308203369379044;1.1200628;0.5541118131645068;0.46169038962295894;0.7973657807105512;0.03345455622735316;0.32269704735341365;-0.24325396754604445;-0.33567539108759226
Temporomandibular joint ankylosis;Difficulty walking;0.8699566274881363;1.0460275;0.5415116591901044;0.4853438100545018;0.9132464539952869;-0.04328982650715063;0.13278108716529657;-0.37173479480518257;-0.42790264394078514
Temporomandibular joint ankylosis;Bilobate gallbladder;0.8305289894342422;0.9617894;0.5542059107041848;0.5121657629178802;0.9999556674707869;-0.16942667803654465;-0.038166238283012244;-0.4457497567666021;-0.4877899045529067
Temporomandibular joint ankylosis;Histidinuria;0.8356582522392273;1.0136636;0.5525499855666268;0.4956506047449457;0.9999545338528789;-0.16429628161365162;0.013709115706142083;-0.4474045482862521;-0.5043039291079332
Temporomandibular joint ankylosis;Widened interpedicular distance;0.6776641309261322;0.7688575;0.6044680406282721;0.5742463572155503;0.7356548868117849;-0.05799075588565272;0.03320259228367406;-0.13118684618351284;-0.16140852959623464
Dyslexia;Stippling of the epiphysis of the proximal phalanx of the 4th toe;0.8874050304293633;0.9938778;0.5359162551471452;0.5019487659367423;0.9998944404568447;-0.11248941002748147;-0.0060166123356594214;-0.4639781853096995;-0.4979456745201024
Dyslexia;Ankle joint effusion;0.9588909409940243;1.1965978;0.5130891083268614;0.4370106889139973;0.9998944404568447;-0.04100349946282045;0.1967033741030918;-0.48680533212998334;-0.5628837515428474
Dyslexia;Reduced C-peptide level;0.8337018191814423;0.96033674;0.5531814262947382;0.5126285105655656;0.9999501780647019;-0.16624835888325962;-0.03961343327939304;-0.44676875176996367;-0.4873216674991363
Dyslexia;Loss of voice;0.78037029504776;0.8275162;0.5704849151283995;0.5551792351217857;0.9999501780647019;-0.21957988301694187;-0.17243397990643772;-0.4294652629363024;-0.4447709429429162
Dyslexia;Elevated circulating growth hormone concentration;0.8889089971780777;1.0352712;0.5354345050625688;0.4887705011281611;0.9179484122564726;-0.029039415078394915;0.11732275549865434;-0.38251390719390377;-0.4291779111283115
Dyslexia;Visual acuity no light perception;0.7267404794692993;0.8921884;0.5881017764835312;0.5343843432453481;0.9998944404568447;-0.2731539609875454;-0.107706070229031;-0.4117926639733135;-0.4655100972114966
Dyslexia;Spinal hypomyelination;0.5322359204292297;0.72691053;0.6549403095459784;0.5880455069960728;0.8344817810370084;-0.3022458606077787;-0.10757124951616492;-0.17954147149103006;-0.2464362740409356
Dyslexia;Bladder polyp;0.8718272745609283;0.96955174;0.5409111880161255;0.5096934719947497;0.9999545338528789;-0.12812725929195057;-0.030402791776005134;-0.45904334583675344;-0.49026106185812923
Dyslexia;Aberrant melanosome maturation;0.6819837093353271;0.87073785;0.6030166716250573;0.5412608713374534;0.9999545338528789;-0.31797082451755176;-0.12921668318683277;-0.39693786222782157;-0.45869366251542554
Dyslexia;Vertebral artery tortuosity;0.7036600112915039;0.9742269;0.5957661464647319;0.5082047394329069;0.9999545338528789;-0.296294522561375;-0.025727641858402595;-0.404188387388147;-0.491749794419972
Dyslexia;Warm reactive autoantibody positivity;1.0476245358586311;1.1784306;0.4848349030726936;0.4428980185108018;0.9998944404568447;0.04773009540178641;0.17853611679413184;-0.5150595373841511;-0.5569964219460429
Dyslexia;Right aortic arch with retroesophageal left subclavian artery;0.8671762347221375;0.95023954;0.5424044308116024;0.5158457976507422;0.9998944404568447;-0.13271820573470727;-0.049654901310421384;-0.45749000964524233;-0.4840486428061025
Dyslexia;Elevated urine suberic acid level;0.881329633295536;0.9777024;0.5378631771199334;0.5070981508823946;0.9999545338528789;-0.11862490055734287;-0.022252154626194343;-0.46209135673294555;-0.4928563829704843
Dyslexia;Burkitt lymphoma;0.844635397195816;1.0678629;0.5496552368073081;0.4783819703682439;0.9999511492611326;-0.15531575206531656;0.0679117190478884;-0.4502959124538245;-0.5215691788928887
Dyslexia;Snail-like ilia;0.8676174432039261;0.998944;0.5422627385339268;0.5003361390475812;0.9999545338528789;-0.13233709064895283;-0.0010105493443645086;-0.4576917953189521;-0.4996183948052977
Dyslexia;Indurated nodule;0.8840464949607849;1.0875635;0.5369923600205802;0.47209191432834907;0.9998944404568447;-0.11584794549605981;0.08766907425262793;-0.4629020804362646;-0.5278025261284957
Dyslexia;Absent leukocyte alkaline phosphatase;0.8899790495634079;1.0422137;0.5350917959510362;0.4865589879113844;0.9999545338528789;-0.10997548428947101;0.04225914450710644;-0.46486273790184274;-0.5133955459414945
Dyslexia;Hippocampal sclerosis;0.7003657519817352;0.7907637;0.5968646474629681;0.5670977924145504;0.8344817810370084;-0.1341160290552732;-0.043718104870474006;-0.23761713357404035;-0.26738398862245805
Dyslexia;Decreased sensitivity to hypoxemia;0.6998435258865356;0.88571763;0.5970388975601929;0.5364568513909862;0.9999545338528789;-0.30011100796634327;-0.11423690346652637;-0.402915636292686;-0.4634976824618927
Dyslexia;Decreased level of tissue plasminogen activator;0.891184888780117;0.98742235;0.5347056468751042;0.5040036968400996;0.9998944404568447;-0.10870955167672769;-0.012472093388058103;-0.4651887935817405;-0.4958907436167451
Dyslexia;Submandibular lymph node enlargement;0.8918425440788269;1.1032555;0.5344950658271573;0.4670740504938653;0.9999545338528789;-0.10811198977405201;0.10330097647732128;-0.4654594680257216;-0.5328804833590136
Dyslexia;Hepatic hemangioma;0.8726383447647095;1.0535175;0.540650882932496;0.48295670423759096;0.9999524555142131;-0.1273141107495036;0.053565005308846;-0.4593015725817171;-0.5169957512766221
Dyslexia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.6955755352973938;0.8629977;0.598464120466788;0.5437467649765716;0.9998944404568447;-0.3043189051594509;-0.13689672975204126;-0.40143031999005674;-0.45614767548027313
Dyslexia;Acne inversa;0.863150104880333;1.0052474;0.5436977999586292;0.4983296897315379;0.9999476714516888;-0.1367975665713559;0.005299683055757454;-0.4562498714930596;-0.5016179817201509
Dyslexia;Dentin dysplasia;0.6171748042106628;0.9113165;0.6250488441751819;0.5282659712112516;0.9998944404568447;-0.3827196362461819;-0.08857792644164697;-0.3748455962816628;-0.4716284692455931
Dyslexia;Aplasia of the inner ear;0.7300989925861359;0.9729235;0.5869909794591641;0.5086197721361119;0.9999545338528789;-0.26985554126674305;-0.02703101662570606;-0.4129635543937148;-0.49133476171676704
Dyslexia;Polycystic liver disease;0.7620488703250885;1.0012207;0.5764758103708216;0.49961142735853803;0.9999501780647019;-0.23790130773961338;0.0012705250602981222;-0.42347436769388025;-0.5003387507061638
Dyslexia;Subungual hyperkeratosis;0.9165362417697906;0.9802311;0.5265982820418303;0.5062930495886651;0.9999487417813083;-0.08341250001151768;-0.019717635500027808;-0.473350459739478;-0.49365569219264327
Dyslexia;Broad humeral epiphyses;0.8858920633792877;0.9289991;0.5364009715843807;0.5226193165652956;0.9998944404568447;-0.114002377077557;-0.07089531449935571;-0.463493468872464;-0.47727512389154914
Dyslexia;Autoimmune thrombocytopenia;0.8334076255559921;1.0223373;0.5532763957932194;0.4928892350276365;0.9999422754987515;-0.16653464994275935;0.022395041967984364;-0.44666587970553207;-0.507053040471115
Dyslexia;Adenomyosis;0.8575067073106766;1.0606682;0.5455119341299242;0.48067683544030815;0.9999545338528789;-0.14244782654220234;0.06071369620388378;-0.45444259972295475;-0.5192776984125708
Dyslexia;Elevated leukocyte alkaline phosphatase;0.9640502892434597;1.0750299;0.5114456145930848;0.4760947802389657;0.9999545338528789;-0.03590424460941921;0.0750753161532246;-0.4885089192597941;-0.5238597536139132
Dyslexia;Clasp-knife sign;0.9516885615885258;0.91934466;0.5153839967864753;0.52570131770924;0.801972397045473;0.1497161645430528;0.11737226657452215;-0.2865884002589977;-0.27627107933623296
Dyslexia;Keratosis pilaris;0.8570206314325333;0.8979135;0.5456682575235158;0.5325518529051154;0.9999419656013786;-0.14292133416884534;-0.10202845003359906;-0.4542737080778628;-0.4673901126962632
Dyslexia;Lamina lucida cleavage;0.8537111282348633;0.99169105;0.546732900130761;0.5026448424303451;0.9999476714516888;-0.14623654321682555;-0.008256618538023064;-0.4532147713209278;-0.4973028290213437
Dyslexia;Abnormal central response of multifocal electroretinogram;0.7473466694355011;0.9443378;0.5813032130275713;0.5177269963519994;0.9998944404568447;-0.2525477710213436;-0.05555665521285669;-0.41859122742927346;-0.48216744410484536
Dyslexia;Atypical or prolonged hepatitis;0.823413297533989;1.0911801;0.5565055979100932;0.47093610995449686;0.9999545338528789;-0.17654123631888996;0.09122555228298534;-0.44344893594278567;-0.529018423898382
Dyslexia;Cubitus varus;0.8757427036762238;0.95671386;0.5396548200828113;0.513782722488655;0.9998944404568447;-0.12415173678062097;-0.04318058519027368;-0.46023962037403343;-0.48611171796818975
Dyslexia;Nasal regurgitation;0.9000396430492401;1.0069313;0.5318715981091025;0.49779368893609355;0.9999524555142131;-0.09991281246497297;0.006978849417427546;-0.46808085740511063;-0.5021587665781195
Dyslexia;Moon facies;0.9640628695487976;1.0099328;0.5114416075682913;0.49683825848216423;0.9999524555142131;-0.03588958596541547;0.009980300909737116;-0.4885108479459218;-0.5031141970320488
Dyslexia;Intestinal pseudo-obstruction;0.7558093518018723;0.9869616;0.578522270047538;0.504150359910676;0.9999464332748575;-0.2441370814729853;-0.012984830110184697;-0.42142416322731957;-0.4957960733641815
Dyslexia;Bilateral renal atrophy;0.747389942407608;0.8673624;0.5812889770329305;0.5423446499880613;0.9999545338528789;-0.2525645914452709;-0.13259215382510792;-0.41866555681994844;-0.4576098838648176
Dyslexia;Fractured left clavicle;0.8874198645353317;1.0511822;0.5359115030900724;0.4837010987152539;0.9998944404568447;-0.112474575921513;0.05128771038391455;-0.4639829373667723;-0.5161933417415908
Dyslexia;Positive urine norcotinine test;0.9175736531615257;1.0261492;0.5262669218979821;0.4916755063158841;0.9998944404568447;-0.082320787295319;0.026254713252566897;-0.47362751855886265;-0.5082189341409606
Dyslexia;Long fibula;0.9800697825849056;1.1670461;0.5063444052982722;0.4465771311964766;0.9999501780647019;-0.019880395479796253;0.16709589203417508;-0.4936057727664297;-0.5533730468682253
Dyslexia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7559113204479218;1.0036432;0.5784887996065661;0.4988403638265624;0.9998944404568447;-0.24398312000892297;0.0037487146411167016;-0.42140564085027865;-0.5010540766302823
Dyslexia;Type II cryptotia;0.7319435775279999;0.8997103;0.5863813629942627;0.5319769519579507;0.9998944404568447;-0.26795086292884485;-0.10018414287231103;-0.41351307746258203;-0.46791748849889403
Dyslexia;Increased variability in muscle fiber diameter;0.829315111041069;1.0245535;0.5545980129132004;0.49218359977015946;0.9999372395362296;-0.17062212849516056;0.02461629783254482;-0.44533922662302916;-0.5077536397660701
Dyslexia;Widened proximal tibial metaphyses;0.9923411794006824;1.075683;0.5024379021472212;0.4758863102028469;0.9999545338528789;-0.0076133544521964636;0.07572846385067333;-0.49751663170565774;-0.524068223650032
Dyslexia;Wide anterior fontanel;0.9752264097332954;0.9336221;0.5078864855349592;0.5211442884401608;0.9999377423921926;-0.024711332658897134;-0.06631562058127949;-0.4920512568572334;-0.47879345395203177
Dyslexia;Increased circulating oleate level;0.9626765996217728;1.1302359;0.5118831673631872;0.4584265092831715;0.9998944404568447;-0.03721784083507196;0.1303414699588047;-0.48801127309365755;-0.5414679311736732
Dyslexia;Lozenge-shaped umbilicus;0.888294905424118;0.9338723;0.5356312008024604;0.5210644821012581;0.9999524555142131;-0.11165755009009504;-0.06608017300917768;-0.4643212547117527;-0.47888797341295497
Dyslexia;Anti-myelin-associated glycoprotein antibody positivity;0.8713700622320175;0.95082694;0.5410579379756445;0.5156585813515612;0.9998944404568447;-0.1285243782248272;-0.04906749753615991;-0.4588365024812002;-0.48423585910528355
Dyslexia;Fractured radius;0.7972999811172485;0.9339027;0.564971629839721;0.5210547800303004;0.9999545338528789;-0.20265455273563038;-0.06605185297900806;-0.43498290401315787;-0.47889975382257854
Dyslexia;Abnormal manual kinetic perimetry test;0.6296306848526001;0.79086626;0.6207688650159904;0.5670644015794797;0.9998944404568447;-0.3702637556042446;-0.20902818469665185;-0.37912557544085435;-0.43283003887736504
Dyslexia;Small radial epiphyses;0.7482256591320038;0.8091029;0.5810140744981371;0.5611396928090715;0.9998944404568447;-0.25166878132484094;-0.19079154758117334;-0.4188803659587076;-0.4387547476477732
Dyslexia;Generalized keratosis follicularis;0.8568401634693146;1.0120347;0.5457262993582961;0.49616916450506177;0.9999545338528789;-0.14311437038356434;0.012080120764430657;-0.4542282344945828;-0.5037853693478171
Dyslexia;Hypoplasia of the calcaneus;0.8542119264602661;1.0679876;0.5465717635431837;0.4783421827440145;0.9999524555142131;-0.14574052905394697;0.06803510571167803;-0.45338069197102937;-0.5216102727701986
Dyslexia;2-hydroxyadipic aciduria;0.6404396295547485;0.82360053;0.6170733296029196;0.5564450396289117;0.9998944404568447;-0.3594548109020962;-0.17629390983245508;-0.3828211108539251;-0.44344940082793305
Dyslexia;Potter facies;0.9531681016087532;0.93952787;0.5149125107240263;0.5192606210856293;0.9999481737645268;-0.04678007215577362;-0.06042030453997849;-0.4850356630405005;-0.4806875526788975
Dyslexia;Increased heart rate variability;0.9835382588207722;1.109243;0.5052401716507329;0.4651573094459267;0.9999545338528789;-0.016416275032106742;0.10928850146358837;-0.49471436220214604;-0.5347972244069522
Dyslexia;Aplastic zygomatic arch;0.7988865971565247;0.92788017;0.5644559741529491;0.522976407461188;0.9999524555142131;-0.20106585835768842;-0.07207228755309247;-0.43549648136126395;-0.47697604805302507
Dyslexia;Testicular torsion;0.8182231485843658;1.0733575;0.558184852826036;0.47662859129212043;0.9999545338528789;-0.18173138526851307;0.07340292903011669;-0.4417696810268429;-0.5233259425607585
Dyslexia;Abolished vibration sense;0.824906200170517;0.99049795;0.5560228706812603;0.5030246519023402;0.9108074905152194;-0.0859012903447024;0.07969045622397741;-0.35478461983395904;-0.4077828386128791
Dyslexia;Fractured metatarsal bone of digit 5;0.8299042880535126;1.0078918;0.5544076888675541;0.49748792876827663;0.9998944404568447;-0.16999015240333215;0.007997333720706545;-0.44548675158929063;-0.5024065116885681
Dyslexia;Prolonged G2 phase of cell cycle;0.9004242569208145;1.0232431;0.531748557828423;0.49260082711259345;0.9999501780647019;-0.09952592114388736;0.023292891584040798;-0.46820162023627887;-0.5073493509521084
Dyslexia;Single naris;0.9541384503245354;0.88085544;0.5146033068561353;0.5380151909301996;0.9999501780647019;-0.04581172774016651;-0.11909473697125705;-0.48534687120856657;-0.4619349871345023
Dyslexia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8301228731870651;1.0219631;0.5543370834964436;0.49300834492369794;0.9998944404568447;-0.1697715672697796;0.022068679049991213;-0.4455573569604011;-0.5068860955331468
Dyslexia;Asymmetry of the thorax;0.8262154161930084;0.9143346;0.5555996453316114;0.5273016145074872;0.9999501780647019;-0.17373476187169345;-0.08561558286130222;-0.44435053273309044;-0.47264856355721463
Dyslexia;Type 2 muscle fiber predominance;0.8619637936353683;1.0190796;0.5440790326031919;0.49392643477543563;0.9999487417813083;-0.13798494814593998;0.019130824220583764;-0.4558697091781164;-0.5060223070058727
Dyslexia;Dependency on parenteral nutrition;0.8548096567392349;0.8728577;0.54637945387715;0.5405804957457858;0.9999524555142131;-0.14514279877497815;-0.12709476565673017;-0.45357300163706304;-0.45937195976842726
Dyslexia;Limited shoulder flexion;0.8004176616668701;0.96191806;0.5639585354702641;0.5121247922801242;0.9998944404568447;-0.1994767787899746;-0.03797638444564477;-0.43593590498658064;-0.4877696481767205
Dyslexia;Paroxysmal vertigo;0.7194300889968872;0.98129493;0.5905234539614661;0.5059543589261624;0.9999524555142131;-0.28052236651732587;-0.01865752553298139;-0.409429001552747;-0.4939980965880507
Dyslexia;Long hallux;0.9271850660443306;1.076646;0.5231982437905801;0.4755788816236628;0.9999446427564167;-0.0727595767120861;0.07670132758812676;-0.4767463989658366;-0.5243657611327539
Dyslexia;Broad medial eyebrow;1.002585094422102;1.0497525;0.49917713797223273;0.484156772782969;0.9999545338528789;0.0026305605692230616;0.049797939978297845;-0.5007773958806462;-0.5157977610699099
Dyslexia;Myxoid subcutaneous tumors;0.8917795047163963;1.0828253;0.5345152503556323;0.4736056554253807;0.9999545338528789;-0.10817502913648258;0.08287076922481884;-0.4654392834972466;-0.5263488784274982
Dyslexia;Bulbous tips of toes;0.8932996392250061;1.0136026;0.5340285582065998;0.495670021006378;0.9999524555142131;-0.10665281628920698;0.013650158888557917;-0.4659238973076133;-0.504282434507835
Dyslexia;Absent internal genitalia;0.8344383239746094;1.0218816;0.5529436939785487;0.4930343278241015;0.9998944404568447;-0.16545611648223535;0.02198713989593848;-0.446950746478296;-0.5068601126327432
Dyslexia;Hyperphalangy of the 2nd finger;0.7329521775245667;0.86381626;0.5860481684833039;0.5434837518114737;0.9999545338528789;-0.26700235632831226;-0.136138272561375;-0.41390636536957504;-0.45647078204140523
Dyslexia;Renal interstitial hemosiderin;0.8863369524478912;1.0159764;0.5362584316125631;0.49491433130739537;0.9998944404568447;-0.11355748800895349;0.01608198852875098;-0.4636360088442816;-0.5049801091494494
Dyslexia;Abnormality of depressor anguli oris muscle;0.6872150003910065;0.9232279;0.6012619328409912;0.5244613762145092;0.9998944404568447;-0.31267944006583825;-0.07666653422973291;-0.39863250761585356;-0.47543306424233556
Dyslexia;Paroxysmal dyspnea;0.6644921004772186;0.89304376;0.6089079222443685;0.5341104674532086;0.9998944404568447;-0.3354023399796261;-0.10685068397185937;-0.3909865182124762;-0.46578397300363616
Dyslexia;Phenylpyruvic acidemia;0.7961333394050598;0.82629937;0.5653509026898136;0.5555725046940228;0.9999545338528789;-0.2038211944478191;-0.17365516451770435;-0.43460363116306533;-0.44438202915885616
Dyslexia;Lateral ventricle dilatation;0.7307525277137756;0.85238194;0.5867749554697941;0.547160640990386;0.9050479411786477;-0.1742954134648721;-0.05266599652227566;-0.31827298570885365;-0.35788730018826176
Dyslexia;Neonatal unconjugated hyperbilirubinemia;0.7930139899253845;0.86022323;0.5663654608505275;0.5446384890188145;0.9999545338528789;-0.2069405439274944;-0.13973130015308033;-0.4335890730023514;-0.4553160448340644
Dyslexia;High maternal circulating alpha-fetoprotein concentration;1.0129658244550228;1.0923456;0.49587273424703526;0.4705635330227269;0.9998944404568447;0.013071383998178088;0.09245115490295752;-0.5040217062098095;-0.5293309074341178
Dyslexia;Prominent nasolabial fold;0.9149434864521027;0.97848743;0.5271070812569777;0.5068481937251365;0.9999472202284223;-0.08500373377631965;-0.021459788225401066;-0.4728401389714446;-0.49309902650328585
Dyslexia;Abnormality of inferior alveolar nerve;0.8070889711380005;1.0308021;0.5617928748945447;0.4901938351276205;0.8344817810370084;-0.02739280989900794;0.19632034966214928;-0.27268890614246377;-0.34428794590938794
Dyslexia;Unilateral conductive hearing impairment;0.669156402349472;0.98144484;0.6073332579113593;0.5059066359617581;0.9999545338528789;-0.33079813150340687;-0.018509698190037116;-0.39262127594151963;-0.4940478978911208
Dyslexia;Macular hypopigmented whorls, streaks, and patches;0.7160088419914246;0.9909534;0.5916586371745727;0.5028796737149637;0.9999545338528789;-0.28394569186145435;-0.009001148022953376;-0.40829589667830624;-0.49707486013791524
Dyslexia;Delayed ossification of pubic rami;0.837359607219696;1.0524105;0.5520010412356948;0.4833095851374103;0.9999524555142131;-0.16259284829451703;0.05245802784607745;-0.44795141427851826;-0.5166428703768028
Dyslexia;Hyperphenylalaninemia;0.8322045207023621;0.80895394;0.5536648234850097;0.5611879850100204;0.9999493977362748;-0.16774487703391272;-0.1909954568678971;-0.4462845742512651;-0.43876141272625435
Dyslexia;Ureteropelvic junction obstruction;0.8576558530330658;0.9826384;0.5454639706563091;0.5055266442014967;0.9999448992541466;-0.14228904622108085;-0.017306480579677652;-0.4544809285978375;-0.4944182550526499
Dyslexia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7704483866691589;0.96676004;0.5737259710858609;0.5105825479856831;0.9998944404568447;-0.2294460537876858;-0.033134401127315916;-0.42616846937098385;-0.4893118924711616
Dyslexia;Difficulty walking;0.7628924697637558;0.81928253;0.5761993727770849;0.557841961566702;0.8790687609298627;-0.11617629116610695;-0.0597862291915815;-0.30286938815277786;-0.3212267993631608
Dyslexia;Bilobate gallbladder;0.8223916888237;0.99145466;0.5568360087803323;0.5027200960596832;0.9999524555142131;-0.17756076669051313;-0.008497794621726507;-0.44311644673388073;-0.4972323594545299
Dyslexia;Histidinuria;0.7499960660934448;0.86108845;0.5804319165238356;0.5443603720420046;0.9999511492611326;-0.24995508316768777;-0.13886269453777444;-0.41951923273729697;-0.455590777219128
Dyslexia;Widened interpedicular distance;0.9144348278641701;0.99114186;0.5272695847411792;0.502819676517874;0.9998944404568447;-0.08545961259267465;-0.008752584740139402;-0.4726248557156655;-0.49707476393897077
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Ankle joint effusion;0.688007652759552;0.75266874;0.6009963315644974;0.5795535987348439;1.0;-0.311992347240448;-0.24733126163482666;-0.3990036684355026;-0.4204464012651561
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Reduced C-peptide level;0.7943700551986694;0.939731;0.5659243216480925;0.5191958568774344;0.9999056439461368;-0.20553558874746736;-0.06017464209219392;-0.4339813222980443;-0.4807097870687024
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Loss of voice;0.9807771760970354;1.1779743;0.50611919178567;0.4430455932844195;0.9999056439461368;-0.019128467849101383;0.17806869935372893;-0.4937864521604668;-0.5568600506617173
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated circulating growth hormone concentration;0.7088512778282166;0.9708571;0.5940374492196958;0.5092777907555989;0.9998962300503706;-0.2910449522221541;-0.029039146252915815;-0.40585878083067484;-0.4906184392947718
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Visual acuity no light perception;0.8712832033634186;1.014182;0.5410858177761897;0.49548558157543054;1.0;-0.12871679663658142;0.014181971549987793;-0.4589141822238103;-0.5045144184245695
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Spinal hypomyelination;0.8428554832935333;0.95364183;0.5502288468377793;0.5147615549224109;1.0;-0.15714451670646667;-0.04635816812515259;-0.4497711531622207;-0.48523844507758906
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bladder polyp;0.8798359781503677;1.1079777;0.5383420490953599;0.4655624692153141;0.9999201345566091;-0.12008415640624137;0.10805761336056618;-0.46157808546124923;-0.534357665341295
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aberrant melanosome maturation;0.8090891540050507;0.91460717;0.5611441382993271;0.527214525895838;0.9999201345566091;-0.19083098055155845;-0.08531296731265159;-0.43877599625728203;-0.47270560866077116
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Vertebral artery tortuosity;0.8081712573766708;1.120129;0.5614418155508041;0.4616691835041157;0.9999201345566091;-0.19174887717993827;0.12020885466305642;-0.43847831900580503;-0.5382509510524934
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Warm reactive autoantibody positivity;0.9143851101398468;1.0944202;0.5272854686713792;0.4699002953622533;1.0;-0.0856148898601532;0.09442019462585449;-0.47271453132862085;-0.5300997046377467
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Right aortic arch with retroesophageal left subclavian artery;0.816945418715477;1.1262374;0.5585985074126791;0.4597098787629035;1.0;-0.183054581284523;0.1262373924255371;-0.44140149258732087;-0.5402901212370965
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated urine suberic acid level;0.7898409515619278;1.025033;0.5673981836072391;0.49203091826506784;0.9999201345566091;-0.2100791829946813;0.025112862574738548;-0.43252195094936996;-0.5078892162915413
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Burkitt lymphoma;0.9793610088527203;1.0777022;0.5065700614186179;0.47524166934163437;0.9999090677057578;-0.020548058853037565;0.07779309694420555;-0.4933390062871399;-0.5246673983641235
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Snail-like ilia;0.9126674979925156;1.0111729;0.5278342573565147;0.4964434708091664;0.683723727808895;0.22894377018362055;0.32744916285425196;-0.15588947045238033;-0.1872802569997286
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Indurated nodule;0.8289215266704559;1.0013485;0.5547251649184237;0.4995707444177985;1.0;-0.17107847332954407;0.0013484954833984375;-0.4452748350815763;-0.5004292555822015
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Absent leukocyte alkaline phosphatase;0.7211332023143768;0.7228196;0.5899587961114758;0.5893999579744849;0.9999201345566091;-0.2787869322422323;-0.27710050822527976;-0.40996133844513327;-0.41052017658212425
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hippocampal sclerosis;0.7695569396018982;0.89443004;0.5740175442208542;0.5336666961254146;1.0;-0.2304430603981018;-0.10556995868682861;-0.42598245577914584;-0.4663333038745854
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Decreased sensitivity to hypoxemia;0.8297074735164642;0.88310087;0.5544712644124745;0.5372954284861831;0.9999201345566091;-0.17021266104014487;-0.11681926728518577;-0.4454488701441346;-0.46262470607042605
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Decreased level of tissue plasminogen activator;0.7887990921735764;0.9325016;0.5677374321732231;0.5215017446420078;1.0;-0.21120090782642365;-0.06749838590621948;-0.43226256782677686;-0.4784982553579922
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Submandibular lymph node enlargement;0.8771638870239258;1.1608411;0.539198950808128;0.4485793211668445;0.9999201345566091;-0.12275624753268333;0.16092097281186013;-0.46072118374848114;-0.5513408133897646
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hepatic hemangioma;0.885783962905407;1.0782194;0.536435607478262;0.4750765140577198;0.9999134918687169;-0.11412952896330997;0.0783059218886073;-0.4634778843904549;-0.5248369778109971
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Triangular epiphysis of the distal phalanx of the 2nd finger;0.35472720861434937;0.1754986;0.7232562861740223;0.8085442942741632;1.0;-0.6452727913856506;-0.8245013952255249;-0.27674371382597773;-0.1914557057258368
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Acne inversa;0.9583855345845222;1.0279869;0.5132501219749304;0.49109032050283463;0.9998962300503706;-0.0415106954658484;0.028090654066755816;-0.4866461080754403;-0.508805909547536
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Dentin dysplasia;0.7582912743091583;0.8161235;0.5777078483430418;0.558864644759455;1.0;-0.24170872569084167;-0.18387651443481445;-0.4222921516569582;-0.44113535524054504
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aplasia of the inner ear;0.704373687505722;0.92699826;0.5955283200117863;0.523257870183713;0.9999201345566091;-0.29554644705088706;-0.07292187691958518;-0.40439181454482276;-0.47666226437289616
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Polycystic liver disease;0.8443876504898071;1.1299698;0.5497350679632961;0.4585119392277943;0.9999056439461368;-0.15551799345632966;0.13006419133523528;-0.4501705759828407;-0.5413937047183425
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Subungual hyperkeratosis;0.6039634346961975;0.5869963;0.6296146537633606;0.6355203321686946;0.9999003561294039;-0.39593692143320636;-0.4129040392196138;-0.3702857023660433;-0.36438002396070923
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Broad humeral epiphyses;0.5560259819030762;0.7052904;0.6464317522708298;0.5952229217188022;1.0;-0.44397401809692383;-0.29470962285995483;-0.35356824772917017;-0.4047770782811978
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Autoimmune thrombocytopenia;0.758126899600029;0.9280395;0.5777617703929411;0.5229255516832021;0.9998726169824932;-0.2417457173824642;-0.07183312580588797;-0.4221108465895521;-0.4769470652992911
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Adenomyosis;0.9240057170391083;1.0584978;0.5242130754221108;0.4813689530890263;0.9999201345566091;-0.07591441751750083;0.05857765196530251;-0.4757070591344983;-0.5185511814675828
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Elevated leukocyte alkaline phosphatase;0.6523805558681488;0.73103136;0.6130098812829409;0.5866828013908412;0.9999201345566091;-0.3475395786884603;-0.2688887763145742;-0.38691025327366824;-0.41323733316576794
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Clasp-knife sign;0.8216229975223541;1.0045013;0.5570846613580176;0.49856718452059157;1.0;-0.17837700247764587;0.0045013427734375;-0.4429153386419824;-0.5014328154794084
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Keratosis pilaris;0.6230336725711823;0.80191344;0.6230327562407751;0.5634727139616987;0.9998710980331391;-0.37683742546195687;-0.19795765780563057;-0.376838341792364;-0.4363983840714404
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lamina lucida cleavage;0.9397065490484238;1.0517707;0.5192036486881237;0.4835135107280767;0.9998962300503706;-0.06018968100194688;0.051874457052900835;-0.4806925813622469;-0.516382719322294
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormal central response of multifocal electroretinogram;0.8631324172019958;1.0983;0.5437034836013221;0.4686595323970705;1.0;-0.13686758279800415;0.09829998016357422;-0.45629651639867785;-0.5313404676029295
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Atypical or prolonged hepatitis;0.9190884679555893;1.1215869;0.5257831252092717;0.46120168318655974;0.9999201345566091;-0.08083166660101981;0.12166678427426247;-0.4741370093473374;-0.5387184513700494
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Cubitus varus;0.8480938971042633;1.0143639;0.548541134437226;0.4954276708503883;1.0;-0.1519061028957367;0.014363884925842285;-0.45145886556277404;-0.5045723291496117
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Nasal regurgitation;0.9281138852238655;1.1350836;0.5229018145905264;0.4568697278979733;0.9999134918687169;-0.07179960664485141;0.13517006430651501;-0.4770116772781905;-0.5430437639707436
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Moon facies;0.9320661574602127;1.0753329;0.5216406808192597;0.47599805140610363;0.9999134918687169;-0.06784733440850421;0.07541938815142468;-0.4782728110494572;-0.5239154404626133
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Intestinal pseudo-obstruction;0.8168293684720993;1.0383639;0.5586360826770811;0.4877853998089222;0.9998912449978579;-0.18306187652575856;0.03847268856537456;-0.4412551623207768;-0.5121058451889356
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bilateral renal atrophy;0.7835170328617096;0.91596544;0.569458579317524;0.5267806056027902;0.9999201345566091;-0.2164031016948995;-0.08395469666750999;-0.43046155523908514;-0.47313952895381894
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured left clavicle;0.6101654767990112;0.8420801;0.627467796362546;0.5504787840735244;1.0;-0.38983452320098877;-0.15791988372802734;-0.372532203637454;-0.44952121592647565
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Positive urine norcotinine test;0.852112352848053;1.0495201;0.5472474022496847;0.4842307948945508;1.0;-0.14788764715194702;0.049520134925842285;-0.4527525977503153;-0.5157692051054492
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Long fibula;0.6970045566558838;0.57858837;0.5979866974900414;0.638465232963878;0.6109530888848884;0.08605146777099537;-0.03236472237640453;-0.01296639139484701;0.02751214407898961
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.3431333303451538;0.09127045;0.7281185707795121;0.862946507761613;1.0;-0.6568666696548462;-0.9087295532226562;-0.27188142922048786;-0.13705349223838703
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Type II cryptotia;0.9158508405089378;1.0038171;0.526817222264147;0.4987849757652133;1.0;-0.08414915949106216;0.0038170814514160156;-0.47318277773585304;-0.5012150242347867
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased variability in muscle fiber diameter;0.8131253570318222;0.9431789;0.559835821285301;0.5180964611858304;0.7712186293488323;0.041906727682989864;0.17196026278678778;-0.21138280806353138;-0.2531221681630019
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Widened proximal tibial metaphyses;0.4235873818397522;0.35803425;0.695547882475934;0.7218808719779402;0.4693866352828394;-0.04579925344308722;-0.11135238216241705;0.2261612471930946;0.25249423669510074
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Wide anterior fontanel;0.8865903913974762;1.134866;0.5361772344557805;0.4569395892670539;0.6617971500655027;0.22479324133197354;0.4730688491562991;-0.1256199156097222;-0.20485756079844875
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased circulating oleate level;0.812137633562088;0.9543414;0.5601558919953584;0.5145386369057121;1.0;-0.187862366437912;-0.04565858840942383;-0.4398441080046416;-0.4854613630942879
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lozenge-shaped umbilicus;0.8932798579335213;0.99863887;0.5340348909461707;0.5004332626894821;0.9999134918687169;-0.10663363393519565;-0.0012746235368077397;-0.4658786009225462;-0.49948022917923485
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Anti-myelin-associated glycoprotein antibody positivity;0.8812064677476883;1.012074;0.537902661228487;0.49615663209465466;1.0;-0.1187935322523117;0.012073993682861328;-0.46209733877151304;-0.5038433679053453
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured radius;0.5606663823127747;0.5243594;0.6447853947530318;0.6577837072101507;0.4693866352828394;0.09127974702993524;0.05497276975790155;0.17539875947019234;0.18839707192731125
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormal manual kinetic perimetry test;0.7519752383232117;0.9624196;0.5797814360371651;0.5119650186745646;1.0;-0.24802476167678833;-0.03758037090301514;-0.42021856396283486;-0.48803498132543544
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Small radial epiphyses;0.5654131770133972;0.4802419;0.643105587220763;0.673977928207695;1.0;-0.4345868229866028;-0.5197581052780151;-0.35689441277923695;-0.326022071792305
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Generalized keratosis follicularis;0.7990601509809494;0.88326484;0.5643995789913978;0.5372428627044616;0.9999201345566091;-0.2008599835756597;-0.11665529490740867;-0.4355205555652113;-0.46267727185214746
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hypoplasia of the calcaneus;0.560867965221405;0.59504485;0.6447139702846172;0.6327128697684916;0.5863259809806012;-0.02545801575919615;0.008718870322499406;0.05838798930401601;0.046386888787890435
Stippling of the epiphysis of the proximal phalanx of the 4th toe;2-hydroxyadipic aciduria;0.8494183719158173;0.97006035;0.5481146347295076;0.5095315054684779;1.0;-0.15058162808418274;-0.029939651489257812;-0.4518853652704924;-0.4904684945315221
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Potter facies;0.8307191133499146;0.954782;0.5541445051650924;0.5143982346666993;0.9998981869165328;-0.1691790735666182;-0.0451161777917769;-0.44575368175144037;-0.48549995224983344
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Increased heart rate variability;0.8912981003522873;1.0498886;0.5346693954764079;0.48411337208791105;0.9999201345566091;-0.10862203420432182;0.04996847628323464;-0.4652507390802012;-0.515806762468698
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Aplastic zygomatic arch;0.7360222339630127;0.94508517;0.5850345574615438;0.5174887409326332;0.8072246192530101;-0.07120238528999745;0.13786054863181652;-0.2221900617914664;-0.28973587832037695
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Testicular torsion;0.802016943693161;0.9791535;0.5634391021020313;0.5066361262894541;0.9999201345566091;-0.1979031908634481;-0.020766620648222878;-0.4364810324545778;-0.493284008267155
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abolished vibration sense;0.8163335621356964;1.0493844;0.5587966263751656;0.484274079631149;0.9999134918687169;-0.1835799297330205;0.049470863676327026;-0.44111686549355134;-0.5156394122375679
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Fractured metatarsal bone of digit 5;0.40256834030151367;0.1413722;0.7038120801507421;0.8286825516375632;1.0;-0.5974316596984863;-0.8586277961730957;-0.29618791984925785;-0.17131744836243679
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Prolonged G2 phase of cell cycle;0.9054002463817596;1.0397822;0.5301571313164055;0.48733359703791534;0.9999056439461368;-0.09450539756437715;0.039876522534881276;-0.4697485126297313;-0.5125720469082214
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Single naris;0.924293726682663;1.041104;0.52412113424245;0.48691252470973057;0.9999056439461368;-0.07561191726347383;0.04119831513742034;-0.4757845097036868;-0.5129931192364062
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8831004574894905;1.0585415;0.5372955550483764;0.4813549996221882;1.0;-0.11689954251050949;0.05854153633117676;-0.46270444495162355;-0.5186450003778118
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Asymmetry of the thorax;0.8357505351305008;1.1433288;0.5525202063445688;0.45421936680616537;0.789736248610815;0.046014286519685754;0.35359253728548623;-0.23721604226624626;-0.33551688180464967
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Type 2 muscle fiber predominance;0.9638515263795853;1.0089396;0.511508923927553;0.49715438018688574;0.8527273749847077;0.11112415139487752;0.1562122488479949;-0.34121845105715476;-0.355572994797822
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Dependency on parenteral nutrition;0.7678961455821991;0.8615952;0.5745609231133125;0.5441974923707469;0.9999134918687169;-0.23201734628651782;-0.1383182784554784;-0.4253525687554044;-0.45571599949797004
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Limited shoulder flexion;0.7745539247989655;1.2061708;0.5723839464859439;0.4338997597078722;1.0;-0.22544607520103455;0.20617079734802246;-0.42761605351405607;-0.5661002402921278
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Paroxysmal vertigo;0.8709882497787476;1.1239775;0.5411804938044833;0.4604349391697039;0.9999134918687169;-0.12892524208996936;0.12406405005480603;-0.4587329980642336;-0.539478552699013
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Long hallux;0.6194310784339905;0.30562168;0.6242718189830885;0.7443205430198849;0.1431341874814257;0.4762968909525648;0.162487496116139;0.4811376315016628;0.6011863555384592
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Broad medial eyebrow;0.8371222764253616;0.9763155;0.5520776069126562;0.5075397255326619;0.9999201345566091;-0.16279785813124747;-0.023604636204558327;-0.44784252764395294;-0.4923804090239472
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Myxoid subcutaneous tumors;0.8623504340648651;0.9018657;0.543954774981337;0.5312874647242687;0.9999201345566091;-0.137569700491744;-0.09805441380770774;-0.45596535957527207;-0.4686326698323404
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bulbous tips of toes;0.533954918384552;0.3151592;0.6543215495824615;0.740128267390749;0.36317310279071235;0.17078181559383965;-0.04801390116870308;0.2911484467917491;0.37695516460003664
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Absent internal genitalia;0.8355319201946259;0.9401083;0.5525907530308876;0.5190755313488682;1.0;-0.16446807980537415;-0.059891700744628906;-0.44740924696911244;-0.4809244686511318
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hyperphalangy of the 2nd finger;0.4978893995285034;0.36000317;0.6674429706615582;0.7210643492842228;0.6245600766986774;-0.126670677170174;-0.26455690334738957;0.04288289396288081;0.09650427258554539
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Renal interstitial hemosiderin;0.8641664236783981;1.0674069;0.5433712462198557;0.4785274331207596;1.0;-0.13583357632160187;0.06740689277648926;-0.45662875378014434;-0.5214725668792404
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormality of depressor anguli oris muscle;0.9256393611431122;1.2073544;0.5236915945924344;0.4335146728281637;1.0;-0.07436063885688782;0.20735442638397217;-0.4763084054075656;-0.5664853271718363
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Paroxysmal dyspnea;0.7715453207492828;0.9974123;0.5733672739710413;0.5008236858628015;1.0;-0.22845467925071716;-0.0025876760482788086;-0.42663272602895874;-0.49917631413719854
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Phenylpyruvic acidemia;0.7214232087135315;0.9560081;0.5898626751133506;0.5140075906450214;0.9999201345566091;-0.2784969258430776;-0.043912057888823464;-0.41005745944325855;-0.48591254391158767
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Lateral ventricle dilatation;0.7993153780698776;1.0827864;0.5643166483679364;0.4736180540078194;0.9998579617208769;-0.2005425836509993;0.08292847912842727;-0.43554131335294055;-0.5262399077130575
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Neonatal unconjugated hyperbilirubinemia;0.9006525725126266;1.0508212;0.5316755205557909;0.4838161248445817;0.9999201345566091;-0.09926756204398246;0.050901050555390404;-0.4682446140008182;-0.5161040097120274
Stippling of the epiphysis of the proximal phalanx of the 4th toe;High maternal circulating alpha-fetoprotein concentration;0.7689262926578522;1.0220925;0.5742238534443853;0.49296717533677625;1.0;-0.23107370734214783;0.022092461585998535;-0.4257761465556147;-0.5070328246632237
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Prominent nasolabial fold;0.8819501399993896;1.0724994;0.5376642654960878;0.4769024474646083;0.9998944404568447;-0.11794430045745508;0.07260495395996436;-0.4622301749607569;-0.5229919929922364
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Abnormality of inferior alveolar nerve;0.8564835339784622;0.938415;0.5458410025024452;0.5196155263699029;1.0;-0.14351646602153778;-0.06158500909805298;-0.45415899749755484;-0.48038447363009706
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Unilateral conductive hearing impairment;0.868826687335968;1.0125666;0.5418744378786027;0.4959998436358509;0.9999201345566091;-0.1310934472206411;0.012646431910676048;-0.45804569667800643;-0.5039202909207582
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Macular hypopigmented whorls, streaks, and patches;0.8835596367716789;1.0298009;0.537148388704992;0.49051265848605163;0.9999201345566091;-0.11636049778493018;0.029880757319611595;-0.46277174585161707;-0.5094074760705575
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Delayed ossification of pubic rami;0.642797976732254;0.7578398;0.6162692321976538;0.5778559524680971;0.0;0.642797976732254;0.7578397989273071;0.6162692321976538;0.5778559524680971
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Hyperphenylalaninemia;0.7410619556903839;0.9202742;0.5833725488179482;0.5254044674771415;0.9999028053808913;-0.25884084969050736;-0.07962860732562393;-0.41653025656294307;-0.47449833790374973
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Ureteropelvic junction obstruction;0.7293597459793091;0.80493665;0.5872353846575604;0.5624912472043582;0.9998847295244674;-0.2705249835451583;-0.19494808210930625;-0.41264934486690696;-0.4373934823201092
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.31006723642349243;0.045911193;0.7423599264350165;0.9031721786079101;1.0;-0.6899327635765076;-0.9540888071060181;-0.25764007356498353;-0.0968278213920899
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Difficulty walking;0.8231299221515656;0.83933127;0.556597241599087;0.5513650770228097;0.7552776988623575;0.06785222328920804;0.08405357040186368;-0.19868045726327055;-0.20391262183954784
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Bilobate gallbladder;1.0005111452192068;1.1346519;0.49983729741636607;0.457008381097479;0.9999134918687169;0.0005976533504898907;0.13473840746905164;-0.5000761944523509;-0.5429051107712379
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Histidinuria;0.7995346933603287;0.9658101;0.5642453900566877;0.5108850922335407;0.9999090677057578;-0.20037437434542915;-0.03409894760001442;-0.4356636776490701;-0.4890239754722171
Stippling of the epiphysis of the proximal phalanx of the 4th toe;Widened interpedicular distance;0.6970776915550232;0.9050754;0.5979622699215763;0.5302610025904383;1.0;-0.3029223084449768;-0.09492462873458862;-0.4020377300784237;-0.4697389974095617
Ankle joint effusion;Reduced C-peptide level;0.916381224989891;1.0780213;0.5266477985092471;0.4751397918249134;0.9999056439461368;-0.08352441895624574;0.07811564397195403;-0.47325784543688965;-0.5247658521212234
Ankle joint effusion;Loss of voice;0.9282586202025414;1.1481442;0.5228556247564996;0.4526700007769153;0.9999056439461368;-0.07164702374359544;0.1482386012015683;-0.4770500191896372;-0.5472356431692215
Ankle joint effusion;Elevated circulating growth hormone concentration;0.7837963402271271;0.9659463;0.5693675164106595;0.510841720177714;0.9998962300503706;-0.21609988982324357;-0.03394991333131547;-0.4305287136397111;-0.48905450987265664
Ankle joint effusion;Visual acuity no light perception;0.8949765339493752;1.0903392;0.53349176967177;0.4712049034447242;1.0;-0.10502346605062485;0.09033918380737305;-0.46650823032822997;-0.5287950965552758
Ankle joint effusion;Spinal hypomyelination;0.8888852596282959;1.0960894;0.5354421080299849;0.46936652454533456;1.0;-0.1111147403717041;0.09608936309814453;-0.46455789197001507;-0.5306334754546654
Ankle joint effusion;Bladder polyp;0.8432193547487259;1.0160828;0.5501115692471346;0.4948804754253262;0.9999201345566091;-0.15670077980788322;0.016162629115265892;-0.44980856530947455;-0.5050396591312829
Ankle joint effusion;Aberrant melanosome maturation;0.9924126658588648;1.1476115;0.5024151466396629;0.4528414883112474;0.9999201345566091;-0.007507468697744324;0.14769136427609353;-0.4975049879169462;-0.5470786462453617
Ankle joint effusion;Vertebral artery tortuosity;0.7101853787899017;1.0724494;0.5935936555126113;0.47691841708205795;0.9999201345566091;-0.2897347557667074;0.0725293111678782;-0.40632647904399777;-0.5230017174745512
Ankle joint effusion;Warm reactive autoantibody positivity;0.6939626336097717;0.7506171;0.5990032513036341;0.5802277683124116;1.0;-0.30603736639022827;-0.24938291311264038;-0.4009967486963659;-0.41977223168758837
Ankle joint effusion;Right aortic arch with retroesophageal left subclavian artery;0.7555479109287262;1.0455302;0.578608090097628;0.48550226818956466;1.0;-0.2444520890712738;0.04553020000457764;-0.42139190990237196;-0.5144977318104353
Ankle joint effusion;Elevated urine suberic acid level;0.7889818400144577;0.94289136;0.5676779204785738;0.5181881310185292;0.9999201345566091;-0.2109382945421514;-0.057028775227385475;-0.4322422140780353;-0.4817320035380799
Ankle joint effusion;Burkitt lymphoma;0.844960629940033;0.883342;0.5495504421872315;0.5372181215838105;0.9999090677057578;-0.15494843776572487;-0.11656704004157326;-0.45035862551852635;-0.4626909461219473
Ankle joint effusion;Snail-like ilia;0.8766773194074631;0.980861;0.5393550166882659;0.5060925094149329;0.822027235707794;0.05465008369966906;0.15883377245947283;-0.2826722190195281;-0.3159347262928611
Ankle joint effusion;Indurated nodule;0.6063504219055176;0.74913526;0.6287876571534093;0.5807149398966291;1.0;-0.3936495780944824;-0.25086474418640137;-0.37121234284659066;-0.41928506010337085
Ankle joint effusion;Absent leukocyte alkaline phosphatase;0.6872387230396271;0.7673894;0.6012539828177298;0.5747267490121064;0.9999201345566091;-0.31268141151698203;-0.232530717861968;-0.3986661517388793;-0.4251933855445027
Ankle joint effusion;Hippocampal sclerosis;0.9088115021586418;1.0380809;0.5290665787756778;0.48787552693073966;1.0;-0.09118849784135818;0.03808093070983887;-0.47093342122432225;-0.5121244730692603
Ankle joint effusion;Decreased sensitivity to hypoxemia;0.885675922036171;1.0600795;0.536470224707478;0.4808646061845815;0.9999201345566091;-0.11424421252043815;0.06015932081906228;-0.46344990984913115;-0.5190555283720276
Ankle joint effusion;Decreased level of tissue plasminogen activator;0.8270722329616547;0.98732454;0.555322719189736;0.5040348294506222;1.0;-0.17292776703834534;-0.012675464153289795;-0.44467728081026403;-0.49596517054937783
Ankle joint effusion;Submandibular lymph node enlargement;0.7871510982513428;0.91947746;0.5682742090191674;0.5256588942120248;0.9999201345566091;-0.21276903630526633;-0.08044267178805442;-0.43164592553744174;-0.4742612403445843
Ankle joint effusion;Hepatic hemangioma;0.794955775141716;0.9543391;0.5657338218965133;0.5145393681191173;0.9999134918687169;-0.20495771672700092;-0.04557440485928699;-0.4341796699722036;-0.48537412374959965
Ankle joint effusion;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7898302972316742;0.9339788;0.5674016524589982;0.5210304987940182;1.0;-0.2101697027683258;-0.06602120399475098;-0.4325983475410018;-0.4789695012059818
Ankle joint effusion;Acne inversa;0.730847030878067;0.9833117;0.5867437211390549;0.5053122987520385;0.9998962300503706;-0.26904919917230363;-0.016584517308518842;-0.4131525089113157;-0.4945839312983321
Ankle joint effusion;Dentin dysplasia;0.9371209740638733;1.0992101;0.520028228244902;0.46836839538514363;1.0;-0.06287902593612671;0.09921014308929443;-0.479971771755098;-0.5316316046148564
Ankle joint effusion;Aplasia of the inner ear;0.8076175004243851;1.0506619;0.5616214272677255;0.4838669186604895;0.9999201345566091;-0.19230263413222404;0.05074178694455056;-0.43829870728888365;-0.5160532158961196
Ankle joint effusion;Polycystic liver disease;0.7882359325885773;1.1098305;0.5679208397920562;0.4649692058904862;0.9999056439461368;-0.21166971135755952;0.10992485474923674;-0.4319848041540806;-0.5349364380556506
Ankle joint effusion;Subungual hyperkeratosis;0.8652927577495575;0.9340332;0.543009397072046;0.5210131340774611;0.9999003561294039;-0.13460759837984637;-0.06586714108347491;-0.4568909590573579;-0.4788872220519428
Ankle joint effusion;Broad humeral epiphyses;0.785603404045105;0.95038563;0.5687784962960366;0.5157992225019411;1.0;-0.21439659595489502;-0.04961436986923218;-0.4312215037039634;-0.4842007774980589
Ankle joint effusion;Autoimmune thrombocytopenia;0.6715172231197357;0.91904104;0.6065372893004939;0.5257982796041353;0.9998726169824932;-0.32835539386275747;-0.08083157942298391;-0.3933353276819993;-0.4740743373783579
Ankle joint effusion;Adenomyosis;0.769950807094574;0.9945419;0.5738887108635014;0.501737376483318;0.9999201345566091;-0.22996932746203513;-0.0053782510879811785;-0.42603142369310776;-0.49818275807329115
Ankle joint effusion;Elevated leukocyte alkaline phosphatase;0.6358152329921722;0.799584;0.6186523360396736;0.5642293842564692;0.9999201345566091;-0.36410490156443687;-0.20033616305621238;-0.3812677985169355;-0.43569075030013993
Ankle joint effusion;Clasp-knife sign;0.9291277676820755;1.0546614;0.5225782604620265;0.4825920477921536;1.0;-0.0708722323179245;0.05466139316558838;-0.4774217395379735;-0.5174079522078464
Ankle joint effusion;Keratosis pilaris;0.9052325263619423;1.086093;0.5302107591846459;0.4725617798037687;0.9998710980331391;-0.09463857167119683;0.0862218508804351;-0.46966033884849323;-0.5273093182293704
Ankle joint effusion;Lamina lucida cleavage;0.8954551592469215;1.0587112;0.5333385751686892;0.48130088639125845;0.9998962300503706;-0.10444107080344911;0.05881494109983687;-0.46655765488168144;-0.5185953436591122
Ankle joint effusion;Abnormal central response of multifocal electroretinogram;0.8571041077375412;1.1534191;0.5456414105171896;0.4509715299401752;1.0;-0.1428958922624588;0.1534191370010376;-0.4543585894828104;-0.5490284700598248
Ankle joint effusion;Atypical or prolonged hepatitis;0.8195668309926987;0.9801215;0.5577499538020634;0.5063279372481551;0.9999201345566091;-0.18035330356391044;-0.019798641217070534;-0.4421701807545457;-0.49359219730845405
Ankle joint effusion;Cubitus varus;0.8167286217212677;0.983868;0.5586687035787029;0.5051351921678784;1.0;-0.1832713782787323;-0.016131997108459473;-0.4413312964212971;-0.4948648078321216
Ankle joint effusion;Nasal regurgitation;0.7724061906337738;1.0154974;0.5730858362159408;0.49506679354849314;0.9999134918687169;-0.22750730123494312;0.015583954191463745;-0.42682765565277614;-0.5048466983202238
Ankle joint effusion;Moon facies;0.9738388266414404;1.0514457;0.5083283102907787;0.48361709767428496;0.9999134918687169;-0.026074665227276528;0.051532230711239135;-0.4915851815779382;-0.516296394194432
Ankle joint effusion;Intestinal pseudo-obstruction;0.7957353591918945;0.865;0.5654803067502059;0.5431034503358148;0.9998912449978579;-0.20415588580596333;-0.1348912354611147;-0.434410938247652;-0.4567877946620431
Ankle joint effusion;Bilateral renal atrophy;0.6304729580879211;0.86651367;0.6204802871986141;0.5426172267806055;0.9999201345566091;-0.36944717646868797;-0.1334064650657949;-0.37943984735799496;-0.4573029077760036
Ankle joint effusion;Fractured left clavicle;0.8106260001659393;1.1006325;0.5606458544849926;0.46791334520728023;1.0;-0.18937399983406067;0.10063254833221436;-0.4393541455150074;-0.5320866547927198
Ankle joint effusion;Positive urine norcotinine test;0.907612144947052;1.0812827;0.529449964498587;0.4740983339259117;1.0;-0.092387855052948;0.08128273487091064;-0.47055003550141306;-0.5259016660740883
Ankle joint effusion;Long fibula;0.7307553291320801;0.6328405;0.5867740295580428;0.6196696864168751;0.6164553286055281;0.11430000052655198;0.016385185577516337;-0.029681299047485288;0.003214357811347046
Ankle joint effusion;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.681247740983963;0.68262815;0.6032637976440258;0.6028003203336938;1.0;-0.318752259016037;-0.31737184524536133;-0.3967362023559742;-0.3971996796663062
Ankle joint effusion;Type II cryptotia;0.9215838760137558;1.0530852;0.5249862793969787;0.4830944952220053;1.0;-0.0784161239862442;0.05308520793914795;-0.47501372060302127;-0.5169055047779947
Ankle joint effusion;Increased variability in muscle fiber diameter;0.8145438432693481;0.8996194;0.5593762693547998;0.5320060392964692;0.7712186293488323;0.043325213920515804;0.12840077115241888;-0.21184235999403256;-0.23921259005236317
Ankle joint effusion;Widened proximal tibial metaphyses;0.6900581121444702;0.6027731;0.6003096023291121;0.6300274037155716;0.7527521012230838;-0.06269398907861357;-0.1499790308876956;-0.15244249889397166;-0.12272469750751214
Ankle joint effusion;Wide anterior fontanel;0.8079778552055359;1.075025;0.5615045435177104;0.47609635942801354;0.6617971500655027;0.14618070514003323;0.4132278123597293;-0.10029260654779226;-0.18570079063748912
Ankle joint effusion;Increased circulating oleate level;0.6366066038608551;0.82920206;0.6183819053087025;0.5546345261509806;1.0;-0.3633933961391449;-0.1707979440689087;-0.3816180946912975;-0.44536547384901937
Ankle joint effusion;Lozenge-shaped umbilicus;0.8978811204433441;1.0633736;0.532562211614735;0.4798140450304852;0.9999134918687169;-0.1020323714253728;0.0634600738051112;-0.46735128025398187;-0.5200994468382317
Ankle joint effusion;Anti-myelin-associated glycoprotein antibody positivity;0.7950710356235504;0.9388173;0.565696337353138;0.5194872302435017;1.0;-0.20492896437644958;-0.06118267774581909;-0.43430366264686204;-0.48051276975649826
Ankle joint effusion;Fractured radius;0.784446507692337;1.1159706;0.5691555638797655;0.46300216497931834;0.7527521012230838;0.031694406469253256;0.36321851034918184;-0.18359653734331827;-0.28974993624376544
Ankle joint effusion;Abnormal manual kinetic perimetry test;0.8803503140807152;1.1557151;0.5381771410948756;0.4502318337851291;1.0;-0.11964968591928482;0.15571510791778564;-0.4618228589051244;-0.5497681662148709
Ankle joint effusion;Small radial epiphyses;0.9079848825931549;1.1087658;0.5293308108698866;0.46531011818484913;1.0;-0.09201511740684509;0.10876584053039551;-0.47066918913011335;-0.5346898818151509
Ankle joint effusion;Generalized keratosis follicularis;0.8117350935935974;1.0212033;0.5602863522707929;0.49325029967431144;0.9999201345566091;-0.1881850409630117;0.02128314493863015;-0.4396337822858162;-0.5066698348822977
Ankle joint effusion;Hypoplasia of the calcaneus;0.7146619558334351;0.705869;0.592105867583262;0.5950301917231857;0.6483560786248226;0.06630587720861247;0.05751294040670207;-0.05625021104156058;-0.053325886901636865
Ankle joint effusion;2-hydroxyadipic aciduria;0.7717473953962326;1.0032715;0.5733012059813092;0.49895866880607576;1.0;-0.2282526046037674;0.00327146053314209;-0.4266987940186908;-0.5010413311939242
Ankle joint effusion;Potter facies;1.0222583953291178;1.0247363;0.4929143475525941;0.4921253968251458;0.9998981869165328;0.022360208412585014;0.024838098293123;-0.5069838393639386;-0.507772790091387
Ankle joint effusion;Increased heart rate variability;0.7695795148611069;1.0170158;0.5740101595602545;0.49458344601652715;0.9999201345566091;-0.23034061969550224;0.017095680224579857;-0.42590997499635463;-0.505336688540082
Ankle joint effusion;Aplastic zygomatic arch;0.8466339707374573;1.0778276;0.549011353283783;0.47520161991338095;0.8072246192530101;0.03940935148444713;0.27060295356956066;-0.2582132659692271;-0.3320229993396292
Ankle joint effusion;Testicular torsion;0.8145623356103897;0.96793514;0.5593702791555368;0.5102083161062737;0.9999201345566091;-0.1853577989462194;-0.03198498965533347;-0.4405498554010723;-0.4897118184503354
Ankle joint effusion;Abolished vibration sense;0.8350740373134613;1.0006977;0.5527385195493446;0.49977789002678064;0.9999134918687169;-0.16483945455525562;0.0007842401030238033;-0.4471749723193723;-0.5001356018419363
Ankle joint effusion;Fractured metatarsal bone of digit 5;0.8937455639243126;0.78116465;0.533885804427396;0.5702257607701474;1.0;-0.10625443607568741;-0.21883535385131836;-0.46611419557260403;-0.4297742392298526
Ankle joint effusion;Prolonged G2 phase of cell cycle;0.8766951337456703;1.1005745;0.5393493025968148;0.46793192127908134;0.9999056439461368;-0.12321051020046647;0.10066884946206633;-0.460556341349322;-0.5319737226670554
Ankle joint effusion;Single naris;0.9844982661306858;1.0194017;0.5049345527889761;0.49382388231907226;0.9999056439461368;-0.015407377815450984;0.01949602555612151;-0.49497109115716065;-0.5060817616270645
Ankle joint effusion;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7823554575443268;1.1091744;0.5698373511437729;0.4651793071092105;1.0;-0.21764454245567322;0.10917437076568604;-0.4301626488562271;-0.5348206928907895
Ankle joint effusion;Asymmetry of the thorax;0.7540099620819092;1.0193652;0.5791130523998754;0.49383548692741164;0.789736248610815;-0.03572628652890586;0.22962894284884072;-0.2106231962109396;-0.2959007616834034
Ankle joint effusion;Type 2 muscle fiber predominance;0.8214342594146729;0.78932804;0.5571457188350801;0.5675651828746915;0.8527273749847077;-0.03129311557003489;-0.06339933629223338;-0.2955816561496276;-0.28516219211001625
Ankle joint effusion;Dependency on parenteral nutrition;0.869013786315918;0.9736253;0.5418143640963995;0.5083963018421158;0.9999134918687169;-0.13089970555279895;-0.02628818955395862;-0.4580991277723174;-0.4915171900266011
Ankle joint effusion;Limited shoulder flexion;0.6956818401813507;0.8436157;0.5984285971111252;0.5499838343358392;1.0;-0.3043181598186493;-0.15638428926467896;-0.40157140288887483;-0.4500161656641608
Ankle joint effusion;Paroxysmal vertigo;0.7876883000135422;1.0455351;0.5680992125967548;0.48550070724793315;0.9999134918687169;-0.21222519185517474;0.0456215957167323;-0.43181427927196214;-0.5144127846207838
Ankle joint effusion;Long hallux;0.6369892060756683;0.5632379;0.6182511929426149;0.6438748433031685;0.5268546983069159;0.11013450776875244;0.036383207195403444;0.09139649463569899;0.11702014499625257
Ankle joint effusion;Broad medial eyebrow;0.9383008182048798;1.0661558;0.5196519414754661;0.4789265573699396;0.9999201345566091;-0.06161931635172935;0.0662356567260447;-0.480268193081143;-0.5209935771866695
Ankle joint effusion;Myxoid subcutaneous tumors;0.9562252685427666;0.8357606;0.5139383837252656;0.5525169606153211;0.9999201345566091;-0.04369486601384254;-0.16415954114230247;-0.48598175083134354;-0.44740317394128803
Ankle joint effusion;Bulbous tips of toes;0.7251620888710022;0.71762764;0.5886241942248377;0.5911213636275316;0.6483560786248226;0.07680601024617961;0.06927156591405681;-0.05973188439998489;-0.057234714997290936
Ankle joint effusion;Absent internal genitalia;0.8518362641334534;0.962339;0.5473362629498032;0.5119907046139018;1.0;-0.14816373586654663;-0.03766101598739624;-0.4526637370501968;-0.48800929538609816
Ankle joint effusion;Hyperphalangy of the 2nd finger;0.7541534900665283;0.89911366;0.5790659185701744;0.5321678516066279;0.7527521012230838;0.0014013888434445398;0.14636155386724825;-0.17368618265290936;-0.22058424961645584
Ankle joint effusion;Renal interstitial hemosiderin;0.6803566813468933;0.8311498;0.6035630871464093;0.5540053961018877;1.0;-0.3196433186531067;-0.16885018348693848;-0.39643691285359073;-0.4459946038981123
Ankle joint effusion;Abnormality of depressor anguli oris muscle;0.7846477031707764;0.98557705;0.5690899811082005;0.504591132794016;1.0;-0.21535229682922363;-0.014422953128814697;-0.4309100188917995;-0.495408867205984
Ankle joint effusion;Paroxysmal dyspnea;0.7077279090881348;0.9577752;0.5944112881145397;0.5134445845220637;1.0;-0.29227209091186523;-0.04222482442855835;-0.4055887118854603;-0.48655541547793635
Ankle joint effusion;Phenylpyruvic acidemia;0.8011344075202942;1.1031772;0.5637257211745257;0.4670991383965656;0.9999201345566091;-0.19878572703631492;0.10325705527035622;-0.4361944133820834;-0.5328209961600435
Ankle joint effusion;Lateral ventricle dilatation;0.7545552849769592;1.1223509;0.5789339806600733;0.460956680262425;0.9998579617208769;-0.2453026767439177;0.12249296944672561;-0.42092398106080364;-0.538901281458452
Ankle joint effusion;Neonatal unconjugated hyperbilirubinemia;0.80709508061409;1.0447056;0.561790892960957;0.48576501423773644;0.9999201345566091;-0.19282505394251914;0.044785494792145775;-0.43812924159565214;-0.5141551203188727
Ankle joint effusion;High maternal circulating alpha-fetoprotein concentration;0.8012291193008423;1.0189661;0.5636949593613185;0.49396255830881686;1.0;-0.19877088069915771;0.018966078758239746;-0.4363050406386815;-0.5060374416911831
Ankle joint effusion;Prominent nasolabial fold;0.7969009578227997;1.0181564;0.5651013409481355;0.4942203267486941;0.9998944404568447;-0.20299348263404504;0.018261968806766116;-0.43479309950870926;-0.5056741137081506
Ankle joint effusion;Abnormality of inferior alveolar nerve;0.7821118384599686;1.0215027;0.5699168043090708;0.49315492682789885;1.0;-0.21788816154003143;0.02150273323059082;-0.43008319569092923;-0.5068450731721011
Ankle joint effusion;Unilateral conductive hearing impairment;0.8154844641685486;1.0247401;0.5590716022170189;0.4921241733013756;0.9999201345566091;-0.18443567038806052;0.02481996535031228;-0.4408485323395902;-0.5077959612552335
Ankle joint effusion;Macular hypopigmented whorls, streaks, and patches;0.939461462199688;1.0956484;0.5192818050245714;0.469507560638022;0.9999201345566091;-0.06045867235692115;0.09572827337948708;-0.48063832953203767;-0.5304125739185871
Ankle joint effusion;Delayed ossification of pubic rami;0.7678771913051605;0.83322406;0.5745671258516261;0.5533356561451733;0.8072246192530101;-0.03934742794784962;0.025999438898234972;-0.23265749340138409;-0.2538889631078368
Ankle joint effusion;Hyperphenylalaninemia;0.7494664192199707;1.0909432;0.5806060499130146;0.47101181269318126;0.9999028053808913;-0.25043638616092057;0.09104041189663559;-0.4192967554678767;-0.52889099268771
Ankle joint effusion;Ureteropelvic junction obstruction;0.7074927389621735;0.9554516;0.594489565887294;0.5141848904879935;0.9998847295244674;-0.2923919905622939;-0.04443312182030479;-0.40539516363717343;-0.48569983903647385
Ankle joint effusion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.71834796667099;0.73275614;0.590882377723053;0.5861129331366626;1.0;-0.28165203332901;-0.2672438621520996;-0.40911762227694703;-0.4138870668633374
Ankle joint effusion;Difficulty walking;0.7687534838914871;0.92152655;0.5742803914749419;0.5250045899766603;0.7552776988623575;0.013475785029129606;0.16624885238428555;-0.1809973073874156;-0.2302731088856972
Ankle joint effusion;Bilobate gallbladder;0.8558748513460159;1.0632064;0.5460367876370107;0.47986735148496984;0.9999134918687169;-0.144038640522701;0.06329294238116101;-0.45387670423170623;-0.5200461403837471
Ankle joint effusion;Histidinuria;0.8534098118543625;0.98037624;0.5468298573492313;0.5062468402050564;0.9999090677057578;-0.14649925585139534;-0.019532824114449232;-0.45307921035652654;-0.49366222750070143
Ankle joint effusion;Widened interpedicular distance;0.642277866601944;0.81451833;0.6164465009601603;0.5593845234112023;1.0;-0.35772213339805603;-0.18548166751861572;-0.3835534990398397;-0.44061547658879774
Reduced C-peptide level;Loss of voice;0.7430980205535889;0.9598471;0.5827017535952111;0.512784511382028;0.9999528219730685;-0.2568548014194796;-0.04010572934458945;-0.4172510683778573;-0.4871683105910405
Reduced C-peptide level;Elevated circulating growth hormone concentration;0.791721448302269;0.67184806;0.5667860557064041;0.6064258009846433;0.9999505803237132;-0.20822913202144422;-0.3281025216231517;-0.43316452461730914;-0.39352477933906993
Reduced C-peptide level;Visual acuity no light perception;0.8549588620662689;0.96659833;0.5463314522339939;0.5106340650726351;0.9999056439461368;-0.14494678187986787;-0.03330731201788362;-0.45357419171214286;-0.4892715788735017
Reduced C-peptide level;Spinal hypomyelination;0.6056869626045227;0.8122954;0.6290174269520654;0.5601047712023902;0.9999056439461368;-0.3942186813416141;-0.1876102666916507;-0.3708882169940714;-0.4398008727437466
Reduced C-peptide level;Bladder polyp;0.7598170042037964;0.9934354;0.5772074509456813;0.5020895975485177;0.9999567459343585;-0.24013974173056207;-0.0065213630913408815;-0.4227492949886772;-0.4978671483858408
Reduced C-peptide level;Aberrant melanosome maturation;0.8054369986057281;0.92613417;0.5623288693722799;0.52353365083938;0.9999567459343585;-0.1945197473286303;-0.07382257683264337;-0.4376278765620786;-0.4764230950949785
Reduced C-peptide level;Vertebral artery tortuosity;0.8143115639686584;0.89849627;0.5594515130902701;0.532365371045824;0.9999567459343585;-0.1856451819657;-0.10146047575460992;-0.4405052328440884;-0.4675913748885344
Reduced C-peptide level;Warm reactive autoantibody positivity;0.9425773397088051;0.92581326;0.5182882603695209;0.523636083530417;0.9999056439461368;-0.057328304237331706;-0.0740923862518924;-0.4816173835766159;-0.4762695604157198
Reduced C-peptide level;Right aortic arch with retroesophageal left subclavian artery;0.8935244977474213;1.0224694;0.5339565734387062;0.49284715121131784;0.9999056439461368;-0.10638114619871553;0.022563757413421315;-0.4659490705074306;-0.507058492734819
Reduced C-peptide level;Elevated urine suberic acid level;0.8245786130428314;0.8732765;0.5561287841671007;0.5404461014010686;0.851762385589393;-0.02718377254656157;0.021514086502281815;-0.29563360142229234;-0.31131628418832435
Reduced C-peptide level;Burkitt lymphoma;0.9049681723117828;1.0403264;0.5302952871805618;0.48716023316835233;0.9999536937290383;-0.09498552141725547;0.040372663158779076;-0.46965840654847646;-0.512793460560686
Reduced C-peptide level;Snail-like ilia;0.9224940240383148;0.93719965;0.5246956858236563;0.5200031322474717;0.9999567459343585;-0.07746272189604364;-0.06275709373938165;-0.4752610601107021;-0.4799536136868867
Reduced C-peptide level;Indurated nodule;0.8644683063030243;1.0114719;0.5432742570740761;0.4963482932551353;0.9999056439461368;-0.1354373376431125;0.011566223615203541;-0.45663138687206073;-0.5035573506910015
Reduced C-peptide level;Absent leukocyte alkaline phosphatase;0.7593302130699158;0.90112805;0.5773670838297611;0.5315234261110626;0.851762385589393;-0.09243217251947722;0.04936566807576814;-0.2743953017596319;-0.32023895947833037
Reduced C-peptide level;Hippocampal sclerosis;0.736289918422699;0.8779676;0.5849462206712469;0.5389411877659831;0.9999056439461368;-0.2636157255234378;-0.12193804789205964;-0.4149594232748899;-0.4609644561801537
Reduced C-peptide level;Decreased sensitivity to hypoxemia;0.5771496295928955;0.76166797;0.6389704140586088;0.5766006472157191;0.9999567459343585;-0.42280711634146295;-0.2382887790917071;-0.3609863318757497;-0.42335609871863933
Reduced C-peptide level;Decreased level of tissue plasminogen activator;0.44751405715942383;0.6743985;0.6863207042019687;0.6055667875497059;0.9999056439461368;-0.552391586786713;-0.3255071621002811;-0.3135849397441681;-0.39433885639643085
Reduced C-peptide level;Submandibular lymph node enlargement;0.9363270252943039;1.0389023;0.5202814574487313;0.48761390280626604;0.9999567459343585;-0.06362972064005457;0.03894553678048529;-0.4796752884856271;-0.5123428431280924
Reduced C-peptide level;Hepatic hemangioma;0.8519694656133652;0.99820805;0.5472933908434219;0.5005703910629609;0.9999548690865008;-0.1479854034731356;-0.0017468231270281187;-0.4526614782430789;-0.4993844780235399
Reduced C-peptide level;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7739684283733368;0.9559842;0.572575253842362;0.51401520134569;0.9999056439461368;-0.2259372155728;-0.04392146874090608;-0.4273303901037748;-0.4858904426004468
Reduced C-peptide level;Acne inversa;0.8935697451233864;1.0636367;0.5339420884442272;0.4797301204348504;0.9999505803237132;-0.10638083520032682;0.0636860802521535;-0.466008491879486;-0.5202204598888628
Reduced C-peptide level;Dentin dysplasia;0.7973590940237045;0.9441849;0.564952414848445;0.517775732472219;0.9999056439461368;-0.20254654992243226;-0.05572074461599763;-0.43495322909769174;-0.4821299114739178
Reduced C-peptide level;Aplasia of the inner ear;0.7638627588748932;0.9612231;0.5758814928944074;0.5123461566964147;0.9999567459343585;-0.23609398705946527;-0.03873362047659479;-0.4240752530399511;-0.48761058923794376
Reduced C-peptide level;Polycystic liver disease;0.7432288527488708;1.1285774;0.582658662931256;0.4589589265432209;0.9999528219730685;-0.2567239692241976;0.12862452959706094;-0.41729415904181244;-0.5409938954298475
Reduced C-peptide level;Subungual hyperkeratosis;0.9294129088521004;1.0498354;0.5224872693229634;0.48413030023437076;0.9999515360511232;-0.07053862719902282;0.04988390744558091;-0.4774642667281598;-0.5158212358167524
Reduced C-peptide level;Broad humeral epiphyses;0.8908191621303558;1.1065238;0.5348227590416443;0.46602798981568094;0.9999056439461368;-0.10908648181578096;0.10661810826638762;-0.46508288490449246;-0.5338776541304558
Reduced C-peptide level;Autoimmune thrombocytopenia;0.7527798712253571;0.9699277;0.5795170804921896;0.509573739442129;0.9999457950338347;-0.24716592380847768;-0.030018066857717796;-0.4204287145416451;-0.4903720555917057
Reduced C-peptide level;Adenomyosis;0.8565302640199661;1.0733663;0.5458259723257224;0.4766257995186495;0.9999567459343585;-0.14342648191439233;0.0734095384360639;-0.4541307736086361;-0.523330946415709
Reduced C-peptide level;Elevated leukocyte alkaline phosphatase;0.8479808568954468;0.8471025;0.5485775390476246;0.5488604332720446;0.851762385589393;-0.0037815286939462123;-0.0046598627393563685;-0.30318484654176836;-0.3029019523173484
Reduced C-peptide level;Clasp-knife sign;0.7178590297698975;0.82163984;0.5910445897109051;0.5570792190253304;0.9999056439461368;-0.28204661417623933;-0.17826580811163362;-0.40886105423523167;-0.44282642492080637
Reduced C-peptide level;Keratosis pilaris;0.7809790074825287;0.98899853;0.5702863205131175;0.5035019388686749;0.9999455218634979;-0.21896651438096926;-0.010946989568270893;-0.4296592013503805;-0.49644358299482305
Reduced C-peptide level;Lamina lucida cleavage;0.762286975979805;0.86074793;0.5763977800058497;0.5444698175761702;0.9999505803237132;-0.2376636043439082;-0.13920264693595685;-0.42355280031786346;-0.455480762747543
Reduced C-peptide level;Abnormal central response of multifocal electroretinogram;0.7099306285381317;0.8231404;0.5936783846424354;0.5565938681868859;0.9999056439461368;-0.2899750154080051;-0.17676526117941316;-0.4062272593037014;-0.44331177575925085
Reduced C-peptide level;Atypical or prolonged hepatitis;0.8925547301769257;0.9770873;0.5342670411216066;0.5072939747787515;0.9999567459343585;-0.1074020157574328;-0.022869427037111145;-0.46568970481275185;-0.49266277115560697
Reduced C-peptide level;Cubitus varus;0.8528352677822113;1.0803008;0.5470147455793346;0.4744119137040256;0.9999056439461368;-0.1470703761639255;0.08039516400674407;-0.4528908983668022;-0.5254937302421112
Reduced C-peptide level;Nasal regurgitation;0.8244615495204926;1.0433894;0.5561666339584078;0.4861843668191709;0.9999548690865008;-0.17549331956600822;0.04343457049632393;-0.44378823512809296;-0.5137705022673299
Reduced C-peptide level;Moon facies;1.001145128160715;1.0438344;0.499635494305833;0.4860425825682384;0.9999548690865008;0.0011902590742143282;0.043879578774217;-0.5003193747806678;-0.5139122865182624
Reduced C-peptide level;Intestinal pseudo-obstruction;0.7704737782478333;0.9860018;0.5737176669711952;0.5044559074805337;0.9999494774285466;-0.2294756991807133;-0.013947687858691826;-0.42623181045735137;-0.49549356994801286
Reduced C-peptide level;Bilateral renal atrophy;0.7707130908966064;0.829469;0.5736394041740032;0.554548296384217;0.9999567459343585;-0.22924365503775201;-0.17048772079931818;-0.4263173417603553;-0.44540844955014147
Reduced C-peptide level;Fractured left clavicle;0.7247841358184814;1.0027229;0.5887493259310925;0.499133276382445;0.9999056439461368;-0.27512150812765535;0.002817215436492604;-0.41115631801504426;-0.5007723675636918
Reduced C-peptide level;Positive urine norcotinine test;0.7450857162475586;0.7251581;0.5820472562318264;0.5886255064461949;0.6766288643064248;0.06845685194113382;0.048529231053377475;-0.09458160807459837;-0.08800335786022984
Reduced C-peptide level;Long fibula;0.9148279204964638;1.0047244;0.5271440010178291;0.4984961835928916;0.9999528219730685;-0.08512490147660468;0.004771561381118561;-0.47280882095523935;-0.5014566383801768
Reduced C-peptide level;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7884050011634827;0.94536;0.5678657757950734;0.5174011117959083;0.9999056439461368;-0.21150064278265412;-0.054545639044250804;-0.43203986815106343;-0.4825045321502285
Reduced C-peptide level;Type II cryptotia;0.8193458616733551;0.9443077;0.5578214656777462;0.5177366007884003;0.9999056439461368;-0.1805597822727817;-0.055597959047760326;-0.44208417826839064;-0.48216904315773645
Reduced C-peptide level;Increased variability in muscle fiber diameter;0.8642346262931824;0.7907827;0.5433493336629038;0.5670915934201934;0.9999413779434757;-0.13570675165029333;-0.20915868789525793;-0.4565920442805719;-0.43284978452328227
Reduced C-peptide level;Widened proximal tibial metaphyses;0.8832295387983322;0.9687515;0.5372541838543412;0.5099483314852389;0.9999567459343585;-0.11672720713602625;-0.031205255818239075;-0.46270256208001725;-0.4900084144491196
Reduced C-peptide level;Wide anterior fontanel;0.9880161853507161;0.93474567;0.5038146579857685;0.5207858583669263;0.9999418169014338;-0.011925631550717686;-0.0651961475365046;-0.4961271589156653;-0.47915595853450754
Reduced C-peptide level;Increased circulating oleate level;0.9025413990020752;0.87952167;0.531071356093932;0.5384428245260688;0.4583148495442064;0.44422654945786877;0.4212068184130995;0.07275650654972554;0.08012797498186242
Reduced C-peptide level;Lozenge-shaped umbilicus;0.8856500387191772;0.95961416;0.5364785180104845;0.5128587004567657;0.9999548690865008;-0.11430483036732353;-0.040340711409804;-0.46347635107601626;-0.48709616862973504
Reduced C-peptide level;Anti-myelin-associated glycoprotein antibody positivity;0.7742409855127335;0.791759;0.5724861941586233;0.5667738203683015;0.9999056439461368;-0.22566465843340333;-0.20814662981649812;-0.42741944978751345;-0.4331318235778353
Reduced C-peptide level;Fractured radius;0.7341062724590302;0.965136;0.5856670277220773;0.5110998055904625;0.9999567459343585;-0.2658504734753283;-0.03482075436102472;-0.4142897182122811;-0.48885694034389593
Reduced C-peptide level;Abnormal manual kinetic perimetry test;0.7618828415870667;0.8889653;0.5765302229520124;0.5354164689768617;0.9999056439461368;-0.23802280235907014;-0.11094033527990754;-0.4233754209941244;-0.4644891749692751
Reduced C-peptide level;Small radial epiphyses;0.7494266629219055;0.96963334;0.5806191216892418;0.5096674957777718;0.9999056439461368;-0.2504789810242313;-0.0302723031105655;-0.419286522256895;-0.490238148168365
Reduced C-peptide level;Generalized keratosis follicularis;0.8953765332698822;1.0092942;0.5333637406007088;0.4970415356724772;0.9999567459343585;-0.10458021266447626;0.0093374063254682;-0.46659300533364967;-0.5029152102618812
Reduced C-peptide level;Hypoplasia of the calcaneus;0.6905765533447266;0.9805986;0.6001360452978377;0.50617602754341;0.9999548690865008;-0.3093783157417742;-0.0193562405655352;-0.39981882378866307;-0.4937788415430908
Reduced C-peptide level;2-hydroxyadipic aciduria;0.8845443576574326;0.93994975;0.5368328138359262;0.5191260886689849;0.6766288643064248;0.20791549335100779;0.2633208865938438;-0.1397960504704986;-0.15750277563743986
Reduced C-peptide level;Potter facies;0.9547814540565014;1.0636057;0.5143984198403977;0.4797400062912033;0.9999510285821799;-0.04516957452567849;0.06365463757840362;-0.4855526087417822;-0.5202110222909766
Reduced C-peptide level;Increased heart rate variability;0.9080374240875244;0.8124014;0.5293140151796938;0.5600704034198238;0.9999567459343585;-0.09191932184683405;-0.18755533201681696;-0.4706427307546647;-0.4398863425145346
Reduced C-peptide level;Aplastic zygomatic arch;0.9330791085958481;0.9981772;0.521317512974437;0.5005802280040339;0.9999548690865008;-0.06687576049065269;-0.001777698333021771;-0.4786373561120638;-0.4993746410824669
Reduced C-peptide level;Testicular torsion;0.8748931288719177;1.0740758;0.5399273749663684;0.47639932455024914;0.9999567459343585;-0.12506361706244074;0.07411907212747015;-0.46002937096799;-0.5235574213841093
Reduced C-peptide level;Abolished vibration sense;0.7119127810001373;1.0045782;0.5930193067451107;0.4985426943047836;0.9999548690865008;-0.28804208808636345;0.004623363678696979;-0.40693556234139006;-0.5014121747817172
Reduced C-peptide level;Fractured metatarsal bone of digit 5;0.8016000390052795;0.950213;0.5635744926871664;0.5158542450648884;0.9999056439461368;-0.19830560494085725;-0.0496926288666385;-0.4363311512589704;-0.4840513988812484
Reduced C-peptide level;Prolonged G2 phase of cell cycle;0.8956636488437653;0.861726;0.5332718459349954;0.5441554668247441;0.8383144321532123;0.05734921669055293;0.023411553850663402;-0.3050425862182169;-0.2941589653284682
Reduced C-peptide level;Single naris;0.9124155417084694;1.0126342;0.5279147660287272;0.49597832030939837;0.9999528219730685;-0.08753728026459906;0.012681336161391998;-0.47203805594434123;-0.5039745016636701
Reduced C-peptide level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8333813846111298;0.8933977;0.5532848669412478;0.5339971737781133;0.9999056439461368;-0.16652425933500703;-0.10650795508047517;-0.446620777004889;-0.4659084701680235
Reduced C-peptide level;Asymmetry of the thorax;0.8112855553627014;0.9997653;0.5604320564578762;0.500074724167481;0.9999528219730685;-0.18866726661036703;-0.00018754506419393913;-0.43952076551519226;-0.49987809780558745
Reduced C-peptide level;Type 2 muscle fiber predominance;0.9022883400321007;0.9426019;0.5311522935659693;0.5182804330591968;0.9999515360511232;-0.09766319601902251;-0.057349616876928855;-0.4687992424851539;-0.4816711029919264
Reduced C-peptide level;Dependency on parenteral nutrition;0.6824451088905334;0.8133621;0.6028617740983442;0.5597591071001806;0.9999548690865008;-0.3175097601959673;-0.18659274750446952;-0.3970930949881566;-0.44019576198632016
Reduced C-peptide level;Limited shoulder flexion;0.7396526336669922;1.0721742;0.5838370812549765;0.47700623942764153;0.9999056439461368;-0.2602530102791446;0.07226854752877776;-0.4160685626911603;-0.5228994045184953
Reduced C-peptide level;Paroxysmal vertigo;0.7168931663036346;1.0179354;0.5913651005889854;0.4942906743302624;0.9999548690865008;-0.28306170278286613;0.017980526154282916;-0.4085897684975154;-0.5056641947562384
Reduced C-peptide level;Long hallux;0.9920797189697623;0.9952314;0.5025211301125203;0.5015179044238676;0.9999478876548411;-0.00786816868507878;-0.004716497655451457;-0.4974267575423208;-0.49842998323097354
Reduced C-peptide level;Broad medial eyebrow;0.9708956256508827;0.90338564;0.5092655184827242;0.5308013590385373;0.9999567459343585;-0.02906112028347574;-0.09657110674368463;-0.4906912274516343;-0.46915538689582115
Reduced C-peptide level;Myxoid subcutaneous tumors;0.8269505351781845;0.994488;0.5553620497518512;0.5017545362577235;0.9999567459343585;-0.17300621075617395;-0.005468745064607483;-0.44459469618250724;-0.498202209676635
Reduced C-peptide level;Bulbous tips of toes;0.9315697178244591;0.97325975;0.5217990710555016;0.5085126950499463;0.9999548690865008;-0.0683851512620417;-0.026695122058149945;-0.47815579803099917;-0.49144217403655444
Reduced C-peptide level;Absent internal genitalia;0.9038543328642845;1.1224495;0.530651464273705;0.4609250376958359;0.9999056439461368;-0.09605131108185228;0.12254387330392424;-0.46925417967243177;-0.5389806062503009
Reduced C-peptide level;Hyperphalangy of the 2nd finger;0.7934973239898682;0.9545958;0.5662082135089317;0.514457571216809;0.9999567459343585;-0.2064594219444903;-0.04536094171988092;-0.43374853242542677;-0.48549917471754944
Reduced C-peptide level;Renal interstitial hemosiderin;0.8370891809463501;0.8951638;0.5520882841408867;0.5334318383129032;0.9999056439461368;-0.1628164629997867;-0.10474186945578035;-0.44781735980525006;-0.4664738056332336
Reduced C-peptide level;Abnormality of depressor anguli oris muscle;0.8076868653297424;1.0346879;0.5615989275919764;0.4889562880650067;0.9999056439461368;-0.19221877861639436;0.03478223275521819;-0.4383067163541604;-0.5109493558811301
Reduced C-peptide level;Paroxysmal dyspnea;0.6974219977855682;0.90825796;0.5978472772319026;0.5292435132329376;0.9999056439461368;-0.30248364616056855;-0.09164768267294343;-0.4020583667142342;-0.4706621307131992
Reduced C-peptide level;Phenylpyruvic acidemia;0.6958079934120178;0.86902475;0.5983864427788385;0.5418108427743323;0.851762385589393;-0.15595439217737517;0.01726236798116365;-0.25337594281055453;-0.30995154281506065
Reduced C-peptide level;Lateral ventricle dilatation;0.7493390440940857;0.8067876;0.5806479310419754;0.561890650075956;0.9999433058680118;-0.25060426177392614;-0.19315569581399572;-0.4192953748260364;-0.4380526557920559
Reduced C-peptide level;Neonatal unconjugated hyperbilirubinemia;0.8663654327392578;1.0508834;0.5426648385740116;0.48379630113410155;0.7516843477913018;0.11468108494795604;0.29919906456984324;-0.20901950921729018;-0.26788804665720023
Reduced C-peptide level;High maternal circulating alpha-fetoprotein concentration;0.830266535282135;0.863652;0.5542906805505741;0.5435365330314186;0.9999056439461368;-0.16963910866400178;-0.13625365305563386;-0.4456149633955627;-0.4563691109147182
Reduced C-peptide level;Prominent nasolabial fold;0.8565299212932587;1.0027235;0.5458260825594246;0.49913309465842226;0.9999501780647019;-0.1434202567714432;0.0027732773643752706;-0.4541240955052773;-0.5008170834062796
Reduced C-peptide level;Abnormality of inferior alveolar nerve;0.8234561383724213;0.98077494;0.5564917435813829;0.5061198980581403;0.9999056439461368;-0.17644950557371553;-0.01913070488592561;-0.4434139003647539;-0.4937857458879965
Reduced C-peptide level;Unilateral conductive hearing impairment;0.8353210836648941;1.065101;0.5526587921076742;0.4792630435214321;0.9999567459343585;-0.16463566226946436;0.06514428155435004;-0.44729795382668425;-0.5206937024129263
Reduced C-peptide level;Macular hypopigmented whorls, streaks, and patches;0.8973848447203636;0.9720514;0.5327210153291486;0.5088974829570965;0.9999567459343585;-0.10257190121399484;-0.027905363869539124;-0.46723573060520984;-0.491059262977262
Reduced C-peptide level;Delayed ossification of pubic rami;0.7885615527629852;1.0014168;0.5678147902945598;0.4995490010352529;0.9999548690865008;-0.21139331632351555;0.0014619333198102602;-0.43214007879194094;-0.5004058680512479
Reduced C-peptide level;Hyperphenylalaninemia;0.8425007164478302;0.85878;0.5503431965871497;0.5451024737637225;0.7251438428351311;0.11735687361269909;0.13363618360072094;-0.17480064624798142;-0.18004136907140866
Reduced C-peptide level;Ureteropelvic junction obstruction;0.7141819000244141;0.9414408;0.592265314177185;0.5186506307133959;0.9999481150251853;-0.28576621500077126;-0.0585072943312156;-0.40768280084800035;-0.4812974843117894
Reduced C-peptide level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7697484493255615;0.9404912;0.5739549001893307;0.5189534338234829;0.9999056439461368;-0.23015719462057527;-0.05941444445272859;-0.4259507437568061;-0.4809522101226539
Reduced C-peptide level;Difficulty walking;0.8830606937408447;0.9554724;0.5373082996527765;0.5141782529261663;0.9999398952172014;-0.11687920147635666;-0.04446748549201218;-0.4626315955644249;-0.48576164229103513
Reduced C-peptide level;Bilobate gallbladder;0.8742265105247498;1.0725183;0.5401412555842113;0.4768963958299167;0.9999548690865008;-0.12572835856175102;0.07256347960734688;-0.45981361350228944;-0.5230584732565841
Reduced C-peptide level;Histidinuria;0.8501805663108826;0.9194779;0.5478692368079827;0.5256587728667264;0.8413020594063172;0.008878506904565375;0.07817582059475092;-0.2934328225983345;-0.31564328653959084
Reduced C-peptide level;Widened interpedicular distance;0.9000104367733002;1.0538439;0.5318809415666308;0.4828526618289414;0.9999056439461368;-0.09989520717283662;0.05393821191171233;-0.468024702379506;-0.5170529821171954
Loss of voice;Elevated circulating growth hormone concentration;1.083976112306118;1.1538259;0.4732380560246914;0.4508405237874755;0.9999505803237132;0.08402553198240481;0.15387529877327166;-0.5267125242990218;-0.5491100565362377
Loss of voice;Visual acuity no light perception;0.7286108434200287;0.95485497;0.5874830360556715;0.5143749918452194;0.9999056439461368;-0.2712948005261081;-0.04505067873617585;-0.41242260789046525;-0.4855306521009174
Loss of voice;Spinal hypomyelination;0.7388429045677185;1.010044;0.5841040620399829;0.49680283251982627;0.9999056439461368;-0.2610627393784183;0.010138334744964284;-0.4158015819061539;-0.5031028114263105
Loss of voice;Bladder polyp;0.8486994504928589;0.92454493;0.5483461267914059;0.5240409347153131;0.9999567459343585;-0.15125729544149957;-0.07541181547628961;-0.45161061914295253;-0.47591581121904536
Loss of voice;Aberrant melanosome maturation;0.8924079537391663;1.0607439;0.5343140339269987;0.48065271334898774;0.9999567459343585;-0.1075487921951922;0.06078718202126898;-0.46564271200735974;-0.5193040325853707
Loss of voice;Vertebral artery tortuosity;0.8419894278049469;0.94558036;0.5505080085455846;0.5173308709682171;0.9999567459343585;-0.15796731812941156;-0.054376382660737854;-0.4494487373887739;-0.4826258749661414
Loss of voice;Warm reactive autoantibody positivity;1.074395403265953;1.1419431;0.4762973088162332;0.45466498263438004;0.9999056439461368;0.07448975931981627;0.1420374531684262;-0.5236083351299036;-0.5452406613117567
Loss of voice;Right aortic arch with retroesophageal left subclavian artery;1.017840426415205;0.73044986;0.49432091461381356;0.5868749977769695;0.9999056439461368;0.01793478246906821;-0.2694557886185306;-0.5055847293323232;-0.4130306461691673
Loss of voice;Elevated urine suberic acid level;0.9854587893933058;0.99889857;0.5046287742262193;0.5003505900643006;0.9999567459343585;-0.014497956541052681;-0.001058180165162903;-0.49532797170813914;-0.49960615587005786
Loss of voice;Burkitt lymphoma;0.979183703660965;1.1320074;0.5066265115418827;0.4578577428034458;0.9999536937290383;-0.02076999006807334;0.13205366672933572;-0.49332718218715566;-0.5420959509255925
Loss of voice;Snail-like ilia;1.0316911563277245;1.1176968;0.4899107023257723;0.46244892765811974;0.9999567459343585;0.031734410393366;0.11774001615060248;-0.5100460436085862;-0.5375078182762387
Loss of voice;Indurated nodule;0.913615994155407;1.0487835;0.5275311962744575;0.48446553316812635;0.9999056439461368;-0.08628964979072984;0.04887789677957122;-0.47237444767167924;-0.5154401107780104
Loss of voice;Absent leukocyte alkaline phosphatase;0.9210269525647163;1.1547394;0.5251641051170559;0.4505462189189845;0.9999567459343585;-0.07892979336964212;0.15478263394845404;-0.47479264081730255;-0.549410527015374
Loss of voice;Hippocampal sclerosis;0.9500961825251579;1.1570966;0.5158914791201548;0.4497866039015229;0.9999056439461368;-0.04980946142097886;0.15719098042825286;-0.48401416482598203;-0.5501190400446139
Loss of voice;Decreased sensitivity to hypoxemia;0.6454151272773743;0.8221848;0.6153778018879683;0.5569029235547371;0.9999567459343585;-0.3545416186569842;-0.1777719448326739;-0.38457894404639015;-0.4430538223796213
Loss of voice;Decreased level of tissue plasminogen activator;0.8663418889045715;1.0143518;0.5426724006480412;0.495431515006745;0.9999056439461368;-0.13356375504156526;0.014446200841460866;-0.45723324329809556;-0.5044741289393918
Loss of voice;Submandibular lymph node enlargement;0.9381667971611023;0.93481046;0.5196946833079816;0.5207652028681173;0.9999567459343585;-0.061789948773256165;-0.06514628632055841;-0.48026206262637683;-0.4791915430662411
Loss of voice;Hepatic hemangioma;0.9650287143886089;1.0730792;0.5111339761879965;0.47671739681021186;0.9999548690865008;-0.03492615469789184;0.07312435931468331;-0.4888208928985043;-0.5232374722762889
Loss of voice;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9928882159292698;1.1862012;0.502263770261021;0.4403823769189996;0.9999056439461368;-0.007017428016867;0.18629557084420745;-0.4976418736851158;-0.5595232670271372
Loss of voice;Acne inversa;0.8469456136226654;0.88122344;0.5489109690982632;0.5378972297701831;0.9999505803237132;-0.1530049667010478;-0.11872714015342511;-0.45103961122545;-0.46205335055353014
Loss of voice;Dentin dysplasia;0.897542729973793;1.0693384;0.5326704926004977;0.477911174253945;0.9999056439461368;-0.10236291397234376;0.06943279694894378;-0.4672351513456391;-0.5219944696921918
Loss of voice;Aplasia of the inner ear;0.7344979047775269;0.96831423;0.5855377194699936;0.5100875809642171;0.9999567459343585;-0.2654588411568316;-0.03164251549231134;-0.4144190264643649;-0.4898691649701413
Loss of voice;Polycystic liver disease;0.9467193558812141;0.96415263;0.5169677903356309;0.5114130078819304;0.9999528219730685;-0.05323346609185431;-0.035800187829239105;-0.48298503163743756;-0.488539814091138
Loss of voice;Subungual hyperkeratosis;0.9403002262115479;1.072735;0.5190143343405642;0.47682727344068176;0.9999515360511232;-0.05965130983957534;0.07278341592183823;-0.480937201710559;-0.5231242626104414
Loss of voice;Broad humeral epiphyses;1.0929438322782516;1.061881;0.4703722976928689;0.4802900867987404;0.9999056439461368;0.09303818833211486;0.061975302213226;-0.5295333462532679;-0.5196155571473964
Loss of voice;Autoimmune thrombocytopenia;0.917575478553772;1.083473;0.526266338873689;0.4733987668842874;0.9999457950338347;-0.08237031648006277;0.08352717211399241;-0.47367945616014573;-0.5265470281495473
Loss of voice;Adenomyosis;0.9288497418165207;0.9543297;0.5226669828222046;0.5145423665696955;0.9999567459343585;-0.07110700411783777;-0.045627016854158264;-0.4772897631121539;-0.4854143793646629
Loss of voice;Elevated leukocyte alkaline phosphatase;1.0470021404325962;1.1573322;0.4850332398110657;0.449710679443999;0.9999567459343585;0.04704539449823775;0.15737543599618353;-0.5149235061232927;-0.5502460664903595
Loss of voice;Clasp-knife sign;0.9225432723760605;0.9255687;0.524679962322907;0.523714158801617;0.9999056439461368;-0.0773623715700763;-0.07433694410940583;-0.47522568162322976;-0.4761914851445198
Loss of voice;Keratosis pilaris;0.8774983584880829;0.9613191;0.5390916750503068;0.512315588825021;0.9999455218634979;-0.12244716337541506;-0.03862643292764589;-0.4608538468131912;-0.4876299330384769
Loss of voice;Lamina lucida cleavage;0.8969798907637596;1.0012589;0.532850602963411;0.49959928123328745;0.9999505803237132;-0.10297068955995359;0.0013082697739430493;-0.4670999773603022;-0.5003512990904257
Loss of voice;Abnormal central response of multifocal electroretinogram;0.8506346046924591;1.0474502;0.5477230671634133;0.48489045879613;0.9999056439461368;-0.14927103925367768;0.04754454087594573;-0.45218257678272344;-0.5150151851500068
Loss of voice;Atypical or prolonged hepatitis;0.9338301718235016;0.971676;0.5210779110167201;0.5090170123444036;0.9999567459343585;-0.06612657411085687;-0.028280753922334534;-0.4788788349176384;-0.4909397335899549
Loss of voice;Cubitus varus;0.9244613125920296;0.9708927;0.5240676368018237;0.5092664461687952;0.9999056439461368;-0.07544433135410722;-0.029012916571106273;-0.4758380071443131;-0.49063919777734155
Loss of voice;Nasal regurgitation;0.6210457682609558;0.5739693;0.6237162244514526;0.6400884473681354;0.9999548690865008;-0.37890910082554496;-0.4259855645248858;-0.3762386446350482;-0.35986642171836536
Loss of voice;Moon facies;0.9938984466716647;0.93208313;0.501942196796606;0.5216352563145812;0.9999548690865008;-0.00605642241483606;-0.06787173920368827;-0.49801267228989476;-0.4783196127719196
Loss of voice;Intestinal pseudo-obstruction;0.9420062005519867;1.0254421;0.518470363087759;0.4919006347825351;0.9999494774285466;-0.05794327687655987;0.025492645984539375;-0.4814791143407876;-0.5080488426460115
Loss of voice;Bilateral renal atrophy;0.86582350730896;0.99467635;0.542838906435827;0.5016945843112968;0.9999567459343585;-0.1341332386253985;-0.005280394387117249;-0.45711783949853146;-0.4982621616230617
Loss of voice;Fractured left clavicle;0.838375598192215;0.8658898;0.5516733049753482;0.542817621105399;0.9999056439461368;-0.16153004575392182;-0.1340158562721866;-0.4482323389707886;-0.4570880228407378
Loss of voice;Positive urine norcotinine test;0.8912604600191116;0.902441;0.5346814482111645;0.5311034639489944;0.9999056439461368;-0.10864518392702516;-0.09746461916586335;-0.4652241957349723;-0.46880217999714235
Loss of voice;Long fibula;1.023080425336957;1.1435789;0.49265262000715837;0.45413891556381947;0.9999528219730685;0.023127603363888527;0.14362606501271036;-0.5073002019659101;-0.545813906409249
Loss of voice;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8904109299182892;1.1606934;0.5349534878345485;0.4486269744661048;0.9999056439461368;-0.1094947140278476;0.16078776311257903;-0.46495215611158824;-0.551278669480032
Loss of voice;Type II cryptotia;0.9218993782997131;1.0618411;0.5248855429522872;0.4803027956066329;0.9999056439461368;-0.07800626564642366;0.06193548631051604;-0.4750201009938496;-0.5196028483395039
Loss of voice;Increased variability in muscle fiber diameter;0.9748766496777534;1.041591;0.5079978522831833;0.4867573419627581;0.9999413779434757;-0.025064728265722258;0.041649670297185915;-0.4919435256602924;-0.5131840359807176
Loss of voice;Widened proximal tibial metaphyses;1.1505893766880035;1.1755967;0.451882870363844;0.4438145082977173;0.9999567459343585;0.15063263075364508;0.17563996808541693;-0.5480738755705145;-0.5561422376366412
Loss of voice;Wide anterior fontanel;0.978504091501236;0.8667101;0.5068428872434758;0.5425541287525457;0.9999418169014338;-0.021437725400197838;-0.1332316905014399;-0.493098929657958;-0.4573876881488881
Loss of voice;Increased circulating oleate level;1.0745589658617973;1.1886954;0.47624510022692323;0.4395741114046736;0.9999056439461368;0.07465332191566054;0.18878978680947844;-0.5236605437192136;-0.5603315325414632
Loss of voice;Lozenge-shaped umbilicus;0.8828700333833694;0.9535159;0.5373694086809716;0.5148016899772073;0.9999548690865008;-0.11708483570313133;-0.04643898182606376;-0.46258546040552917;-0.48515317910929345
Loss of voice;Anti-myelin-associated glycoprotein antibody positivity;1.023490684106946;1.1150489;0.49252199516554895;0.4632975438379777;0.9999056439461368;0.0235850401608092;0.1151432413993222;-0.5073836487805878;-0.5366081001081591
Loss of voice;Fractured radius;0.8311467468738556;1.0833129;0.5540063970570146;0.47344992723356616;0.9999567459343585;-0.16880999906050287;0.08335612313760199;-0.44595034887734386;-0.5265068187007923
Loss of voice;Abnormal manual kinetic perimetry test;0.8939864337444305;1.0708815;0.5338086976705687;0.4774187842148777;0.9999056439461368;-0.10591921020170625;0.07097584199288909;-0.4660969462755681;-0.5224868597312591
Loss of voice;Small radial epiphyses;1.0286502316594124;1.1519455;0.49087909993752055;0.45144618208873033;0.9999056439461368;0.028744587713275593;0.15203982781747405;-0.5090265440086162;-0.5484594618574065
Loss of voice;Generalized keratosis follicularis;0.9487721435725689;1.1197479;0.5163134736846284;0.4617913773303717;0.9999567459343585;-0.051184602361789566;0.11979113118661322;-0.48364327224973;-0.5381653686039868
Loss of voice;Hypoplasia of the calcaneus;0.8497063666582108;1.1071014;0.5480219078777147;0.46584301929817307;0.9999548690865008;-0.15024850242829002;0.10714657134318673;-0.4519329612087861;-0.5341118497883277
Loss of voice;2-hydroxyadipic aciduria;0.9594470448791981;1.0589777;0.512911947219624;0.481215914365027;0.9999056439461368;-0.040458599066938716;0.059072079175506276;-0.4869936967265128;-0.5186897295811098
Loss of voice;Potter facies;1.0938940420746803;0.9699068;0.4700685080029118;0.5095803983329081;0.9999510285821799;0.09394301349250045;-0.030044221636379098;-0.5298825205792681;-0.49037063024927174
Loss of voice;Increased heart rate variability;1.0082566235214472;0.7998144;0.4973718052445737;0.5641545087333514;0.9999567459343585;0.008299877587088722;-0.20014234287726007;-0.5025849406897848;-0.4358022372010071
Loss of voice;Aplastic zygomatic arch;0.9044771865010262;0.9234184;0.5304522870484999;0.5244005602706081;0.9999548690865008;-0.09547768258547462;-0.07653646641468681;-0.4695025820380009;-0.47555430881589267
Loss of voice;Testicular torsion;0.9589160680770874;1.0557538;0.5130811033651769;0.482243787678973;0.9999567459343585;-0.04104067785727106;0.05579708116067328;-0.4868756425691816;-0.5177129582553854
Loss of voice;Abolished vibration sense;0.5396313965320587;0.6613854;0.6522827520416787;0.6099582646169803;0.9999548690865008;-0.46032347255444206;-0.33856945210194267;-0.34767211704482204;-0.38999660446952045
Loss of voice;Fractured metatarsal bone of digit 5;0.912882573902607;1.1282034;0.5277655346408788;0.45907895973655555;0.9999056439461368;-0.08702307004352983;0.1282977480826718;-0.47214010930525796;-0.5408266842095812
Loss of voice;Prolonged G2 phase of cell cycle;1.0599160119891167;1.1135509;0.48091671146775583;0.4637775006173481;0.9999528219730685;0.05996319001604822;0.11359807943989542;-0.5190361105053126;-0.5361753213557203
Loss of voice;Single naris;0.8749845921993256;0.8381872;0.5398980309058841;0.5517340585626407;0.9999528219730685;-0.12496822977374289;-0.1617656042606661;-0.4600547910671844;-0.44821876341042777
Loss of voice;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9745827540755272;1.0900007;0.5080914320434415;0.4713130570522719;0.9999056439461368;-0.0253228898706096;0.09009510468820159;-0.49181421190269525;-0.5285925868938649
Loss of voice;Asymmetry of the thorax;0.9131544306874275;0.78047466;0.5276786707177776;0.5704508628020317;0.9999528219730685;-0.08679839128564093;-0.21947815919230673;-0.4722741512552908;-0.42950195917103673
Loss of voice;Type 2 muscle fiber predominance;1.0172093156725168;1.0630212;0.4945218342615274;0.47992643182801453;0.9999515360511232;0.017257779621393632;0.06306964696279282;-0.5054297017895958;-0.5200251042231087
Loss of voice;Dependency on parenteral nutrition;0.9304415956139565;1.0293428;0.5221590212703129;0.4906585770803368;0.9999548690865008;-0.06951327347254432;0.029387901489976276;-0.4777958478161879;-0.509296292006164
Loss of voice;Limited shoulder flexion;0.833229273557663;0.9017414;0.5533339724500395;0.5313272364623782;0.9999056439461368;-0.16667637038847383;-0.09816425848623689;-0.44657167149609733;-0.46857840748375856
Loss of voice;Paroxysmal vertigo;0.5811501145362854;0.7686263;0.6375666512598529;0.5743220128300439;0.9999548690865008;-0.4188047545502154;-0.23132859640812553;-0.3623882178266479;-0.42563285625645686
Loss of voice;Long hallux;0.937673807144165;1.0822568;0.5198519101656606;0.47378724187191634;0.9999478876548411;-0.062274080510676066;0.08230890632098897;-0.48009597748918054;-0.5261606457829248
Loss of voice;Broad medial eyebrow;1.0221419669687748;1.0859463;0.4929514169866692;0.47260863830500077;0.9999567459343585;0.022185221034416336;0.0859895755530683;-0.5070053289476892;-0.5273481076293577
Loss of voice;Myxoid subcutaneous tumors;0.9184259921312332;1.0502079;0.5259946972020302;0.4840116182325258;0.9999567459343585;-0.08153075380312524;0.05025110738290228;-0.4739620487323283;-0.5159451277018327
Loss of voice;Bulbous tips of toes;0.9421645849943161;1.0970035;0.5184198629915291;0.4690742166706856;0.9999548690865008;-0.057790284092184674;0.09704859084391915;-0.4815350060949717;-0.5308806524158152
Loss of voice;Absent internal genitalia;0.8194792419672012;0.96925735;0.5577782997170809;0.5097872311828009;0.9999056439461368;-0.18042640197893556;-0.030648289209808666;-0.44212734422905586;-0.4901184127633359
Loss of voice;Hyperphalangy of the 2nd finger;0.9379572011530399;1.0697787;0.5197615281317167;0.4777707108043897;0.9999567459343585;-0.06199954478131853;0.06982193486703314;-0.48019521780264174;-0.5221860351299688
Loss of voice;Renal interstitial hemosiderin;0.9928497979417443;1.1439582;0.5022759993971947;0.45401690068200495;0.9999056439461368;-0.007055846004392463;0.1440525669989926;-0.4976296445489421;-0.5458887432641318
Loss of voice;Abnormality of depressor anguli oris muscle;0.801214337348938;0.8350625;0.5636997604101335;0.5527422513697406;0.9999056439461368;-0.1986913065971988;-0.16484314013143953;-0.4362058835360033;-0.44716339257639615
Loss of voice;Paroxysmal dyspnea;0.6436867117881775;0.5442157;0.6159664125787557;0.6506411676252655;0.9999056439461368;-0.3562189321579593;-0.4556899647774356;-0.38393923136738106;-0.3492644763208713
Loss of voice;Phenylpyruvic acidemia;0.9202189669013023;0.9391435;0.5254221090376758;0.5193832044789177;0.9999567459343585;-0.07973777903305612;-0.060813267063966614;-0.4745346368966826;-0.48057354145544073
Loss of voice;Lateral ventricle dilatation;0.8603312373161316;0.92728007;0.5446037746179404;0.5231679327321308;0.9999433058680118;-0.13961206855188024;-0.07266323747048986;-0.4553395312500714;-0.47677537313588103
Loss of voice;Neonatal unconjugated hyperbilirubinemia;0.9026325047016144;0.8763709;0.5310422176678655;0.5394533053599194;0.9999567459343585;-0.09732424123274408;-0.12358583910452448;-0.46891452826649294;-0.46050344057443904
Loss of voice;High maternal circulating alpha-fetoprotein concentration;1.082164540886879;1.0696869;0.4738166971626898;0.4777999977571823;0.9999056439461368;0.08225889694074218;0.06978124570230071;-0.526088946783447;-0.5221056461889545
Loss of voice;Prominent nasolabial fold;0.7518375068902969;0.6814214;0.5798266921999465;0.6032054803006509;0.9999501780647019;-0.24811267117440494;-0.31852877894818576;-0.42012348586475534;-0.39674469776405097
Loss of voice;Abnormality of inferior alveolar nerve;0.8338154256343842;0.98588896;0.5531447539451606;0.5044918320727794;0.9999056439461368;-0.16609021831175264;-0.014016685968841869;-0.4467608900009762;-0.4954138118733574
Loss of voice;Unilateral conductive hearing impairment;0.6620908975601196;0.7376248;0.6097196466087627;0.5845057971095884;0.9999567459343585;-0.33786584837423883;-0.26233192188726984;-0.3902370993255958;-0.41545094882477007
Loss of voice;Macular hypopigmented whorls, streaks, and patches;0.8946299254894257;1.067947;0.533602714155414;0.47835512362394417;0.9999567459343585;-0.1053268204449328;0.06799028413308539;-0.4663540317789444;-0.5216016223104143
Loss of voice;Delayed ossification of pubic rami;0.9382643587887287;1.1146748;0.5196635690341116;0.4634173767178571;0.9999548690865008;-0.06169051029777206;0.11471993750834786;-0.4802913000523892;-0.5365374923686437
Loss of voice;Hyperphenylalaninemia;0.9872807674109936;0.9751295;0.5040487666502436;0.507917350661707;0.9999521228478421;-0.012671355436848497;-0.024822637717532015;-0.4959033561975985;-0.4920347721861351
Loss of voice;Ureteropelvic junction obstruction;0.7856539487838745;0.98981434;0.5687620244729775;0.5032422493314033;0.9999481150251853;-0.2142941662413108;-0.010133773956917502;-0.4311860905522078;-0.49670586569378206
Loss of voice;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9362263381481171;1.1873002;0.5203135724331527;0.44002626394040234;0.9999056439461368;-0.06367930579801973;0.1873945612845761;-0.4795920715129841;-0.5598793800057345
Loss of voice;Difficulty walking;0.8036628067493439;0.9288361;0.5629047182912676;0.5226713338676069;0.9999398952172014;-0.19627708846785752;-0.07110378796317307;-0.43703517692593374;-0.4772685613495945
Loss of voice;Bilobate gallbladder;0.8789687305688858;0.9362007;0.5386201321813219;0.5203217568680789;0.9999548690865008;-0.12098613851761497;-0.06375419073795952;-0.4613347369051789;-0.47963311221842186
Loss of voice;Histidinuria;0.9817137904465199;1.096508;0.5058210057223878;0.4692326591667274;0.9999536937290383;-0.018239903282518455;0.09655433239400857;-0.49413268800665056;-0.5307210345623109
Loss of voice;Widened interpedicular distance;1.064108096063137;1.0417819;0.4795797555664605;0.4866965312495125;0.9999056439461368;0.06420245211700026;0.04187625836709563;-0.5203258883796763;-0.5132091126966243
Elevated circulating growth hormone concentration;Visual acuity no light perception;0.9103875160217285;1.0050547;0.5285628554299542;0.4983910356642227;0.9998962300503706;-0.08950871402864213;0.0051584822451615775;-0.47133337462041647;-0.5015051943861479
Elevated circulating growth hormone concentration;Spinal hypomyelination;0.9116242974996567;1.0643226;0.5281676073489805;0.47951133142433844;0.6800123916089407;0.231611905890716;0.3843101992190012;-0.15184478425996017;-0.20050106018460223
Elevated circulating growth hormone concentration;Bladder polyp;0.8775828257203102;1.019706;0.5390645843980446;0.4937269711531508;0.9999548690865008;-0.12237204336619056;0.01975114173198067;-0.46089028468845616;-0.50622789793335
Elevated circulating growth hormone concentration;Aberrant melanosome maturation;0.808695524930954;0.91302764;0.5612717870089793;0.5277191718832894;0.9999548690865008;-0.1912593441555468;-0.08692722492909111;-0.4386830820775215;-0.47223569720321135
Elevated circulating growth hormone concentration;Vertebral artery tortuosity;0.7814400792121887;0.96839875;0.5701359127217552;0.5100606581965885;0.9999548690865008;-0.21851478987431205;-0.03155611925816215;-0.42981895636474554;-0.48989421088991225
Elevated circulating growth hormone concentration;Warm reactive autoantibody positivity;0.733381062746048;0.8266947;0.585906514065911;0.5554447155821213;0.9998962300503706;-0.2665151673043227;-0.17320150310640092;-0.41398971598445966;-0.4444515144682494
Elevated circulating growth hormone concentration;Right aortic arch with retroesophageal left subclavian artery;0.8162432909011841;1.086072;0.5588258581202503;0.4725685187999046;0.9998962300503706;-0.18365293914918657;0.08617573802824263;-0.44107037193012033;-0.5273277112504661
Elevated circulating growth hormone concentration;Elevated urine suberic acid level;0.6777122020721436;0.7943976;0.6044518764843079;0.5659153648563223;0.9999548690865008;-0.3222426670143572;-0.2055572765419451;-0.3955029926021929;-0.43403950423017845
Elevated circulating growth hormone concentration;Burkitt lymphoma;0.9025055393576622;0.96411735;0.5310828251911259;0.5114242588449094;0.9999515360511232;-0.09744599669346099;-0.035834187857000876;-0.46886871085999726;-0.4885272772062138
Elevated circulating growth hormone concentration;Snail-like ilia;0.9644518494606018;0.9772982;0.511317712250374;0.5072268198710643;0.9999548690865008;-0.03550301962589897;-0.02265666895603813;-0.48863715683612674;-0.49272804921543645
Elevated circulating growth hormone concentration;Indurated nodule;0.7585059702396393;0.9469905;0.5776374221714868;0.5168813659144369;0.9998962300503706;-0.24139025981073137;-0.05290574009065385;-0.4222588078788838;-0.48301486413593375
Elevated circulating growth hormone concentration;Absent leukocyte alkaline phosphatase;0.7914629578590393;0.9044493;0.5668701830365901;0.5304612047130921;0.9999548690865008;-0.20849191122746147;-0.0955055850098101;-0.4330846860499107;-0.46949366437340867
Elevated circulating growth hormone concentration;Hippocampal sclerosis;0.8151781111955643;0.96083134;0.5591708239287461;0.5124709581970346;0.6486170521183526;0.16656105907721164;0.3122142920093024;-0.08944622818960657;-0.13614609392131805
Elevated circulating growth hormone concentration;Decreased sensitivity to hypoxemia;0.936929315328598;1.0018945;0.5200893564477278;0.499396957968574;0.9999548690865008;-0.06302555375790275;0.0019396049430402407;-0.479865512638773;-0.5005579111179268
Elevated circulating growth hormone concentration;Decreased level of tissue plasminogen activator;0.8810984790325165;1.0217719;0.5379372804674248;0.49306925252190614;0.9998962300503706;-0.11879775101785417;0.021875677756025835;-0.4619589495829458;-0.5068269775284645
Elevated circulating growth hormone concentration;Submandibular lymph node enlargement;0.778915211558342;0.9029396;0.5709597545542073;0.5309439953557624;0.9999548690865008;-0.2210396575281588;-0.0970152514526812;-0.42899511453229344;-0.46901087373073835
Elevated circulating growth hormone concentration;Hepatic hemangioma;0.6758859753608704;0.8743936;0.605066150480192;0.5400876498559866;0.9999528219730685;-0.3240668466121981;-0.12555923962901328;-0.3948866714928765;-0.4598651721170819
Elevated circulating growth hormone concentration;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8474811166524887;0.99492264;0.5487384881227266;0.501616178519214;0.9998962300503706;-0.15241511339788194;-0.004973592110917524;-0.451157741927644;-0.4982800515311566
Elevated circulating growth hormone concentration;Acne inversa;0.9589703530073166;1.0150578;0.5130638093531525;0.49520676473066505;0.9999481150251853;-0.040977762017868735;0.015109687175132058;-0.4868843056720328;-0.5047413502945203
Elevated circulating growth hormone concentration;Dentin dysplasia;0.9612827487289906;1.0166041;0.5123271649436865;0.49471450337483147;0.9998962300503706;-0.038613481321380094;0.016707835844709917;-0.4875690651066842;-0.5051817266755392
Elevated circulating growth hormone concentration;Aplasia of the inner ear;0.74081951379776;1.0602657;0.5834524481174734;0.4808052205987585;0.9999548690865008;-0.25913535528874077;0.06031079119944893;-0.41650242096902734;-0.5191496484877423
Elevated circulating growth hormone concentration;Polycystic liver disease;0.7462931573390961;1.0397173;0.5816498500873708;0.4873542509677272;0.9999505803237132;-0.25365742298461713;0.03976673630378924;-0.4183007302363424;-0.512596329355986
Elevated circulating growth hormone concentration;Subungual hyperkeratosis;0.7527123391628265;0.9834327;0.5795392654418908;0.5052737728189491;0.9999491674684583;-0.24723682830563176;-0.01651645729771245;-0.4204099020265675;-0.49467539464950916
Elevated circulating growth hormone concentration;Broad humeral epiphyses;0.5998626351356506;0.9668058;0.631037589438689;0.5105679783617437;0.9998962300503706;-0.40003359491472;-0.03309041435365434;-0.3688586406116816;-0.4893282516886269
Elevated circulating growth hormone concentration;Autoimmune thrombocytopenia;0.7575000822544098;1.0517625;0.5779674146434836;0.4835161443563595;0.9999428147971705;-0.24244273254276072;0.05181964686512197;-0.42197540015368695;-0.516426670440811
Elevated circulating growth hormone concentration;Adenomyosis;0.766513779759407;1.1082813;0.5750133745979643;0.46546527827708783;0.9999548690865008;-0.23344108932709373;0.10832638568187081;-0.42494149448853646;-0.5344895908094129
Elevated circulating growth hormone concentration;Elevated leukocyte alkaline phosphatase;0.6750062108039856;0.84813136;0.6053622150539507;0.5485290652936003;0.9999548690865008;-0.3249486582825152;-0.15182351046299614;-0.39459265403255006;-0.4514258037929004
Elevated circulating growth hormone concentration;Clasp-knife sign;0.9300602376461029;0.9791233;0.5222807076414074;0.5066457469733572;0.8372878781858968;0.09277235946020612;0.14183541616758832;-0.31500717054448935;-0.3306421312125396
Elevated circulating growth hormone concentration;Keratosis pilaris;0.9580310434103012;1.1257162;0.5133630586885909;0.4598771135428128;0.9999425106785123;-0.041911467268211045;0.12577369873310884;-0.48657945198992136;-0.5400653971356995
Elevated circulating growth hormone concentration;Lamina lucida cleavage;1.0115716401487589;1.1054282;0.49631655033409827;0.46637867903241803;0.9999481150251853;0.011623525123573564;0.10548010381636741;-0.503631564691087;-0.5335694359927673
Elevated circulating growth hormone concentration;Abnormal central response of multifocal electroretinogram;0.7256978750228882;0.9136998;0.5884468316360298;0.5275044182182269;0.9998962300503706;-0.27419835502748247;-0.0861964243138289;-0.4114493984143408;-0.47239181183214374
Elevated circulating growth hormone concentration;Atypical or prolonged hepatitis;0.7162789106369019;0.87876195;0.591568983937397;0.5386864464624748;0.9999548690865008;-0.2836759584495989;-0.121192921931502;-0.4083858851491038;-0.461268422624026
Elevated circulating growth hormone concentration;Cubitus varus;0.9342461749911308;1.0684723;0.5209452040786309;0.478187524087334;0.9998962300503706;-0.06565005505923982;0.06857603614683394;-0.4789510259717398;-0.5217087059630366
Elevated circulating growth hormone concentration;Nasal regurgitation;0.906126581132412;1.0918363;0.5299248983031499;0.4707263231991564;0.9999528219730685;-0.0938262408406565;0.09188351130177286;-0.4700279236699185;-0.529226498773912
Elevated circulating growth hormone concentration;Moon facies;0.8606244325637817;0.8455942;0.5445095258192922;0.5493463036303634;0.9999528219730685;-0.1393283894092867;-0.1543585946590731;-0.4554432961537762;-0.45060651834270504
Elevated circulating growth hormone concentration;Intestinal pseudo-obstruction;0.8831953480839729;1.0784531;0.5372651420847916;0.47500190925378316;0.9999468979947994;-0.11675154991082648;0.07850616597004434;-0.4626817559100078;-0.5249449887410162
Elevated circulating growth hormone concentration;Bilateral renal atrophy;0.7903203964233398;0.9280045;0.5672420936813818;0.5229367247814387;0.9999548690865008;-0.20963447266316093;-0.0719503658363787;-0.432712775405119;-0.47701814430506206
Elevated circulating growth hormone concentration;Fractured left clavicle;0.8732531666755676;1.0807319;0.5404535800488378;0.47427424158037534;0.9998962300503706;-0.12664306337480302;0.08083563869352584;-0.45944265000153284;-0.5256219884699953
Elevated circulating growth hormone concentration;Positive urine norcotinine test;0.7464999258518219;0.8243911;0.5815818092527563;0.5561894135984188;0.9998962300503706;-0.25339630419854875;-0.17550510341768022;-0.4183144207976144;-0.44370681645195187
Elevated circulating growth hormone concentration;Long fibula;0.744801253080368;0.95477015;0.5821409008592225;0.5144020247934327;0.9999505803237132;-0.25514932724334516;-0.045180432523267644;-0.41780967946449066;-0.48554855553028053
Elevated circulating growth hormone concentration;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.893530935049057;0.98989075;0.5339545126678549;0.5032179253129403;0.9998962300503706;-0.10636529500131364;-0.010005475827500776;-0.4659417173825158;-0.49667830473743035
Elevated circulating growth hormone concentration;Type II cryptotia;0.9517662972211838;0.9679507;0.5153592238858355;0.5102033533678976;0.9998962300503706;-0.04812993282918687;-0.03194552833680864;-0.4845370061645351;-0.4896928766824731
Elevated circulating growth hormone concentration;Increased variability in muscle fiber diameter;0.6436179280281067;0.7085079;0.6159898454149388;0.5941517070939283;0.999937876518323;-0.3563199484902163;-0.29142998104865747;-0.38394803110338416;-0.4057861694243947
Elevated circulating growth hormone concentration;Widened proximal tibial metaphyses;0.5986801385879517;0.92619336;0.6314484186209324;0.5235147688466286;0.9999548690865008;-0.4012747304985491;-0.07376151257252372;-0.3685064504655684;-0.47644010023987216
Elevated circulating growth hormone concentration;Wide anterior fontanel;0.6818139255046844;0.94408447;0.6030736765151227;0.5178077610570802;0.9999383692587659;-0.31812444375408144;-0.055853903755073264;-0.3968646927436432;-0.48213060820168574
Elevated circulating growth hormone concentration;Increased circulating oleate level;0.6342937350273132;0.6901982;0.6191725217552484;0.6002627081628572;0.9998962300503706;-0.3656024950230574;-0.30969804699067827;-0.38072370829512225;-0.39963352188751344
Elevated circulating growth hormone concentration;Lozenge-shaped umbilicus;0.9487909004092216;1.0736461;0.5163074953513607;0.47653647608362526;0.9999528219730685;-0.0511619215638468;0.0736932465999296;-0.4836453266217078;-0.5234163458894432
Elevated circulating growth hormone concentration;Anti-myelin-associated glycoprotein antibody positivity;0.7365601062774658;0.98599255;0.5848570645478638;0.5044588473588674;0.9998962300503706;-0.26333612377290483;-0.013903679200456098;-0.41503916550250686;-0.4954373826915033
Elevated circulating growth hormone concentration;Fractured radius;0.7773575782775879;0.9371768;0.571468237240337;0.520010415563126;0.9999548690865008;-0.22259729080891288;-0.06277804547047294;-0.42848663184616376;-0.4799444535233748
Elevated circulating growth hormone concentration;Abnormal manual kinetic perimetry test;0.7551403194665909;0.9442733;0.5787418968826139;0.5177475532147668;0.9998962300503706;-0.24475591058377977;-0.055622937032029585;-0.42115433316775674;-0.4821486768356038
Elevated circulating growth hormone concentration;Small radial epiphyses;0.8363426029682159;0.96380854;0.5523291600725637;0.5115226217281394;0.9998962300503706;-0.1635536270821547;-0.03608769352082963;-0.44756706997780693;-0.4883736083222312
Elevated circulating growth hormone concentration;Generalized keratosis follicularis;0.7205014824867249;0.92156816;0.5901682053079834;0.5249912989188265;0.9999548690865008;-0.2794533865997759;-0.07838671379780449;-0.40978666377851736;-0.4749635701676743
Elevated circulating growth hormone concentration;Hypoplasia of the calcaneus;0.8568800091743469;0.9853232;0.545713484110977;0.5046719353114031;0.9999528219730685;-0.14307281279872153;-0.014629631283981537;-0.4542393378620915;-0.49528088666166536
Elevated circulating growth hormone concentration;2-hydroxyadipic aciduria;0.783541351556778;0.8591634;0.569450650435464;0.5449792138806877;0.9998962300503706;-0.2163548784935927;-0.14073282653932329;-0.4304455796149067;-0.45491701616968294
Elevated circulating growth hormone concentration;Potter facies;0.8620229363441467;0.9131314;0.5440600250164774;0.5276860267415884;0.9999486088983908;-0.13792567255424404;-0.08681719305442714;-0.45588858388191333;-0.4722625821568024
Elevated circulating growth hormone concentration;Increased heart rate variability;0.5252311825752258;0.75617903;0.657468326792995;0.5784009237379606;0.9999548690865008;-0.47472368651127494;-0.24377583437657036;-0.3424865422935057;-0.4215539453485402
Elevated circulating growth hormone concentration;Aplastic zygomatic arch;0.7835473120212555;1.0014694;0.5694487070886998;0.4995322780229905;0.9999528219730685;-0.21640550995181296;0.0015165517299344788;-0.4305041148843687;-0.500420543950078
Elevated circulating growth hormone concentration;Testicular torsion;0.7594044804573059;0.97584146;0.5773427281244395;0.5076906566155057;0.9999548690865008;-0.24055038862919487;-0.024113406474348675;-0.42261214096206123;-0.49226421247099506
Elevated circulating growth hormone concentration;Abolished vibration sense;0.8738604038953781;1.0070504;0.5402587265110731;0.4977557769023644;0.9260244715116542;-0.05216406761627612;0.08102592350024762;-0.38576574500058114;-0.42826869460928985
Elevated circulating growth hormone concentration;Fractured metatarsal bone of digit 5;0.8894936665892601;0.9907011;0.5352472460282998;0.5029599905138679;0.9998962300503706;-0.11040256346111055;-0.00919515068177934;-0.4646489840220709;-0.4969362395365028
Elevated circulating growth hormone concentration;Prolonged G2 phase of cell cycle;0.6188088357448578;0.72586024;0.6244860313619115;0.5883930897690255;0.9999505803237132;-0.3811417445788554;-0.27409034224845685;-0.3754645489618017;-0.4115574905546877
Elevated circulating growth hormone concentration;Single naris;0.9663837030529976;1.0314487;0.5107024160214335;0.4899879136493439;0.9999505803237132;-0.03356687727071561;0.03149814156196795;-0.4892481643022797;-0.5099626666743693
Elevated circulating growth hormone concentration;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.726895272731781;0.88947946;0.5880505559479487;0.5352518036891769;0.9998962300503706;-0.27300095731858964;-0.11041677171830888;-0.4118456741024219;-0.46464442636119374
Elevated circulating growth hormone concentration;Asymmetry of the thorax;0.7187217772006989;0.9199003;0.5907583769649998;0.525523865374952;0.9999505803237132;-0.28122880312301435;-0.08005028220512189;-0.4091922033587134;-0.4744267149487612
Elevated circulating growth hormone concentration;Type 2 muscle fiber predominance;0.8130068182945251;0.8472727;0.5598742303941899;0.5488056127356009;0.9999491674684583;-0.18694234917393315;-0.15267647335758794;-0.44007493707426837;-0.4511435547328574
Elevated circulating growth hormone concentration;Dependency on parenteral nutrition;0.7500607967376709;0.9219838;0.5804106365482168;0.5248585905608707;0.9999528219730685;-0.24989202523539755;-0.07796904349635336;-0.41954218542485167;-0.47509423141219775
Elevated circulating growth hormone concentration;Limited shoulder flexion;0.829849362373352;1.0130272;0.5544254308833743;0.4958531865156477;0.9998962300503706;-0.1700468676770186;0.013130961111738726;-0.4454707991669964;-0.504043043534723
Elevated circulating growth hormone concentration;Paroxysmal vertigo;0.8971527442336082;1.0317366;0.532795288175095;0.48989620815635926;0.9999528219730685;-0.1028000777394602;0.03178379034687784;-0.4671575337979734;-0.5100566138167092
Elevated circulating growth hormone concentration;Long hallux;0.7769661843776703;0.943516;0.5715960352098716;0.5179889941427538;0.9999451389191131;-0.2229789545414428;-0.05642912291264335;-0.4283491037092415;-0.4819561447763593
Elevated circulating growth hormone concentration;Broad medial eyebrow;0.680672287940979;0.7894194;0.6034570702226942;0.5675354447566301;0.9999548690865008;-0.31928258114552177;-0.21053545647358574;-0.39649779886380654;-0.4324194243298707
Elevated circulating growth hormone concentration;Myxoid subcutaneous tumors;0.8737244606018066;0.9447168;0.5403023474043676;0.5176061709026234;0.9999548690865008;-0.12623040848469413;-0.05523805790638603;-0.4596525216821332;-0.4823486981838774
Elevated circulating growth hormone concentration;Bulbous tips of toes;0.7138426005840302;0.89690566;0.5923780240672697;0.5328743647853993;0.9999528219730685;-0.2861102213890383;-0.10304716134379599;-0.40757479790579876;-0.46707845718766916
Elevated circulating growth hormone concentration;Absent internal genitalia;0.8955493867397308;1.0367863;0.5333084165112987;0.48828789694866137;0.9998962300503706;-0.10434684331063981;0.036890087774946734;-0.46658781353907197;-0.5116083331017093
Elevated circulating growth hormone concentration;Hyperphalangy of the 2nd finger;0.746538370847702;0.9893171;0.5815691586674927;0.5034005330577622;0.9999548690865008;-0.25341649823879875;-0.010637749964949261;-0.41838571041900807;-0.49655433602873855
Elevated circulating growth hormone concentration;Renal interstitial hemosiderin;0.8199978470802307;0.96485496;0.5576104733719425;0.5111893240719934;0.9998962300503706;-0.17989838297013994;-0.035041274377152876;-0.4422857566784282;-0.4887069059783773
Elevated circulating growth hormone concentration;Abnormality of depressor anguli oris muscle;0.8508066534996033;1.0355546;0.547667681736701;0.4886802314640102;0.9998962300503706;-0.14908957655076738;0.03565841739530806;-0.45222854831366965;-0.5112159985863605
Elevated circulating growth hormone concentration;Paroxysmal dyspnea;0.9240057840943336;1.0589259;0.5242130540158683;0.4812324399098643;0.9998962300503706;-0.075890445956037;0.05902963703031783;-0.4756831760345024;-0.5186637901405063
Elevated circulating growth hormone concentration;Phenylpyruvic acidemia;0.8340178579092026;0.98990273;0.5530794102387846;0.5032141053702548;0.9999548690865008;-0.1659370111772982;-0.010052134330031048;-0.4468754588477162;-0.496740763716246
Elevated circulating growth hormone concentration;Lateral ventricle dilatation;0.7514525502920151;0.9192101;0.5799531910147306;0.5257442889193367;0.796956230946341;-0.04550368065432597;0.12225384538575124;-0.2170030399316104;-0.2712119420270044
Elevated circulating growth hormone concentration;Neonatal unconjugated hyperbilirubinemia;0.7456973195075989;1.0275177;0.5818459424095037;0.4912397481301377;0.9999548690865008;-0.2542575495789019;0.027562807266953815;-0.41810892667699706;-0.5087151209563631
Elevated circulating growth hormone concentration;High maternal circulating alpha-fetoprotein concentration;0.5704973936080933;0.71548027;0.6413111024368443;0.5918341266955416;0.9998962300503706;-0.4293988364422774;-0.28441596204881425;-0.35858512761352634;-0.40806210335482906
Elevated circulating growth hormone concentration;Prominent nasolabial fold;0.7933301478624344;1.0140914;0.5662626005388683;0.49551441888330394;0.9999476714516888;-0.20661752358925445;0.014143701038240364;-0.4336850709128205;-0.5044332525683849
Elevated circulating growth hormone concentration;Abnormality of inferior alveolar nerve;0.8362559080123901;0.96480805;0.5523571332915982;0.5112042577476682;0.705060803258061;0.13119510475432916;0.25974724355971857;-0.15270366996646279;-0.19385654551039277
Elevated circulating growth hormone concentration;Unilateral conductive hearing impairment;0.8806470111012459;1.1489624;0.5380820178502769;0.4524066828804717;0.9999548690865008;-0.1193078579852549;0.14900750941539131;-0.4618728512362239;-0.5475481862060291
Elevated circulating growth hormone concentration;Macular hypopigmented whorls, streaks, and patches;0.9339565634727478;0.9541383;0.5210375911079925;0.5146033543379647;0.9999548690865008;-0.06599830561375297;-0.045816590125319134;-0.47891727797850825;-0.4853515147485361
Elevated circulating growth hormone concentration;Delayed ossification of pubic rami;0.7144478559494019;0.8604239;0.5921769761610027;0.5445739897331815;0.9999528219730685;-0.2855049660236666;-0.13952889943431113;-0.4077758458120657;-0.45537883223988695
Elevated circulating growth hormone concentration;Hyperphenylalaninemia;0.6185270249843597;0.9156068;0.6245830666841232;0.5268951834990376;0.9999498126421364;-0.3814227876577767;-0.08434301590065085;-0.3753667459580132;-0.4730546291430988
Elevated circulating growth hormone concentration;Ureteropelvic junction obstruction;0.8485950827598572;1.0717427;0.5483797352481826;0.47714397578648693;0.9999453908499725;-0.1513503080901153;0.07179726299676825;-0.45156565560178985;-0.5228014150634855
Elevated circulating growth hormone concentration;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8496921062469482;0.97736144;0.5480264992642871;0.5072066840179258;0.9998962300503706;-0.1502041238034224;-0.022534789391801313;-0.4518697307860835;-0.49268954603244486
Elevated circulating growth hormone concentration;Difficulty walking;0.8506547808647156;0.9983966;0.5477165720363245;0.5005103909217328;0.8999749757540185;-0.04932019488930295;0.09842159969687869;-0.352258403717694;-0.39946458483228575
Elevated circulating growth hormone concentration;Bilobate gallbladder;0.8825806081295013;1.0919511;0.5374621757384814;0.47068964308797145;0.9999528219730685;-0.11737221384356711;0.09199830984761026;-0.462490646234587;-0.529263178885097
Elevated circulating growth hormone concentration;Histidinuria;0.729834794998169;0.9062838;0.5870783208039361;0.5298746408667632;0.9999515360511232;-0.27011674105295425;-0.09366774021753554;-0.4128732152471871;-0.47007689518436
Elevated circulating growth hormone concentration;Widened interpedicular distance;0.674855649471283;1.0113603;0.6054128924923421;0.49638381907579754;0.9998962300503706;-0.3250405805790877;0.011464057615950152;-0.39448333755802856;-0.5035124109745731
Visual acuity no light perception;Spinal hypomyelination;0.7147123515605927;0.84241927;0.5920891304362295;0.550369445889056;1.0;-0.28528764843940735;-0.15758073329925537;-0.40791086956377054;-0.449630554110944
Visual acuity no light perception;Bladder polyp;0.8928465247154236;1.0742317;0.5341736206961206;0.47634956432981657;0.9999201345566091;-0.10707360984118552;0.07431160925595193;-0.4657465138604885;-0.5235705702267925
Visual acuity no light perception;Aberrant melanosome maturation;0.7956182956695557;0.74317664;0.5655183722764896;0.5826758597483943;0.9999201345566091;-0.20430183888705344;-0.2567434954765615;-0.4344017622801195;-0.4172442748082148
Visual acuity no light perception;Vertebral artery tortuosity;0.7952260226011276;0.94004416;0.565645934577784;0.5190959863412844;0.9999201345566091;-0.20469411195548148;-0.059875969899016335;-0.4342741999788251;-0.4808241482153247
Visual acuity no light perception;Warm reactive autoantibody positivity;0.9140138328075409;1.000028;0.5274040873433664;0.4999910848837267;1.0;-0.0859861671924591;2.8014183044433594e-05;-0.4725959126566336;-0.5000089151162733
Visual acuity no light perception;Right aortic arch with retroesophageal left subclavian artery;0.891396164894104;1.0050725;0.5346379946626625;0.49838535621796864;1.0;-0.108603835105896;0.005072474479675293;-0.4653620053373375;-0.5016146437820314
Visual acuity no light perception;Elevated urine suberic acid level;0.8951375931501389;0.98669285;0.5334402182817104;0.5042359273124832;0.9999201345566091;-0.10478254140647025;-0.013227288735228493;-0.4664799162748987;-0.4956842072441259
Visual acuity no light perception;Burkitt lymphoma;0.928835429251194;1.1002259;0.5226715502311775;0.46804344691875466;0.9999090677057578;-0.07107363845456383;0.10031685773979881;-0.4772375174745803;-0.5318656207870032
Visual acuity no light perception;Snail-like ilia;0.952177993953228;0.9565707;0.5152280253414341;0.5138283272426921;0.9999201345566091;-0.04774214060338111;-0.04334944964678855;-0.484692109215175;-0.486091807313917
Visual acuity no light perception;Indurated nodule;0.8462122529745102;0.99559504;0.5491472018299528;0.501402148100267;1.0;-0.1537877470254898;-0.004404962062835693;-0.4508527981700472;-0.49859785189973305
Visual acuity no light perception;Absent leukocyte alkaline phosphatase;0.7615556865930557;1.0268487;0.5766374481004246;0.49145277223001826;0.9999201345566091;-0.23836444796355338;0.026928539263886497;-0.4232826864561845;-0.5084673623265908
Visual acuity no light perception;Hippocampal sclerosis;0.8598954379558563;1.064949;0.5447438713620446;0.4793115195062293;1.0;-0.14010456204414368;0.06494903564453125;-0.4552561286379554;-0.5206884804937707
Visual acuity no light perception;Decreased sensitivity to hypoxemia;0.7988151162862778;0.8735491;0.5644792019829057;0.5403586162771499;0.9999201345566091;-0.20110501827033134;-0.12637103081973167;-0.4354409325737034;-0.45956151827945924
Visual acuity no light perception;Decreased level of tissue plasminogen activator;0.9220151081681252;0.9584713;0.5248485922919846;0.5132228072503324;1.0;-0.07798489183187485;-0.04152870178222656;-0.47515140770801545;-0.4867771927496676
Visual acuity no light perception;Submandibular lymph node enlargement;0.9230940863490105;1.0195917;0.5245041082276607;0.49376339044438144;0.9999201345566091;-0.07682604820759864;0.019671554553193138;-0.4754160263289484;-0.5061567441122277
Visual acuity no light perception;Hepatic hemangioma;0.9426343068480492;1.0177475;0.5182700972257036;0.49435049306730905;0.9999134918687169;-0.057279185020667756;0.01783402953173474;-0.4816433946430133;-0.5055629988014079
Visual acuity no light perception;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8910121470689774;1.0181241;0.5347609612492003;0.4942305998103874;1.0;-0.10898785293102264;0.018124103546142578;-0.46523903875079975;-0.5057694001896126
Visual acuity no light perception;Acne inversa;0.8446064889431;0.93567765;0.5496645517202766;0.520488590150672;0.9998962300503706;-0.15528974110727067;-0.06421858245973344;-0.45023167833009403;-0.4794076398996987
Visual acuity no light perception;Dentin dysplasia;0.8529299795627594;0.9394115;0.5469842662387857;0.5192977405540558;1.0;-0.1470700204372406;-0.06058847904205322;-0.4530157337612143;-0.48070225944594425
Visual acuity no light perception;Aplasia of the inner ear;0.7479179203510284;0.90738153;0.581115295587509;0.5295236909128697;0.9999201345566091;-0.25200221420558067;-0.09253859998019309;-0.41880483896910015;-0.47039644364373945
Visual acuity no light perception;Polycystic liver disease;0.9528080523014069;1.1066799;0.5150272448369555;0.46597800111391796;0.9999056439461368;-0.04709759164472993;0.10677427243569915;-0.4848783991091813;-0.5339276428322188
Visual acuity no light perception;Subungual hyperkeratosis;0.8836941868066788;0.99564147;0.5371052671119873;0.5013873699666378;0.9999003561294039;-0.1162061693227251;-0.004258886173959531;-0.4627950890174166;-0.49851298616276607
Visual acuity no light perception;Broad humeral epiphyses;0.903984785079956;1.0407552;0.5306097470420039;0.4870236534664655;1.0;-0.09601521492004395;0.04075515270233154;-0.4693902529579961;-0.5129763465335345
Visual acuity no light perception;Autoimmune thrombocytopenia;0.877519354224205;1.0601515;0.539084941191323;0.4808416194447216;0.9998726169824932;-0.12235326275828817;0.06027884080406687;-0.4607876757911702;-0.5190309975377716
Visual acuity no light perception;Adenomyosis;0.8567768186330795;1.0751306;0.5457466725920993;0.4760626302951606;0.9999201345566091;-0.14314331592352958;0.07521044729916482;-0.4541734619645098;-0.5238575042614485
Visual acuity no light perception;Elevated leukocyte alkaline phosphatase;0.9762779269367456;1.0453427;0.5075516787576291;0.48556201578781044;0.9999201345566091;-0.023642207619863465;0.04542254923550515;-0.49236845579898003;-0.5143581187687987
Visual acuity no light perception;Clasp-knife sign;1.0147560322657228;0.93835187;0.49530283857808577;0.5196356650759713;1.0;0.014756032265722752;-0.06164813041687012;-0.5046971614219142;-0.48036433492402875
Visual acuity no light perception;Keratosis pilaris;0.8605965822935104;0.9097271;0.5445184782323971;0.5287739265902848;0.9998710980331391;-0.13927451573962868;-0.09014400147552193;-0.45535261980074204;-0.47109717144285435
Visual acuity no light perception;Lamina lucida cleavage;0.983551437035203;0.8663602;0.5052359763267706;0.5426665137149038;0.9998962300503706;-0.01634479301516767;-0.13353604251985307;-0.4946602537236;-0.45722971633546683
Visual acuity no light perception;Abnormal central response of multifocal electroretinogram;0.5415617525577545;0.29380572;0.651590979417353;0.7495894954443283;1.0;-0.4584382474422455;-0.706194281578064;-0.348409020582647;-0.2504105045556717
Visual acuity no light perception;Atypical or prolonged hepatitis;0.9278768599033356;1.08491;0.5229774584424064;0.47293970879609504;0.9999201345566091;-0.07204327465327354;0.08498990057675271;-0.4769426761142027;-0.5269804257605141
Visual acuity no light perception;Cubitus varus;0.8795776143670082;1.0035428;0.5384248904019124;0.49887230020671813;1.0;-0.12042238563299179;0.003542780876159668;-0.46157510959808756;-0.5011276997932819
Visual acuity no light perception;Nasal regurgitation;0.8484434634447098;1.0130064;0.5484285606095329;0.4958598067867843;0.9999134918687169;-0.15147002842400714;0.01309295687701062;-0.451484931259184;-0.5040536850819326
Visual acuity no light perception;Moon facies;0.9007017090916634;0.77052975;0.531659802173589;0.5736993678847517;0.9999134918687169;-0.09921178277705356;-0.22938374485943958;-0.46825368969512793;-0.4262141239839652
Visual acuity no light perception;Intestinal pseudo-obstruction;0.8184156566858292;0.98592895;0.5581225385344118;0.504479104245698;0.9998912449978579;-0.1814755883120287;-0.013962292303918655;-0.441768706463446;-0.4954121407521599
Visual acuity no light perception;Bilateral renal atrophy;0.811624065041542;0.85232854;0.5603223376193449;0.5471778193529537;0.9999201345566091;-0.18829606951506705;-0.1475915956619558;-0.4395977969372642;-0.4527423152036554
Visual acuity no light perception;Fractured left clavicle;0.8912185207009315;1.062241;0.5346948775739928;0.48017529027449535;1.0;-0.10878147929906845;0.06224095821380615;-0.4653051224260072;-0.5198247097255047
Visual acuity no light perception;Positive urine norcotinine test;0.8289888501167297;0.95074654;0.5547034146719605;0.5156842196981379;1.0;-0.17101114988327026;-0.04925346374511719;-0.4452965853280395;-0.48431578030186206
Visual acuity no light perception;Long fibula;0.9171822145581245;1.0681685;0.5263919481468236;0.4782844594218365;0.9999056439461368;-0.08272342938801225;0.06826287698129241;-0.47351369579931324;-0.5216211845243003
Visual acuity no light perception;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8296881318092346;1.0079775;0.5544775123395561;0.4974606700007159;1.0;-0.17031186819076538;0.007977485656738281;-0.4455224876604439;-0.5025393299992841
Visual acuity no light perception;Type II cryptotia;0.8968077525496483;0.87783617;0.5329056898523614;0.5389833284836875;1.0;-0.10319224745035172;-0.12216383218765259;-0.4670943101476386;-0.46101667151631254
Visual acuity no light perception;Increased variability in muscle fiber diameter;0.9144017696380615;0.9502004;0.5272801462498977;0.5158582687211771;0.9998452077479463;-0.08544343810988475;-0.049644828853140366;-0.47256506149804856;-0.48398693902676915
Visual acuity no light perception;Widened proximal tibial metaphyses;0.9346140250563622;1.0508801;0.5208278612412551;0.4837973685480008;0.9999201345566091;-0.06530610950024696;0.05095993994442849;-0.479092273315354;-0.5161227660086083
Visual acuity no light perception;Wide anterior fontanel;0.8365384638309479;0.8490381;0.5522659646002358;0.5482370613956444;0.999848231156753;-0.16330976732580516;-0.15081010707228037;-0.4475822665565172;-0.4516111697611086
Visual acuity no light perception;Increased circulating oleate level;0.9866683389991522;1.0006266;0.504243725210618;0.4998005738785466;1.0;-0.013331661000847816;0.0006265640258789062;-0.495756274789382;-0.5001994261214534
Visual acuity no light perception;Lozenge-shaped umbilicus;0.944378025829792;1.0366297;0.517714166313343;0.4883377897699763;0.9999134918687169;-0.0555354660389249;0.03671618495013074;-0.4821993255553739;-0.5115757020987406
Visual acuity no light perception;Anti-myelin-associated glycoprotein antibody positivity;0.8146464079618454;0.8703063;0.5593430459795141;0.5413994049084925;1.0;-0.1853535920381546;-0.12969368696212769;-0.4406569540204859;-0.4586005950915075
Visual acuity no light perception;Fractured radius;0.8109569400548935;0.9651081;0.5605385752536622;0.5111086926150286;0.9999201345566091;-0.18896319450171561;-0.03481203795703025;-0.43938155930294687;-0.48881144194158055
Visual acuity no light perception;Abnormal manual kinetic perimetry test;0.6092002987861633;0.3406012;0.6278014905493109;0.7291890973546907;1.0;-0.39079970121383667;-0.6593987941741943;-0.3721985094506891;-0.27081090264530927
Visual acuity no light perception;Small radial epiphyses;0.8696330189704895;0.9458157;0.5416155514080817;0.5172558451919338;1.0;-0.1303669810295105;-0.05418431758880615;-0.4583844485919183;-0.4827441548080662
Visual acuity no light perception;Generalized keratosis follicularis;0.7971283197402954;0.82326794;0.5650274307219505;0.5565526166943088;0.9999201345566091;-0.2027918148163137;-0.17665219785006614;-0.4348927038346586;-0.44336751786230033
Visual acuity no light perception;Hypoplasia of the calcaneus;0.8652132749557495;1.0438755;0.5430349300912598;0.48602954048609426;0.9999134918687169;-0.1347002169129674;0.04396196398760632;-0.4568785617774571;-0.5138839513826227
Visual acuity no light perception;2-hydroxyadipic aciduria;0.8513568043708801;0.9874424;0.547490588597352;0.5039973179357047;1.0;-0.14864319562911987;-0.012557625770568848;-0.452509411402648;-0.4960026820642953
Visual acuity no light perception;Potter facies;0.9965990427881479;0.9248639;0.5010825603899349;0.5239391320368362;0.9998981869165328;-0.0032991441283848344;-0.0750343120042708;-0.49881562652659783;-0.4759590548796966
Visual acuity no light perception;Increased heart rate variability;1.0108540458604693;0.99392015;0.496544982055799;0.5019352896989813;0.9999201345566091;0.010933911303860233;-0.005999987137633278;-0.5033751525008101;-0.49798484485762784
Visual acuity no light perception;Aplastic zygomatic arch;0.8967758044600487;0.9986082;0.5329159138435652;0.5004430375176449;0.9999134918687169;-0.10313768740866824;-0.0013053199288670658;-0.46699757802515174;-0.49947045435107207
Visual acuity no light perception;Testicular torsion;0.8977353423833847;1.0793825;0.5326088584216813;0.47470512971132295;0.9999201345566091;-0.1021847921732244;0.07946240423886208;-0.46731127613492784;-0.5252150048452862
Visual acuity no light perception;Abolished vibration sense;0.6262586116790771;0.8141191;0.6219252460859723;0.5595138518946098;0.9999134918687169;-0.37365488018963977;-0.1857943912980382;-0.3779882457827446;-0.44039963997410714
Visual acuity no light perception;Fractured metatarsal bone of digit 5;0.8617780208587646;1.0008662;0.5441387382389491;0.49972429540726027;1.0;-0.13822197914123535;0.0008661746978759766;-0.4558612617610509;-0.5002757045927397
Visual acuity no light perception;Prolonged G2 phase of cell cycle;0.9755728300660849;1.0678941;0.5077761831363221;0.4783720151741503;0.9999056439461368;-0.02433281388005193;0.06798845719674651;-0.4921294608098147;-0.5215336287719865
Visual acuity no light perception;Single naris;0.7349789142608643;0.7368187;0.5853789206622164;0.5847717402832837;0.9999056439461368;-0.26492672968527253;-0.2630869727196353;-0.4145267232839204;-0.4151339036628531
Visual acuity no light perception;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6455023884773254;0.34487957;0.6153480961091525;0.7273821244768919;1.0;-0.35449761152267456;-0.6551204323768616;-0.38465190389084747;-0.2726178755231081
Visual acuity no light perception;Asymmetry of the thorax;0.9440234452486038;0.9821244;0.5178272089379585;0.5056902870226033;0.9999056439461368;-0.05588219869753297;-0.017781255728210765;-0.48207843500817826;-0.49421535692353347
Visual acuity no light perception;Type 2 muscle fiber predominance;0.9250257834792137;1.0079633;0.5238874491616494;0.497465182100599;0.9999003561294039;-0.07487457265019015;0.008062943621877872;-0.47601290696775445;-0.5024351740288049
Visual acuity no light perception;Dependency on parenteral nutrition;0.923699714243412;1.0507294;0.524310762764894;0.48384540792153696;0.9999134918687169;-0.0762137776253049;0.05081590209032849;-0.47560272910382295;-0.51606808394718
Visual acuity no light perception;Limited shoulder flexion;0.7654162049293518;0.93014944;0.5753727233102021;0.5222522500701714;1.0;-0.2345837950706482;-0.06985056400299072;-0.42462727668979794;-0.4777477499298286
Visual acuity no light perception;Paroxysmal vertigo;0.7650316208600998;0.855731;0.5754986602248755;0.5460830619772181;0.9999134918687169;-0.23488187100861713;-0.1441824814317052;-0.4244148316438414;-0.4538304298914988
Visual acuity no light perception;Long hallux;0.8992510437965393;0.996505;0.5321238906956107;0.5011124844447752;0.9998836012415208;-0.10063255744498145;-0.0033785791925705633;-0.46775971054591003;-0.4987711167967456
Visual acuity no light perception;Broad medial eyebrow;0.8884709104895592;0.7062242;0.5355748243700132;0.5949118973590868;0.9999201345566091;-0.11144922406704993;-0.2936959314468679;-0.46434531018659586;-0.4050082371975223
Visual acuity no light perception;Myxoid subcutaneous tumors;0.9184556305408478;1.0419672;0.5259852314681457;0.4866375086220741;0.9999201345566091;-0.08146450401576133;0.04204701899258523;-0.4739349030884634;-0.513282625934535
Visual acuity no light perception;Bulbous tips of toes;0.9109787046909332;0.98258895;0.5283739190996617;0.5055423904047889;0.9999134918687169;-0.08893478717778369;-0.0173245450494115;-0.4715395727690552;-0.49437110146392804
Visual acuity no light perception;Absent internal genitalia;0.6648863554000854;0.88265324;0.6087747153325591;0.5374389012855278;1.0;-0.33511364459991455;-0.11734676361083984;-0.3912252846674409;-0.46256109871447215
Visual acuity no light perception;Hyperphalangy of the 2nd finger;0.9396955743432045;0.99039793;0.5192071484135212;0.5030564792492936;0.9999201345566091;-0.06022456021340461;-0.009522204411345436;-0.4807129861430879;-0.49686365530731547
Visual acuity no light perception;Renal interstitial hemosiderin;0.8933327198028564;0.9045708;0.5340179678926678;0.5304223369269528;1.0;-0.10666728019714355;-0.0954291820526123;-0.46598203210733224;-0.46957766307304716
Visual acuity no light perception;Abnormality of depressor anguli oris muscle;0.8245518803596497;0.9784086;0.5561374274932683;0.5068732886411969;1.0;-0.17544811964035034;-0.0215914249420166;-0.44386257250673167;-0.49312671135880315
Visual acuity no light perception;Paroxysmal dyspnea;0.8452016413211823;0.9425013;0.5494727883825954;0.518312506097713;1.0;-0.15479835867881775;-0.05749869346618652;-0.4505272116174046;-0.48168749390228704
Visual acuity no light perception;Phenylpyruvic acidemia;0.904766820371151;1.0135406;0.5303596715014354;0.4956897396575912;0.9999201345566091;-0.09515331418545814;0.013620491015595482;-0.46956046305517374;-0.5042303948990179
Visual acuity no light perception;Lateral ventricle dilatation;0.9263027608394623;0.89943117;0.5234798468907595;0.5320662671247609;0.9998579617208769;-0.07355520088141465;-0.1004267926878264;-0.4763781148301174;-0.467791694596116
Visual acuity no light perception;Neonatal unconjugated hyperbilirubinemia;0.8105391263961792;1.0490614;0.5606740171024394;0.48437700348401835;0.9999201345566091;-0.1893810081604299;0.04914128302304177;-0.43924611745416975;-0.5155431310725908
Visual acuity no light perception;High maternal circulating alpha-fetoprotein concentration;0.9093663021922112;0.944157;0.5288892461053823;0.5177846279636507;1.0;-0.09063369780778885;-0.05584299564361572;-0.47111075389461765;-0.48221537203634934
Visual acuity no light perception;Prominent nasolabial fold;0.8231612145900726;0.91353106;0.5565871213817557;0.5275583316024339;0.9998944404568447;-0.1767332258667721;-0.08636337546966211;-0.443307319075089;-0.4723361088544108
Visual acuity no light perception;Abnormality of inferior alveolar nerve;0.8104667067527771;0.940983;0.560697494368822;0.5187966223709262;1.0;-0.1895332932472229;-0.05901700258255005;-0.439302505631178;-0.48120337762907384
Visual acuity no light perception;Unilateral conductive hearing impairment;0.6169235706329346;0.85080224;0.6251354136042011;0.547669101611683;0.9999201345566091;-0.38299656392367454;-0.14911789180071922;-0.374784720952408;-0.4522510329449261
Visual acuity no light perception;Macular hypopigmented whorls, streaks, and patches;0.6880308091640472;0.43500245;0.6009885734313077;0.691122896905163;0.9999201345566091;-0.31188932539256187;-0.5649176883819875;-0.39893156112530137;-0.30879723765144607
Visual acuity no light perception;Delayed ossification of pubic rami;0.9094733744859695;1.1038873;0.5288550232513114;0.46687188055799655;0.9999134918687169;-0.09044011738274738;0.10397382769610242;-0.4710584686174055;-0.5330416113107204
Visual acuity no light perception;Hyperphenylalaninemia;0.9305248931050301;0.9753502;0.5221324425557516;0.507847065321117;0.9999028053808913;-0.06937791227586121;-0.02455260425097794;-0.4777703628251396;-0.49205574005977426
Visual acuity no light perception;Ureteropelvic junction obstruction;0.8161908537149429;0.92571056;0.5588428386264834;0.5236688782999601;0.9998847295244674;-0.18369387580952445;-0.074174170633171;-0.44104189089798396;-0.47621585122450727
Visual acuity no light perception;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8522979617118835;0.9863385;0.5471876650821177;0.5043487201772556;1.0;-0.14770203828811646;-0.013661503791809082;-0.4528123349178823;-0.4956512798227444
Visual acuity no light perception;Difficulty walking;0.7494915127754211;0.7816963;0.5805977992831926;0.5700523256946677;0.9998344221996177;-0.25034290942419657;-0.2181381026195396;-0.41923662291642516;-0.42978209650495003
Visual acuity no light perception;Bilobate gallbladder;0.9289954528212547;1.1013422;0.5226204839640574;0.46768630445571857;0.9999134918687169;-0.07091803904746219;0.10142870936419324;-0.47729300790465956;-0.5322271874129983
Visual acuity no light perception;Histidinuria;0.8790023028850555;1.0491328;0.5386093666626037;0.48435425381120467;0.9999090677057578;-0.12090676482070228;0.04922375623833397;-0.4612997010431541;-0.5155548138945532
Visual acuity no light perception;Widened interpedicular distance;0.9412975572049618;1.0177151;0.5186963162327127;0.49436079985415415;1.0;-0.05870244279503822;0.017715096473693848;-0.48130368376728727;-0.5056392001458458
Spinal hypomyelination;Bladder polyp;0.8116448372602463;1.0129443;0.5603156050978171;0.49587955819054574;0.9999201345566091;-0.18827529729636283;0.013024206149262474;-0.439604529458792;-0.5040405763660634
Spinal hypomyelination;Aberrant melanosome maturation;0.5626057088375092;0.7356938;0.6440985804557855;0.5851429567175545;0.9999201345566091;-0.43731442571909995;-0.2642263221863088;-0.3558215541008236;-0.41477717783905466
Spinal hypomyelination;Vertebral artery tortuosity;0.6967659294605255;0.71243453;0.598066404790413;0.5928458803592176;0.9999201345566091;-0.3031542050960836;-0.2874856042984304;-0.40185372976619615;-0.4070742541973915
Spinal hypomyelination;Warm reactive autoantibody positivity;0.8978776931762695;1.0472628;0.5325633082810701;0.48495018561171166;1.0;-0.10212230682373047;0.04726278781890869;-0.4674366917189299;-0.5150498143882883
Spinal hypomyelination;Right aortic arch with retroesophageal left subclavian artery;0.8374214470386505;0.9403922;0.5519810914889716;0.518985008350791;1.0;-0.1625785529613495;-0.05960780382156372;-0.44801890851102844;-0.481014991649209
Spinal hypomyelination;Elevated urine suberic acid level;0.8664298355579376;1.0120949;0.5426441530750075;0.49615000715747015;0.9999201345566091;-0.13349029899867149;0.012174720751923607;-0.45727598148160165;-0.503770127399139
Spinal hypomyelination;Burkitt lymphoma;0.8333130925893784;0.9836516;0.5533069132705639;0.5052040907083768;0.9999090677057578;-0.16659597511637947;-0.016257489279396742;-0.4466021544351939;-0.49470497699738103
Spinal hypomyelination;Snail-like ilia;0.8646455705165863;0.9221917;0.543217307338032;0.52479220946128;0.9999201345566091;-0.1352745640400228;-0.07772845507891746;-0.45670282721857713;-0.4751279250953291
Spinal hypomyelination;Indurated nodule;0.8151011914014816;0.95977527;0.5591957376526755;0.512807389654715;1.0;-0.18489880859851837;-0.04022473096847534;-0.4408042623473245;-0.48719261034528505
Spinal hypomyelination;Absent leukocyte alkaline phosphatase;0.8062073290348053;0.9758804;0.5620789078932139;0.507678262020899;0.9999201345566091;-0.1937128055218038;-0.02403975011141868;-0.4378412266633952;-0.49224187253571006
Spinal hypomyelination;Hippocampal sclerosis;0.6434286832809448;0.7636348;0.6160543195691845;0.5759561729539106;1.0;-0.3565713167190552;-0.2363651990890503;-0.38394568043081545;-0.42404382704608945
Spinal hypomyelination;Decreased sensitivity to hypoxemia;0.4515734910964966;0.6275802;0.6847729540942504;0.6214718258807144;0.9999201345566091;-0.5483466434601125;-0.3723399090889272;-0.3151471804623587;-0.37844830867589474
Spinal hypomyelination;Decreased level of tissue plasminogen activator;0.7341007888317108;1.0233902;0.5856688383962547;0.49255400327793364;1.0;-0.2658992111682892;0.02339017391204834;-0.4143311616037453;-0.5074459967220664
Spinal hypomyelination;Submandibular lymph node enlargement;0.8617631494998932;1.0375618;0.5441435178223684;0.48804089313873966;0.9999201345566091;-0.13815698505671592;0.03764163969723611;-0.45577661673424075;-0.5118792414178694
Spinal hypomyelination;Hepatic hemangioma;0.853812962770462;0.9870748;0.5467001329256062;0.5041143382995216;0.9999134918687169;-0.14610052909825488;-0.012838699483615601;-0.45321335894311077;-0.49579915356919535
Spinal hypomyelination;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7159451842308044;0.87817574;0.5916797703882998;0.538874422559976;1.0;-0.28405481576919556;-0.12182426452636719;-0.4083202296117002;-0.461125577440024
Spinal hypomyelination;Acne inversa;0.798992395401001;1.0013514;0.5644215954727181;0.4995698681132159;0.9998962300503706;-0.20090383464936967;0.0014551264559770072;-0.43547463457765256;-0.5003263619371547
Spinal hypomyelination;Dentin dysplasia;0.6347036361694336;0.80067706;0.6190323476359313;0.563874273026133;1.0;-0.3652963638305664;-0.19932293891906738;-0.3809676523640687;-0.436125726973867
Spinal hypomyelination;Aplasia of the inner ear;0.6423389613628387;0.7208309;0.6164256761175387;0.5900589957410954;0.9999201345566091;-0.35758117319377036;-0.27908921719821067;-0.3834944584390704;-0.40986113881551367
Spinal hypomyelination;Polycystic liver disease;0.7156549096107483;0.9573114;0.5917761415309989;0.5135923435208032;0.9999056439461368;-0.2842507343353885;-0.042594252115692455;-0.4081295024151379;-0.4863133004253336
Spinal hypomyelination;Subungual hyperkeratosis;0.841627836227417;0.9439232;0.55062457446315;0.51785917724211;0.9999003561294039;-0.15827251990198687;-0.05597718079447345;-0.4492757816662538;-0.4820411788872939
Spinal hypomyelination;Broad humeral epiphyses;0.9540875181555748;0.9912762;0.5146195361644093;0.5027768969512685;1.0;-0.0459124818444252;-0.008723795413970947;-0.48538046383559075;-0.4972231030487315
Spinal hypomyelination;Autoimmune thrombocytopenia;0.7403709292411804;0.9842589;0.5836002981174966;0.5050107602002636;0.9998726169824932;-0.25950168774131277;-0.01561372683051565;-0.4162723188649966;-0.4948618567822296
Spinal hypomyelination;Adenomyosis;0.7553392946720123;0.929084;0.5786765742306295;0.5225922263423176;0.9999201345566091;-0.24458083988459678;-0.07083613158495994;-0.42124356032597965;-0.4773279082142915
Spinal hypomyelination;Elevated leukocyte alkaline phosphatase;0.9723207987844944;1.0377759;0.5088116887947729;0.4879726993734035;0.9999201345566091;-0.027599335772114708;0.03785573958126931;-0.4911084457618362;-0.5119474351832056
Spinal hypomyelination;Clasp-knife sign;0.9424577504396439;0.9505209;0.5183263898626802;0.5157561310849441;1.0;-0.05754224956035614;-0.049479126930236816;-0.4816736101373198;-0.4842438689150559
Spinal hypomyelination;Keratosis pilaris;0.8026100397109985;0.8984707;0.5632465130850224;0.5323735597735124;0.9998710980331391;-0.19726105832214058;-0.10140039824599922;-0.43662458494811673;-0.4674975382596267
Spinal hypomyelination;Lamina lucida cleavage;0.7995434999465942;0.8291358;0.5642425287536357;0.5546559434162531;0.9998962300503706;-0.2003527301037764;-0.17076045448426957;-0.435653701296735;-0.4452402866341175
Spinal hypomyelination;Abnormal central response of multifocal electroretinogram;0.7109854221343994;0.793577;0.5933276079844108;0.5661822883738152;1.0;-0.2890145778656006;-0.20642298460006714;-0.40667239201558925;-0.43381771162618477
Spinal hypomyelination;Atypical or prolonged hepatitis;0.8588280379772186;1.0560305;0.5450870461427978;0.48215560679967984;0.9999201345566091;-0.14109209657939048;0.05611037729946999;-0.4548330884138113;-0.5177645277569293
Spinal hypomyelination;Cubitus varus;0.9223819822072983;0.9506397;0.5247314576075501;0.5157182531429494;1.0;-0.07761801779270172;-0.04936027526855469;-0.47526854239244987;-0.4842817468570506
Spinal hypomyelination;Nasal regurgitation;0.8642936050891876;1.0108131;0.5433303847580395;0.496558003460966;0.9999134918687169;-0.1356198867795293;0.010899625158565796;-0.4565831071106774;-0.5033554884077509
Spinal hypomyelination;Moon facies;1.0325829945504665;1.0557709;0.48962667468457677;0.48223837439478046;0.9999134918687169;0.03266950268174962;0.05585738215472058;-0.5102868171841402;-0.5176751174739365
Spinal hypomyelination;Intestinal pseudo-obstruction;0.7224089801311493;0.8716051;0.5895360095698299;0.5409825029161351;0.9998912449978579;-0.2774822648667086;-0.1282861467503298;-0.410355235428028;-0.4589087420817227
Spinal hypomyelination;Bilateral renal atrophy;0.7030615210533142;0.70889294;0.5959656306901175;0.5940235868067747;0.9999201345566091;-0.2968586135032949;-0.29102719308169456;-0.40395450386649157;-0.4058965477498344
Spinal hypomyelination;Fractured left clavicle;0.7990219444036484;1.048088;0.5644119937887218;0.4846872361817641;1.0;-0.20097805559635162;0.0480879545211792;-0.43558800621127824;-0.5153127638182359
Spinal hypomyelination;Positive urine norcotinine test;0.9039502069354057;1.0115684;0.5306208047136234;0.4963175553640998;1.0;-0.09604979306459427;0.011568427085876465;-0.4693791952863766;-0.5036824446359002
Spinal hypomyelination;Long fibula;0.9635542258620262;1.0547016;0.5116036200225322;0.482579238624125;0.9999056439461368;-0.036351418084110576;0.0547959227500302;-0.48830202392360456;-0.5173264053220118
Spinal hypomyelination;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7682060301303864;0.98236316;0.5744595182818792;0.5056142773266785;1.0;-0.23179396986961365;-0.01763683557510376;-0.42554048171812076;-0.4943857226733215
Spinal hypomyelination;Type II cryptotia;0.7586553543806076;0.8438946;0.5775884223514459;0.5498939474032835;1.0;-0.2413446456193924;-0.1561053991317749;-0.4224115776485541;-0.45010605259671654
Spinal hypomyelination;Increased variability in muscle fiber diameter;0.7723053246736526;0.8137082;0.5731188085578387;0.5596469752305442;0.9998452077479463;-0.22753988307429363;-0.1861370215983491;-0.4267263991901076;-0.4401982325174021
Spinal hypomyelination;Widened proximal tibial metaphyses;0.9536675065755844;1.0353421;0.5147533724332782;0.48874791659230854;0.9999201345566091;-0.046252627981024697;0.03542196272580056;-0.4851667621233309;-0.5111722179643006
Spinal hypomyelination;Wide anterior fontanel;1.046463593840599;0.89930654;0.48520485201715924;0.5321061272484995;0.999848231156753;0.04661536268384603;-0.10054169543592784;-0.5146433791395938;-0.46774210390825355
Spinal hypomyelination;Increased circulating oleate level;0.9837094750255346;1.0549836;0.5051856645307274;0.4824893361374255;1.0;-0.01629052497446537;0.05498361587524414;-0.49481433546927256;-0.5175106638625745
Spinal hypomyelination;Lozenge-shaped umbilicus;0.890050008893013;0.8695066;0.5350690710272206;0.5416561488966589;0.9999134918687169;-0.10986348297570392;-0.13040689434979602;-0.46484442084149635;-0.458257342972058
Spinal hypomyelination;Anti-myelin-associated glycoprotein antibody positivity;0.5641187131404877;0.3481564;0.6435632488572989;0.7260041478818708;1.0;-0.43588128685951233;-0.6518436074256897;-0.3564367511427011;-0.27399585211812916
Spinal hypomyelination;Fractured radius;0.7489159405231476;0.9245868;0.580787058365575;0.5240275777897163;0.9999201345566091;-0.2510041940334615;-0.07533336163790794;-0.4191330761910341;-0.4758925567668928
Spinal hypomyelination;Abnormal manual kinetic perimetry test;0.6651792526245117;0.7305479;0.6086757669829588;0.5868425884649129;1.0;-0.3348207473754883;-0.2694520950317383;-0.3913242330170412;-0.4131574115350871
Spinal hypomyelination;Small radial epiphyses;0.7229090929031372;0.8530922;0.5893703189432019;0.5469320649022464;1.0;-0.2770909070968628;-0.14690780639648438;-0.4106296810567981;-0.45306793509775356
Spinal hypomyelination;Generalized keratosis follicularis;0.7592766582965851;0.9262805;0.5773846471993596;0.5234869549186032;0.9999201345566091;-0.24064347626002403;-0.07363963605197044;-0.42253548735724955;-0.4764331796380059
Spinal hypomyelination;Hypoplasia of the calcaneus;0.6334758102893829;0.9346645;0.6194523004666699;0.5208117568880365;0.9999134918687169;-0.366437681579334;-0.0652490040299718;-0.38046119140204704;-0.4791017349806804
Spinal hypomyelination;2-hydroxyadipic aciduria;0.6438567340373993;0.76517737;0.6159084932474211;0.5754509268197359;1.0;-0.3561432659626007;-0.23482263088226318;-0.38409150675257886;-0.42454907318026414
Spinal hypomyelination;Potter facies;0.9815594255924225;0.9967239;0.5058701498683249;0.5010428223413042;0.9998981869165328;-0.018338761324110275;-0.003174296611967331;-0.49402803704820786;-0.4988553645752286
Spinal hypomyelination;Increased heart rate variability;1.0462635904550552;1.1481564;0.4852685836071663;0.45266611112949506;0.9999201345566091;0.04634345589844613;0.14823626993863015;-0.5146515509494428;-0.547254023427114
Spinal hypomyelination;Aplastic zygomatic arch;0.8620789051055908;0.9414853;0.5440420376348345;0.5186364515439981;0.9999134918687169;-0.1378345867631261;-0.05842820610974475;-0.4558714542338824;-0.48127704032471885
Spinal hypomyelination;Testicular torsion;0.8770888522267342;1.059667;0.5392230174954249;0.48099610267499215;0.9999201345566091;-0.12283128232987495;0.059746856677216575;-0.4606971170611842;-0.518924031881617
Spinal hypomyelination;Abolished vibration sense;0.752004012465477;0.95563763;0.5797719815605602;0.5141256084480511;0.8643545492165687;-0.11235053675109175;0.09128308458393786;-0.28458256765600853;-0.3502289407685176
Spinal hypomyelination;Fractured metatarsal bone of digit 5;0.773006409406662;0.96091735;0.5728896455998844;0.512443559542922;1.0;-0.226993590593338;-0.03908264636993408;-0.4271103544001156;-0.487556440457078
Spinal hypomyelination;Prolonged G2 phase of cell cycle;0.8736532181501389;0.99837846;0.5403252076765024;0.5005161476017839;0.9999056439461368;-0.12625242579599794;-0.0015271883072512926;-0.4595804362696344;-0.4993894963443529
Spinal hypomyelination;Single naris;0.9379554316401482;0.9782753;0.519762092472403;0.5069157406355032;0.9999056439461368;-0.06195021230598863;-0.021630344873871166;-0.4801435514737338;-0.49298990331063364
Spinal hypomyelination;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7374081313610077;0.82567954;0.5845772789389286;0.5557728685809442;1.0;-0.2625918686389923;-0.17432045936584473;-0.41542272106107136;-0.4442271314190558
Spinal hypomyelination;Asymmetry of the thorax;0.8307887315750122;0.9089314;0.5541220206299495;0.5290282723067701;0.9999056439461368;-0.16911691237112458;-0.09097426939627107;-0.44578362331618726;-0.4708773716393667
Spinal hypomyelination;Type 2 muscle fiber predominance;0.7198066711425781;0.86713976;0.5903985750750864;0.5424161507475274;0.9999003561294039;-0.28009368498682574;-0.13276059944986895;-0.40950178105431745;-0.4574842053818765
Spinal hypomyelination;Dependency on parenteral nutrition;0.7372771799564362;0.78781134;0.5846204788501895;0.568059130093796;0.9999134918687169;-0.26263631191228076;-0.21210215296719714;-0.4152930130185274;-0.43185436177492087
Spinal hypomyelination;Limited shoulder flexion;0.660673588514328;0.924718;0.6101991152266911;0.5239856925914275;1.0;-0.339326411485672;-0.07528197765350342;-0.3898008847733089;-0.47601430740857253
Spinal hypomyelination;Paroxysmal vertigo;0.6816729307174683;0.8914468;0.6031210180933249;0.5346217719162603;0.9999134918687169;-0.31824056115124866;-0.10846666302655383;-0.39679247377539206;-0.46529171995245666
Spinal hypomyelination;Long hallux;1.0082833310589194;1.059286;0.49736330368063375;0.48111761293231703;0.9998836012415208;0.008399729817398671;0.05940239710290063;-0.502520297560887;-0.5187659883092037
Spinal hypomyelination;Broad medial eyebrow;1.0264444090425968;1.0036404;0.49158150178750937;0.49884120041170366;0.9999201345566091;0.02652427448598771;0.0037202787276926497;-0.5083386327690997;-0.5010789341449055
Spinal hypomyelination;Myxoid subcutaneous tumors;0.6523381173610687;0.8712866;0.6130242884877637;0.5410847320411942;0.9999201345566091;-0.3475820171955404;-0.12863356353076072;-0.3868958460688454;-0.4588354025154149
Spinal hypomyelination;Bulbous tips of toes;0.929632693529129;0.98655456;0.5224171352913483;0.504279937352426;0.9999134918687169;-0.07028079833958789;-0.01335892882321521;-0.47749635657736866;-0.4956335545162909
Spinal hypomyelination;Absent internal genitalia;0.8063274323940277;0.96795833;0.5620399395262274;0.5102009200490792;1.0;-0.1936725676059723;-0.03204166889190674;-0.43796006047377256;-0.48979907995092076
Spinal hypomyelination;Hyperphalangy of the 2nd finger;0.712318629026413;0.8268436;0.5928844104990499;0.5553966085701665;0.9999201345566091;-0.28760150553019614;-0.17307651520999046;-0.40703572405755917;-0.4445235259864426
Spinal hypomyelination;Renal interstitial hemosiderin;0.7531356066465378;0.8588278;0.5794002244011655;0.5450871228015202;1.0;-0.24686439335346222;-0.14117217063903809;-0.42059977559883455;-0.45491287719847984
Spinal hypomyelination;Abnormality of depressor anguli oris muscle;0.7642271816730499;0.9610702;0.5757621229824361;0.5123948692481344;1.0;-0.23577281832695007;-0.03892982006072998;-0.4242378770175639;-0.4876051307518656
Spinal hypomyelination;Paroxysmal dyspnea;0.6283891499042511;0.86284506;0.621194427388327;0.5437958315935165;1.0;-0.3716108500957489;-0.1371549367904663;-0.378805572611673;-0.4562041684064835
Spinal hypomyelination;Phenylpyruvic acidemia;0.6834219098091125;0.7968191;0.6025339331851711;0.565127959770556;0.9999201345566091;-0.31649822474749656;-0.20310104371340842;-0.397386201371438;-0.43479217478605314
Spinal hypomyelination;Lateral ventricle dilatation;0.7148480117321014;0.6028819;0.5920440770403432;0.6299896647036154;0.5620072150087421;0.15284079672335937;0.04087469340800598;0.030036862031601164;0.06798244969487333
Spinal hypomyelination;Neonatal unconjugated hyperbilirubinemia;0.7388325333595276;0.8925297;0.5841074819876748;0.534275056085099;0.9999201345566091;-0.2610876011970815;-0.10739040852816673;-0.4158126525689343;-0.46564507847151015
Spinal hypomyelination;High maternal circulating alpha-fetoprotein concentration;0.9017257690429688;0.92801785;0.5313322314975302;0.5229324519418481;1.0;-0.09827423095703125;-0.07198214530944824;-0.46866776850246983;-0.4770675480581519
Spinal hypomyelination;Prominent nasolabial fold;0.9545716047286987;1.0297499;0.5144652856699377;0.49052893246125173;0.9998944404568447;-0.045322835728145994;0.029855429843448245;-0.48542915478690707;-0.509365507995593
Spinal hypomyelination;Abnormality of inferior alveolar nerve;0.6680735051631927;0.85523283;0.607698598147476;0.5462433185524105;1.0;-0.33192649483680725;-0.144767165184021;-0.39230140185252405;-0.4537566814475895
Spinal hypomyelination;Unilateral conductive hearing impairment;0.7060211598873138;0.8470561;0.5949795236756472;0.5488753841445565;0.9999201345566091;-0.29389897466929527;-0.15286404372485252;-0.4049406108809619;-0.4510447504120526
Spinal hypomyelination;Macular hypopigmented whorls, streaks, and patches;0.6483308672904968;0.8459963;0.6143857819901685;0.5492167592392776;0.9999201345566091;-0.3515892672661123;-0.15392381430895896;-0.38553435256644064;-0.4507033753173315
Spinal hypomyelination;Delayed ossification of pubic rami;0.7669966518878937;0.9969058;0.5748553119482963;0.500984917221529;0.9999134918687169;-0.23291683998082324;-0.0030076881882969975;-0.4250581799204206;-0.4989285746471879
Spinal hypomyelination;Hyperphenylalaninemia;0.8482081294059753;0.87108946;0.5485043465632302;0.5411479972347515;0.9999028053808913;-0.15169467597491593;-0.1288133469153151;-0.45139845881766105;-0.4587548081461398
Spinal hypomyelination;Ureteropelvic junction obstruction;0.7663550525903702;1.028765;0.575065336229289;0.4908425694570121;0.9998847295244674;-0.2335296769340972;0.028880233625557028;-0.42481939329517837;-0.5090421600674553
Spinal hypomyelination;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7168354094028473;0.9137206;0.5913842695793684;0.5274977790806008;1.0;-0.2831645905971527;-0.08627939224243164;-0.4086157304206316;-0.4725022209193992
Spinal hypomyelination;Difficulty walking;0.7222075760364532;0.7678233;0.589602743098175;0.5745847687036911;0.7403726674076037;-0.01816509137115041;0.027450611496357524;-0.1507699243094287;-0.16578789870391253
Spinal hypomyelination;Bilobate gallbladder;0.8640929013490677;1.0368701;0.5433948681591736;0.4882612173958262;0.9999134918687169;-0.13582059051964923;0.03695663008715466;-0.4565186237095433;-0.5116522744728907
Spinal hypomyelination;Histidinuria;0.7628156244754791;0.8376993;0.5762245516435689;0.5518914595776186;0.9999090677057578;-0.2370934432302787;-0.16220977361548683;-0.42368451606218893;-0.4480176081281392
Spinal hypomyelination;Widened interpedicular distance;0.9169290661811829;0.89472646;0.5264728064011054;0.533571818325397;1.0;-0.08307093381881714;-0.1052735447883606;-0.4735271935988946;-0.466428181674603
Bladder polyp;Aberrant melanosome maturation;0.8480773419141769;0.99697536;0.5485464659978196;0.5009627765142438;0.9999600672783046;-0.1518827253641276;-0.0029847049774317513;-0.4514136012804849;-0.49899729076406074
Bladder polyp;Vertebral artery tortuosity;0.8707217872142792;1.0062302;0.5412660277583754;0.49801683937305075;0.9999600672783046;-0.12923828006402538;0.006270167821487926;-0.45869403951992915;-0.5019432279052538
Bladder polyp;Warm reactive autoantibody positivity;0.8642243295907974;0.8519754;0.5433526418377358;0.5472914868220549;0.9999201345566091;-0.13569580496581168;-0.14794475318224998;-0.4565674927188733;-0.45262864773455425
Bladder polyp;Right aortic arch with retroesophageal left subclavian artery;0.8961300998926163;1.0346802;0.5331225588029118;0.4889587156657411;0.9999201345566091;-0.10379003466399284;0.03476011275021462;-0.4667975757536973;-0.510961418890868
Bladder polyp;Elevated urine suberic acid level;0.7414674758911133;0.8621676;0.5832389173444763;0.5440135291699824;0.8144325676816837;-0.07296509179057042;0.047735029135332896;-0.2311936503372074;-0.27041903851170135
Bladder polyp;Burkitt lymphoma;0.7082918584346771;0.6838615;0.5942235981824188;0.6023864435546392;0.9999574798349273;-0.2916656214002502;-0.3160959857705963;-0.40573388165250857;-0.3975710362802881
Bladder polyp;Snail-like ilia;0.8139209449291229;0.82398975;0.5595780564227191;0.5563191782991487;0.9999600672783046;-0.18603912234918163;-0.1759703183235316;-0.4403820108555855;-0.4436408889791559
Bladder polyp;Indurated nodule;0.6641418933868408;0.6800636;0.6090262633666459;0.6036615564030863;0.9999201345566091;-0.3357782411697683;-0.3198565292480764;-0.3908938711899632;-0.39625857815352283
Bladder polyp;Absent leukocyte alkaline phosphatase;0.7985803484916687;0.9484155;0.5645554926257851;0.5164271331687245;0.9999600672783046;-0.20137971878663585;-0.05154454947129772;-0.43540457465251947;-0.4835329341095801
Bladder polyp;Hippocampal sclerosis;0.7910367548465729;0.94950897;0.567008903827043;0.5160786250788642;0.9999201345566091;-0.20888337971003623;-0.05041116954119773;-0.43291123072956605;-0.48384150947774496
Bladder polyp;Decreased sensitivity to hypoxemia;0.8992842435836792;1.0841224;0.5321132688477553;0.47319130301173595;0.9999600672783046;-0.10067582369462535;0.08416235207899525;-0.4678467984305492;-0.5267687642665686
Bladder polyp;Decreased level of tissue plasminogen activator;0.8329392820596695;1.0530362;0.5534275929981789;0.48311013182082585;0.9999201345566091;-0.1669808524969396;0.05311607836453347;-0.4464925415584302;-0.5168100027357833
Bladder polyp;Submandibular lymph node enlargement;0.7846992760896683;0.66951895;0.569073170599196;0.60721097781092;0.9999600672783046;-0.21526079118863628;-0.3304411196769862;-0.4308868966791085;-0.3927490894673845
Bladder polyp;Hepatic hemangioma;0.8448708206415176;0.9324492;0.5495793794800785;0.521518464591837;0.9999584729108851;-0.1550876522693675;-0.06750925129986218;-0.4503790934308066;-0.4784400083190481
Bladder polyp;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9616439454257488;1.0985755;0.5122121069971194;0.4685714123767525;0.9999201345566091;-0.03827618913086028;0.09865533827511697;-0.4877080275594897;-0.5313487221798566
Bladder polyp;Acne inversa;0.7972886562347412;0.9085878;0.5649753110855187;0.529138082138773;0.9999548690865008;-0.20266621285175956;-0.0913670557091204;-0.4349795580009821;-0.4708167869477278
Bladder polyp;Dentin dysplasia;0.8550631999969482;0.99093205;0.5462978857512304;0.5028864623832581;0.9999201345566091;-0.14485693455966087;-0.008988087189513161;-0.4536222488053787;-0.49703367217335104
Bladder polyp;Aplasia of the inner ear;0.7395414412021637;1.0104822;0.5838737396288284;0.4966633416813432;0.9999600672783046;-0.26041862607614086;0.010522124761185192;-0.4160863276494762;-0.5032967255969614
Bladder polyp;Polycystic liver disease;0.6820605397224426;0.79519033;0.6029908769621175;0.5656575356454806;0.9999567459343585;-0.31789620621191583;-0.2047664116142901;-0.39696586897224095;-0.43429921028887786
Bladder polyp;Subungual hyperkeratosis;0.8690411448478699;1.0108019;0.5418055799384452;0.4965615815151213;0.9999556674707869;-0.13091452262291703;0.01084624388327804;-0.45815008753234165;-0.5033940859556656
Bladder polyp;Broad humeral epiphyses;0.8739797472953796;0.9494276;0.5402204327460578;0.5161045536326937;0.9999201345566091;-0.12594038726122947;-0.05049252988131614;-0.4596997018105513;-0.4838155809239154
Bladder polyp;Autoimmune thrombocytopenia;0.8563033938407898;1.0132557;0.5458989434551403;0.4957804461307088;0.9999509115718902;-0.1436475177311004;0.013304803798288023;-0.45405196811674986;-0.5041704654411814
Bladder polyp;Adenomyosis;0.703398585319519;0.66855067;0.5958532782099604;0.6075375974295489;0.8586132879499475;-0.15521470263042847;-0.19006261780300537;-0.26276000973998714;-0.2510756905203986
Bladder polyp;Elevated leukocyte alkaline phosphatase;0.8139666020870209;0.95370615;0.5595632650268816;0.5147410530156966;0.9999600672783046;-0.18599346519128368;-0.046253921991744495;-0.44039680225142297;-0.48521901426260794
Bladder polyp;Clasp-knife sign;0.9082473665475845;0.97668695;0.5292469046860933;0.5074214523373961;0.9999201345566091;-0.09167276800902457;-0.023233180058318093;-0.47067322987051585;-0.492498682219213
Bladder polyp;Keratosis pilaris;0.7730959057807922;0.9273121;0.5728603947679144;0.5231577030649299;0.9999506876445663;-0.22685478186377406;-0.07263861155279994;-0.4270902928766519;-0.47679298457963637
Bladder polyp;Lamina lucida cleavage;0.9235982373356819;1.02764;0.5243431584307979;0.4912007953064397;0.9999548690865008;-0.07635663175081886;0.027685115998032916;-0.47561171065570285;-0.5087540737800611
Bladder polyp;Abnormal central response of multifocal electroretinogram;0.8129863440990448;1.0605367;0.5598808645646809;0.4807187723315596;0.9999201345566091;-0.1869337904575643;0.060616607653779075;-0.4400392699919282;-0.5192013622250495
Bladder polyp;Atypical or prolonged hepatitis;0.8657034635543823;1.012265;0.5428774665448508;0.49609584305975485;0.9999600672783046;-0.13425660372392223;0.012304899686417126;-0.45708260073345375;-0.5038642242185497
Bladder polyp;Cubitus varus;0.8903576135635376;0.9748612;0.5349705618446661;0.5080027642188075;0.9999201345566091;-0.10956252099307151;-0.025058929932433083;-0.46494957271194304;-0.4919173703378016
Bladder polyp;Nasal regurgitation;0.672197163105011;0.88131654;0.6063081709633344;0.5378673784439145;0.9999584729108851;-0.32776130980587415;-0.11864193028545789;-0.3936503019475507;-0.4620910944669706
Bladder polyp;Moon facies;1.0425069630146027;1.109263;0.48646553557940575;0.46515095824568853;0.9999584729108851;0.04254849010371753;0.10930447035693713;-0.5134929373314794;-0.5348075146651966
Bladder polyp;Intestinal pseudo-obstruction;0.6082313060760498;0.67267174;0.6281366530744039;0.6061482890096759;0.9999539510871024;-0.3917226450110526;-0.32728221580038974;-0.37181729801269847;-0.3938056620774265
Bladder polyp;Bilateral renal atrophy;0.7029374241828918;1.0008291;0.5960069985811697;0.49973608430614547;0.8144325676816837;-0.11149514349879186;0.18639653292714198;-0.21842556910051403;-0.31469648337553824
Bladder polyp;Fractured left clavicle;0.9404600858688354;1.109956;0.5189633587535225;0.46492898671940164;0.9999201345566091;-0.05946004868777366;0.1100358915206614;-0.4809567758030866;-0.5349911478372075
Bladder polyp;Positive urine norcotinine test;0.5647717118263245;0.77728707;0.6433323394279788;0.5714912649202426;0.9999201345566091;-0.43514842273028465;-0.2226330685737905;-0.35658779512863026;-0.4284288696363665
Bladder polyp;Long fibula;0.8628507554531097;0.92670476;0.5437939928334528;0.5233515381814269;0.9999567459343585;-0.13710599048124872;-0.07325198156820856;-0.4561627531009057;-0.4766052077529316
Bladder polyp;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.896578922867775;1.0952207;0.5329789204187754;0.46964431905232906;0.9999201345566091;-0.10334121168883414;0.09530055044857888;-0.46694121413783374;-0.53027581550428
Bladder polyp;Type II cryptotia;0.9695291351526976;1.0059167;0.5097006790539635;0.49811664794644106;0.9999201345566091;-0.030390999403911545;0.005996580111664818;-0.49021945550264556;-0.501803486610168
Bladder polyp;Increased variability in muscle fiber diameter;0.8355551660060883;0.9811641;0.5525832515213116;0.5059960013647146;0.9999473166570552;-0.1643921506509669;-0.018783218871105456;-0.44736406513574356;-0.4939513152923406
Bladder polyp;Widened proximal tibial metaphyses;0.8591319620609283;0.9862172;0.5449893275755601;0.5043873475852911;0.9999600672783046;-0.1408281052173762;-0.013742866522231556;-0.4549707397027445;-0.4955727196930134
Bladder polyp;Wide anterior fontanel;0.9202036485075951;1.0805811;0.5254270006292057;0.4743224257053996;0.9999476714516888;-0.07974402294409377;0.08063339754092591;-0.47452067082248317;-0.5256252457462892
Bladder polyp;Increased circulating oleate level;0.9638135507702827;1.1284621;0.5115210198532685;0.4589959505954122;0.9999201345566091;-0.03610658378632636;0.12854194163052468;-0.48839911470334063;-0.5409241839611969
Bladder polyp;Lozenge-shaped umbilicus;0.8225955367088318;0.8252211;0.5567700749303743;0.5559210630113216;0.9999584729108851;-0.17736293620205335;-0.1747373515996974;-0.4431883979805108;-0.44403740989956353
Bladder polyp;Anti-myelin-associated glycoprotein antibody positivity;0.7618815302848816;0.9027708;0.5765306527140166;0.5309979862835552;0.9999201345566091;-0.23803860427172752;-0.09714931727679343;-0.4233894818425925;-0.4689221482730539
Bladder polyp;Fractured radius;0.8155544698238373;0.9788085;0.5590489295754332;0.5067459618543991;0.9999600672783046;-0.18440559745446727;-0.021151545053878285;-0.4409111377028714;-0.4932141054239054
Bladder polyp;Abnormal manual kinetic perimetry test;0.8206659257411957;1.0556778;0.5573942995903225;0.4822680559460436;0.9999201345566091;-0.17925420881541343;0.05575763701168923;-0.4425258349662866;-0.5176520786105655
Bladder polyp;Small radial epiphyses;0.8965824767947197;1.0297505;0.532977783070057;0.4905287479882062;0.9999201345566091;-0.10333765776188941;0.029830331790131615;-0.46694235148655205;-0.5093913865684029
Bladder polyp;Generalized keratosis follicularis;0.9400249943137169;1.0025642;0.5191021006400135;0.49918379742874563;0.9999600672783046;-0.059935072964587666;0.0026041245399327506;-0.48085796663829106;-0.5007762698495589
Bladder polyp;Hypoplasia of the calcaneus;0.8513891994953156;1.0025364;0.5474801610941282;0.4991926260105676;0.9999584729108851;-0.14856927341556958;0.0025779431428868405;-0.4524783118167569;-0.5007658469003176
Bladder polyp;2-hydroxyadipic aciduria;0.7680093050003052;0.9674684;0.5745238925853573;0.5103569597594522;0.6288651353633673;0.13914416963693788;0.33860324556467225;-0.05434124277801;-0.11850817560391513
Bladder polyp;Potter facies;0.8406543433666229;0.9716689;0.5509384324686952;0.509019279311703;0.9999552432134126;-0.15930089984678963;-0.028286344154116905;-0.44901681074471733;-0.49093596390170957
Bladder polyp;Increased heart rate variability;0.8918780535459518;1.0584593;0.5344836961375328;0.4813812031747;0.9999600672783046;-0.10808201373235271;0.058499214643082165;-0.4654763711407718;-0.5185788641036045
Bladder polyp;Aplastic zygomatic arch;0.8990628570318222;1.1142329;0.5321840993260886;0.46355897831156956;0.9999584729108851;-0.10089561587906293;0.11427442484759875;-0.46777437358479657;-0.5363994945993156
Bladder polyp;Testicular torsion;0.7809525728225708;0.9532148;0.5702949443374974;0.5148976233288451;0.8586132879499475;-0.07766071512737671;0.094601536249729;-0.2883183436124501;-0.34371566462110237
Bladder polyp;Abolished vibration sense;0.9109274595975876;1.0774547;0.5283902959777464;0.47532069420924583;0.9999584729108851;-0.08903101331329755;0.07749621325397082;-0.4715681769331387;-0.5246377787016393
Bladder polyp;Fractured metatarsal bone of digit 5;0.9710847176611423;1.1065352;0.5092053032833801;0.4660242975784863;0.9999201345566091;-0.02883541689546676;0.10661506174771218;-0.490714831273229;-0.5338958369781228
Bladder polyp;Prolonged G2 phase of cell cycle;0.9191842302680016;0.9388027;0.5257525429669341;0.519491870661037;0.9999567459343585;-0.0807725156663569;-0.06115402681814752;-0.4742042029674244;-0.4804648752733215
Bladder polyp;Single naris;0.766592264175415;0.83338666;0.5749876823434354;0.5532831736706798;0.9999567459343585;-0.23336448175894342;-0.16657008631216608;-0.424969063590923;-0.44667357226367865
Bladder polyp;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9520086348056793;1.149382;0.5152819960007501;0.4522715793785288;0.9999201345566091;-0.04791149975092979;0.14946186064450173;-0.484638138555859;-0.5476485551780803
Bladder polyp;Asymmetry of the thorax;0.8168942183256149;0.9042543;0.5586150852009855;0.5305235504133305;0.9999567459343585;-0.18306252760874353;-0.09570242865072809;-0.441341660733373;-0.4694331955210279
Bladder polyp;Type 2 muscle fiber predominance;0.8808670789003372;0.9457052;0.5380114647047949;0.5172910855855097;0.9999556674707869;-0.11908858857044968;-0.05425049207100663;-0.461944202765992;-0.48266458188527717
Bladder polyp;Dependency on parenteral nutrition;0.7785689681768417;0.94258654;0.5710727682536328;0.5182853325503269;0.9999584729108851;-0.2213895047340434;-0.05737193173504285;-0.4288857046572523;-0.4816731403605582
Bladder polyp;Limited shoulder flexion;0.8478138148784637;0.9716786;0.5486313361181785;0.5090161807672933;0.9999201345566091;-0.15210631967814536;-0.028241519940215065;-0.4512887984384306;-0.49090395378931584
Bladder polyp;Paroxysmal vertigo;0.7490012049674988;0.9426931;0.5807590199576464;0.518251340267075;0.9999584729108851;-0.25095726794338635;-0.05726535863018445;-0.4191994529532387;-0.48170713264381015
Bladder polyp;Long hallux;0.9814734496176243;1.1119648;0.505897521547144;0.46428561309219707;0.9999526340597648;-0.018479184442140473;0.11201218775572597;-0.4940551125126208;-0.5356670209675677
Bladder polyp;Broad medial eyebrow;0.9850824885070324;1.0992824;0.5047485675147333;0.46834529585670803;0.9999600672783046;-0.01487757877127216;0.09932231664045765;-0.49521149976357126;-0.5316147714215965
Bladder polyp;Myxoid subcutaneous tumors;0.8059066385030746;0.79382306;0.5621764731540482;0.5661022422394069;0.9999600672783046;-0.1940534287752299;-0.20613700390473888;-0.4377835941242564;-0.4338578250388977
Bladder polyp;Bulbous tips of toes;0.9381220452487469;1.181757;0.5197089556140031;0.44182156248107496;0.9999584729108851;-0.06183642766213826;0.18179850035571643;-0.48024951729688203;-0.5581369104298102
Bladder polyp;Absent internal genitalia;0.7991129755973816;0.8721118;0.5643824143903545;0.5408198796444941;0.717226575899895;0.08188639969748657;0.15488522143286865;-0.1528441615095405;-0.17640669625540095
Bladder polyp;Hyperphalangy of the 2nd finger;0.9284643828868866;1.1409014;0.5227899597441367;0.45499994543803657;0.9999600672783046;-0.07149568439141796;0.1409413790641637;-0.4771701075341679;-0.544960121840268
Bladder polyp;Renal interstitial hemosiderin;0.7985870540142059;0.9012548;0.5645533135327478;0.53148287739306;0.6288651353633673;0.16972191865083863;0.2723896377765863;-0.06431182183061945;-0.0973822579703073
Bladder polyp;Abnormality of depressor anguli oris muscle;0.7946395725011826;0.97696626;0.5658366607787085;0.5073325150434658;0.9999201345566091;-0.20528056205542655;-0.022953872692900612;-0.4340834737779006;-0.49258761951314334
Bladder polyp;Paroxysmal dyspnea;0.583599328994751;0.8667925;0.6367086356790319;0.542527672495094;0.9999201345566091;-0.41632080556185813;-0.13312763453753562;-0.3632114988775772;-0.45739246206151507
Bladder polyp;Phenylpyruvic acidemia;0.59546959400177;0.8656994;0.6325650184115105;0.5428787732726411;0.9999600672783046;-0.40449047327653453;-0.13426065683976696;-0.3673950488667941;-0.45708129400566344
Bladder polyp;Lateral ventricle dilatation;0.9049640148878098;1.099336;0.5302966165463752;0.46832812840382887;0.9999488789551968;-0.09498486406738704;0.09938714914386326;-0.46965226240882163;-0.5316207505513679
Bladder polyp;Neonatal unconjugated hyperbilirubinemia;0.7472709715366364;0.8887527;0.5813281166136068;0.5354845666571018;0.9999600672783046;-0.2526890957416682;-0.11120736837998912;-0.4186319506646977;-0.4644755006212028
Bladder polyp;High maternal circulating alpha-fetoprotein concentration;0.927524596452713;1.0088272;0.5230898815951456;0.49719017487363126;0.9999201345566091;-0.0723955381038961;0.008907074916047142;-0.47683025296146353;-0.5027299596829778
Bladder polyp;Prominent nasolabial fold;0.8253514766693115;0.96087646;0.5558789166270193;0.512456590743327;0.9999545338528789;-0.1746030571835674;-0.03907806900912891;-0.44407561722585964;-0.48749794310955197
Bladder polyp;Abnormality of inferior alveolar nerve;0.8573232889175415;1.0245793;0.5455709207096606;0.4921753714149233;0.9999201345566091;-0.1425968456390676;0.024659152018708275;-0.4543492138469485;-0.5077447631416858
Bladder polyp;Unilateral conductive hearing impairment;0.7583598494529724;0.9912544;0.5776853533876429;0.5027838421312172;0.9999600672783046;-0.24160021782533214;-0.008705677992263294;-0.4222747138906616;-0.49717622514708737
Bladder polyp;Macular hypopigmented whorls, streaks, and patches;0.9054596424102783;1.0786713;0.5301381398575771;0.4749322418118891;0.9999600672783046;-0.09450042486802623;0.07871126889570668;-0.4698219274207275;-0.5250278254664155
Bladder polyp;Delayed ossification of pubic rami;0.8439379036426544;0.952638;0.5498799974724915;0.5150814465515519;0.9999584729108851;-0.1560205692682307;-0.04732050246334485;-0.45007847543839363;-0.4848770263593333
Bladder polyp;Hyperphenylalaninemia;0.7791135609149933;0.99751884;0.570895017503203;0.5007897847147169;0.9999561589935034;-0.22084259807851014;-0.0024373215415686156;-0.4290611414903004;-0.4991663742787865
Bladder polyp;Ureteropelvic junction obstruction;0.4636320471763611;0.8326333;0.6802040569134518;0.553526375648702;0.7807636207142028;-0.3171315735378417;0.05186969580267342;-0.10055956380075104;-0.2272372450655008
Bladder polyp;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9544851072132587;1.1377828;0.5144928471930584;0.45600240342552933;0.9999201345566091;-0.045435027343350365;0.13786267756192117;-0.4854272873635507;-0.5439177311310798
Bladder polyp;Difficulty walking;0.8893494755029678;1.1011262;0.5352934266840448;0.4677553976788965;0.9999461221900431;-0.11059664668707525;0.10118007181020106;-0.4646526955059983;-0.5321907245111466
Bladder polyp;Bilobate gallbladder;0.5478412508964539;0.43914747;0.6493459535123569;0.6895265346194197;0.9999584729108851;-0.4521172220144313;-0.5608110005292933;-0.3506125193985282;-0.3104319382914654
Bladder polyp;Histidinuria;0.7841314971446991;0.9069458;0.5692582524222799;0.5296629713403765;0.8024087134738423;-0.018277216329143253;0.10453711114926556;-0.23315046105156245;-0.2727457421334658
Bladder polyp;Widened interpedicular distance;0.920006550848484;1.097206;0.5254899399613533;0.4690094387730419;0.9999201345566091;-0.07991358370812507;0.09728586195675759;-0.4744301945952558;-0.5309106957835672
Aberrant melanosome maturation;Vertebral artery tortuosity;0.8290162533521652;0.9405012;0.554694561557865;0.5189502466834952;0.9999600672783046;-0.17094381392613933;-0.059458854204574085;-0.44526550572043955;-0.48100982059480935
Aberrant melanosome maturation;Warm reactive autoantibody positivity;0.7784142643213272;0.82126486;0.5711232664735251;0.5572005210081261;0.9999201345566091;-0.2215058702352819;-0.17865527154238792;-0.42879686808308404;-0.442719613548483
Aberrant melanosome maturation;Right aortic arch with retroesophageal left subclavian artery;0.9324353635311127;1.007256;0.5215228882336607;0.4976903155422945;0.9999201345566091;-0.06748477102549644;0.007335896479767845;-0.47839724632294844;-0.5022298190143146
Aberrant melanosome maturation;Elevated urine suberic acid level;0.8274011015892029;0.8995301;0.5552164389567551;0.5320346001154672;0.9999600672783046;-0.17255896568910167;-0.10042995453492687;-0.44474362832154946;-0.46792546716283734
Aberrant melanosome maturation;Burkitt lymphoma;0.7329133749008179;0.92598814;0.5860609852748169;0.5235802640334963;0.9999574798349273;-0.26704410493410946;-0.07396934211291195;-0.41389649456011046;-0.476377215801431
Aberrant melanosome maturation;Snail-like ilia;0.9605976790189743;0.91129076;0.5125453959468527;0.5282741974888139;0.9999600672783046;-0.03936238825933025;-0.08866930246964977;-0.4874146713314519;-0.4716858697894907
Aberrant melanosome maturation;Indurated nodule;0.8557189702987671;0.9257301;0.5460869301998452;0.5236626213524285;0.656988850480855;0.1987301198179121;0.26874125873392773;-0.11090192028100976;-0.1333262291284265
Aberrant melanosome maturation;Absent leukocyte alkaline phosphatase;0.7937055826187134;0.9068717;0.5661404639451852;0.5296866787575972;0.9999600672783046;-0.20625448465959118;-0.09308839083329723;-0.4338196033331193;-0.4702733885207073
Aberrant melanosome maturation;Hippocampal sclerosis;0.768031045794487;0.936969;0.5745167781994391;0.5200767049115729;0.9999201345566091;-0.2318890887621221;-0.06295115233691306;-0.42540335635716997;-0.47984342964503623
Aberrant melanosome maturation;Decreased sensitivity to hypoxemia;0.7413082420825958;0.9204812;0.5832913880274615;0.5253383652567352;0.9999600672783046;-0.25865182519570873;-0.07947886229173229;-0.41666867925084305;-0.4746217020215694
Aberrant melanosome maturation;Decreased level of tissue plasminogen activator;0.768332913517952;1.030635;0.5744179999159955;0.49024704084866155;0.9999201345566091;-0.23158722103865714;0.03071486471859841;-0.4255021346406136;-0.5096730937079476
Aberrant melanosome maturation;Submandibular lymph node enlargement;0.8328086584806442;0.9624436;0.553469764899783;0.5119573803087757;0.9999600672783046;-0.16715140879766033;-0.037516477114119984;-0.4464903023785216;-0.48800268696952886
Aberrant melanosome maturation;Hepatic hemangioma;0.7705720812082291;0.9169222;0.573685518248402;0.5264749982150156;0.9999584729108851;-0.22938639170265607;-0.08303626126385144;-0.42627295466248316;-0.4734834746958695
Aberrant melanosome maturation;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8119793683290482;0.89789176;0.5602071833847917;0.5325588071834526;0.9999201345566091;-0.18794076622756095;-0.10202837468417258;-0.4397129511718174;-0.4673613273731565
Aberrant melanosome maturation;Acne inversa;0.853937417268753;0.8075566;0.5466600879925811;0.5616411818050642;0.8230814931248395;0.030855924143913582;-0.015524863943931266;-0.2764214051322583;-0.2614403113197753
Aberrant melanosome maturation;Dentin dysplasia;0.6861448884010315;0.75645596;0.6016206208992636;0.5783100365637417;0.9999201345566091;-0.3137752461555776;-0.24346417666705222;-0.3982995136573455;-0.4216100979928674
Aberrant melanosome maturation;Aplasia of the inner ear;0.6730673909187317;0.84788823;0.6060150150696413;0.5486073600163015;0.9999600672783046;-0.32689267635957286;-0.15207183600083873;-0.39394505220866327;-0.45135270726200305
Aberrant melanosome maturation;Polycystic liver disease;0.6892510950565338;0.9272787;0.600579826480568;0.5231683655079802;0.9999567459343585;-0.31070565087782465;-0.07267804844366632;-0.3993769194537905;-0.4767883804263783
Aberrant melanosome maturation;Subungual hyperkeratosis;0.723945140838623;0.72100013;0.5890271485566918;0.5900029033670382;0.8095978540801885;-0.08565271324156543;-0.0885977191352727;-0.22057070552349667;-0.21959495071315027
Aberrant melanosome maturation;Broad humeral epiphyses;0.8671319633722305;1.0281309;0.5424186488385307;0.49104446962762716;0.9999201345566091;-0.13278817118437858;0.0282107543822947;-0.45750148571807836;-0.508875664928982
Aberrant melanosome maturation;Autoimmune thrombocytopenia;0.7038484811782837;0.90669996;0.5957033351461731;0.5297415830357781;0.9999509115718902;-0.2961024303936065;-0.09325095610848078;-0.40424757642571707;-0.4702093285361121
Aberrant melanosome maturation;Adenomyosis;0.7035736441612244;0.8970051;0.5957949313044655;0.532842544109059;0.9999600672783046;-0.2963864231170802;-0.10295498610154674;-0.4041651359738391;-0.4671175231692456
Aberrant melanosome maturation;Elevated leukocyte alkaline phosphatase;0.8020870685577393;0.91426873;0.5634163300631856;0.527322644903816;0.9999600672783046;-0.1978729987205653;-0.0856913352073817;-0.43654373721511897;-0.4726374223744886
Aberrant melanosome maturation;Clasp-knife sign;1.0033909045159817;0.8944979;0.4989206395009945;0.5336449838860622;0.9999201345566091;0.003470769959372566;-0.10542226315768333;-0.5009994950556146;-0.4662751506705469
Aberrant melanosome maturation;Keratosis pilaris;0.6670277714729309;0.68037665;0.6080515405140144;0.6035563793961286;0.7882101819680228;-0.12118241049509193;-0.10783353306512977;-0.1801586414540084;-0.18465380257189423
Aberrant melanosome maturation;Lamina lucida cleavage;0.806999921798706;0.7246593;0.5618217630605247;0.5887906613627192;0.8061689028324591;0.0008310189662469325;-0.08150957914013734;-0.24434713977193445;-0.21737824146973994
Aberrant melanosome maturation;Abnormal central response of multifocal electroretinogram;0.6368170380592346;0.6552979;0.6183100098998806;0.6120200643974302;0.9999201345566091;-0.3631030964973745;-0.3446222591522512;-0.3816101246567285;-0.38790007015917893
Aberrant melanosome maturation;Atypical or prolonged hepatitis;0.7604347169399261;1.0484711;0.5770049135894135;0.4845651191668914;0.9999600672783046;-0.2395253503383784;0.048511025899490856;-0.42295515368889103;-0.5153949481114132
Aberrant melanosome maturation;Cubitus varus;0.9609255380928516;1.0647261;0.5124409547293893;0.4793826224522072;0.9999201345566091;-0.03899459646375747;0.06480597971646218;-0.4874791798272198;-0.5205375121044019
Aberrant melanosome maturation;Nasal regurgitation;0.8698185384273529;1.0062255;0.541555991158428;0.4980183667088601;0.9999584729108851;-0.13013993448353223;0.006266993817325317;-0.4584024817524571;-0.501940106202025
Aberrant melanosome maturation;Moon facies;0.7618619352579117;0.6412954;0.5765370747427323;0.6167814666778553;0.9999584729108851;-0.23809653765297345;-0.3586630994710963;-0.42342139816815283;-0.38317700623302986
Aberrant melanosome maturation;Intestinal pseudo-obstruction;0.7691783905029297;0.9859466;0.5741413785972224;0.5044734847922479;0.9999539510871024;-0.2307755605841727;-0.014007355418309664;-0.42581257248988;-0.49548046629485454
Aberrant melanosome maturation;Bilateral renal atrophy;0.7939094305038452;0.8139523;0.5660741522047142;0.5595678945653062;0.9999600672783046;-0.20605063677445934;-0.18600774050370739;-0.4338859150735903;-0.44039217271299835
Aberrant melanosome maturation;Fractured left clavicle;0.9635682366788387;1.0422606;0.5115991572772625;0.48654400741665427;0.9999201345566091;-0.03635189787777038;0.04234051226345925;-0.48832097727934665;-0.5133761271399548
Aberrant melanosome maturation;Positive urine norcotinine test;0.8751757442951202;0.91152704;0.5398367049276442;0.5281986926375322;0.9999201345566091;-0.12474439026148887;-0.08839309693606467;-0.46008342962896487;-0.47172144191907694
Aberrant melanosome maturation;Long fibula;0.927818775177002;1.082603;0.5229959956999017;0.473676645691522;0.9999567459343585;-0.0721379707573565;0.08264623181832709;-0.4769607502344567;-0.5262801002428364
Aberrant melanosome maturation;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8255657851696014;0.9567425;0.5558096366539733;0.5137735797327463;0.9999201345566091;-0.17435434938700767;-0.0431776094559011;-0.4441104979026358;-0.4861465548238628
Aberrant melanosome maturation;Type II cryptotia;0.7536896467208862;0.6722469;0.5792182486569191;0.6062914224144923;0.9999201345566091;-0.24623048783572288;-0.32767326117785545;-0.42070188589969004;-0.3936287121421168
Aberrant melanosome maturation;Increased variability in muscle fiber diameter;0.6905322968959808;0.8518833;0.6001508596957974;0.5473211216450985;0.9999473166570552;-0.30941501976107433;-0.148064024458874;-0.39979645696125776;-0.45262619501195667
Aberrant melanosome maturation;Widened proximal tibial metaphyses;0.721608430147171;0.98577183;0.589801288911735;0.504529127641995;0.9999600672783046;-0.27835163713113353;-0.014188232427993275;-0.41015877836656955;-0.4954309396363096
Aberrant melanosome maturation;Wide anterior fontanel;0.8813547343015671;0.8739408;0.5378551303729479;0.5402329119833704;0.9999476714516888;-0.11859293715012176;-0.12600684598934753;-0.462092541078741;-0.4597147594683184
Aberrant melanosome maturation;Increased circulating oleate level;0.7732947021722794;0.8654398;0.5727954227573293;0.542962170815152;0.9999201345566091;-0.22662543238432975;-0.1344803619507131;-0.4271247117992798;-0.45695796374145714
Aberrant melanosome maturation;Lozenge-shaped umbilicus;0.950100377202034;0.9984772;0.5158901422474704;0.500484706459045;0.9999584729108851;-0.049858095708851136;-0.0014812523756068119;-0.4840683306634147;-0.49947376645184016
Aberrant melanosome maturation;Anti-myelin-associated glycoprotein antibody positivity;0.6605600118637085;0.75361377;0.6102375489053062;0.5792431738689763;0.9999201345566091;-0.3393601226929006;-0.24630636454852195;-0.38968258565130287;-0.42067696068763283
Aberrant melanosome maturation;Fractured radius;0.9020136669278145;0.9172785;0.5312401463121588;0.5263611802412762;0.9999600672783046;-0.09794640035049007;-0.08268153906480358;-0.4687199209661458;-0.47359888703702835
Aberrant melanosome maturation;Abnormal manual kinetic perimetry test;0.5911519527435303;0.6943852;0.6340693969496163;0.5988619850592928;0.9999201345566091;-0.40876818181307883;-0.30553496362002464;-0.3658507376069928;-0.40105814949731633
Aberrant melanosome maturation;Small radial epiphyses;0.7472622096538544;0.8329134;0.5813309991875281;0.5534359397458805;0.9999201345566091;-0.25265792490275474;-0.16700673581393333;-0.41858913536908104;-0.44648419481072865
Aberrant melanosome maturation;Generalized keratosis follicularis;0.736131876707077;0.59928787;0.5849983741688973;0.6312372492570492;0.8284944252404275;-0.09236254853335046;-0.22920655769434595;-0.24349605107153016;-0.19725717598337833
Aberrant melanosome maturation;Hypoplasia of the calcaneus;0.8778787702322006;1.0205036;0.5389696701899566;0.49347304192737573;0.9999584729108851;-0.12207970267868451;0.02054516726398059;-0.46098880272092857;-0.5064854309835094
Aberrant melanosome maturation;2-hydroxyadipic aciduria;0.804421603679657;0.79577494;0.5626584103836795;0.5654674472516998;0.9999201345566091;-0.19549853087695213;-0.20414519788058372;-0.43726172417292963;-0.43445268730490927
Aberrant melanosome maturation;Potter facies;0.7889106422662735;0.73408675;0.5677011056851053;0.5856734733414681;0.9999552432134126;-0.21104460094713906;-0.26586849127554635;-0.4322541375283072;-0.4142817698719444
Aberrant melanosome maturation;Increased heart rate variability;0.860993504524231;0.96936816;0.5443908917270435;0.50975194541227;0.9999600672783046;-0.1389665627540736;-0.030591907507338978;-0.4555691755512611;-0.4902081218660346
Aberrant melanosome maturation;Aplastic zygomatic arch;0.7035652101039886;0.8169944;0.5957977422896683;0.5585826293616276;0.9999584729108851;-0.2963932628068965;-0.18296404427624158;-0.4041607306212168;-0.4413758435492575
Aberrant melanosome maturation;Testicular torsion;0.757370263338089;0.90628564;0.5780100093710556;0.52987405249377;0.9999600672783046;-0.24258980394021556;-0.09367442370072887;-0.42195005790724893;-0.4700860147845346
Aberrant melanosome maturation;Abolished vibration sense;0.8663681447505951;0.98248935;0.5426639675012173;0.5055740987002024;0.9999584729108851;-0.13359032816029004;-0.01746912545299939;-0.4572945054096679;-0.4943843742106827
Aberrant melanosome maturation;Fractured metatarsal bone of digit 5;0.7784358561038971;0.8651465;0.5711162184042564;0.5430563657882008;0.9999201345566091;-0.221484278452712;-0.13477361680300803;-0.4288039161523527;-0.4568637687684083
Aberrant melanosome maturation;Prolonged G2 phase of cell cycle;0.8047675490379333;0.81804407;0.5625461280381387;0.5582428135566129;0.9999567459343585;-0.1951891968964251;-0.18191267950522028;-0.4374106178962197;-0.4417139323777456
Aberrant melanosome maturation;Single naris;0.8476138114929199;0.71967787;0.5486957504739302;0.5904412868668881;0.9999567459343585;-0.15234293444143854;-0.28027888042913995;-0.4512609954604283;-0.40951545906747033
Aberrant melanosome maturation;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7418625950813293;0.6253116;0.5831087277664859;0.6222503031081896;0.9999201345566091;-0.25805753947527976;-0.37460852147372337;-0.4168114067901232;-0.3776698314484195
Aberrant melanosome maturation;Asymmetry of the thorax;0.8113974034786224;0.9441918;0.5603958030859388;0.5177735388865483;0.9999567459343585;-0.18855934245573602;-0.055764932465425354;-0.4395609428484196;-0.48218320704781015
Aberrant melanosome maturation;Type 2 muscle fiber predominance;0.8126830756664276;0.9374279;0.5599791344887275;0.5199303495682934;0.9999556674707869;-0.1872725918043593;-0.06252778909096512;-0.4399765329820594;-0.4800253179024935
Aberrant melanosome maturation;Dependency on parenteral nutrition;0.7826372981071472;0.8974054;0.5697454380620708;0.5327144421540126;0.9999584729108851;-0.21732117480373792;-0.1025530869398158;-0.43021303484881435;-0.4672440307568725
Aberrant melanosome maturation;Limited shoulder flexion;0.9348492622375488;1.0950619;0.5207528229200677;0.46969509753791516;0.9999201345566091;-0.06507087231906028;0.09514176367489724;-0.47916731163654136;-0.530225037018694
Aberrant melanosome maturation;Paroxysmal vertigo;0.7885722368955612;1.0119088;0.5678113107659919;0.49620924197058647;0.9999584729108851;-0.21138623601532391;0.011950296696658813;-0.43214716214489324;-0.5037492309402987
Aberrant melanosome maturation;Long hallux;0.9475199766457081;1.0068945;0.5167125877592614;0.4978054214892875;0.9999526340597648;-0.05243265741405667;0.006941835201404678;-0.4832400463005033;-0.5021472125704772
Aberrant melanosome maturation;Broad medial eyebrow;0.7271104454994202;0.65742975;0.5879793599370505;0.6112974715770099;0.8733283781844945;-0.14621793268507433;-0.21589862345045518;-0.28534901824744396;-0.2620309066074846
Aberrant melanosome maturation;Myxoid subcutaneous tumors;0.6604085564613342;0.8438894;0.6102888031391812;0.5498956233222957;0.8434590184411804;-0.1830504619798462;0.00043039682294920834;-0.23317021530199922;-0.29356339511888474
Aberrant melanosome maturation;Bulbous tips of toes;0.789978414773941;0.82951146;0.5673534288708344;0.5545345870278439;0.9999584729108851;-0.2099800581369441;-0.17044700926876477;-0.43260504404005073;-0.44542388588304127
Aberrant melanosome maturation;Absent internal genitalia;0.8147734552621841;0.7796984;0.5593018929567257;0.5707041697298543;0.9999201345566091;-0.18514667929442497;-0.22022176266940208;-0.4406182415998834;-0.42921596482675484
Aberrant melanosome maturation;Hyperphalangy of the 2nd finger;0.8270720541477203;0.89679044;0.5553227769785976;0.5329112238694893;0.9999600672783046;-0.17288801313058422;-0.10316962242738292;-0.444637290299707;-0.46704884340881525
Aberrant melanosome maturation;Renal interstitial hemosiderin;0.7495357096195221;0.80828977;0.5805832677265095;0.5614033796139881;0.9999201345566091;-0.250384424937087;-0.1916303682449636;-0.41933686683009963;-0.438516754942621
Aberrant melanosome maturation;Abnormality of depressor anguli oris muscle;0.8291377574205399;1.0381446;0.5546553079712053;0.4878552362501083;0.9999201345566091;-0.17078237713606925;0.038224453913849876;-0.4452648265854038;-0.5120648983065008
Aberrant melanosome maturation;Paroxysmal dyspnea;0.7544279396533966;0.9763994;0.5789757957073911;0.5075129890150432;0.9999201345566091;-0.2454921949032125;-0.023520712864714577;-0.420944338849218;-0.49240714554156595
Aberrant melanosome maturation;Phenylpyruvic acidemia;0.7031664252281189;0.8142842;0.5959306620189195;0.5594603709104058;0.9999600672783046;-0.29679364205018566;-0.185675861841598;-0.404029405259385;-0.44049969636789876
Aberrant melanosome maturation;Lateral ventricle dilatation;0.7940434664487839;0.9201946;0.5660305518820241;0.5254298818174995;0.9999488789551968;-0.20590541250641292;-0.07975425310070461;-0.4339183270731727;-0.4745189971376973
Aberrant melanosome maturation;Neonatal unconjugated hyperbilirubinemia;0.7998248338699341;1.0315291;0.5641511247507058;0.4899623304419797;0.9999600672783046;-0.20013523340837047;0.031569001668533825;-0.4358089425275987;-0.5099977368363249
Aberrant melanosome maturation;High maternal circulating alpha-fetoprotein concentration;0.7673663645982742;0.74724996;0.574734303447969;0.5813350387243605;0.9999201345566091;-0.23255376995833488;-0.2526701736572561;-0.42518583110864006;-0.41858509583224857
Aberrant melanosome maturation;Prominent nasolabial fold;0.9009166285395622;0.8963443;0.531591052142816;0.5330540006757852;0.9999545338528789;-0.09903790531331669;-0.10361022976810108;-0.4683634817100629;-0.4669005331770937
Aberrant melanosome maturation;Abnormality of inferior alveolar nerve;0.7988914251327515;0.8620739;0.5644544053064374;0.5440436563018272;0.9999201345566091;-0.20102870942385764;-0.13784623624117942;-0.4354657292501717;-0.45587647825478195
Aberrant melanosome maturation;Unilateral conductive hearing impairment;0.8249038010835648;1.0266908;0.5560236463167261;0.4915030395668444;0.9999600672783046;-0.1750562661947398;0.026730773442825817;-0.4439364209615785;-0.5084570277114602
Aberrant melanosome maturation;Macular hypopigmented whorls, streaks, and patches;0.5585228502750397;0.51329684;0.645545372983484;0.6618006612844093;0.6434261658134761;-0.08490331553843644;-0.13012932323840287;0.0021192071700079085;0.018374495470933172
Aberrant melanosome maturation;Delayed ossification of pubic rami;0.7398019134998322;0.87459826;0.5837878678761397;0.5400219877430272;0.9999584729108851;-0.260156559411053;-0.12536020821667127;-0.41617060503474546;-0.4599364851678579
Aberrant melanosome maturation;Hyperphenylalaninemia;0.6930248737335205;0.7866659;0.5993168431592688;0.5684322679586779;0.9999561589935034;-0.3069312852599829;-0.21329024255063234;-0.4006393158342346;-0.4315238910348256
Aberrant melanosome maturation;Ureteropelvic junction obstruction;0.8343311250209808;0.9031556;0.5529782942802987;0.530874917436521;0.9999528219730685;-0.16562169695208762;-0.09679719710658286;-0.4469745276927698;-0.4690779045365474
Aberrant melanosome maturation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7849176228046417;0.8929359;0.5690020013170909;0.5341450159932013;0.9999201345566091;-0.21500251175196738;-0.10698426247866721;-0.4309181332395182;-0.4657751185634078
Aberrant melanosome maturation;Difficulty walking;0.8430750519037247;0.9140277;0.5501580779544726;0.5273996502623329;0.9999461221900431;-0.15687107028631841;-0.08591843130259191;-0.4497880442355705;-0.47254647192771015
Aberrant melanosome maturation;Bilobate gallbladder;0.8605967909097672;1.0242232;0.544518411172991;0.49228875963724716;0.9999584729108851;-0.13936168200111798;0.024264735516544067;-0.4554400617378941;-0.507669713273638
Aberrant melanosome maturation;Histidinuria;0.7187847793102264;0.7566578;0.5907374792445204;0.5782438021904601;0.9999574798349273;-0.2811727005247009;-0.24329970061816097;-0.409220000590407;-0.4217136776444672
Aberrant melanosome maturation;Widened interpedicular distance;0.8446881771087646;1.0021896;0.5496382299994726;0.4993030266630426;0.9999201345566091;-0.15523195744784446;0.002269501673859642;-0.45028190455713646;-0.5006171078935665
Vertebral artery tortuosity;Warm reactive autoantibody positivity;0.7907030582427979;0.9836929;0.5671175245967468;0.5051909497359173;0.9999201345566091;-0.20921707631381126;-0.01622725011141868;-0.4328026099598623;-0.49472918482069184
Vertebral artery tortuosity;Right aortic arch with retroesophageal left subclavian artery;0.6985793113708496;0.68085915;0.5974608498297764;0.603394306604115;0.26000653562401765;0.43857277574683196;0.4208526128783322;0.3374543142057588;0.3433877709800973
Vertebral artery tortuosity;Elevated urine suberic acid level;0.9079110771417618;1.005488;0.5293544040466494;0.4982530766724377;0.9999600672783046;-0.09204899013654277;0.005527970784744762;-0.4706056632316552;-0.5017069906058669
Vertebral artery tortuosity;Burkitt lymphoma;0.8132975697517395;0.9652739;0.5597800222183947;0.5110558736785542;0.9999574798349273;-0.18665991008318783;-0.03468356311358334;-0.4401774576165326;-0.4889016061563731
Vertebral artery tortuosity;Snail-like ilia;0.9489035196602345;0.98640096;0.5162716005382835;0.5043288354833548;0.9999600672783046;-0.0510565476180701;-0.013559105402389027;-0.4836884667400211;-0.4956312317949497
Vertebral artery tortuosity;Indurated nodule;0.8044146150350571;0.95714176;0.562660678746389;0.5136463751811169;0.9999201345566091;-0.19550551952155204;-0.042778377545195534;-0.4372594558102201;-0.4862737593754922
Vertebral artery tortuosity;Absent leukocyte alkaline phosphatase;0.8668847233057022;1.0821412;0.5424980531320409;0.47382415732547856;0.9999600672783046;-0.13307534397260234;0.08218109368666127;-0.45746201414626364;-0.526135909952826
Vertebral artery tortuosity;Hippocampal sclerosis;0.7941714525222778;1.0572631;0.5659889206847477;0.4817625848807773;0.9999201345566091;-0.20574868203433128;0.05734300135342507;-0.4339312138718614;-0.5181575496758318
Vertebral artery tortuosity;Decreased sensitivity to hypoxemia;0.6981776356697083;0.85237783;0.5975949526491335;0.5471619598156621;0.9999600672783046;-0.3017824316085963;-0.14758223534242199;-0.402365114629171;-0.4527981074626425
Vertebral artery tortuosity;Decreased level of tissue plasminogen activator;0.8113552629947662;0.95795375;0.5604094620037154;0.5133876762144879;0.9999201345566091;-0.18856487156184287;-0.04196638346942039;-0.43951067255289367;-0.4865324583421212
Vertebral artery tortuosity;Submandibular lymph node enlargement;0.9035638198256493;0.9096769;0.5307443691536553;0.5287899766982691;0.8116988959058551;0.09186492391979417;0.09797801354086122;-0.2809545267521998;-0.282908919207586
Vertebral artery tortuosity;Hepatic hemangioma;0.6427581310272217;0.72803545;0.6162828114445931;0.5876733375086706;0.8041807220209305;-0.16142259099370881;-0.07614527203924104;-0.18789791057633742;-0.21650738451225993
Vertebral artery tortuosity;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8142803311347961;1.0449036;0.5594616308003239;0.4857019388429219;0.9999201345566091;-0.18563980342181297;0.04498350142208962;-0.44045850375628526;-0.5142181957136872
Vertebral artery tortuosity;Acne inversa;0.8459082245826721;1.0880474;0.5492451445271427;0.47193731303657116;0.9999548690865008;-0.15404664450382866;0.0880925161292585;-0.4507097245593581;-0.5280175560499296
Vertebral artery tortuosity;Dentin dysplasia;0.7939005941152573;0.9357549;0.5660770266225907;0.5204639481300174;0.9999201345566091;-0.20601954044135184;-0.064165239346343;-0.43384310793401837;-0.4794561864265917
Vertebral artery tortuosity;Aplasia of the inner ear;0.8061635196208954;1.0126724;0.562093122395609;0.49596611718765027;0.9999600672783046;-0.19379654765740917;0.012712357038101696;-0.4378669448826955;-0.5039939500906543
Vertebral artery tortuosity;Polycystic liver disease;0.7572663575410843;0.820285;0.5780441028035057;0.5575175472791363;0.9999567459343585;-0.24269038839327417;-0.17967172367559991;-0.42191264313085275;-0.4424391986552222
Vertebral artery tortuosity;Subungual hyperkeratosis;0.91756671667099;1.1228081;0.5262691373911013;0.460810034413068;0.9999556674707869;-0.08238895079979691;0.12285243132224288;-0.47368653007968564;-0.5391456330577189
Vertebral artery tortuosity;Broad humeral epiphyses;0.7544985860586166;0.949273;0.5789525981169851;0.5161538428761252;0.9999201345566091;-0.24542154849799247;-0.0506471443298635;-0.42096753643962403;-0.4837662916804839
Vertebral artery tortuosity;Autoimmune thrombocytopenia;0.6183245182037354;0.96908677;0.6246528029673126;0.5098415528552338;0.9999509115718902;-0.38162639336815485;-0.030864145328909243;-0.3752981086045776;-0.4901093587166564
Vertebral artery tortuosity;Adenomyosis;0.9074913561344147;1.0076013;0.5294885781350736;0.4975804388082552;0.9999600672783046;-0.09246871114388988;0.0076411938606114616;-0.470471489143231;-0.5023796284700494
Vertebral artery tortuosity;Elevated leukocyte alkaline phosphatase;0.8839596658945084;1.1035382;0.5370201864108037;0.4669836112154132;0.9999600672783046;-0.11600040138379619;0.10357808827742054;-0.4629398808675008;-0.5329764560628913
Vertebral artery tortuosity;Clasp-knife sign;0.9409556500613689;0.8680571;0.5188053377597086;0.5421215571067692;0.9999201345566091;-0.058964484495240166;-0.13186306239398093;-0.4811147967969005;-0.45779857744983987
Vertebral artery tortuosity;Keratosis pilaris;0.8350888043642044;0.9937778;0.5527337537945015;0.501980594068402;0.9999506876445663;-0.1648618832803619;-0.006172876117314097;-0.4472169338500648;-0.4979700935761643
Vertebral artery tortuosity;Lamina lucida cleavage;0.7659711837768555;0.7773109;0.575191009658585;0.5714834803249844;0.9999548690865008;-0.2339836853096453;-0.22264396124577202;-0.4247638594279157;-0.42847138876151636
Vertebral artery tortuosity;Abnormal central response of multifocal electroretinogram;0.7865063548088074;0.9502821;0.568484265413939;0.5158322271971464;0.9999201345566091;-0.21341377974780174;-0.04963803769381614;-0.43143586914267007;-0.4840879073594627
Vertebral artery tortuosity;Atypical or prolonged hepatitis;0.7802354097366333;1.0143533;0.5705289257177613;0.49543105279485977;0.9999600672783046;-0.21972465754167125;0.014393208020767712;-0.4294311415605433;-0.5045290144834448
Vertebral artery tortuosity;Cubitus varus;0.5931731164455414;0.7124485;0.6333647768351035;0.5928412449509142;0.9999201345566091;-0.4067470181110677;-0.28747165681155296;-0.3665553577215056;-0.40707888960569494
Vertebral artery tortuosity;Nasal regurgitation;0.8028920292854309;0.88189346;0.5631549541971346;0.5376824356924048;0.9999584729108851;-0.19706644362545422;-0.11806501692867688;-0.43680351871375056;-0.4622760372184803
Vertebral artery tortuosity;Moon facies;0.8930015116930008;0.9475623;0.5341240015404434;0.5166990961600328;0.9999584729108851;-0.10695696121788434;-0.05239619559383801;-0.46583447137044176;-0.4832593767508523
Vertebral artery tortuosity;Intestinal pseudo-obstruction;0.7637100666761398;0.90617657;0.5759315118081914;0.5299089167479707;0.9999539510871024;-0.23624388441096256;-0.09377738400946567;-0.42402243927891103;-0.4700450343391317
Vertebral artery tortuosity;Bilateral renal atrophy;0.7231414318084717;0.8999347;0.5892933520106023;0.5319051703291776;0.9999600672783046;-0.2768186354698329;-0.10002535820619152;-0.41066671526770226;-0.46805489694912694
Vertebral artery tortuosity;Fractured left clavicle;0.7152529954910278;0.8375264;0.5919095912651169;0.5519472398840667;0.9999201345566091;-0.2846671390655813;-0.16239375354083152;-0.4080105432914922;-0.4479728946725424
Vertebral artery tortuosity;Positive urine norcotinine test;0.8786304295063019;1.0044956;0.5387286164948423;0.4985689986597208;0.9999201345566091;-0.12128970505030723;0.004575486170929954;-0.46119151806176684;-0.5013511358968883
Vertebral artery tortuosity;Long fibula;0.7743586897850037;1.1152223;0.5724477353657873;0.4632419444212732;0.9999567459343585;-0.2255980561493548;0.11526558892739691;-0.42750901056857116;-0.5367148015130853
Vertebral artery tortuosity;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.813275158405304;1.1294415;0.5597872836686171;0.45868156554974737;0.9999201345566091;-0.18664497615130515;0.1295213651534739;-0.44013285088799203;-0.5412385690068617
Vertebral artery tortuosity;Type II cryptotia;0.7900203764438629;0.85211784;0.5673397674233371;0.5472456325551734;0.9999201345566091;-0.2098997581127462;-0.1478022980812368;-0.43258036713327197;-0.45267450200143566
Vertebral artery tortuosity;Increased variability in muscle fiber diameter;0.6503889858722687;0.7635472;0.613686249182096;0.5759848814170343;0.9999473166570552;-0.3495583307847865;-0.23640013457392528;-0.38626106747495914;-0.42396243524002086
Vertebral artery tortuosity;Widened proximal tibial metaphyses;0.7135201692581177;1.0486336;0.5924851416829577;0.4845133241419822;0.9999600672783046;-0.2864398980201869;0.04867350816114857;-0.4074749255953468;-0.5154467431363223
Vertebral artery tortuosity;Wide anterior fontanel;0.7707988023757935;0.68832207;0.5736113749149455;0.6008909979901194;0.9999476714516888;-0.22914886907589538;-0.31162560419094665;-0.4263362965367433;-0.3990566734615695
Vertebral artery tortuosity;Increased circulating oleate level;0.7723115086555481;1.0102978;0.5731167870365763;0.49672206550530107;0.9999201345566091;-0.227608625901061;0.01037764071194558;-0.4268033475200328;-0.503198069051308
Vertebral artery tortuosity;Lozenge-shaped umbilicus;0.7802443355321884;0.79198366;0.5705260133529437;0.5667007207945203;0.9999584729108851;-0.21971413737869672;-0.207974808875088;-0.4294324595579414;-0.43325775211636486
Vertebral artery tortuosity;Anti-myelin-associated glycoprotein antibody positivity;0.8749018013477325;0.8930488;0.5399245925725873;0.5341088621628658;0.9999201345566091;-0.12501833320887656;-0.10687131167681785;-0.4599955419840218;-0.4658112723937433
Vertebral artery tortuosity;Fractured radius;0.6769780516624451;0.91192544;0.6046987684252902;0.5280713722780663;0.9999600672783046;-0.3229820156158595;-0.08803463221208141;-0.3952612988530143;-0.4718886950002382
Vertebral artery tortuosity;Abnormal manual kinetic perimetry test;0.7952611744403839;0.98376393;0.5656345032028642;0.5051683335980732;0.9999201345566091;-0.2046589601162252;-0.016156201374846413;-0.43428563135374487;-0.4947518009585359
Vertebral artery tortuosity;Small radial epiphyses;0.8481614887714386;0.94244397;0.5485193668398753;0.5183307822185523;0.9999201345566091;-0.1517586457851705;-0.05747616769106956;-0.45140076771673376;-0.4815893523380568
Vertebral artery tortuosity;Generalized keratosis follicularis;0.8537383377552032;1.0733559;0.5467241448995281;0.4766290764041924;0.9999600672783046;-0.1462217295231013;0.07339584588392689;-0.4532359223787764;-0.5233309908741122
Vertebral artery tortuosity;Hypoplasia of the calcaneus;0.7673353552818298;0.8769222;0.5747444525025862;0.5392764711526645;0.9999584729108851;-0.2326231176290553;-0.12303628272152356;-0.4252140204082989;-0.4606820017582206
Vertebral artery tortuosity;2-hydroxyadipic aciduria;0.7956428527832031;0.98107475;0.5655103869651303;0.5060244471769837;0.9999201345566091;-0.20427728177340598;-0.01884538413317771;-0.43440974759147877;-0.4938956873796254
Vertebral artery tortuosity;Potter facies;0.9594719037413597;0.94885993;0.5129040278875157;0.5162855020211299;0.9999552432134126;-0.04048333947205285;-0.05109531317496041;-0.4870512153258969;-0.4836697411922827
Vertebral artery tortuosity;Increased heart rate variability;0.6692681312561035;0.9550093;0.6072955719728272;0.5143258202537055;0.8658135241678199;-0.19654539291171635;0.08919575746746455;-0.25851795219499263;-0.3514877039141143
Vertebral artery tortuosity;Aplastic zygomatic arch;0.7945611476898193;0.7766475;0.5658621680324651;0.5717000980708506;0.9999584729108851;-0.2053973252210658;-0.22331096476650647;-0.43409630487842;-0.4282583748400345
Vertebral artery tortuosity;Testicular torsion;0.6126802563667297;0.97087723;0.6265990471696953;0.5092713811753056;0.9999600672783046;-0.3872798109115748;-0.029082837110915638;-0.3733610201086093;-0.490688686102999
Vertebral artery tortuosity;Abolished vibration sense;0.7356466054916382;0.8591507;0.5851585274621844;0.5449833005553;0.9999584729108851;-0.26431186741924695;-0.14080776518917493;-0.4147999454487007;-0.45497517235558516
Vertebral artery tortuosity;Fractured metatarsal bone of digit 5;0.8058008104562759;1.082441;0.562210812659422;0.4737284115247993;0.9999201345566091;-0.19411932410033317;0.08252083777157693;-0.43770932189718714;-0.5261917230318098
Vertebral artery tortuosity;Prolonged G2 phase of cell cycle;0.8954622447490692;1.0249748;0.5333363073569375;0.49204942188628165;0.9999567459343585;-0.10449450118528925;0.025018077063688415;-0.46662043857742097;-0.5079073240480768
Vertebral artery tortuosity;Single naris;1.0654682144522667;1.0613661;0.4791459049001858;0.48045429496482317;0.9999567459343585;0.06551146851790823;0.06140933530343451;-0.5208108410341726;-0.5195024509695353
Vertebral artery tortuosity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7818853855133057;0.9069553;0.5699906629346897;0.5296599534382624;0.9999201345566091;-0.21803474904330344;-0.09296483279498191;-0.4299294716219194;-0.47026018111834667
Vertebral artery tortuosity;Asymmetry of the thorax;0.5766235589981079;0.5912602;0.6391552256412936;0.6340316542196969;0.9999567459343585;-0.42333318693625055;-0.4086965511559161;-0.3608015202930649;-0.3659250917146616
Vertebral artery tortuosity;Type 2 muscle fiber predominance;0.8619249314069748;0.985201;0.5440915224313496;0.5047108369301927;0.9999556674707869;-0.1380307360638121;-0.014754666303489539;-0.4558641450394373;-0.4952448305405942
Vertebral artery tortuosity;Dependency on parenteral nutrition;0.8647821247577667;1.0433993;0.5431734374583113;0.48618124167255483;0.9999584729108851;-0.1351763481531184;0.04344086104297229;-0.4567850354525739;-0.5137772312383303
Vertebral artery tortuosity;Limited shoulder flexion;0.7554004639387131;0.956254;0.5786564933193885;0.5139292289052786;0.9999201345566091;-0.24451967061789603;-0.0436661291244802;-0.4212636412372206;-0.4859909056513305
Vertebral artery tortuosity;Paroxysmal vertigo;0.5469380021095276;0.762565;0.649668382956915;0.5763066683017544;0.9999584729108851;-0.45302047080135754;-0.23739345616436414;-0.35029008995397015;-0.42365180460913077
Vertebral artery tortuosity;Long hallux;0.8306715786457062;1.1458471;0.5541598575621985;0.4534092600940618;0.9999526340597648;-0.16928105541405858;0.14589444807829677;-0.4457927764975662;-0.546543373965703
Vertebral artery tortuosity;Broad medial eyebrow;0.9480749405920506;0.93517053;0.5165356960576859;0.52065035266433;0.9999600672783046;-0.051885126686254;-0.06478953600541637;-0.48342437122061865;-0.47930971461397454
Vertebral artery tortuosity;Myxoid subcutaneous tumors;0.9208935797214508;0.97605544;0.5252066922469156;0.5076225176250859;0.9999600672783046;-0.07906648755685375;-0.023904623991408802;-0.4747533750313889;-0.49233754965321863
Vertebral artery tortuosity;Bulbous tips of toes;0.7914122045040131;1.0517826;0.5668867015898001;0.48350969445857883;0.9999584729108851;-0.20854626840687207;0.05182413512134143;-0.433071771321085;-0.5164487784523063
Vertebral artery tortuosity;Absent internal genitalia;0.8134694695472717;0.9088832;0.5597243263966726;0.5290436496182125;0.9999201345566091;-0.18645066500933738;-0.0910369205597219;-0.44019580815993653;-0.4708764849383966
Vertebral artery tortuosity;Hyperphalangy of the 2nd finger;0.7930314540863037;0.976715;0.5663597787947973;0.507412511967591;0.9999600672783046;-0.20692861319200084;-0.02324503899232433;-0.4336002884835073;-0.4925475553107136
Vertebral artery tortuosity;Renal interstitial hemosiderin;0.838573232293129;0.94642484;0.5516095590084911;0.5170616723304756;0.9999201345566091;-0.16134690226348014;-0.05349529267581077;-0.44831057554811804;-0.4828584622261335
Vertebral artery tortuosity;Abnormality of depressor anguli oris muscle;0.7351020574569702;0.8045075;0.5853382700953922;0.5626305325175807;0.9999201345566091;-0.2648180770996389;-0.1954126405838308;-0.4145818644612169;-0.43728960203902845
Vertebral artery tortuosity;Paroxysmal dyspnea;0.7236620187759399;0.8050181;0.5891209165708604;0.5624647988739992;0.9999201345566091;-0.27625811578066917;-0.19490200759204002;-0.4107992179857487;-0.43745533568260986
Vertebral artery tortuosity;Phenylpyruvic acidemia;0.7910282164812088;0.9978184;0.567011683030791;0.5006944155672999;0.9999600672783046;-0.20893185079709575;-0.0021416568817286263;-0.4329483842475136;-0.4992656517110047
Vertebral artery tortuosity;Lateral ventricle dilatation;0.5561178028583527;0.53535247;0.6463991345450408;0.6538189626706514;0.9999488789551968;-0.44383107609684413;-0.4645964104645962;-0.35354974441015596;-0.34612991628454537
Vertebral artery tortuosity;Neonatal unconjugated hyperbilirubinemia;0.7213174104690552;0.8276485;0.58989774037347;0.5551364896932711;0.9999600672783046;-0.2786426568092494;-0.17231154680863903;-0.4100623269048346;-0.44482357758503344
Vertebral artery tortuosity;High maternal circulating alpha-fetoprotein concentration;0.7923237830400467;0.8580688;0.5665900404601868;0.5453311792141757;0.9999201345566091;-0.20759635151656242;-0.14185131074221702;-0.4333300940964223;-0.4545889553424334
Vertebral artery tortuosity;Prominent nasolabial fold;0.801102876663208;0.9273468;0.5637359623399403;0.5231466126299283;0.9999545338528789;-0.1988516571896709;-0.0726077082532085;-0.43621857151293864;-0.47680792122295057
Vertebral artery tortuosity;Abnormality of inferior alveolar nerve;0.7505791932344437;0.820438;0.5802402287280778;0.5574680388673928;0.9999201345566091;-0.24934094132216544;-0.17948210717471214;-0.4196799058285313;-0.4424520956892163
Vertebral artery tortuosity;Unilateral conductive hearing impairment;0.8062110543251038;1.053611;0.5620776991828087;0.482926888449819;0.9999600672783046;-0.1937490129532008;0.05365097283705189;-0.43788236809549586;-0.5170331788284855
Vertebral artery tortuosity;Macular hypopigmented whorls, streaks, and patches;0.826847180724144;0.9373313;0.5553954527461851;0.519961138731091;0.9999600672783046;-0.17311288655416057;-0.06262874842301891;-0.4445646145321195;-0.4799989285472136
Vertebral artery tortuosity;Delayed ossification of pubic rami;0.6426992118358612;0.84310406;0.6163028912606799;0.5501487319421172;0.9999584729108851;-0.3572592610750239;-0.15685440844631604;-0.3836555816502052;-0.4498097409687679
Vertebral artery tortuosity;Hyperphenylalaninemia;0.7798541635274887;1.0272932;0.5706533267407141;0.4913112316833561;0.9999561589935034;-0.22010199546601472;0.02733704626772704;-0.4293028322527893;-0.5086449273101473
Vertebral artery tortuosity;Ureteropelvic junction obstruction;0.6461102366447449;0.9897775;0.6151411993373093;0.5032539745070269;0.9999528219730685;-0.3538425853283236;-0.01017531657527182;-0.3848116226357592;-0.49669884746604154
Vertebral artery tortuosity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8137173801660538;1.1124988;0.5596440061986705;0.4641145459639936;0.9999201345566091;-0.18620275439055534;0.11257862566677956;-0.4402761283579386;-0.5358055885926155
Vertebral artery tortuosity;Difficulty walking;0.8570358455181122;1.0148835;0.545663364462112;0.49526224578034106;0.9999461221900431;-0.1429102766719309;0.014937396028951055;-0.45428275772793103;-0.504683876409702
Vertebral artery tortuosity;Bilobate gallbladder;0.7736784517765045;0.88752675;0.5726700117871094;0.5358772651263293;0.9999584729108851;-0.22628002113438062;-0.11243172234630994;-0.4272884611237757;-0.46408120778455586
Vertebral artery tortuosity;Histidinuria;0.8861456736922264;1.1451608;0.5363197153605591;0.45363006695662156;0.9999574798349273;-0.11381180614270092;0.14520331442319034;-0.4636377644743682;-0.5463274128783058
Vertebral artery tortuosity;Widened interpedicular distance;0.718633770942688;0.8468169;0.5907875692033349;0.5489524200586093;0.9999201345566091;-0.2812863636139211;-0.15310323716433616;-0.40913256535327425;-0.45096771449799977
Warm reactive autoantibody positivity;Right aortic arch with retroesophageal left subclavian artery;0.7714671194553375;0.9442367;0.5733928426252437;0.5177592170612887;1.0;-0.22853288054466248;-0.055763304233551025;-0.4266071573747563;-0.4822407829387113
Warm reactive autoantibody positivity;Elevated urine suberic acid level;0.8103125393390656;0.83922017;0.5607474740414387;0.5514009080514086;0.9999201345566091;-0.18960759521754356;-0.16069996835024924;-0.43917266051517045;-0.4485192265052005
Warm reactive autoantibody positivity;Burkitt lymphoma;0.6809556484222412;0.6542014;0.6033618953816633;0.6123919543719162;0.9999090677057578;-0.3189534192835166;-0.345707679346688;-0.39654717232409453;-0.38751711333384165
Warm reactive autoantibody positivity;Snail-like ilia;0.982775242999196;0.9291294;0.5054830815945708;0.5225777278859076;0.9999201345566091;-0.017144891557413056;-0.07079071284564109;-0.4944370529620383;-0.4773424066707015
Warm reactive autoantibody positivity;Indurated nodule;0.7093185484409332;0.62885284;0.59388198851195;0.621035459745797;1.0;-0.2906814515590668;-0.37114715576171875;-0.40611801148805005;-0.378964540254203
Warm reactive autoantibody positivity;Absent leukocyte alkaline phosphatase;0.7403644919395447;0.81802493;0.5836024199366214;0.5582490216833763;0.9999201345566091;-0.25955564261706443;-0.18189520121844382;-0.4163177146199877;-0.4416711128732328
Warm reactive autoantibody positivity;Hippocampal sclerosis;0.8904154300689697;1.018969;0.5349520467125477;0.4939615881525594;1.0;-0.10958456993103027;0.018969058990478516;-0.4650479532874523;-0.5060384118474406
Warm reactive autoantibody positivity;Decreased sensitivity to hypoxemia;0.916336864233017;1.0681251;0.5266619686294427;0.47829827999486185;0.9999201345566091;-0.08358327032359214;0.0682049941894236;-0.4732581659271664;-0.5216218545617473
Warm reactive autoantibody positivity;Decreased level of tissue plasminogen activator;0.8120217323303223;0.9695247;0.5601934536920491;0.5097020925872306;1.0;-0.18797826766967773;-0.030475318431854248;-0.4398065463079509;-0.49029790741276935
Warm reactive autoantibody positivity;Submandibular lymph node enlargement;0.7732842415571213;0.7025708;0.5727988414909044;0.5961292343803892;0.6369582787135069;0.13632596284361442;0.06561251729937156;-0.06415943722260242;-0.040829044333117626
Warm reactive autoantibody positivity;Hepatic hemangioma;0.7633835077285767;0.8991914;0.5760384924124777;0.532142977216643;0.9999134918687169;-0.23652998414014026;-0.10072211232159778;-0.4238749994562392;-0.46777051465207387
Warm reactive autoantibody positivity;Triangular epiphysis of the distal phalanx of the 2nd finger;1.0106306001543999;1.1342437;0.4966161111373919;0.45713948734468457;1.0;0.010630600154399872;0.13424372673034668;-0.5033838888626081;-0.5428605126553154
Warm reactive autoantibody positivity;Acne inversa;0.8405597805976868;0.8303455;0.5509689225417906;0.5542651717000594;0.45807765254028776;0.382482128057399;0.37226785889617464;0.09289127000150288;0.09618751915977164
Warm reactive autoantibody positivity;Dentin dysplasia;0.9385430552065372;0.96951056;0.5195746884374686;0.5097066007097135;1.0;-0.06145694479346275;-0.030489444732666016;-0.48042531156253143;-0.4902933992902865
Warm reactive autoantibody positivity;Aplasia of the inner ear;0.8929616659879684;1.1039922;0.5341367580826016;0.46683828044262987;0.9999201345566091;-0.10695846856864066;0.10407208918301492;-0.46578337647400747;-0.5330818541139792
Warm reactive autoantibody positivity;Polycystic liver disease;0.8473604619503021;1.0971584;0.5487773487164533;0.4690246653284935;0.9999056439461368;-0.15254518199583467;0.09725278806069915;-0.45112829522968345;-0.5308809786176433
Warm reactive autoantibody positivity;Subungual hyperkeratosis;0.7867740094661713;0.94750243;0.5683970602774804;0.5167181876960878;0.9999003561294039;-0.2131263466632326;-0.05239792187571124;-0.4315032958519235;-0.4831821684333161
Warm reactive autoantibody positivity;Broad humeral epiphyses;0.8286495506763458;1.061034;0.5548130350762236;0.4805601870779006;1.0;-0.17135044932365417;0.06103396415710449;-0.4451869649237764;-0.5194398129220994
Warm reactive autoantibody positivity;Autoimmune thrombocytopenia;0.5908901691436768;0.77813196;0.6341607112583719;0.5712154296891285;0.0;0.5908901691436768;0.7781319618225098;0.6341607112583719;0.5712154296891285
Warm reactive autoantibody positivity;Adenomyosis;0.8337833136320114;0.98242533;0.5531551196800533;0.5055944708585021;0.9999201345566091;-0.1661368209245977;-0.017494802487212135;-0.44676501487655584;-0.49432566369810704
Warm reactive autoantibody positivity;Elevated leukocyte alkaline phosphatase;0.6778573989868164;0.8271467;0.6044030550504176;0.5552986502890277;0.9999201345566091;-0.3220627355697927;-0.1727734255913076;-0.3955170795061915;-0.4446214842675814
Warm reactive autoantibody positivity;Clasp-knife sign;0.9203768819570541;0.8963953;0.5253716826943524;0.5330376792422824;1.0;-0.07962311804294586;-0.10360467433929443;-0.4746283173056476;-0.4669623207577176
Warm reactive autoantibody positivity;Keratosis pilaris;0.8326024413108826;0.92319614;0.553536344166903;0.5244715329067845;0.9998710980331391;-0.16726865672225655;-0.07667496108169258;-0.4463347538662361;-0.4753995651263546
Warm reactive autoantibody positivity;Lamina lucida cleavage;0.9170472770929337;0.8971431;0.5264350483797466;0.5327983709946726;0.9998962300503706;-0.082848952957437;-0.10275310451631303;-0.473461181670624;-0.467097859055698
Warm reactive autoantibody positivity;Abnormal central response of multifocal electroretinogram;0.8171431124210358;0.94004214;0.558534499166174;0.5190966290135021;1.0;-0.18285688757896423;-0.05995786190032959;-0.44146550083382596;-0.48090337098649794
Warm reactive autoantibody positivity;Atypical or prolonged hepatitis;0.7338975369930267;0.9253348;0.5857359534330493;0.5237888108468494;0.5829152011936182;0.15098233579940856;0.34241961001701415;0.0028207522394311235;-0.05912639034676881
Warm reactive autoantibody positivity;Cubitus varus;0.9667441621422768;1.0590177;0.5105876141386163;0.4812031851945823;1.0;-0.033255837857723236;0.05901765823364258;-0.4894123858613837;-0.5187968148054177
Warm reactive autoantibody positivity;Nasal regurgitation;0.9138600826263428;0.97926694;0.5274532098054998;0.5066000020779593;0.9999134918687169;-0.08605340924237415;-0.02064655032132312;-0.4724602820632171;-0.4933134897907576
Warm reactive autoantibody positivity;Moon facies;0.9253222942352295;0.8982482;0.5237928015218853;0.5324447608927534;0.9999134918687169;-0.07459119763348743;-0.10166529622052356;-0.4761206903468316;-0.46746873097596353
Warm reactive autoantibody positivity;Intestinal pseudo-obstruction;0.8445475846529007;0.94021404;0.5496835321885373;0.5190418132734206;0.9998912449978579;-0.15534366034495717;-0.05967720710265523;-0.4502077128093206;-0.4808494317244373
Warm reactive autoantibody positivity;Bilateral renal atrophy;0.82082599401474;0.88692296;0.5573425094216551;0.5360706906434817;0.9999201345566091;-0.17909414054186912;-0.11299717904360862;-0.442577625134954;-0.46384944391312743
Warm reactive autoantibody positivity;Fractured left clavicle;0.986961992457509;1.1631892;0.5041502442856665;0.4478219161534466;1.0;-0.01303800754249096;0.16318917274475098;-0.49584975571433354;-0.5521780838465534
Warm reactive autoantibody positivity;Positive urine norcotinine test;0.6992300748825073;0.7691066;0.5972436248333574;0.5741648608410614;1.0;-0.3007699251174927;-0.23089337348937988;-0.40275637516664264;-0.42583513915893856
Warm reactive autoantibody positivity;Long fibula;0.8536582142114639;1.0130289;0.5467499264244681;0.495852686066955;0.9999056439461368;-0.14624742973467286;0.013123216146026295;-0.4531557175216687;-0.5040529578791818
Warm reactive autoantibody positivity;Fragmentation of the epiphysis of the distal phalanx of the hallux;1.031209398061037;1.0842611;0.4900641266425959;0.4731470365800876;1.0;0.031209398061037064;0.08426105976104736;-0.5099358733574041;-0.5268529634199124
Warm reactive autoantibody positivity;Type II cryptotia;0.8575818836688995;0.88605344;0.5454877581857405;0.5363492727855861;1.0;-0.14241811633110046;-0.11394655704498291;-0.45451224181425953;-0.4636507272144139
Warm reactive autoantibody positivity;Increased variability in muscle fiber diameter;0.8172824084758759;0.86332023;0.558489400047059;0.5436431428970219;0.9998452077479463;-0.18256279927207042;-0.13652497631026317;-0.4413558077008872;-0.4562020648509244
Warm reactive autoantibody positivity;Widened proximal tibial metaphyses;0.770367294549942;1.016145;0.5737524919632683;0.4948606605608379;0.9999201345566091;-0.2295528400066671;0.0162248563644114;-0.42616764259334083;-0.5050594739957712
Warm reactive autoantibody positivity;Wide anterior fontanel;0.7468863725662231;0.9942358;0.5814546523444746;0.5018348041144423;0.999848231156753;-0.2529618585905299;-0.005612417539046732;-0.41839357881227845;-0.4980134270423108
Warm reactive autoantibody positivity;Increased circulating oleate level;0.7886138558387756;0.91277736;0.5677977566975894;0.5277991590199318;1.0;-0.21138614416122437;-0.0872226357460022;-0.43220224330241064;-0.4722008409800682
Warm reactive autoantibody positivity;Lozenge-shaped umbilicus;0.9253886267542839;1.047693;0.523771628155938;0.4848130821473168;0.9999134918687169;-0.07452486511443301;0.04777952227618054;-0.4761418637127789;-0.5151004097214001
Warm reactive autoantibody positivity;Anti-myelin-associated glycoprotein antibody positivity;0.48736512660980225;0.6790863;0.6713305403385024;0.6039899384186724;1.0;-0.5126348733901978;-0.3209136724472046;-0.32866945966149763;-0.39601006158132757
Warm reactive autoantibody positivity;Fractured radius;0.9418454356491566;1.1260837;0.5185216226580267;0.4597592083742301;0.9999201345566091;-0.05807469890745254;0.12616359709469704;-0.4813985118985824;-0.540160926182379
Warm reactive autoantibody positivity;Abnormal manual kinetic perimetry test;0.897246465086937;1.0345132;0.5327652970078729;0.48901192101399593;1.0;-0.10275353491306305;0.034513235092163086;-0.4672347029921271;-0.5109880789860041
Warm reactive autoantibody positivity;Small radial epiphyses;1.0406593978404999;1.141176;0.4870541430426025;0.4549116746144286;1.0;0.04065939784049988;0.1411759853363037;-0.5129458569573975;-0.5450883253855714
Warm reactive autoantibody positivity;Generalized keratosis follicularis;0.7052536606788635;0.8108104;0.5952351521945185;0.5605860769364873;0.9999201345566091;-0.2946664738777456;-0.1891097474220571;-0.4046849823620906;-0.4393340576201218
Warm reactive autoantibody positivity;Hypoplasia of the calcaneus;0.9829901531338692;1.0487409;0.5054146635498844;0.4844791587660088;0.9999134918687169;-0.016923338734847748;0.04882737193133191;-0.4944988283188325;-0.5154343331027081
Warm reactive autoantibody positivity;2-hydroxyadipic aciduria;0.8128364831209183;0.87638354;0.5599294242110449;0.5394492424858885;1.0;-0.18716351687908173;-0.12361645698547363;-0.44007057578895514;-0.46055075751411145
Warm reactive autoantibody positivity;Potter facies;0.8816392868757248;0.89749926;0.537763911720736;0.5326843993217112;0.9998981869165328;-0.11825890004080797;-0.10239892362994218;-0.46213427519579675;-0.4672137875948216
Warm reactive autoantibody positivity;Increased heart rate variability;0.7598817646503448;0.9639718;0.5771862156169931;0.5114706250186609;0.9999201345566091;-0.24003836990626426;-0.0359483409050283;-0.422733918939616;-0.4884495095379482
Warm reactive autoantibody positivity;Aplastic zygomatic arch;0.8492624461650848;1.0067139;0.5481648405012358;0.49786290016614554;0.9999134918687169;-0.15065104570363208;0.006800375318783081;-0.4517486513674811;-0.5020505917025714
Warm reactive autoantibody positivity;Testicular torsion;0.8275001347064972;0.9940604;0.555184435715622;0.5018906424599647;0.9999201345566091;-0.17241999985011192;-0.005859737408476784;-0.44473569884098707;-0.4980294920966444
Warm reactive autoantibody positivity;Abolished vibration sense;0.8947009220719337;0.98742586;0.5335799888165962;0.5040025732088407;0.9999134918687169;-0.10521256979678317;-0.01248762812588855;-0.46633350305212073;-0.49591091865987624
Warm reactive autoantibody positivity;Fractured metatarsal bone of digit 5;1.059416763484478;1.0741299;0.48107591083785717;0.4763820474220709;1.0;0.059416763484478;0.07412993907928467;-0.5189240891621428;-0.5236179525779291
Warm reactive autoantibody positivity;Prolonged G2 phase of cell cycle;0.8468765765428543;0.93840235;0.5489332064073433;0.5196195562433197;0.9999056439461368;-0.15302906740328248;-0.06150328922888215;-0.45097243753879346;-0.4802860877028171
Warm reactive autoantibody positivity;Single naris;0.9445889070630074;0.88365436;0.5176469370487515;0.5371180299242628;0.9999056439461368;-0.055316736883129436;-0.11625128794332917;-0.48225870689738526;-0.46278761402187396
Warm reactive autoantibody positivity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6260932087898254;0.8568751;0.6219820109338208;0.5457150560595125;1.0;-0.37390679121017456;-0.14312487840652466;-0.3780179890661792;-0.45428494394048746
Warm reactive autoantibody positivity;Asymmetry of the thorax;0.8892392739653587;0.98850936;0.5353287218739854;0.5036576598368341;0.9999056439461368;-0.11066636998077806;-0.01139628697058137;-0.4645769220721514;-0.4962479841093027
Warm reactive autoantibody positivity;Type 2 muscle fiber predominance;0.7587166130542755;0.7932643;0.5775683293018192;0.5662840184852895;0.9999003561294039;-0.24118374307512835;-0.2066360266959627;-0.42233202682758464;-0.43361633764411434
Warm reactive autoantibody positivity;Dependency on parenteral nutrition;0.8968483954668045;1.0178348;0.5328926834015952;0.494322717904651;0.9999134918687169;-0.10306509640191241;0.017921290731685913;-0.4670208084671217;-0.5055907739640659
Warm reactive autoantibody positivity;Limited shoulder flexion;0.8482833504676819;0.95739394;0.5484801223974956;0.5135660411492231;1.0;-0.15171664953231812;-0.04260605573654175;-0.45151987760250445;-0.4864339588507769
Warm reactive autoantibody positivity;Paroxysmal vertigo;0.804949164390564;0.97739774;0.5624871848981141;0.5071951426697026;0.9999134918687169;-0.19496432747815295;-0.02251575198147937;-0.4374263069706028;-0.49271834919901436
Warm reactive autoantibody positivity;Long hallux;0.8762595653533936;1.0137933;0.5394890183007153;0.49560930310990625;0.9998836012415208;-0.1236240358881272;0.013909748024531488;-0.4603945829408055;-0.5042742981316145
Warm reactive autoantibody positivity;Broad medial eyebrow;0.8278146237134933;0.86503446;0.5550828101383116;0.5430923732229214;0.9999201345566091;-0.17210551084311576;-0.13488567353518577;-0.4448373244182975;-0.45682776133368774
Warm reactive autoantibody positivity;Myxoid subcutaneous tumors;0.8149896413087845;0.7289969;0.5592318685132445;0.5873553846909003;0.9999201345566091;-0.18493049324782462;-0.2709232616546926;-0.44068826604336464;-0.4125647498657088
Warm reactive autoantibody positivity;Bulbous tips of toes;0.8830447196960449;1.0064199;0.5373134194807909;0.49795648170490125;0.9999134918687169;-0.116868772172672;0.006506405210750854;-0.462600072387926;-0.5019570101638157
Warm reactive autoantibody positivity;Absent internal genitalia;0.8973785936832428;0.90112543;0.5327230156561709;0.5315242578727847;1.0;-0.1026214063167572;-0.09887456893920898;-0.46727698434382914;-0.4684757421272153
Warm reactive autoantibody positivity;Hyperphalangy of the 2nd finger;0.8526172786951065;1.0652004;0.5470848986256882;0.479231331976651;0.9999201345566091;-0.1473028558615026;0.06528031347958474;-0.4528352359309209;-0.5206888025799581
Warm reactive autoantibody positivity;Renal interstitial hemosiderin;0.7290355265140533;0.7045501;0.5873425927532772;0.5954695447288294;1.0;-0.27096447348594666;-0.2954499125480652;-0.41265740724672284;-0.4045304552711706
Warm reactive autoantibody positivity;Abnormality of depressor anguli oris muscle;0.9125496447086334;0.9708509;0.5278719152993164;0.5092797647599858;1.0;-0.08745035529136658;-0.029149115085601807;-0.47212808470068357;-0.4907202352400142
Warm reactive autoantibody positivity;Paroxysmal dyspnea;0.8290694653987885;0.9262446;0.554677370559496;0.5234984148249378;1.0;-0.17093053460121155;-0.07375538349151611;-0.44532262944050405;-0.47650158517506225
Warm reactive autoantibody positivity;Phenylpyruvic acidemia;0.7438172698020935;0.9695835;0.5824648820602841;0.5096833530547322;0.9999201345566091;-0.2561028647545156;-0.030336623204070046;-0.417455252496325;-0.4902367815018769
Warm reactive autoantibody positivity;Lateral ventricle dilatation;0.9178496599197388;1.1079514;0.526178767246988;0.46557091878929147;0.9998579617208769;-0.08200830180113816;0.10809344094330764;-0.47367919447388895;-0.5342870429315855
Warm reactive autoantibody positivity;Neonatal unconjugated hyperbilirubinemia;0.7787246555089951;1.1273072;0.5710219508450656;0.4593665813482195;0.9999201345566091;-0.22119547904761405;0.1273870420333567;-0.42889818371154353;-0.5405535532083896
Warm reactive autoantibody positivity;High maternal circulating alpha-fetoprotein concentration;0.6821744441986084;0.84283197;0.6029526365134933;0.5502364353701605;1.0;-0.3178255558013916;-0.15716803073883057;-0.3970473634865067;-0.44976356462983946
Warm reactive autoantibody positivity;Prominent nasolabial fold;0.8954315707087517;0.9276834;0.5333461250147944;0.5230391957074256;0.9998944404568447;-0.10446286974809305;-0.07221102742812768;-0.46654831544205033;-0.4768552447494191
Warm reactive autoantibody positivity;Abnormality of inferior alveolar nerve;0.8939751535654068;0.9449687;0.5338123086140507;0.5175258698266241;1.0;-0.1060248464345932;-0.05503129959106445;-0.4661876913859493;-0.4824741301733759
Warm reactive autoantibody positivity;Unilateral conductive hearing impairment;0.8756483048200607;1.0658934;0.5396851030430101;0.47901027230149984;0.9999201345566091;-0.12427182973654838;0.06597327707974343;-0.460235031513599;-0.5209098622551093
Warm reactive autoantibody positivity;Macular hypopigmented whorls, streaks, and patches;0.8140808194875717;0.80319816;0.5595262629698056;0.5630555633511439;0.9999201345566091;-0.1858393150690374;-0.1967219758156118;-0.44039387158680354;-0.4368645712054652
Warm reactive autoantibody positivity;Delayed ossification of pubic rami;0.9797700326889753;0.9973155;0.5064398378955209;0.5008544891150668;0.9999134918687169;-0.020143459179741585;-0.0025979658601109623;-0.493473653973196;-0.4990590027536501
Warm reactive autoantibody positivity;Hyperphenylalaninemia;0.6381010711193085;0.9649755;0.6178714534982952;0.5111509316104164;0.9999028053808913;-0.3618017342615828;-0.034927329115937655;-0.38203135188259607;-0.4887518737704749
Warm reactive autoantibody positivity;Ureteropelvic junction obstruction;0.8694806694984436;1.0592538;0.5416644636678684;0.4811278845742418;0.9998847295244674;-0.13040406002602378;0.05936908231177529;-0.45822026585659903;-0.5187568449502256
Warm reactive autoantibody positivity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9316819459199905;1.0844924;0.5217632639455128;0.4730730993631298;1.0;-0.06831805408000946;0.08449244499206543;-0.47823673605448724;-0.5269269006368702
Warm reactive autoantibody positivity;Difficulty walking;0.9922026162967086;1.0595586;0.5024820094702546;0.4810306660852012;0.9998344221996177;-0.007631805902909128;0.05972420779000631;-0.49735241272936315;-0.5188037561144165
Warm reactive autoantibody positivity;Bilobate gallbladder;0.9167100191116333;1.0357349;0.526542773720708;0.4886228166460056;0.9999134918687169;-0.08320347275708362;0.03582140002276257;-0.4733707181480089;-0.5112906752227113
Warm reactive autoantibody positivity;Histidinuria;0.7342295050621033;0.7912729;0.5856263375053483;0.5669320436787544;0.9999090677057578;-0.26567956264365455;-0.20863618905890724;-0.4142827302004095;-0.43297702402700344
Warm reactive autoantibody positivity;Widened interpedicular distance;0.7841930389404297;1.0121824;0.5692381901780692;0.49612212909753084;1.0;-0.2158069610595703;0.012182354927062988;-0.4307618098219308;-0.5038778709024692
Right aortic arch with retroesophageal left subclavian artery;Elevated urine suberic acid level;0.7205874919891357;0.99783444;0.5901396916085195;0.5006893118861142;0.9999201345566091;-0.27933264256747337;-0.0020856905105886003;-0.4097804429480896;-0.4992308226704949
Right aortic arch with retroesophageal left subclavian artery;Burkitt lymphoma;0.9743905887007713;1.0160671;0.5081526200999136;0.49488543269619467;0.9999090677057578;-0.025518479004986494;0.016158079549186022;-0.49175644760584425;-0.5050236350095632
Right aortic arch with retroesophageal left subclavian artery;Snail-like ilia;0.9637890718877316;1.1215672;0.5115288168336294;0.4612079981525332;0.9999201345566091;-0.036131062668877556;0.1216471147414866;-0.4883913177229797;-0.5387121364040759
Right aortic arch with retroesophageal left subclavian artery;Indurated nodule;0.8519078195095062;0.9780123;0.5473132320944871;0.5069994517939304;1.0;-0.14809218049049377;-0.0219876766204834;-0.4526867679055129;-0.49300054820606964
Right aortic arch with retroesophageal left subclavian artery;Absent leukocyte alkaline phosphatase;0.8143009841442108;1.0800319;0.5594549403612006;0.47449778563435563;0.9999201345566091;-0.1856191504123983;0.08011173723904519;-0.4404651941954085;-0.5254223489222535
Right aortic arch with retroesophageal left subclavian artery;Hippocampal sclerosis;0.9149531424045563;1.1534255;0.5271039964943391;0.4509695139335912;1.0;-0.08504685759544373;0.1534254550933838;-0.47289600350566086;-0.5490304860664088
Right aortic arch with retroesophageal left subclavian artery;Decreased sensitivity to hypoxemia;0.8062926083803177;0.77844924;0.5620512383217677;0.5711118456033972;0.9999201345566091;-0.19362752617629142;-0.22147089720995994;-0.4378688962348414;-0.4288082889532119
Right aortic arch with retroesophageal left subclavian artery;Decreased level of tissue plasminogen activator;0.7044622302055359;0.8990858;0.5954988177563953;0.5321767597135266;1.0;-0.2955377697944641;-0.10091418027877808;-0.40450118224360465;-0.4678232402864734
Right aortic arch with retroesophageal left subclavian artery;Submandibular lymph node enlargement;0.7701375633478165;0.7457572;0.5738276275338238;0.581826236604918;0.6233977918117102;0.1467397715361063;0.12235943036388797;-0.04957016427788641;-0.04157155520679223
Right aortic arch with retroesophageal left subclavian artery;Hepatic hemangioma;0.745945006608963;0.9655287;0.5817644238617615;0.5109747142191345;0.5920744707068977;0.15387053590206534;0.3734542558708611;-0.010310046845136145;-0.08109975648776313
Right aortic arch with retroesophageal left subclavian artery;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7998449206352234;1.0919217;0.5641445988650136;0.47069906025132846;1.0;-0.2001550793647766;0.09192168712615967;-0.43585540113498644;-0.5293009397486715
Right aortic arch with retroesophageal left subclavian artery;Acne inversa;0.7057109475135803;0.8712992;0.5950828375108878;0.5410806760838769;0.9998962300503706;-0.2941852825367903;-0.12859702283982988;-0.4048133925394829;-0.45881555396649376
Right aortic arch with retroesophageal left subclavian artery;Dentin dysplasia;0.9528126791119576;0.9401875;0.5150257704348562;0.519050276034072;1.0;-0.04718732088804245;-0.05981248617172241;-0.4849742295651438;-0.48094972396592806
Right aortic arch with retroesophageal left subclavian artery;Aplasia of the inner ear;0.7752220332622528;0.94075066;0.5721656786472966;0.5188707065956374;0.9999201345566091;-0.2246981012943563;-0.05916947604449363;-0.4277544559093125;-0.4810494279609717
Right aortic arch with retroesophageal left subclavian artery;Polycystic liver disease;0.7875272333621979;0.72462857;0.5681516787459143;0.5888008351076434;0.9999056439461368;-0.21237841058393891;-0.2752770762505191;-0.43175396520022247;-0.41110480883849343
Right aortic arch with retroesophageal left subclavian artery;Subungual hyperkeratosis;0.9511025175452232;1.139654;0.5155707611377874;0.45540095803394787;0.9999003561294039;-0.04879783858418063;0.13975368420720502;-0.48432959499161643;-0.544499398095456
Right aortic arch with retroesophageal left subclavian artery;Broad humeral epiphyses;0.7657926231622696;1.0274401;0.5752494720445452;0.4912644605723372;1.0;-0.2342073768377304;0.02744007110595703;-0.42475052795545476;-0.5087355394276628
Right aortic arch with retroesophageal left subclavian artery;Autoimmune thrombocytopenia;0.7297099828720093;0.973193;0.5871195849080737;0.5085339634166754;0.9998726169824932;-0.2701626341104839;-0.026679627156290797;-0.4127530320744195;-0.49133865356581774
Right aortic arch with retroesophageal left subclavian artery;Adenomyosis;0.6947035789489746;0.89033896;0.5987555455015035;0.5349765291825321;0.9999201345566091;-0.3052165556076345;-0.10958117724688621;-0.40116458905510566;-0.464943605374077
Right aortic arch with retroesophageal left subclavian artery;Elevated leukocyte alkaline phosphatase;0.8711557388305664;1.1400605;0.541126731682383;0.4552702891232988;0.9999201345566091;-0.1287643957260427;0.14014040945736794;-0.4587934028742261;-0.5446498454333103
Right aortic arch with retroesophageal left subclavian artery;Clasp-knife sign;0.9606735035777092;0.85500765;0.5125212415186029;0.5463157667179057;1.0;-0.0393264964222908;-0.14499235153198242;-0.4874787584813971;-0.4536842332820943
Right aortic arch with retroesophageal left subclavian artery;Keratosis pilaris;0.9138159602880478;0.9200273;0.5274673068067309;0.5254833043280991;0.9998710980331391;-0.08605513774509133;-0.07984378241653145;-0.4724037912264082;-0.47438779370504003
Right aortic arch with retroesophageal left subclavian artery;Lamina lucida cleavage;0.921830952167511;0.9344203;0.5249073904588295;0.5208896671837439;0.9998962300503706;-0.07806527788285966;-0.06547594244127031;-0.47498883959154115;-0.4790065628666268
Right aortic arch with retroesophageal left subclavian artery;Abnormal central response of multifocal electroretinogram;0.8497720956802368;1.0637758;0.5480007454099658;0.47968575978970474;1.0;-0.15022790431976318;0.06377577781677246;-0.4519992545900342;-0.5203142402102953
Right aortic arch with retroesophageal left subclavian artery;Atypical or prolonged hepatitis;0.8153563737869263;1.0814809;0.5591130874692385;0.4740350562489334;0.9999201345566091;-0.18456376076968284;0.08156072615353493;-0.4408070470873706;-0.5258850783076757
Right aortic arch with retroesophageal left subclavian artery;Cubitus varus;0.8476728796958923;0.8954307;0.5486767263857448;0.53334641117484;1.0;-0.15232712030410767;-0.10456931591033936;-0.45132327361425517;-0.46665358882515995
Right aortic arch with retroesophageal left subclavian artery;Nasal regurgitation;0.7358843088150024;0.5271627;0.5850800758525234;0.6567701878886141;0.9999134918687169;-0.2640291830537145;-0.47275082077954456;-0.4148334160161935;-0.34314330398010284
Right aortic arch with retroesophageal left subclavian artery;Moon facies;0.8999116569757462;0.8758161;0.531912542679065;0.5396312775414089;0.9999134918687169;-0.10000183489297076;-0.12409738507245227;-0.46800094918965196;-0.460282214327308
Right aortic arch with retroesophageal left subclavian artery;Intestinal pseudo-obstruction;0.7720017284154892;0.91737443;0.5732180567673633;0.52633055298669;0.9998912449978579;-0.22788951658236867;-0.08251681291091328;-0.4266731882304946;-0.4735606920111679
Right aortic arch with retroesophageal left subclavian artery;Bilateral renal atrophy;0.6215998232364655;0.9343694;0.6235256726516927;0.5209059001383904;0.9999201345566091;-0.37832031132014365;-0.06555074931414695;-0.37639446190491643;-0.47901423441821867
Right aortic arch with retroesophageal left subclavian artery;Fractured left clavicle;0.6911494135856628;0.63755774;0.5999443063658662;0.6180569957044226;1.0;-0.30885058641433716;-0.3624422550201416;-0.40005569363413385;-0.38194300429557737
Right aortic arch with retroesophageal left subclavian artery;Positive urine norcotinine test;0.8973354250192642;0.9672376;0.5327368296305127;0.5104304602327162;1.0;-0.10266457498073578;-0.03276240825653076;-0.4672631703694873;-0.4895695397672838
Right aortic arch with retroesophageal left subclavian artery;Long fibula;0.850253701210022;1.2152815;0.5478456916314189;0.4309331096129735;0.9999056439461368;-0.14965194273611482;0.21537584256509368;-0.45205995231471785;-0.5689725343331633
Right aortic arch with retroesophageal left subclavian artery;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9316036328673363;1.155595;0.5217882502095115;0.4502705499945274;1.0;-0.06839636713266373;0.15559494495391846;-0.4782117497904885;-0.5497294500054726
Right aortic arch with retroesophageal left subclavian artery;Type II cryptotia;0.9236541092395782;0.88651925;0.5243253217550246;0.5362000255636822;1.0;-0.07634589076042175;-0.11348074674606323;-0.47567467824497545;-0.4637999744363178
Right aortic arch with retroesophageal left subclavian artery;Increased variability in muscle fiber diameter;0.8566200137138367;1.0160964;0.5457971056645027;0.49487615441560284;0.9998452077479463;-0.1432251940341096;0.016251145782937515;-0.4540481020834436;-0.5049690533323434
Right aortic arch with retroesophageal left subclavian artery;Widened proximal tibial metaphyses;0.8244285583496094;1.1481758;0.5561773010379025;0.4526598473913096;0.9999201345566091;-0.17549157620699973;0.14825570105282693;-0.4437428335187066;-0.5472602871652995
Right aortic arch with retroesophageal left subclavian artery;Wide anterior fontanel;0.6555162966251373;0.4702577;0.6119460127508298;0.6777113598102793;0.999848231156753;-0.3443319345316157;-0.5295905316671595;-0.3879022184059232;-0.32213687134647373
Right aortic arch with retroesophageal left subclavian artery;Increased circulating oleate level;0.8365571200847626;1.0087156;0.5522599451765031;0.49722569500247515;1.0;-0.16344287991523743;0.008715629577636719;-0.4477400548234969;-0.5027743049975248
Right aortic arch with retroesophageal left subclavian artery;Lozenge-shaped umbilicus;0.8791068196296692;0.84889114;0.538575851923045;0.548284391141116;0.9999134918687169;-0.12080667223904773;-0.15102235283826038;-0.4613376399456719;-0.4516291007276009
Right aortic arch with retroesophageal left subclavian artery;Anti-myelin-associated glycoprotein antibody positivity;0.7343727350234985;0.95405275;0.5855790461555996;0.5146306148970534;1.0;-0.26562726497650146;-0.045947253704071045;-0.41442095384440036;-0.4853693851029466
Right aortic arch with retroesophageal left subclavian artery;Fractured radius;0.796954795718193;1.0954552;0.5650838391423442;0.46956933395970046;0.9999201345566091;-0.20296533883841605;0.09553503512112527;-0.43483629541426494;-0.5303508005969086
Right aortic arch with retroesophageal left subclavian artery;Abnormal manual kinetic perimetry test;0.94239192456007;1.1006035;0.5183473777060894;0.4679226654366555;1.0;-0.05760807543992996;0.10060346126556396;-0.4816526222939106;-0.5320773345633445
Right aortic arch with retroesophageal left subclavian artery;Small radial epiphyses;0.7908375859260559;1.0625339;0.5670737338641019;0.4800818548363047;1.0;-0.2091624140739441;0.06253385543823242;-0.43292626613589813;-0.5199181451636953
Right aortic arch with retroesophageal left subclavian artery;Generalized keratosis follicularis;0.8935466706752777;1.0877931;0.5339494752340099;0.4720185797115809;0.9999201345566091;-0.1063734638813314;0.08787297724453835;-0.4659706593225992;-0.5279015548450282
Right aortic arch with retroesophageal left subclavian artery;Hypoplasia of the calcaneus;0.7778608053922653;0.95560586;0.5713039406933967;0.5141357451388;0.9999134918687169;-0.2220526864764516;-0.04430762734387561;-0.4286095511753202;-0.4857777467299169
Right aortic arch with retroesophageal left subclavian artery;2-hydroxyadipic aciduria;0.7621487975120544;0.9452854;0.5764430623426906;0.517424909576246;1.0;-0.23785120248794556;-0.0547146201133728;-0.4235569376573094;-0.482575090423754
Right aortic arch with retroesophageal left subclavian artery;Potter facies;1.0127585958689451;0.87376195;0.4959387026118136;0.5402903172760689;0.9998981869165328;0.012860408952412361;-0.1261362349931624;-0.5039594843047192;-0.45960786964046385
Right aortic arch with retroesophageal left subclavian artery;Increased heart rate variability;0.7458117604255676;0.8610684;0.5818082770394553;0.5443668140945066;0.7316270483356397;0.014184712089927887;0.12944137922707388;-0.14981877129618448;-0.18726023424113314
Right aortic arch with retroesophageal left subclavian artery;Aplastic zygomatic arch;0.5642329454421997;0.4672165;0.643522848873822;0.6788539939260056;0.9999134918687169;-0.4356805464265172;-0.5326970001694982;-0.35639064299489487;-0.32105949794271127
Right aortic arch with retroesophageal left subclavian artery;Testicular torsion;0.8350629806518555;1.0709842;0.5527420878619927;0.47738598071079663;0.9999201345566091;-0.16485715390475364;0.07106410979000954;-0.44717804669461636;-0.5225341538458125
Right aortic arch with retroesophageal left subclavian artery;Abolished vibration sense;0.9135203659534454;0.90404344;0.5275617500157371;0.5305909841093224;0.9999134918687169;-0.08639312591527148;-0.09587005581830188;-0.4723517418529798;-0.46932250775939455
Right aortic arch with retroesophageal left subclavian artery;Fractured metatarsal bone of digit 5;0.8532124310731888;1.1499019;0.5468933726689187;0.452104214585506;1.0;-0.14678756892681122;0.1499018669128418;-0.4531066273310813;-0.547895785414494
Right aortic arch with retroesophageal left subclavian artery;Prolonged G2 phase of cell cycle;0.8908578678965569;1.014603;0.5348103645444535;0.4953515347140758;0.9999056439461368;-0.10904777604957994;0.014697374814544362;-0.46509527940168327;-0.504554109232061
Right aortic arch with retroesophageal left subclavian artery;Single naris;0.8625962436199188;0.79574466;0.5438757807718163;0.5654772784109208;0.9999056439461368;-0.13730940032621797;-0.2041609864296573;-0.4560298631743205;-0.434428365535216
Right aortic arch with retroesophageal left subclavian artery;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7758520841598511;1.0302092;0.5719598756619546;0.49038264433173984;1.0;-0.22414791584014893;0.03020918369293213;-0.4280401243380454;-0.5096173556682602
Right aortic arch with retroesophageal left subclavian artery;Asymmetry of the thorax;0.6992790997028351;0.585925;0.5972272622329524;0.6358948959501747;0.9999056439461368;-0.3006265442433017;-0.4139806609215396;-0.4026783817131844;-0.3640107479959621
Right aortic arch with retroesophageal left subclavian artery;Type 2 muscle fiber predominance;0.8533256947994232;1.0289664;0.5468569252139244;0.4907784195816074;0.9999003561294039;-0.14657466132998065;0.029066070719961368;-0.4530434309154795;-0.5091219365477965
Right aortic arch with retroesophageal left subclavian artery;Dependency on parenteral nutrition;0.8760702311992645;1.0353261;0.5395497527181873;0.4887530115850107;0.9999134918687169;-0.12384326066945239;0.035412631368892944;-0.46036373915052964;-0.5111604802837062
Right aortic arch with retroesophageal left subclavian artery;Limited shoulder flexion;0.7521105706691742;1.0021844;0.5797369697773043;0.4993046695883423;1.0;-0.2478894293308258;0.0021843910217285156;-0.42026303022269573;-0.5006953304116577
Right aortic arch with retroesophageal left subclavian artery;Paroxysmal vertigo;0.9048141241073608;0.9656477;0.5303445455411591;0.5109368209862662;0.9999134918687169;-0.09509936776135608;-0.03426579441998645;-0.46956894632755786;-0.48897667088245067
Right aortic arch with retroesophageal left subclavian artery;Long hallux;0.9280446320772171;1.166241;0.5229239157861121;0.44683701098158846;0.9998836012415208;-0.07183896916430366;0.16635744852501977;-0.4769596854554087;-0.5530465902599323
Right aortic arch with retroesophageal left subclavian artery;Broad medial eyebrow;0.8528759479522705;0.89833677;0.5470016541794396;0.5324164156578486;0.9999201345566091;-0.1470441866043386;-0.10158336640627952;-0.45291848037716953;-0.4675037188987605
Right aortic arch with retroesophageal left subclavian artery;Myxoid subcutaneous tumors;0.8560062348842621;0.99370813;0.5459945261295212;0.5020027723105862;0.9999201345566091;-0.14391389967234702;-0.0062120008590993425;-0.45392560842708796;-0.4979173622460229
Right aortic arch with retroesophageal left subclavian artery;Bulbous tips of toes;0.9355451390147209;1.1103864;0.5205308518945725;0.4647911597316787;0.9999134918687169;-0.064368352853996;0.11047287974383191;-0.47938263997414443;-0.5351223321370382
Right aortic arch with retroesophageal left subclavian artery;Absent internal genitalia;0.7591621577739716;0.80261576;0.5774221986267533;0.5632446648242382;1.0;-0.24083784222602844;-0.19738423824310303;-0.42257780137324674;-0.4367553351757618
Right aortic arch with retroesophageal left subclavian artery;Hyperphalangy of the 2nd finger;0.8119910955429077;1.0236683;0.5602033827163264;0.49246545192143976;0.9999201345566091;-0.1879290390137014;0.023748154627961204;-0.4397167518402827;-0.5074546826351694
Right aortic arch with retroesophageal left subclavian artery;Renal interstitial hemosiderin;0.7348464727401733;1.025619;0.5854226422739282;0.4918443142025858;1.0;-0.26515352725982666;0.025619029998779297;-0.41457735772607185;-0.5081556857974142
Right aortic arch with retroesophageal left subclavian artery;Abnormality of depressor anguli oris muscle;0.7464002966880798;0.73159945;0.5816145935144426;0.5864950688687895;1.0;-0.25359970331192017;-0.26840054988861084;-0.41838540648555744;-0.41350493113121045
Right aortic arch with retroesophageal left subclavian artery;Paroxysmal dyspnea;0.8195795267820358;0.60082614;0.5577458451777508;0.6307030131581377;1.0;-0.18042047321796417;-0.3991738557815552;-0.44225415482224917;-0.3692969868418623
Right aortic arch with retroesophageal left subclavian artery;Phenylpyruvic acidemia;0.8065499067306519;0.90906966;0.5619677586737946;0.5289840673798938;0.9999201345566091;-0.19337022782595725;-0.09085047723086448;-0.43795237588281455;-0.4709360671767153
Right aortic arch with retroesophageal left subclavian artery;Lateral ventricle dilatation;0.8166141957044601;0.8479958;0.558705754460904;0.5485727208947528;0.9998579617208769;-0.1832437660164168;-0.15186214405959153;-0.44115220725997295;-0.4512852408261241
Right aortic arch with retroesophageal left subclavian artery;Neonatal unconjugated hyperbilirubinemia;0.8535237908363342;0.8806881;0.5467931808168804;0.5380688539339957;0.9999201345566091;-0.14639634372027488;-0.11923206330569358;-0.45312695373972867;-0.4618512806226134
Right aortic arch with retroesophageal left subclavian artery;High maternal circulating alpha-fetoprotein concentration;0.751318633556366;0.79848564;0.5799971997998232;0.5645862811170962;1.0;-0.24868136644363403;-0.2015143632888794;-0.4200028002001768;-0.4354137188829038
Right aortic arch with retroesophageal left subclavian artery;Prominent nasolabial fold;0.7612577378749847;0.6373843;0.5767351085994099;0.6181162363965764;0.9998944404568447;-0.23863670258185998;-0.3625101449932827;-0.4231593318574348;-0.3817782040602683
Right aortic arch with retroesophageal left subclavian artery;Abnormality of inferior alveolar nerve;0.7194415330886841;0.7152345;0.5905196587606745;0.5919157169334184;1.0;-0.2805584669113159;-0.28476548194885254;-0.40948034123932553;-0.4080842830665816
Right aortic arch with retroesophageal left subclavian artery;Unilateral conductive hearing impairment;0.8755774199962616;0.9180404;0.5397078429870104;0.5261178442669457;0.9999201345566091;-0.12434271456034751;-0.08187973977358909;-0.46021229156959875;-0.47380229028966336
Right aortic arch with retroesophageal left subclavian artery;Macular hypopigmented whorls, streaks, and patches;0.936990886926651;1.0172089;0.520069718539705;0.4945219706483487;0.9999201345566091;-0.06292924762995811;0.017288799273652122;-0.47985041601690415;-0.5053981639082604
Right aortic arch with retroesophageal left subclavian artery;Delayed ossification of pubic rami;0.7361147999763489;0.9652896;0.5850040096009397;0.5110508784629046;0.9999134918687169;-0.26379869189236804;-0.034623899125797;-0.41490948226777724;-0.4888626134058123
Right aortic arch with retroesophageal left subclavian artery;Hyperphenylalaninemia;0.7627204954624176;0.96427053;0.5762557219669141;0.5113754699693507;0.9999028053808913;-0.23718230991847367;-0.0356322732496962;-0.42364708341397717;-0.4885273354115406
Right aortic arch with retroesophageal left subclavian artery;Ureteropelvic junction obstruction;0.7132447957992554;1.0781089;0.5925766343438411;0.4751118284068574;0.9998847295244674;-0.286639933725212;0.07822417722144326;-0.4073080951806263;-0.52477290111761
Right aortic arch with retroesophageal left subclavian artery;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8144699931144714;1.116242;0.5594001917487055;0.4629151747530448;1.0;-0.18553000688552856;0.11624205112457275;-0.4405998082512945;-0.5370848252469552
Right aortic arch with retroesophageal left subclavian artery;Difficulty walking;0.9618802666664124;0.98214114;0.5121368285559139;0.5056849477133981;0.9998344221996177;-0.03795415553320536;-0.0176932850765098;-0.4876975936437038;-0.4941494744862196
Right aortic arch with retroesophageal left subclavian artery;Bilobate gallbladder;0.8992811143398285;0.9798707;0.5321142700078257;0.5064078012234843;0.9999134918687169;-0.10063237752888843;-0.02004281487439319;-0.4677992218608912;-0.49350569064523264
Right aortic arch with retroesophageal left subclavian artery;Histidinuria;0.8960878625512123;1.2078209;0.5331360765148186;0.43336287108790306;0.9999090677057578;-0.10382120515454552;0.20791182462822655;-0.4667729911909392;-0.5665461966178548
Right aortic arch with retroesophageal left subclavian artery;Widened interpedicular distance;0.8133566677570343;0.9438686;0.5597608741568565;0.5178765741941507;1.0;-0.1866433322429657;-0.05613142251968384;-0.4402391258431435;-0.4821234258058493
Elevated urine suberic acid level;Burkitt lymphoma;0.9735919255763292;1.0385959;0.508406928503538;0.48771147229134204;0.9999574798349273;-0.0263655542585981;0.03863843500577091;-0.49155055133138936;-0.5122460075435853
Elevated urine suberic acid level;Snail-like ilia;0.8413408696651459;0.84316796;0.5507170884612129;0.5501281334079533;0.9999600672783046;-0.15861919761315868;-0.15679210663453624;-0.44924297881709163;-0.44983193387035125
Elevated urine suberic acid level;Indurated nodule;0.8280030190944672;0.96601754;0.5550219338135831;0.510819032241254;0.9999201345566091;-0.17191711546214195;-0.03390259028704734;-0.444898200743026;-0.4891011023153551
Elevated urine suberic acid level;Absent leukocyte alkaline phosphatase;0.7335346341133118;0.66876477;0.5858557959660293;0.6074653670716275;0.8631450867506595;-0.12961045263734772;-0.19438031671968414;-0.27728929078463016;-0.255679719679032
Elevated urine suberic acid level;Hippocampal sclerosis;0.8232598304748535;0.97330433;0.5565552286178189;0.508498500145955;0.9999201345566091;-0.1766603040817556;-0.026615803253966286;-0.4433649059387902;-0.4914216344106541
Elevated urine suberic acid level;Decreased sensitivity to hypoxemia;0.8745346367359161;0.91481483;0.5400423928237104;0.527148192627501;0.9999600672783046;-0.12542543054238842;-0.08514523745194957;-0.4599176744545942;-0.47281187465080354
Elevated urine suberic acid level;Decreased level of tissue plasminogen activator;0.8781979233026505;1.1157602;0.5388673165227092;0.46306957142215155;0.9999201345566091;-0.12172221125395866;0.11584007261959939;-0.46105281803389986;-0.5368505631344576
Elevated urine suberic acid level;Submandibular lymph node enlargement;0.6817782819271088;0.9450501;0.6030856442748768;0.5174999019025093;0.9999600672783046;-0.3181817853511958;-0.054909946924605824;-0.3968744230034278;-0.4824601653757953
Elevated urine suberic acid level;Hepatic hemangioma;0.8761810213327408;1.0026433;0.5395142133962876;0.4991586086491979;0.9999584729108851;-0.12377745157814435;0.0026848738756138912;-0.46044425951459755;-0.5007998642616872
Elevated urine suberic acid level;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8797815665602684;1.0611631;0.5383594953142654;0.4805190448869796;0.9999201345566091;-0.1201385679963407;0.06124293326107888;-0.4615606392423437;-0.5194010896696295
Elevated urine suberic acid level;Acne inversa;0.8589032292366028;0.97232175;0.545062870029555;0.5088113845213353;0.9999548690865008;-0.141051639849898;-0.027633120352980267;-0.4548919990569458;-0.49114348456516543
Elevated urine suberic acid level;Dentin dysplasia;0.9009338766336441;0.9510884;0.5315855347583873;0.5155752500063474;0.9999201345566091;-0.098986257922965;-0.048831706059294655;-0.4683345997982218;-0.4843448845502617
Elevated urine suberic acid level;Aplasia of the inner ear;0.7729583084583282;1.0422345;0.5729053670850963;0.4865523308405161;0.9999600672783046;-0.2270017588199763;0.042274472707352184;-0.42705470019320824;-0.5134077364377885
Elevated urine suberic acid level;Polycystic liver disease;0.8767643645405769;1.0795894;0.5393270963866653;0.4746390876902902;0.9999567459343585;-0.12319238139378152;0.07963262097848334;-0.46062964954769314;-0.5253176582440683
Elevated urine suberic acid level;Subungual hyperkeratosis;0.637082576751709;0.9625158;0.6182192969244336;0.5119343928682524;0.9999556674707869;-0.3628730907190779;-0.037439896081779334;-0.38173637054635334;-0.4880212746025345
Elevated urine suberic acid level;Broad humeral epiphyses;0.7237392067909241;0.9123878;0.5890953516619648;0.5279236295436196;0.9999201345566091;-0.27618092776568504;-0.08753234626086326;-0.4108247828946443;-0.4719965050129895
Elevated urine suberic acid level;Autoimmune thrombocytopenia;0.9078234508633614;1.0731152;0.5293824154975048;0.4767059231777204;0.9999509115718902;-0.09212746070852884;0.07316431803473822;-0.47056849607438545;-0.5232449883941698
Elevated urine suberic acid level;Adenomyosis;0.848793238401413;1.0055724;0.5483159257089334;0.4982262227090085;0.8586132879499475;-0.009820049548534548;0.14695915029010376;-0.3102973622410141;-0.360387065240939
Elevated urine suberic acid level;Elevated leukocyte alkaline phosphatase;0.6843354105949402;0.65294665;0.6022274394629974;0.6128177240108434;0.8631450867506595;-0.1788096761557193;-0.2101984357687564;-0.2609176472876621;-0.25032736273981604
Elevated urine suberic acid level;Clasp-knife sign;0.9517914056777954;0.92931396;0.5153512223075031;0.5225188405737979;0.9999201345566091;-0.0481287288788137;-0.07060617686541648;-0.48456891224910603;-0.47740129398281117
Elevated urine suberic acid level;Keratosis pilaris;0.85487100481987;0.88202983;0.546359717129741;0.5376387180455942;0.9999506876445663;-0.1450796828246963;-0.11792085623511195;-0.45359097051482533;-0.46231196959897214
Elevated urine suberic acid level;Lamina lucida cleavage;0.9603255577385426;0.981601;0.5126320826253583;0.5058569087942607;0.9999548690865008;-0.03962931134795822;-0.018353869254347455;-0.48732278646114247;-0.49409796029224007
Elevated urine suberic acid level;Abnormal central response of multifocal electroretinogram;0.8316851109266281;0.98341495;0.5538325421169941;0.5052794268816987;0.9999201345566091;-0.168235023629981;-0.016505186570006325;-0.44608759243961504;-0.4946407076749104
Elevated urine suberic acid level;Atypical or prolonged hepatitis;0.8350697308778763;0.92177033;0.5527399093630443;0.5249267354963453;0.9999600672783046;-0.16489033640042827;-0.07818973303453014;-0.44722015791526026;-0.4750333317819593
Elevated urine suberic acid level;Cubitus varus;0.9723889529705048;0.9955411;0.5087899863489133;0.5014193183091131;0.9999201345566091;-0.027531181586104347;-0.00437903882296653;-0.49113014820769585;-0.498500816247496
Elevated urine suberic acid level;Nasal regurgitation;0.8036673814058304;0.85485953;0.5629032332289602;0.5463634132618767;0.9999584729108851;-0.19629109150505475;-0.1450989419851344;-0.43705523968192495;-0.4535950596490085
Elevated urine suberic acid level;Moon facies;0.8684541285037994;0.88156044;0.5419940636214857;0.5377891761471894;0.9999584729108851;-0.1315043444070857;-0.11839802807903699;-0.4579644092893994;-0.4621692967636958
Elevated urine suberic acid level;Intestinal pseudo-obstruction;0.7404575049877167;0.86033225;0.583571761984335;0.5446034584688206;0.9999539510871024;-0.2594964460993857;-0.13962170049200961;-0.41638218910276736;-0.45535049261828175
Elevated urine suberic acid level;Bilateral renal atrophy;0.7227537631988525;0.72856283;0.589421778023296;0.587498904782999;0.8144325676816837;-0.09167880448283117;-0.0858697358030216;-0.22501078965838772;-0.22693366289868466
Elevated urine suberic acid level;Fractured left clavicle;0.8591810762882233;1.0550253;0.5449735366252951;0.4824760493288086;0.9999201345566091;-0.14073905826838584;0.055105204569977806;-0.454946597931314;-0.5174440852278005
Elevated urine suberic acid level;Positive urine norcotinine test;0.6435605883598328;0.55218613;0.616009380049889;0.6477972794476595;0.726290173501319;-0.0827295851414862;-0.174104042023963;-0.11028079345142994;-0.07849289405365945
Elevated urine suberic acid level;Long fibula;0.8616079241037369;0.97954065;0.5441934071184165;0.5065128648866772;0.9999567459343585;-0.13834882183062158;-0.020416099858156067;-0.455763338815942;-0.4934438810476812
Elevated urine suberic acid level;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9469155445694923;1.0959097;0.5169052530341303;0.46942399995170714;0.9999201345566091;-0.05300458998711677;0.0959895801421824;-0.48301488152247884;-0.530496134604902
Elevated urine suberic acid level;Type II cryptotia;0.8815758377313614;0.8514605;0.5377842512610274;0.5474572102156452;0.9999201345566091;-0.11834429682524772;-0.1484596181038198;-0.46213588329558175;-0.4524629243409639
Elevated urine suberic acid level;Increased variability in muscle fiber diameter;0.7745898365974426;0.8643436;0.572372213393338;0.5433143276210448;0.9999473166570552;-0.22535748005961254;-0.13560373307322338;-0.42757510326371717;-0.45663298903601035
Elevated urine suberic acid level;Widened proximal tibial metaphyses;0.7577317357063293;1.0061243;0.5778914106484319;0.49805057845359924;0.9999600672783046;-0.2422283315719752;0.006164190763077282;-0.4220686566298727;-0.5019094888247053
Elevated urine suberic acid level;Wide anterior fontanel;0.791061744093895;0.94824624;0.5670007699568622;0.5164810973407483;0.9999476714516888;-0.20888592735779388;-0.05170143083584411;-0.4329469014948266;-0.4834665741109405
Elevated urine suberic acid level;Increased circulating oleate level;0.758269265294075;0.8285409;0.5777150681247449;0.5548481323238337;0.726290173501319;0.03197909179275604;0.1022507477099237;-0.14857510537657403;-0.1714420411774853
Elevated urine suberic acid level;Lozenge-shaped umbilicus;0.8765028044581413;0.90019476;0.539410994428352;0.5318219709867611;0.9999584729108851;-0.1234556684527438;-0.09976370877361707;-0.4605474784825331;-0.46813650192412404
Elevated urine suberic acid level;Anti-myelin-associated glycoprotein antibody positivity;0.7995591163635254;0.98008144;0.5642374549161553;0.5063406853083703;0.9999201345566091;-0.20036101819308372;-0.019838695538359596;-0.4356826796404538;-0.4935794492482388
Elevated urine suberic acid level;Fractured radius;0.746655136346817;0.8766072;0.5815307369998;0.5393775099232763;0.9999600672783046;-0.25330493093148754;-0.12335288763658092;-0.4184293302785046;-0.4605825573550283
Elevated urine suberic acid level;Abnormal manual kinetic perimetry test;0.8469744324684143;0.9700854;0.5489016864248459;0.5095235416478938;0.9999201345566091;-0.1529457020881948;-0.029834752095061257;-0.45101844813176317;-0.4903965929087153
Elevated urine suberic acid level;Small radial epiphyses;0.7750063687562943;0.9155804;0.5722361314308465;0.5269036185274134;0.9999201345566091;-0.22491376580031486;-0.08433974267275901;-0.4276840031257626;-0.4730165160291957
Elevated urine suberic acid level;Generalized keratosis follicularis;0.7872520685195923;0.90373206;0.56824131580237;0.5306905611066732;0.9999600672783046;-0.21270799875871227;-0.09622800589219616;-0.4317187514759345;-0.4692695061716313
Elevated urine suberic acid level;Hypoplasia of the calcaneus;0.8604200482368469;0.9937911;0.5445752255729501;0.5019763721058118;0.9999584729108851;-0.1395384246740382;-0.006167369547848023;-0.455383247337935;-0.4979821008050733
Elevated urine suberic acid level;2-hydroxyadipic aciduria;0.7230768799781799;0.62959635;0.5893147355637991;0.6207806300763543;0.0;0.7230768799781799;0.6295963525772095;0.5893147355637991;0.6207806300763543
Elevated urine suberic acid level;Potter facies;0.9215189814567566;0.8779928;0.5250069998330628;0.5389331042626513;0.9999552432134126;-0.07843626175665597;-0.12196243439459542;-0.4749482433803498;-0.4610221389507613
Elevated urine suberic acid level;Increased heart rate variability;0.8385842889547348;0.92379093;0.5516059927950366;0.5242816330449205;0.9999600672783046;-0.16137577832356975;-0.0761691355766444;-0.4483540744832679;-0.4756784342333841
Elevated urine suberic acid level;Aplastic zygomatic arch;0.89255391061306;1.0097848;0.5342673035158995;0.49688536209977907;0.9999584729108851;-0.10740456229782513;0.009826344784732544;-0.46569116939498567;-0.5030731108111061
Elevated urine suberic acid level;Testicular torsion;0.8695344626903534;1.0569113;0.5416471930876103;0.48187476870438306;0.8586132879499475;0.010921174740405881;0.1982980613466223;-0.3169660948623372;-0.37673851924556445
Elevated urine suberic acid level;Abolished vibration sense;0.869581937789917;0.9499317;0.5416319510657506;0.515943902322503;0.9999584729108851;-0.13037653512096814;-0.050026791754726685;-0.45832652184513456;-0.48401457058838215
Elevated urine suberic acid level;Fractured metatarsal bone of digit 5;0.9105179831385612;1.0569158;0.5285211589443152;0.48187336362938027;0.9999201345566091;-0.08940215141804786;0.056995625483674095;-0.47139897561229394;-0.5180467709272288
Elevated urine suberic acid level;Prolonged G2 phase of cell cycle;0.8499050736427307;0.9124988;0.5479579317670704;0.5278881637105973;0.851762385589393;-0.0018573119466622767;0.06073638655492464;-0.3038044538223226;-0.32387422187879567
Elevated urine suberic acid level;Single naris;0.7008914947509766;0.80098444;0.5966892542204569;0.5637744302259824;0.9999567459343585;-0.2990652511833819;-0.19897230370031915;-0.4032674917139015;-0.43618231570837607
Elevated urine suberic acid level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8566932529211044;0.9668879;0.5457735496380669;0.510541838518654;0.9999201345566091;-0.14322688163550468;-0.03303224326403709;-0.4541465849185422;-0.48937829603795513
Elevated urine suberic acid level;Asymmetry of the thorax;0.8741225600242615;1.0068276;0.5401746091371037;0.4978266750243474;0.9999567459343585;-0.12583418591009699;0.006870846915372986;-0.45978213679725477;-0.502130070910011
Elevated urine suberic acid level;Type 2 muscle fiber predominance;0.8198720812797546;0.8927726;0.5576511710856574;0.5341972903908223;0.9999556674707869;-0.18008358619103226;-0.1071830525148848;-0.4423044963851295;-0.4657583770799646
Elevated urine suberic acid level;Dependency on parenteral nutrition;0.7664313763380051;0.75243455;0.5750403502938158;0.5796305206184944;0.9999584729108851;-0.23352709657288007;-0.2475239211950343;-0.4249181226170693;-0.4203279522923907
Elevated urine suberic acid level;Limited shoulder flexion;0.7074750661849976;0.9161884;0.5944954486139259;0.5267093796569695;0.9999201345566091;-0.29244506837161155;-0.08373171569140525;-0.4054246859426832;-0.4732107548996396
Elevated urine suberic acid level;Paroxysmal vertigo;0.8650093674659729;0.9465082;0.5431004345220025;0.5170350877782961;0.9999584729108851;-0.13494910544491223;-0.05345024413204602;-0.4568580383888826;-0.48292338513258903
Elevated urine suberic acid level;Long hallux;0.9840981476008892;1.0907484;0.5050619301766864;0.47107407546297586;0.9999526340597648;-0.01585448645887555;0.09079579523863612;-0.4948907038830783;-0.5288785585967889
Elevated urine suberic acid level;Broad medial eyebrow;0.8414406329393387;0.9469174;0.5506849256901674;0.51690465573623;0.9999600672783046;-0.15851943433896587;-0.053042652613082386;-0.4492751415881372;-0.48305541154207454
Elevated urine suberic acid level;Myxoid subcutaneous tumors;0.7915043532848358;0.9375936;0.5668567103178996;0.5198774996700579;0.9999600672783046;-0.20845571399346874;-0.06236648798600719;-0.4331033569604049;-0.48008256760824664
Elevated urine suberic acid level;Bulbous tips of toes;0.872050330042839;1.0056808;0.5408395977961987;0.4981917433445533;0.9999584729108851;-0.12790814286804608;0.0057223265733677975;-0.4591188751146864;-0.5017667295663318
Elevated urine suberic acid level;Absent internal genitalia;0.8415326029062271;0.9563329;0.5506552758727506;0.5139040861470163;0.717226575899895;0.12430602700633209;0.2391063460819165;-0.16657130002714438;-0.2033224897528787
Elevated urine suberic acid level;Hyperphalangy of the 2nd finger;0.8531395196914673;1.0210832;0.5469168353564002;0.4932885104364523;0.9999600672783046;-0.14682054758683727;0.021123168462357067;-0.4530432319219043;-0.5066715568418523
Elevated urine suberic acid level;Renal interstitial hemosiderin;0.6736367344856262;0.7137333;0.605823269378404;0.5924143293858342;0.6288651353633673;0.04477159912225892;0.08486818010446717;-0.023041865984963272;-0.03645080597753314
Elevated urine suberic acid level;Abnormality of depressor anguli oris muscle;0.8223656415939331;1.040588;0.5568444338387002;0.4870768911725398;0.9999201345566091;-0.177554492962676;0.04066788672177224;-0.4430757007179089;-0.5128432433840693
Elevated urine suberic acid level;Paroxysmal dyspnea;0.8335644006729126;0.87828004;0.553225786167238;0.5388409856464347;0.9999201345566091;-0.1663557338836965;-0.12164009095461936;-0.44669434838937105;-0.46107914891017443
Elevated urine suberic acid level;Phenylpyruvic acidemia;0.7435529828071594;0.6774189;0.5825519146934368;0.6045505091711976;0.8631450867506595;-0.11959210394350006;-0.18572619913545563;-0.2805931720572227;-0.2585945775794619
Elevated urine suberic acid level;Lateral ventricle dilatation;0.8354935348033905;0.89952356;0.5526031402035358;0.532036702499447;0.9999488789551968;-0.1644553441518063;-0.1004253227227444;-0.44734573875166095;-0.4679121764557498
Elevated urine suberic acid level;Neonatal unconjugated hyperbilirubinemia;0.7513947784900665;0.8665541;0.5799721762532342;0.5426042471336435;0.8631450867506595;-0.11175030826059296;0.003408994689312439;-0.2831729104974253;-0.32054083961701596
Elevated urine suberic acid level;High maternal circulating alpha-fetoprotein concentration;0.7055977582931519;0.79647756;0.595120536877202;0.5652389838933987;0.9999201345566091;-0.29432237626345725;-0.2034425783279714;-0.4047995976794071;-0.43468115066321045
Elevated urine suberic acid level;Prominent nasolabial fold;0.8171258270740509;0.9871513;0.5585400956309625;0.5040899731930499;0.9999545338528789;-0.182828706778828;-0.012803209103885993;-0.4414144382219164;-0.495864560659829
Elevated urine suberic acid level;Abnormality of inferior alveolar nerve;0.8012793362140656;1.0331842;0.5636786494563837;0.4894352226813289;0.9999201345566091;-0.19864079834254356;0.03326403616635232;-0.4362414851002254;-0.5104849118752802
Elevated urine suberic acid level;Unilateral conductive hearing impairment;0.8370234668254852;1.0957102;0.5521094849359512;0.46948780236673093;0.9999600672783046;-0.16293660045281932;0.09575009106977894;-0.4478505823423533;-0.5304722649115736
Elevated urine suberic acid level;Macular hypopigmented whorls, streaks, and patches;0.984770730137825;1.012135;0.5048478145616124;0.4961371880504799;0.9999600672783046;-0.015189337140479542;0.012174961560806774;-0.4951122527166921;-0.5038228792278246
Elevated urine suberic acid level;Delayed ossification of pubic rami;0.9053141474723816;1.0817637;0.5301846610231726;0.4739447196515354;0.9999584729108851;-0.09464432543850354;0.08180527144336291;-0.4697738118877125;-0.5260137532593497
Elevated urine suberic acid level;Hyperphenylalaninemia;0.7169440388679504;0.8152023;0.591348216729549;0.5591629859790807;0.8497508587917271;-0.13280681992377663;-0.034548563011545186;-0.2584026420621781;-0.2905878728126464
Elevated urine suberic acid level;Ureteropelvic junction obstruction;0.6711902618408203;0.74534106;0.6066474853593486;0.5819632029969335;0.7807636207142028;-0.10957335887338249;-0.03542255816842643;-0.17411613535485415;-0.1988004177172693
Elevated urine suberic acid level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8822586536407471;1.0373274;0.5375653728759827;0.4881155546431819;0.9999201345566091;-0.11766148091586204;0.03740727423397927;-0.4623547616806264;-0.5118045799134272
Elevated urine suberic acid level;Difficulty walking;0.9452495202422142;0.9201745;0.5174363376282638;0.5254363246474325;0.9999461221900431;-0.05469660194782888;-0.07977164270548498;-0.4825097845617793;-0.4745097975426106
Elevated urine suberic acid level;Bilobate gallbladder;0.931450143456459;0.9481766;0.5218372223459231;0.5165032789756356;0.9999584729108851;-0.06850832945442609;-0.05178185052013806;-0.478121250564962;-0.4834551939352495
Elevated urine suberic acid level;Histidinuria;0.7171469330787659;0.69628507;0.591280881739361;0.5982270432132345;0.6496512029409973;0.06749573013776855;0.04663386604780273;-0.05837032120163632;-0.05142415972776282
Elevated urine suberic acid level;Widened interpedicular distance;0.8170556575059891;1.0388267;0.55856281457126;0.4876379677594741;0.9999201345566091;-0.18286447705062003;0.03890656946865945;-0.4413573199853491;-0.512282166797135
Burkitt lymphoma;Snail-like ilia;0.8471164703369141;0.91938263;0.5488559360324534;0.5256891830671659;0.9999574798349273;-0.15284100949801327;-0.08057484805621029;-0.4511015438024739;-0.4742682967677614
Burkitt lymphoma;Indurated nodule;0.6997823715209961;0.7757346;0.5970593047727004;0.5719982478410823;0.9999090677057578;-0.30012669618476173;-0.22417446430075905;-0.4028497629330574;-0.4279108198646755
Burkitt lymphoma;Absent leukocyte alkaline phosphatase;0.7333322763442993;0.8836845;0.5859226266101143;0.5371083617004417;0.9999574798349273;-0.266625203490628;-0.11627296388186337;-0.41403485322481304;-0.4628491181344856
Burkitt lymphoma;Hippocampal sclerosis;0.8114075064659119;0.92989975;0.5603925284399196;0.5223319222095272;0.9999090677057578;-0.18850156123984596;-0.07000931556571266;-0.4395165392658382;-0.47757714549623065
Burkitt lymphoma;Decreased sensitivity to hypoxemia;0.8799515441060066;1.079063;0.5383049950767587;0.4748071490361788;0.9999574798349273;-0.12000593572892071;0.07910557806454777;-0.46165248475816867;-0.5251503307987485
Burkitt lymphoma;Decreased level of tissue plasminogen activator;0.9159224480390549;1.0815969;0.5267943478167402;0.4739979952737253;0.5147561151225537;0.40116633291650117;0.5668407362263232;0.012038232694186468;-0.04075811984882838
Burkitt lymphoma;Submandibular lymph node enlargement;0.6866216063499451;0.65829754;0.6014608145756817;0.611003496544414;0.9999574798349273;-0.31333587348498226;-0.3416599410776031;-0.39849666525924565;-0.38895398329051334
Burkitt lymphoma;Hepatic hemangioma;0.6794121563434601;0.8402693;0.6038804383047095;0.5510625770061077;0.6730162381792475;0.006395918164212588;0.1672530889844488;-0.069135799874538;-0.12195366117313977
Burkitt lymphoma;Triangular epiphysis of the distal phalanx of the 2nd finger;0.9375198483467102;1.0514867;0.5199010124722812;0.483604005729243;0.9999090677057578;-0.06238921935904762;0.0515776628698037;-0.48000805523347667;-0.5163050619765148
Burkitt lymphoma;Acne inversa;0.893756166100502;1.0755627;0.5338824104383615;0.47592467861685916;0.9999515360511232;-0.10619536995062118;0.07561117947927232;-0.4660691256127617;-0.524026857434264
Burkitt lymphoma;Dentin dysplasia;0.7385531961917877;0.8908125;0.5841995982857162;0.5348248872262822;0.9999090677057578;-0.2613558715139701;-0.10909655149329445;-0.4157094694200416;-0.46508418047947564
Burkitt lymphoma;Aplasia of the inner ear;0.7872399389743805;0.9275291;0.5682452672211116;0.5230884358645764;0.9999574798349273;-0.21271754086054684;-0.07242838323153378;-0.43171221261381576;-0.4768690439703509
Burkitt lymphoma;Polycystic liver disease;0.7501736283302307;0.7849442;0.5803735444298996;0.5689933512802146;0.9999536937290383;-0.2497800653988076;-0.21500951705514915;-0.41958014929913867;-0.43096034244882375
Burkitt lymphoma;Subungual hyperkeratosis;0.7694232165813446;1.0190977;0.5740612875903888;0.4939206411027742;0.9999524555142131;-0.23052923893286847;0.01914523029969073;-0.4258911679238243;-0.5060318144114389
Burkitt lymphoma;Broad humeral epiphyses;0.9587519019842148;1.0085198;0.5131334033892408;0.4972880476958217;0.9999090677057578;-0.04115716572154304;0.00861070100914696;-0.486775664316517;-0.5026210200099361
Burkitt lymphoma;Autoimmune thrombocytopenia;0.6187427937984467;0.6403822;0.6245087703555114;0.6170929304152595;0.71686901029889;-0.0981262165004434;-0.076486839621705;-0.09236023994337861;-0.09977607988363058
Burkitt lymphoma;Adenomyosis;0.9810991939157248;0.9393122;0.506016671702839;0.5193293884168877;0.9999574798349273;-0.018858285919202578;-0.060645260215176355;-0.4939408081320883;-0.48062809141803964
Burkitt lymphoma;Elevated leukocyte alkaline phosphatase;0.7337892949581146;0.9197884;0.5857716972284854;0.5255595993161211;0.9999574798349273;-0.2661681848768127;-0.08016905963457943;-0.4141857826064419;-0.47439788051880627
Burkitt lymphoma;Clasp-knife sign;0.9664738848805428;1.0437936;0.5106736940644049;0.48605560088822664;0.9999090677057578;-0.03343518282521507;0.04388449136864403;-0.48923537364135294;-0.5138534668175312
Burkitt lymphoma;Keratosis pilaris;0.7762998342514038;1.0492947;0.5718136389319822;0.4843026256950794;0.9999466809608285;-0.2236468467094247;0.04934802919847325;-0.4281330420288463;-0.5156440552657491
Burkitt lymphoma;Lamina lucida cleavage;0.6684666275978088;0.9634298;0.6075659522338461;0.5116432520536175;0.9999515360511232;-0.33148490845331435;-0.03652172743448501;-0.39238558381727706;-0.4883082839975057
Burkitt lymphoma;Abnormal central response of multifocal electroretinogram;0.8445355594158173;1.0680234;0.5496874070492541;0.47833071563014984;0.9999090677057578;-0.15537350828994057;0.06811437551628807;-0.4502216606565037;-0.521578352075608
Burkitt lymphoma;Atypical or prolonged hepatitis;0.7255954742431641;0.9062037;0.5884807274336628;0.5299002459105069;0.9999574798349273;-0.27436200559176327;-0.09375379264391781;-0.4114767524012646;-0.47005723392442045
Burkitt lymphoma;Cubitus varus;0.9427667856216431;0.9992071;0.5182278585256912;0.5002523938961287;0.9999090677057578;-0.05714228208411476;-0.0007019882952048473;-0.4816812091800666;-0.4996566738096291
Burkitt lymphoma;Nasal regurgitation;0.9668545424938202;1.086714;0.5105524596009949;0.47236334165470684;0.9999556674707869;-0.03310112497696671;0.08675836184134689;-0.48940320786979197;-0.5275923258160801
Burkitt lymphoma;Moon facies;1.038996148854494;1.0984089;0.48758399210317116;0.46862469315233846;0.9999556674707869;0.03904048138370719;0.09845326998343673;-0.5123716753676157;-0.5313309743184484
Burkitt lymphoma;Intestinal pseudo-obstruction;0.7474066615104675;0.8538129;0.5812834768067934;0.5467001616937853;0.9999504758588345;-0.2525438143483669;-0.14613760249533958;-0.4186669990520411;-0.45325031416504913
Burkitt lymphoma;Bilateral renal atrophy;0.8639517575502396;0.98771524;0.5434402168286324;0.5039104501411691;0.9999574798349273;-0.13600572228468777;-0.012242235541714441;-0.4565172630062949;-0.49604702969375825
Burkitt lymphoma;Fractured left clavicle;0.9711864981800318;1.0458957;0.5091728920334021;0.48538581267412917;0.9999090677057578;-0.02872256952572605;0.045986627980582506;-0.4907361756723557;-0.5145232550316287
Burkitt lymphoma;Positive urine norcotinine test;0.8657162934541702;0.97298294;0.5428733453311974;0.508600844046088;0.9999090677057578;-0.1341927742515876;-0.02692612464774391;-0.45703572237456047;-0.49130822365966986
Burkitt lymphoma;Long fibula;0.8599851876497269;0.9314043;0.5447150187487848;0.5218518539447662;0.9999536937290383;-0.13996850607931144;-0.06854940114557273;-0.4552386749802535;-0.4781018397842721
Burkitt lymphoma;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8273263871669769;1.0281328;0.5552405838154468;0.49104385276918694;0.9999090677057578;-0.1725826805387809;0.028223728581778795;-0.444668483890311;-0.5088652149365709
Burkitt lymphoma;Type II cryptotia;0.7678418755531311;0.94190574;0.5745786829174062;0.5185023956601611;0.9999090677057578;-0.23206719215262672;-0.05800333078254005;-0.4253303847883516;-0.48140667204559673
Burkitt lymphoma;Increased variability in muscle fiber diameter;0.8261063098907471;1.0030584;0.5556349119130453;0.4990264614412949;0.9999427179139311;-0.173836408023184;0.0031157156187837654;-0.4443078060008858;-0.5009162564726362
Burkitt lymphoma;Widened proximal tibial metaphyses;0.8582992553710938;0.9592237;0.5452570720872153;0.5129830981435253;0.9999574798349273;-0.14165822446383358;-0.04073379218615414;-0.45470040774771203;-0.48697438169140206
Burkitt lymphoma;Wide anterior fontanel;0.8474070280790329;0.9964332;0.5487623505618063;0.5011353508985807;0.9999431371057684;-0.15253610902673553;-0.003509938653772582;-0.4511807865439621;-0.4988077862071877
Burkitt lymphoma;Increased circulating oleate level;0.8111123442649841;0.96574;0.5604882010022842;0.5109074303152403;0.9999090677057578;-0.1887967234407737;-0.03416904266227028;-0.4394208667034736;-0.4890016373905175
Burkitt lymphoma;Lozenge-shaped umbilicus;0.6422654390335083;0.8150152;0.61645073710178;0.5592235910705334;0.9999556674707869;-0.3576902284372786;-0.18494047067055497;-0.3835049303690069;-0.44073207640025347
Burkitt lymphoma;Anti-myelin-associated glycoprotein antibody positivity;0.7042207717895508;0.8220098;0.59557927322389;0.5569595353518422;0.9999090677057578;-0.29568829591620704;-0.1778992658411338;-0.4043297944818678;-0.44294953235391565
Burkitt lymphoma;Fractured radius;0.951254740357399;1.0598856;0.5155222492625656;0.4809264168546691;0.9999574798349273;-0.048702739477528345;0.059928141235934484;-0.4844352305723617;-0.5190310629802583
Burkitt lymphoma;Abnormal manual kinetic perimetry test;0.8793866112828255;1.1060371;0.5384861349741418;0.4661837417624497;0.9999090677057578;-0.12052245642293236;0.1061280721868203;-0.46142293273161605;-0.5337253259433081
Burkitt lymphoma;Small radial epiphyses;0.9957296960055828;1.0877336;0.5013592841096578;0.47203756881326464;0.9999090677057578;-0.004179371700175016;0.0878245586599038;-0.4985497835961;-0.5278714988924932
Burkitt lymphoma;Generalized keratosis follicularis;0.7916423082351685;1.033279;0.5668118118326511;0.4894050429009992;0.9999574798349273;-0.20831517159975887;0.033321462273226965;-0.4331456680022763;-0.5105524369339282
Burkitt lymphoma;Hypoplasia of the calcaneus;0.8734495937824249;0.9011103;0.5403905478005587;0.5315290983013039;0.9999556674707869;-0.12650607368836198;-0.09884537598976884;-0.4595651196702282;-0.468426569169483
Burkitt lymphoma;2-hydroxyadipic aciduria;0.9295094609260559;1.0094476;0.522456459096093;0.49699268818871023;0.9999090677057578;-0.07039960677970192;0.00953850690972069;-0.4774526086096649;-0.5029163795170476
Burkitt lymphoma;Potter facies;0.9544180557131767;1.0342133;0.5145142125228099;0.4891074293144263;0.999951967215123;-0.0455339115019463;0.03426133730453029;-0.4854377546923131;-0.5108445379006967
Burkitt lymphoma;Increased heart rate variability;0.8581487983465195;1.049828;0.5453054527498675;0.48413268665061837;0.9999574798349273;-0.14180868148840786;0.04987057268582462;-0.4546520270850598;-0.515824793184309
Burkitt lymphoma;Aplastic zygomatic arch;0.8393555134534836;0.9428731;0.5513572582952416;0.5181939485483278;0.9999556674707869;-0.16060015401730332;-0.05708254716286454;-0.4485984091755453;-0.4817617189224591
Burkitt lymphoma;Testicular torsion;0.936872586607933;0.9562631;0.520107449815554;0.5139263197330803;0.9999574798349273;-0.06308489322699429;-0.04369435489214779;-0.4798500300193733;-0.486031160101847
Burkitt lymphoma;Abolished vibration sense;0.9980161041021347;1.1688564;0.500631494091694;0.4459925731135901;0.9999556674707869;-0.0019395633686521974;0.16890071489920822;-0.49932417337909285;-0.5539630943571968
Burkitt lymphoma;Fractured metatarsal bone of digit 5;0.9266718551516533;1.0477773;0.5233620417741018;0.48478623712328117;0.9999090677057578;-0.07323721255410454;0.04786822740685204;-0.476547025931656;-0.5151228305824767
Burkitt lymphoma;Prolonged G2 phase of cell cycle;0.818932369351387;0.87811863;0.5579552913333229;0.5388927516383921;0.9999536937290383;-0.18102132437765128;-0.12183505950510032;-0.4419984023957154;-0.4610609420906462
Burkitt lymphoma;Single naris;0.9146585837006569;0.96817523;0.5271980995660936;0.510131846550345;0.9999536937290383;-0.08529511002838142;-0.0317784613186074;-0.47275559416294466;-0.48982184717869326
Burkitt lymphoma;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8423912674188614;1.150186;0.5503784759208821;0.45201276468206975;0.9999090677057578;-0.15751780028689644;0.15027687494408348;-0.44953059178487575;-0.5478963030236881
Burkitt lymphoma;Asymmetry of the thorax;0.8138264864683151;0.9142319;0.5596086582257543;0.5273344134086647;0.9999536937290383;-0.18612720726072318;-0.08572179732858665;-0.44034503550328397;-0.4726192803203736
Burkitt lymphoma;Type 2 muscle fiber predominance;0.8630659580230713;0.94680893;0.5437248392838734;0.5169392373641526;0.9999524555142131;-0.1368864974911418;-0.05314352130248212;-0.4562276162303397;-0.4830132181500605
Burkitt lymphoma;Dependency on parenteral nutrition;0.8604134023189545;0.99282455;0.5445773619487192;0.5022840396017383;0.9999556674707869;-0.13954226515183243;-0.007131113027427527;-0.4553783055220677;-0.4976716278690486
Burkitt lymphoma;Limited shoulder flexion;0.9811657518148422;1.0339382;0.5059954818935946;0.4891950773921513;0.9999090677057578;-0.0187433158909156;0.03402910177361229;-0.49391358581216327;-0.5107139903136065
Burkitt lymphoma;Paroxysmal vertigo;0.8052224963903427;1.0037569;0.5623984792730348;0.4988041615009967;0.9999556674707869;-0.1947331710804442;0.003801213289405969;-0.43755718819775213;-0.5011515059697902
Burkitt lymphoma;Long hallux;0.8001510202884674;1.0099033;0.5640451551056395;0.49684761754673934;0.9999489492479948;-0.19979792895952742;0.00995436248143633;-0.43590379414235536;-0.5031013317012555
Burkitt lymphoma;Broad medial eyebrow;0.9170405939221382;1.0471305;0.5264371830568754;0.4849923604109706;0.9999574798349273;-0.08291688591278912;0.04717298567257999;-0.47352029677805196;-0.5149651194239567
Burkitt lymphoma;Myxoid subcutaneous tumors;0.7549090832471848;0.8473674;0.5788178149320656;0.5487751121847088;0.6863837057007169;0.06852537754646781;0.16098370019070152;-0.1075658907686513;-0.13760859351600818
Burkitt lymphoma;Bulbous tips of toes;0.8690028786659241;1.0540313;0.5418178662859516;0.4827929423640064;0.9999556674707869;-0.13095278880486283;0.05407558539023605;-0.45813780118483527;-0.5171627251067805
Burkitt lymphoma;Absent internal genitalia;0.9113871678709984;0.9627897;0.5282433853551748;0.511847140362455;0.9999090677057578;-0.08852189983475944;-0.03711935336936256;-0.47166568235058304;-0.4880619273433028
Burkitt lymphoma;Hyperphalangy of the 2nd finger;0.9060088843107224;1.0779759;0.5299625287446934;0.4751542837222813;0.9999574798349273;-0.09394859552420498;0.07801838934384464;-0.4699949510902339;-0.524803196112646
Burkitt lymphoma;Renal interstitial hemosiderin;0.8119307458400726;0.89822817;0.5602229415222074;0.5324511618499017;0.9999090677057578;-0.1879783218656852;-0.101680899218209;-0.4396861261835504;-0.4674579058558561
Burkitt lymphoma;Abnormality of depressor anguli oris muscle;0.8770432323217392;0.9971495;0.539237649749983;0.5009073396849144;0.9999090677057578;-0.12286583538401863;-0.0027595406328513317;-0.4606714179557748;-0.4990017280208434
Burkitt lymphoma;Paroxysmal dyspnea;0.7964648455381393;0.9776649;0.5652431211725821;0.5071100746664461;0.9999090677057578;-0.20344422216761848;-0.022244179800636976;-0.4346659465331757;-0.49279899303931174
Burkitt lymphoma;Phenylpyruvic acidemia;0.8233000636100769;1.0009003;0.5565422172289016;0.49971342194344537;0.9999574798349273;-0.17665741622485043;0.0009427887197601681;-0.4434152626060257;-0.500244057891482
Burkitt lymphoma;Lateral ventricle dilatation;0.82581926882267;1.07447;0.5557276958922932;0.4762735031296441;0.9999445600944175;-0.17412529127174747;0.07452548308795559;-0.44421686420212425;-0.5236710569647733
Burkitt lymphoma;Neonatal unconjugated hyperbilirubinemia;0.6065067052841187;0.8164457;0.6287335432979888;0.558760302119101;0.9999574798349273;-0.3934507745508087;-0.18351177156008602;-0.3712239365369385;-0.44119717771582634
Burkitt lymphoma;High maternal circulating alpha-fetoprotein concentration;0.8941324576735497;0.9491117;0.5337619537572547;0.5162052542746878;0.9999090677057578;-0.10577661003220817;-0.05079736764777443;-0.46614711394850317;-0.48370381343107005
Burkitt lymphoma;Prominent nasolabial fold;0.8738517165184021;1.0122758;0.5402615140561021;0.49609237790083516;0.9999511492611326;-0.1260994327427305;0.012324665748938202;-0.4596896352050305;-0.5038587713602974
Burkitt lymphoma;Abnormality of inferior alveolar nerve;0.7654001116752625;0.8756645;0.5753779930084888;0.5396799068724887;0.9999090677057578;-0.23450895603049537;-0.12424459512580177;-0.42453107469726903;-0.46022916083326915
Burkitt lymphoma;Unilateral conductive hearing impairment;0.7329536080360413;0.93226683;0.5860476959775944;0.5215766663597781;0.9999574798349273;-0.26700387179888607;-0.06769064843691708;-0.4139097838573329;-0.47838081347514927
Burkitt lymphoma;Macular hypopigmented whorls, streaks, and patches;0.8163045346736908;1.0651692;0.5588060260298215;0.479241283002233;0.9999574798349273;-0.18365294516123654;0.06521173536740421;-0.4411514538051058;-0.5207161968326943
Burkitt lymphoma;Delayed ossification of pubic rami;0.8353725373744965;0.8347235;0.5526421872522398;0.5528516508218901;0.9999556674707869;-0.16458313009629044;-0.16523219487557206;-0.4473134802185471;-0.44710401664889676
Burkitt lymphoma;Hyperphenylalaninemia;0.7912901639938354;0.98833305;0.5669264225234731;0.5037137855799491;0.9999530203863651;-0.20866285639252968;-0.011619973950055318;-0.433026597862892;-0.4962392348064161
Burkitt lymphoma;Ureteropelvic junction obstruction;0.8111266940832138;0.9754945;0.5604835495882118;0.5078011166402376;0.9999491674684583;-0.1888224733852445;-0.02445466349354375;-0.4394656178802465;-0.49214805082822066
Burkitt lymphoma;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.944348618388176;1.0637441;0.5177235415141689;0.4796958833766345;0.9999090677057578;-0.05556044931758186;0.06383500043999413;-0.48218552619158894;-0.5202131843291233
Burkitt lymphoma;Difficulty walking;0.8915338069200516;1.0752624;0.5345939214883252;0.4760205505530656;0.9999413030146577;-0.10840749609460609;0.07532112431535942;-0.4653473815263325;-0.5239207524615921
Burkitt lymphoma;Bilobate gallbladder;0.638934850692749;0.71485555;0.6175868050096118;0.5920415829271064;0.9999556674707869;-0.3610208167780379;-0.2851001157511214;-0.3823688624611751;-0.4079140845436805
Burkitt lymphoma;Histidinuria;0.7979591190814972;0.93183047;0.5647573868115138;0.5217158781296514;0.9999545338528789;-0.20199541477138172;-0.0681240680592693;-0.43519714704136514;-0.47823865572322755
Burkitt lymphoma;Widened interpedicular distance;0.8902866691350937;0.9646868;0.5349932812193707;0.5112428770641071;0.9999090677057578;-0.10962239857066414;-0.03522225673545143;-0.4649157864863871;-0.48866619064165073
Snail-like ilia;Indurated nodule;0.7677924036979675;0.8477402;0.574594872730718;0.5486550485452846;0.9999201345566091;-0.23212773085864158;-0.15217996121676536;-0.42532526182589114;-0.45126508601132453
Snail-like ilia;Absent leukocyte alkaline phosphatase;0.9614550992846489;0.9654806;0.5122722630758907;0.5109900462091834;0.9999600672783046;-0.03850496799365566;-0.034479441648879505;-0.48768780420241387;-0.48897002106912113
Snail-like ilia;Hippocampal sclerosis;0.9173106849193573;0.94326323;0.5263509140154122;0.5180695844333435;0.9999201345566091;-0.08260944963725181;-0.05665690184863181;-0.4735692205411969;-0.4818505501232656
Snail-like ilia;Decreased sensitivity to hypoxemia;0.95976272970438;1.0327682;0.5128113795335091;0.48956769367635566;0.9999600672783046;-0.04019733757392452;0.032808182233414196;-0.48714868774479547;-0.5103923736019489
Snail-like ilia;Decreased level of tissue plasminogen activator;0.9538333266973495;1.0770004;0.5147005337072283;0.47546574242367623;0.9999201345566091;-0.04608680785925956;0.07708024500576882;-0.48521960084938076;-0.5244543921329329
Snail-like ilia;Submandibular lymph node enlargement;0.9268746599555016;0.9437446;0.523297313224408;0.5179161106530139;0.9999600672783046;-0.073085407322803;-0.056215467459121204;-0.4766627540538966;-0.48204395662529065
Snail-like ilia;Hepatic hemangioma;0.9312328547239304;0.97522897;0.5219065510983265;0.5078856795387354;0.9999584729108851;-0.06872561818695477;-0.024729507628444947;-0.4780519218125586;-0.4920727933721497
Snail-like ilia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8918866068124771;1.0105;0.5344809574945979;0.4966576821549824;0.683723727808895;0.2081628790035821;0.3267762264147378;-0.1492427703142971;-0.1870660456539126
Snail-like ilia;Acne inversa;0.8105259537696838;0.944603;0.5606782874280865;0.517642431215072;0.9999548690865008;-0.18942891531681694;-0.05535184317326225;-0.4392765816584143;-0.48231243787142875
Snail-like ilia;Dentin dysplasia;0.9106263741850853;0.91732806;0.5284865182077697;0.5263453644583047;0.9999201345566091;-0.08929376037152381;-0.08259207488329978;-0.4714336163488394;-0.4735747700983044
Snail-like ilia;Aplasia of the inner ear;0.740102082490921;0.8896938;0.5836889167738907;0.5351831436542587;0.9999600672783046;-0.25985798478738353;-0.11026627064363048;-0.4162711505044139;-0.4647769236240459
Snail-like ilia;Polycystic liver disease;1.0013013212010264;1.0644088;0.49958577647970237;0.47948386121272646;0.9999567459343585;0.00134457526666798;0.06445203320992865;-0.5003709694546561;-0.520472884721632
Snail-like ilia;Subungual hyperkeratosis;0.8694941848516464;0.90837914;0.5416601244827786;0.5292047808828129;0.9999556674707869;-0.13046148261914048;-0.09157652995476517;-0.45829554298800834;-0.47075088658797404
Snail-like ilia;Broad humeral epiphyses;0.9338388890028;1.0543588;0.5210751301585761;0.48268850992183987;0.683723727808895;0.250115161193905;0.3706351121798135;-0.16264859765031892;-0.20103521788705514
Snail-like ilia;Autoimmune thrombocytopenia;0.9850873788818717;1.1399262;0.5047470106868999;0.45531345026953907;0.9999509115718902;-0.0148635326900185;0.13997528357276312;-0.49520390088499033;-0.5446374613023511
Snail-like ilia;Adenomyosis;0.9650272317230701;0.9113848;0.511134448423966;0.5282441282147131;0.9999600672783046;-0.03493283555523441;-0.0885752463401942;-0.4888256188543385;-0.47171593906359144
Snail-like ilia;Elevated leukocyte alkaline phosphatase;0.9335484951734543;0.95085686;0.5211677692551203;0.5156490538140965;0.9999600672783046;-0.06641157210485027;-0.049103202825942494;-0.47879229802318424;-0.484311013464208
Snail-like ilia;Clasp-knife sign;0.9064739570021629;0.8345236;0.5298138365129337;0.552916164247907;0.8819596887815145;0.024514268220648394;-0.04743607056023158;-0.35214585226858086;-0.3290435245336075
Snail-like ilia;Keratosis pilaris;0.9324362352490425;0.9473619;0.5215226101217201;0.516762975502864;0.9999506876445663;-0.06751445239552378;-0.05258880114325404;-0.4784280775228462;-0.4831877121417023
Snail-like ilia;Lamina lucida cleavage;0.8573053181171417;0.833123;0.5455767001278103;0.5533682720224854;0.9999548690865008;-0.14264955096935905;-0.16683184080814994;-0.45437816895869043;-0.4465865970640154
Snail-like ilia;Abnormal central response of multifocal electroretinogram;0.9070001766085625;0.9374965;0.5296456023617949;0.5199084643542653;0.9999201345566091;-0.09291995794804664;-0.062423651230650856;-0.4702745321948142;-0.4800116702023438
Snail-like ilia;Atypical or prolonged hepatitis;0.9144176095724106;1.0727324;0.5272750856719844;0.47682807241224534;0.9999600672783046;-0.08554245770589397;0.0727723812995763;-0.4726849816063201;-0.5231319948660592
Snail-like ilia;Cubitus varus;1.04977385699749;1.0489527;0.48414994005736045;0.48441164190984665;0.822027235707794;0.22774662128969592;0.22692546299978655;-0.33787729565043356;-0.33761559379794737
Snail-like ilia;Nasal regurgitation;0.9882650710642338;1.0583948;0.5037354296307014;0.4814017953247801;0.9999584729108851;-0.011693401846651352;0.058436316784854614;-0.49622304328018374;-0.518556677586105
Snail-like ilia;Moon facies;0.9065721556544304;0.82388943;0.5297824414460552;0.5563516257699459;0.9999584729108851;-0.09338631725645474;-0.17606903857326917;-0.4701760314648299;-0.44360684714093923
Snail-like ilia;Intestinal pseudo-obstruction;0.7911828756332397;0.81711817;0.5669613428993306;0.5585425658005532;0.9999539510871024;-0.20877107545386264;-0.18283578320990512;-0.43299260818777174;-0.4414113852865492
Snail-like ilia;Bilateral renal atrophy;0.931366428732872;0.91898566;0.5218639324773704;0.5258159562364242;0.9999600672783046;-0.06859363854543254;-0.08097440243379161;-0.47809613480093416;-0.47414411104188037
Snail-like ilia;Fractured left clavicle;0.9895226433873177;1.1310656;0.5033351072113543;0.45816014922479376;0.683723727808895;0.30579891557842265;0.44734187926202784;-0.18038862059754068;-0.22556357858410125
Snail-like ilia;Positive urine norcotinine test;0.9039389118552208;0.89336383;0.5306244167514271;0.534008016848347;0.9999201345566091;-0.09598122270138831;-0.10655630112917991;-0.469295717805182;-0.46591211770826213
Snail-like ilia;Long fibula;0.9320009872317314;1.0224025;0.521661473227456;0.49286847601857986;0.8287089627579918;0.10329202447373964;0.19369356219012834;-0.30704748953053573;-0.3358404867394119
Snail-like ilia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.91103895008564;1.0374104;0.5283546660066383;0.4880891320522227;0.683723727808895;0.22731522227674494;0.3536866506472207;-0.15536906180225674;-0.1956345957566723
Snail-like ilia;Type II cryptotia;0.7277952134609222;0.7165868;0.5877528150798075;0.5914667851938271;0.9999201345566091;-0.27212492109568687;-0.2833333063247976;-0.41216731947680163;-0.408453349362782
Snail-like ilia;Increased variability in muscle fiber diameter;0.9208266064524651;0.94068503;0.525228077575228;0.5188916217027739;0.922134556158444;-0.001307949705978917;0.0185504776397738;-0.3969064785832159;-0.40324293445567005
Snail-like ilia;Widened proximal tibial metaphyses;0.9686235710978508;1.0543694;0.5099890669766999;0.4826851123329531;0.8418618639044475;0.1267617071934033;0.212507585711031;-0.3318727969277476;-0.3591767515714944
Snail-like ilia;Wide anterior fontanel;0.9860386252403259;0.9860711;0.5044441879955385;0.5044338486213582;0.8833906631088758;0.10264796213145011;0.1026804466628527;-0.37894647511333734;-0.3789568144875176
Snail-like ilia;Increased circulating oleate level;0.9546584598720074;1.05263;0.5144376103016586;0.48323962737149406;0.9999201345566091;-0.04526167468460174;0.05270981310574441;-0.48548252425495053;-0.516680507185115
Snail-like ilia;Lozenge-shaped umbilicus;0.7380582094192505;0.8296294;0.5843628465397321;0.5544964872988982;0.9999584729108851;-0.26190026349163464;-0.17032905167675427;-0.415595626371153;-0.4454619856119869
Snail-like ilia;Anti-myelin-associated glycoprotein antibody positivity;0.9176710247993469;0.88314235;0.5262358218396571;0.5372821179972598;0.9999201345566091;-0.08224910975726218;-0.1167777824524221;-0.473684312716952;-0.46263801655934933
Snail-like ilia;Fractured radius;0.8625005483627319;0.9561677;0.5439065334073898;0.5139567218863577;0.8418618639044475;0.02063868445828443;0.11430583400204664;-0.2979553304970577;-0.32790514201808985
Snail-like ilia;Abnormal manual kinetic perimetry test;0.9406290203332901;0.98993415;0.5189094899472404;0.5032041065205275;0.9999201345566091;-0.05929111422331901;-0.00998598815234275;-0.4810106446093687;-0.4967160280360816
Snail-like ilia;Small radial epiphyses;0.8519833981990814;0.9777956;0.5472889065640811;0.5070684523651487;0.683723727808895;0.1682596703901864;0.29407187308221827;-0.13643482124481388;-0.17665527544374626
Snail-like ilia;Generalized keratosis follicularis;0.9054174423217773;0.9124303;0.5301516330254831;0.5279100640654948;0.9999600672783046;-0.09454262495652721;-0.08752978087083385;-0.4698084342528215;-0.47205000321280977
Snail-like ilia;Hypoplasia of the calcaneus;1.0150924883782864;1.1005903;0.49519572934160994;0.4679268392695599;0.8355479869321181;0.1795445014461683;0.2650423613115953;-0.34035225759050813;-0.36762114766255816
Snail-like ilia;2-hydroxyadipic aciduria;0.8160624504089355;0.89834285;0.5588844196266278;0.5324144632075162;0.9999201345566091;-0.18385768414767356;-0.10157728673251243;-0.4410357149299813;-0.46750567134909293
Snail-like ilia;Potter facies;0.9672256298363209;0.8661423;0.5104342746176361;0.5427365165231438;0.9999552432134126;-0.03272961337709168;-0.1338129702641938;-0.48952096859577643;-0.45721872669026875
Snail-like ilia;Increased heart rate variability;0.9722221922129393;1.0712376;0.5088430883147494;0.4773051466375353;0.9999600672783046;-0.02773787506536529;0.07127749680860951;-0.4911169789635551;-0.5226549206407692
Snail-like ilia;Aplastic zygomatic arch;0.946907751262188;0.96802557;0.5169077372240484;0.5101795042590878;0.9074607173141833;0.03944703394800464;0.060564847833216584;-0.39055298009013495;-0.39728121305509556
Snail-like ilia;Testicular torsion;0.9301843717694283;0.95979637;0.5222410976988328;0.5128006595573609;0.9999600672783046;-0.0697756955088763;-0.04016369820252941;-0.4777189695794718;-0.4871594077209437
Snail-like ilia;Abolished vibration sense;0.9400322921574116;1.0313526;0.5190997734755505;0.4900185092486359;0.9999584729108851;-0.05992618075347356;0.03139416628741809;-0.48085869943533466;-0.5099399636622493
Snail-like ilia;Fractured metatarsal bone of digit 5;0.9829340241849422;1.002209;0.5054325325430182;0.49929685279743163;0.683723727808895;0.29921029637604724;0.31848522032648097;-0.17829119526587678;-0.18442687501146338
Snail-like ilia;Prolonged G2 phase of cell cycle;0.9227540343999863;0.93493336;0.5246126730813846;0.5207259954499571;0.9999567459343585;-0.07720271153437219;-0.06502338154303156;-0.47534407285297386;-0.47923075048440134
Snail-like ilia;Single naris;0.8585718870162964;0.8544458;0.5451694078765768;0.5464965021871718;0.9999567459343585;-0.14138485891806207;-0.1455109308479937;-0.4547873380577817;-0.45346024374718663
Snail-like ilia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8802796676754951;0.90838486;0.5381997913560879;0.5292029589511824;0.9999201345566091;-0.11964046688111396;-0.09153527499468894;-0.46172034320052124;-0.4707171756054267
Snail-like ilia;Asymmetry of the thorax;1.007838562130928;1.08008;0.497504882628542;0.47448241105069144;0.9036123096265051;0.10422625250442297;0.17646772272212774;-0.4061074269979631;-0.42912989857581363
Snail-like ilia;Type 2 muscle fiber predominance;0.9553784690797329;0.9696425;0.5142081920347743;0.5096645661020653;0.9344769737294281;0.020901495350304833;0.03516554622143864;-0.42026878169465376;-0.4248124076273627
Snail-like ilia;Dependency on parenteral nutrition;0.886388324201107;0.9210132;0.5362419728606976;0.5251685063133928;0.9999584729108851;-0.11357014870977811;-0.0789452964696925;-0.4637165000501875;-0.4747899665974923
Snail-like ilia;Limited shoulder flexion;0.895775280892849;1.0384637;0.5332361175562451;0.48775361003683815;0.8332104407109631;0.0625648401818859;0.20525327102762336;-0.29997432315471795;-0.3454568306741249
Snail-like ilia;Paroxysmal vertigo;0.935306191444397;0.94787794;0.5206070703442232;0.5165984872028513;0.9999584729108851;-0.06465228146648816;-0.052080529395107544;-0.479351402566662;-0.48335998570803385
Snail-like ilia;Long hallux;0.9597845487296581;1.0116608;0.5128044286959952;0.4962881634095587;0.8124254700108346;0.14735907871882348;0.19923534427444367;-0.29962104131483946;-0.3161373066012759
Snail-like ilia;Broad medial eyebrow;1.024105565622449;0.98519427;0.49232621684979294;0.504712985532823;0.9999600672783046;0.024145498344144367;-0.01476580143586681;-0.5076338504285116;-0.4952470817454816
Snail-like ilia;Myxoid subcutaneous tumors;0.8884865194559097;0.8995405;0.5355698246939586;0.5320312939883944;0.9999600672783046;-0.11147354782239483;-0.10041958332673595;-0.4643902425843459;-0.4679287732899101
Snail-like ilia;Bulbous tips of toes;0.8554884493350983;0.9433854;0.5461610844426544;0.5180306229322555;0.8355479869321181;0.019940462402980197;0.10783743529764878;-0.28938690248946364;-0.3175173639998625
Snail-like ilia;Absent internal genitalia;0.8227177560329437;0.8032813;0.556730544719447;0.5630285686659878;0.9999201345566091;-0.17720237852366538;-0.19663882733615012;-0.44318958983716206;-0.4368915658906213
Snail-like ilia;Hyperphalangy of the 2nd finger;0.9101858884096146;1.0140762;0.5286272953377453;0.49551926541878066;0.8418618639044475;0.06832402450516706;0.17221436900570875;-0.3132345685667022;-0.34634259848566684
Snail-like ilia;Renal interstitial hemosiderin;0.7675339579582214;0.78566164;0.5746794530730616;0.5687595187521359;0.9999201345566091;-0.23238617659838767;-0.21425849677355857;-0.42524068148354754;-0.4311606158044732
Snail-like ilia;Abnormality of depressor anguli oris muscle;0.969979902729392;0.9893251;0.5095571296029502;0.503397992046926;0.8819596887815145;0.08802021394787751;0.10736541736243688;-0.37240255917856435;-0.3785616967345885
Snail-like ilia;Paroxysmal dyspnea;0.9563656263053417;1.0698584;0.5138936637318245;0.47774524652657635;0.9999201345566091;-0.04355450825126739;0.06993829725949197;-0.48602647082478456;-0.5221748880300328
Snail-like ilia;Phenylpyruvic acidemia;0.9567526429891586;1.0679797;0.513770356092066;0.47834469533133095;0.9999600672783046;-0.043207424289145924;0.06801962613447621;-0.48618971118623855;-0.5216153719469736
Snail-like ilia;Lateral ventricle dilatation;0.940896961838007;1.0263538;0.5188240514825987;0.4916103462665291;0.9999488789551968;-0.05905191711718982;0.026404957104373517;-0.4811248274725981;-0.5083385326886677
Snail-like ilia;Neonatal unconjugated hyperbilirubinemia;0.8953781574964523;1.1912192;0.5333632207403356;0.43875586396993516;0.9999600672783046;-0.10458190978185222;0.19125914334639027;-0.46659684653796896;-0.5612042033083694
Snail-like ilia;High maternal circulating alpha-fetoprotein concentration;1.0070945415645838;1.0776994;0.49774171833761316;0.4752425328406603;0.9999201345566091;0.00717440700797467;0.0777792882796946;-0.502178416218996;-0.5246776017159488
Snail-like ilia;Prominent nasolabial fold;1.0152476439252496;1.0285698;0.4951463361132844;0.49090472482225167;0.9999545338528789;0.015293110072370664;0.028615283690150872;-0.5048081977395945;-0.5090498090306272
Snail-like ilia;Abnormality of inferior alveolar nerve;0.7612650990486145;0.97364724;0.5767326956931678;0.5083893257467622;0.9999201345566091;-0.2386550355079946;-0.026272897732573464;-0.42318743886344135;-0.4915308088098469
Snail-like ilia;Unilateral conductive hearing impairment;0.8231795579195023;1.0305669;0.5565811890336161;0.49026872914865827;0.9999600672783046;-0.1767805093588023;0.03060686349256947;-0.44337887824468847;-0.5096913381296463
Snail-like ilia;Macular hypopigmented whorls, streaks, and patches;0.9115145355463028;0.88489354;0.5282026830785932;0.5367209207352703;0.9999600672783046;-0.08844553173200176;-0.11506653071061657;-0.47175738419971136;-0.4632391465430342
Snail-like ilia;Delayed ossification of pubic rami;0.988316249102354;1.0114281;0.503719138038313;0.49636223202364993;0.6462043805334825;0.34211186856887155;0.3652237372185927;-0.14248524249516947;-0.14984214850983257
Snail-like ilia;Hyperphenylalaninemia;0.9497710131108761;1.0711237;0.5159951137289313;0.47734147673917304;0.9999561589935034;-0.05018514588262735;0.07116756022188964;-0.4839610452645722;-0.5226146822543304
Snail-like ilia;Ureteropelvic junction obstruction;0.8079982697963715;0.92776626;0.5614979221450294;0.5230127568148843;0.9999528219730685;-0.191954552176697;-0.07218655848811362;-0.4384548998280391;-0.4769400651581841
Snail-like ilia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8222823888063431;0.9736493;0.5568713624845796;0.5083886442698858;0.683723727808895;0.13855866099744807;0.2899255951777078;-0.12685236532431543;-0.17533508353900917
Snail-like ilia;Difficulty walking;0.9526012316346169;0.97049326;0.5150931516531074;0.5093936431174158;0.9203691460904122;0.03223208554420465;0.050124110955333645;-0.4052759944373048;-0.41097550297299645
Snail-like ilia;Bilobate gallbladder;0.905035950243473;0.9670229;0.5302736147807392;0.5104988500687078;0.9999584729108851;-0.09492252266741208;-0.03293557709789685;-0.46968485813014593;-0.48945962284217737
Snail-like ilia;Histidinuria;0.7948937118053436;0.84003127;0.5657540062644163;0.5511393316338646;0.9999574798349273;-0.2050637680295837;-0.15992621362246395;-0.43420347357051103;-0.4488181482010627
Snail-like ilia;Widened interpedicular distance;0.9434674419462681;1.0959198;0.5180044709899423;0.4694207453498591;0.822027235707794;0.12144020623847407;0.2738926117806093;-0.3040227647178517;-0.3526064903579349
Indurated nodule;Absent leukocyte alkaline phosphatase;0.8437569886445999;0.9812143;0.5499382997013923;0.5059800394951333;0.9999201345566091;-0.1561631459120092;-0.018705849659758522;-0.4499818348552168;-0.49394009506147585
Indurated nodule;Hippocampal sclerosis;0.8531073778867722;1.0455292;0.5469271785846586;0.4855025791908215;1.0;-0.14689262211322784;0.04552924633026123;-0.45307282141534144;-0.5144974208091785
Indurated nodule;Decreased sensitivity to hypoxemia;0.8788788393139839;1.0794927;0.5386489575182865;0.4746699616800655;0.9999201345566091;-0.12104129524262519;0.079572553622407;-0.46127117703832266;-0.5252501728765436
Indurated nodule;Decreased level of tissue plasminogen activator;0.8722029626369476;1.0385256;0.5407906111770755;0.4877338922236517;1.0;-0.12779703736305237;0.03852558135986328;-0.4592093888229245;-0.5122661077763483
Indurated nodule;Submandibular lymph node enlargement;0.49106109142303467;0.44590002;0.6699620932906809;0.6869374765946775;0.9999201345566091;-0.5088590431335744;-0.5540201115730581;-0.3299580412659282;-0.3129826579619316
Indurated nodule;Hepatic hemangioma;0.6933757662773132;0.7560409;0.599199491189573;0.5784462719520107;0.9999134918687169;-0.3065377255914037;-0.24387262072537585;-0.40071400067914387;-0.4214672199167062
Indurated nodule;Triangular epiphysis of the distal phalanx of the 2nd finger;0.830639660358429;0.9417361;0.5541701663591688;0.5185564813409005;1.0;-0.16936033964157104;-0.05826389789581299;-0.4458298336408312;-0.4814435186590995
Indurated nodule;Acne inversa;0.5554042756557465;0.49147528;0.6466526457180721;0.6698089537970642;0.593209551425613;-0.037805275769866586;-0.10173426732603419;0.05344309429245908;0.07659940237145113
Indurated nodule;Dentin dysplasia;0.7872013449668884;0.8308468;0.5682578399881697;0.5541032660796634;1.0;-0.21279865503311157;-0.16915321350097656;-0.4317421600118303;-0.4458967339203366
Indurated nodule;Aplasia of the inner ear;0.7441595792770386;1.0574951;0.5823521651332657;0.4816886472188615;0.9999201345566091;-0.25576055527957053;0.05757498263089089;-0.4175679694233434;-0.5182314873377476
Indurated nodule;Polycystic liver disease;0.8220479488372803;1.004226;0.5569471958011527;0.49865482166263797;0.9999056439461368;-0.17785769510885652;0.004320325368438405;-0.4429584481449841;-0.5012508222834988
Indurated nodule;Subungual hyperkeratosis;0.7397900819778442;0.6946955;0.5837917683226498;0.5987582551651864;0.5720432123760241;0.16774686960182017;0.12265226034126109;0.011748555946625716;0.02671504278916237
Indurated nodule;Broad humeral epiphyses;0.858417734503746;1.014063;0.5452189749129691;0.49552344695194983;1.0;-0.14158226549625397;0.014063000679016113;-0.4547810250870309;-0.5044765530480502
Indurated nodule;Autoimmune thrombocytopenia;0.7671818882226944;1.0074916;0.5747946819526315;0.4976153410608224;0.9998726169824932;-0.2326907287597988;0.007618971610036107;-0.4250779350298617;-0.5022572759216708
Indurated nodule;Adenomyosis;0.7886233776807785;0.894522;0.5677946557306356;0.5336372568089182;0.9999201345566091;-0.2112967568758306;-0.1053981232765493;-0.4321254788259735;-0.46628287774769095
Indurated nodule;Elevated leukocyte alkaline phosphatase;0.7905792891979218;0.9899057;0.5671578143738123;0.503213171211272;0.9999201345566091;-0.20934084535868736;-0.010014419567900612;-0.4327623201827968;-0.49670696334533715
Indurated nodule;Clasp-knife sign;0.952184159308672;0.922682;0.5152260606002217;0.5246356728044151;1.0;-0.04781584069132805;-0.07731801271438599;-0.4847739393997783;-0.47536432719558486
Indurated nodule;Keratosis pilaris;0.9053367599844933;0.75027895;0.5301774307606821;0.5803389173085132;0.44638369298437486;0.4589530670001184;0.30389525675317397;0.08379373777630728;0.1339552243241383
Indurated nodule;Lamina lucida cleavage;0.8695479333400726;0.9124916;0.5416428682857115;0.5278904539687113;0.55432226759585;0.3152256657442226;0.35816935199109456;-0.012679399310138506;-0.026431813627138756
Indurated nodule;Abnormal central response of multifocal electroretinogram;0.7777233421802521;1.007397;0.5713488185711082;0.49764540480550346;1.0;-0.22227665781974792;0.007397055625915527;-0.4286511814288918;-0.5023545951944965
Indurated nodule;Atypical or prolonged hepatitis;0.7397883534431458;0.9536073;0.5837923381622612;0.5147725460398896;0.9999201345566091;-0.26013178111346336;-0.04631281377108665;-0.41612779639434794;-0.48514758851671946
Indurated nodule;Cubitus varus;0.8934762105345726;1.0193664;0.5339720316508011;0.49383511392438906;1.0;-0.1065237894654274;0.01936638355255127;-0.4660279683491989;-0.5061648860756109
Indurated nodule;Nasal regurgitation;0.7609845101833344;0.90804064;0.576824672609531;0.5293129767647795;0.9999134918687169;-0.23892898168538257;-0.09187284913037463;-0.42308881925918596;-0.4706005151039374
Indurated nodule;Moon facies;0.9796857088804245;0.9618681;0.506466684514431;0.5121406970658677;0.9999134918687169;-0.02022778298829242;-0.038045384549838746;-0.4934468073542859;-0.4877727948028492
Indurated nodule;Intestinal pseudo-obstruction;0.6792141199111938;0.8111111;0.6039469901782801;0.5604886067337267;0.9998912449978579;-0.320677125086664;-0.18878015243041402;-0.39594425481957773;-0.4394026382641312
Indurated nodule;Bilateral renal atrophy;0.7838758379220963;1.0121859;0.5693415987391927;0.49612100784349156;0.9999201345566091;-0.21604429663451286;0.012265796649140404;-0.43057853581741645;-0.5037991267131176
Indurated nodule;Fractured left clavicle;0.8723042607307434;0.99765253;0.5407581006290915;0.5007472318303019;1.0;-0.1276957392692566;-0.0023474693298339844;-0.45924189937090854;-0.4992527681696981
Indurated nodule;Positive urine norcotinine test;0.6805880665779114;0.9158457;0.6034853602599819;0.5268188716287925;1.0;-0.3194119334220886;-0.08415430784225464;-0.3965146397400181;-0.4731811283712075
Indurated nodule;Long fibula;0.8516705930233002;1.042418;0.5473895869088755;0.4864938803421561;0.9999056439461368;-0.14823505092283662;0.0425123591361386;-0.4525160570372613;-0.5134117636039807
Indurated nodule;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8351712673902512;0.98835826;0.5527071408076393;0.5037057589696565;1.0;-0.16482873260974884;-0.011641740798950195;-0.4472928591923607;-0.4962942410303435
Indurated nodule;Type II cryptotia;0.8742336928844452;0.8835594;0.5401389510689727;0.5371484675035902;1.0;-0.1257663071155548;-0.11644059419631958;-0.4598610489310273;-0.46285153249640976
Indurated nodule;Increased variability in muscle fiber diameter;0.767568439245224;0.9523743;0.5746681682312871;0.5151654696904615;0.9998452077479463;-0.23227676850272228;-0.04747092824889232;-0.4251770395166592;-0.48467973805748477
Indurated nodule;Widened proximal tibial metaphyses;0.8253306746482849;1.0313059;0.5558856414837634;0.49003338525621765;0.9999201345566091;-0.1745894599083242;0.03138577460019021;-0.4440344930728457;-0.5098867493003915
Indurated nodule;Wide anterior fontanel;0.867325559258461;1.0440705;0.5423564749100157;0.4859673991761049;0.999848231156753;-0.13252267189829203;0.04422225109727529;-0.4574917562467373;-0.5138808319806482
Indurated nodule;Increased circulating oleate level;0.7859441190958023;1.036462;0.568667465646577;0.48839121121141593;1.0;-0.2140558809041977;0.03646194934844971;-0.431332534353423;-0.5116087887885841
Indurated nodule;Lozenge-shaped umbilicus;0.7564017474651337;0.87282825;0.5783278329954876;0.5405899402044327;0.9999134918687169;-0.24351174440358325;-0.12708524670575305;-0.4215856588732293;-0.4593235516642842
Indurated nodule;Anti-myelin-associated glycoprotein antibody positivity;0.6644163131713867;0.7637236;0.6089335307759612;0.5759270746086124;1.0;-0.3355836868286133;-0.23627638816833496;-0.39106646922403876;-0.42407292539138763
Indurated nodule;Fractured radius;0.7929543256759644;0.96861875;0.5663848730867832;0.5099905985945046;0.9999201345566091;-0.20696580888064475;-0.03130138398440452;-0.4335352614698259;-0.48992953596210453
Indurated nodule;Abnormal manual kinetic perimetry test;0.8551246076822281;1.0866605;0.546278130570117;0.4723804745082282;1.0;-0.1448753923177719;0.08666050434112549;-0.453721869429883;-0.5276195254917718
Indurated nodule;Small radial epiphyses;0.8813018947839737;0.9928606;0.5378720694126895;0.5022725578307885;1.0;-0.1186981052160263;-0.007139384746551514;-0.4621279305873105;-0.4977274421692115
Indurated nodule;Generalized keratosis follicularis;0.7240377068519592;0.6164564;0.5889964930725176;0.6252964094173417;0.656988850480855;0.06704885637110425;-0.04053246105366992;-0.06799235740833742;-0.03169244106351332
Indurated nodule;Hypoplasia of the calcaneus;0.9260581731796265;0.99971133;0.5235579145596826;0.500091877458906;0.9999134918687169;-0.07385531868909045;-0.00020215716336413614;-0.47635557730903433;-0.4998216144098109
Indurated nodule;2-hydroxyadipic aciduria;0.832467183470726;1.0596735;0.5535800147916499;0.48099402620232334;1.0;-0.167532816529274;0.05967354774475098;-0.44641998520835013;-0.5190059737976767
Indurated nodule;Potter facies;0.8819064199924469;0.8280045;0.5376782800372581;0.5550214571344168;0.9998981869165328;-0.11799176692408586;-0.1718937075082686;-0.4622199068792746;-0.444876729782116
Indurated nodule;Increased heart rate variability;0.7327433228492737;0.99967134;0.5861171564032837;0.5001046169184675;0.9999201345566091;-0.2671768117073354;-0.00024879456790061205;-0.41380297815332545;-0.4998155176381416
Indurated nodule;Aplastic zygomatic arch;0.9294382929801941;1.038516;0.5224791691062973;0.4877369218112727;0.9999134918687169;-0.07047519888852283;0.0386025527479823;-0.4774343227624196;-0.5121765700574442
Indurated nodule;Testicular torsion;0.7936847507953644;0.9727239;0.5661472407036933;0.5086833359380651;0.9999201345566091;-0.20623538376124473;-0.02719623328478904;-0.43377289385291584;-0.49123679861854397
Indurated nodule;Abolished vibration sense;0.8455407023429871;0.9425377;0.5493635480330996;0.5183008993017189;0.9999134918687169;-0.15437278952572986;-0.05737576689694568;-0.4505499438356173;-0.48161259256699807
Indurated nodule;Fractured metatarsal bone of digit 5;0.9484166391193867;0.9853646;0.5164267840797307;0.5046587519860726;1.0;-0.05158336088061333;-0.01463538408279419;-0.48357321592026925;-0.4953412480139274
Indurated nodule;Prolonged G2 phase of cell cycle;0.8343922197818756;0.96694785;0.5529585748204662;0.5105227379221167;0.9999056439461368;-0.16551342416426118;-0.032957790380920726;-0.4469470691256706;-0.4893829060240201
Indurated nodule;Single naris;0.8753388971090317;0.8620308;0.5397843629373232;0.544057496430314;0.9999056439461368;-0.12456674683710511;-0.1378748397888797;-0.46012128100881355;-0.4558481475158228
Indurated nodule;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7398823499679565;0.9255334;0.5837613510761417;0.5237254028998268;1.0;-0.26011765003204346;-0.07446658611297607;-0.4162386489238583;-0.47627459710017317
Indurated nodule;Asymmetry of the thorax;0.7258397936820984;0.84897244;0.5883998566825954;0.5482582214591711;0.9999056439461368;-0.2740658502640384;-0.15093320418020661;-0.41150578726354137;-0.45164742248696566
Indurated nodule;Type 2 muscle fiber predominance;0.8843653947114944;0.94126105;0.5368901636265437;0.5187079595033048;0.9999003561294039;-0.11553496141790942;-0.05863930304407672;-0.46301019250286013;-0.48119239662609903
Indurated nodule;Dependency on parenteral nutrition;0.9232003167271614;1.0703993;0.52447019374429;0.4775726629008372;0.9999134918687169;-0.07671317514155551;0.07048579249407605;-0.47544329812442687;-0.5223408289678797
Indurated nodule;Limited shoulder flexion;0.7952158749103546;0.96887213;0.5656492346218727;0.5099099006833958;1.0;-0.20478412508964539;-0.031127870082855225;-0.43435076537812733;-0.4900900993166042
Indurated nodule;Paroxysmal vertigo;0.7468037903308868;0.9717584;0.581481824188788;0.508990774989255;0.9999134918687169;-0.2531097015378301;-0.02815506663296863;-0.4184316676799289;-0.4909227168794619
Indurated nodule;Long hallux;0.8292903900146484;0.9948957;0.5546059990689212;0.5016247590555489;0.9998836012415208;-0.17059321122687232;-0.00498790460150611;-0.4452776021725996;-0.49825884218597183
Indurated nodule;Broad medial eyebrow;0.8824682161211967;0.8474283;0.5374982006707661;0.5487554874426308;0.746656756368989;0.13581145975220776;0.10077156546938992;-0.20915855569822284;-0.19790126892635818
Indurated nodule;Myxoid subcutaneous tumors;0.6164886951446533;0.3616233;0.625285284983202;0.7203937849328531;0.6869180368823609;-0.07042934173770754;-0.3252947496814331;-0.061632751899158844;0.03347574805049225
Indurated nodule;Bulbous tips of toes;0.8245377242565155;0.98944116;0.5561420045223915;0.5033610390558365;0.9999134918687169;-0.17537576761220142;-0.010472335481387818;-0.44377148734632543;-0.4965524528128804
Indurated nodule;Absent internal genitalia;0.8092692494392395;0.7915339;0.561085739049386;0.5668470981069496;1.0;-0.1907307505607605;-0.20846611261367798;-0.43891426095061403;-0.43315290189305045
Indurated nodule;Hyperphalangy of the 2nd finger;0.8142320513725281;0.9542042;0.5594772708915798;0.5145823590917002;0.9999201345566091;-0.18568808318408103;-0.045715932858305885;-0.44044286366502927;-0.48533777546490886
Indurated nodule;Renal interstitial hemosiderin;0.6591827571392059;0.7441188;0.6107037374139248;0.5823655893356161;1.0;-0.34081724286079407;-0.2558811902999878;-0.3892962625860752;-0.4176344106643839
Indurated nodule;Abnormality of depressor anguli oris muscle;0.7233571708202362;0.8866619;0.5892218889273135;0.5361543265724191;1.0;-0.2766428291797638;-0.11333811283111572;-0.41077811107268647;-0.4638456734275809
Indurated nodule;Paroxysmal dyspnea;0.6788107752799988;0.85959065;0.6040825522451364;0.5448418570831304;1.0;-0.3211892247200012;-0.14040935039520264;-0.3959174477548636;-0.4551581429168696
Indurated nodule;Phenylpyruvic acidemia;0.8554875999689102;1.1007427;0.5461613576723876;0.46787811163033854;0.9999201345566091;-0.1444325345876989;0.10082256315915017;-0.4537587768842215;-0.5320420229262706
Indurated nodule;Lateral ventricle dilatation;0.7935483306646347;1.0758561;0.5661916200137975;0.4758310307187499;0.9998579617208769;-0.20630963105624223;0.07599812787110305;-0.4336663417070794;-0.524026931002127
Indurated nodule;Neonatal unconjugated hyperbilirubinemia;0.7398281097412109;1.0809499;0.5837792319207517;0.47420463040589234;0.9999201345566091;-0.26009202481539817;0.08102976797787576;-0.41614090263585746;-0.5257155041507168
Indurated nodule;High maternal circulating alpha-fetoprotein concentration;0.8915871605277061;0.99815744;0.5345768377656615;0.500586497173654;1.0;-0.10841283947229385;-0.0018425583839416504;-0.46542316223433855;-0.499413502826346
Indurated nodule;Prominent nasolabial fold;0.7571807205677032;0.7851091;0.5780722025806084;0.568939596905127;0.9998944404568447;-0.24271371988914148;-0.21478533773086206;-0.4218222378762363;-0.43095484355171776
Indurated nodule;Abnormality of inferior alveolar nerve;0.6684787273406982;0.80837876;0.6075618698917293;0.5613745230516904;1.0;-0.33152127265930176;-0.19162124395370483;-0.39243813010827067;-0.43862547694830956
Indurated nodule;Unilateral conductive hearing impairment;0.6945916414260864;1.007103;0.5987929634232465;0.4977390502277421;0.9999201345566091;-0.3053284931305227;0.007182831751984642;-0.4011271711333626;-0.502181084328867
Indurated nodule;Macular hypopigmented whorls, streaks, and patches;0.7667377293109894;0.76297003;0.574940064941345;0.5761739551629159;0.41730404449774616;0.3494336848132432;0.3456659858100236;0.1576360204435988;0.15886991066516976
Indurated nodule;Delayed ossification of pubic rami;0.8089248389005661;0.94892436;0.5611974223056684;0.5162649608932777;0.9999134918687169;-0.19098865296815082;-0.050989129209262574;-0.43871606956304854;-0.48364853097543925
Indurated nodule;Hyperphenylalaninemia;0.8024948090314865;1.0967745;0.5632839287346869;0.46914744500594374;0.9999028053808913;-0.19740799634940476;0.0968716535043016;-0.43661887664620436;-0.5307553603749475
Indurated nodule;Ureteropelvic junction obstruction;0.7989674508571625;1.0645683;0.5644297010252879;0.4794329580948544;0.9998847295244674;-0.2009172786673049;0.06468355164923867;-0.4354550284991795;-0.520451771429613
Indurated nodule;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8887111991643906;0.99681157;0.5354978589722323;0.5010149020185184;1.0;-0.11128880083560944;-0.0031884312629699707;-0.46450214102776766;-0.4989850979814816
Indurated nodule;Difficulty walking;0.8471289575099945;1.0409806;0.5488519139631094;0.48695182785645397;0.9998344221996177;-0.1527054646896232;0.04114615526925436;-0.4509825082365083;-0.5128825943431637
Indurated nodule;Bilobate gallbladder;0.7516461610794067;0.95148057;0.5798895678545204;0.5154502858568588;0.9999134918687169;-0.24826733078931018;-0.04843292441342517;-0.4200239240141965;-0.4844632060118581
Indurated nodule;Histidinuria;0.7253400087356567;0.93515944;0.5885652938507361;0.520653889035944;0.9999090677057578;-0.2745690589701011;-0.06474962289679786;-0.41134377385502174;-0.4792551786698138
Indurated nodule;Widened interpedicular distance;0.7761619687080383;1.038164;0.5718586646512609;0.487849065614011;1.0;-0.22383803129196167;0.03816401958465576;-0.4281413353487391;-0.512150934385989
Absent leukocyte alkaline phosphatase;Hippocampal sclerosis;0.7847807854413986;0.90866846;0.5690466025255342;0.5291122970331882;0.9999201345566091;-0.2151393491152105;-0.09125167609484763;-0.4308735320310749;-0.4708078375234209
Absent leukocyte alkaline phosphatase;Decreased sensitivity to hypoxemia;0.8303377777338028;0.98674625;0.5542676696266677;0.5042189318642638;0.9999600672783046;-0.16962228954450176;-0.013213815695205189;-0.4456923976516368;-0.49574113541404075
Absent leukocyte alkaline phosphatase;Decreased level of tissue plasminogen activator;0.6450208127498627;0.91896933;0.6155120490052572;0.5258211719170287;0.9999201345566091;-0.35489932180674644;-0.08095080138476463;-0.38440808555135186;-0.4740989626395804
Absent leukocyte alkaline phosphatase;Submandibular lymph node enlargement;0.8276688903570175;0.98438114;0.5551299024506009;0.5049718319332183;0.9999600672783046;-0.17229117692128704;-0.015578927999892689;-0.44483016482770366;-0.4949882353450863
Absent leukocyte alkaline phosphatase;Hepatic hemangioma;0.7381248474121094;0.9715187;0.584340867789346;0.5090671093442677;0.9999584729108851;-0.26183362549877576;-0.028439777556423462;-0.4156176051215391;-0.49089136356661744
Absent leukocyte alkaline phosphatase;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8029423654079437;0.8235537;0.5631386111734737;0.5564602091230066;0.9999201345566091;-0.19697776914866538;-0.17636645318301292;-0.43678152338313536;-0.44345992543360246
Absent leukocyte alkaline phosphatase;Acne inversa;0.9037833958864212;0.9479476;0.5306741493867003;0.5165762743503389;0.9999548690865008;-0.09617147320007957;-0.052007247740980755;-0.46928071969980045;-0.48337859473616185
Absent leukocyte alkaline phosphatase;Dentin dysplasia;0.8250098526477814;0.77946925;0.5559893596959609;0.5707789447384783;0.9999201345566091;-0.17491028190882774;-0.22045088292391868;-0.44393077486064825;-0.42914118981813076
Absent leukocyte alkaline phosphatase;Aplasia of the inner ear;0.727370023727417;1.0011467;0.5878934771312829;0.499635009166427;0.9999600672783046;-0.27259004355088756;0.0011866068778844108;-0.4120665901470216;-0.5003250581118776
Absent leukocyte alkaline phosphatase;Polycystic liver disease;0.7135554552078247;1.0278262;0.5924734185165698;0.4911414951116465;0.9999567459343585;-0.28640129072653375;0.027869444060453552;-0.4074833274177887;-0.508815250822712
Absent leukocyte alkaline phosphatase;Subungual hyperkeratosis;0.7800000011920929;0.82592964;0.5706057384687673;0.555692008439689;0.9999556674707869;-0.219955666278694;-0.1740260257471541;-0.4293499290020196;-0.4442636590310979
Absent leukocyte alkaline phosphatase;Broad humeral epiphyses;0.7562124133110046;0.92860305;0.5783899733072524;0.5227456969810941;0.9999201345566091;-0.24370772124560447;-0.07131708146365257;-0.4215301612493567;-0.47717443757551503
Absent leukocyte alkaline phosphatase;Autoimmune thrombocytopenia;0.5846390128135681;0.84222436;0.6363447312261209;0.550432272702764;0.9999509115718902;-0.4153118987583221;-0.1577265520595611;-0.3636061803457693;-0.44951863886912624
Absent leukocyte alkaline phosphatase;Adenomyosis;0.805850476026535;1.0402602;0.5621946968864225;0.4871813242760268;0.9999600672783046;-0.19410959125176952;0.040300128453812145;-0.437765370391882;-0.5127787430022778
Absent leukocyte alkaline phosphatase;Elevated leukocyte alkaline phosphatase;0.2757915258407593;0.10697281;0.7577946776993327;0.8514230099833168;0.493452701440124;-0.2176611755993647;-0.3864798878338618;0.26434197625920874;0.3579703085431928
Absent leukocyte alkaline phosphatase;Clasp-knife sign;0.8633023798465729;0.93107444;0.5436488694981725;0.5219570910928626;0.9999201345566091;-0.13661775471003623;-0.06884569407733054;-0.4562712650584366;-0.4779630434637465
Absent leukocyte alkaline phosphatase;Keratosis pilaris;0.6548217236995697;0.7398397;0.6121815488423795;0.5837754199377752;0.9999506876445663;-0.3451289639449966;-0.26011101460226893;-0.3877691388021868;-0.41617526770679114
Absent leukocyte alkaline phosphatase;Lamina lucida cleavage;0.8165843337774277;0.9436164;0.5587154238168484;0.517956978784562;0.9999548690865008;-0.1833705353090731;-0.05633847885822929;-0.4412394452696524;-0.48199789030193874
Absent leukocyte alkaline phosphatase;Abnormal central response of multifocal electroretinogram;0.8713848888874054;1.0717255;0.541053178974609;0.47714944691780437;0.9999201345566091;-0.1285352456692037;0.0718053531524363;-0.4588669555820001;-0.5227706876388047
Absent leukocyte alkaline phosphatase;Atypical or prolonged hepatitis;0.723772257566452;0.89132345;0.589084405323528;0.5346612816187454;0.9999600672783046;-0.2761878097118525;-0.10863662005082653;-0.41087566195477654;-0.4652987856595592
Absent leukocyte alkaline phosphatase;Cubitus varus;0.9393470920622349;1.0413747;0.5193182771916175;0.4868262735580361;0.9999201345566091;-0.06057304249437423;0.041454548823517845;-0.4806018573649916;-0.513093860998573
Absent leukocyte alkaline phosphatase;Nasal regurgitation;0.8910980671644211;1.0225477;0.5347334482703832;0.4928222455417125;0.9999584729108851;-0.10886040574646405;0.022589248951907837;-0.46522502464050197;-0.5071362273691726
Absent leukocyte alkaline phosphatase;Moon facies;0.9880856713280082;0.9893856;0.503792538333059;0.5033787368780334;0.9999584729108851;-0.011872801582876957;-0.010572868052486695;-0.4961659345778261;-0.49657973603285177
Absent leukocyte alkaline phosphatase;Intestinal pseudo-obstruction;0.8044186383485794;1.0343994;0.562659372865544;0.4890481710007911;0.9999539510871024;-0.19553531273852298;0.0344454391335397;-0.43729457822155837;-0.5109057800863113
Absent leukocyte alkaline phosphatase;Bilateral renal atrophy;0.707291305065155;0.72736734;0.5945566190378467;0.587894364520491;0.9999600672783046;-0.2926687622131495;-0.27259272575990245;-0.4054034482404578;-0.4120657027578135
Absent leukocyte alkaline phosphatase;Fractured left clavicle;0.7805580049753189;0.95974976;0.5704236711203421;0.5128155177591214;0.9999201345566091;-0.2193621295812902;-0.04017037631304832;-0.429496463436267;-0.48710461679748773
Absent leukocyte alkaline phosphatase;Positive urine norcotinine test;0.8370014131069183;0.91064525;0.5521165999942752;0.528480482067854;0.726290173501319;0.11071123960559937;0.18435507300441834;-0.17417357350704377;-0.19780969143346494
Absent leukocyte alkaline phosphatase;Long fibula;0.7958149611949921;0.8038102;0.5654544231225405;0.5628568825677518;0.9999567459343585;-0.2041417847393664;-0.19614656670080743;-0.434502322811818;-0.43709986336660667
Absent leukocyte alkaline phosphatase;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6893024444580078;0.7414186;0.6005626302525975;0.5832550226419102;0.9999201345566091;-0.3106176900986013;-0.25850153447421165;-0.3993575043040116;-0.4166651119146989
Absent leukocyte alkaline phosphatase;Type II cryptotia;0.843146800994873;0.91031253;0.5501349531370192;0.5285868148800611;0.9999201345566091;-0.15677333356173606;-0.08960760117800803;-0.4497851814195899;-0.471333319676548
Absent leukocyte alkaline phosphatase;Increased variability in muscle fiber diameter;0.934155136346817;1.0483565;0.520974245515577;0.48460161335288865;0.9999473166570552;-0.06579218031023815;0.048409216393481946;-0.47897307114147814;-0.5153457033041665
Absent leukocyte alkaline phosphatase;Widened proximal tibial metaphyses;0.7473282814025879;0.75836265;0.5813092623951852;0.5776844246604891;0.9999600672783046;-0.25263178587571666;-0.2415974164070277;-0.41865080488311934;-0.42227564261781547
Absent leukocyte alkaline phosphatase;Wide anterior fontanel;0.8186931014060974;1.0713009;0.5580327344773817;0.4772849438344625;0.9999476714516888;-0.18125457004559142;0.07135319276797669;-0.44191493697430717;-0.5226627276172263
Absent leukocyte alkaline phosphatase;Increased circulating oleate level;0.7887884676456451;0.8803045;0.5677408921165485;0.5381918200281226;0.726290173501319;0.06249829414432617;0.15401434186046692;-0.15854928138477042;-0.18809835347319637
Absent leukocyte alkaline phosphatase;Lozenge-shaped umbilicus;0.8372355997562408;1.0240934;0.5520410471079561;0.4923300890078304;0.9999584729108851;-0.1627228731546443;0.024134916600223266;-0.44791742580292904;-0.5076283839030548
Absent leukocyte alkaline phosphatase;Anti-myelin-associated glycoprotein antibody positivity;0.6747622489929199;0.913527;0.6054443315531819;0.5275596361218979;0.9999201345566091;-0.3251578855636892;-0.08639312268527122;-0.3944758030034272;-0.4723604984347112
Absent leukocyte alkaline phosphatase;Fractured radius;0.8367934674024582;0.9007292;0.5521836895562228;0.5316510146902619;0.9999600672783046;-0.16316659987584636;-0.09923088789598034;-0.4477763777220818;-0.4683090525880427
Absent leukocyte alkaline phosphatase;Abnormal manual kinetic perimetry test;0.7622395157814026;1.0221926;0.576413332965424;0.49293530753698966;0.9999201345566091;-0.23768061877520652;0.022272462832612083;-0.42350680159118514;-0.5069848270196194
Absent leukocyte alkaline phosphatase;Small radial epiphyses;0.830270305275917;0.86716807;0.5542894628559353;0.5424070533157208;0.9999201345566091;-0.16964982928069205;-0.13275206567080589;-0.44563067170067383;-0.4575130812408883
Absent leukocyte alkaline phosphatase;Generalized keratosis follicularis;0.7511225491762161;0.8196126;0.5800616414304947;0.5577351444753464;0.9999600672783046;-0.24883751810208843;-0.1803474450172572;-0.4198984258478099;-0.4422249228029581
Absent leukocyte alkaline phosphatase;Hypoplasia of the calcaneus;0.7087264955043793;0.68325776;0.5940789681465378;0.6025890188950809;0.9999584729108851;-0.29123197740650586;-0.316700714293484;-0.4058795047643473;-0.39736945401580426
Absent leukocyte alkaline phosphatase;2-hydroxyadipic aciduria;0.7582872807979584;0.7358781;0.577709158361337;0.585082111829109;0.726290173501319;0.031997107296639404;0.009587936430626831;-0.148581015139982;-0.14120806167221
Absent leukocyte alkaline phosphatase;Potter facies;0.8402690887451172;0.8899996;0.5510626538841656;0.5350851960649106;0.9999552432134126;-0.15968615446829537;-0.10995561514639596;-0.4488925893292469;-0.464870047148502
Absent leukocyte alkaline phosphatase;Increased heart rate variability;0.9246400147676468;1.0542887;0.5240105915328144;0.48271086318113476;0.9999600672783046;-0.07532005251065776;0.05432867764814808;-0.4759494757454902;-0.5172492040971698
Absent leukocyte alkaline phosphatase;Aplastic zygomatic arch;0.6982994377613068;0.8785298;0.5975542861055774;0.5387608931584256;0.9999584729108851;-0.30165903514957837;-0.1214286858472865;-0.40240418680530776;-0.46119757975245956
Absent leukocyte alkaline phosphatase;Testicular torsion;0.9247772246599197;1.0698861;0.5239667919457744;0.4777364097160377;0.9999600672783046;-0.07518284261838482;0.0699260210929723;-0.4759932753325301;-0.5222236575622669
Absent leukocyte alkaline phosphatase;Abolished vibration sense;0.7950844466686249;1.0920352;0.5656919759278408;0.4706627680675298;0.9999584729108851;-0.20487402624226025;0.09207670145892688;-0.4342664969830443;-0.5292957048433553
Absent leukocyte alkaline phosphatase;Fractured metatarsal bone of digit 5;0.8070572167634964;0.7727579;0.5618031761542943;0.5729708849637456;0.9999201345566091;-0.1928629177931127;-0.2271622467163381;-0.4381169584023148;-0.4269492495928635
Absent leukocyte alkaline phosphatase;Prolonged G2 phase of cell cycle;0.8531379848718643;0.97429824;0.5469173292599994;0.5081820292385522;0.851762385589393;0.0013755992824713292;0.12253585316487947;-0.3048450563293936;-0.34358035635084083
Absent leukocyte alkaline phosphatase;Single naris;0.8522852957248688;0.9166379;0.5471917415054592;0.5265658156205568;0.9999567459343585;-0.14767145020948969;-0.08331884844290338;-0.4527650044288992;-0.47339093031380164
Absent leukocyte alkaline phosphatase;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7357573509216309;1.0025809;0.5851219763791269;0.4991784642903009;0.9999201345566091;-0.26416278363497825;0.002660746562165306;-0.4147981581774822;-0.5007416702663082
Absent leukocyte alkaline phosphatase;Asymmetry of the thorax;0.7588741183280945;1.0373824;0.5775166684933042;0.4880980459924681;0.9999567459343585;-0.24108262760626398;0.03742561833871283;-0.4224400774410543;-0.5118586999418904
Absent leukocyte alkaline phosphatase;Type 2 muscle fiber predominance;0.8879729062318802;0.93046504;0.5357343437273927;0.5221515349959762;0.9999556674707869;-0.11198276123890671;-0.06949062487969193;-0.4642213237433942;-0.4778041324748107
Absent leukocyte alkaline phosphatase;Dependency on parenteral nutrition;0.8300936967134476;0.86164063;0.5543465076579592;0.5441828946915298;0.9999584729108851;-0.16986477619743756;-0.13831784075832776;-0.4456119652529259;-0.4557755782193553
Absent leukocyte alkaline phosphatase;Limited shoulder flexion;0.8123907595872879;1.0844388;0.560073860930584;0.47309026701721;0.9999201345566091;-0.1875293749693212;0.08451866625515847;-0.43984627362602513;-0.5268298675393991
Absent leukocyte alkaline phosphatase;Paroxysmal vertigo;0.8144468367099762;1.0768598;0.5594076929082206;0.47551059410852625;0.9999584729108851;-0.18551163620090894;0.07690135889911243;-0.44055078000266457;-0.5244478788023589
Absent leukocyte alkaline phosphatase;Long hallux;0.7617078721523285;0.83701026;0.5765875681348808;0.5521137347378985;0.9999526340597648;-0.23824476190743626;-0.16294236966309728;-0.423365065924884;-0.44783889932186627
Absent leukocyte alkaline phosphatase;Broad medial eyebrow;0.8733763694763184;0.9938815;0.5404140448429127;0.5019475894561258;0.9999600672783046;-0.1265836978019862;-0.006078543669143177;-0.4595460224353919;-0.4980124778221787
Absent leukocyte alkaline phosphatase;Myxoid subcutaneous tumors;0.950449351221323;0.9328469;0.5157789227814182;0.5213915998303529;0.9999600672783046;-0.04951071605698154;-0.0671131634773402;-0.4841811444968863;-0.4785684674479517
Absent leukocyte alkaline phosphatase;Bulbous tips of toes;0.8770688846707344;0.8866446;0.5392294219343332;0.5361598571966177;0.9999584729108851;-0.12288958824015073;-0.11331387108898572;-0.4607290509765519;-0.4637986157142674
Absent leukocyte alkaline phosphatase;Absent internal genitalia;0.6492909491062164;0.933791;0.6140593886702467;0.5210904058838384;0.9999201345566091;-0.3506291854503927;-0.06612915278704734;-0.38586074588636243;-0.47882972867277074
Absent leukocyte alkaline phosphatase;Hyperphalangy of the 2nd finger;0.7930372655391693;0.8582598;0.5663578880130922;0.5452697649015644;0.9999600672783046;-0.20692280173913524;-0.1417002701820521;-0.4336021792652124;-0.45469030237674013
Absent leukocyte alkaline phosphatase;Renal interstitial hemosiderin;0.8223545551300049;0.81304085;0.5568480198025286;0.5598632121284288;0.9999201345566091;-0.17756557942660423;-0.1868792820099172;-0.4430721147540805;-0.4400569224281803
Absent leukocyte alkaline phosphatase;Abnormality of depressor anguli oris muscle;0.8316929936408997;1.0982441;0.5538299966574646;0.4686774082460933;0.9999201345566091;-0.16822714091570945;0.0983239364501658;-0.44609013789914453;-0.5312427263105158
Absent leukocyte alkaline phosphatase;Paroxysmal dyspnea;0.7562834173440933;0.97528315;0.5783666691104592;0.5078684215051563;0.9999201345566091;-0.24363671721251579;-0.024636988652068093;-0.4215534654461499;-0.4920517130514528
Absent leukocyte alkaline phosphatase;Phenylpyruvic acidemia;0.5881150960922241;0.7609093;0.6351294257628257;0.5768493311547589;0.8631450867506595;-0.27502999065843536;-0.10223576782670929;-0.22801566098783377;-0.2862957555959006
Absent leukocyte alkaline phosphatase;Lateral ventricle dilatation;0.776242583990097;1.0201699;0.5718323362051085;0.49357928757201563;0.9999488789551968;-0.22370629496509975;0.02022097520892674;-0.42811654275008826;-0.5063695913831812
Absent leukocyte alkaline phosphatase;Neonatal unconjugated hyperbilirubinemia;0.6760815382003784;0.8439111;0.6050003511191939;0.549888631531861;0.8631450867506595;-0.18706354855028107;-0.019233975395831604;-0.25814473563146556;-0.3132564552187985
Absent leukocyte alkaline phosphatase;High maternal circulating alpha-fetoprotein concentration;0.6729429960250854;0.8384079;0.6060569145716719;0.5516629039978544;0.9999201345566091;-0.32697713853152366;-0.16151226044924827;-0.39386321998493723;-0.44825723055875466
Absent leukocyte alkaline phosphatase;Prominent nasolabial fold;0.8309971243143082;0.99716985;0.5540547178448278;0.5009008715823304;0.9999545338528789;-0.16895740953857075;-0.0027846815961040106;-0.44589981600805106;-0.4990536622705485
Absent leukocyte alkaline phosphatase;Abnormality of inferior alveolar nerve;0.8153590261936188;0.8690436;0.5591122284111409;0.5418047905140536;0.9999201345566091;-0.18456110836299033;-0.13087654591830344;-0.44080790614546816;-0.4581153440425555
Absent leukocyte alkaline phosphatase;Unilateral conductive hearing impairment;0.7426145076751709;1.0339106;0.5828610160172247;0.4892038537822344;0.9999600672783046;-0.25734555960313366;0.03395056485517933;-0.4170990512610798;-0.5107562134960701
Absent leukocyte alkaline phosphatase;Macular hypopigmented whorls, streaks, and patches;0.887136809527874;1.0292864;0.5360021802189141;0.49067652945754714;0.9999600672783046;-0.11282325775043056;0.029326317304214977;-0.46395788705939045;-0.5092835378207574
Absent leukocyte alkaline phosphatase;Delayed ossification of pubic rami;0.8038226664066315;0.8144872;0.5628528241677804;0.5593946021032783;0.9999584729108851;-0.19613580650425366;-0.1854712540540736;-0.43710564874310476;-0.44056387080760684
Absent leukocyte alkaline phosphatase;Hyperphenylalaninemia;0.5820509791374207;0.87998545;0.6372509342378214;0.5382941329086985;0.8497508587917271;-0.2676998796543064;0.030234592906576152;-0.21249992455390565;-0.31145672588302853
Absent leukocyte alkaline phosphatase;Ureteropelvic junction obstruction;0.796234205365181;0.737882;0.5653181076625081;0.584420970327775;0.9999528219730685;-0.20371861660788748;-0.262070803883774;-0.43463471431056033;-0.4155318516452935
Absent leukocyte alkaline phosphatase;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7653344124555588;0.728068;0.575399506282251;0.5876625923980445;0.9999201345566091;-0.23458572210105033;-0.2718521404388723;-0.4245206282743581;-0.4122575421585646
Absent leukocyte alkaline phosphatase;Difficulty walking;0.8584850430488586;0.96583456;0.5451973320219848;0.510877313605692;0.9999461221900431;-0.14146107914118444;-0.03411156417994177;-0.45474879016805825;-0.4890688085843511
Absent leukocyte alkaline phosphatase;Bilobate gallbladder;0.7894089818000793;0.91832626;0.5675388314463505;0.5260265448781012;0.9999584729108851;-0.2105494911108058;-0.08163221425152234;-0.4324196414645346;-0.47393192803278394
Absent leukocyte alkaline phosphatase;Histidinuria;0.7184840440750122;0.7614273;0.5908372363664824;0.5766795445141146;0.8542775634790427;-0.1357935194040305;-0.09285028019199437;-0.26344032711256027;-0.2775980189649281
Absent leukocyte alkaline phosphatase;Widened interpedicular distance;0.818558394908905;0.96588665;0.5580763360566761;0.5108607146335764;0.9999201345566091;-0.18136173964770408;-0.0340334820869741;-0.44184379849993305;-0.4890594199230327
Hippocampal sclerosis;Decreased sensitivity to hypoxemia;0.7851815819740295;0.9045826;0.5689159695072565;0.5304185726320099;0.9999201345566091;-0.21473855258257957;-0.09533751488955589;-0.43100416504935257;-0.46950156192459924
Hippocampal sclerosis;Decreased level of tissue plasminogen activator;0.8029234707355499;0.9887702;0.5631447458351677;0.5035746288454128;1.0;-0.19707652926445007;-0.01122981309890747;-0.4368552541648323;-0.4964253711545872
Hippocampal sclerosis;Submandibular lymph node enlargement;0.8576337993144989;1.07776;0.5454710628019084;0.4752232218188208;0.9999201345566091;-0.1422863352421102;0.0778398465987864;-0.45444907175470073;-0.5246969127377883
Hippocampal sclerosis;Hepatic hemangioma;0.7120272219181061;0.95365053;0.5929812669977603;0.5147587759851407;0.9999134918687169;-0.28788626995061084;-0.0462629577157323;-0.4069322248709566;-0.48515471588357617
Hippocampal sclerosis;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8466239273548126;0.9637686;0.5490145884683046;0.5115353287592219;1.0;-0.15337607264518738;-0.036231398582458496;-0.45098541153169536;-0.4884646712407781
Hippocampal sclerosis;Acne inversa;0.8877964690327644;1.0658166;0.5357908617669973;0.4790347599867535;0.9998962300503706;-0.11209976101760621;0.06592041080351119;-0.46410536828337334;-0.5208614700636172
Hippocampal sclerosis;Dentin dysplasia;0.7823370695114136;0.98285407;0.569843348004883;0.5054579787208997;1.0;-0.21766293048858643;-0.017145931720733643;-0.430156651995117;-0.4945420212791003
Hippocampal sclerosis;Aplasia of the inner ear;0.7069989442825317;0.80567497;0.5946539475491746;0.5622516419415382;0.9999201345566091;-0.29292119027407737;-0.1942451644066152;-0.40526618700743455;-0.4376684926150709
Hippocampal sclerosis;Polycystic liver disease;0.7556123435497284;1.0616506;0.5785869390349117;0.48036353417389854;0.9999056439461368;-0.2442933003964084;0.06174498986581389;-0.42131870491122514;-0.5195421097722382
Hippocampal sclerosis;Subungual hyperkeratosis;0.7811415493488312;0.9346841;0.5702332953541577;0.5208055086225017;0.9999003561294039;-0.2187588067805727;-0.06521625836252765;-0.4296670607752462;-0.4790948475069021
Hippocampal sclerosis;Broad humeral epiphyses;0.8543384224176407;1.015042;0.5465310641701261;0.49521181531450187;1.0;-0.14566157758235931;0.015041947364807129;-0.4534689358298739;-0.5047881846854981
Hippocampal sclerosis;Autoimmune thrombocytopenia;0.7407348453998566;0.97406757;0.5834803527545989;0.508255469950734;0.9998726169824932;-0.2591377715826366;-0.02580504820350149;-0.4163922642278943;-0.4916171470317592
Hippocampal sclerosis;Adenomyosis;0.8863159939646721;0.9884096;0.5362651464293562;0.5036894330045651;0.9999201345566091;-0.11360414059193702;-0.011510555756407692;-0.4636549881272529;-0.49623070155204396
Hippocampal sclerosis;Elevated leukocyte alkaline phosphatase;0.8391263782978058;0.9233981;0.5514311554101863;0.5244070585524019;0.9999201345566091;-0.16079375625880332;-0.07652205706866355;-0.44848897914642283;-0.4755130760042072
Hippocampal sclerosis;Clasp-knife sign;0.9909702241420746;1.1454084;0.5028743059868142;0.45355037542548415;1.0;-0.009029775857925415;0.14540839195251465;-0.49712569401318585;-0.5464496245745158
Hippocampal sclerosis;Keratosis pilaris;0.8359672427177429;1.0363898;0.5524502777259426;0.48841418466814124;0.9998710980331391;-0.1639038553153962;0.03651872969513237;-0.44742082030719654;-0.5114569133649979
Hippocampal sclerosis;Lamina lucida cleavage;0.9047096446156502;1.0138593;0.530377954254931;0.49558833384770584;0.9998962300503706;-0.09518658543472047;0.013963041952803179;-0.4695182757954397;-0.5043078962026648
Hippocampal sclerosis;Abnormal central response of multifocal electroretinogram;0.7545232772827148;0.9640715;0.5789444905598062;0.5114388452496201;1.0;-0.24547672271728516;-0.03592848777770996;-0.42105550944019376;-0.48856115475037987
Hippocampal sclerosis;Atypical or prolonged hepatitis;0.826444149017334;1.0099239;0.5555257139408758;0.4968410508746458;0.9999201345566091;-0.17347598553927512;0.01000380037991433;-0.4443944206157333;-0.5030790836819633
Hippocampal sclerosis;Cubitus varus;0.9354984387755394;1.0525085;0.5205457480395557;0.4832783331208753;1.0;-0.0645015612244606;0.05250847339630127;-0.47945425196044433;-0.5167216668791247
Hippocampal sclerosis;Nasal regurgitation;0.8791554868221283;1.1349823;0.5385602462614145;0.45690224619811803;0.9999134918687169;-0.12075800504658862;0.1350688556196864;-0.4613532456073024;-0.5430112456705989
Hippocampal sclerosis;Moon facies;0.9432053901255131;1.1048772;0.5180880189094899;0.4665550313101603;0.9999134918687169;-0.05670810174320384;0.1049637416365321;-0.48182547295922706;-0.5333584605585566
Hippocampal sclerosis;Intestinal pseudo-obstruction;0.8348971903324127;1.0786223;0.5527955941179633;0.4749478953831209;0.9998912449978579;-0.16499405466544514;0.078731096158148;-0.44709565087989456;-0.524943349614737
Hippocampal sclerosis;Bilateral renal atrophy;0.8255570530891418;0.9268779;0.5558124594403112;0.523296266922207;0.9999201345566091;-0.17436308146746726;-0.0730422186973867;-0.4441076751162979;-0.4766238676344021
Hippocampal sclerosis;Fractured left clavicle;0.8738541156053543;1.1171103;0.5402607442534768;0.462636912430341;1.0;-0.1261458843946457;0.1171102523803711;-0.4597392557465232;-0.537363087569659
Hippocampal sclerosis;Positive urine norcotinine test;0.8026446402072906;0.8758631;0.5632352784022973;0.5396162080392027;1.0;-0.19735535979270935;-0.12413692474365234;-0.43676472159770274;-0.46038379196079726
Hippocampal sclerosis;Long fibula;0.8857758566737175;0.8847285;0.536438204770002;0.5367738035398375;0.9999056439461368;-0.11412978727241929;-0.11517715263983186;-0.46346743917613475;-0.4631318404062993
Hippocampal sclerosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6815478801727295;0.8410814;0.6031630080789965;0.5508007573490357;1.0;-0.3184521198272705;-0.1589186191558838;-0.3968369919210035;-0.44919924265096434
Hippocampal sclerosis;Type II cryptotia;0.756785586476326;0.8398614;0.578201864670618;0.5511941197624852;1.0;-0.243214413523674;-0.16013860702514648;-0.42179813532938204;-0.4488058802375148
Hippocampal sclerosis;Increased variability in muscle fiber diameter;0.8909954503178596;0.98094815;0.5347663078442733;0.5060647679782646;0.9998452077479463;-0.10884975743008662;-0.018897057590017807;-0.465078899903673;-0.49378043976968167
Hippocampal sclerosis;Widened proximal tibial metaphyses;0.8053368031978607;0.8960561;0.5623613842427204;0.5331462321258043;0.9999201345566091;-0.1945833313587484;-0.10386401892932029;-0.4375587503138887;-0.46677390243080485
Hippocampal sclerosis;Wide anterior fontanel;0.9480703622102737;1.0228246;0.5165371553706782;0.49273404877651217;0.999848231156753;-0.05177786894647929;0.022976413885666402;-0.4833110757860748;-0.5071141823802409
Hippocampal sclerosis;Increased circulating oleate level;0.968978688120842;1.0523522;0.5098759746632282;0.48332816124356304;1.0;-0.03102131187915802;0.052352190017700195;-0.4901240253367718;-0.516671838756437
Hippocampal sclerosis;Lozenge-shaped umbilicus;0.8935597613453865;1.031397;0.5339452845344221;0.49000437114864537;0.9999134918687169;-0.10635373052333041;0.031483493185299194;-0.4659682073342948;-0.5099091207200716
Hippocampal sclerosis;Anti-myelin-associated glycoprotein antibody positivity;0.7646036148071289;0.75831145;0.575638830380774;0.5777012298383057;1.0;-0.2353963851928711;-0.2416885495185852;-0.424361169619226;-0.42229877016169426
Hippocampal sclerosis;Fractured radius;0.8924303352832794;1.0254104;0.534306868072043;0.49191072443152273;0.9999201345566091;-0.10748979927332969;0.02549027918545632;-0.46561326648456614;-0.5080094101250864
Hippocampal sclerosis;Abnormal manual kinetic perimetry test;0.7801175713539124;0.9166168;0.5705673753306535;0.5265725506785681;1.0;-0.21988242864608765;-0.08338320255279541;-0.4294326246693465;-0.4734274493214319
Hippocampal sclerosis;Small radial epiphyses;0.8079280704259872;0.9625389;0.5615206910804447;0.5119270227083518;1.0;-0.19207192957401276;-0.03746110200881958;-0.43847930891955533;-0.4880729772916482
Hippocampal sclerosis;Generalized keratosis follicularis;0.9079233109951019;0.9878591;0.5293504932746952;0.5038646669687122;0.9999201345566091;-0.09199682356150718;-0.0120610642555532;-0.4705696412819139;-0.49605546758789687
Hippocampal sclerosis;Hypoplasia of the calcaneus;0.7711202800273895;1.0147219;0.573506250877287;0.49531372922890027;0.9999134918687169;-0.2287932118413274;0.014808378553646362;-0.4264072409914299;-0.5045997626398167
Hippocampal sclerosis;2-hydroxyadipic aciduria;0.7914048433303833;0.865225;0.5668890974256753;0.54303115804164;1.0;-0.2085951566696167;-0.13477498292922974;-0.4331109025743247;-0.45696884195835996
Hippocampal sclerosis;Potter facies;0.8993236124515533;1.0544196;0.5321006733278127;0.4826691373446784;0.9998981869165328;-0.10057457446497942;0.054521449809846634;-0.46779751358872;-0.5172290495718543
Hippocampal sclerosis;Increased heart rate variability;0.9020663648843765;0.98994076;0.5312232909633473;0.503202015262115;0.9999201345566091;-0.09785376967223258;-0.009979372036772682;-0.4686968435932618;-0.49671811929449405
Hippocampal sclerosis;Aplastic zygomatic arch;0.8938751444220543;1.0147622;0.5338443231342958;0.49530087972497416;0.9999134918687169;-0.10603834744666263;0.014848671293514526;-0.46606916873442117;-0.5046126121437428
Hippocampal sclerosis;Testicular torsion;0.852713093161583;0.96087366;0.5470540634191559;0.5124574783989361;0.9999201345566091;-0.14720704139502616;-0.03904647113116355;-0.45286607113745325;-0.48746265615767304
Hippocampal sclerosis;Abolished vibration sense;0.9367585331201553;1.1849049;0.5201438268544494;0.4408022883461531;0.8643545492165687;0.0724039839035866;0.3205503837592003;-0.34421072236211936;-0.42355226087041564
Hippocampal sclerosis;Fractured metatarsal bone of digit 5;0.865436315536499;0.89529586;0.5429632813344893;0.5333895620347859;1.0;-0.13456368446350098;-0.10470414161682129;-0.45703671866551066;-0.46661043796521406
Hippocampal sclerosis;Prolonged G2 phase of cell cycle;0.9614491164684296;0.99293095;0.5122741688819235;0.5022501706093523;0.9999056439461368;-0.038456527477707225;-0.006974695211853343;-0.48763147506421334;-0.4976554733367845
Hippocampal sclerosis;Single naris;0.9175980165600777;1.0249968;0.5262591403157142;0.49204244425863297;0.9999056439461368;-0.08230762738605912;0.025091113561187428;-0.4736465036304226;-0.5078631996875038
Hippocampal sclerosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7552728354930878;0.98090875;0.5786983920994451;0.5060773023507528;1.0;-0.24472716450691223;-0.019091248512268066;-0.42130160790055493;-0.49392269764924723
Hippocampal sclerosis;Asymmetry of the thorax;0.8076412677764893;1.03876;0.5616137178915183;0.487659246297946;0.9999056439461368;-0.19226437616964753;0.038854302876983327;-0.43829192605461853;-0.5122463976481908
Hippocampal sclerosis;Type 2 muscle fiber predominance;0.939309548586607;1.0362693;0.5193302497071187;0.4884526049431427;0.9999003561294039;-0.06059080754279689;0.03636895100713178;-0.48057010642228515;-0.5114477511862612
Hippocampal sclerosis;Dependency on parenteral nutrition;0.9165082424879074;1.0201942;0.5266072257066642;0.4935715522302161;0.9999134918687169;-0.08340524938080951;0.020280680990474975;-0.47330626616205274;-0.5063419396385008
Hippocampal sclerosis;Limited shoulder flexion;0.8898236900568008;1.0927333;0.5351415508948423;0.4704396239238461;1.0;-0.11017630994319916;0.09273326396942139;-0.4648584491051577;-0.5295603760761539
Hippocampal sclerosis;Paroxysmal vertigo;0.7777744084596634;1.0628092;0.5713321466968595;0.4799940494789384;0.9999134918687169;-0.22213908340905353;0.06289573702837781;-0.4285813451718574;-0.5199194423897785
Hippocampal sclerosis;Long hallux;0.7742335349321365;0.87375647;0.5724886286038213;0.5402920720646286;0.9998836012415208;-0.22565006630938422;-0.12612713294546973;-0.42739497263769943;-0.45959152917689217
Hippocampal sclerosis;Broad medial eyebrow;1.0121052116155624;1.12;0.49614669735649086;0.4617105540301193;0.9999201345566091;0.01218507705895333;0.12007987021176247;-0.5037734372001182;-0.5382095805264898
Hippocampal sclerosis;Myxoid subcutaneous tumors;0.7904170453548431;0.98020774;0.5672106302700447;0.5063004806520062;0.9999201345566091;-0.20950308920176597;-0.019712393296080544;-0.4327095042865644;-0.49361965390460294
Hippocampal sclerosis;Bulbous tips of toes;0.8933179527521133;0.9768949;0.5340226953659724;0.507355233840307;0.9999134918687169;-0.10659553911660358;-0.023018576764804566;-0.46589079650274456;-0.4925582580284099
Hippocampal sclerosis;Absent internal genitalia;0.9139765352010727;1.0411421;0.5274160036936362;0.4869003718710143;1.0;-0.08602346479892731;0.04114210605621338;-0.47258399630636383;-0.5130996281289857
Hippocampal sclerosis;Hyperphalangy of the 2nd finger;0.8948232680559158;1.0342237;0.5335408274200046;0.4891041462922546;0.9999201345566091;-0.10509686650069328;0.03430354117123513;-0.46637930713660447;-0.5108159882643545
Hippocampal sclerosis;Renal interstitial hemosiderin;0.7342908978462219;0.9216225;0.5856060667354552;0.5249739447216328;1.0;-0.2657091021537781;-0.07837748527526855;-0.41439393326454477;-0.47502605527836717
Hippocampal sclerosis;Abnormality of depressor anguli oris muscle;0.9660852774977684;1.1263142;0.5107974620231908;0.45968523989066445;1.0;-0.0339147225022316;0.1263141632080078;-0.48920253797680924;-0.5403147601093355
Hippocampal sclerosis;Paroxysmal dyspnea;0.8027527928352356;1.0430489;0.5632001620662926;0.4862928998558603;1.0;-0.1972472071647644;0.043048858642578125;-0.43679983793370736;-0.5137071001441397
Hippocampal sclerosis;Phenylpyruvic acidemia;0.8267515897750854;0.91976535;0.5554263472117932;0.5255669536149106;0.9999201345566091;-0.17316854478152366;-0.08015478135378928;-0.4444937873448159;-0.47435318094169854
Hippocampal sclerosis;Lateral ventricle dilatation;0.6483896970748901;0.71892524;0.614365778364895;0.5906908908351516;0.5190338878590747;0.12935580921581546;0.19989134979656498;0.09533189050582036;0.07165700297607691
Hippocampal sclerosis;Neonatal unconjugated hyperbilirubinemia;0.9096003174781799;1.044944;0.5288144496822581;0.48568906350706287;0.9999201345566091;-0.09031981707842918;0.04502391337124734;-0.471105684874351;-0.5142310710495462
Hippocampal sclerosis;High maternal circulating alpha-fetoprotein concentration;0.8495655953884125;1.0006162;0.548067232068931;0.49980385260714055;1.0;-0.15043440461158752;0.0006161928176879883;-0.45193276793106896;-0.5001961473928594
Hippocampal sclerosis;Prominent nasolabial fold;0.9323210716247559;1.1389189;0.5215593519418076;0.455637252303588;0.9998944404568447;-0.06757336883208886;0.1390244361911045;-0.47833508851503714;-0.5442571881532567
Hippocampal sclerosis;Abnormality of inferior alveolar nerve;0.956041231751442;1.1443608;0.5139970209001319;0.4538874348628309;1.0;-0.043958768248558044;0.14436078071594238;-0.4860029790998681;-0.5461125651371691
Hippocampal sclerosis;Unilateral conductive hearing impairment;0.8189178556203842;0.9821439;0.5579599888505848;0.5056840855016885;0.9999201345566091;-0.1810022789362249;-0.01777625561984153;-0.44196014570602427;-0.4942360490549206
Hippocampal sclerosis;Macular hypopigmented whorls, streaks, and patches;0.696489155292511;0.96160674;0.5981588620662048;0.5122239630251564;0.9999201345566091;-0.3034309792640981;-0.03831339360507102;-0.4017612724904043;-0.4876961715314527
Hippocampal sclerosis;Delayed ossification of pubic rami;0.8715368062257767;0.99060446;0.5410044176813931;0.5029907395664301;0.9999134918687169;-0.12837668564294025;-0.009309031629306519;-0.45890907418732385;-0.4969227523022868
Hippocampal sclerosis;Hyperphenylalaninemia;0.8181110471487045;0.8293296;0.5582211407613364;0.554593319438238;0.9999028053808913;-0.18179175823218674;-0.17057319550998062;-0.4416816646195548;-0.4453094859426533
Hippocampal sclerosis;Ureteropelvic junction obstruction;0.8847297132015228;1.110512;0.5367734167634819;0.4647509285220105;0.9998847295244674;-0.11515501632294456;0.11062728867926797;-0.4631113127609855;-0.5351338010024569
Hippocampal sclerosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8129999190568924;0.91862476;0.5598764659232274;0.5259312263035341;1.0;-0.1870000809431076;-0.08137524127960205;-0.4401235340767726;-0.47406877369646594
Hippocampal sclerosis;Difficulty walking;0.8102046251296997;0.91337025;0.5607824597481061;0.5276097033584877;0.7403726674076037;0.06983195772209605;0.17299758424797496;-0.1795902076594975;-0.212762964049116
Hippocampal sclerosis;Bilobate gallbladder;0.9442429430782795;1.0806046;0.5177572313197207;0.4743149260472671;0.9999134918687169;-0.055670548790437424;0.08069106135393933;-0.4821562605489962;-0.5255985658214498
Hippocampal sclerosis;Histidinuria;0.6643323600292206;0.8308474;0.6089618994006154;0.55410306876567;0.9999090677057578;-0.33557670767653724;-0.16906168516028663;-0.3909471683051424;-0.4458059989400879
Hippocampal sclerosis;Widened interpedicular distance;0.9354753494262695;1.0158079;0.5205531129498342;0.494967975818568;1.0;-0.06452465057373047;0.0158078670501709;-0.4794468870501658;-0.505032024181432
Decreased sensitivity to hypoxemia;Decreased level of tissue plasminogen activator;0.6270158886909485;0.78992605;0.6216654071776464;0.5673704767486629;0.9999201345566091;-0.3729042458656606;-0.20999408246310325;-0.3782547273789627;-0.4325496578079462
Decreased sensitivity to hypoxemia;Submandibular lymph node enlargement;0.9547560252249241;1.1624267;0.5144065223814869;0.44806789267798053;0.9999600672783046;-0.04520404205338047;0.16246664285047963;-0.4855535448968177;-0.551892174600324
Decreased sensitivity to hypoxemia;Hepatic hemangioma;0.8462409973144531;1.0227128;0.5491379420883311;0.4927696734167175;0.9999584729108851;-0.153717475596432;0.02275435381793567;-0.450820530822554;-0.5071887994941676
Decreased sensitivity to hypoxemia;Triangular epiphysis of the distal phalanx of the 2nd finger;0.713233232498169;0.88476014;0.5925804764156126;0.5367636757473189;0.9999201345566091;-0.28668690205844016;-0.11515999318392844;-0.4073396581409965;-0.46315645880929024
Decreased sensitivity to hypoxemia;Acne inversa;0.7899872362613678;1.0432636;0.5673505568515305;0.486224490355036;0.9999548690865008;-0.20996763282513298;0.04330868548655831;-0.4326043122349703;-0.5137303787314648
Decreased sensitivity to hypoxemia;Dentin dysplasia;0.7385743856430054;0.9580274;0.5841926104419914;0.5133642146732154;0.9999201345566091;-0.26134574891360374;-0.041892712128478005;-0.41572752411461766;-0.48655591988339375
Decreased sensitivity to hypoxemia;Aplasia of the inner ear;0.737542450428009;0.82640684;0.5845329697180064;0.5555377643102142;0.9999600672783046;-0.2624176168502955;-0.17355323076859996;-0.41542709756029816;-0.4444223029680904
Decreased sensitivity to hypoxemia;Polycystic liver disease;0.8331263661384583;1.0307531;0.5533671944387446;0.49020943099988257;0.9999567459343585;-0.1668303797959002;0.030796389746793884;-0.44658955149561386;-0.5097473149344759
Decreased sensitivity to hypoxemia;Subungual hyperkeratosis;0.8395466208457947;1.0417721;0.5512956274401285;0.4866996549936631;0.9999556674707869;-0.16040904662499222;0.041816459680702356;-0.4486600400306584;-0.5132560124771238
Decreased sensitivity to hypoxemia;Broad humeral epiphyses;0.8113710880279541;0.96531886;0.56040433265152;0.511041566723754;0.9999201345566091;-0.188549046528655;-0.03460127593310447;-0.4395158019050891;-0.4888785678328551
Decreased sensitivity to hypoxemia;Autoimmune thrombocytopenia;0.7613944262266159;0.8730856;0.5766903044967909;0.5405073370769508;0.9999509115718902;-0.2385564853452743;-0.1268652935527862;-0.42326060707509927;-0.45944357449493944
Decreased sensitivity to hypoxemia;Adenomyosis;0.8573369830846786;1.0055847;0.5455665166690036;0.49822232078414974;0.9999600672783046;-0.1426230841936259;0.005624649518570446;-0.454393550609301;-0.5017377464941548
Decreased sensitivity to hypoxemia;Elevated leukocyte alkaline phosphatase;0.967011459171772;0.9765648;0.5105024841413272;0.507460325074176;0.9999600672783046;-0.03294860810653255;-0.023395242697158314;-0.4894575831369774;-0.4924997422041285
Decreased sensitivity to hypoxemia;Clasp-knife sign;1.022875901311636;1.0580906;0.4927177392201053;0.48149879689372854;0.9999201345566091;0.022955766755026863;0.058170433032197044;-0.5072023953365038;-0.5184213376628806
Decreased sensitivity to hypoxemia;Keratosis pilaris;0.7863539159297943;0.9097691;0.568533934184372;0.5287604983738099;0.9999506876445663;-0.21359677171477198;-0.09018156981238246;-0.43141675346019426;-0.4711901892707564
Decreased sensitivity to hypoxemia;Lamina lucida cleavage;0.810940682888031;0.92666554;0.5605438451005125;0.523364060692616;0.9999548690865008;-0.18901418619846977;-0.07328932457661308;-0.4394110239859883;-0.4765908083938848
Decreased sensitivity to hypoxemia;Abnormal central response of multifocal electroretinogram;0.8439116030931473;0.9016151;0.5498884730643645;0.531367640227294;0.9999201345566091;-0.15600853146346183;-0.09830505133898826;-0.4500316614922446;-0.4685524943293151
Decreased sensitivity to hypoxemia;Atypical or prolonged hepatitis;0.8971429243683815;1.0373806;0.53279843060065;0.4880986131997448;0.9999600672783046;-0.10281714290992305;0.03742050885542347;-0.46716163667765453;-0.5118614540785598
Decreased sensitivity to hypoxemia;Cubitus varus;0.8561107069253922;0.9644381;0.5459609216959456;0.5113221012875837;0.9999201345566091;-0.14380942763121696;-0.03548205376895042;-0.45395921286066354;-0.4885980332690254
Decreased sensitivity to hypoxemia;Nasal regurgitation;0.7684837728738785;0.8821422;0.5743686378904889;0.5376026983931705;0.9999584729108851;-0.23147470003700665;-0.11781628674602918;-0.42558983502039627;-0.4623557745177146
Decreased sensitivity to hypoxemia;Moon facies;0.9838920719921589;1.0381417;0.5051275344833861;0.48785614641854613;0.9999584729108851;-0.016066400918726242;0.03818325453662463;-0.49483093842749903;-0.512102326492339
Decreased sensitivity to hypoxemia;Intestinal pseudo-obstruction;0.7747818231582642;1.023054;0.5723094892955878;0.49266103369501313;0.9999539510871024;-0.22517212792883823;0.02310005262841275;-0.4276444617915146;-0.5072929173920893
Decreased sensitivity to hypoxemia;Bilateral renal atrophy;0.688010036945343;0.70207834;0.600995532783438;0.5962934207783515;0.9999600672783046;-0.31195003033296154;-0.2978817248405604;-0.3989645344948666;-0.4036666464999531
Decreased sensitivity to hypoxemia;Fractured left clavicle;0.8177596628665924;0.9878249;0.5583348910104571;0.5038755385637744;0.9999201345566091;-0.1821604716900167;-0.012095217717009499;-0.44158524354615203;-0.4960445959928347
Decreased sensitivity to hypoxemia;Positive urine norcotinine test;0.9315510392189026;0.9281575;0.5218050306139241;0.522887892915178;0.9999201345566091;-0.06836909533770652;-0.07176262618334861;-0.47811510394268497;-0.4770322416414311
Decreased sensitivity to hypoxemia;Long fibula;0.9857969796285033;1.031699;0.5045211138108134;0.4899082239512308;0.9999567459343585;-0.014159766305855137;0.03174219625008978;-0.495435632123545;-0.5100485219831277
Decreased sensitivity to hypoxemia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7356180548667908;0.9199257;0.585167950667414;0.5255157640768497;0.9999201345566091;-0.26430207968981834;-0.07999444485934348;-0.4147521838891951;-0.47440437047975936
Decreased sensitivity to hypoxemia;Type II cryptotia;0.6882925629615784;0.8850517;0.6009008818866304;0.5366702258232348;0.9999201345566091;-0.31162757159503074;-0.11486840726168723;-0.39901925266997873;-0.46324990873337435
Decreased sensitivity to hypoxemia;Increased variability in muscle fiber diameter;0.7633940130472183;0.83527684;0.5760350507372842;0.5526730696098654;0.9999473166570552;-0.23655330360983684;-0.1646704745397456;-0.42391226591977094;-0.44727424704718977
Decreased sensitivity to hypoxemia;Widened proximal tibial metaphyses;0.9284306243062019;0.9936314;0.5228007330478653;0.5020271996197776;0.9999600672783046;-0.07152944297210262;-0.006328644758620716;-0.4771593342304392;-0.49793286765852696
Decreased sensitivity to hypoxemia;Wide anterior fontanel;1.0143131613731384;0.8991513;0.49544382365530437;0.5321557874432845;0.9999476714516888;0.014365489921449592;-0.10079634622585876;-0.5045038477963845;-0.4677918840084043
Decreased sensitivity to hypoxemia;Increased circulating oleate level;0.8531819581985474;0.84975713;0.5469031787271904;0.5480055622394171;0.9999201345566091;-0.14673817635806174;-0.15016299964221091;-0.4530169558294187;-0.451914572317192
Decreased sensitivity to hypoxemia;Lozenge-shaped umbilicus;0.8577537089586258;0.8502209;0.5454325019302728;0.5478562408741138;0.9999584729108851;-0.14220476395225934;-0.14973755425548962;-0.4545259709806123;-0.45210223203677136
Decreased sensitivity to hypoxemia;Anti-myelin-associated glycoprotein antibody positivity;0.8627148866653442;0.896138;0.5438376542053676;0.5331200336275315;0.9999201345566091;-0.13720524789126487;-0.1037821221473989;-0.45608248035124155;-0.46680010092907764
Decreased sensitivity to hypoxemia;Fractured radius;0.7551482021808624;0.87356436;0.5787393089591031;0.5403537151735185;0.9999600672783046;-0.24481186509744213;-0.1263957047523646;-0.42122075831920147;-0.45960635210478606
Decreased sensitivity to hypoxemia;Abnormal manual kinetic perimetry test;0.7830323874950409;0.86520046;0.5696166025268601;0.5430390420152215;0.9999201345566091;-0.21688774706156821;-0.1347196745994863;-0.430303532029749;-0.45688109254138765
Decreased sensitivity to hypoxemia;Small radial epiphyses;0.6160614192485809;0.84656674;0.625432565855172;0.5490330108774506;0.9999201345566091;-0.3838587153080282;-0.15335339785845847;-0.37448756870143707;-0.4508871236791585
Decreased sensitivity to hypoxemia;Generalized keratosis follicularis;0.8458715826272964;1.0665587;0.5492569490443064;0.47879802066190336;0.9999600672783046;-0.1540884846510081;0.0665986514030309;-0.4507031182339981;-0.5211620466164012
Decreased sensitivity to hypoxemia;Hypoplasia of the calcaneus;0.5931840538978577;0.9181816;0.6333609657022982;0.5260727463643681;0.9999584729108851;-0.40677441901302747;-0.08177687472439221;-0.36659750720858697;-0.47388572654651706
Decreased sensitivity to hypoxemia;2-hydroxyadipic aciduria;0.6937289834022522;0.8575356;0.5990813758648336;0.5455026327096144;0.9999201345566091;-0.3061911511543569;-0.14238453389437766;-0.40083875869177554;-0.4544175018469947
Decreased sensitivity to hypoxemia;Potter facies;1.0032267635688186;1.0596288;0.49897288747327895;0.48100829183833393;0.9999552432134126;0.00327152035540601;0.059673601047756875;-0.5009823557401336;-0.5189469513750786
Decreased sensitivity to hypoxemia;Increased heart rate variability;0.8625041395425797;0.7910305;0.5439053793380975;0.5670109312386895;0.9999600672783046;-0.1374559277357249;-0.2089295411171107;-0.4560546879402071;-0.43294913603961505
Decreased sensitivity to hypoxemia;Aplastic zygomatic arch;0.8032159358263016;0.86604273;0.5630497918681944;0.5427684841745111;0.9999584729108851;-0.19674253708458356;-0.13391573971844128;-0.43690868104269076;-0.45718998873637406
Decreased sensitivity to hypoxemia;Testicular torsion;0.8910612240433693;1.0634148;0.5347452459908285;0.47980090368571693;0.9999600672783046;-0.10889884323493526;0.06345474480970814;-0.46521482128747604;-0.5201591635925876
Decreased sensitivity to hypoxemia;Abolished vibration sense;0.6543079912662506;0.856104;0.6123558014932269;0.54596306419685;0.9999584729108851;-0.3456504816446345;-0.14385445660686902;-0.38760267141765825;-0.4539954087140351
Decreased sensitivity to hypoxemia;Fractured metatarsal bone of digit 5;0.7805839627981186;0.9093718;0.570415202085361;0.5288874862552344;0.9999201345566091;-0.21933617175849052;-0.09054834128649802;-0.4295049324712481;-0.4710326483013747
Decreased sensitivity to hypoxemia;Prolonged G2 phase of cell cycle;0.8794872984290123;0.95539397;0.5384538497611666;0.514203257764757;0.9999567459343585;-0.12046944750534616;-0.044562775921693665;-0.46150289617319185;-0.4857534881696015
Decreased sensitivity to hypoxemia;Single naris;0.9911642484366894;1.0071464;0.5028125436713929;0.4977252368274817;0.9999567459343585;-0.008792497497669083;0.007189612555631775;-0.4971442022629655;-0.5022315091068768
Decreased sensitivity to hypoxemia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7815187871456146;0.88637507;0.5701102387281486;0.5362462146500917;0.9999201345566091;-0.21840134741099448;-0.11354506493838401;-0.4298098958284605;-0.4636739199065174
Decreased sensitivity to hypoxemia;Asymmetry of the thorax;0.7665417790412903;0.84737545;0.5750042088400107;0.5487725204985983;0.9999567459343585;-0.23341496689306818;-0.15258129341589532;-0.42495253709434777;-0.4511842254357602
Decreased sensitivity to hypoxemia;Type 2 muscle fiber predominance;0.7929148375988007;0.9434375;0.5663977209833223;0.518014018887375;0.9999556674707869;-0.20704082987198624;-0.056518150781486365;-0.4335579464874646;-0.48194164858341193
Decreased sensitivity to hypoxemia;Dependency on parenteral nutrition;0.8083411753177643;0.7879403;0.5613867064416563;0.5680171218169561;0.9999584729108851;-0.19161729759312085;-0.2120181495580714;-0.4385717664692288;-0.43194135109392906
Decreased sensitivity to hypoxemia;Limited shoulder flexion;0.7460973262786865;1.0634533;0.581714295277495;0.47978859641674243;0.9999201345566091;-0.2538228082779226;0.06353318213192849;-0.41820583927911414;-0.5201315381398667
Decreased sensitivity to hypoxemia;Paroxysmal vertigo;0.6890677809715271;0.9074732;0.6006412183946102;0.5294943706944302;0.9999584729108851;-0.31089069193935803;-0.09248526639080457;-0.399317254516275;-0.47046410221645496
Decreased sensitivity to hypoxemia;Long hallux;0.9918923964723945;0.9876367;0.5025807586302242;0.5039354569359435;0.9999526340597648;-0.00806023758737029;-0.01231594868836583;-0.49737187542954053;-0.4960171771238212
Decreased sensitivity to hypoxemia;Broad medial eyebrow;1.059018298983574;1.0709943;0.48120296900273773;0.4773827852272261;0.9999600672783046;0.05905823170526936;0.07103419064863636;-0.5187570982755668;-0.5225772820510785
Decreased sensitivity to hypoxemia;Myxoid subcutaneous tumors;0.7593767791986465;1.0546111;0.5773518125921225;0.48260808355767393;0.9999600672783046;-0.240583288079658;0.054651019567093395;-0.422608254686182;-0.5173519837206306
Decreased sensitivity to hypoxemia;Bulbous tips of toes;0.8276911228895187;0.8694926;0.555122718145872;0.5416606363818273;0.9999584729108851;-0.1722673500213664;-0.13046588248348645;-0.44483575476501314;-0.45829783652905787
Decreased sensitivity to hypoxemia;Absent internal genitalia;0.8186804950237274;1.0398103;0.5580368148439514;0.48732462886757233;0.9999201345566091;-0.1812396395328817;0.03989016531674294;-0.4418833197126577;-0.5125955056890368
Decreased sensitivity to hypoxemia;Hyperphalangy of the 2nd finger;0.7343032956123352;0.8627268;0.5856019732639401;0.5438338138101344;0.9999600672783046;-0.26565677166596935;-0.13723325968400524;-0.4143580940143644;-0.45612625346817015
Decreased sensitivity to hypoxemia;Renal interstitial hemosiderin;0.7998374700546265;0.938741;0.5641470194425711;0.5195115574350218;0.9999201345566091;-0.20008266450198264;-0.0611791062477407;-0.43577311511403805;-0.48040857712158735
Decreased sensitivity to hypoxemia;Abnormality of depressor anguli oris muscle;0.6984562873840332;0.9973068;0.5975019205264411;0.5008572733758558;0.9999201345566091;-0.3014638471725759;-0.002613310826140358;-0.402418214030168;-0.49906286118075327
Decreased sensitivity to hypoxemia;Paroxysmal dyspnea;0.5701192319393158;0.52642024;0.6414444090183142;0.6570384380243065;0.5071389135049151;0.06298031843440066;0.019281322128934963;0.1343054955133991;0.14989952451939137
Decreased sensitivity to hypoxemia;Phenylpyruvic acidemia;0.7486859858036041;0.74628204;0.5808626799997234;0.5816535081993375;0.9999600672783046;-0.25127408147470043;-0.2536780262054591;-0.41909738727858115;-0.4183065590789671
Decreased sensitivity to hypoxemia;Lateral ventricle dilatation;0.7742784321308136;0.772987;0.5724739587023943;0.5728959770312678;0.9999488789551968;-0.2256704468243832;-0.2269618708604092;-0.42747492025280254;-0.427052901923929
Decreased sensitivity to hypoxemia;Neonatal unconjugated hyperbilirubinemia;0.7930392324924469;0.75554854;0.5663572480567456;0.578607884650819;0.9999600672783046;-0.20692083478585765;-0.24441153050080822;-0.43360281922155897;-0.4213521826274855
Decreased sensitivity to hypoxemia;High maternal circulating alpha-fetoprotein concentration;0.9299403429031372;0.85746676;0.5223189651686833;0.545524781751128;0.9999201345566091;-0.0699797916534719;-0.14245337725909324;-0.47760116938792585;-0.45439535280548116
Decreased sensitivity to hypoxemia;Prominent nasolabial fold;0.9180624634027481;1.060333;0.5261108006595485;0.4807837339949683;0.9999545338528789;-0.0818920704501308;0.060378479681666986;-0.4738437331933304;-0.5191707998579106
Decreased sensitivity to hypoxemia;Abnormality of inferior alveolar nerve;0.8016940951347351;1.061494;0.5635439467640107;0.4804134869625456;0.9999201345566091;-0.198226039421874;0.06157385824887185;-0.43637618779259846;-0.5195066475940635
Decreased sensitivity to hypoxemia;Unilateral conductive hearing impairment;0.8324883878231049;0.89825493;0.5535731684867398;0.5324425962517509;0.9999600672783046;-0.1674716794551997;-0.10170513630525158;-0.4463868987915648;-0.4675174710265536
Decreased sensitivity to hypoxemia;Macular hypopigmented whorls, streaks, and patches;0.7116544246673584;0.95011723;0.5931051884860121;0.5158847710140416;0.9999600672783046;-0.28830564261094616;-0.049842836862960316;-0.40685487879229243;-0.48407529626426293
Decreased sensitivity to hypoxemia;Delayed ossification of pubic rami;0.8134957253932953;1.1035111;0.5597158196215053;0.4669922809124559;0.9999584729108851;-0.18646274751758984;0.10355262213611194;-0.44024265328937984;-0.5329661919984292
Decreased sensitivity to hypoxemia;Hyperphenylalaninemia;0.9523788243532181;0.9981287;0.5151640261237085;0.5005956555422706;0.9999561589935034;-0.04757733464028535;-0.0018274468162268187;-0.48479213286979495;-0.49936050345123284
Decreased sensitivity to hypoxemia;Ureteropelvic junction obstruction;0.7744857668876648;1.003435;0.5724062152946179;0.4989066034397909;0.9999528219730685;-0.22546705508540366;0.003482193705337311;-0.42754660667845057;-0.5010462185332776
Decreased sensitivity to hypoxemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6972790360450745;0.86976993;0.5978950225295805;0.5415716058485343;0.9999201345566091;-0.30264109851153465;-0.13015020371707053;-0.4020251120270286;-0.45834852870807485
Decreased sensitivity to hypoxemia;Difficulty walking;0.7735783457756042;0.8265543;0.5727027257378476;0.5554901075438332;0.9999461221900431;-0.22636777641443884;-0.17339182378916418;-0.42724339645219545;-0.4444560146462099
Decreased sensitivity to hypoxemia;Bilobate gallbladder;0.9185026437044144;1.0847723;0.5259702167389078;0.47298369681434604;0.9999584729108851;-0.08145582920647076;0.08481387549304553;-0.4739882561719774;-0.5269747760965391
Decreased sensitivity to hypoxemia;Histidinuria;0.8859173282980919;1.0649403;0.5363928766494811;0.4793142763747692;0.9999574798349273;-0.11404015153683544;0.06498285353146671;-0.46356460318544623;-0.5206432034601581
Decreased sensitivity to hypoxemia;Widened interpedicular distance;0.9482927247881889;1.0362965;0.5164662799440383;0.4884439239383336;0.9999201345566091;-0.051627409768420174;0.036376352297944115;-0.48345385461257084;-0.5114762106182755
Decreased level of tissue plasminogen activator;Submandibular lymph node enlargement;0.9549618288874626;1.1465167;0.514340946194062;0.4531937865950013;0.9999201345566091;-0.04495830566914649;0.14659654616085915;-0.4855791883625471;-0.5467263479616078
Decreased level of tissue plasminogen activator;Hepatic hemangioma;0.6975860893726349;0.872427;0.597792477947563;0.5407187136064209;0.9999134918687169;-0.30232740249608203;-0.12748650517438098;-0.40212101392115396;-0.45919477826229604
Decreased level of tissue plasminogen activator;Triangular epiphysis of the distal phalanx of the 2nd finger;0.7899013161659241;0.975191;0.5673785301683957;0.5078977683012416;1.0;-0.21009868383407593;-0.02480900287628174;-0.4326214698316043;-0.49210223169875844
Decreased level of tissue plasminogen activator;Acne inversa;0.8120110630989075;1.042535;0.5601969114583676;0.48645661625010783;0.9998962300503706;-0.18788516695146318;0.04263871734495406;-0.43969931859200306;-0.5134396138002628
Decreased level of tissue plasminogen activator;Dentin dysplasia;0.7968511581420898;0.9686631;0.5651175301750986;0.5099764699925606;1.0;-0.20314884185791016;-0.03133690357208252;-0.4348824698249014;-0.49002353000743937
Decreased level of tissue plasminogen activator;Aplasia of the inner ear;0.815877839922905;1.0752028;0.5589442040483293;0.4760395605738489;0.9999201345566091;-0.18404229463370414;0.07528268812863259;-0.44097593050827977;-0.5238805739827602
Decreased level of tissue plasminogen activator;Polycystic liver disease;0.7552958428859711;1.0417193;0.5786908389649281;0.4867164913828933;0.9999056439461368;-0.24460980106016572;0.04181367349008147;-0.42121480498120867;-0.5131891525632435
Decreased level of tissue plasminogen activator;Subungual hyperkeratosis;0.8341960906982422;0.9739409;0.5530218798243461;0.5082958107519338;0.9999003561294039;-0.16570426543116168;-0.025959447220559873;-0.4468784763050577;-0.4916045453774701
Decreased level of tissue plasminogen activator;Broad humeral epiphyses;0.9364001005887985;1.1171;0.5202581496185275;0.46264020551571183;1.0;-0.06359989941120148;0.11710000038146973;-0.47974185038147255;-0.5373597944842882
Decreased level of tissue plasminogen activator;Autoimmune thrombocytopenia;0.5819408297538757;0.6974152;0.637289529455245;0.5978495564533401;0.32024336570956036;0.2616974640443154;0.3771718073441811;0.3170461637456846;0.2776061907437798
Decreased level of tissue plasminogen activator;Adenomyosis;0.8252105563879013;1.0906518;0.5559244736890047;0.47110500282199075;0.9999201345566091;-0.1747095781687078;0.09073161600796609;-0.44399566086760445;-0.5288151317346184
Decreased level of tissue plasminogen activator;Elevated leukocyte alkaline phosphatase;0.6857320070266724;0.8898368;0.6017590492345262;0.5351373608711439;0.9999201345566091;-0.31418812752993674;-0.11008334637911887;-0.39816108532208294;-0.46478277368546517
Decreased level of tissue plasminogen activator;Clasp-knife sign;0.8856801241636276;0.9807484;0.5364688783013913;0.5061283549468777;1.0;-0.11431987583637238;-0.019251585006713867;-0.46353112169860866;-0.4938716450531223
Decreased level of tissue plasminogen activator;Keratosis pilaris;0.7504143565893173;0.9436102;0.5802944114463182;0.5179589645961146;0.9998710980331391;-0.2494567414438218;-0.05626090668792427;-0.4195766865868209;-0.48191213343702455
Decreased level of tissue plasminogen activator;Lamina lucida cleavage;0.767660528421402;0.8749399;0.5746380302719762;0.539912363462393;0.9998962300503706;-0.23223570162896867;-0.12495631153230424;-0.4252581997783944;-0.45998386658797763
Decreased level of tissue plasminogen activator;Abnormal central response of multifocal electroretinogram;0.8557442128658295;0.9651393;0.5460788102955701;0.5110987531490079;1.0;-0.14425578713417053;-0.03486067056655884;-0.45392118970442985;-0.4889012468509921
Decreased level of tissue plasminogen activator;Atypical or prolonged hepatitis;0.8248212337493896;0.971437;0.556050340907421;0.5090931351270849;0.9999201345566091;-0.17509890080721946;-0.0284831571701345;-0.4438697936491881;-0.49082699942952424
Decreased level of tissue plasminogen activator;Cubitus varus;0.9425351284444332;1.0951378;0.5183017188556919;0.4696707971487749;1.0;-0.05746487155556679;0.0951378345489502;-0.4816982811443081;-0.5303292028512251
Decreased level of tissue plasminogen activator;Nasal regurgitation;0.8452129662036896;1.0185845;0.549469139581434;0.4940840361385045;0.9999134918687169;-0.15470052566502734;0.018670997953670776;-0.45044435228728297;-0.5058294557302124
Decreased level of tissue plasminogen activator;Moon facies;0.9343914240598679;1.0416014;0.5208988698125514;0.4867540437790747;0.9999134918687169;-0.06552206780884906;0.04168792758013562;-0.4790146220561655;-0.5131594480896422
Decreased level of tissue plasminogen activator;Intestinal pseudo-obstruction;0.7600175589323044;1.0065504;0.577141689016381;0.49791491480151184;0.9998912449978579;-0.23987368606555348;0.006659186253668015;-0.4227495559814769;-0.501976330196346
Decreased level of tissue plasminogen activator;Bilateral renal atrophy;0.7064460813999176;0.9928251;0.5948380235824673;0.5022838661745019;0.9999201345566091;-0.2934740531566915;-0.007095043671446755;-0.4050821109741418;-0.49763626838210717
Decreased level of tissue plasminogen activator;Fractured left clavicle;0.8047389686107635;0.98148215;0.5625554039942846;0.5058947522367001;1.0;-0.19526103138923645;-0.01851785182952881;-0.4374445960057154;-0.4941052477632999
Decreased level of tissue plasminogen activator;Positive urine norcotinine test;0.8771879076957703;1.0065734;0.5391912464569714;0.49790759649942573;1.0;-0.12281209230422974;0.00657343864440918;-0.46080875354302864;-0.5020924035005743
Decreased level of tissue plasminogen activator;Long fibula;0.8547768592834473;0.96976817;0.5463900054643049;0.5096245561502976;0.9999056439461368;-0.14512878466268953;-0.030137477404083568;-0.45351563848183185;-0.49028108779583923
Decreased level of tissue plasminogen activator;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8000091910362244;0.9191094;0.5640912309261903;0.5257764414949336;1.0;-0.19999080896377563;-0.08089059591293335;-0.4359087690738097;-0.47422355850506637
Decreased level of tissue plasminogen activator;Type II cryptotia;0.918799452483654;1.0937054;0.5258754254011442;0.4701288131432717;1.0;-0.08120054751634598;0.09370541572570801;-0.4741245745988558;-0.5298711868567283
Decreased level of tissue plasminogen activator;Increased variability in muscle fiber diameter;0.8781798779964447;1.0052781;0.5388731036168195;0.4983199328609196;0.9998452077479463;-0.12166532975150157;0.0054329027562041166;-0.46097210413112677;-0.5015252748870267
Decreased level of tissue plasminogen activator;Widened proximal tibial metaphyses;0.8453551828861237;0.9337825;0.5494233188782299;0.5210931130697227;0.9999201345566091;-0.15456495167048545;-0.06613761664660545;-0.4504968156783792;-0.4788270214868864
Decreased level of tissue plasminogen activator;Wide anterior fontanel;0.9510045126080513;1.0342557;0.5156019945144442;0.48909391754100173;0.999848231156753;-0.04884371854870173;0.03440751186998037;-0.4842462366423088;-0.5107543136157513
Decreased level of tissue plasminogen activator;Increased circulating oleate level;0.8946320191025734;0.9305356;0.5336020440070623;0.5221290144358461;1.0;-0.1053679808974266;-0.06946438550949097;-0.46639795599293765;-0.47787098556415386
Decreased level of tissue plasminogen activator;Lozenge-shaped umbilicus;0.9652822017669678;1.082287;0.5110532396215064;0.4737776161444389;0.9999134918687169;-0.034631290101749146;0.0823734620573695;-0.4888602522472105;-0.526135875724278
Decreased level of tissue plasminogen activator;Anti-myelin-associated glycoprotein antibody positivity;0.7473083436489105;1.0069778;0.5813158216299754;0.4977788791625739;1.0;-0.2526916563510895;0.00697779655456543;-0.4186841783700246;-0.5022211208374261
Decreased level of tissue plasminogen activator;Fractured radius;0.8970442861318588;1.0390809;0.532829995704236;0.4875569922741374;0.9999201345566091;-0.10287584842475028;0.03916072367398171;-0.46709013885237316;-0.5123631422824717
Decreased level of tissue plasminogen activator;Abnormal manual kinetic perimetry test;0.8256405591964722;1.0031416;0.5557854649211122;0.49899997921209327;1.0;-0.17435944080352783;0.003141641616821289;-0.44421453507888775;-0.5010000207879067
Decreased level of tissue plasminogen activator;Small radial epiphyses;0.8052191436290741;1.0090573;0.5623995673295087;0.49711693951081726;1.0;-0.1947808563709259;0.009057283401489258;-0.4376004326704913;-0.5028830604891827
Decreased level of tissue plasminogen activator;Generalized keratosis follicularis;0.8686801493167877;1.0064334;0.5419214893859666;0.4979521914037307;0.9999201345566091;-0.1312399852398214;0.006513233172577904;-0.4579986451706425;-0.5019679431528784
Decreased level of tissue plasminogen activator;Hypoplasia of the calcaneus;0.733148068189621;1.0458534;0.5859834665412171;0.4853992998958062;0.9999134918687169;-0.26676542367909595;0.045939884519832885;-0.4139300253274998;-0.5145141919729107
Decreased level of tissue plasminogen activator;2-hydroxyadipic aciduria;0.8355787694454193;1.1466933;0.552575634634052;0.45313695629851536;1.0;-0.1644212305545807;0.14669334888458252;-0.447424365365948;-0.5468630437014846
Decreased level of tissue plasminogen activator;Potter facies;0.9442758187651634;1.0897133;0.5177467503686586;0.4714049200006458;0.9998981869165328;-0.05562236815136934;0.08981514812069868;-0.4821514365478742;-0.5284932669158869
Decreased level of tissue plasminogen activator;Increased heart rate variability;0.8559599816799164;0.88556826;0.5460094040809622;0.5365047158443513;0.9999201345566091;-0.14396015287669273;-0.1143518734100637;-0.4539107304756469;-0.4634154187122578
Decreased level of tissue plasminogen activator;Aplastic zygomatic arch;0.8575597852468491;1.0060909;0.5454948647837337;0.4980612044280691;0.9999134918687169;-0.14235370662186786;0.006177387571590698;-0.45441862708498326;-0.5018522874406478
Decreased level of tissue plasminogen activator;Testicular torsion;0.8364426493644714;1.1046733;0.5522968793500124;0.46662031299665085;0.9999201345566091;-0.16347748519213767;0.10475313185421853;-0.44762325520659674;-0.5332998215599583
Decreased level of tissue plasminogen activator;Abolished vibration sense;0.8265887051820755;1.0412103;0.5554789918259877;0.48687864981100426;0.9999134918687169;-0.17332478668664142;0.041296801901119506;-0.4444345000427292;-0.5130348420577127
Decreased level of tissue plasminogen activator;Fractured metatarsal bone of digit 5;0.7807232737541199;0.9086033;0.5703697511667898;0.529133118961409;1.0;-0.21927672624588013;-0.09139668941497803;-0.4296302488332102;-0.470866881038591
Decreased level of tissue plasminogen activator;Prolonged G2 phase of cell cycle;0.9318299815058708;1.0401647;0.5217160326426646;0.4872117527161496;0.9999056439461368;-0.06807566244026597;0.04025906514504973;-0.47818961130347215;-0.5126938912299872
Decreased level of tissue plasminogen activator;Single naris;0.9673766680061817;1.0563993;0.5103861719520122;0.48203799017476245;0.9999056439461368;-0.032528975939955074;0.05649370145181243;-0.4895194719941246;-0.5178676537713743
Decreased level of tissue plasminogen activator;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7987328916788101;0.9254855;0.5645059214390415;0.523740713756377;1.0;-0.20126710832118988;-0.07451450824737549;-0.43549407856095845;-0.476259286243623
Decreased level of tissue plasminogen activator;Asymmetry of the thorax;0.7562146633863449;1.011839;0.5783892348046149;0.496231426826903;0.9999056439461368;-0.24369098055979188;0.011933388227019948;-0.4215164091415219;-0.5036742171192338
Decreased level of tissue plasminogen activator;Type 2 muscle fiber predominance;0.86441870033741;1.1042246;0.5432901942495623;0.46676393728910415;0.9999003561294039;-0.1354816557919939;0.10432420651555463;-0.4566101618798416;-0.5331364188402997
Decreased level of tissue plasminogen activator;Dependency on parenteral nutrition;0.7719383984804153;0.99141836;0.5732387607771213;0.5027316574088357;0.9999134918687169;-0.22797509338830158;-0.00849513020489856;-0.4266747310915956;-0.4971818344598812
Decreased level of tissue plasminogen activator;Limited shoulder flexion;0.7754606902599335;1.0909753;0.5720877189220249;0.4710015628654134;1.0;-0.22453930974006653;0.09097528457641602;-0.4279122810779751;-0.5289984371345866
Decreased level of tissue plasminogen activator;Paroxysmal vertigo;0.83904829621315;1.0698436;0.5514563378711499;0.47774997042120804;0.9999134918687169;-0.1608651956555669;0.06993015799547986;-0.448457153997567;-0.5221635214475089
Decreased level of tissue plasminogen activator;Long hallux;0.9283440858125687;0.95372665;0.5228283500119758;0.5147345205757369;0.9998836012415208;-0.0715395154289521;-0.046156951957157966;-0.47705525122954495;-0.4851490806657839
Decreased level of tissue plasminogen activator;Broad medial eyebrow;1.012040663510561;1.045268;0.4961672451539859;0.4855858012059663;0.9999201345566091;0.012120528953951881;0.04534792422024636;-0.5037528894026232;-0.5143343333506428
Decreased level of tissue plasminogen activator;Myxoid subcutaneous tumors;0.7967492640018463;1.0440714;0.5651506551641168;0.4859670976908137;0.9999201345566091;-0.2031708705547628;0.04415130137173562;-0.43476947939249233;-0.5139530368657954
Decreased level of tissue plasminogen activator;Bulbous tips of toes;0.9518140032887459;0.9482332;0.5153440208953043;0.5164852591370213;0.9999134918687169;-0.04809948857997104;-0.051680304670078;-0.48456947097341263;-0.48342823273169566
Decreased level of tissue plasminogen activator;Absent internal genitalia;0.8762770518660545;1.1079826;0.5394834090678893;0.4655609043000123;1.0;-0.12372294813394547;0.10798263549804688;-0.4605165909321107;-0.5344390956999877
Decreased level of tissue plasminogen activator;Hyperphalangy of the 2nd finger;0.7942788302898407;0.9717014;0.5659539938225558;0.5090089338304309;0.9999201345566091;-0.2056413042667684;-0.028218750965910866;-0.43396614073405326;-0.4909112007261782
Decreased level of tissue plasminogen activator;Renal interstitial hemosiderin;0.7120276689529419;0.87700945;0.592981118407678;0.5392484895728951;1.0;-0.2879723310470581;-0.12299054861068726;-0.407018881592322;-0.46075151042710494
Decreased level of tissue plasminogen activator;Abnormality of depressor anguli oris muscle;0.745522528886795;1.0900856;0.5819034726392277;0.47128592966436456;1.0;-0.25447747111320496;0.09008562564849854;-0.4180965273607723;-0.5287140703356354
Decreased level of tissue plasminogen activator;Paroxysmal dyspnea;0.7696204781532288;0.9109618;0.5739967600387648;0.5283793193180745;1.0;-0.23037952184677124;-0.0890381932258606;-0.42600323996123524;-0.47162068068192553
Decreased level of tissue plasminogen activator;Phenylpyruvic acidemia;0.7580313384532928;1.036093;0.5777931196496692;0.4885087512347699;0.9999201345566091;-0.24188879610331626;0.03617286204068093;-0.42212701490693993;-0.5114113833218392
Decreased level of tissue plasminogen activator;Lateral ventricle dilatation;0.8162397742271423;0.99457365;0.5588269969042308;0.5017272616356372;0.9998579617208769;-0.1836181874937346;-0.005284308976583718;-0.44103096481664616;-0.49813070008523974
Decreased level of tissue plasminogen activator;Neonatal unconjugated hyperbilirubinemia;0.9124244302511215;0.9783193;0.5279119258041305;0.5069017283325791;0.9999201345566091;-0.08749570430548759;-0.021600847256499245;-0.4720082087524786;-0.49301840622403004
Decreased level of tissue plasminogen activator;High maternal circulating alpha-fetoprotein concentration;0.7064167559146881;0.88691324;0.594847788433035;0.5360738079399139;1.0;-0.2935832440853119;-0.1130867600440979;-0.405152211566965;-0.4639261920600861
Decreased level of tissue plasminogen activator;Prominent nasolabial fold;0.8886375725269318;1.0591596;0.5355214416491152;0.48115791657095874;0.9998944404568447;-0.11125686792991296;0.059265196040652834;-0.46437299880772953;-0.518736523885886
Decreased level of tissue plasminogen activator;Abnormality of inferior alveolar nerve;0.8560186326503754;1.061213;0.5459905382422088;0.4805030980571998;1.0;-0.14398136734962463;0.061213016510009766;-0.4540094617577912;-0.5194969019428002
Decreased level of tissue plasminogen activator;Unilateral conductive hearing impairment;0.9257965981960297;1.1115307;0.5236414058261742;0.46442466492272416;0.9999201345566091;-0.07412353636057945;0.11161052702633767;-0.47627872873043486;-0.535495469633885
Decreased level of tissue plasminogen activator;Macular hypopigmented whorls, streaks, and patches;0.8682836592197418;0.9375393;0.5420488019709169;0.519894812875981;0.9999201345566091;-0.1316364753368673;-0.062380855095702126;-0.45787133258569224;-0.48002532168062806
Decreased level of tissue plasminogen activator;Delayed ossification of pubic rami;0.7664371132850647;1.0672712;0.5750384722212585;0.47857070620328246;0.9999134918687169;-0.23347637858365222;0.06735774073626355;-0.42487501964745844;-0.5213427856654345
Decreased level of tissue plasminogen activator;Hyperphenylalaninemia;0.7811234593391418;1.0620694;0.5702391966627307;0.4802299948705818;0.9999028053808913;-0.21877934604174942;0.06216661066525131;-0.42966360871816056;-0.5196728105103094
Decreased level of tissue plasminogen activator;Ureteropelvic junction obstruction;0.7725086212158203;0.933086;0.5730523532275582;0.5213153214530025;0.9998847295244674;-0.22737610830864707;-0.06679875149330894;-0.4268323762969092;-0.47856940807146486
Decreased level of tissue plasminogen activator;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8022882789373398;0.9717592;0.56335099171854;0.5089905258725782;1.0;-0.19771172106266022;-0.02824079990386963;-0.43664900828146;-0.4910094741274218
Decreased level of tissue plasminogen activator;Difficulty walking;0.9108220785856247;1.020587;0.5284239738190769;0.4934465041240045;0.9998344221996177;-0.08901234361399302;0.020752545268644007;-0.4714104483805408;-0.5063879180756132
Decreased level of tissue plasminogen activator;Bilobate gallbladder;0.9024372696876526;1.0475566;0.5311046601955336;0.48485653635864323;0.9999134918687169;-0.09747622218106433;0.04764314684893445;-0.4688088316731833;-0.5150569555100737
Decreased level of tissue plasminogen activator;Histidinuria;0.7458457946777344;1.0370018;0.5817970757413443;0.48821924712630826;0.9999090677057578;-0.25406327302802345;0.03709278051506737;-0.4181119919644135;-0.5116898205794496
Decreased level of tissue plasminogen activator;Widened interpedicular distance;0.9647645205259323;1.1187108;0.5112181235677804;0.46212388927764536;1.0;-0.03523547947406769;0.11871075630187988;-0.4887818764322196;-0.5378761107223546
Submandibular lymph node enlargement;Hepatic hemangioma;0.8602514863014221;0.8567615;0.5446294115849115;0.5457515898017062;0.8041807220209305;0.056070764280491625;0.05258079311960295;-0.259551310436019;-0.25842913221922426
Submandibular lymph node enlargement;Triangular epiphysis of the distal phalanx of the 2nd finger;0.875211164355278;1.1402137;0.5398253415229495;0.45522102404626175;0.9999201345566091;-0.12470897020133109;0.1402935933944407;-0.46009479303365963;-0.5446991105103474
Submandibular lymph node enlargement;Acne inversa;0.7471075654029846;0.7411318;0.5813818767592891;0.5833495278173946;0.7948498897099963;-0.04774232430701164;-0.05371810717825798;-0.21346801295070716;-0.21150036189260168
Submandibular lymph node enlargement;Dentin dysplasia;0.7574427276849747;0.81855464;0.5779862330061434;0.5580775563379619;0.9999201345566091;-0.24247740687163444;-0.18136549474032493;-0.42193390155046573;-0.44184257821864725
Submandibular lymph node enlargement;Aplasia of the inner ear;0.7560023665428162;1.0262272;0.5784589151594323;0.4916506660270734;0.9999600672783046;-0.2439577007354884;0.02626716851576283;-0.4215011521188723;-0.5083094012512311
Submandibular lymph node enlargement;Polycystic liver disease;0.8448192775249481;0.8742633;0.5495959872816969;0.540129460504648;0.9999567459343585;-0.15513746840941034;-0.1256934593437823;-0.45036075865266156;-0.4598272854297104
Submandibular lymph node enlargement;Subungual hyperkeratosis;0.6694803833961487;0.9479592;0.6072239840530829;0.5165725969537307;0.9999556674707869;-0.3304752840746382;-0.05199648282418046;-0.39273168341770404;-0.4833830705170562
Submandibular lymph node enlargement;Broad humeral epiphyses;0.8712538182735443;1.1171663;0.5410952498202546;0.4626189377013734;0.9999201345566091;-0.1286663162830648;0.11724614618985085;-0.4588248847363545;-0.5373011968552357
Submandibular lymph node enlargement;Autoimmune thrombocytopenia;0.8644516915082932;1.0774432;0.5432795949864188;0.47532435033021647;0.7768603456063276;0.0875913459019656;0.30058289646673153;-0.2335807506199088;-0.3015359952761111
Submandibular lymph node enlargement;Adenomyosis;0.7572358101606369;0.8956285;0.5780541261432878;0.5332830941541034;0.9999600672783046;-0.24272425711766765;-0.10433155537263439;-0.4219059411350168;-0.4666769731242012
Submandibular lymph node enlargement;Elevated leukocyte alkaline phosphatase;0.7840284556150436;1.0139532;0.5692918439486263;0.4955584293127917;0.9999600672783046;-0.21593161166326091;0.01399314164503529;-0.43066822332967825;-0.5044016379655129
Submandibular lymph node enlargement;Clasp-knife sign;0.9479706883430481;0.89077246;0.5165689254963614;0.5348377088560445;0.9999201345566091;-0.05194944621356101;-0.10914767266543479;-0.48335120906024776;-0.4650824257005646
Submandibular lymph node enlargement;Keratosis pilaris;0.902498409152031;0.9574568;0.5310851056709169;0.5135460031743695;0.9999506876445663;-0.09745227849253535;-0.042493860480870005;-0.46886558197364936;-0.4864046844701968
Submandibular lymph node enlargement;Lamina lucida cleavage;0.8350532948970795;0.94164807;0.5527452137478415;0.5185845625374917;0.9999548690865008;-0.1649015741894213;-0.058306803042647015;-0.4472096553386593;-0.48137030654900903
Submandibular lymph node enlargement;Abnormal central response of multifocal electroretinogram;0.7598624229431152;1.0078559;0.5771925578390636;0.497499380362297;0.9999201345566091;-0.24005771161349387;0.007935757624787376;-0.42272757671754546;-0.5024207541943121
Submandibular lymph node enlargement;Atypical or prolonged hepatitis;0.8554267585277557;1.0118709;0.5461809296386996;0.4962212940746814;0.8184791393567534;0.03694761917100231;0.19339172169671337;-0.27229820971805385;-0.322257845282072
Submandibular lymph node enlargement;Cubitus varus;1.0420685857534409;1.0806456;0.4866052003306707;0.4743018039904926;0.9999201345566091;0.04214845119683175;0.08072542666165261;-0.5133149342259384;-0.5256183305661165
Submandibular lymph node enlargement;Nasal regurgitation;0.8126674741506577;0.81278896;0.5599841900996382;0.5599448224089103;0.9999584729108851;-0.18729099876022748;-0.18716950959301404;-0.43997428281124695;-0.44001365050197483
Submandibular lymph node enlargement;Moon facies;0.9233856201171875;0.8520052;0.5244110355439445;0.5472818995967893;0.9999584729108851;-0.07657285279369763;-0.1479532892141383;-0.4755474373669406;-0.45267657331409583
Submandibular lymph node enlargement;Intestinal pseudo-obstruction;0.7544989883899689;0.8841429;0.5789524660079095;0.5369614800797298;0.9999539510871024;-0.24545496269713352;-0.11581107541571567;-0.4210014850791929;-0.4629924710073726
Submandibular lymph node enlargement;Bilateral renal atrophy;0.8464301228523254;1.0436351;0.5490770179694882;0.4861061119389313;0.9999600672783046;-0.15352994442597911;0.04367506265028431;-0.4508830493088164;-0.5138539553393733
Submandibular lymph node enlargement;Fractured left clavicle;0.9425335004925728;0.9664874;0.5183022379066042;0.5106693919479631;0.9999201345566091;-0.057386634064036324;-0.033432726872282936;-0.4816178966500049;-0.489250742608646
Submandibular lymph node enlargement;Positive urine norcotinine test;0.7830347120761871;0.86779803;0.5696158445335887;0.5422047461420663;0.9999201345566091;-0.21688542248042197;-0.13212210418017478;-0.4303042900230204;-0.45771538841454285
Submandibular lymph node enlargement;Long fibula;0.8255947679281235;1.0337694;0.5558002675399776;0.48924884852177186;0.9999567459343585;-0.17436197800623499;0.03381262319100775;-0.4441564783943809;-0.5107078974125866
Submandibular lymph node enlargement;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9073668569326401;1.1119283;0.5295283783601913;0.4642972739956679;0.9999201345566091;-0.09255327762396903;0.11200820921627908;-0.4703917561964178;-0.5356228605609412
Submandibular lymph node enlargement;Type II cryptotia;0.9869505297392607;0.873435;0.5041538932926402;0.5403952146761752;0.9999201345566091;-0.012969604817348435;-0.12648511410983176;-0.49576624126396895;-0.45952491988043387
Submandibular lymph node enlargement;Increased variability in muscle fiber diameter;0.707421749830246;0.9531745;0.5945131961981589;0.5149104819717379;0.9999473166570552;-0.2925255668268092;-0.04677284480189159;-0.40543412045889626;-0.4850368346853172
Submandibular lymph node enlargement;Widened proximal tibial metaphyses;0.7769793719053268;1.078799;0.5715917290262247;0.47489147087255656;0.9999600672783046;-0.2229806953729777;0.07883894204481556;-0.42836833825207987;-0.525068596405748
Submandibular lymph node enlargement;Wide anterior fontanel;0.7390714287757874;0.8462192;0.584028707783459;0.5491449648952698;0.9999476714516888;-0.2608762426759015;-0.1537284894372235;-0.4159189636682299;-0.4508027065564191
Submandibular lymph node enlargement;Increased circulating oleate level;0.8196957260370255;1.0446583;0.5577082411080355;0.4857800806030005;0.9999201345566091;-0.18022440851958366;0.044738168704194115;-0.4422118934485736;-0.5141400539536086
Submandibular lymph node enlargement;Lozenge-shaped umbilicus;0.8342574387788773;1.0021137;0.5530020781457408;0.4993271843628694;0.9999584729108851;-0.16570103413200787;0.00215522700213977;-0.44695639476514437;-0.5006312885480158
Submandibular lymph node enlargement;Anti-myelin-associated glycoprotein antibody positivity;0.6454732418060303;0.83373815;0.6153580182093444;0.5531696943362661;0.6369582787135069;0.00851496309252342;0.196779869498926;-0.021600260504162416;-0.0837885843772408
Submandibular lymph node enlargement;Fractured radius;1.0190948024392128;1.1569188;0.4939215661929146;0.4498438959500214;0.9999600672783046;0.019134735160908245;0.15695869683607533;-0.50603850108539;-0.5501161713282832
Submandibular lymph node enlargement;Abnormal manual kinetic perimetry test;0.9138667210936546;1.1098257;0.5274510888327834;0.46497072340397916;0.9999201345566091;-0.08605341346295448;0.1099055957671824;-0.47246904572382575;-0.53494941115263
Submandibular lymph node enlargement;Small radial epiphyses;0.974424920976162;1.183733;0.508141688216665;0.4411818045250354;0.9999201345566091;-0.02549521358044715;0.1838128518935862;-0.49177844633994405;-0.5587383300315737
Submandibular lymph node enlargement;Generalized keratosis follicularis;0.7714309394359589;0.88108575;0.5734046721885925;0.5379413553157336;0.9999600672783046;-0.2285291278423457;-0.11887431383744762;-0.4265553950897121;-0.46201871196257094
Submandibular lymph node enlargement;Hypoplasia of the calcaneus;0.9306652471423149;0.98729473;0.5220876584844436;0.5040443260755685;0.9999584729108851;-0.06929322576857022;-0.012663739386562622;-0.4778708144264415;-0.49591414683531665
Submandibular lymph node enlargement;2-hydroxyadipic aciduria;0.8469325602054596;1.015629;0.5489151736735447;0.49502492244141383;0.9999201345566091;-0.1529875743511495;0.01570891855923562;-0.4510049608830644;-0.5048952121151953
Submandibular lymph node enlargement;Potter facies;0.9095722734928131;0.8372952;0.5288234130714591;0.5520218276488751;0.9999552432134126;-0.09038296972059945;-0.1626600686147187;-0.4711318301419535;-0.4479334155645375
Submandibular lymph node enlargement;Increased heart rate variability;0.790150910615921;0.9591073;0.5672972702595789;0.513020194719156;0.8658135241678199;-0.07566261355189885;0.09329375560970699;-0.298516253908241;-0.3527933294486638
Submandibular lymph node enlargement;Aplastic zygomatic arch;0.8139165490865707;0.81212306;0.5595794805359108;0.5601606052705042;0.9999584729108851;-0.1860419238243144;-0.1878354126844447;-0.44037899237497435;-0.439797867640381
Submandibular lymph node enlargement;Testicular torsion;0.9048386886715889;1.0179319;0.5303366907421545;0.4942917933094333;0.9999600672783046;-0.09512137860671566;0.017971870893082165;-0.46962337653615005;-0.5056682739688713
Submandibular lymph node enlargement;Abolished vibration sense;0.9133347123861313;0.97372633;0.5276210680880516;0.5083641259555061;0.9999584729108851;-0.08662376052475385;-0.026232140723232544;-0.4723374048228335;-0.49159434695537907
Submandibular lymph node enlargement;Fractured metatarsal bone of digit 5;0.9389327876269817;1.1177541;0.5194503993038482;0.46243055045480297;0.9999201345566091;-0.06098734692962737;0.11783396719662576;-0.48046973525276093;-0.5374895841018061
Submandibular lymph node enlargement;Prolonged G2 phase of cell cycle;0.7347374558448792;0.88109803;0.585458632184477;0.5379374190026106;0.9999567459343585;-0.2652192900894793;-0.1188587139366778;-0.41449811374988144;-0.46201932693174785
Submandibular lymph node enlargement;Single naris;0.8187225759029388;0.7446674;0.5580231943671681;0.5821849541202428;0.9999567459343585;-0.18123417003141962;-0.25528933508383356;-0.4419335515671904;-0.4177717918141156
Submandibular lymph node enlargement;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8999149948358536;1.0319933;0.531911474843294;0.4898144711828605;0.9999201345566091;-0.10000513972075553;0.03207313536374001;-0.46800865971331507;-0.5101056633737486
Submandibular lymph node enlargement;Asymmetry of the thorax;0.7827575951814651;0.7412685;0.5697062089057747;0.5833044692321686;0.9999567459343585;-0.2171991507528933;-0.25868823034750543;-0.43025053702858373;-0.41665227670218985
Submandibular lymph node enlargement;Type 2 muscle fiber predominance;0.7170320451259613;0.89281887;0.5913190093647822;0.5341824702725546;0.9999556674707869;-0.2829236223448256;-0.1071367993105391;-0.4086366581060047;-0.4657731971982323
Submandibular lymph node enlargement;Dependency on parenteral nutrition;0.9152290523052216;1.1231495;0.5270158533352103;0.4607005272775927;0.9999584729108851;-0.08472942060566357;0.12319104128741809;-0.47294261957567485;-0.5392579456332924
Submandibular lymph node enlargement;Limited shoulder flexion;0.8091621100902557;0.97649616;0.561120480698713;0.5074821948182526;0.9999201345566091;-0.19075802446635337;-0.023423974526244118;-0.4387996538578961;-0.4924379397383565
Submandibular lymph node enlargement;Paroxysmal vertigo;0.8020318448543549;0.940219;0.563434263137222;0.5190402428412169;0.9999584729108851;-0.19792662805653027;-0.05973948783016614;-0.43652420977366313;-0.4809182300696683
Submandibular lymph node enlargement;Long hallux;0.8185451924800873;1.0557488;0.5580806094565811;0.48224538149707774;0.9999526340597648;-0.18140744157967748;0.05579618624510585;-0.44187202460318364;-0.517707252562687
Submandibular lymph node enlargement;Broad medial eyebrow;0.7761279940605164;0.80887127;0.5718697607081249;0.5612147845591967;0.9999600672783046;-0.2238320732177882;-0.19108879805223034;-0.42809030657017966;-0.43874528271910784
Submandibular lymph node enlargement;Myxoid subcutaneous tumors;0.59074667096138;0.5769516;0.6342107707039739;0.6390399585609169;0.9999600672783046;-0.40921339631692455;-0.4230084443153529;-0.36574929657433064;-0.36092010871738767
Submandibular lymph node enlargement;Bulbous tips of toes;0.9434907250106335;1.1372272;0.517997047893926;0.456180963511139;0.9999584729108851;-0.056467747900251664;0.13726870470904895;-0.48196142501695916;-0.5437775093997461
Submandibular lymph node enlargement;Absent internal genitalia;0.8400700986385345;0.7902042;0.5511268192814608;0.5672799127500789;0.9999201345566091;-0.15985003591807456;-0.2097159075859365;-0.4487933152751483;-0.43264022180653017
Submandibular lymph node enlargement;Hyperphalangy of the 2nd finger;0.826642781496048;1.1143745;0.5554615140872292;0.4635136255301341;0.9999600672783046;-0.17331728578225658;0.11441445111616566;-0.44449855319107534;-0.5364464417481705
Submandibular lymph node enlargement;Renal interstitial hemosiderin;0.8816294297575951;0.95025647;0.5377670715522567;0.5158404038965758;0.9999201345566091;-0.11829070479901405;-0.04966366769106956;-0.46215306300435244;-0.4840797306600333
Submandibular lymph node enlargement;Abnormality of depressor anguli oris muscle;0.7190574407577515;0.778247;0.5906470424189716;0.5711778719719536;0.9999201345566091;-0.28086269379885764;-0.22167313576968284;-0.4092730921376375;-0.42874226258465553
Submandibular lymph node enlargement;Paroxysmal dyspnea;0.7818313241004944;0.8517449;0.5700082958687074;0.5473656633840298;0.9999201345566091;-0.21808881045611472;-0.1481752443435964;-0.4299118386879017;-0.4525544711725793
Submandibular lymph node enlargement;Phenylpyruvic acidemia;0.9133197441697121;1.0990579;0.5276258506167629;0.46841709642288576;0.9999600672783046;-0.08664032310859249;0.09909784554823353;-0.47233421666154163;-0.5315429708554188
Submandibular lymph node enlargement;Lateral ventricle dilatation;0.7715877592563629;1.0534403;0.5733533985006949;0.4829813032185557;0.9999488789551968;-0.22836111969883388;0.05349145345752293;-0.4265954804545019;-0.5169675757366411
Submandibular lymph node enlargement;Neonatal unconjugated hyperbilirubinemia;0.888964019715786;1.1071403;0.5354168818153342;0.465830577476418;0.9999600672783046;-0.11099604756251857;0.1071802353797765;-0.46454318546297035;-0.5341294898018866
Submandibular lymph node enlargement;High maternal circulating alpha-fetoprotein concentration;0.8907345086336136;0.92081296;0.5348498672682127;0.5252324312604489;0.9999201345566091;-0.10918562592299552;-0.07910717011721702;-0.4650702672883964;-0.47468770329616017
Submandibular lymph node enlargement;Prominent nasolabial fold;0.6105713248252869;0.5753863;0.6273275254218487;0.6395900741541498;0.9999545338528789;-0.38938320902759205;-0.42456824807101856;-0.37262700843103025;-0.3603644596987291
Submandibular lymph node enlargement;Abnormality of inferior alveolar nerve;0.5774649977684021;0.5858703;0.638859647435101;0.6359139993824484;0.9999201345566091;-0.422455136788207;-0.414049808991271;-0.36106048712150807;-0.3640061351741607
Submandibular lymph node enlargement;Unilateral conductive hearing impairment;0.7070057690143585;0.89214945;0.5946516754545164;0.5343968098829195;0.9999600672783046;-0.29295429826394603;-0.10781061888352916;-0.4053083918237882;-0.46556325739538507
Submandibular lymph node enlargement;Macular hypopigmented whorls, streaks, and patches;0.8237245827913284;0.896678;0.5564049336139494;0.5329472297973843;0.9999600672783046;-0.17623548448697612;-0.10328209639207409;-0.4435551336643552;-0.46701283748092026
Submandibular lymph node enlargement;Delayed ossification of pubic rami;0.8157115280628204;0.9022607;0.5589980644279496;0.5311611225806072;0.9999584729108851;-0.1842469448480647;-0.09769775218105725;-0.4409604084829355;-0.4687973503302779
Submandibular lymph node enlargement;Hyperphenylalaninemia;0.8095287978649139;1.0149637;0.5610015793699867;0.4952367278538614;0.9999561589935034;-0.1904273611285895;0.015007587077358386;-0.4389545796235167;-0.504719431139642
Submandibular lymph node enlargement;Ureteropelvic junction obstruction;0.8553382903337479;1.1319611;0.5462093891158006;0.45787261473073804;0.9999528219730685;-0.1446145316393206;0.13200828528095987;-0.4537434328572678;-0.5420802072423304
Submandibular lymph node enlargement;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8835671246051788;1.1386683;0.5371459889305952;0.4557178124228781;0.9999201345566091;-0.11635300995143028;0.13874816416470437;-0.46277414562601393;-0.544202322133731
Submandibular lymph node enlargement;Difficulty walking;0.8651521801948547;1.0132738;0.5430545563358931;0.49577468176209327;0.9999461221900431;-0.13479394199518835;0.013327712992146856;-0.45689156585415003;-0.5041714404279498
Submandibular lymph node enlargement;Bilobate gallbladder;0.8529495000839233;0.8819735;0.5469779843644549;0.5376567758190915;0.9999584729108851;-0.1470089728269618;-0.11798496789074353;-0.45298048854643025;-0.4623016970917936
Submandibular lymph node enlargement;Histidinuria;0.9004576131701469;1.0697358;0.5317378871890663;0.47778438552159497;0.9999574798349273;-0.09949986666478039;0.06977828562222599;-0.468219592645861;-0.5221730943133324
Submandibular lymph node enlargement;Widened interpedicular distance;0.7809540629386902;0.97853965;0.5702944582129694;0.5068315750976466;0.9999201345566091;-0.21896607161791892;-0.021380488884764626;-0.4296256763436397;-0.49308855945896246
Hepatic hemangioma;Triangular epiphysis of the distal phalanx of the 2nd finger;0.8619610518217087;1.0055964;0.5440799137851475;0.4982186204476253;0.9999134918687169;-0.13795244004700824;0.005682907438534057;-0.4558335780835694;-0.5016948714210916
Hepatic hemangioma;Acne inversa;0.9053094387054443;1.0703362;0.5301861666349874;0.47759277881812756;0.9999528219730685;-0.09464338326762411;0.07038340067555215;-0.46976665533808104;-0.5223600431549409
Hepatic hemangioma;Dentin dysplasia;0.8267768919467926;0.9628311;0.5554181696386347;0.511833955854297;0.9999134918687169;-0.17313659992192432;-0.037082411908847535;-0.44449532223008226;-0.4880795360144199
Hepatic hemangioma;Aplasia of the inner ear;0.7505315691232681;1.0294638;0.5802558827931124;0.4906200404043539;0.9999584729108851;-0.249426903787617;0.02950529509448596;-0.4197025901177728;-0.5093384325065312
Hepatic hemangioma;Polycystic liver disease;0.5921413004398346;0.6287906;0.633724402512219;0.6210567911771795;0.6905613626982415;-0.09842006225840694;-0.06177074570910579;-0.05683696018602258;-0.06950457152106204
Hepatic hemangioma;Subungual hyperkeratosis;0.7020012736320496;0.87036586;0.5963191198361129;0.5413802945470209;0.9999536937290383;-0.29795242009698875;-0.12958783565103538;-0.40363457389292545;-0.45857339918201745
Hepatic hemangioma;Broad humeral epiphyses;0.783680647611618;0.9532499;0.5694052351090155;0.5148864456361418;0.9999134918687169;-0.21623284425709888;-0.046663620137912476;-0.4305082567597014;-0.4850270462325751
Hepatic hemangioma;Autoimmune thrombocytopenia;0.591797947883606;0.895736;0.6338441136871383;0.5332486867056876;0.9999484800242363;-0.40815053214063035;-0.10421250094403611;-0.366104366337098;-0.4666997933185487
Hepatic hemangioma;Adenomyosis;0.8656341731548309;1.0666515;0.5428997240955111;0.47876843098846256;0.9999584729108851;-0.1343242997560542;0.06669299059772082;-0.457058748815374;-0.5211900419224226
Hepatic hemangioma;Elevated leukocyte alkaline phosphatase;0.6695758402347565;0.94508886;0.6071917904255644;0.5174875462184697;0.9999584729108851;-0.33038263267612866;-0.0548696095380824;-0.39276668248532076;-0.4824709266924154
Hepatic hemangioma;Clasp-knife sign;0.8967078179121017;0.9072865;0.5329376709345566;0.5295540593974724;0.9999134918687169;-0.10320567395661517;-0.09262696709607288;-0.46697582093416035;-0.47035943247124457
Hepatic hemangioma;Keratosis pilaris;0.7733680903911591;0.9368683;0.572771438292691;0.5201088067019461;0.9999482333076865;-0.2265801429165274;-0.06307992333301604;-0.4271767950149955;-0.4798394266057403
Hepatic hemangioma;Lamina lucida cleavage;0.8467547446489334;0.92308944;0.5489724498694731;0.5245055924981299;0.9999528219730685;-0.15319807732413504;-0.07686337733576987;-0.4509803721035953;-0.47544722947493856
Hepatic hemangioma;Abnormal central response of multifocal electroretinogram;0.8317334651947021;0.9658235;0.5538169277744178;0.5108808469718377;0.9999134918687169;-0.16818002667401477;-0.034090020322543824;-0.4460965640942991;-0.48903264489687925
Hepatic hemangioma;Atypical or prolonged hepatitis;0.4895366430282593;0.5810627;0.6705261035915938;0.6375973136215183;0.7152708671182011;-0.22573422408994182;-0.1342081925958012;-0.04474476352660728;-0.07767355349668281
Hepatic hemangioma;Cubitus varus;0.989289278164506;1.0564942;0.5034093938378827;0.4820077527655122;0.9999134918687169;-0.01062421370421096;0.05658074412371472;-0.4965040980308342;-0.5179057391032047
Hepatic hemangioma;Nasal regurgitation;0.9135893136262894;1.1116115;0.527539720826003;0.46439877146665953;0.8526023716255289;0.06098694200076049;0.25900911385573333;-0.3250626507995259;-0.38820360015886934
Hepatic hemangioma;Moon facies;0.9555165022611618;0.99034643;0.5141642110372626;0.503072870387863;0.9999567459343585;-0.044440243673196655;-0.009610314202180725;-0.48579253489709584;-0.4968838755464955
Hepatic hemangioma;Intestinal pseudo-obstruction;0.7116200923919678;0.8625498;0.5931166016037486;0.543890721272017;0.7306935736890814;-0.019073481297113615;0.13185620811023502;-0.13757697208533282;-0.1868028524170644
Hepatic hemangioma;Bilateral renal atrophy;0.7650130391120911;0.94720894;0.5755047453580191;0.5168117273570889;0.9999584729108851;-0.23494543379879407;-0.05274953192806653;-0.42445372755286603;-0.4831467455537962
Hepatic hemangioma;Fractured left clavicle;0.8862989842891693;0.91650915;0.5362705961130589;0.5266069424982214;0.9999134918687169;-0.11361450757954761;-0.08340434040997668;-0.463642895755658;-0.47330654937049554
Hepatic hemangioma;Positive urine norcotinine test;0.977805532515049;1.0534497;0.5070652985544241;0.4829782964839824;0.9999134918687169;-0.02210795935366794;0.05353625807787732;-0.49284819331429286;-0.5169351953847345
Hepatic hemangioma;Long fibula;0.8055299520492554;1.0572972;0.5622987052139286;0.48175172649912634;0.9999548690865008;-0.1944249170372454;0.05734236068034493;-0.4376561638725722;-0.5182031425873744
Hepatic hemangioma;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8864804655313492;1.0986369;0.5362124523815887;0.4685517652104709;0.9999134918687169;-0.11343302633736774;0.09872337374712781;-0.46370103948712826;-0.531361726658246
Hepatic hemangioma;Type II cryptotia;0.8101911246776581;0.88778216;0.5607868366369538;0.5357954393935371;0.9999134918687169;-0.18972236719105884;-0.11213133540127918;-0.4391266552317631;-0.4641180524751798
Hepatic hemangioma;Increased variability in muscle fiber diameter;0.8172907829284668;0.9834594;0.5584866887343607;0.5052652789788853;0.9999445057306702;-0.18265372280220338;-0.01648509267906495;-0.4414578169963095;-0.4946792267517849
Hepatic hemangioma;Widened proximal tibial metaphyses;0.8393010199069977;1.0976635;0.5513748324550705;0.4688630957899238;0.9999584729108851;-0.16065745300388745;0.09770504885577747;-0.44858364045581467;-0.5310953771209613
Hepatic hemangioma;Wide anterior fontanel;0.8009269535541534;0.9841016;0.5637931030756584;0.5050608302111664;0.9999448992541466;-0.1990179456999932;-0.015843305759731363;-0.4361517961784882;-0.4948840690429802
Hepatic hemangioma;Increased circulating oleate level;0.7183571755886078;0.8766403;0.5908793227625158;0.5393668942006198;0.9999134918687169;-0.28155631628010913;-0.12327317204449817;-0.40903416910620116;-0.46054659766809714
Hepatic hemangioma;Lozenge-shaped umbilicus;0.7575022280216217;0.83597386;0.5779667106103712;0.5524481428347923;0.8526023716255289;-0.09510014360390717;-0.016628512792215888;-0.2746356610151577;-0.3001542287907366
Hepatic hemangioma;Anti-myelin-associated glycoprotein antibody positivity;0.80479596555233;0.92870826;0.5625369053342544;0.5227121340408891;0.9999134918687169;-0.1951175263163869;-0.07120523657773181;-0.43737658653446254;-0.4772013578278278
Hepatic hemangioma;Fractured radius;0.8728537410497665;0.97854596;0.5405817581928616;0.506829562930226;0.9999584729108851;-0.1271047318611186;-0.02141250914669446;-0.45937671471802355;-0.49312890998065917
Hepatic hemangioma;Abnormal manual kinetic perimetry test;0.89201470464468;1.0697218;0.5344399425676107;0.4777888526186803;0.9999134918687169;-0.1078987872240369;0.06980832610155896;-0.4654735493011062;-0.5221246392500366
Hepatic hemangioma;Small radial epiphyses;0.8862730786204338;1.0148231;0.5362788959803703;0.4952815076157402;0.9999134918687169;-0.11364041324828311;0.014909587240474975;-0.46363459588834666;-0.5046319842529767
Hepatic hemangioma;Generalized keratosis follicularis;0.7853272408246994;0.92314684;0.5688684973301898;0.52448726988258;0.9999584729108851;-0.21463123208618573;-0.07681162900066785;-0.4310899755806953;-0.47547120302830514
Hepatic hemangioma;Hypoplasia of the calcaneus;0.9371464848518372;1.1110268;0.5200200918147017;0.4645860748704408;0.9999567459343585;-0.0628102610825213;0.11107001798165717;-0.4799366541196568;-0.5353706710639177
Hepatic hemangioma;2-hydroxyadipic aciduria;0.7553710043430328;1.0171913;0.5786661644028825;0.4945275725879159;0.9999134918687169;-0.24454248752568408;0.017277798986690796;-0.4212473274658344;-0.505385919280801
Hepatic hemangioma;Potter facies;0.9361138120293617;0.9798515;0.5203494637992168;0.506413909315424;0.9999532306564473;-0.06383941862708553;-0.0201017463577412;-0.4796037668572305;-0.4935393213410233
Hepatic hemangioma;Increased heart rate variability;0.7002238035202026;1.051972;0.59691200814434;0.4834493498267013;0.8604559493242481;-0.16023214580404543;0.19151608226907468;-0.2635439411799081;-0.3770065994975468
Hepatic hemangioma;Aplastic zygomatic arch;0.8242493569850922;1.0664079;0.5562352435692202;0.4788461186423807;0.9999567459343585;-0.1757073889492663;0.06645117299569525;-0.4437215023651383;-0.5211106272919778
Hepatic hemangioma;Testicular torsion;0.824577197432518;1.0053024;0.5561292418672704;0.4983121906857245;0.9999584729108851;-0.17538127547836713;0.005343956288333618;-0.4438292310436147;-0.5016462822251606
Hepatic hemangioma;Abolished vibration sense;0.9765042401850224;1.1303253;0.507479620928545;0.45839782944382923;0.9999567459343585;-0.023452505749336106;0.13036857144845404;-0.4924771250058134;-0.5415589164905292
Hepatic hemangioma;Fractured metatarsal bone of digit 5;0.8785557672381401;1.0302975;0.5387525593424102;0.4903545090978776;0.9999134918687169;-0.12135772463057681;0.03038402590777234;-0.46116093252630674;-0.5095589827708393
Hepatic hemangioma;Prolonged G2 phase of cell cycle;0.8242098987102509;0.9603673;0.5562480021642826;0.512618777007387;0.9999548690865008;-0.17574497037624992;-0.03958754711842216;-0.44370686692221817;-0.48733609207911377
Hepatic hemangioma;Single naris;1.0478750169277191;1.0909387;0.48475508142163715;0.4710132844364222;0.9999548690865008;0.04792014784121834;0.09098381823802315;-0.5151997876648636;-0.5289415846500786
Hepatic hemangioma;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6890299916267395;0.8630865;0.6006538745332417;0.5437182266623493;0.9999134918687169;-0.3108835002419774;-0.13682697024319812;-0.3992596173354752;-0.45619526520636766
Hepatic hemangioma;Asymmetry of the thorax;0.6924358010292053;0.8057421;0.5995138831328938;0.562229868451817;0.9999548690865008;-0.30751906805729545;-0.1942127841064898;-0.400440985953607;-0.4377250006346838
Hepatic hemangioma;Type 2 muscle fiber predominance;0.8643973171710968;1.0235236;0.5432970641681367;0.49251153591976926;0.9999536937290383;-0.1355563765579415;0.023569875378017358;-0.4566566295609016;-0.507442157809269
Hepatic hemangioma;Dependency on parenteral nutrition;0.84286068379879;1.0380551;0.5502271706405211;0.48788376232947894;0.8526023716255289;-0.009741687826738898;0.18545269066847747;-0.3023752009850078;-0.36471860929604993
Hepatic hemangioma;Limited shoulder flexion;0.8737579137086868;0.9908252;0.540291613046249;0.5029204685943576;0.9999134918687169;-0.1261555781600301;-0.009088315629703247;-0.45962187882246797;-0.49699302327435935
Hepatic hemangioma;Paroxysmal vertigo;0.8173998892307281;1.0857352;0.5584513648710114;0.47267609112628106;0.9999567459343585;-0.1825568567036303;0.08577845590127386;-0.441505381063347;-0.5272806548080774
Hepatic hemangioma;Long hallux;0.8230940252542496;1.0722711;0.5566088510053213;0.4769753256106585;0.9999503740898522;-0.17685634883560264;0.07232073453746712;-0.4433415230845309;-0.5229750484791937
Hepatic hemangioma;Broad medial eyebrow;0.7841036319732666;0.86380523;0.5692673363875064;0.5434872995680063;0.9999584729108851;-0.21585484093761853;-0.13615323847866467;-0.43069113652337876;-0.4564711733428788
Hepatic hemangioma;Myxoid subcutaneous tumors;0.7979397475719452;0.7467196;0.5647636828088887;0.5815095359768261;0.693708343348085;0.10423140422386024;0.05301125542205665;-0.1289446605391963;-0.11219880737125887
Hepatic hemangioma;Bulbous tips of toes;0.9182962998747826;1.0702354;0.5260361177923094;0.47762497693769224;0.9999567459343585;-0.0816604460595759;0.07027862565530218;-0.47392062814204905;-0.5223317689966662
Hepatic hemangioma;Absent internal genitalia;0.9011090770363808;1.0515049;0.531529491541756;0.483598235100721;0.9999134918687169;-0.09880441483233615;0.05159135851885632;-0.4683840003269609;-0.516315256767996
Hepatic hemangioma;Hyperphalangy of the 2nd finger;0.7566544711589813;0.9460329;0.5782448927018267;0.5171866166931146;0.9999584729108851;-0.2433040017519038;-0.05392559117412976;-0.42171358020905847;-0.4827718562177705
Hepatic hemangioma;Renal interstitial hemosiderin;0.5355238318443298;0.60553634;0.6537573656697502;0.6290696103573052;0.9999134918687169;-0.4643896600243871;-0.3943771502015416;-0.34615612619896674;-0.3708438815114117
Hepatic hemangioma;Abnormality of depressor anguli oris muscle;0.8655140101909637;1.0646119;0.5429383234966592;0.4794190409829019;0.9999134918687169;-0.13439948167775317;0.06469841990496472;-0.45697516837205776;-0.520494450885815
Hepatic hemangioma;Paroxysmal dyspnea;0.8501313626766205;1.0467658;0.5478850776600259;0.48510853769988604;0.9999134918687169;-0.14978212919209644;0.046852312422054565;-0.452028414208691;-0.5148049541688309
Hepatic hemangioma;Phenylpyruvic acidemia;0.8101103603839874;1.0333207;0.5608130209170226;0.4893917510486826;0.9999584729108851;-0.1898481125268977;0.03336219244861194;-0.43914545199386257;-0.5105667218622025
Hepatic hemangioma;Lateral ventricle dilatation;0.6793548166751862;0.85738;0.6038997073167671;0.5455526912012574;0.9999462364511621;-0.32059141977597594;-0.1425662635164392;-0.396046529134395;-0.4543935452499047
Hepatic hemangioma;Neonatal unconjugated hyperbilirubinemia;0.7084594666957855;0.8294148;0.5941678224062366;0.5545658086952479;0.9999584729108851;-0.2914990062150996;-0.17054368800259045;-0.4057906505046486;-0.4453926642156373
Hepatic hemangioma;High maternal circulating alpha-fetoprotein concentration;0.6846532225608826;0.77807015;0.6021208316369692;0.5712356026028269;0.9999134918687169;-0.31526026930783435;-0.22184334006283923;-0.39779266023174775;-0.42867788926589
Hepatic hemangioma;Prominent nasolabial fold;0.8852531909942627;1.1111088;0.5366056755584252;0.4645598058388033;0.9999524555142131;-0.11469926451995038;0.11115632439301348;-0.4633467799557879;-0.5353926496754098
Hepatic hemangioma;Abnormality of inferior alveolar nerve;0.822550356388092;0.96502036;0.5567846881267646;0.5111366304392295;0.9999134918687169;-0.17736313548062488;-0.03489313330624744;-0.4431288037419523;-0.4887768614294874
Hepatic hemangioma;Unilateral conductive hearing impairment;0.8779502958059311;1.1107461;0.5389467313004452;0.4646759528368245;0.9999584729108851;-0.12200817710495404;0.11078767233752795;-0.4610117416104399;-0.5352825200740606
Hepatic hemangioma;Macular hypopigmented whorls, streaks, and patches;0.7197508215904236;0.8229682;0.5904170945128024;0.556649549587235;0.9999584729108851;-0.28020765132046155;-0.1769902879629176;-0.4095413783980827;-0.44330892332365013
Hepatic hemangioma;Delayed ossification of pubic rami;0.8163710534572601;1.05124;0.5587844860355313;0.48368268284365323;0.9999567459343585;-0.18358569247709833;0.05128322141183295;-0.44117225989882713;-0.5162740630907052
Hepatic hemangioma;Hyperphenylalaninemia;0.6179934144020081;0.97328347;0.6247668371801971;0.5085051453493942;0.9999542297279059;-0.3819608153258979;-0.026670760050934494;-0.37518739254770883;-0.49144908437851176
Hepatic hemangioma;Ureteropelvic junction obstruction;0.8320779800415039;0.9214799;0.5537056823728239;0.525019484482319;0.9999505803237132;-0.1678726002822093;-0.07847069951392927;-0.4462448979508893;-0.47493109584139415
Hepatic hemangioma;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9488433748483658;1.0821468;0.5162907702970507;0.4738223892563025;0.9999134918687169;-0.051070117020351136;0.08223327193285779;-0.4836227215716662;-0.5260911026124144
Hepatic hemangioma;Difficulty walking;0.9743424728512764;1.141492;0.508167940884769;0.45481004673269454;0.9999431787962207;-0.025600705944944346;0.1415488303666821;-0.4917752379114517;-0.5451331320635262
Hepatic hemangioma;Bilobate gallbladder;0.6421450078487396;0.80793667;0.6164917891757686;0.5615179023399602;0.7034299088560918;-0.06128490100735218;0.10450675953990429;-0.08693811968032317;-0.14191200651613156
Hepatic hemangioma;Histidinuria;0.6353986263275146;0.979423;0.6187947367913158;0.5065503220116196;0.9999556674707869;-0.36455704114327225;-0.02053268096337113;-0.3811609306794711;-0.49340534545916725
Hepatic hemangioma;Widened interpedicular distance;0.8578170537948608;1.0814275;0.545412131595439;0.47405212202525415;0.9999134918687169;-0.14209643807385608;0.08151396307970837;-0.4545013602732779;-0.5258613698434628
Triangular epiphysis of the distal phalanx of the 2nd finger;Acne inversa;0.9013434275984764;0.9896441;0.5314545288671245;0.5032964475475403;0.9998962300503706;-0.09855280245189424;-0.010252119847581342;-0.46844170118324613;-0.4965997825028303
Triangular epiphysis of the distal phalanx of the 2nd finger;Dentin dysplasia;0.6743656694889069;0.7475314;0.60557783406661;0.5812424366868786;1.0;-0.32563433051109314;-0.2524685859680176;-0.39442216593338997;-0.4187575633131214
Triangular epiphysis of the distal phalanx of the 2nd finger;Aplasia of the inner ear;0.8289311826229095;0.959296;0.5547220453453123;0.5129600710118543;0.9999201345566091;-0.17098895193369956;-0.040624146473723366;-0.4451980892112968;-0.48696006354475485
Triangular epiphysis of the distal phalanx of the 2nd finger;Polycystic liver disease;0.9096393436193466;1.080666;0.5288019762260584;0.4742953131364396;0.9999056439461368;-0.09026630032679017;0.08076030206063811;-0.4711036677200784;-0.5256103308096972
Triangular epiphysis of the distal phalanx of the 2nd finger;Subungual hyperkeratosis;0.7734047472476959;0.6572616;0.5727594583927134;0.6113544325396136;0.9999003561294039;-0.22649560888170794;-0.34263874609827594;-0.4271408977366905;-0.38854592358979023
Triangular epiphysis of the distal phalanx of the 2nd finger;Broad humeral epiphyses;0.6071566939353943;0.63849866;0.6285085238818117;0.6177356946774768;1.0;-0.3928433060646057;-0.3615013360977173;-0.37149147611818834;-0.3822643053225232
Triangular epiphysis of the distal phalanx of the 2nd finger;Autoimmune thrombocytopenia;0.7699360102415085;0.9079381;0.573893550664887;0.5293457489093242;0.9998726169824932;-0.2299366067409847;-0.09193449423316458;-0.4259790663176062;-0.470526868073169
Triangular epiphysis of the distal phalanx of the 2nd finger;Adenomyosis;0.982121279463172;1.0878187;0.5056912767281394;0.4720103707510612;0.9999201345566091;-0.01779885509343715;0.08789860724179177;-0.4942288578284697;-0.5279097638055479
Triangular epiphysis of the distal phalanx of the 2nd finger;Elevated leukocyte alkaline phosphatase;0.822077065706253;0.849211;0.556937777311691;0.5481814224892003;0.9999201345566091;-0.17784306885035606;-0.15070915700228782;-0.4429823572449181;-0.4517387120674088
Triangular epiphysis of the distal phalanx of the 2nd finger;Clasp-knife sign;0.8890646249055862;0.95588195;0.5353846591171652;0.5140477748078918;1.0;-0.11093537509441376;-0.04411804676055908;-0.46461534088283485;-0.48595222519210823
Triangular epiphysis of the distal phalanx of the 2nd finger;Keratosis pilaris;0.7729092091321945;0.78216034;0.5729214150703638;0.5699009852484768;0.9998710980331391;-0.2269618889009446;-0.21771075629348458;-0.42694968296277536;-0.42997011278466235
Triangular epiphysis of the distal phalanx of the 2nd finger;Lamina lucida cleavage;0.9123881161212921;1.0310203;0.5279235295521943;0.49012434565604635;0.9998962300503706;-0.08750811392907853;0.031124053648664995;-0.4719727004981763;-0.5097718843943243
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormal central response of multifocal electroretinogram;0.897245928645134;1.0869223;0.5327654686712475;0.4722968258094269;1.0;-0.10275407135486603;0.086922287940979;-0.4672345313287525;-0.5277031741905731
Triangular epiphysis of the distal phalanx of the 2nd finger;Atypical or prolonged hepatitis;0.9256899356842041;1.0972971;0.5236754515530739;0.46898030319232276;0.9999201345566091;-0.074230198872405;0.09737693785397439;-0.4762446830035352;-0.5309398313642864
Triangular epiphysis of the distal phalanx of the 2nd finger;Cubitus varus;0.9262328743934631;0.9542551;0.5235021531533381;0.5145661322444646;1.0;-0.07376712560653687;-0.045744895935058594;-0.47649784684666185;-0.48543386775553543
Triangular epiphysis of the distal phalanx of the 2nd finger;Nasal regurgitation;1.0333159416913986;1.1816682;0.4893932436096521;0.4418503153045852;0.9999134918687169;0.0334024498226817;0.1817546704771693;-0.5105202482590648;-0.5580631765641317
Triangular epiphysis of the distal phalanx of the 2nd finger;Moon facies;0.914925791323185;1.0637764;0.5271127342815538;0.47968554591088564;0.9999134918687169;-0.08498770054553195;0.0638628819945033;-0.4728007575871631;-0.5202279459578313
Triangular epiphysis of the distal phalanx of the 2nd finger;Intestinal pseudo-obstruction;0.8208892494440079;1.007907;0.557322043519517;0.4974830840445723;0.9998912449978579;-0.17900199555385;0.008015787968755905;-0.4425692014783409;-0.5024081609532856
Triangular epiphysis of the distal phalanx of the 2nd finger;Bilateral renal atrophy;0.7638619840145111;0.9386827;0.5758817467183652;0.5195301714905236;0.9999201345566091;-0.236058150542098;-0.06123745919497581;-0.4240383878382439;-0.4803899630660855
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured left clavicle;0.6110290288925171;0.8273909;0.6271693631228665;0.5552197279164288;1.0;-0.3889709711074829;-0.1726090908050537;-0.37283063687713347;-0.4447802720835712
Triangular epiphysis of the distal phalanx of the 2nd finger;Positive urine norcotinine test;0.9671344496309757;1.1243818;0.5104633138224324;0.46030523119108835;1.0;-0.03286555036902428;0.12438178062438965;-0.4895366861775676;-0.5396947688089117
Triangular epiphysis of the distal phalanx of the 2nd finger;Long fibula;0.8121272027492523;0.783816;0.5601592724167527;0.5693611183216171;0.6109530888848884;0.2011741138643639;0.17286289107269215;-0.050793816468135744;-0.04159197056327135
Triangular epiphysis of the distal phalanx of the 2nd finger;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.38922274112701416;0.29087174;0.7091429171326366;0.7509112911692573;1.0;-0.6107772588729858;-0.7091282606124878;-0.29085708286736345;-0.24908870883074274
Triangular epiphysis of the distal phalanx of the 2nd finger;Type II cryptotia;0.7152280807495117;0.9391304;0.5919178643892391;0.5193873779198663;1.0;-0.2847719192504883;-0.060869574546813965;-0.4080821356107609;-0.48061262208013367
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased variability in muscle fiber diameter;0.8277411609888077;0.9783775;0.5551065487487672;0.5068831834604404;0.7712186293488323;0.05652253163997534;0.20715889168922308;-0.21611208060006515;-0.264335445888392
Triangular epiphysis of the distal phalanx of the 2nd finger;Widened proximal tibial metaphyses;0.6925623416900635;0.6223115;0.5994715530006474;0.6232809889277732;0.4693866352828394;0.22317570640722406;0.15292483760992182;0.13008491771780795;0.15389435364493376
Triangular epiphysis of the distal phalanx of the 2nd finger;Wide anterior fontanel;1.0023064129054546;1.1387218;0.49926584531967666;0.4557006229915307;0.6617971500655027;0.340509262839952;0.4769246736268191;-0.162531304745826;-0.20609652707397197
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased circulating oleate level;0.8926086127758026;0.9793081;0.5342497899408376;0.5065868991776623;1.0;-0.10739138722419739;-0.020691871643066406;-0.4657502100591624;-0.4934131008223377
Triangular epiphysis of the distal phalanx of the 2nd finger;Lozenge-shaped umbilicus;0.7979648262262344;0.90670097;0.5647555319187251;0.5297412543220593;0.9999134918687169;-0.20194866564248248;-0.09321252312634631;-0.43515795994999185;-0.4701722375466576
Triangular epiphysis of the distal phalanx of the 2nd finger;Anti-myelin-associated glycoprotein antibody positivity;0.9052764400839806;1.0301687;0.5301967178481852;0.49039555286955505;1.0;-0.09472355991601944;0.030168652534484863;-0.46980328215181477;-0.509604447130445
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured radius;0.5610102415084839;0.4138416;0.6446635639396835;0.6993603750797447;0.4693866352828394;0.09162360622564447;-0.05554503009637701;0.17527692865684408;0.22997373979690527
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormal manual kinetic perimetry test;0.7172149419784546;0.9377182;0.5912583124021894;0.5198377396378322;1.0;-0.2827850580215454;-0.062281787395477295;-0.4087416875978106;-0.4801622603621678
Triangular epiphysis of the distal phalanx of the 2nd finger;Small radial epiphyses;0.45746713876724243;0.34859717;0.6825346039242648;0.725819183400685;1.0;-0.5425328612327576;-0.6514028310775757;-0.3174653960757352;-0.27418081659931504
Triangular epiphysis of the distal phalanx of the 2nd finger;Generalized keratosis follicularis;0.8736893087625504;0.8859047;0.5403136268975814;0.5363969085972913;0.9999201345566091;-0.12623082579405875;-0.11401540519030662;-0.45960650765902766;-0.46352322595931783
Triangular epiphysis of the distal phalanx of the 2nd finger;Hypoplasia of the calcaneus;0.6622463464736938;0.7135569;0.6096670748106265;0.5924729333545263;0.6433114794007544;0.018934867072939454;0.07024540631854492;-0.03364440459012785;-0.05083854604622806
Triangular epiphysis of the distal phalanx of the 2nd finger;2-hydroxyadipic aciduria;0.684747040271759;0.9534591;0.602089363403353;0.5148197917830222;1.0;-0.31525295972824097;-0.046540915966033936;-0.39791063659664705;-0.4851802082169778
Triangular epiphysis of the distal phalanx of the 2nd finger;Potter facies;0.8839396387338638;0.9504286;0.5370266046197354;0.5157855441067551;0.9998981869165328;-0.11595854818266893;-0.04946958183688188;-0.46287158229679737;-0.4841126428097776
Triangular epiphysis of the distal phalanx of the 2nd finger;Increased heart rate variability;0.9565864652395248;1.1087003;0.513823301839601;0.46533112938422505;0.9999201345566091;-0.04333366931708427;0.10878014086453347;-0.4860968327170081;-0.5345890051723841
Triangular epiphysis of the distal phalanx of the 2nd finger;Aplastic zygomatic arch;0.744959682226181;0.936895;0.5820887454483183;0.5201003041869475;0.8072246192530101;-0.062264937026829115;0.12967039360251964;-0.2251358738046918;-0.2871243150660626
Triangular epiphysis of the distal phalanx of the 2nd finger;Testicular torsion;0.7944976687431335;0.9493729;0.5658828145372412;0.5161219941419346;0.9999201345566091;-0.20542246581347556;-0.05054724694521995;-0.4340373200193679;-0.4837981404146745
Triangular epiphysis of the distal phalanx of the 2nd finger;Abolished vibration sense;0.906081348657608;1.0400035;0.5299393601393347;0.487263096290255;0.9999134918687169;-0.09383214321110889;0.04009004626299695;-0.4699741317293822;-0.5126503955784619
Triangular epiphysis of the distal phalanx of the 2nd finger;Fractured metatarsal bone of digit 5;0.42921173572540283;0.25611436;0.6933622895991924;0.7670192923206745;1.0;-0.5707882642745972;-0.7438856363296509;-0.30663771040080756;-0.23298070767932555
Triangular epiphysis of the distal phalanx of the 2nd finger;Prolonged G2 phase of cell cycle;0.7568098604679108;0.9997772;0.5781938988500883;0.5000709230959606;0.9999056439461368;-0.24309578347822602;-0.00012844610830720082;-0.4217117450960485;-0.4998347208501762
Triangular epiphysis of the distal phalanx of the 2nd finger;Single naris;1.0066297962330282;1.0864105;0.4978896548556958;0.472460348208423;0.9999056439461368;0.006724152286891383;0.08650487851480071;-0.502015989090441;-0.5274452957377138
Triangular epiphysis of the distal phalanx of the 2nd finger;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7965057790279388;1.0308985;0.565229813125878;0.4901631576008675;1.0;-0.20349422097206116;0.030898451805114746;-0.43477018687412206;-0.5098368423991325
Triangular epiphysis of the distal phalanx of the 2nd finger;Asymmetry of the thorax;0.7587451636791229;1.040145;0.5775589647092236;0.48721799741509386;0.789736248610815;-0.030991084931692114;0.2504087909475956;-0.2121772839015914;-0.3025182511957212
Triangular epiphysis of the distal phalanx of the 2nd finger;Type 2 muscle fiber predominance;0.729976236820221;0.97780836;0.5870315605746224;0.5070644072086454;0.8527273749847077;-0.1227511381644868;0.12508098130038747;-0.2656958144100854;-0.3456629677760623
Triangular epiphysis of the distal phalanx of the 2nd finger;Dependency on parenteral nutrition;0.882794126868248;0.9085672;0.5373937380530149;0.5291446624083902;0.9999134918687169;-0.11711936500046893;-0.09134630169842883;-0.462519753815702;-0.4707688294603267
Triangular epiphysis of the distal phalanx of the 2nd finger;Limited shoulder flexion;0.686826229095459;1.0908437;0.6013922286615048;0.4710436526955185;1.0;-0.313173770904541;0.09084367752075195;-0.39860777133849523;-0.5289563473044815
Triangular epiphysis of the distal phalanx of the 2nd finger;Paroxysmal vertigo;0.8999610468745232;1.1082151;0.5318967420834186;0.46548648397819203;0.9999134918687169;-0.09995244499419376;0.10830160174395398;-0.4680167497852983;-0.5344270078905249
Triangular epiphysis of the distal phalanx of the 2nd finger;Long hallux;0.8177060186862946;0.59416664;0.5583522573867892;0.6330186800108699;0.4528204051665701;0.3648856135197245;0.1413462313004099;0.1055318522202191;0.18019827484429984
Triangular epiphysis of the distal phalanx of the 2nd finger;Broad medial eyebrow;0.8599592298269272;0.959679;0.5447233635974122;0.5128380602679472;0.9999201345566091;-0.13996090472968192;-0.040241127026396706;-0.45519677095919686;-0.4870820742886619
Triangular epiphysis of the distal phalanx of the 2nd finger;Myxoid subcutaneous tumors;0.8325051665306091;0.8904005;0.553567751119139;0.5349568114845548;0.9999201345566091;-0.16741496802599998;-0.10951960564883323;-0.4463523834374701;-0.46496332307205435
Triangular epiphysis of the distal phalanx of the 2nd finger;Bulbous tips of toes;0.6747112572193146;0.4712301;0.605461496085901;0.6773465569109416;0.593333426887708;0.08137783033160662;-0.12210333722324873;0.012128069198193092;0.08401313002323363
Triangular epiphysis of the distal phalanx of the 2nd finger;Absent internal genitalia;0.8475695848464966;0.95933694;0.5487099946587617;0.5129470223735976;1.0;-0.15243041515350342;-0.040663063526153564;-0.4512900053412383;-0.48705297762640243
Triangular epiphysis of the distal phalanx of the 2nd finger;Hyperphalangy of the 2nd finger;0.28099799156188965;0.23575747;0.7554008097805415;0.776886950644912;0.40280785677892184;-0.12180986521703219;-0.16705038664800143;0.35259295300161964;0.37407909386599014
Triangular epiphysis of the distal phalanx of the 2nd finger;Renal interstitial hemosiderin;0.8414084613323212;1.0626143;0.5506952974662509;0.48005618420590657;1.0;-0.15859153866767883;0.0626143217086792;-0.4493047025337491;-0.5199438157940934
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormality of depressor anguli oris muscle;0.7837347090244293;1.0927753;0.569387609607426;0.47042616164208795;1.0;-0.21626529097557068;0.09277534484863281;-0.43061239039257404;-0.529573838357912
Triangular epiphysis of the distal phalanx of the 2nd finger;Paroxysmal dyspnea;0.7733574211597443;1.0128219;0.572774925145078;0.4959185379712032;1.0;-0.22664257884025574;0.01282191276550293;-0.427225074854922;-0.5040814620287968
Triangular epiphysis of the distal phalanx of the 2nd finger;Phenylpyruvic acidemia;0.7729182094335556;0.9705162;0.5729184733314777;0.5093863437343168;0.9999201345566091;-0.2270019251230535;-0.029403929722624733;-0.4270016612251314;-0.4905337908222923
Triangular epiphysis of the distal phalanx of the 2nd finger;Lateral ventricle dilatation;0.8533712923526764;1.101388;0.5468422524229567;0.4676716650972712;0.9998579617208769;-0.14648666936820054;0.10153001587922073;-0.45301570929792023;-0.5321862966236057
Triangular epiphysis of the distal phalanx of the 2nd finger;Neonatal unconjugated hyperbilirubinemia;0.8991590440273285;0.9926764;0.532153325034293;0.5023312070920325;0.9999201345566091;-0.10076109052928062;-0.007243757260161354;-0.4677668095223161;-0.4975889274645766
Triangular epiphysis of the distal phalanx of the 2nd finger;High maternal circulating alpha-fetoprotein concentration;0.8851291686296463;1.0596931;0.5366454158819127;0.4809877777728171;1.0;-0.1148708313703537;0.059693098068237305;-0.4633545841180873;-0.5190122222271829
Triangular epiphysis of the distal phalanx of the 2nd finger;Prominent nasolabial fold;0.8867273256182671;1.0794455;0.5361333642456272;0.47468505004529704;0.9998944404568447;-0.11316711483857766;0.07955104084350928;-0.46376107621121754;-0.5252093904115477
Triangular epiphysis of the distal phalanx of the 2nd finger;Abnormality of inferior alveolar nerve;0.8040840923786163;0.87877434;0.5627679629277759;0.5386824612505248;1.0;-0.19591590762138367;-0.12122565507888794;-0.43723203707222413;-0.46131753874947523
Triangular epiphysis of the distal phalanx of the 2nd finger;Unilateral conductive hearing impairment;0.9529103189706802;1.0682237;0.514994656114697;0.47826683064379494;0.9999201345566091;-0.04700981558592887;0.0683035802718821;-0.48492547844191214;-0.5216533039128142
Triangular epiphysis of the distal phalanx of the 2nd finger;Macular hypopigmented whorls, streaks, and patches;0.8552967458963394;1.0067134;0.5462227537417359;0.4978630340159681;0.9999201345566091;-0.1446233886602697;0.006793255793732689;-0.4536973808148732;-0.502057100540641
Triangular epiphysis of the distal phalanx of the 2nd finger;Delayed ossification of pubic rami;0.7189357876777649;0.81357825;0.5906873915954268;0.5596890781161432;0.6574179255159834;0.061517862161781456;0.15616032250800338;-0.06673053392055661;-0.09772884739984022
Triangular epiphysis of the distal phalanx of the 2nd finger;Hyperphenylalaninemia;0.8578072339296341;1.01118;0.5454152894403017;0.4964411921584254;0.9999028053808913;-0.14209557145125717;0.011277237839628751;-0.45448751594058956;-0.5034616132224659
Triangular epiphysis of the distal phalanx of the 2nd finger;Ureteropelvic junction obstruction;0.8262844085693359;0.8434967;0.5555773451859869;0.550022190454071;0.9998847295244674;-0.17360032095513145;-0.1563880492647628;-0.4443073843384805;-0.4498625390703964
Triangular epiphysis of the distal phalanx of the 2nd finger;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.2021855115890503;0.14353323;0.7940105848100782;0.8273453164538563;1.0;-0.7978144884109497;-0.8564667701721191;-0.20598941518992175;-0.17265468354614366
Triangular epiphysis of the distal phalanx of the 2nd finger;Difficulty walking;0.982350368052721;0.98972416;0.5056183440566723;0.5032709580834056;0.7552776988623575;0.2270726691903635;0.23444646037836514;-0.24965935480568524;-0.2520067407789519
Triangular epiphysis of the distal phalanx of the 2nd finger;Bilobate gallbladder;0.911673054099083;1.0642024;0.5281520267113379;0.47954966208372385;0.9999134918687169;-0.08824043776963397;0.06428893599535779;-0.47176146515737905;-0.5203638297849931
Triangular epiphysis of the distal phalanx of the 2nd finger;Histidinuria;0.8287491500377655;0.9910861;0.5547808559690506;0.502837416737381;0.9999090677057578;-0.17115991766799232;-0.008822942331917494;-0.44512821173670725;-0.4970716509683768
Triangular epiphysis of the distal phalanx of the 2nd finger;Widened interpedicular distance;0.7436480820178986;0.9133207;0.5825205967437376;0.5276255340031707;1.0;-0.25635191798210144;-0.08667927980422974;-0.4174794032562624;-0.4723744659968293
Acne inversa;Dentin dysplasia;0.8693604916334152;0.7562988;0.5417030478337543;0.5783616170714639;0.9998962300503706;-0.13053573841695543;-0.24359744960908647;-0.4581931822166163;-0.4215346129789067
Acne inversa;Aplasia of the inner ear;0.7914312183856964;1.1417577;0.5668805131732315;0.4547246145878451;0.9999548690865008;-0.20852365070080436;0.14180285758281075;-0.43307435591326926;-0.5452302544986557
Acne inversa;Polycystic liver disease;0.9593857824802399;1.1083503;0.5129314637256008;0.4654431968930044;0.9999505803237132;-0.04056479784347333;0.10839969662330828;-0.48701911659811237;-0.5345073834307088
Acne inversa;Subungual hyperkeratosis;0.8460621535778046;0.6150329;0.5491955557394891;0.6257872061369112;0.8007304775429361;0.04533167603486843;-0.18569756624227696;-0.25153492180344705;-0.17494327140602495
Acne inversa;Broad humeral epiphyses;0.9488290846347809;1.0914967;0.5162953249786835;0.4708349108118848;0.9998962300503706;-0.051067145415589765;0.09160047595854048;-0.4836009050716872;-0.5290613192384859
Acne inversa;Autoimmune thrombocytopenia;0.8570700287818909;1.1467392;0.5456523706889478;0.45312218746357513;0.7013592136452191;0.15571081513667173;0.44538003081584043;-0.15570684295627135;-0.248237026181644
Acne inversa;Adenomyosis;0.6599360108375549;0.9390297;0.6104487371235692;0.5194195015281254;0.9999548690865008;-0.34001885824894584;-0.06092517548298515;-0.3895061319629316;-0.48053536755837534
Acne inversa;Elevated leukocyte alkaline phosphatase;0.8881322965025902;0.94836485;0.5356832872945078;0.5164432862742692;0.9999548690865008;-0.1118225725839106;-0.05159001522755302;-0.464271581791993;-0.4835115828122316
Acne inversa;Clasp-knife sign;0.9809842053800821;0.8932391;0.5060532802700168;0.5340479404871948;0.9998962300503706;-0.01891202467028852;-0.10665714914445634;-0.4938429497803538;-0.4658482895631758
Acne inversa;Keratosis pilaris;0.8218850493431091;0.49478525;0.5569998901429813;0.6685867168566132;0.7746350753780699;0.04724997396503927;-0.279849826144824;-0.2176351852350885;-0.10604835852145666
Acne inversa;Lamina lucida cleavage;0.7901976108551025;0.84024596;0.5672820666614045;0.5510701206798648;0.7966047757128065;-0.006407164857703984;0.04364118643013781;-0.22932270905140206;-0.2455346550329417
Acne inversa;Abnormal central response of multifocal electroretinogram;0.8843060061335564;1.0182513;0.5369091953319507;0.4941901212794969;0.9998962300503706;-0.11559022391681428;0.018355069807722613;-0.46298703471841995;-0.5057061087708737
Acne inversa;Atypical or prolonged hepatitis;0.9096325486898422;1.0504934;0.5288041480044756;0.48392063166432586;0.7102929024706535;0.19933964621918876;0.3402004570950814;-0.18148875446617785;-0.2263722708063276
Acne inversa;Cubitus varus;0.7940245121717453;1.0588741;0.566036717409975;0.4812489285804862;0.9998962300503706;-0.20587171787862535;0.05897790019865279;-0.4338595126403957;-0.5186473014698845
Acne inversa;Nasal regurgitation;0.7238970100879669;0.6962795;0.589043088559157;0.5982288951609515;0.9999528219730685;-0.27605581188510153;-0.3036732962162325;-0.41090973341391146;-0.401723926812117
Acne inversa;Moon facies;0.8815260082483292;0.74486905;0.5378002249306886;0.5821185805004878;0.9999528219730685;-0.11842681372473929;-0.2550837686092684;-0.4621525970423799;-0.41783424147258064
Acne inversa;Intestinal pseudo-obstruction;0.7079586684703827;0.9884592;0.5943344842022207;0.5036736258697962;0.9999468979947994;-0.2919882295244167;-0.011487668525500094;-0.40561241379257873;-0.49627327212500316
Acne inversa;Bilateral renal atrophy;0.77292799949646;0.9983391;0.5729152734670728;0.5005286814901109;0.9999548690865008;-0.22702686959004081;-0.0016157525131670347;-0.42703959561942795;-0.4994261875963899
Acne inversa;Fractured left clavicle;0.8686152845621109;1.0029715;0.5419423169336395;0.4990541193864143;0.9998962300503706;-0.13128094548825975;0.003075299910261675;-0.45795391311673117;-0.5008421106639563
Acne inversa;Positive urine norcotinine test;0.8280459940433502;0.9444266;0.5550080475745873;0.5176986890709452;0.9998962300503706;-0.17185023600702043;-0.05546963388566728;-0.4448881824757833;-0.48219754097942547
Acne inversa;Long fibula;1.0267816372215748;1.1950672;0.49147412069050334;0.4375074954130481;0.9999505803237132;0.026831056897861583;0.1951165869583913;-0.5084764596332099;-0.5624430849106651
Acne inversa;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8781303763389587;1.0227505;0.5388889787670503;0.4927576564119731;0.9998962300503706;-0.12176585371141191;0.0228542668139482;-0.4610072512833203;-0.5071385736383975
Acne inversa;Type II cryptotia;0.8727436512708664;0.8884126;0.5406170878433807;0.5355934986556572;0.9998962300503706;-0.12715257877950426;-0.1114836352551436;-0.45927914220698995;-0.46430273139471345
Acne inversa;Increased variability in muscle fiber diameter;0.8135708570480347;0.9787989;0.5596914775441488;0.5067490082577257;0.999937876518323;-0.18636701947028833;-0.021138950641705567;-0.44024639897417417;-0.49318886826059727
Acne inversa;Widened proximal tibial metaphyses;0.9584413319826126;1.1241839;0.5132323457333465;0.46036872245859095;0.9999548690865008;-0.041513537103888165;0.12422902411723458;-0.48672252335315425;-0.5395861466279098
Acne inversa;Wide anterior fontanel;0.8841751515865326;1.0102303;0.5369511295398592;0.4967435354860825;0.9999383692587659;-0.1157632176722333;0.010291933551903054;-0.46298723971890665;-0.5031948337726834
Acne inversa;Increased circulating oleate level;0.9703495502471924;1.068373;0.5094394147397316;0.47821920218183744;0.9998962300503706;-0.029546679803178266;0.06847673480863814;-0.490456815310639;-0.5216770278685332
Acne inversa;Lozenge-shaped umbilicus;0.8415094017982483;1.0056478;0.5506627555402215;0.49820226093738196;0.9999528219730685;-0.15844342017482016;0.0056949565379789124;-0.44929006643284697;-0.5017505610356865
Acne inversa;Anti-myelin-associated glycoprotein antibody positivity;0.7431395649909973;0.8964969;0.5826880704236899;0.5330051797007369;0.45807765254028776;0.28506191245070955;0.43841923943511507;0.1246104178834021;0.07492752716044915
Acne inversa;Fractured radius;0.8719239234924316;0.9857397;0.5408801680423443;0.5045393392772097;0.9999548690865008;-0.12803094559406913;-0.014215161139723431;-0.4590747010441565;-0.49541552980929104
Acne inversa;Abnormal manual kinetic perimetry test;0.9134644344449043;1.0380281;0.5275796205611223;0.48789234897001377;0.9998962300503706;-0.08643179560546632;0.03813189094419722;-0.47231660948924836;-0.5120038810803569
Acne inversa;Small radial epiphyses;0.8609817922115326;0.9934335;0.5443946564247433;0.5020902079505414;0.9998962300503706;-0.13891443783883806;-0.0064627545559858834;-0.4555015736256274;-0.49780602209982927
Acne inversa;Generalized keratosis follicularis;0.6775276362895966;0.32961953;0.6045139391014096;0.7338690927475371;0.8230814931248395;-0.1455538568352429;-0.4934619662617413;-0.21856755402342987;-0.08921240037730238
Acne inversa;Hypoplasia of the calcaneus;0.798554390668869;1.0639021;0.5645639281659769;0.4796454434699149;0.9999528219730685;-0.20139843130419943;0.06394931769062784;-0.43538889380709156;-0.5203073785031536
Acne inversa;2-hydroxyadipic aciduria;0.7441057860851288;0.97230536;0.5823698776540582;0.5088166123315749;0.9998962300503706;-0.25579044396524186;-0.027590872594163374;-0.4175263523963124;-0.4910796177187957
Acne inversa;Potter facies;0.9954334544017911;0.7519698;0.5014535816616539;0.5797832182458837;0.9999486088983908;-0.0045151544965996715;-0.24797879459785366;-0.4984950272367369;-0.420165390652507
Acne inversa;Increased heart rate variability;0.8437325656414032;0.9639466;0.5499461704635905;0.5114786509620584;0.9999548690865008;-0.15622230344509758;-0.036008288199659955;-0.45000869862291026;-0.4884762181244424
Acne inversa;Aplastic zygomatic arch;0.7902571260929108;0.847716;0.5672626912742342;0.5486628567649056;0.9999528219730685;-0.20969569588015768;-0.1522368481190035;-0.4326901306988342;-0.4512899652081629
Acne inversa;Testicular torsion;0.8450558185577393;1.0233306;0.549519772084275;0.49257297942534317;0.9999548690865008;-0.15489905052876152;0.023375700180772174;-0.4504350970022257;-0.5073818896611576
Acne inversa;Abolished vibration sense;0.8548910170793533;0.9076259;0.5463532788756973;0.5294455558264428;0.9999528219730685;-0.14506180489371512;-0.09232690835307333;-0.45359954309737116;-0.47050726614662564
Acne inversa;Fractured metatarsal bone of digit 5;1.0619560331106186;1.0109512;0.4802661434950234;0.49651408280322373;0.9998962300503706;0.06205980306024794;0.01105493133421187;-0.5196300865553473;-0.5033821472471469
Acne inversa;Prolonged G2 phase of cell cycle;0.8908114358782768;0.9406942;0.5348252331757264;0.5188886994985411;0.9999505803237132;-0.10913914444543638;-0.05925636741020002;-0.4651253471479868;-0.4810618808251721
Acne inversa;Single naris;0.8331884890794754;0.7255688;0.5533471389861588;0.5884895665536838;0.9999505803237132;-0.1667620912442378;-0.2743818089614085;-0.44660344133755436;-0.4114610137700294
Acne inversa;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7999235987663269;0.8740661;0.5641190377954988;0.5401927252363289;0.9998962300503706;-0.19997263128404374;-0.12583011562471147;-0.4357771922548719;-0.45970350481404176
Acne inversa;Asymmetry of the thorax;0.7671234309673309;0.94785917;0.5748138153900153;0.5166044800678637;0.9999505803237132;-0.23282714935638227;-0.05209141227103986;-0.4251367649336979;-0.48334610025584945
Acne inversa;Type 2 muscle fiber predominance;0.8121529817581177;0.95355576;0.5601509179592203;0.514788972801735;0.9999491674684583;-0.18779618571034062;-0.04639340470066655;-0.43979824950923796;-0.48516019466672333
Acne inversa;Dependency on parenteral nutrition;0.99355414416641;1.1123255;0.5020517938452644;0.46417004678135065;0.9999528219730685;-0.0063986778066584815;0.11237272715260294;-0.497901028127804;-0.5357827751917178
Acne inversa;Limited shoulder flexion;0.7907552421092987;0.9996383;0.5671005378303201;0.5001151254497233;0.9998962300503706;-0.20914098794107194;-0.0002579110348677194;-0.43279569222005054;-0.4997811046006474
Acne inversa;Paroxysmal vertigo;0.8599109649658203;1.0053447;0.5447388797328856;0.4982987153971752;0.9999528219730685;-0.14004185700724814;0.0053919265239408265;-0.45521394224018286;-0.5016541065758933
Acne inversa;Long hallux;0.9602520801126957;1.0236871;0.5126554897436201;0.4924594530726609;0.9999451389191131;-0.03969305880641738;0.02374198533320626;-0.487289649175493;-0.5074856858464522
Acne inversa;Broad medial eyebrow;0.9247767478227615;0.74972034;0.5239669441590163;0.5805225564839682;0.8568390591914515;0.06793768863131;-0.10711872418473767;-0.3328721150324352;-0.2763165027074833
Acne inversa;Myxoid subcutaneous tumors;0.6540316939353943;0.6564374;0.6124495331797787;0.6116337475917671;0.8230814931248395;-0.16904979918944518;-0.16664409612166564;-0.2106319599450608;-0.21144774553307233
Acne inversa;Bulbous tips of toes;1.030324049293995;1.0246942;0.49034607539381503;0.4921387974571775;0.9999528219730685;0.030371227320926453;0.024741382357375885;-0.5096067465792534;-0.507814024515891
Acne inversa;Absent internal genitalia;0.7073915004730225;0.6632393;0.5945232655323232;0.6093313378132865;0.9998962300503706;-0.2925047295773482;-0.33665692979936357;-0.4053729645180475;-0.3905648922370841
Acne inversa;Hyperphalangy of the 2nd finger;0.8836033493280411;0.9356204;0.5371343793056997;0.520506841818184;0.9999548690865008;-0.1163515197584597;-0.06433444195484794;-0.46282048978080104;-0.4794480272683168
Acne inversa;Renal interstitial hemosiderin;0.7299959063529968;0.9119502;0.5870250580404612;0.5280634726407003;0.9998962300503706;-0.2699003236973738;-0.08794605905656572;-0.4128711720099094;-0.47183275740967034
Acne inversa;Abnormality of depressor anguli oris muscle;0.652877151966095;0.8644289;0.6128413126827461;0.5432869292500776;0.9998962300503706;-0.3470190780842757;-0.13546735221986528;-0.38705491736762454;-0.45660930080029305
Acne inversa;Paroxysmal dyspnea;0.777141273021698;0.8733249;0.5715388638010406;0.540430579931362;0.9998962300503706;-0.22275495702867265;-0.12657135898713823;-0.4283573662493301;-0.45946565011900864
Acne inversa;Phenylpyruvic acidemia;0.9032675549387932;1.0692288;0.530839116156997;0.4779461729545593;0.9999548690865008;-0.09668731414770759;0.06927389926219307;-0.4691157529295038;-0.5220086961319415
Acne inversa;Lateral ventricle dilatation;0.9329115450382233;1.1181488;0.5213709702480392;0.4623040249472983;0.9999400373813975;-0.0670284923431742;0.11820876632954003;-0.47856906713335823;-0.5376360124340992
Acne inversa;Neonatal unconjugated hyperbilirubinemia;0.8825872540473938;1.1237382;0.5374600455421399;0.4605116986875508;0.9999548690865008;-0.11736761503910698;0.1237833005836042;-0.4624948235443609;-0.53944317039895
Acne inversa;High maternal circulating alpha-fetoprotein concentration;0.916037380695343;1.0250945;0.5267576337974513;0.4920113310504187;0.9998962300503706;-0.08385884935502763;0.02519827907438521;-0.4731385962529193;-0.5078848989999519
Acne inversa;Prominent nasolabial fold;0.7152354419231415;0.5633509;0.5919154200504639;0.6438348564752963;0.9999476714516888;-0.28471222952854736;-0.43659675554287536;-0.4080322514012249;-0.3561128149763926
Acne inversa;Abnormality of inferior alveolar nerve;0.6413979828357697;0.75598866;0.6167464772769544;0.5784634100090713;0.9998962300503706;-0.358498247214601;-0.24390757257585283;-0.38314975277341623;-0.42143282004129934
Acne inversa;Unilateral conductive hearing impairment;0.8174298852682114;1.0824873;0.5584416535895893;0.47371361217898644;0.9999548690865008;-0.1825249838182894;0.08253247565532051;-0.44151321549691147;-0.5262412569075143
Acne inversa;Macular hypopigmented whorls, streaks, and patches;0.7763041257858276;0.6363261;0.5718122373766364;0.6184777485520898;0.8230814931248395;-0.04677736733901183;-0.18675541852461974;-0.251269255748203;-0.20460374457274966
Acne inversa;Delayed ossification of pubic rami;0.862774521112442;0.98660123;0.5438184906013019;0.5042650862821749;0.9999528219730685;-0.13717830086062643;-0.013351588490707611;-0.4561343313717665;-0.4956877356908935
Acne inversa;Hyperphenylalaninemia;0.9078408926725388;1.0594544;0.5293768398644547;0.4810638798194141;0.9999498126421364;-0.09210891996959769;0.05950462842842019;-0.47057297277768173;-0.5188859328227223
Acne inversa;Ureteropelvic junction obstruction;0.79267817735672;1.0718747;0.566474723394984;0.477101832868879;0.9999453908499725;-0.2072672134932525;0.07192934688959052;-0.4334706674549885;-0.5228435579810935
Acne inversa;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8982978612184525;1.0137457;0.5324288646434507;0.495624472073976;0.9998962300503706;-0.1015983688319182;0.013849435499861285;-0.4674673654069199;-0.5042717579763947
Acne inversa;Difficulty walking;0.9098146036267281;0.9877773;0.5287459605239593;0.5038907137408175;0.99993620886009;-0.09012160523336199;-0.012158916131665976;-0.47119024833613077;-0.49604549511927254
Acne inversa;Bilobate gallbladder;0.9465109407901764;1.0950632;0.5170342256556228;0.4696946687090545;0.9999528219730685;-0.05344188118289206;0.09511038756062296;-0.4829185963174456;-0.5302581532640139
Acne inversa;Histidinuria;0.8014660477638245;0.9203748;0.563618009070217;0.5253723417181704;0.9999515360511232;-0.19848548828729873;-0.079576725355475;-0.4363335269809062;-0.4745791943329528
Acne inversa;Widened interpedicular distance;0.8749959319829941;1.0915338;0.5398943928015796;0.47082306955949593;0.9998962300503706;-0.12490029806737657;0.09163755004759078;-0.46000183724879107;-0.5290731604908747
Dentin dysplasia;Aplasia of the inner ear;0.7550941109657288;0.94579446;0.5787570674068978;0.5172626118060821;0.9999201345566091;-0.24482602359088035;-0.0541256713989553;-0.4211630671497113;-0.482657522750527
Dentin dysplasia;Polycystic liver disease;0.8281596302986145;1.0016222;0.5549713294783771;0.4994836466622128;0.9999056439461368;-0.1717460136475223;0.0017165560660702406;-0.44493431446775966;-0.500421997283924
Dentin dysplasia;Subungual hyperkeratosis;0.6732375621795654;0.68048006;0.6059576999620884;0.6035216400194645;0.9999003561294039;-0.32666279394983844;-0.3194202931678255;-0.3939426561673155;-0.39637871610993936
Dentin dysplasia;Broad humeral epiphyses;0.8562137335538864;0.9898942;0.5459277826983786;0.5032168301737172;1.0;-0.1437862664461136;-0.010105788707733154;-0.4540722173016214;-0.4967831698262828
Dentin dysplasia;Autoimmune thrombocytopenia;0.8597238957881927;0.9986007;0.5447990195417927;0.5004454128190345;0.9998726169824932;-0.14014872119430044;-0.00127189562324026;-0.45507359744070053;-0.49942720416345865
Dentin dysplasia;Adenomyosis;0.8698667138814926;0.96293676;0.5415405248687497;0.5118003058444089;0.9999201345566091;-0.1300534206751165;-0.036983375561552956;-0.4583796096878594;-0.48811982871220017
Dentin dysplasia;Elevated leukocyte alkaline phosphatase;0.8310833275318146;0.8024909;0.5540268782572546;0.5632852012597511;0.9999201345566091;-0.16883680702479453;-0.19742924453051658;-0.4458932562993545;-0.436634933296858
Dentin dysplasia;Clasp-knife sign;0.8873661160469055;0.7593802;0.5359287212798243;0.5773506935229714;1.0;-0.11263388395309448;-0.24061977863311768;-0.46407127872017573;-0.4226493064770286
Dentin dysplasia;Keratosis pilaris;0.6985931694507599;0.6766784;0.5974562235118166;0.6047995524674441;0.9998710980331391;-0.30127792858237923;-0.32319267891997994;-0.4024148745213225;-0.395071545565695
Dentin dysplasia;Lamina lucida cleavage;0.7101052403450012;0.6839833;0.593620308569913;0.6023455576901707;0.9998962300503706;-0.28979098970536943;-0.3159129040921187;-0.40627592148045766;-0.3975506723601999
Dentin dysplasia;Abnormal central response of multifocal electroretinogram;0.8128244429826736;0.92936826;0.5599333256538361;0.5225015273564482;1.0;-0.18717555701732635;-0.07063174247741699;-0.44006667434616387;-0.47749847264355183
Dentin dysplasia;Atypical or prolonged hepatitis;0.7823164016008377;0.98204756;0.5698500884290908;0.5057147385175129;0.9999201345566091;-0.2176037329557714;-0.01787257672579856;-0.4300700461275183;-0.4942053960390962
Dentin dysplasia;Cubitus varus;0.9433397687971592;1.0593433;0.5180451758597607;0.48109933252076587;1.0;-0.056660231202840805;0.05934333801269531;-0.48195482414023927;-0.5189006674792341
Dentin dysplasia;Nasal regurgitation;0.855169489979744;0.92214507;0.5462636918082775;0.5248070960513511;0.9999134918687169;-0.14474400188897296;-0.07776842322323962;-0.4536498000604394;-0.4751063958173658
Dentin dysplasia;Moon facies;0.9609015211462975;0.8662112;0.5124486054073174;0.5427143849580762;0.7692950606685226;0.19160646047777485;0.0969161152500565;-0.2568464552612052;-0.22658067571044638
Dentin dysplasia;Intestinal pseudo-obstruction;0.7456628680229187;0.9445285;0.5818572814847609;0.5176661943614838;0.9998912449978579;-0.25422837697493916;-0.05536272489058858;-0.41803396351309696;-0.4822250506363741
Dentin dysplasia;Bilateral renal atrophy;0.7975286692380905;0.9008902;0.5648972947783171;0.5315995129452118;0.9999201345566091;-0.2023914653185186;-0.09902996302874656;-0.43502283977829204;-0.4683206216113973
Dentin dysplasia;Fractured left clavicle;0.8915544003248215;0.95536935;0.5345873275078314;0.5142110870771566;1.0;-0.10844559967517853;-0.04463064670562744;-0.46541267249216856;-0.48578891292284343
Dentin dysplasia;Positive urine norcotinine test;0.9257849007844925;1.0095758;0.5236451395228605;0.4969518812984839;1.0;-0.07421509921550751;0.009575843811035156;-0.4763548604771395;-0.5030481187015161
Dentin dysplasia;Long fibula;0.8976098820567131;1.0359952;0.5326490044193595;0.48853988677287097;0.9999056439461368;-0.10229576188942369;0.03608960103372161;-0.4672566395267773;-0.5113657571732658
Dentin dysplasia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6215654611587524;0.83224773;0.6235374891755803;0.5536508608432047;1.0;-0.37843453884124756;-0.16775226593017578;-0.3764625108244197;-0.4463491391567953
Dentin dysplasia;Type II cryptotia;0.8370137065649033;0.826111;0.552112633826766;0.555633389877533;1.0;-0.16298629343509674;-0.17388898134231567;-0.447887366173234;-0.44436661012246703
Dentin dysplasia;Increased variability in muscle fiber diameter;0.840272456407547;0.9793237;0.5510615679818751;0.5065819397076097;0.9998452077479463;-0.15957275134039928;-0.020521522578726303;-0.44878363976607116;-0.4932632680403366
Dentin dysplasia;Widened proximal tibial metaphyses;0.8334258198738098;0.9587282;0.5532705222938635;0.513140960978524;0.9999201345566091;-0.1664943146827993;-0.04119194031985374;-0.4466496122627456;-0.4867791735780851
Dentin dysplasia;Wide anterior fontanel;0.9876611810177565;0.9149039;0.5039276677324271;0.5271197297625705;0.6559975620430308;0.3316636189747256;0.2589063171226186;-0.1520698943106037;-0.12887783228046035
Dentin dysplasia;Increased circulating oleate level;0.9419227242469788;1.0773422;0.5184969792820355;0.4753566106395162;1.0;-0.05807727575302124;0.07734215259552002;-0.48150302071796447;-0.5246433893604838
Dentin dysplasia;Lozenge-shaped umbilicus;0.9092164859175682;0.9070067;0.5289371315154723;0.5296435181855916;0.9999134918687169;-0.09069700595114871;-0.09290681090329334;-0.47097636035324464;-0.4702699736831253
Dentin dysplasia;Anti-myelin-associated glycoprotein antibody positivity;0.8286034166812897;0.8541671;0.554827940491725;0.5465861851801139;1.0;-0.17139658331871033;-0.14583289623260498;-0.445172059508275;-0.4534138148198861
Dentin dysplasia;Fractured radius;0.8078025281429291;0.8638555;0.5615614111028313;0.5434711503774182;0.9999201345566091;-0.19211760641368003;-0.136064653408843;-0.4383587234537778;-0.4564489841791909
Dentin dysplasia;Abnormal manual kinetic perimetry test;0.8000665754079819;0.9704022;0.5640725884020141;0.5094226574133657;1.0;-0.19993342459201813;-0.029597818851470947;-0.43592741159798587;-0.4905773425866343
Dentin dysplasia;Small radial epiphyses;0.752938523888588;0.77502203;0.5794649630767582;0.5722310151709344;1.0;-0.24706147611141205;-0.22497797012329102;-0.4205350369232418;-0.42776898482906556
Dentin dysplasia;Generalized keratosis follicularis;0.7248878180980682;0.7038425;0.5887149976728607;0.5957053215300254;0.9999201345566091;-0.27503231645854087;-0.29607761384280296;-0.4112051368837484;-0.4042148130265837
Dentin dysplasia;Hypoplasia of the calcaneus;0.7772002518177032;0.87650895;0.5715196060797948;0.5394090227713102;0.9999134918687169;-0.22271324005101367;-0.12340454068158313;-0.4283938857889221;-0.4605044690974067
Dentin dysplasia;2-hydroxyadipic aciduria;0.7489756345748901;0.8799921;0.5807674284727213;0.5382919757691544;1.0;-0.25102436542510986;-0.12000787258148193;-0.41923257152727866;-0.46170802423084556
Dentin dysplasia;Potter facies;0.8239889293909073;0.76021004;0.5563194529485577;0.5770785736222327;0.7284789198879239;0.09551000950298338;0.03173111734352141;-0.17215946693936623;-0.1514003462656912
Dentin dysplasia;Increased heart rate variability;0.961292278021574;1.1124892;0.5123241294001772;0.4641176296366568;0.9999201345566091;-0.03862785653503509;0.1125690889236155;-0.48759600515643187;-0.5358025049199523
Dentin dysplasia;Aplastic zygomatic arch;0.8184042572975159;0.7441265;0.5581262284192472;0.5823630575666902;0.7692950606685226;0.04910919662899327;-0.02516856196933437;-0.2111688322492754;-0.18693200310183244
Dentin dysplasia;Testicular torsion;0.8665721714496613;0.995211;0.5425984369460382;0.5015243854699044;0.9999201345566091;-0.13334796310694785;-0.004709129345732643;-0.45732169761057095;-0.4983957490867047
Dentin dysplasia;Abolished vibration sense;0.897459402680397;1.0062933;0.5326971569398111;0.49799676017979666;0.9999134918687169;-0.10245408918831989;0.006379804945247924;-0.4672163349289058;-0.5019167316889203
Dentin dysplasia;Fractured metatarsal bone of digit 5;0.7484165132045746;0.82188946;0.5809513032014195;0.5569984585250194;1.0;-0.2515834867954254;-0.1781105399131775;-0.4190486967985805;-0.4430015414749806
Dentin dysplasia;Prolonged G2 phase of cell cycle;0.8896579593420029;0.9385079;0.5351946282393594;0.519585885749646;0.9999056439461368;-0.11024768460413392;-0.061397729402984935;-0.4647110157067774;-0.48031975819649075
Dentin dysplasia;Single naris;1.0223923474550247;0.8886495;0.49287169863670255;0.5355176114196106;0.7483657621638067;0.27402658529121804;0.14028376109440255;-0.25549406352710413;-0.21284815074419605
Dentin dysplasia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7898329198360443;0.89762807;0.5674007985870421;0.5326431919313608;1.0;-0.2101670801639557;-0.1023719310760498;-0.43259920141295793;-0.4673568080686392
Dentin dysplasia;Asymmetry of the thorax;0.8953377828001976;1.0193204;0.533376143351053;0.49384974998736086;0.9999056439461368;-0.10456786114593919;0.019414724820647877;-0.4665295005950838;-0.5060558939587759
Dentin dysplasia;Type 2 muscle fiber predominance;0.8517669141292572;0.95796776;0.5473585842210682;0.5133832302895585;0.9999003561294039;-0.14813344200014666;-0.04193259795069293;-0.45254177190833567;-0.4865171258398454
Dentin dysplasia;Dependency on parenteral nutrition;0.8684252798557281;0.9531139;0.5420033269466142;0.5149297806656605;0.9999134918687169;-0.13148821201298877;-0.04679957833264514;-0.4579101649221027;-0.4849837112030564
Dentin dysplasia;Limited shoulder flexion;0.9034166783094406;1.1272819;0.5307914254097419;0.4593747204644104;1.0;-0.09658332169055939;0.12728190422058105;-0.4692085745902581;-0.5406252795355896
Dentin dysplasia;Paroxysmal vertigo;0.8125063329935074;1.0286862;0.5600364081652077;0.4908676404310357;0.9999134918687169;-0.18740715887520953;0.02877267394091443;-0.4398770837035092;-0.5090458514376812
Dentin dysplasia;Long hallux;0.8493210077285767;0.9500284;0.5481459844076084;0.515913078082566;0.9998836012415208;-0.1505625935129441;-0.04985518174689185;-0.45173761683391234;-0.4839705231589547
Dentin dysplasia;Broad medial eyebrow;1.0348455049097538;0.957044;0.4889060854697823;0.5136775215426752;0.7870101688836642;0.24783533602608965;0.17003383651031778;-0.29810408341388184;-0.27333264734098894
Dentin dysplasia;Myxoid subcutaneous tumors;0.7627021670341492;0.8509778;0.5762617276129842;0.5476125999591095;0.9999201345566091;-0.23721796752245994;-0.1489423561218557;-0.4236584069436249;-0.4523075345974996
Dentin dysplasia;Bulbous tips of toes;0.846117377281189;0.88443804;0.5491777655152776;0.5368668940786617;0.9999134918687169;-0.15379611458752795;-0.11547545399640247;-0.4507357263534393;-0.4630465977900552
Dentin dysplasia;Absent internal genitalia;0.8739406764507294;0.8509048;0.5402329693593177;0.5476360705782686;1.0;-0.12605932354927063;-0.14909517765045166;-0.45976703064068225;-0.4523639294217314
Dentin dysplasia;Hyperphalangy of the 2nd finger;0.7559938728809357;0.84078705;0.5784617030403525;0.550895652990594;0.9999201345566091;-0.24392626167567344;-0.15913308144839378;-0.4214584315162566;-0.44902448156601515
Dentin dysplasia;Renal interstitial hemosiderin;0.8623902499675751;0.94081515;0.5439419794202356;0.5188501419943722;1.0;-0.13760975003242493;-0.05918484926223755;-0.4560580205797644;-0.4811498580056278
Dentin dysplasia;Abnormality of depressor anguli oris muscle;0.7772024720907211;0.917522;0.571518881122776;0.5262834227119528;1.0;-0.22279752790927887;-0.08247798681259155;-0.42848111887722395;-0.47371657728804717
Dentin dysplasia;Paroxysmal dyspnea;0.7191356718540192;0.97797114;0.5906210959811277;0.5070125716622472;1.0;-0.28086432814598083;-0.022028863430023193;-0.40937890401887234;-0.4929874283377528
Dentin dysplasia;Phenylpyruvic acidemia;0.8434721827507019;0.9992848;0.5500300855566309;0.5002276510545012;0.9999201345566091;-0.1564479518059072;-0.0006353306892690203;-0.4498900489999782;-0.49969248350210793
Dentin dysplasia;Lateral ventricle dilatation;0.7640607059001923;0.9392167;0.5758166522463088;0.5193598722374192;0.9998579617208769;-0.23579725582068467;-0.060641288346700906;-0.4240413094745681;-0.48049808948345774
Dentin dysplasia;Neonatal unconjugated hyperbilirubinemia;0.8474703878164291;0.9924946;0.5487419436478935;0.5023890666695452;0.9999201345566091;-0.15244974674017997;-0.007425551426726296;-0.4511781909087156;-0.4975310678870639
Dentin dysplasia;High maternal circulating alpha-fetoprotein concentration;0.924827516078949;0.9763921;0.5239507382362346;0.5075153268717703;1.0;-0.07517248392105103;-0.023607909679412842;-0.4760492617637654;-0.49248467312822974
Dentin dysplasia;Prominent nasolabial fold;0.8583754152059555;0.74301136;0.5452325826829805;0.5827302983329736;0.7184876422794455;0.13988777292651;0.024523713120639945;-0.17325505959646503;-0.13575734394647188
Dentin dysplasia;Abnormality of inferior alveolar nerve;0.6718096733093262;0.4251874;0.6064387357856033;0.6949250493938226;1.0;-0.32819032669067383;-0.5748125910758972;-0.39356126421439674;-0.3050749506061774
Dentin dysplasia;Unilateral conductive hearing impairment;0.8275091499090195;1.034558;0.5551815224181678;0.48899762126150703;0.9999201345566091;-0.17241098464758964;0.03463792322842507;-0.44473861213844135;-0.5109225132951021
Dentin dysplasia;Macular hypopigmented whorls, streaks, and patches;0.685941755771637;0.76916254;0.6016887234729349;0.5741465654224427;0.9999201345566091;-0.31397837878497215;-0.23075759888918967;-0.3982314110836742;-0.4257735691341664
Dentin dysplasia;Delayed ossification of pubic rami;0.7060903310775757;0.83979917;0.5949564881515675;0.5512141767708738;0.9999134918687169;-0.29382316079114124;-0.1601143261430089;-0.4049570037171494;-0.4486993150978431
Dentin dysplasia;Hyperphenylalaninemia;0.9122536480426788;1.074517;0.5279664975506645;0.4762584752756265;0.9999028053808913;-0.08764915733821244;0.07461420626156479;-0.4719363078302268;-0.5236443301052648
Dentin dysplasia;Ureteropelvic junction obstruction;0.8274910748004913;0.94939166;0.5551873634638836;0.5161160171793354;0.9998847295244674;-0.17239365472397605;-0.05049306644997398;-0.44469736606058374;-0.48376871234513197
Dentin dysplasia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7391650676727295;0.81006265;0.5839978324060805;0.5608284804661443;1.0;-0.2608349323272705;-0.18993735313415527;-0.4160021675939195;-0.4391715195338557
Dentin dysplasia;Difficulty walking;0.8800533562898636;0.9877181;0.5382723513748299;0.5039095461994151;0.9998344221996177;-0.11978106590975413;-0.012116316883455602;-0.46156207082478784;-0.49592487600020263
Dentin dysplasia;Bilobate gallbladder;0.809109166264534;0.984225;0.561137648854017;0.5050215528834988;0.9999134918687169;-0.19080432560418292;-0.015688516759616578;-0.43877584301469996;-0.4948919389852181
Dentin dysplasia;Histidinuria;0.7670246213674545;0.91275996;0.5748461570367127;0.5278047083579174;0.9999090677057578;-0.2328844463383033;-0.08714910800803444;-0.4250629106690451;-0.47210435934784045
Dentin dysplasia;Widened interpedicular distance;0.9156968519091606;1.0429767;0.5268664131495894;0.4863158579692657;1.0;-0.08430314809083939;0.0429767370223999;-0.4731335868504106;-0.5136841420307343
Aplasia of the inner ear;Polycystic liver disease;0.7557580322027206;0.87789714;0.5785391156551309;0.5389637681854135;0.9999567459343585;-0.24419871373163782;-0.12205960257040582;-0.4214176302792275;-0.460992977748945
Aplasia of the inner ear;Subungual hyperkeratosis;0.8098793625831604;0.9975229;0.5608879141232592;0.5007884880420068;0.9999556674707869;-0.1900763048876265;-0.002432776903007361;-0.4390677533475277;-0.4991671794287801
Aplasia of the inner ear;Broad humeral epiphyses;0.8102422505617142;0.9381254;0.5607702615265611;0.5197078922884129;0.9999201345566091;-0.18967788399489494;-0.06179476262362571;-0.43914987303004804;-0.48021224226819625
Aplasia of the inner ear;Autoimmune thrombocytopenia;0.7465925812721252;0.93188804;0.5815513205854417;0.5216975077574557;0.9999509115718902;-0.25335833029976496;-0.06806286769142755;-0.4183995909864485;-0.4782534038144345
Aplasia of the inner ear;Adenomyosis;0.7192324995994568;0.8788643;0.5905889825614173;0.5386536235973908;0.9999600672783046;-0.28072756767884777;-0.12109577894822643;-0.4093710847168872;-0.4613064436809138
Aplasia of the inner ear;Elevated leukocyte alkaline phosphatase;0.78714519739151;1.0448258;0.5682761313729171;0.485726736291633;0.9999600672783046;-0.21281486988679454;0.044865725034317516;-0.43168393590538745;-0.5142333309866716
Aplasia of the inner ear;Clasp-knife sign;1.0099859684705734;1.1382427;0.4968213146816839;0.4558546048234884;0.9999201345566091;0.010065833913964317;0.13832258700100808;-0.5030988198749252;-0.5440655297331207
Aplasia of the inner ear;Keratosis pilaris;0.7785457670688629;1.0613054;0.5710803414114306;0.48047363733939497;0.9999506876445663;-0.22140492057570338;0.06135471606484533;-0.4288703462331357;-0.5194770503051713
Aplasia of the inner ear;Lamina lucida cleavage;0.8600290715694427;0.9819532;0.5447009111387676;0.5057447831735218;0.9999548690865008;-0.13992579751705803;-0.01800166540836967;-0.45525395794773316;-0.494210085912979
Aplasia of the inner ear;Abnormal central response of multifocal electroretinogram;0.6242546439170837;0.8079851;0.6226132660096483;0.5615021897857944;0.9999201345566091;-0.37566549063952537;-0.19193500758441062;-0.3773068685469608;-0.43841794477081475
Aplasia of the inner ear;Atypical or prolonged hepatitis;0.7908598184585571;1.0471139;0.5670664969730115;0.48499761814533393;0.9999600672783046;-0.20910024881974743;0.04715382813795521;-0.4328935703052931;-0.5149624491329706
Aplasia of the inner ear;Cubitus varus;0.997383052483201;1.0448198;0.5008330012170126;0.48572861410935664;0.9999201345566091;-0.0025370820734080812;0.04489969729153542;-0.49908713333959653;-0.5141915204472525
Aplasia of the inner ear;Nasal regurgitation;0.7075226306915283;1.0635641;0.5944796159211446;0.47975328325066746;0.9999584729108851;-0.2924358422193568;0.06360558920764514;-0.4054788569897405;-0.5202051896602177
Aplasia of the inner ear;Moon facies;0.9907340109348297;1.140619;0.5029494981323485;0.45509073752533047;0.9999584729108851;-0.00922446197605542;0.14066056662463733;-0.49700897477853667;-0.5448677353855547
Aplasia of the inner ear;Intestinal pseudo-obstruction;0.6856476664543152;0.9343648;0.6017873288748854;0.5209073641967127;0.9999539510871024;-0.3143062846327872;-0.06558915540228794;-0.398166622212217;-0.4790465868903897
Aplasia of the inner ear;Bilateral renal atrophy;0.7948748618364334;0.93906957;0.5657601367437821;0.5194067791775059;0.9999600672783046;-0.20508520544187114;-0.06089049816743419;-0.43419993053452244;-0.48055328810079867
Aplasia of the inner ear;Fractured left clavicle;0.873946487903595;0.83697975;0.5402311046417032;0.5521235996989142;0.9999201345566091;-0.12597364665301414;-0.16294038773806663;-0.4596890299149059;-0.4477965348576949
Aplasia of the inner ear;Positive urine norcotinine test;0.8395687639713287;1.0590948;0.5512884865557727;0.4811785701530624;0.9999201345566091;-0.16035137058528037;0.059174652087372825;-0.44863164800083644;-0.5187415644035467
Aplasia of the inner ear;Long fibula;0.7804373353719711;0.9453241;0.5704630416166983;0.5174125528644293;0.9999567459343585;-0.21951941056238733;-0.05463262302862726;-0.4294937043176602;-0.48254419306992913
Aplasia of the inner ear;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7524938881397247;0.9630625;0.5796110314646088;0.511760230489886;0.9999201345566091;-0.24742624641688438;-0.03685760976107688;-0.4203091030920003;-0.48815990406672316
Aplasia of the inner ear;Type II cryptotia;0.806795209646225;0.8795945;0.5618881749267505;0.5384194698149132;0.5881001503332186;0.21869505931300637;0.29149435450000283;-0.026211975406468135;-0.04968068051830543
Aplasia of the inner ear;Increased variability in muscle fiber diameter;0.8000767230987549;1.0115448;0.5640692917336991;0.4963250708527712;0.9999473166570552;-0.19987059355830028;0.011597506989490247;-0.43587802492335603;-0.5036222458042839
Aplasia of the inner ear;Widened proximal tibial metaphyses;0.7643385678529739;0.9928158;0.5757256396214491;0.5022868251100566;0.9999600672783046;-0.23562149942533062;-0.0071442747177271615;-0.4242344276568555;-0.49767324216824793
Aplasia of the inner ear;Wide anterior fontanel;0.68769770860672;0.74946606;0.6011001787096066;0.5806061674995877;0.9999476714516888;-0.31224996284496886;-0.2504816098595868;-0.3988474927420822;-0.4193415039521011
Aplasia of the inner ear;Increased circulating oleate level;0.7148687243461609;0.9594114;0.5920371984484856;0.5129233153262557;0.9999201345566091;-0.2850514102104482;-0.04050875188143821;-0.40788293610812354;-0.48699681923035343
Aplasia of the inner ear;Lozenge-shaped umbilicus;0.8032275587320328;0.82358235;0.5630460184036901;0.5564509281528468;0.9999584729108851;-0.19673091417885236;-0.17637612170315198;-0.43691245450719507;-0.44350754475803833
Aplasia of the inner ear;Anti-myelin-associated glycoprotein antibody positivity;0.6766982078552246;0.7751236;0.6047928960139358;0.5721978451319188;0.9999201345566091;-0.3232219267013845;-0.22479653836520286;-0.3951272385426733;-0.42772228942469026
Aplasia of the inner ear;Fractured radius;0.792266458272934;0.92956924;0.5666086943121242;0.5224373843927079;0.9999600672783046;-0.2076936090053706;-0.07039082289353893;-0.4333513729661803;-0.4775226828855966
Aplasia of the inner ear;Abnormal manual kinetic perimetry test;0.6865469217300415;0.83593726;0.6014858487500079;0.5524599424656684;0.9999201345566091;-0.3133732128265676;-0.1639828729751882;-0.39843428580660123;-0.4474601920909407
Aplasia of the inner ear;Small radial epiphyses;0.8342599719762802;0.9515332;0.5530012604952583;0.5154335131878662;0.9999201345566091;-0.1656601625803289;-0.04838693619998069;-0.4469188740613508;-0.4844866213687429
Aplasia of the inner ear;Generalized keratosis follicularis;0.8856100738048553;1.100803;0.5364913232629416;0.4678588248877139;0.9999600672783046;-0.11434999347344921;0.10084295033796742;-0.463468744015363;-0.5321012423905906
Aplasia of the inner ear;Hypoplasia of the calcaneus;0.7581771314144135;0.883776;0.5777452919327448;0.5370790396611447;0.9999584729108851;-0.24178134149647168;-0.11618246382809094;-0.4222131809781403;-0.46287943324974046
Aplasia of the inner ear;2-hydroxyadipic aciduria;0.7925336509943008;0.93070203;0.5665217500429336;0.5220759216973611;0.9999201345566091;-0.20738648356230827;-0.06921810389788718;-0.4333983845136755;-0.47784421285924805
Aplasia of the inner ear;Potter facies;0.9423242583870888;1.0865237;0.5183689523896451;0.47242419065481356;0.9999552432134126;-0.05763098482632378;0.08656840886330863;-0.48158629082376747;-0.527531052558599
Aplasia of the inner ear;Increased heart rate variability;0.8042900860309601;1.0614204;0.5627010987052998;0.480436968621866;0.9999600672783046;-0.19566998124734447;0.06146037339552357;-0.4372589685730047;-0.5195230986564385
Aplasia of the inner ear;Aplastic zygomatic arch;0.5609628558158875;0.73785603;0.6446803515434221;0.584429532353735;0.9999584729108851;-0.4389956170949977;-0.26210244244671277;-0.35527812136746306;-0.4155289405571502
Aplasia of the inner ear;Testicular torsion;0.8423982858657837;0.92885417;0.550376213605879;0.5226655752718135;0.9999600672783046;-0.15756178141252086;-0.07110589981690929;-0.4495838536724256;-0.4772944920064911
Aplasia of the inner ear;Abolished vibration sense;0.7791795432567596;0.94172966;0.5708734829181046;0.5185585338848647;0.9999584729108851;-0.2207789296541255;-0.05822880810833386;-0.42908498999278055;-0.4813999390260204
Aplasia of the inner ear;Fractured metatarsal bone of digit 5;0.8361472189426422;0.97828525;0.5523922037648912;0.5069125577991409;0.9999201345566091;-0.1637729156139669;-0.021634881508665993;-0.44752793079171793;-0.4930075767574682
Aplasia of the inner ear;Prolonged G2 phase of cell cycle;0.9153027310967445;1.1010936;0.5269923159977428;0.46776583161470353;0.9999567459343585;-0.08465401483761392;0.10113690392983832;-0.4729644299366157;-0.5321909143196549
Aplasia of the inner ear;Single naris;0.7946261167526245;0.8987093;0.5658410371590423;0.5322972302217686;0.9999567459343585;-0.20533062918173395;-0.10124744875418268;-0.43411570877531613;-0.4676595157125899
Aplasia of the inner ear;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7837679386138916;0.9978397;0.5693767759582169;0.5006876452449105;0.9999201345566091;-0.2161521959427175;-0.002080445301848366;-0.4305433585983922;-0.4992324893116986
Aplasia of the inner ear;Asymmetry of the thorax;0.7371324896812439;1.0297027;0.5846682129709878;0.4905439720456338;0.9999567459343585;-0.26282425625311456;0.0297459174872724;-0.41528853296337065;-0.5094127738887246
Aplasia of the inner ear;Type 2 muscle fiber predominance;0.9430015906691551;1.1016064;0.5181529955482185;0.4676017880928873;0.9999556674707869;-0.05695407680163178;0.10165070154776779;-0.4818026719225684;-0.5323538793778996
Aplasia of the inner ear;Dependency on parenteral nutrition;0.848046213388443;0.9962606;0.5485564909045494;0.5011903019751764;0.9999584729108851;-0.15191225952244214;-0.003697889510158814;-0.45140198200633574;-0.4987681709357087
Aplasia of the inner ear;Limited shoulder flexion;0.8333756327629089;1.0535877;0.553286723768109;0.4829343234107608;0.9999201345566091;-0.16654450179370017;0.053667540537995384;-0.44663341078850016;-0.5169858111458483
Aplasia of the inner ear;Paroxysmal vertigo;0.6401450335979462;0.8606919;0.6171738293545004;0.544487827501168;0.8384531378237817;-0.19830810422583556;0.022238767197885756;-0.22127930846928134;-0.29396531032261375
Aplasia of the inner ear;Long hallux;0.8072148859500885;0.998546;0.5617520282168467;0.5004628147002209;0.9999526340597648;-0.19273774810967625;-0.0014066297644156345;-0.4382006058429181;-0.49948981935954384
Aplasia of the inner ear;Broad medial eyebrow;0.7829805761575699;0.97640467;0.5696334971348667;0.5075113331817058;0.9999600672783046;-0.21697949112073467;-0.02355540037766979;-0.4303265701434379;-0.49244873409659873
Aplasia of the inner ear;Myxoid subcutaneous tumors;0.8071242272853851;1.0346124;0.5617814377209426;0.4889803255554176;0.9999600672783046;-0.19283583999291942;0.03465234994276478;-0.438178629557362;-0.510979741722887
Aplasia of the inner ear;Bulbous tips of toes;0.8202416896820068;0.9203867;0.5575315688106478;0.5253685660127909;0.9999584729108851;-0.1797167832288783;-0.07957180089092664;-0.44242690410023733;-0.4745899068980942
Aplasia of the inner ear;Absent internal genitalia;0.7231232523918152;0.859282;0.5892993741143675;0.5449410831227952;0.9999201345566091;-0.2767968821647939;-0.14063811780245872;-0.4106207604422416;-0.4549790514338139
Aplasia of the inner ear;Hyperphalangy of the 2nd finger;0.8663714975118637;1.0208702;0.5426628906259545;0.49335630846020473;0.9999600672783046;-0.13358856976644085;0.02091014146192982;-0.45729717665235003;-0.5066037588180998
Aplasia of the inner ear;Renal interstitial hemosiderin;0.8457597643136978;1.0644779;0.5492929726860696;0.47946178321742217;0.9999201345566091;-0.1541603702429113;0.06455778597561745;-0.4506271618705395;-0.5204583513391869
Aplasia of the inner ear;Abnormality of depressor anguli oris muscle;0.7466827034950256;0.837723;0.5815216662115953;0.5518838021688521;0.9999201345566091;-0.2532374310615835;-0.1621971178177175;-0.4183984683450138;-0.448036332387757
Aplasia of the inner ear;Paroxysmal dyspnea;0.7291787266731262;1.0417522;0.5872952401909479;0.4867059808090094;0.9999201345566091;-0.2707414078834829;0.04183208464352517;-0.4126248943656612;-0.5132141537475997
Aplasia of the inner ear;Phenylpyruvic acidemia;0.7691630423069;0.956474;0.5741463996777176;0.5138591277928657;0.9999600672783046;-0.23079702497140453;-0.04348606110230968;-0.4258136676005869;-0.48610093948543887
Aplasia of the inner ear;Lateral ventricle dilatation;0.6688044965267181;0.85598135;0.6074519652732109;0.5460025402712018;0.9999488789551968;-0.33114438242847866;-0.14396752901012844;-0.3924969136819859;-0.45394633868399503
Aplasia of the inner ear;Neonatal unconjugated hyperbilirubinemia;0.7530669718980789;0.9788075;0.5794227694868537;0.5067462927660018;0.9999600672783046;-0.24689309538022564;-0.021152558332839466;-0.4205372977914509;-0.49321377451230275
Aplasia of the inner ear;High maternal circulating alpha-fetoprotein concentration;0.7339462339878082;0.9412955;0.5857198730230422;0.5186969766746512;0.9999201345566091;-0.2659739005688009;-0.058624629986601784;-0.4142002615335669;-0.4812231578819579
Aplasia of the inner ear;Prominent nasolabial fold;0.7558904588222504;0.9843799;0.5784956472061635;0.504972232484928;0.9999545338528789;-0.24406407503062855;-0.015574646272007331;-0.4214588866467154;-0.49498230136795096
Aplasia of the inner ear;Abnormality of inferior alveolar nerve;0.5049800276756287;0.87705123;0.6648392630197122;0.5392350927437499;0.9999201345566091;-0.49494010688098045;-0.12286890031130882;-0.3350808715368969;-0.4606850418128592
Aplasia of the inner ear;Unilateral conductive hearing impairment;0.40655648708343506;0.28849375;0.7022319612552276;0.751986668237873;0.7940500751666093;-0.38749358808317425;-0.5055563226870561;-0.09181811391138173;-0.042063406928736335
Aplasia of the inner ear;Macular hypopigmented whorls, streaks, and patches;0.742305725812912;1.0240688;0.5829627355749332;0.4923379027097108;0.9999600672783046;-0.25765434146539257;0.024108765119156383;-0.4169973317033714;-0.5076221645685938
Aplasia of the inner ear;Delayed ossification of pubic rami;0.708648681640625;0.91665554;0.5941048600531305;0.5265601848356234;0.9999584729108851;-0.29130979127026013;-0.08330293244457654;-0.4058536128577547;-0.47339828807526174
Aplasia of the inner ear;Hyperphenylalaninemia;0.6979610919952393;0.90297145;0.5976672549999182;0.5309338158617563;0.9999561589935034;-0.30199506699826417;-0.09698471247937379;-0.4022889039935852;-0.4690223431317472
Aplasia of the inner ear;Ureteropelvic junction obstruction;0.7542502880096436;0.98406124;0.5790341316380492;0.5050736858766557;0.9999528219730685;-0.2457025339634249;-0.015891580823166107;-0.4209186903350193;-0.49487913609641276
Aplasia of the inner ear;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.807585820555687;0.9348102;0.5616317032706064;0.5207652836741785;0.9999201345566091;-0.19233431400092216;-0.06510991336138816;-0.4382884312860027;-0.4791548508824306
Aplasia of the inner ear;Difficulty walking;0.8552150726318359;0.9809763;0.5462490278385161;0.5060557975789386;0.9999461221900431;-0.14473104955820715;-0.018969838639780634;-0.45369709435152694;-0.4938903246111045
Aplasia of the inner ear;Bilobate gallbladder;0.8290724456310272;1.0168108;0.5546764077528135;0.4946487133039478;0.9999584729108851;-0.1708860272798579;0.01685230189227649;-0.44528206515807167;-0.5053097596069374
Aplasia of the inner ear;Histidinuria;0.7258237302303314;0.9068595;0.5884051735720282;0.5296905660942529;0.9999574798349273;-0.2741337496045959;-0.09309796273745419;-0.4115523062628992;-0.4702669137406744
Aplasia of the inner ear;Widened interpedicular distance;0.7680728882551193;0.90553075;0.5745030859170813;0.5301154059936035;0.9999201345566091;-0.23184724630148978;-0.09438938380511375;-0.4254170486395278;-0.4698047285630056
Polycystic liver disease;Subungual hyperkeratosis;0.9212890639901161;1.1197152;0.5250804119324171;0.4618018664527892;0.9999515360511232;-0.07866247206100707;0.11976367772451157;-0.47487112411870613;-0.538149669598334
Polycystic liver disease;Broad humeral epiphyses;0.7826803028583527;0.8977015;0.5697314139888646;0.5326196798374487;0.9999056439461368;-0.21722534108778413;-0.10220414209982331;-0.43017422995727217;-0.46728596410868806
Polycystic liver disease;Autoimmune thrombocytopenia;0.6319902539253235;0.8888124;0.6199606968057746;0.535465444446313;0.9999457950338347;-0.36795554110851125;-0.11113337228145437;-0.37998509822806015;-0.4644803505875217
Polycystic liver disease;Adenomyosis;0.6764933168888092;0.7341113;0.6048618186758281;0.5856653745003095;0.9999567459343585;-0.32346342904554926;-0.2658454368828448;-0.39509492725853035;-0.4142913714340489
Polycystic liver disease;Elevated leukocyte alkaline phosphatase;0.6803979277610779;1.0354722;0.6035492311893542;0.48870650038824526;0.9999567459343585;-0.3195588181732806;0.03551540868295111;-0.39640751474500424;-0.5112502455461132
Polycystic liver disease;Clasp-knife sign;0.8477856069803238;0.9888362;0.5486404208106825;0.5035536095771918;0.9999056439461368;-0.152120036965813;-0.011069415098633129;-0.45126522313545425;-0.49635203436894504
Polycystic liver disease;Keratosis pilaris;0.7272721827030182;0.98046976;0.587925847571298;0.5062170704088762;0.9999455218634979;-0.27267333916047976;-0.019475758584536762;-0.4120196742922;-0.49372845145462174
Polycystic liver disease;Lamina lucida cleavage;0.8638599812984467;1.0321342;0.5434697044725763;0.48976962738049556;0.9999505803237132;-0.13609059902526655;0.032183594976884944;-0.45648087585113695;-0.5101809529432176
Polycystic liver disease;Abnormal central response of multifocal electroretinogram;0.7044265866279602;1.0139232;0.5955106940253911;0.4955679569292528;0.9999056439461368;-0.2954790573181766;0.014017524236236256;-0.40439494992074565;-0.504337687016884
Polycystic liver disease;Atypical or prolonged hepatitis;0.5131134390830994;0.8096644;0.6618674936301616;0.56095760236454;0.6815865513953562;-0.1684731123122568;0.12807787683874416;-0.01971905776519456;-0.12062894903081622
Polycystic liver disease;Cubitus varus;0.7766768932342529;0.7934422;0.5716905021232312;0.5662261500075663;0.9999056439461368;-0.22322875071188386;-0.20646345425268586;-0.42821514182290554;-0.4336794939385705
Polycystic liver disease;Nasal regurgitation;0.7816839963197708;0.7904641;0.5700563501246679;0.5671953159892751;0.8462066046856518;-0.06452260836588097;-0.055742501463758476;-0.27615025456098385;-0.2790112886963767
Polycystic liver disease;Moon facies;0.8630051612854004;0.92522985;0.5437443755974312;0.5238223059972347;0.9999548690865008;-0.13694970780110038;-0.07472502165531791;-0.4562104934890696;-0.4761325630892661
Polycystic liver disease;Intestinal pseudo-obstruction;0.6553305387496948;0.78210163;0.6120089986907935;0.5699201236611124;0.8278333585256364;-0.17250281977594162;-0.04573172736108566;-0.21582435983484294;-0.257913234864524
Polycystic liver disease;Bilateral renal atrophy;0.6231220960617065;0.8940013;0.6230023689538752;0.5338039419167941;0.9999567459343585;-0.3768346498726519;-0.10595544083105646;-0.3769543769804833;-0.4661528040175643
Polycystic liver disease;Fractured left clavicle;0.8057299554347992;0.7450731;0.5622338043883653;0.5820514158808717;0.9999056439461368;-0.1941756885113376;-0.2548325638832706;-0.43767183955777145;-0.41785422806526507
Polycystic liver disease;Positive urine norcotinine test;0.8599733859300613;0.9856396;0.5447188127289406;0.5045712161645852;0.9999056439461368;-0.13993225801607545;-0.014266071802582103;-0.45518683121719616;-0.49533442778155157
Polycystic liver disease;Long fibula;0.8222858011722565;1.0867552;0.5568702587249457;0.47235021760132534;0.9999528219730685;-0.17766702080081198;0.08680233454396036;-0.4430825632481228;-0.5276026043717431
Polycystic liver disease;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8689077198505402;1.1633313;0.5418484197567206;0.44777607481497483;0.9999056439461368;-0.13099792409559663;0.16342562627175872;-0.4580572241894162;-0.552129569131162
Polycystic liver disease;Type II cryptotia;0.8424378633499146;0.9460233;0.5503634563107087;0.5171896757642306;0.9999056439461368;-0.15746778059622224;-0.05388235855719026;-0.4495421876354281;-0.4827159681819062
Polycystic liver disease;Increased variability in muscle fiber diameter;0.7782096713781357;1.074623;0.5711900522168771;0.4762246570591888;0.9999413779434757;-0.22173170656534003;0.07468161075739099;-0.4287513257265986;-0.5237167208842869
Polycystic liver disease;Widened proximal tibial metaphyses;0.7575483173131943;1.1100199;0.5779515886597691;0.46490852855564935;0.9999567459343585;-0.24240842862116418;0.11006317632211127;-0.4220051572745893;-0.5350482173787091
Polycystic liver disease;Wide anterior fontanel;0.8733101338148117;0.8151387;0.5404352994807766;0.5591835992853369;0.9999418169014338;-0.1266316830866221;-0.18480311927722726;-0.4595065174206572;-0.4407582176160969
Polycystic liver disease;Increased circulating oleate level;0.6741717755794525;0.9255402;0.6056431125471845;0.5237232482543452;0.9999056439461368;-0.3257338683666843;-0.07436543512960847;-0.3942625313989523;-0.47618239569179155
Polycystic liver disease;Lozenge-shaped umbilicus;0.9171581193804741;0.7828969;0.5263996443264203;0.5696607903409706;0.8462066046856518;0.0709515146948223;-0.06330972835050774;-0.3198069603592315;-0.2765458143446812
Polycystic liver disease;Anti-myelin-associated glycoprotein antibody positivity;0.8063344210386276;1.0104067;0.5620376720410691;0.49668737316290024;0.9999056439461368;-0.19357122290750917;0.010501088613067311;-0.43786797190506765;-0.5032182707832366
Polycystic liver disease;Fractured radius;0.8997381180524826;1.0413227;0.5319680611015931;0.4868428117793623;0.9999567459343585;-0.10021862788187585;0.04136596219552435;-0.46798868483276534;-0.5131139341549962
Polycystic liver disease;Abnormal manual kinetic perimetry test;0.7405945658683777;1.0479827;0.5835265869093065;0.48472075584631535;0.9999056439461368;-0.2593110780777591;0.04807704877236907;-0.4163790570368303;-0.5151848880998214
Polycystic liver disease;Small radial epiphyses;0.8634384572505951;0.9976477;0.5436051446727992;0.500748754249283;0.9999056439461368;-0.1364671866955417;-0.0022579412521975817;-0.4563004992733376;-0.4991568896968538
Polycystic liver disease;Generalized keratosis follicularis;0.8633945286273956;1.143419;0.5436192598675396;0.4541903374084514;0.9999567459343585;-0.13656221730696283;0.14346228139413275;-0.4563374860668189;-0.5457664085259071
Polycystic liver disease;Hypoplasia of the calcaneus;0.7574902772903442;0.9397133;0.5779706316886309;0.5192014913568576;0.9999548690865008;-0.24246459179615654;-0.060241569812056195;-0.42198423739786983;-0.4807533777296432
Polycystic liver disease;2-hydroxyadipic aciduria;0.692757785320282;0.8785455;0.5994061771563262;0.5387558374342858;0.9999056439461368;-0.3071478586258548;-0.12136012125631745;-0.40049946678981063;-0.461149806511851
Polycystic liver disease;Potter facies;0.8079005181789398;0.9026151;0.5615296276484576;0.5310477865470753;0.9999510285821799;-0.19205051040324006;-0.0973359582391623;-0.4384214009337223;-0.4689032420351046
Polycystic liver disease;Increased heart rate variability;0.7634055614471436;1.0849702;0.5760312673459322;0.47292049823942395;0.9999567459343585;-0.2365511844872149;0.0850134898902265;-0.4239254785884262;-0.5270362476949345
Polycystic liver disease;Aplastic zygomatic arch;0.8295555114746094;0.89307505;0.5545203530886134;0.534100461237117;0.9999548690865008;-0.1703993576118914;-0.10687982016300834;-0.4454345159978874;-0.4658544078493838
Polycystic liver disease;Testicular torsion;0.7963867783546448;0.94145507;0.5652685022201197;0.5186461003121102;0.9999567459343585;-0.20356996757971368;-0.058501679730287415;-0.43468824371423875;-0.48131064562224823
Polycystic liver disease;Abolished vibration sense;0.9414282254874706;1.0694816;0.5186546515367927;0.4778654820278272;0.9999548690865008;-0.05852664359903015;0.06952674216533028;-0.4813002175497081;-0.5220893870586736
Polycystic liver disease;Fractured metatarsal bone of digit 5;0.91630719602108;1.1733161;0.5266714455516086;0.4445517686886068;0.9999056439461368;-0.08359844792505677;0.1734104771552426;-0.4732341983945282;-0.55535387525753
Polycystic liver disease;Prolonged G2 phase of cell cycle;0.7658925503492355;1.0167645;0.5752167546467182;0.49466342044178147;0.9999528219730685;-0.23406027162383292;0.016811699625747467;-0.4247360673263503;-0.505289401531287
Polycystic liver disease;Single naris;1.020629096776247;0.9700031;0.4934330887281799;0.5095497286769946;0.9999528219730685;0.020676274803178574;-0.02994969392131064;-0.5065197332448885;-0.4904030932960739
Polycystic liver disease;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8146393001079559;1.0822871;0.5593453483774213;0.47377757331049275;0.9999056439461368;-0.18526634383818086;0.08238142918923919;-0.44056029556871545;-0.526128070635644
Polycystic liver disease;Asymmetry of the thorax;0.6848649978637695;0.6954438;0.6020497996637146;0.5985081405122628;0.9999528219730685;-0.3150878241092989;-0.30450901294062827;-0.3979030223093538;-0.4014446814608057
Polycystic liver disease;Type 2 muscle fiber predominance;0.8748234808444977;1.1211797;0.5399497202812682;0.4613322610443886;0.9999515360511232;-0.1251280552066255;0.12122816384664292;-0.460001815769855;-0.5386192750067346
Polycystic liver disease;Dependency on parenteral nutrition;0.6915062069892883;1.0025519;0.5998249049445188;0.4991877142763873;0.8462066046856518;-0.15470039769636346;0.1563453085757618;-0.246381699741133;-0.3470188904092645
Polycystic liver disease;Limited shoulder flexion;0.8583934009075165;0.9840456;0.5452267993705578;0.5050786549968058;0.9999056439461368;-0.1415122430386203;-0.0158600192131656;-0.45467884457557894;-0.49482698894933097
Polycystic liver disease;Paroxysmal vertigo;0.742996096611023;0.99527466;0.5827353241619473;0.5015041193815549;0.9999548690865008;-0.2569587724754778;-0.004680206115004193;-0.4172195449245535;-0.49845074970494585
Polycystic liver disease;Long hallux;0.8965575397014618;1.1689057;0.5329857635950355;0.445976653995931;0.9999478876548411;-0.10339034795337931;0.16895784736102804;-0.46696212405980564;-0.5539712336589101
Polycystic liver disease;Broad medial eyebrow;0.9005575776100159;1.0391902;0.5317059088533573;0.4875221968718344;0.9999567459343585;-0.09939916832434259;0.03923342721475043;-0.4682508370810011;-0.5124345490625241
Polycystic liver disease;Myxoid subcutaneous tumors;0.8669353723526001;1.0201434;0.5424817863296023;0.4935877410556697;0.9999567459343585;-0.13302137358175836;0.020186643767484802;-0.45747495960475615;-0.5063690048786887
Polycystic liver disease;Bulbous tips of toes;0.8636018931865692;1.1302806;0.543552630011022;0.45841219093376306;0.9999548690865008;-0.13635297589993156;0.13032574481273018;-0.4564022390754787;-0.5415426781527377
Polycystic liver disease;Absent internal genitalia;1.0311917886137962;0.95871264;0.490069734634033;0.5131459099692408;0.9999056439461368;0.03128614466765944;-0.041193006521667797;-0.5098359093121038;-0.486759733976896
Polycystic liver disease;Hyperphalangy of the 2nd finger;0.7911947071552277;1.0647924;0.5669574919177598;0.479361478001188;0.9999567459343585;-0.2087620387791308;0.06483564870370306;-0.43299925401659867;-0.5205952679331705
Polycystic liver disease;Renal interstitial hemosiderin;0.7414990961551666;0.9418382;0.5832284981188465;0.5185239222528353;0.9999056439461368;-0.25840654779097016;-0.058067439085449535;-0.4166771458272903;-0.4813817216933015
Polycystic liver disease;Abnormality of depressor anguli oris muscle;0.9020810574293137;0.9794172;0.531218591594325;0.5065521651300904;0.9999056439461368;-0.09782458651682313;-0.020488439089264232;-0.46868705235181174;-0.4933534788160464
Polycystic liver disease;Paroxysmal dyspnea;0.5766610503196716;0.8857129;0.6391420530687293;0.5364583648976773;0.9999056439461368;-0.42324459362646516;-0.11419272232672151;-0.3607635908774075;-0.4634472790484595
Polycystic liver disease;Phenylpyruvic acidemia;0.527334988117218;0.813566;0.656707931928848;0.5596930417606322;0.9999567459343585;-0.47262175781714044;-0.1863907168625506;-0.34324881400551044;-0.4402637041737263
Polycystic liver disease;Lateral ventricle dilatation;0.6367545425891876;0.77006966;0.6183313609840325;0.5738498371179062;0.9999433058680118;-0.3631887632788242;-0.22987364711175573;-0.3816119448839793;-0.4260934687501057
Polycystic liver disease;Neonatal unconjugated hyperbilirubinemia;0.6273236274719238;0.59104306;0.6215598393982729;0.6341073807790567;0.9999567459343585;-0.37263311846243463;-0.4089136908768328;-0.3783969065360856;-0.36584936515530175
Polycystic liver disease;High maternal circulating alpha-fetoprotein concentration;0.757599487900734;0.79436016;0.5779347997403134;0.5659275399022234;0.9999056439461368;-0.24230615604540284;-0.20554548311850007;-0.4219708442058234;-0.43397810404391335
Polycystic liver disease;Prominent nasolabial fold;0.9365363121032715;1.0187461;0.5202147043794052;0.49403255766315535;0.9999501780647019;-0.0634138659614304;0.018795959554316677;-0.4797354736852967;-0.5059176204015465
Polycystic liver disease;Abnormality of inferior alveolar nerve;0.9411579668521881;1.0251281;0.5187408261611131;0.4920006347554431;0.9999056439461368;-0.05874767709394868;0.02522248219827239;-0.48116481778502374;-0.5079050091906937
Polycystic liver disease;Unilateral conductive hearing impairment;0.8111138790845871;0.95284325;0.5604877034983894;0.5150160313166914;0.9999567459343585;-0.18884286684977136;-0.04711349709021173;-0.43946904243596907;-0.4849407146176671
Polycystic liver disease;Macular hypopigmented whorls, streaks, and patches;0.7423571944236755;1.0690092;0.5829457800772652;0.47801622185482795;0.9999567459343585;-0.2575995515106829;0.06905243890298285;-0.4170109658570933;-0.5219405240795305
Polycystic liver disease;Delayed ossification of pubic rami;0.7498525679111481;0.93023723;0.5804790923653675;0.5222242253612575;0.9999548690865008;-0.2501023011753527;-0.06971763544773735;-0.41947577672113323;-0.4777306437252433
Polycystic liver disease;Hyperphenylalaninemia;0.5562913417816162;0.8550093;0.646337492517016;0.5463152298073798;0.9999521228478421;-0.44366078106622586;-0.14494280544977078;-0.3536146303308261;-0.4536368930404623
Polycystic liver disease;Ureteropelvic junction obstruction;0.7011237144470215;0.8197485;0.5966117929684838;0.5576911512485794;0.9999481150251853;-0.29882440057816384;-0.18019959417405007;-0.40333632205670156;-0.44225696377660595
Polycystic liver disease;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8629842549562454;1.1403534;0.543751093637685;0.4551761173459553;0.9999056439461368;-0.13692138898989137;0.14044779729226653;-0.45615455030845176;-0.5447295266001815
Polycystic liver disease;Difficulty walking;0.8383501768112183;1.1031855;0.5516815046761394;0.46709647511155383;0.9999398952172014;-0.16158971840598313;0.1032456392600325;-0.448258390541062;-0.5328434201056476
Polycystic liver disease;Bilobate gallbladder;0.4990495443344116;0.4824859;0.6670161199334225;0.6731425006682528;0.6905613626982415;-0.1915118183638299;-0.20807547230975276;-0.023545242764819063;-0.01741886202998877
Polycystic liver disease;Histidinuria;0.7286775708198547;0.97735375;0.5874609680535;0.507209145770165;0.9999536937290383;-0.27127612290918357;-0.022599942069644996;-0.4124927256755383;-0.49274454795887335
Polycystic liver disease;Widened interpedicular distance;0.7621354460716248;0.90738386;0.5764474378143463;0.5295229406360744;0.9999056439461368;-0.23777019787451203;-0.09252178478857453;-0.4234582061317905;-0.4703827033100624
Subungual hyperkeratosis;Broad humeral epiphyses;0.8180569410324097;1.0443201;0.5582386555230889;0.4858878434169668;0.9999003561294039;-0.1818434150969942;0.04441975037694379;-0.44166170060631493;-0.5140125127124371
Subungual hyperkeratosis;Autoimmune thrombocytopenia;0.8226589858531952;1.0226814;0.5567495530401326;0.4927796835269491;0.9999440906008153;-0.17728510474762016;0.022737264875564045;-0.4431945375606827;-0.5071644070738662
Subungual hyperkeratosis;Adenomyosis;0.9278857111930847;1.0780803;0.522974633633728;0.47512093943531497;0.9999556674707869;-0.07206995627770219;0.07812462904563156;-0.4769810338370589;-0.5248347280354719
Subungual hyperkeratosis;Elevated leukocyte alkaline phosphatase;0.7216314673423767;0.8347626;0.5897936541502864;0.5528390359956112;0.9999556674707869;-0.2783242001284102;-0.1651930942285994;-0.4101620133205005;-0.44711663147517566
Subungual hyperkeratosis;Clasp-knife sign;0.7920544147491455;0.87605935;0.5666776966716145;0.5395532373670049;0.9999003561294039;-0.20784594138025836;-0.12384100277781085;-0.43322265945778937;-0.460347118762399
Subungual hyperkeratosis;Keratosis pilaris;0.5662009716033936;0.5002116;0.6428272154639534;0.6665888883592102;0.7586284122695459;-0.19242744066615236;-0.2584168157805933;-0.11580119680559253;-0.09203952391033576
Subungual hyperkeratosis;Lamina lucida cleavage;0.872051864862442;0.86438006;0.540839105199173;0.5433026127792069;0.7816812336249286;0.09037063123751343;0.08269882800150574;-0.24084212842575559;-0.2383786208457217
Subungual hyperkeratosis;Abnormal central response of multifocal electroretinogram;0.8827454000711441;1.054476;0.5374093559634401;0.4826511434607753;0.9999003561294039;-0.11715495605825976;0.05457566659093305;-0.4624910001659638;-0.5172492126686286
Subungual hyperkeratosis;Atypical or prolonged hepatitis;0.7813867926597595;0.97724116;0.5701532946967313;0.5072449909717947;0.9999556674707869;-0.21856887481102738;-0.022714508985374304;-0.42980237277405564;-0.49271067649899225
Subungual hyperkeratosis;Cubitus varus;1.0215863734483719;1.1643311;0.49312831018543024;0.4474534477469724;0.9999003561294039;0.02168601731896802;0.16443072239995404;-0.5067720459439736;-0.5524469083824315
Subungual hyperkeratosis;Nasal regurgitation;0.9637150689959526;1.1121719;0.5115523881761237;0.46421929108619586;0.9999536937290383;-0.0362386247330857;0.11221819462240212;-0.4884013055529146;-0.5357344026428424
Subungual hyperkeratosis;Moon facies;0.9055943489074707;0.9099175;0.5300950688092063;0.5287130797250961;0.9999536937290383;-0.0943593448215676;-0.09003621993600852;-0.469858624919832;-0.47124061400394224
Subungual hyperkeratosis;Intestinal pseudo-obstruction;0.9047705456614494;1.0400864;0.5303584802908552;0.4872366792653764;0.999947999865749;-0.09517745420429957;0.040138388722202656;-0.4695895195748938;-0.5127113206003726
Subungual hyperkeratosis;Bilateral renal atrophy;0.9153780713677406;1.0675067;0.5269682480390396;0.47849559310097967;0.9999556674707869;-0.08457759610304627;0.06755100348105636;-0.47298741943174727;-0.5214600743698072
Subungual hyperkeratosis;Fractured left clavicle;0.9778966903686523;0.94940555;0.5070362749884427;0.5161116003572309;0.9999003561294039;-0.022003665760751523;-0.05049480517267779;-0.49286408114096114;-0.48378875577217295
Subungual hyperkeratosis;Positive urine norcotinine test;0.8634278774261475;1.0692055;0.5436085441860313;0.47795357347427514;0.9999003561294039;-0.1364724787032564;0.06930516640782758;-0.45629181194337254;-0.5219467826551287
Subungual hyperkeratosis;Long fibula;0.8910945877432823;0.9848853;0.5347345624312159;0.5048113435568693;0.9999515360511232;-0.10885694830784087;-0.015066260687201072;-0.4652169736199073;-0.4951401924942539
Subungual hyperkeratosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7732838988304138;0.62253904;0.5727989535008386;0.6232027706783566;0.9999003561294039;-0.22661645729899005;-0.3773613127028902;-0.4271014026285652;-0.37669758545104726
Subungual hyperkeratosis;Type II cryptotia;0.9165905639529228;0.89563525;0.5265809302497235;0.5332809336915687;0.9999003561294039;-0.08330979217648105;-0.10426510889887408;-0.47331942587968034;-0.46661942243783516
Subungual hyperkeratosis;Increased variability in muscle fiber diameter;0.8117847889661789;1.0356771;0.5602702458079281;0.48864123314054786;0.9999393792871378;-0.18815459032095894;0.03573769609890953;-0.4396691334792098;-0.51129814614659
Subungual hyperkeratosis;Widened proximal tibial metaphyses;0.7073701024055481;0.8451554;0.5945303885290473;0.5494876813205687;0.9999556674707869;-0.2925855650652388;-0.15480024955162797;-0.40542527894173963;-0.4504679861502182
Subungual hyperkeratosis;Wide anterior fontanel;0.838538646697998;1.0258126;0.5516207142817222;0.4917826709250249;0.9999398485671395;-0.16140120186914142;0.0258727773178703;-0.44831913428541725;-0.5081571776421145
Subungual hyperkeratosis;Increased circulating oleate level;0.9057711809873581;1.0296116;0.530038529368023;0.490572950842165;0.9999003561294039;-0.09412917514204577;0.029711231395010196;-0.4698618267613809;-0.5093274052872389
Subungual hyperkeratosis;Lozenge-shaped umbilicus;0.7985136657953262;0.9102893;0.5645771626623848;0.5285942561058692;0.9999536937290383;-0.20144002793371207;-0.08966440616189963;-0.4353765310666535;-0.4713594376231691
Subungual hyperkeratosis;Anti-myelin-associated glycoprotein antibody positivity;0.9034651294350624;0.9411934;0.5307759305338262;0.5187295284847897;0.9999003561294039;-0.09643522669434146;-0.05870695431589679;-0.46912442559557765;-0.48117082764461416
Subungual hyperkeratosis;Fractured radius;0.903048001229763;0.8115263;0.5309093323070271;0.5603540349295839;0.9999556674707869;-0.09690766624102387;-0.18842936894783768;-0.4690463351637598;-0.439601632541203
Subungual hyperkeratosis;Abnormal manual kinetic perimetry test;0.8671838939189911;1.0274878;0.542401971020225;0.49124929147480256;0.9999003561294039;-0.13271646221041278;0.027587398692373477;-0.45749838510917884;-0.5086510646546013
Subungual hyperkeratosis;Small radial epiphyses;0.8170286267995834;0.81275517;0.5585715664372146;0.5599557736124938;0.9999003561294039;-0.18287172932982043;-0.18714518864512042;-0.44132878969218925;-0.43994458251691004
Subungual hyperkeratosis;Generalized keratosis follicularis;0.4915252923965454;0.32368672;0.6697904671696611;0.7364234291012801;0.5961274693045353;-0.1046021769079899;-0.27244075036380044;0.07366299786512576;0.1402959597967448
Subungual hyperkeratosis;Hypoplasia of the calcaneus;0.8482181578874588;0.9714038;0.5485011169780303;0.5091036942169724;0.9999536937290383;-0.1517355358415795;-0.02854991612970359;-0.45145257675100803;-0.49084999951206587
Subungual hyperkeratosis;2-hydroxyadipic aciduria;0.8436218351125717;1.0089113;0.5499818558004508;0.49716340742408094;0.9999003561294039;-0.15627852101683215;0.009010895892385684;-0.4499185003289531;-0.5027369487053229
Subungual hyperkeratosis;Potter facies;0.7925823330879211;0.78487086;0.5665059094764315;0.5690172470724102;0.9999496416008017;-0.20736730851288054;-0.21507877863998626;-0.43344373212437015;-0.4309323945283915
Subungual hyperkeratosis;Increased heart rate variability;0.8532435745000839;1.0813098;0.5468833508757329;0.47408969883092955;0.9999556674707869;-0.14671209297070298;0.08135412790885177;-0.453072316595054;-0.5258659686398574
Subungual hyperkeratosis;Aplastic zygomatic arch;0.9667820110917091;1.0628735;0.5105755597838126;0.47997352308478436;0.9999536937290383;-0.03317168263732917;0.06291978897512429;-0.48937813394522567;-0.519980170644254
Subungual hyperkeratosis;Testicular torsion;0.9107865244150162;0.9537876;0.5284353363527723;0.5147150966045868;0.9999556674707869;-0.08916914305577073;-0.046168042634818884;-0.4715203311180146;-0.4852405708662001
Subungual hyperkeratosis;Abolished vibration sense;0.8662604987621307;1.0414124;0.5426985426374805;0.4868142677483823;0.9999536937290383;-0.13369319496690757;0.041458659786586693;-0.4572551510915578;-0.513139425980656
Subungual hyperkeratosis;Fractured metatarsal bone of digit 5;0.8518648445606232;0.59551233;0.5473270640068103;0.6325501436664612;0.9999003561294039;-0.1480355115687807;-0.4043880255973299;-0.45257329212259356;-0.36735021246294264
Subungual hyperkeratosis;Prolonged G2 phase of cell cycle;0.9107537195086479;1.0117705;0.5284458202986309;0.49625325916241747;0.9999515360511232;-0.08919781654247527;0.011818950780541848;-0.47150571575249234;-0.5036982768887057
Subungual hyperkeratosis;Single naris;0.7835530191659927;0.8279612;0.5694468463366381;0.5550354349601193;0.9999515360511232;-0.21639851688513045;-0.17199032961496596;-0.4305046897144851;-0.4449161010910039
Subungual hyperkeratosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7931697964668274;0.9456763;0.5663147691386696;0.517300271279802;0.9999003561294039;-0.20673055966257647;-0.05422402937769488;-0.43358558699073424;-0.4826000848496018
Subungual hyperkeratosis;Asymmetry of the thorax;0.8933835029602051;1.157954;0.5340017104032073;0.4495102399875457;0.9999515360511232;-0.10656803309091811;0.15800244153371568;-0.46594982564791587;-0.5504412960635775
Subungual hyperkeratosis;Type 2 muscle fiber predominance;0.8416676372289658;1.052561;0.5506117435187707;0.48326157720486584;0.9999501780647019;-0.15828254083573612;0.052610866628291286;-0.44933843454593114;-0.516688600859836
Subungual hyperkeratosis;Dependency on parenteral nutrition;0.8457356989383698;0.94560564;0.5493007257252291;0.5173228039024325;0.9999536937290383;-0.15421799479066856;-0.054348058086032935;-0.45065296800380916;-0.48263088982660585
Subungual hyperkeratosis;Limited shoulder flexion;0.8308288902044296;1.1937975;0.5541090507577773;0.4379195401212964;0.9999003561294039;-0.16907146592497424;0.19389711300969525;-0.4457913053716266;-0.5619808160081075
Subungual hyperkeratosis;Paroxysmal vertigo;0.8651038706302643;1.0626647;0.5430700755464131;0.48004010643123773;0.9999536937290383;-0.13484982309877402;0.06271105350912087;-0.45688361818262524;-0.5199135872978006
Subungual hyperkeratosis;Long hallux;0.7551008760929108;0.65201926;0.5787548463641985;0.6131325323720513;0.9999463141932816;-0.24484543810037085;-0.34792705187943884;-0.4211914678290831;-0.3868137818212303
Subungual hyperkeratosis;Broad medial eyebrow;0.7886303663253784;0.81551933;0.5677923797512228;0.5590603189445552;0.7760104688418579;0.012619897483520548;0.03950886404388432;-0.2082180890906351;-0.21695014989730266
Subungual hyperkeratosis;Myxoid subcutaneous tumors;0.6877810657024384;0.57199883;0.6010722487243327;0.640782098300837;0.8262112537450956;-0.13843018804265728;-0.2542124191351103;-0.2251390050207629;-0.18542915544425864
Subungual hyperkeratosis;Bulbous tips of toes;0.6619045734405518;0.57907426;0.6097826643060784;0.6382947050077104;0.9999536937290383;-0.33804912028848655;-0.42087943015634544;-0.3901710294229599;-0.36165898872132796
Subungual hyperkeratosis;Absent internal genitalia;0.8096690773963928;0.80086887;0.5609560949336903;0.5638119649125513;0.9999003561294039;-0.19023127873301104;-0.19903148730158404;-0.4389442611957136;-0.4360883912168526
Subungual hyperkeratosis;Hyperphalangy of the 2nd finger;0.6926559209823608;0.71067184;0.5994402502102041;0.5934318783157333;0.9999556674707869;-0.30729974648842606;-0.2892838253725508;-0.4005154172605828;-0.4065237891550536
Subungual hyperkeratosis;Renal interstitial hemosiderin;0.6805199086666107;0.88315815;0.6035082551887389;0.5372770722549438;0.9999003561294039;-0.31938044746279315;-0.11674220879435138;-0.396392100940665;-0.46262328387446006
Subungual hyperkeratosis;Abnormality of depressor anguli oris muscle;0.9894665013998747;1.238319;0.5033529787472042;0.4234036066745577;0.9999003561294039;-0.01043385472952918;0.23841868321538373;-0.4965473773821997;-0.5764967494548462
Subungual hyperkeratosis;Paroxysmal dyspnea;0.8826796114444733;1.1182942;0.5374304426741242;0.4622573901751623;0.9999003561294039;-0.1172207446849306;0.11839388291478559;-0.46246991345527966;-0.5376429659542415
Subungual hyperkeratosis;Phenylpyruvic acidemia;0.8862790837883949;1.063629;0.5362769719939677;0.479732572889502;0.9999556674707869;-0.11367658368239197;0.06367336371054855;-0.46367869547681917;-0.5202230945812849
Subungual hyperkeratosis;Lateral ventricle dilatation;0.8843754902482033;1.0687791;0.536886928416933;0.4780896191971076;0.9999414386047084;-0.11556594835650513;0.06883767230379989;-0.46305451018777544;-0.5218518194076008
Subungual hyperkeratosis;Neonatal unconjugated hyperbilirubinemia;0.7975630760192871;1.0596654;0.5648861111666533;0.48099659447103205;0.9999556674707869;-0.2023925914514998;0.05970977404227462;-0.4350695563041336;-0.5189590729997549
Subungual hyperkeratosis;High maternal circulating alpha-fetoprotein concentration;0.8221798986196518;0.9869921;0.5569045141550941;0.5041406462258902;0.9999003561294039;-0.17772045750975207;-0.012908235386606015;-0.44299584197430975;-0.4957597099035137
Subungual hyperkeratosis;Prominent nasolabial fold;0.7623175084590912;0.8550278;0.5763877744482193;0.5463092662743889;0.9999487417813083;-0.23763123332221714;-0.14492094694335667;-0.423560967333089;-0.4536394755069194
Subungual hyperkeratosis;Abnormality of inferior alveolar nerve;0.8970909342169762;0.9182731;0.5328150678661905;0.5260435300948146;0.9999003561294039;-0.1028094219124277;-0.08162726481318072;-0.4670852882632134;-0.47385682603458923
Subungual hyperkeratosis;Unilateral conductive hearing impairment;0.8032537400722504;1.0303847;0.5630375184658929;0.490326765282324;0.9999556674707869;-0.19670192739853654;0.030428992296363977;-0.436918149004894;-0.5096289021884629
Subungual hyperkeratosis;Macular hypopigmented whorls, streaks, and patches;0.7438419759273529;0.72162735;0.5824567463821724;0.5897950072671391;0.8095978540801885;-0.06575587815283557;-0.08797049945830127;-0.2271411076980161;-0.2198028468130494
Subungual hyperkeratosis;Delayed ossification of pubic rami;0.8643808364868164;0.9982972;0.5433023590460564;0.5005420051210235;0.9999536937290383;-0.1355728572422219;-0.0016564792209816659;-0.4566513346829819;-0.49941168860801477
Subungual hyperkeratosis;Hyperphenylalaninemia;0.7771521508693695;0.9834338;0.5715353119526859;0.5052734365994338;0.9999507979965523;-0.22279864712718278;-0.01651701494220048;-0.42841548604386637;-0.4946773613971185
Subungual hyperkeratosis;Ureteropelvic junction obstruction;0.8369317501783371;0.8888244;0.5521390750977302;0.5354616047467021;0.9999465554694025;-0.16301480529106538;-0.11112215218342225;-0.4478074803716723;-0.46448495072270035
Subungual hyperkeratosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7573922127485275;0.6029716;0.5780028074764363;0.6299585529232363;0.9999003561294039;-0.24250814338087634;-0.39692874272226886;-0.4218975486529676;-0.36994180320616754
Subungual hyperkeratosis;Difficulty walking;0.8621610403060913;0.9432604;0.5440156410732984;0.5180704918438024;0.9999377923649526;-0.1377767520588613;-0.05667742067992454;-0.45592215129165425;-0.48186730052115023
Subungual hyperkeratosis;Bilobate gallbladder;0.9902535639703274;1.1231248;0.5031024360629175;0.46070843745107404;0.9999536937290383;-0.00970012975871093;0.1231711441463279;-0.4968512576661208;-0.5392452562779643
Subungual hyperkeratosis;Histidinuria;0.6941123008728027;0.8527615;0.598953210977927;0.5470384829373185;0.9999524555142131;-0.30584015464141034;-0.14719094847991132;-0.4009992445362861;-0.4529139725768946
Subungual hyperkeratosis;Widened interpedicular distance;0.8691708445549011;1.1385158;0.5417639369585756;0.4557668224230125;0.9999003561294039;-0.13072951157450274;0.13861547391057416;-0.45813641917082826;-0.5441335337063914
Broad humeral epiphyses;Autoimmune thrombocytopenia;0.8519447445869446;0.9996376;0.5473013474650127;0.5001153544567319;0.9998726169824932;-0.1479278723955486;-0.00023501322272756475;-0.4525712695174805;-0.49975726252576125
Broad humeral epiphyses;Adenomyosis;0.8821090534329414;0.9300627;0.537613326074791;0.5222799183396174;0.9999201345566091;-0.11781108112366767;-0.06985742331774802;-0.46230680848181815;-0.4776402162169917
Broad humeral epiphyses;Elevated leukocyte alkaline phosphatase;0.7099250257015228;0.95212543;0.5936802482050157;0.5152447773065618;0.9999201345566091;-0.2899951088550863;-0.04779470444949241;-0.40623988635159336;-0.4846753572500473
Broad humeral epiphyses;Clasp-knife sign;0.9693740420043468;1.0511603;0.5097500697876425;0.4837080340399762;1.0;-0.030625957995653152;0.051160335540771484;-0.4902499302123575;-0.5162919659600238
Broad humeral epiphyses;Keratosis pilaris;0.832992285490036;1.0545639;0.5534104810786343;0.4826231621010013;0.9998710980331391;-0.1668788125431031;0.054692781933596724;-0.4464606169545048;-0.5172479359321378
Broad humeral epiphyses;Lamina lucida cleavage;1.005265899002552;1.2060298;0.49832380454105074;0.4339456341120095;0.9998962300503706;0.005369668952181383;0.20613354270811324;-0.5015724255093199;-0.5659505959383612
Broad humeral epiphyses;Abnormal central response of multifocal electroretinogram;0.8722710907459259;1.1357027;0.5407687461365478;0.45667078338566236;1.0;-0.1277289092540741;0.1357027292251587;-0.4592312538634522;-0.5433292166143376
Broad humeral epiphyses;Atypical or prolonged hepatitis;0.7958488911390305;0.9822259;0.5654433904929457;0.5056579707060999;0.9999201345566091;-0.20407124341757865;-0.017694239628630593;-0.43447674406366343;-0.49426216385050925
Broad humeral epiphyses;Cubitus varus;0.8177665024995804;0.58096266;0.5583326768100985;0.637632365452132;1.0;-0.18223349750041962;-0.4190373420715332;-0.44166732318990154;-0.362367634547868
Broad humeral epiphyses;Nasal regurgitation;0.8946327269077301;1.0140654;0.5336018174444861;0.49552268470571004;0.9999134918687169;-0.10528076496098682;0.01415189299609021;-0.4663116744242308;-0.5043908071630069
Broad humeral epiphyses;Moon facies;0.7854198813438416;1.0287187;0.5688383053495758;0.4908572995804982;0.9999134918687169;-0.21449361052487537;0.02880521807696179;-0.4310751865191411;-0.5090561922882187
Broad humeral epiphyses;Intestinal pseudo-obstruction;0.8387715220451355;0.95329076;0.551545603662895;0.5148734196586777;0.9998912449978579;-0.16111972295272237;-0.0466004844807375;-0.4483456413349629;-0.48501782533918014
Broad humeral epiphyses;Bilateral renal atrophy;0.7237830758094788;0.9229696;0.5890808223706083;0.5245438673558838;0.9999201345566091;-0.27613705874713035;-0.07695055485995383;-0.4108393121860008;-0.47537626720072534
Broad humeral epiphyses;Fractured left clavicle;0.6667593121528625;0.8282157;0.6081421696716041;0.5549532066306007;1.0;-0.33324068784713745;-0.17178428173065186;-0.39185783032839594;-0.44504679336939934
Broad humeral epiphyses;Positive urine norcotinine test;0.8578987717628479;1.0427656;0.545385853133789;0.4863831141618171;1.0;-0.1421012282371521;0.04276561737060547;-0.45461414686621104;-0.5136168858381829
Broad humeral epiphyses;Long fibula;0.6498359739780426;0.7170379;0.6138741555793392;0.5913170609165008;0.6109530888848884;0.038882885093154185;0.10608482729858326;0.0029210666944508024;-0.019636027968387593
Broad humeral epiphyses;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6023325622081757;0.7974208;0.6301802194860382;0.5649323573079519;1.0;-0.39766743779182434;-0.20257920026779175;-0.3698197805139618;-0.4350676426920481
Broad humeral epiphyses;Type II cryptotia;0.7923080921173096;1.0168854;0.5665951463653942;0.4946249637605251;1.0;-0.20769190788269043;0.01688539981842041;-0.4334048536346058;-0.5053750362394749
Broad humeral epiphyses;Increased variability in muscle fiber diameter;0.6891666054725647;0.9172804;0.6006081215735918;0.5263605995824273;0.7712186293488323;-0.08205202387626764;0.14606174660865667;-0.17061050777524056;-0.24485802976640503
Broad humeral epiphyses;Widened proximal tibial metaphyses;0.3743278980255127;0.7286422;0.7151751942806639;0.587472657437278;0.4693866352828394;-0.09505873725732672;0.2592555899826635;0.24578855899782448;0.11808602215443853
Broad humeral epiphyses;Wide anterior fontanel;0.6946513056755066;1.055918;0.598773018977385;0.4821914800314425;0.6617971500655027;0.03285415561000393;0.3941208282212405;-0.06302413108811766;-0.17960567003406014
Broad humeral epiphyses;Increased circulating oleate level;0.7144639194011688;0.95756775;0.5921716408738429;0.5135106546702529;1.0;-0.2855360805988312;-0.04243224859237671;-0.4078283591261571;-0.4864893453297471
Broad humeral epiphyses;Lozenge-shaped umbilicus;0.9088426157832146;0.9146327;0.5290566335803794;0.5272063781796574;0.9999134918687169;-0.09107087608550235;-0.08528081383679553;-0.47085685828833757;-0.4727071136890595
Broad humeral epiphyses;Anti-myelin-associated glycoprotein antibody positivity;0.8662419766187668;1.1054494;0.5427044918710746;0.46637188687333386;1.0;-0.13375802338123322;0.10544943809509277;-0.4572955081289254;-0.5336281131266661
Broad humeral epiphyses;Fractured radius;0.5854665040969849;0.60852385;0.6360552329778095;0.6280354514507867;0.35601339282121613;0.22945311127576873;0.2525104528513913;0.2800418401565934;0.2720220586295705
Broad humeral epiphyses;Abnormal manual kinetic perimetry test;0.8545593619346619;1.0102193;0.546459979942612;0.4967470207248653;1.0;-0.14544063806533813;0.010219335556030273;-0.453540020057388;-0.5032529792751347
Broad humeral epiphyses;Small radial epiphyses;0.395304799079895;0.36057615;0.7067050664076628;0.7208270591203236;1.0;-0.604695200920105;-0.6394238471984863;-0.29329493359233716;-0.27917294087967637
Broad humeral epiphyses;Generalized keratosis follicularis;0.7527202516794205;1.0747852;0.5795366660816137;0.47617288517718304;0.9999201345566091;-0.24719988287718864;0.0748650979873362;-0.4203834684749954;-0.5237472493794261
Broad humeral epiphyses;Hypoplasia of the calcaneus;0.7543062120676041;0.7427527;0.5790157674179799;0.5828154948777804;0.6433114794007544;0.11099473266684967;0.09944119184100586;-0.0642957119827745;-0.060495984522974
Broad humeral epiphyses;2-hydroxyadipic aciduria;0.7510551512241364;0.8681276;0.5800837920256183;0.5420989192802774;1.0;-0.24894484877586365;-0.13187241554260254;-0.41991620797438167;-0.4579010807197226
Broad humeral epiphyses;Potter facies;0.71852245926857;0.92454076;0.5908244931215709;0.5240422761183039;0.9998981869165328;-0.2813757276479628;-0.07535742878359819;-0.40907369379496183;-0.47585591079822886
Broad humeral epiphyses;Increased heart rate variability;0.7257539629936218;1.1309048;0.5884282663299754;0.45821178255408235;0.9999201345566091;-0.2741661715629873;0.13098465918270974;-0.41149186822663375;-0.5417083520025268
Broad humeral epiphyses;Aplastic zygomatic arch;0.7365951836109161;1.0649772;0.5848454902900193;0.47930253828319813;0.8072246192530101;-0.07062943564209401;0.2577525497838551;-0.22237912896299084;-0.327922080969812
Broad humeral epiphyses;Testicular torsion;0.8243290185928345;0.90421766;0.5562094857472651;0.5305352772923063;0.9999201345566091;-0.17559111596377464;-0.0957024741295156;-0.44371064880934397;-0.4693848572643028
Broad humeral epiphyses;Abolished vibration sense;0.919923834502697;0.90548563;0.5255163541267835;0.5301298210035854;0.9999134918687169;-0.07998965736601993;-0.09442786183331653;-0.4743971377419334;-0.4697836708651315
Broad humeral epiphyses;Fractured metatarsal bone of digit 5;0.7429910004138947;0.843774;0.5827370027149967;0.54993281083542;1.0;-0.25700899958610535;-0.15622597932815552;-0.41726299728500327;-0.45006718916458
Broad humeral epiphyses;Prolonged G2 phase of cell cycle;0.7962049245834351;1.0857368;0.5653276277892899;0.4726756150546424;0.9999056439461368;-0.20370071936270173;0.0858311076102597;-0.4345780161568469;-0.5272300288914944
Broad humeral epiphyses;Single naris;0.9718011263757944;1.0568305;0.5089771702610884;0.48190053270509736;0.9999056439461368;-0.02810451757034238;0.056924881452117604;-0.49092847368504844;-0.5180051112410394
Broad humeral epiphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7557008862495422;1.0723231;0.5785578740218977;0.4769587260780672;1.0;-0.24429911375045776;0.07232308387756348;-0.42144212597810227;-0.5230412739219328
Broad humeral epiphyses;Asymmetry of the thorax;0.6497856974601746;0.84992623;0.613891240955099;0.5479511192779107;0.789736248610815;-0.13995055115064048;0.06018998468081094;-0.1758450076557161;-0.2417851293329043
Broad humeral epiphyses;Type 2 muscle fiber predominance;0.803376168012619;0.9128144;0.5629977720645889;0.527787334268359;0.8527273749847077;-0.049351206972088724;0.06008700375369558;-0.28972960292011884;-0.32494004071634874
Broad humeral epiphyses;Dependency on parenteral nutrition;0.8752250373363495;0.9597006;0.5398208908301786;0.5128311794258399;0.9999134918687169;-0.12468845453236743;-0.040212907457095826;-0.46009260103853833;-0.48708231244287703
Broad humeral epiphyses;Limited shoulder flexion;0.7056804299354553;0.58902866;0.5950930017122762;0.6348103761062611;1.0;-0.2943195700645447;-0.41097134351730347;-0.4049069982877238;-0.3651896238937389
Broad humeral epiphyses;Paroxysmal vertigo;0.9073532074689865;0.9829081;0.5295327418839979;0.5054407691026601;0.9999134918687169;-0.09256028439973041;-0.017005362176639283;-0.470380749984719;-0.4944727227660568
Broad humeral epiphyses;Long hallux;0.7139778137207031;0.9275502;0.592333106981225;0.523081713699266;0.5200670694678955;0.19391074425280763;0.40748312717974855;0.0722660375133295;0.0030146442313705446
Broad humeral epiphyses;Broad medial eyebrow;0.6730546951293945;1.0224462;0.6060192912610383;0.49285455482176677;0.9999201345566091;-0.3268654394272146;0.022526020991486595;-0.39390084329557085;-0.5070655797348423
Broad humeral epiphyses;Myxoid subcutaneous tumors;0.9158820658922195;1.1073377;0.5268072475504794;0.4657674086607002;0.9999201345566091;-0.08403806866438956;0.10741757868496804;-0.47311288700612975;-0.5341527258959089
Broad humeral epiphyses;Bulbous tips of toes;0.7056392133235931;0.9058469;0.5951067294983984;0.5300143168468141;0.6433114794007544;0.062327733922838746;0.26253541438662964;-0.048204749902356014;-0.11329716255394029
Broad humeral epiphyses;Absent internal genitalia;0.8578807711601257;0.9775522;0.5453916416521996;0.5071459629089566;1.0;-0.14211922883987427;-0.022447824478149414;-0.45460835834780045;-0.49285403709104336
Broad humeral epiphyses;Hyperphalangy of the 2nd finger;0.699601411819458;0.7557942;0.5971196934397398;0.5785272346849788;0.660589513309896;0.03901189850956199;0.09520471381336448;-0.06346981987015621;-0.08206227862491722
Broad humeral epiphyses;Renal interstitial hemosiderin;0.8279022574424744;1.0358367;0.5550544927401848;0.4885903631325689;1.0;-0.17209774255752563;0.03583669662475586;-0.4449455072598152;-0.5114096368674311
Broad humeral epiphyses;Abnormality of depressor anguli oris muscle;0.8080853819847107;0.826039;0.5614696680356281;0.5556566636749167;1.0;-0.1919146180152893;-0.17396098375320435;-0.43853033196437186;-0.44434333632508327
Broad humeral epiphyses;Paroxysmal dyspnea;0.8341242372989655;1.0435224;0.5530450726294143;0.48614202114713523;1.0;-0.16587576270103455;0.04352235794067383;-0.44695492737058573;-0.5138579788528648
Broad humeral epiphyses;Phenylpyruvic acidemia;0.7704444378614426;0.94374007;0.5737272625167347;0.5179175441799677;0.9999201345566091;-0.22947569669516654;-0.05618006469042869;-0.42619287203987444;-0.4820025903766414
Broad humeral epiphyses;Lateral ventricle dilatation;0.7944710403680801;0.9948592;0.5658914754904514;0.501636364896876;0.9998579617208769;-0.2053869213527968;-0.004998743123464822;-0.43396648623042555;-0.4982215968240009
Broad humeral epiphyses;Neonatal unconjugated hyperbilirubinemia;0.8245040327310562;0.88877803;0.5561528978988861;0.5354764576594655;0.9999201345566091;-0.1754161018255529;-0.11114210368426414;-0.443767236657723;-0.4644436768971436
Broad humeral epiphyses;High maternal circulating alpha-fetoprotein concentration;0.7345809638500214;1.0389493;0.5855102970777633;0.48759894568836715;1.0;-0.26541903614997864;0.03894925117492676;-0.41448970292223675;-0.5124010543116329
Broad humeral epiphyses;Prominent nasolabial fold;0.7532782107591629;1.0953816;0.5793533832200629;0.46959285126228;0.9998944404568447;-0.24661622969768182;0.09548717708923682;-0.4205410572367818;-0.5303015891945647
Broad humeral epiphyses;Abnormality of inferior alveolar nerve;0.9143058806657791;1.0589797;0.5273107812224218;0.4812152729181879;1.0;-0.08569411933422089;0.05897974967956543;-0.4726892187775782;-0.5187847270818121
Broad humeral epiphyses;Unilateral conductive hearing impairment;0.901219829916954;0.96895474;0.5314940643456127;0.5098836095354171;0.9999201345566091;-0.09870030463965507;-0.03096539260180564;-0.46842607021099636;-0.490036525021192
Broad humeral epiphyses;Macular hypopigmented whorls, streaks, and patches;0.9174464195966721;1.1524583;0.5263075600987981;0.45128101148926714;0.9999201345566091;-0.08247371495993705;0.1525381755706492;-0.473612574457811;-0.548639123067342
Broad humeral epiphyses;Delayed ossification of pubic rami;0.651792585849762;0.7774415;0.6132095093907496;0.5714408361105822;0.6574179255159834;-0.005625339666221474;0.1200235761014482;-0.04420841612523385;-0.08597708940540127
Broad humeral epiphyses;Hyperphenylalaninemia;0.6945304274559021;0.94351774;0.5988134263232314;0.5179884406778998;0.9999028053808913;-0.30537237792498917;-0.056385060839723056;-0.40108937905765984;-0.4819143647029914
Broad humeral epiphyses;Ureteropelvic junction obstruction;0.819798544049263;0.88279873;0.5576749681168025;0.5373922670129018;0.9998847295244674;-0.18008618547520439;-0.1170859981974105;-0.4422097614076649;-0.4624924625115656
Broad humeral epiphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6179002523422241;0.7306471;0.6247989258178324;0.5868098057596969;1.0;-0.3820997476577759;-0.26935291290283203;-0.37520107418216764;-0.4131901942403031
Broad humeral epiphyses;Difficulty walking;0.9522803500294685;1.0814594;0.5151954071509801;0.4740419139778529;0.7552776988623575;0.19700265116711102;0.3261817041756674;-0.2400822917113774;-0.2812357848845046
Broad humeral epiphyses;Bilobate gallbladder;0.8310403227806091;0.88902026;0.5540407667184315;0.5353988625455351;0.9999134918687169;-0.1688731690881078;-0.11089322772000476;-0.4458727251502854;-0.46451462932318177
Broad humeral epiphyses;Histidinuria;0.7811085283756256;0.91422915;0.570244067448261;0.5273352846222844;0.9999090677057578;-0.21880053933013222;-0.08567991311896583;-0.4296650002574969;-0.4725737830834734
Broad humeral epiphyses;Widened interpedicular distance;0.5375621318817139;0.6831256;0.6530251716642874;0.6026333758062656;1.0;-0.46243786811828613;-0.3168743848800659;-0.3469748283357126;-0.39736662419373436
Autoimmune thrombocytopenia;Adenomyosis;0.8112350851297379;0.9610544;0.5604484156532705;0.5123999115223029;0.9999509115718902;-0.18871582644215235;-0.03889652686348566;-0.4395024959186197;-0.4875510000495873
Autoimmune thrombocytopenia;Elevated leukocyte alkaline phosphatase;0.5784105062484741;0.8766;0.6385276645060791;0.5393798089667148;0.9999509115718902;-0.4215404053234161;-0.12335088448753961;-0.3614232470658111;-0.4605711026051754
Autoimmune thrombocytopenia;Clasp-knife sign;0.9791909903287888;1.130634;0.5066241916209665;0.45829875102015727;0.9998726169824932;-0.020681626653704432;0.13076133325096628;-0.4932484253615267;-0.5415738659623359
Autoimmune thrombocytopenia;Keratosis pilaris;0.7298045456409454;0.9460227;0.5870883213981204;0.517189869331284;0.9999359310045346;-0.27013138536358916;-0.053913241662035816;-0.4128476096064142;-0.4827460616732506
Autoimmune thrombocytopenia;Lamina lucida cleavage;0.8544562757015228;1.0088104;0.5464931462187961;0.49719552065317285;0.9999428147971705;-0.14548653909564768;0.00886758616565908;-0.45344966857837443;-0.5027472941439977
Autoimmune thrombocytopenia;Abnormal central response of multifocal electroretinogram;0.797099769115448;1.0201557;0.5650367116902042;0.49358382001562073;0.9998726169824932;-0.2027728478670452;0.020283051276173802;-0.434835905292289;-0.5062887969668725
Autoimmune thrombocytopenia;Atypical or prolonged hepatitis;0.6291514039039612;0.8385871;0.6209331217708736;0.5516050796147449;0.7436433544643041;-0.11449195056034289;0.09494375080989637;-0.12271023269343051;-0.19203827484955915
Autoimmune thrombocytopenia;Cubitus varus;0.9411845728754997;1.0482512;0.5187323425079413;0.48463521299329726;0.9998726169824932;-0.058688044106993464;0.04837853505608103;-0.4811402744745519;-0.5152374039891959
Autoimmune thrombocytopenia;Nasal regurgitation;0.879034161567688;1.0504196;0.5385991506898768;0.4839441261358841;0.9999484800242363;-0.12091431845654832;0.05047108899126662;-0.46134932933435946;-0.5160043538883522
Autoimmune thrombocytopenia;Moon facies;0.928511306643486;1.1045063;0.5227749851093797;0.46667376542678707;0.9999484800242363;-0.07143717338075029;0.10455777417193068;-0.4771734949148566;-0.5332747145974492
Autoimmune thrombocytopenia;Intestinal pseudo-obstruction;0.7129357159137726;0.9329053;0.5926793353212312;0.5213729573775293;0.9999413328681149;-0.28700561695434235;-0.06703601651527069;-0.40726199754688375;-0.4785683754905856
Autoimmune thrombocytopenia;Bilateral renal atrophy;0.6698318123817444;0.9667406;0.6071054672756715;0.5105887531335562;0.9999509115718902;-0.3301190991901458;-0.03321030335655817;-0.3928454442962187;-0.48936215843833397
Autoimmune thrombocytopenia;Fractured left clavicle;0.7867982983589172;0.9653047;0.5683891469195258;0.511046083770349;0.9998726169824932;-0.21307431862357595;-0.034567944264445094;-0.4314834700629674;-0.4888265332121442
Autoimmune thrombocytopenia;Positive urine norcotinine test;0.8693727403879166;1.0468504;0.5416991152346524;0.4850815680224103;0.9998726169824932;-0.13049987659457662;0.04697782590385935;-0.4581735017478408;-0.5147910489600829
Autoimmune thrombocytopenia;Long fibula;0.8557606637477875;1.0315839;0.5460735184733811;0.4899448537664296;0.9999457950338347;-0.14418513128604726;0.031638110186197;-0.4538722765604536;-0.5100009412674051
Autoimmune thrombocytopenia;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8085030913352966;0.9417516;0.561334194312228;0.5185515364710847;0.9998726169824932;-0.19136952564719656;-0.058121017670664576;-0.4385384226702652;-0.48132108051140854
Autoimmune thrombocytopenia;Type II cryptotia;0.7965356558561325;1.1209686;0.5652200998266088;0.4613999701073066;0.9998726169824932;-0.20333696112636068;0.12109596326347849;-0.4346525171558844;-0.5384726468751866
Autoimmune thrombocytopenia;Increased variability in muscle fiber diameter;0.8883428573608398;1.116042;0.53561584113835;0.4629792739635811;0.9999301217850027;-0.11158726442416289;0.11611189615170381;-0.4643142806466527;-0.5369508478214217
Autoimmune thrombocytopenia;Widened proximal tibial metaphyses;0.7376638054847717;0.9722605;0.5844929385118642;0.508830904301461;0.9999509115718902;-0.26228710608711847;-0.027690436413198793;-0.41545797306002596;-0.49112000727042915
Autoimmune thrombocytopenia;Wide anterior fontanel;0.8323342204093933;1.0446348;0.5536229454948159;0.48578755739213964;0.9999307446020095;-0.16759652419261617;0.04470407442875224;-0.44630779910719354;-0.5141431872098698
Autoimmune thrombocytopenia;Increased circulating oleate level;0.7987027615308762;0.9572287;0.5645157125548267;0.5136186720966704;0.9998726169824932;-0.20116985545161703;-0.04264389679435232;-0.4353569044276665;-0.48625394488582274
Autoimmune thrombocytopenia;Lozenge-shaped umbilicus;0.872409999370575;0.93186766;0.5407241653910096;0.521704004414192;0.9999484800242363;-0.12753848065366136;-0.06808082093228685;-0.45922431463322666;-0.47824447561004435
Autoimmune thrombocytopenia;Anti-myelin-associated glycoprotein antibody positivity;0.6955831348896027;0.9704519;0.598461580908148;0.5094068195069934;0.0;0.6955831348896027;0.9704518914222717;0.598461580908148;0.5094068195069934
Autoimmune thrombocytopenia;Fractured radius;0.8385473787784576;0.9926354;0.5516178978215236;0.5023442337168771;0.9999509115718902;-0.16140353279343256;-0.007315482666403139;-0.4483330137503666;-0.4976066778550131
Autoimmune thrombocytopenia;Abnormal manual kinetic perimetry test;0.7372413873672485;1.0371308;0.5846322868415313;0.4881781784793342;0.9998726169824932;-0.26263122961524465;0.03725821568962595;-0.41524033014096184;-0.511694438503159
Autoimmune thrombocytopenia;Small radial epiphyses;0.9181144312024117;1.0247362;0.5260942030204878;0.4921254199552596;0.9998726169824932;-0.08175818578008154;0.02486354901787302;-0.4737784139620054;-0.5077471970272336
Autoimmune thrombocytopenia;Generalized keratosis follicularis;0.8457385003566742;1.0858178;0.5492998232027457;0.4726496809595212;0.9999509115718902;-0.154212411215216;0.08586690230140082;-0.45065108836914447;-0.527301230612369
Autoimmune thrombocytopenia;Hypoplasia of the calcaneus;0.8261461704969406;1.0459653;0.5556220276340436;0.4853636338413029;0.9999484800242363;-0.1738023095272957;0.04601683388720168;-0.44432645239019275;-0.5145848461829334
Autoimmune thrombocytopenia;2-hydroxyadipic aciduria;0.7870563864707947;1.0123229;0.5683050640732583;0.4960773942257696;0.9998726169824932;-0.2128162305116985;0.01245028569695017;-0.4315675529092349;-0.5037952227567236
Autoimmune thrombocytopenia;Potter facies;0.9028561860322952;1.0402017;0.5309706785527848;0.48719997773070045;0.9999434141430041;-0.09708722811070891;0.04025824982794313;-0.46897273559021935;-0.5127434364123037
Autoimmune thrombocytopenia;Increased heart rate variability;0.7402660250663757;1.0017277;0.5836348763846595;0.4994500368371838;0.9999509115718902;-0.25968488650551447;0.001776788661569273;-0.4163160351872307;-0.5005008747347064
Autoimmune thrombocytopenia;Aplastic zygomatic arch;0.7194265723228455;0.9765395;0.5905246201976994;0.5074683907094959;0.9999484800242363;-0.28052190770139085;-0.02340898741711961;-0.40942385982653695;-0.4924800893147404
Autoimmune thrombocytopenia;Testicular torsion;0.6900467276573181;0.88650554;0.600313413826255;0.5362044176712468;0.9999509115718902;-0.3099041839145721;-0.11344536738625177;-0.3996374977456352;-0.4637464939006434
Autoimmune thrombocytopenia;Abolished vibration sense;0.8258655518293381;1.0316805;0.5557127349170017;0.4899141238815776;0.9999484800242363;-0.17408292819489823;0.03173198472033156;-0.4442357451072346;-0.5100343561426587
Autoimmune thrombocytopenia;Fractured metatarsal bone of digit 5;0.8174799829721451;0.910526;0.5584254344732409;0.5285186087383222;0.9998726169824932;-0.1823926340103481;-0.08934663937095144;-0.4414471825092523;-0.47135400824417095
Autoimmune thrombocytopenia;Prolonged G2 phase of cell cycle;0.8116477578878403;0.9864721;0.5603146584900935;0.5043062122544915;0.9999457950338347;-0.18829803714599447;-0.01347372481670217;-0.4396311365437412;-0.4956395827793433
Autoimmune thrombocytopenia;Single naris;1.0406172722578049;1.1358818;0.4870675631180703;0.4566132803359091;0.9999457950338347;0.04067147722397013;0.13593598654422923;-0.5128782319157644;-0.5433325146979257
Autoimmune thrombocytopenia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6990486979484558;1.040061;0.5973041637880312;0.487244775273984;0.9998726169824932;-0.3008239190340374;0.040188380026784154;-0.402568453194462;-0.5126278417085092
Autoimmune thrombocytopenia;Asymmetry of the thorax;0.5697742998600006;0.93865013;0.6415660249494036;0.5195405406461746;0.9999457950338347;-0.43017149517383413;-0.0612956638082488;-0.3583797700844311;-0.48040525438766013
Autoimmune thrombocytopenia;Type 2 muscle fiber predominance;0.944247230887413;1.1246368;0.5177558643413283;0.46022343400966736;0.9999440906008153;-0.055696859713402325;0.12469267869392342;-0.4821882262594871;-0.539720656591148
Autoimmune thrombocytopenia;Dependency on parenteral nutrition;0.8014556467533112;0.9377975;0.5636213870604865;0.5198124592382889;0.9999484800242363;-0.19849283327092515;-0.06215099324216233;-0.43632709296374983;-0.4801360207859474
Autoimmune thrombocytopenia;Limited shoulder flexion;0.7965269237756729;1.0665514;0.5652229387196752;0.4788003571187792;0.9998726169824932;-0.20334569320682028;0.06667882993217966;-0.434649678262818;-0.521072259863714
Autoimmune thrombocytopenia;Paroxysmal vertigo;0.6707170307636261;0.9669429;0.6068070023940246;0.5105243075889401;0.9999484800242363;-0.3292314492606102;-0.0330055736445366;-0.3931414776302117;-0.48942417243529623
Autoimmune thrombocytopenia;Long hallux;0.8729681372642517;0.9890977;0.5405450470676898;0.5034703781816596;0.9999391782875108;-0.12697104102325907;-0.010841463863377476;-0.459394131219821;-0.49646880010585115
Autoimmune thrombocytopenia;Broad medial eyebrow;0.9189329743385315;1.0891677;0.5258327834936933;0.471579285878458;0.9999509115718902;-0.0810179372333587;0.08921680254706732;-0.47411812807819687;-0.5283716256934322
Autoimmune thrombocytopenia;Myxoid subcutaneous tumors;0.8507215976715088;1.0950493;0.5476950624673571;0.46969913090888804;0.9999509115718902;-0.1492293139003814;0.09509835047492377;-0.4522558491045331;-0.5302517806630022
Autoimmune thrombocytopenia;Bulbous tips of toes;0.7991922348737717;0.9244597;0.5643566605819406;0.5240681552906192;0.9999484800242363;-0.20075624515046464;-0.07548878420819627;-0.43559181944229575;-0.4758803247336171
Autoimmune thrombocytopenia;Absent internal genitalia;0.8362368047237396;1.0361325;0.5523632972630569;0.4884961937570238;0.9998726169824932;-0.16363581225875357;0.03625983788963816;-0.4475093197194363;-0.5113764232254694
Autoimmune thrombocytopenia;Hyperphalangy of the 2nd finger;0.7283689379692078;0.90749246;0.5875630423415468;0.5294882256276656;0.9999509115718902;-0.27158197360268244;-0.09245845275154718;-0.41238786923034343;-0.4704626859442246
Autoimmune thrombocytopenia;Renal interstitial hemosiderin;0.7120228409767151;0.98015845;0.5929827231816711;0.5063161836843969;0.9998726169824932;-0.2878497760057781;-0.019714168763193873;-0.4068898938008221;-0.4935564332980963
Autoimmune thrombocytopenia;Abnormality of depressor anguli oris muscle;0.8079072535037994;1.1128011;0.5615274430421151;0.4640177379244327;0.9998726169824932;-0.19196536347869375;0.11292845799919626;-0.4383451739403781;-0.5358548790580605
Autoimmune thrombocytopenia;Paroxysmal dyspnea;0.6552298069000244;0.8791918;0.6120431563041571;0.53854859702542;0.9998726169824932;-0.3446428100824688;-0.1206808011293743;-0.3878294606783361;-0.4613240199570732
Autoimmune thrombocytopenia;Phenylpyruvic acidemia;0.6480402052402496;0.8896945;0.6144846214242297;0.5351829193557347;0.9999509115718902;-0.35191070633164057;-0.11025639968147882;-0.38546629014766054;-0.4647679922161555
Autoimmune thrombocytopenia;Lateral ventricle dilatation;0.8326887786388397;1.0301328;0.5535084690131005;0.4904069731338634;0.9999328439703079;-0.16724406533146818;0.030199926568022173;-0.44642437495720744;-0.5095258708364445
Autoimmune thrombocytopenia;Neonatal unconjugated hyperbilirubinemia;0.6992018222808838;0.75068533;0.5972530545861698;0.5802053310646039;0.9999509115718902;-0.3007490892910064;-0.24926557736626276;-0.40269785698572036;-0.4197455805072863
Autoimmune thrombocytopenia;High maternal circulating alpha-fetoprotein concentration;0.7022750973701477;0.86458004;0.5962278145965246;0.5432383617267922;0.9998726169824932;-0.2975975196123455;-0.13529258177283743;-0.40364480238596856;-0.456634255255701
Autoimmune thrombocytopenia;Prominent nasolabial fold;0.898414321243763;1.1243554;0.5323916012732981;0.46031368276289797;0.9999422754987515;-0.1015279542549885;0.12441315987264745;-0.4675506742254534;-0.5396285927358535
Autoimmune thrombocytopenia;Abnormality of inferior alveolar nerve;0.8301966339349747;1.0971645;0.5543132585834973;0.46902268754831433;0.9998726169824932;-0.16967598304751852;0.09729189469810984;-0.44555935839899585;-0.5308499294341789
Autoimmune thrombocytopenia;Unilateral conductive hearing impairment;0.8702731132507324;1.0123612;0.5414100579836446;0.4960652077539167;0.9999509115718902;-0.12967779832115778;0.01241025728949896;-0.4585408535882456;-0.5038857038179735
Autoimmune thrombocytopenia;Macular hypopigmented whorls, streaks, and patches;0.7323730289936066;1.0289108;0.5862394803709805;0.4907961238267181;0.9999509115718902;-0.26757788257828363;0.02895984453925482;-0.4137114312009097;-0.5091547877451721
Autoimmune thrombocytopenia;Delayed ossification of pubic rami;0.7301656901836395;0.9762671;0.5869689308959707;0.5075551309909445;0.9999484800242363;-0.2697827898405968;-0.023681380643743144;-0.4129795491282656;-0.4923933490332918
Autoimmune thrombocytopenia;Hyperphenylalaninemia;0.5961429178714752;1.0020282;0.6323306990867481;0.49935438363372153;0.9999448700945737;-0.40380195222309845;0.0020833567578433243;-0.36761417100782556;-0.5005904864608521
Autoimmune thrombocytopenia;Ureteropelvic junction obstruction;0.7163663804531097;0.8715012;0.5915399486545493;0.5410158390725721;0.9999394877822739;-0.2835731073291642;-0.12843828043058936;-0.40839953912772464;-0.4589236487097018
Autoimmune thrombocytopenia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8147650063037872;0.95528394;0.5593046297029671;0.5142383116907308;0.9998726169824932;-0.18510761067870596;-0.044588677144083766;-0.44056798727952606;-0.48563430529176244
Autoimmune thrombocytopenia;Difficulty walking;0.8409473896026611;1.0737011;0.5508439479451555;0.4765189117616301;0.9999280047072615;-0.15898061510460038;0.073773138557509;-0.44908405676210605;-0.5234090929456314
Autoimmune thrombocytopenia;Bilobate gallbladder;0.8185613602399826;0.9506729;0.5580753762312908;0.5157076653102306;0.9999484800242363;-0.1813871197842537;-0.0492755555056511;-0.44187310379294553;-0.4842408147140057
Autoimmune thrombocytopenia;Histidinuria;0.6506861448287964;0.92708147;0.6135852954532404;0.5232313158283429;0.9999469426585951;-0.3492607978297987;-0.0728654769374647;-0.3863616472053547;-0.47671562683025215
Autoimmune thrombocytopenia;Widened interpedicular distance;0.7788812816143036;0.99075794;0.5709708288719524;0.5029418849913454;0.9998726169824932;-0.2209913353681896;-0.009114674782786159;-0.4289017881105408;-0.4969307319911478
Adenomyosis;Elevated leukocyte alkaline phosphatase;0.8022615611553192;1.0550331;0.5633596675348813;0.4824735553766988;0.9999600672783046;-0.19769850612298534;0.05507302045210316;-0.43660039974342324;-0.5174865119016058
Adenomyosis;Clasp-knife sign;0.9559299349784851;1.0357171;0.514032482128902;0.4886284504053525;0.9999201345566091;-0.043990199578124;0.03579699515072732;-0.48588765242770715;-0.5112916841512566
Adenomyosis;Keratosis pilaris;0.8965507671236992;1.0394646;0.5329879310014385;0.4874347585385368;0.9999506876445663;-0.1033999205208671;0.03951390528908849;-0.4669627566431278;-0.5125159291060295
Adenomyosis;Lamina lucida cleavage;0.9502009972929955;0.88022065;0.5158580740089229;0.5382187224606954;0.9999548690865008;-0.04975387179350532;-0.11973421745991386;-0.48409679507757786;-0.4617361466258054
Adenomyosis;Abnormal central response of multifocal electroretinogram;0.8093778192996979;1.0341504;0.5610505342853587;0.489127499980617;0.9999201345566091;-0.19054231525691123;0.0342302274581614;-0.43886960027125044;-0.5107926345759921
Adenomyosis;Atypical or prolonged hepatitis;0.7293012738227844;1.0545363;0.5872547186144941;0.4826319168299905;0.9999600672783046;-0.27065879345552013;0.054576275342545055;-0.4127053486638105;-0.517328150448314
Adenomyosis;Cubitus varus;0.8830958008766174;0.8980308;0.5372970475275176;0.5325143067466902;0.9999201345566091;-0.11682433367999168;-0.1018893170479116;-0.4626230870290915;-0.4674058278099189
Adenomyosis;Nasal regurgitation;0.8563508689403534;0.85873485;0.5458836732366804;0.5451170199040043;0.9999584729108851;-0.14360760397053174;-0.14122362679577283;-0.4540747996742047;-0.45484145300688084
Adenomyosis;Moon facies;0.8700058907270432;1.0348799;0.5414958439671907;0.4888951232299581;0.9999584729108851;-0.12995258218384198;0.03492144995593616;-0.4584626289436944;-0.511063349680927
Adenomyosis;Intestinal pseudo-obstruction;0.6615914702415466;0.7623829;0.609888570744229;0.5763663328315567;0.9999539510871024;-0.33836248084555576;-0.2375710265303702;-0.3900653803428734;-0.4235876182555457
Adenomyosis;Bilateral renal atrophy;0.7029203772544861;0.9400649;0.5960126813327756;0.5190893659904243;0.8586132879499475;-0.15569291069546143;0.0814516191240271;-0.2626006066171719;-0.3395239219595232
Adenomyosis;Fractured left clavicle;0.9711117092519999;0.9771971;0.5091967080025401;0.5072590142858425;0.9999201345566091;-0.028808425304609253;-0.022723023903685524;-0.490723426554069;-0.4926611202707666
Adenomyosis;Positive urine norcotinine test;0.785995751619339;0.939022;0.5686506406187504;0.519421955951008;0.9999201345566091;-0.21392438293727012;-0.06089812995226951;-0.43126949393785874;-0.48049817860560107
Adenomyosis;Long fibula;0.8132363110780716;0.9084494;0.559799870578799;0.5291823247493137;0.9999567459343585;-0.18672043485628687;-0.09150733454214655;-0.4401568753555595;-0.47077442118504476
Adenomyosis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9212326258420944;1.0730878;0.5250984327028256;0.47671468118843074;0.9999201345566091;-0.07868750871451469;0.07316767691342263;-0.4748217018537835;-0.5232054533681784
Adenomyosis;Type II cryptotia;0.9520369954407215;1.0377874;0.5152729581225044;0.4879690041640671;0.9999201345566091;-0.047883139115887596;0.037867302882355736;-0.4846471764341047;-0.511951130392542
Adenomyosis;Increased variability in muscle fiber diameter;0.6534327268600464;0.9183289;0.6126527629932249;0.5260257120380603;0.9999473166570552;-0.3465145897970088;-0.08161843539332225;-0.38729455366383025;-0.4739216046189949
Adenomyosis;Widened proximal tibial metaphyses;0.8133598417043686;0.9503174;0.5597598457875808;0.5158209838072785;0.9999600672783046;-0.18660022557393596;-0.049642684465804554;-0.4402002214907238;-0.4841390834710261
Adenomyosis;Wide anterior fontanel;0.7864872217178345;0.9402906;0.5684904994071072;0.5190174134184915;0.9999476714516888;-0.21346044973385436;-0.0596571011925946;-0.43145717204458167;-0.48093025803319733
Adenomyosis;Increased circulating oleate level;0.7946435362100601;1.0220721;0.565835371614816;0.492973653738238;0.9999201345566091;-0.205276598346549;0.022151942240876243;-0.4340847629417931;-0.5069464808183711
Adenomyosis;Lozenge-shaped umbilicus;0.9942046850919724;0.7923264;0.501844716354879;0.5665891870532251;0.9999584729108851;-0.005753787818912781;-0.20763208216762952;-0.4981137565560061;-0.43336928585766
Adenomyosis;Anti-myelin-associated glycoprotein antibody positivity;0.6747326850891113;0.9051315;0.6054542831312645;0.5302430635352052;0.9999201345566091;-0.3251874494674978;-0.09478861571581931;-0.3944658514253446;-0.4696770710214039
Adenomyosis;Fractured radius;0.9304517209529877;1.0066082;0.5221557904505083;0.4978965207691718;0.9999600672783046;-0.06950834632531688;0.006648180478653454;-0.47780427682779625;-0.5020635465091328
Adenomyosis;Abnormal manual kinetic perimetry test;0.8053582608699799;1.0654427;0.5623544208598668;0.4791540545711914;0.9999201345566091;-0.19456187368662925;0.06552254675595193;-0.43756571369674235;-0.5207660799854177
Adenomyosis;Small radial epiphyses;0.8689846396446228;0.97083044;0.5418237224175616;0.509286284671243;0.9999201345566091;-0.1309354949119863;-0.029089694035368874;-0.4580964121390475;-0.49063384988536607
Adenomyosis;Generalized keratosis follicularis;0.8061634004116058;1.0470659;0.5620931610746982;0.4850129188531712;0.9999600672783046;-0.19379666686669872;0.04710578679426625;-0.43786690620360635;-0.5149471484251333
Adenomyosis;Hypoplasia of the calcaneus;0.8487873822450638;0.97064114;0.5483178114643581;0.5093465655640856;0.9999584729108851;-0.15117109066582135;-0.02931733674145154;-0.45164066144652704;-0.4906119073467995
Adenomyosis;2-hydroxyadipic aciduria;0.6630861759185791;0.9709246;0.6093831038608677;0.5092562878919733;0.717226575899895;-0.05414039998131592;0.2536980399600903;-0.10784347203902733;-0.20797028800792172
Adenomyosis;Potter facies;0.8392035961151123;1.0491858;0.5514062520057427;0.4843373547487483;0.9999552432134126;-0.16075164709830025;0.049230509655239785;-0.4485489912076699;-0.5156178884646643
Adenomyosis;Increased heart rate variability;0.7499293088912964;0.9895835;0.5804538631081346;0.5033157385363833;0.9999600672783046;-0.25003075838700817;-0.01037657499925182;-0.4195062041701699;-0.4966443287419212
Adenomyosis;Aplastic zygomatic arch;0.7722574472427368;0.9575619;0.5731344596180337;0.5135125275445374;0.9999584729108851;-0.22770102566814832;-0.04239656275844983;-0.42682401329285147;-0.4864459453663478
Adenomyosis;Testicular torsion;0.7047804594039917;0.759923;0.5953927913873223;0.5771727104038774;0.764574615032594;-0.05979415562860235;-0.00465163377038702;-0.1691818236452718;-0.18740190462871664
Adenomyosis;Abolished vibration sense;0.8456800431013107;0.9089546;0.5493186562414385;0.5290208420675722;0.9999584729108851;-0.1542784298095744;-0.09100385254955701;-0.45063981666944664;-0.47093763084331297
Adenomyosis;Fractured metatarsal bone of digit 5;0.9423637427389622;1.0716926;0.5183563631880731;0.47715993263950107;0.9999201345566091;-0.057556391817646935;0.07177245138852029;-0.481563771368536;-0.522760201917108
Adenomyosis;Prolonged G2 phase of cell cycle;0.8219144642353058;1.0165554;0.5569903749666776;0.4947300103914841;0.9999567459343585;-0.17804228169905267;0.016598682570585388;-0.4429663709676809;-0.5052267355428743
Adenomyosis;Single naris;0.838049978017807;0.98769397;0.5517783368209668;0.5039172378582994;0.9999567459343585;-0.16190676791655145;-0.012262780499330383;-0.4481784091133917;-0.496039508076059
Adenomyosis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8167047202587128;1.0864611;0.5586764427510945;0.4724441869758025;0.9999201345566091;-0.18321541429789634;0.08654093264309792;-0.4412436918055146;-0.5274759475808066
Adenomyosis;Asymmetry of the thorax;0.7269394397735596;0.86415064;0.5880359416612981;0.5433763162510208;0.9999567459343585;-0.2730173061607989;-0.1358061025856646;-0.4119208042730603;-0.4565804296833377
Adenomyosis;Type 2 muscle fiber predominance;0.7000686228275299;0.94725364;0.5969637862538888;0.5167974791309393;0.9999556674707869;-0.299887044643257;-0.052702023004386755;-0.4029918812168981;-0.4831581883398476
Adenomyosis;Dependency on parenteral nutrition;0.8935164958238602;1.0141469;0.5339591350933534;0.4954967481576904;0.9999584729108851;-0.10644197708702496;0.014188451107974731;-0.4659993378175318;-0.5044617247531947
Adenomyosis;Limited shoulder flexion;0.8007225096225739;0.943402;0.5638595101400796;0.5180253305360822;0.9999201345566091;-0.19919762493403526;-0.056518142235594704;-0.4360606244165295;-0.48189480402052687
Adenomyosis;Paroxysmal vertigo;0.8611061871051788;0.9970621;0.5443546723974183;0.5009351772691196;0.9999584729108851;-0.1388522858057063;-0.002896385851864136;-0.45560380051346683;-0.4990232956417655
Adenomyosis;Long hallux;0.9266266226768494;1.0608517;0.5233764786078854;0.4806183375431107;0.9999526340597648;-0.07332601138291539;0.06089905909361659;-0.47657615545187937;-0.5193342965166541
Adenomyosis;Broad medial eyebrow;0.9122978523373604;1.1458167;0.5279523724314481;0.4534190263733334;0.9999600672783046;-0.08766221494094417;0.14585661649092152;-0.47200769484685645;-0.5465410409049711
Adenomyosis;Myxoid subcutaneous tumors;0.6850734055042267;0.8647682;0.6019799023829411;0.5431779038760236;0.9999600672783046;-0.31488666177407787;-0.13519186020509288;-0.3979801648953635;-0.45678216340228095
Adenomyosis;Bulbous tips of toes;0.96432825922966;1.1441503;0.5113570772093881;0.4539551165811706;0.9999584729108851;-0.0356302136812251;0.14419178419971057;-0.4886013957014971;-0.5460033563297145
Adenomyosis;Absent internal genitalia;0.7975537776947021;0.7668509;0.5648891334945803;0.574903023862054;0.20582233176176257;0.5917314459329396;0.5610285569673329;0.3590668017328177;0.3690806921002915
Adenomyosis;Hyperphalangy of the 2nd finger;0.9460906907916069;1.1837077;0.5171681886733124;0.4411900075705678;0.9999600672783046;-0.05386937648669765;0.183747646802506;-0.4827918786049922;-0.5587700597077367
Adenomyosis;Renal interstitial hemosiderin;0.8667654991149902;0.9445057;0.5425363444485054;0.5176734697590103;0.717226575899895;0.1495389232150952;0.2272791156284253;-0.17469023145138962;-0.19955310614088473
Adenomyosis;Abnormality of depressor anguli oris muscle;0.7016105353832245;0.90844864;0.5964494238318323;0.5291825676720273;0.9999201345566091;-0.2983095991733846;-0.09147149802477927;-0.4034707107247768;-0.4707375668845818
Adenomyosis;Paroxysmal dyspnea;0.6689243912696838;0.8792988;0.60741151978597;0.5385142994529579;0.9999201345566091;-0.33099574328692527;-0.12062132836611839;-0.39250861477063914;-0.4614058351036512
Adenomyosis;Phenylpyruvic acidemia;0.6359929442405701;0.96432793;0.6185915999561373;0.5113571899318191;0.9999600672783046;-0.3639671230377345;-0.035632135874190785;-0.3813684673221672;-0.48860287734648544
Adenomyosis;Lateral ventricle dilatation;0.8508971333503723;0.9793953;0.5476385553228941;0.5065591468031759;0.9999488789551968;-0.14905174560482448;-0.02055360860760158;-0.4523103236323027;-0.49338973215202087
Adenomyosis;Neonatal unconjugated hyperbilirubinemia;0.8313777297735214;0.9876541;0.5539318033151835;0.5039299206213688;0.9999600672783046;-0.16858233750478313;-0.012305977350631214;-0.446028263963121;-0.4960301466569358
Adenomyosis;High maternal circulating alpha-fetoprotein concentration;0.704552561044693;0.7774183;0.5954687205681233;0.571448406397276;0.9999201345566091;-0.2953675735119161;-0.2225018191459951;-0.40445141398848583;-0.4284717281593331
Adenomyosis;Prominent nasolabial fold;0.8497165739536285;1.0418919;0.5480186214682208;0.48666147211811484;0.9999545338528789;-0.15023795989925037;0.04193739863460888;-0.45193591238465813;-0.5132930617347641
Adenomyosis;Abnormality of inferior alveolar nerve;0.7821966707706451;0.99708754;0.5698891368627272;0.5009270687563818;0.9999201345566091;-0.21772346378596397;-0.0028325963142690203;-0.43003099769388187;-0.4989930658002273
Adenomyosis;Unilateral conductive hearing impairment;0.8472746908664703;0.94755703;0.5488049744031589;0.5167007704371288;0.9999600672783046;-0.15268537641183422;-0.05240303516999767;-0.45115509287514566;-0.48325929684117575
Adenomyosis;Macular hypopigmented whorls, streaks, and patches;0.8160863518714905;1.0892516;0.5588766795097087;0.4715524843613179;0.9999600672783046;-0.18387371540681408;0.08929157018049672;-0.4410833877685959;-0.5284075829169866
Adenomyosis;Delayed ossification of pubic rami;0.7354042828083038;0.89515245;0.5852385091013281;0.5334354678810564;0.9999584729108851;-0.2645541901025813;-0.10480602330303601;-0.414719963809557;-0.4665230050298287
Adenomyosis;Hyperphenylalaninemia;0.7052884697914124;1.0420318;0.595223557064621;0.48661692400036816;0.9999561589935034;-0.2946676892020911;0.04207560599062743;-0.4047326019288824;-0.5133392349931353
Adenomyosis;Ureteropelvic junction obstruction;0.7910723835229874;0.9338028;0.5669973068914445;0.5210866529043534;0.832960393740828;-0.04188801021784061;0.10084238974839932;-0.2659630868493835;-0.31187374083647457
Adenomyosis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9284176751971245;1.1026245;0.5228048654763213;0.4672759758351962;0.9999201345566091;-0.07150245935948463;0.1027044010039988;-0.4771152690802878;-0.5326441587214129
Adenomyosis;Difficulty walking;0.8698650598526001;1.0621481;0.5415410558779881;0.480204876261788;0.9999461221900431;-0.130081062337443;0.06220197198720301;-0.458405066312055;-0.5197412459282551
Adenomyosis;Bilobate gallbladder;0.9143505021929741;0.8128916;0.5272965253361568;0.5599115732950712;0.9999584729108851;-0.08560797071791104;-0.18706687039471082;-0.47266194757472835;-0.4400468996158139
Adenomyosis;Histidinuria;0.8060401678085327;0.9405508;0.5621331460799257;0.5189344214865692;0.8494521264714628;-0.04341195866293013;0.09109867766672075;-0.28731898039153714;-0.33051770498489363
Adenomyosis;Widened interpedicular distance;0.7751250863075256;0.9533662;0.5721973486096588;0.5148493858281811;0.9999201345566091;-0.22479504824908347;-0.0465539145592031;-0.42772278594695035;-0.48507074872842804
Elevated leukocyte alkaline phosphatase;Clasp-knife sign;0.8350511938333511;0.8936214;0.5527458918252955;0.5339255618505452;0.9999201345566091;-0.16486894072325797;-0.10629874945910545;-0.44717424273131356;-0.4659945727060639
Elevated leukocyte alkaline phosphatase;Keratosis pilaris;0.5600240230560303;0.7323126;0.6450130465677841;0.5862594373986579;0.9999506876445663;-0.439926664588536;-0.2676380679584396;-0.35493764107678216;-0.41369125024590836
Elevated leukocyte alkaline phosphatase;Lamina lucida cleavage;0.7670144885778427;0.92712706;0.5748494736729401;0.5232167629593977;0.9999548690865008;-0.23294038050865806;-0.07282780581211723;-0.4251053954135606;-0.4767381061271031
Elevated leukocyte alkaline phosphatase;Abnormal central response of multifocal electroretinogram;0.8868450671434402;1.0228786;0.5360956434337902;0.4927168484536293;0.9999201345566091;-0.11307506741316886;0.02295851229397683;-0.46382449112281887;-0.5072032861029798
Elevated leukocyte alkaline phosphatase;Atypical or prolonged hepatitis;0.612010657787323;0.8506251;0.6268302673494686;0.5477261276512111;0.9999600672783046;-0.38794940949098156;-0.14933496952668712;-0.373129799928836;-0.45223393962709346
Elevated leukocyte alkaline phosphatase;Cubitus varus;0.9932530391961336;1.0596985;0.5021476406197387;0.4809861016244149;0.9999201345566091;-0.0066670953604754946;0.05977832792965798;-0.4977724939368704;-0.5189340329321942
Elevated leukocyte alkaline phosphatase;Nasal regurgitation;0.9836762435734272;1.0580988;0.5051962438371991;0.4814961730372672;0.9999584729108851;-0.016282229337457932;0.058140320118900024;-0.49476222907368606;-0.5184622998736179
Elevated leukocyte alkaline phosphatase;Moon facies;0.9644692242145538;0.9845331;0.5113121781984151;0.5049234749335937;0.9999584729108851;-0.0354892486963313;-0.015425401392940796;-0.48864629471247;-0.49503499797729145
Elevated leukocyte alkaline phosphatase;Intestinal pseudo-obstruction;0.8034739196300507;1.0663668;0.562966037580484;0.4788592530433361;0.9999539510871024;-0.19648003145705173;0.0664128406380563;-0.43698791350661836;-0.5210946980437663
Elevated leukocyte alkaline phosphatase;Bilateral renal atrophy;0.7419401705265045;0.7566235;0.5830831687598237;0.5782550545523597;0.9999600672783046;-0.25801989675180004;-0.24333656073228405;-0.41687689851848087;-0.42170501272594485
Elevated leukocyte alkaline phosphatase;Fractured left clavicle;0.8440183997154236;0.9902828;0.5498540571006652;0.5030931383833531;0.9999201345566091;-0.15590173484118552;-0.009637360585051491;-0.45006607745594396;-0.496826996173256
Elevated leukocyte alkaline phosphatase;Positive urine norcotinine test;0.8161396980285645;0.88955855;0.5588594043134129;0.5352264646183813;0.726290173501319;0.08984952452724548;0.16326838019435974;-0.16743076918790611;-0.19106370888293767
Elevated leukocyte alkaline phosphatase;Long fibula;0.7954224050045013;0.8229922;0.5655820721380511;0.5566417760616991;0.9999567459343585;-0.20453434092985712;-0.17696454031454645;-0.43437467379630734;-0.4433149698726594
Elevated leukocyte alkaline phosphatase;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7160973846912384;0.7531128;0.5916292433065583;0.5794077279635422;0.9999201345566091;-0.2838227498653707;-0.2468073415878591;-0.4082908912500508;-0.4205124065930669
Elevated leukocyte alkaline phosphatase;Type II cryptotia;0.9133798405528069;0.94190454;0.5276066491231902;0.5185027805082847;0.9999201345566091;-0.08654029400380225;-0.05801558972628684;-0.4723134854334189;-0.4814173540483244
Elevated leukocyte alkaline phosphatase;Increased variability in muscle fiber diameter;0.8740594238042831;1.0290195;0.540194867238238;0.49076153029357905;0.9999473166570552;-0.12588789285277202;0.02907215832616017;-0.4597524494188172;-0.5091857863634761
Elevated leukocyte alkaline phosphatase;Widened proximal tibial metaphyses;0.6212463974952698;0.76762104;0.6236472182152665;0.5746509583001473;0.9999600672783046;-0.3787136697830348;-0.23233902693406627;-0.3763128490630381;-0.4253091089781572
Elevated leukocyte alkaline phosphatase;Wide anterior fontanel;0.7983469665050507;1.1264707;0.5646313366604915;0.4596350290092823;0.9999476714516888;-0.20160070494663818;0.12652301355349915;-0.43531633479119736;-0.5403126424424065
Elevated leukocyte alkaline phosphatase;Increased circulating oleate level;0.6206448674201965;0.8197266;0.62385413227524;0.5576982639659306;0.726290173501319;-0.10564530608112244;0.09343641284053894;-0.10243604122607897;-0.16859190953538838
Elevated leukocyte alkaline phosphatase;Lozenge-shaped umbilicus;0.8522228598594666;1.0412773;0.5472118359885969;0.48685730390806614;0.9999584729108851;-0.14773561305141858;0.04131881647967883;-0.4527466369222882;-0.513101169002819
Elevated leukocyte alkaline phosphatase;Anti-myelin-associated glycoprotein antibody positivity;0.7327685952186584;0.96091557;0.5861088083294853;0.5124441244137572;0.9999201345566091;-0.26715153933795066;-0.03900456906588645;-0.4138113262271238;-0.4874760101428519
Elevated leukocyte alkaline phosphatase;Fractured radius;0.8740163892507553;0.8998202;0.5402086755444697;0.5319418034263046;0.9999600672783046;-0.12594367802754924;-0.10013985872880504;-0.45975139173383484;-0.46801826385199996
Elevated leukocyte alkaline phosphatase;Abnormal manual kinetic perimetry test;0.7934298515319824;1.0157369;0.5662301639343137;0.4949905585690524;0.9999201345566091;-0.2064902830246267;0.015816802966279075;-0.4336899706222954;-0.5049295759875567
Elevated leukocyte alkaline phosphatase;Small radial epiphyses;0.8810981437563896;0.898875;0.53793738795162;0.5322442113756577;0.9999201345566091;-0.11882199080021949;-0.10104513646395774;-0.46198274660498906;-0.4676759231809514
Elevated leukocyte alkaline phosphatase;Generalized keratosis follicularis;0.758385419845581;0.82467985;0.5776769655395051;0.5560960420465171;0.9999600672783046;-0.2415746474327235;-0.17528021574632213;-0.42228310173879946;-0.4438640252317875
Elevated leukocyte alkaline phosphatase;Hypoplasia of the calcaneus;0.7703289091587067;0.7297688;0.5737650459451666;0.5871001350215022;0.9999584729108851;-0.22962956375217847;-0.27018966025448254;-0.4261934269657185;-0.412858337889383
Elevated leukocyte alkaline phosphatase;2-hydroxyadipic aciduria;0.7921835631132126;0.7901765;0.5666356693466756;0.56728893591301;0.726290173501319;0.06589338961189362;0.06388633730953308;-0.15965450415464333;-0.15900123758830897
Elevated leukocyte alkaline phosphatase;Potter facies;0.7950653731822968;0.9089182;0.5656981788475756;0.529032466112243;0.9999552432134126;-0.2048898700311158;-0.0910370412900422;-0.434257064365837;-0.4709227771011696
Elevated leukocyte alkaline phosphatase;Increased heart rate variability;0.7441737055778503;0.97739595;0.5823475137998597;0.5071957084392884;0.9999600672783046;-0.2557863617004542;-0.022564115530410267;-0.41761255347844484;-0.49276435883901615
Elevated leukocyte alkaline phosphatase;Aplastic zygomatic arch;0.7230419814586639;0.9372634;0.5893262962813532;0.5199828008025504;0.9999584729108851;-0.2769164914522212;-0.06269504374599866;-0.4106321766295319;-0.4799756721083347
Elevated leukocyte alkaline phosphatase;Testicular torsion;0.8652533739805222;1.052701;0.5430220486626152;0.4832169697400497;0.9999600672783046;-0.1347066932977824;0.05274092912062123;-0.4569380186156894;-0.5167430975382549
Elevated leukocyte alkaline phosphatase;Abolished vibration sense;0.9417138434946537;1.1381929;0.5185635809132103;0.4558706293323682;0.9999584729108851;-0.05824462941623143;0.13823441916369983;-0.4813948919976748;-0.5440878435785169
Elevated leukocyte alkaline phosphatase;Fractured metatarsal bone of digit 5;0.8606732785701752;0.7860954;0.5444938244548134;0.5686181759064521;0.9999201345566091;-0.13924685598643394;-0.21382475377352805;-0.4554263101017957;-0.43130195865015697
Elevated leukocyte alkaline phosphatase;Prolonged G2 phase of cell cycle;0.7912638187408447;0.9040306;0.5669349973400202;0.5305950893107492;0.851762385589393;-0.06049856684854826;0.05226823546239534;-0.2848273882493728;-0.3211672962786438
Elevated leukocyte alkaline phosphatase;Single naris;0.9787468612194061;1.00295;0.5067655935833217;0.4990610136388254;0.9999567459343585;-0.021209884714952332;0.002993207144865173;-0.4931911523510367;-0.5008957322955331
Elevated leukocyte alkaline phosphatase;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7910793423652649;0.9788251;0.5669950418376053;0.5067406785373444;0.9999201345566091;-0.20884079219134422;-0.02109504224093528;-0.4329250927190038;-0.4931794560192647
Elevated leukocyte alkaline phosphatase;Asymmetry of the thorax;0.7224514782428741;1.0495266;0.5895219286997122;0.48422876706552054;0.9999567459343585;-0.2775052676914843;0.04956982629311957;-0.41043481723464625;-0.5157279788688379
Elevated leukocyte alkaline phosphatase;Type 2 muscle fiber predominance;0.9251750260591507;0.94412255;0.5238398099582742;0.5177956208625243;0.9999556674707869;-0.0747806414116362;-0.0558331145990828;-0.47611585751251273;-0.4821600466082626
Elevated leukocyte alkaline phosphatase;Dependency on parenteral nutrition;0.8054544925689697;0.8894534;0.5623231923937554;0.5352601387390706;0.9999584729108851;-0.1945039803419154;-0.11050506180859021;-0.43763528051712974;-0.4646983341718145
Elevated leukocyte alkaline phosphatase;Limited shoulder flexion;0.9020817577838898;1.1069947;0.5312183675880613;0.46587718633222275;0.9999201345566091;-0.09783837677271934;0.10707461355893044;-0.4687017669685478;-0.5340429482243864
Elevated leukocyte alkaline phosphatase;Paroxysmal vertigo;0.8507609218358994;1.0913031;0.5476824033923058;0.47089677903070437;0.9999584729108851;-0.14919755107498578;0.09134463721179553;-0.45227606951857935;-0.5290616938801808
Elevated leukocyte alkaline phosphatase;Long hallux;0.7087607085704803;0.8307282;0.5940675842404364;0.5541415887052847;0.9999526340597648;-0.2911919254892844;-0.16922446080384435;-0.4058850498193284;-0.44581104535448
Elevated leukocyte alkaline phosphatase;Broad medial eyebrow;0.8570538461208344;0.9920813;0.5456575752320931;0.5025206270224805;0.9999600672783046;-0.1429062211574702;-0.0078787827552943;-0.4543024920462114;-0.4974394402558241
Elevated leukocyte alkaline phosphatase;Myxoid subcutaneous tumors;0.9264627993106842;0.9340658;0.5234287664600282;0.5210027452248343;0.9999600672783046;-0.07349726796762035;-0.06589424849168346;-0.4765313008182763;-0.4789573220534703
Elevated leukocyte alkaline phosphatase;Bulbous tips of toes;0.8314865678548813;0.8769704;0.5538966561234042;0.539261014213611;0.9999584729108851;-0.16847190505600385;-0.12298806256390027;-0.4460618167874809;-0.4606974586972742
Elevated leukocyte alkaline phosphatase;Absent internal genitalia;0.9346756413578987;1.0679454;0.5208082061420121;0.4783556560914175;0.9999201345566091;-0.0652444931987104;0.06802522658078103;-0.47911192841459704;-0.5215644784651916
Elevated leukocyte alkaline phosphatase;Hyperphalangy of the 2nd finger;0.7415264546871185;0.8411384;0.5832194832545735;0.5507823571925624;0.9999600672783046;-0.258433612591186;-0.1588216447891383;-0.41674058402373104;-0.44917771008574214
Elevated leukocyte alkaline phosphatase;Renal interstitial hemosiderin;0.7946274727582932;0.7982135;0.565840596127894;0.5646747082196285;0.9999201345566091;-0.20529266179831596;-0.20170665265353294;-0.43407953842871516;-0.4352454263369806
Elevated leukocyte alkaline phosphatase;Abnormality of depressor anguli oris muscle;0.8639952838420868;1.13452;0.5434262319934065;0.45705072457345897;0.9999201345566091;-0.13592485071452232;0.13459991930691628;-0.45649390256320266;-0.5428694099831501
Elevated leukocyte alkaline phosphatase;Paroxysmal dyspnea;0.7361472845077515;0.9924407;0.5849932895180342;0.5024062265243923;0.9999201345566091;-0.26377285004885764;-0.007479434025603249;-0.4149268450385749;-0.49751390803221685
Elevated leukocyte alkaline phosphatase;Phenylpyruvic acidemia;0.5030141472816467;0.7590098;0.6655599176301042;0.5774721793076008;0.8631450867506595;-0.36013093946901276;-0.10413530825105621;-0.19758516912055524;-0.28567290744305873
Elevated leukocyte alkaline phosphatase;Lateral ventricle dilatation;0.7320380210876465;1.0049233;0.586350159124142;0.4984328423376424;0.9999488789551968;-0.2679108578675503;0.00497446470325047;-0.4135987198310548;-0.5015160366175544
Elevated leukocyte alkaline phosphatase;Neonatal unconjugated hyperbilirubinemia;0.7411037683486938;0.87115693;0.5833587695562357;0.5411263490380573;0.8631450867506595;-0.12204131840196564;0.00801184417280243;-0.2797863171944238;-0.32201873771260214
Elevated leukocyte alkaline phosphatase;High maternal circulating alpha-fetoprotein concentration;0.5427108108997345;0.78859174;0.6511795649483846;0.5678049534895783;0.9999201345566091;-0.4572093236568746;-0.21132839204104514;-0.3487405696082245;-0.43211518106703084
Elevated leukocyte alkaline phosphatase;Prominent nasolabial fold;0.8429773151874542;1.0459037;0.5501895790439348;0.4853832771399973;0.9999545338528789;-0.1569772186654247;0.04594914885586132;-0.4497649548089441;-0.5145712567128816
Elevated leukocyte alkaline phosphatase;Abnormality of inferior alveolar nerve;0.8349049836397171;0.9145818;0.5527930789151094;0.5272226474466699;0.9999201345566091;-0.165015150916892;-0.0853383588913259;-0.4471270556414997;-0.4726974871099392
Elevated leukocyte alkaline phosphatase;Unilateral conductive hearing impairment;0.8456797450780869;1.0729777;0.5493187522553368;0.4767498105500454;0.9999600672783046;-0.1542803222002177;0.07301759480818226;-0.4506413150229678;-0.5232102567282592
Elevated leukocyte alkaline phosphatase;Macular hypopigmented whorls, streaks, and patches;0.8911156952381134;1.0121583;0.5347278035135006;0.4961297896153132;0.9999600672783046;-0.10884437204019115;0.012198207372269176;-0.465232263764804;-0.5038302776629914
Elevated leukocyte alkaline phosphatase;Delayed ossification of pubic rami;0.8027170598506927;0.83044755;0.5632117642084506;0.5542322224868141;0.9999584729108851;-0.19724141306019238;-0.16951091832256726;-0.4367467087024345;-0.445726250424071
Elevated leukocyte alkaline phosphatase;Hyperphenylalaninemia;0.4096263647079468;0.8756061;0.7010195943242036;0.5396986408619531;0.8497508587917271;-0.4401244940837803;0.025855260840993877;-0.1487312644675235;-0.310052217929774
Elevated leukocyte alkaline phosphatase;Ureteropelvic junction obstruction;0.7959065139293671;0.7184205;0.5654246541018068;0.5908583040763759;0.9999528219730685;-0.20404630804370139;-0.2815323164493868;-0.4345281678712617;-0.4090945178966926
Elevated leukocyte alkaline phosphatase;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7822566032409668;0.7423897;0.5698695906432568;0.5829350787000992;0.9999201345566091;-0.2176635313156423;-0.257530455601531;-0.4300505439133523;-0.4169850558565099
Elevated leukocyte alkaline phosphatase;Difficulty walking;0.8965847194194794;0.987482;0.5329770653722365;0.5039846976949274;0.9999461221900431;-0.10336140277056372;-0.012464110871836298;-0.46696905681780654;-0.4959614244951157
Elevated leukocyte alkaline phosphatase;Bilobate gallbladder;0.8010823279619217;0.91942406;0.5637426365569829;0.5256759444532728;0.9999584729108851;-0.19887614494896344;-0.0805344159040492;-0.43621583635390226;-0.4742825284576123
Elevated leukocyte alkaline phosphatase;Histidinuria;0.7226599752902985;0.80691975;0.5894528501228165;0.5618477705854654;0.8542775634790427;-0.13161758818874425;-0.04735780992755956;-0.26482471335622626;-0.2924297928935773
Elevated leukocyte alkaline phosphatase;Widened interpedicular distance;0.7228679656982422;1.0012676;0.5893839437154894;0.49959652543948607;0.9999201345566091;-0.2770521688583669;0.0013474178191843489;-0.4105361908411197;-0.500323609117123
Clasp-knife sign;Keratosis pilaris;0.8006872683763504;0.7495935;0.5638709574150085;0.5805642681955105;0.9998710980331391;-0.1991838296567887;-0.2502776017105073;-0.43600014061813064;-0.41930682983762857
Clasp-knife sign;Lamina lucida cleavage;0.7768229395151138;0.6964972;0.571642810468073;0.5981561639886032;0.9998962300503706;-0.22307329053525682;-0.303399028130815;-0.4282534195822977;-0.4017400660617675
Clasp-knife sign;Abnormal central response of multifocal electroretinogram;0.8683501929044724;0.9102084;0.5420274375975203;0.5286201016883942;1.0;-0.13164980709552765;-0.08979159593582153;-0.45797256240247974;-0.47137989831160576
Clasp-knife sign;Atypical or prolonged hepatitis;0.8589062541723251;1.0341331;0.545061897432775;0.48913300291405026;0.9999201345566091;-0.14101388038428397;0.034212942111176536;-0.4548582371238341;-0.5107871316425588
Clasp-knife sign;Cubitus varus;0.7893190532922745;0.84176403;0.5675681135357983;0.5505806680933338;1.0;-0.21068094670772552;-0.15823596715927124;-0.4324318864642017;-0.44941933190666616
Clasp-knife sign;Nasal regurgitation;1.0519587993621826;0.99610686;0.4834535496641956;0.5012392357159117;0.9999134918687169;0.0520453074934657;-0.0038066288468663334;-0.5164599422045213;-0.49867425615280525
Clasp-knife sign;Moon facies;0.9566204473376274;0.7341023;0.5138124748019531;0.5856683365243232;0.9999134918687169;-0.04329304453108951;-0.26581118311856433;-0.4861010170667638;-0.41424515534439377
Clasp-knife sign;Intestinal pseudo-obstruction;0.9386566318571568;0.9545893;0.5195384675262043;0.5144596437556206;0.9998912449978579;-0.06123461314070111;-0.04530193768966084;-0.4803527774716536;-0.4854316012422373
Clasp-knife sign;Bilateral renal atrophy;0.9905791403725743;0.94895214;0.5029987971153798;0.5162560973581846;0.9999201345566091;-0.009340994184034779;-0.05096799613268943;-0.49692133744122935;-0.48366403719842455
Clasp-knife sign;Fractured left clavicle;0.7130519151687622;0.80414474;0.5926407235012339;0.5627482864460622;1.0;-0.2869480848312378;-0.1958552598953247;-0.40735927649876613;-0.43725171355393777
Clasp-knife sign;Positive urine norcotinine test;0.8522840142250061;0.8992137;0.5471921539440199;0.5321358474685453;1.0;-0.1477159857749939;-0.10078632831573486;-0.4528078460559801;-0.46786415253145475
Clasp-knife sign;Long fibula;1.0249349772930145;1.1575214;0.49206212750478406;0.44964968515503945;0.8605427142144324;0.16439226307858212;0.2969786528586267;-0.36848058670964834;-0.41089302905939296
Clasp-knife sign;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.916796550154686;1.0141727;0.5265151340962171;0.495488556149035;1.0;-0.08320344984531403;0.014172673225402832;-0.4734848659037829;-0.504511443850965
Clasp-knife sign;Type II cryptotia;0.8355039656162262;0.68258744;0.5525997741160575;0.6028139952784615;1.0;-0.1644960343837738;-0.3174125552177429;-0.44740022588394246;-0.39718600472153853
Clasp-knife sign;Increased variability in muscle fiber diameter;1.0254176016896963;0.96179;0.49190845467637256;0.5121655825450544;0.5611913088210261;0.46422629286867023;0.40059871641319633;-0.06928285414465352;-0.04902572627597168
Clasp-knife sign;Widened proximal tibial metaphyses;1.0032245023176074;1.1308147;0.4989736072556392;0.4582407181690026;0.8819596887815145;0.12126481353609286;0.24885498273490392;-0.3829860815258753;-0.42371897061251196
Clasp-knife sign;Wide anterior fontanel;0.8746103942394257;0.80783033;0.5400180865093178;0.5615523825279689;0.7756871967460075;0.09892319749341816;0.032143136963709296;-0.23566911023668968;-0.2141348142180386
Clasp-knife sign;Increased circulating oleate level;0.9796234890818596;1.0558487;0.5064864937917382;0.48221354186742926;1.0;-0.02037651091814041;0.05584871768951416;-0.49351350620826184;-0.5177864581325707
Clasp-knife sign;Lozenge-shaped umbilicus;0.7670048475265503;0.81827074;0.5748526293624489;0.5581694464821081;0.9999134918687169;-0.23290864434216663;-0.18164274897549793;-0.42506086250626807;-0.44174404538660883
Clasp-knife sign;Anti-myelin-associated glycoprotein antibody positivity;0.9734988883137703;0.92803705;0.5084365535522976;0.5229263410988754;1.0;-0.026501111686229706;-0.07196295261383057;-0.49156344644770245;-0.47707365890112463
Clasp-knife sign;Fractured radius;0.8707667589187622;0.9924847;0.5412515917205518;0.5023922212742684;0.8819596887815145;-0.011192929862752332;0.11052499997733556;-0.3407080970609627;-0.3795674675072461
Clasp-knife sign;Abnormal manual kinetic perimetry test;0.9298698306083679;0.9735378;0.5223414652721172;0.5084241683051138;1.0;-0.07013016939163208;-0.026462197303771973;-0.4776585347278828;-0.49157583169488617
Clasp-knife sign;Small radial epiphyses;0.9532525613903999;0.9653715;0.5148855968634979;0.5110247965996357;1.0;-0.04674743860960007;-0.03462851047515869;-0.4851144031365021;-0.48897520340036427
Clasp-knife sign;Generalized keratosis follicularis;0.8437644839286804;0.83508575;0.5499358842143474;0.55273474445497;0.9999201345566091;-0.1561556506279287;-0.16483438493044944;-0.44998425034226175;-0.44718539010163916
Clasp-knife sign;Hypoplasia of the calcaneus;0.8224195092916489;1.0018673;0.556827010206947;0.49940563564440055;0.872141863789474;-0.04972235449782514;0.12972543052204943;-0.315314853582527;-0.37273622814507346
Clasp-knife sign;2-hydroxyadipic aciduria;1.0383231714367867;0.9893638;0.4877983677319938;0.5033856812957045;1.0;0.03832317143678665;-0.010636210441589355;-0.5122016322680062;-0.4966143187042955
Clasp-knife sign;Potter facies;0.8844504579901695;0.6142471;0.5368629044192347;0.6260582787948373;0.9998981869165328;-0.11544772892636324;-0.38565110325259233;-0.4630352824972981;-0.37383990812169543
Clasp-knife sign;Increased heart rate variability;1.0295948591083288;1.0168998;0.49057828808081927;0.49462037703719;0.9999201345566091;0.02967472455171971;0.016979689585846947;-0.5093418464757898;-0.5052997575194191
Clasp-knife sign;Aplastic zygomatic arch;0.9694684147834778;0.90567493;0.5097200159446686;0.5300692979119515;0.872141863789474;0.09732655099400378;0.03353307059773303;-0.36242184784480536;-0.34207256587752255
Clasp-knife sign;Testicular torsion;0.8800145834684372;0.9932895;0.5382847829279178;0.5021360414864307;0.9999201345566091;-0.11990555108817191;-0.006630663884001686;-0.4616353516286913;-0.49778409307017846
Clasp-knife sign;Abolished vibration sense;0.8712970912456512;0.845279;0.5410813600479072;0.5494478806439151;0.8377124667083617;0.0335846245372895;0.007566511639416573;-0.29663110666045456;-0.2882645860644466
Clasp-knife sign;Fractured metatarsal bone of digit 5;1.0093398876488209;1.0469651;0.49702697819994923;0.4850450218550224;1.0;0.009339887648820877;0.04696512222290039;-0.5029730218000508;-0.5149549781449776
Clasp-knife sign;Prolonged G2 phase of cell cycle;0.9300005435943604;0.89479846;0.5222997555322546;0.5335487688836156;0.9999056439461368;-0.06990510035177644;-0.10510718632360871;-0.4776058884138822;-0.4663568750625212
Clasp-knife sign;Single naris;1.0020007863640785;0.84965926;0.4993631294952573;0.5480370734049951;0.9999056439461368;0.002095142417941731;-0.1502463798584598;-0.5005425144508795;-0.4518685705411417
Clasp-knife sign;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;1.003238933160901;0.8770615;0.49896901375156544;0.5392317949263843;1.0;0.0032389331609010696;-0.12293851375579834;-0.5010309862484346;-0.4607682050736157
Clasp-knife sign;Asymmetry of the thorax;0.9722983166575432;0.89280194;0.5088188478232009;0.53418789929807;0.8605427142144324;0.11175560244311078;0.03225922622669919;-0.35172386639123154;-0.3263548149163624
Clasp-knife sign;Type 2 muscle fiber predominance;0.9577885828912258;0.9206754;0.5134403047232567;0.5252763680601202;0.7175272285260154;0.24026135436521046;0.20314816839323513;-0.2040869238027586;-0.19225086046589512
Clasp-knife sign;Dependency on parenteral nutrition;0.913043737411499;1.0540131;0.527714039282564;0.4827987197015412;0.9999134918687169;-0.0868697544572179;0.05409964118029431;-0.4721994525861529;-0.5171147721671757
Clasp-knife sign;Limited shoulder flexion;0.860525831580162;0.91998476;0.5445412210656629;0.5254969039383456;1.0;-0.13947416841983795;-0.08001524209976196;-0.45545877893433706;-0.4745030960616544
Clasp-knife sign;Paroxysmal vertigo;0.9244476035237312;1.0104278;0.5240720130395383;0.4966806422154232;0.9999134918687169;-0.07546588834498569;0.01051434073473767;-0.4758414788291786;-0.5032328496532937
Clasp-knife sign;Long hallux;0.8515909314155579;0.9555874;0.5474152277784308;0.5141416336843565;0.8279638214854832;0.023627109930074663;0.12762356559947774;-0.28054859370705243;-0.3138221878011267
Clasp-knife sign;Broad medial eyebrow;0.9162451848387718;0.7820723;0.526691253871038;0.5699297026837622;0.9999201345566091;-0.08367494971783729;-0.21784782887728782;-0.4732288806855711;-0.4299904318728469
Clasp-knife sign;Myxoid subcutaneous tumors;0.9540746137499809;0.9860139;0.5146236481016824;0.5044520612687617;0.9999201345566091;-0.04584552080662818;-0.013906245243864968;-0.48529648645492673;-0.49546807328784737
Clasp-knife sign;Bulbous tips of toes;0.864863246679306;0.8993424;0.5431473763447728;0.5320946568633391;0.872141863789474;-0.007278617110167973;0.027200553927505977;-0.32899448744470117;-0.3400472069261349
Clasp-knife sign;Absent internal genitalia;0.9520016610622406;0.90352345;0.5152842183733302;0.5307572834066244;1.0;-0.0479983389377594;-0.09647655487060547;-0.48471578162666984;-0.4692427165933756
Clasp-knife sign;Hyperphalangy of the 2nd finger;0.7962774038314819;0.80875534;0.56530406255568;0.5612523945484988;0.8819596887815145;-0.0856822849500326;-0.07320435058952846;-0.31665562622583454;-0.3207072942330157
Clasp-knife sign;Renal interstitial hemosiderin;0.922643706202507;0.87771046;0.5246478970348152;0.5390236418984239;1.0;-0.07735629379749298;-0.12228953838348389;-0.4753521029651848;-0.4609763581015761
Clasp-knife sign;Abnormality of depressor anguli oris muscle;1.011947002261877;0.8489964;0.4961970605999886;0.5482505107263322;1.0;0.01194700226187706;-0.15100359916687012;-0.5038029394000114;-0.45174948927366776
Clasp-knife sign;Paroxysmal dyspnea;0.9366748705506325;0.9795027;0.5201705109629795;0.5065249512828157;1.0;-0.06332512944936752;-0.02049732208251953;-0.4798294890370205;-0.4934750487171843
Clasp-knife sign;Phenylpyruvic acidemia;0.8693414032459259;0.9470489;0.5417091763859936;0.516862753596525;0.9999201345566091;-0.1305787313106832;-0.05287123204501243;-0.4582109581706155;-0.4830573809600841
Clasp-knife sign;Lateral ventricle dilatation;0.9602159298956394;1.0095154;0.5126670058240868;0.49697109563833197;0.7772828274709305;0.18293310242470895;0.23223257723030244;-0.2646158216468437;-0.2803117318325985
Clasp-knife sign;Neonatal unconjugated hyperbilirubinemia;0.9381018429994583;1.0785912;0.5197153985401394;0.4749578251398425;0.9999201345566091;-0.061818291557150795;0.078671092974824;-0.48020473601646974;-0.5249623094167666
Clasp-knife sign;High maternal circulating alpha-fetoprotein concentration;1.0523195788264275;1.0174637;0.4833385535788456;0.49444086300628176;1.0;0.05231957882642746;0.01746368408203125;-0.5166614464211544;-0.5055591369937182
Clasp-knife sign;Prominent nasolabial fold;0.9210185259580612;0.82131684;0.5251667957938113;0.5571836964430541;0.9998944404568447;-0.0788759144987835;-0.1785776021923794;-0.4747276446630334;-0.4427107440137906
Clasp-knife sign;Abnormality of inferior alveolar nerve;0.9735322445631027;0.8425375;0.5084259322026738;0.5503313232743361;1.0;-0.026467755436897278;-0.157462477684021;-0.49157406779732615;-0.4496686767256639
Clasp-knife sign;Unilateral conductive hearing impairment;0.8814055472612381;1.0826117;0.5378388410990417;0.47367389710688834;0.9999201345566091;-0.11851458729537101;0.08269154547421365;-0.46208129345756743;-0.5262462374497208
Clasp-knife sign;Macular hypopigmented whorls, streaks, and patches;1.0604433938860893;0.8978133;0.48074853578571475;0.5325839042237155;0.9999201345566091;0.06052325932948022;-0.102106814396697;-0.5191715987708944;-0.4673362303328936
Clasp-knife sign;Delayed ossification of pubic rami;0.9640908092260361;0.9890908;0.5114327083488521;0.5034725714431454;0.872141863789474;0.09194894543656207;0.11694893649586535;-0.3607091554406219;-0.3686692923463286
Clasp-knife sign;Hyperphenylalaninemia;0.9275424256920815;1.0211438;0.5230841914116328;0.49326920907078264;0.9999028053808913;-0.07236037968880982;0.02124098867886215;-0.4768186139692585;-0.5066335963101086
Clasp-knife sign;Ureteropelvic junction obstruction;0.7970747649669647;0.97432584;0.565044839849377;0.5081732360257116;0.9998847295244674;-0.20280996455750266;-0.02555889381966392;-0.43483988967509035;-0.49171149349875576
Clasp-knife sign;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7696468979120255;0.96318436;0.5739881179300486;0.5117214237984011;1.0;-0.23035310208797455;-0.036815643310546875;-0.42601188206995144;-0.48827857620159887
Clasp-knife sign;Difficulty walking;0.9742845967411995;0.8862633;0.5081863695033365;0.5362820302191346;0.4476650879283087;0.5266195088128908;0.4385982229809625;0.060521281575027785;0.08861694229082584
Clasp-knife sign;Bilobate gallbladder;0.8598700761795044;0.966906;0.5447520246995218;0.5105360735728228;0.9999134918687169;-0.14004341568921252;-0.03300748076413318;-0.45516146716919514;-0.4893774182958941
Clasp-knife sign;Histidinuria;1.0056231617927551;1.036907;0.4982100825768211;0.4882494652663314;0.9999090677057578;0.005714094086997301;0.03699788992058495;-0.5016989851289367;-0.5116596024394264
Clasp-knife sign;Widened interpedicular distance;0.9148437529802322;0.9574581;0.5271389430056259;0.5135456079462405;1.0;-0.08515624701976776;-0.04254192113876343;-0.4728610569943741;-0.4864543920537595
Keratosis pilaris;Lamina lucida cleavage;0.6603481769561768;0.7064036;0.6103092370823793;0.5948521647831138;0.7530912318100624;-0.09274305485388568;-0.0466876187195473;-0.14278199472768316;-0.15823906702694868
Keratosis pilaris;Abnormal central response of multifocal electroretinogram;0.765185758471489;0.97579783;0.5754481844705475;0.5077045487287065;0.9998710980331391;-0.23468533956165016;-0.024073266020962603;-0.42442291356259165;-0.4921665493044326
Keratosis pilaris;Atypical or prolonged hepatitis;0.7942991852760315;0.9822839;0.5659473730288965;0.505639515024293;0.9999506876445663;-0.2056515023685348;-0.017666797397221323;-0.43400331461566977;-0.49431117262027324
Keratosis pilaris;Cubitus varus;0.9158478155732155;1.0401485;0.5268181885584982;0.4872168972945995;0.9998710980331391;-0.08402328245992363;0.0402773985946685;-0.47305290947464096;-0.5126542007385396
Keratosis pilaris;Nasal regurgitation;0.8771869614720345;0.82363683;0.5391915499467943;0.5564333108268;0.9999482333076865;-0.122761271835652;-0.1763114034546286;-0.46075668336089215;-0.4435149224808864
Keratosis pilaris;Moon facies;0.9835796542465687;0.8611244;0.505226993296231;0.5443488194999748;0.9999482333076865;-0.01636857906111777;-0.13882383698352874;-0.49472124001145545;-0.45559941380771163
Keratosis pilaris;Intestinal pseudo-obstruction;0.7852867841720581;0.8642225;0.5688816825408856;0.54335322112788;0.9999410127389031;-0.21465422856684502;-0.13571848618861015;-0.43105933019801757;-0.45658779161102314
Keratosis pilaris;Bilateral renal atrophy;0.7743410468101501;0.9187202;0.5724534999776341;0.5259007428410349;0.9999506876445663;-0.22560964083441615;-0.08123050188788294;-0.42749718766693223;-0.47404994480353135
Keratosis pilaris;Fractured left clavicle;0.8430096209049225;0.87880254;0.5501791666759592;0.538673420480538;0.9998710980331391;-0.15686147712821663;-0.1210685601150483;-0.4496919313571799;-0.4611976775526011
Keratosis pilaris;Positive urine norcotinine test;0.8972839266061783;1.0251508;0.5327533092058667;0.4919934109703048;0.9998710980331391;-0.10258717142696083;0.025279677876284712;-0.4671177888272724;-0.5078776870628343
Keratosis pilaris;Long fibula;0.8464999496936798;1.0733382;0.5490545246976892;0.4766347693329731;0.9999455218634979;-0.15344557216981813;0.07339262911459044;-0.4508909971658087;-0.5233107525305248
Keratosis pilaris;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6864654123783112;0.84070295;0.601513171306089;0.5509227600050541;0.9998710980331391;-0.31340568565482796;-0.15916814707870186;-0.39835792672705017;-0.448948338028085
Keratosis pilaris;Type II cryptotia;0.8120151907205582;0.7771869;0.5601955737462436;0.5715239655608306;0.9998710980331391;-0.18785590731258095;-0.22268422745818794;-0.4396755242868955;-0.4283471324723085
Keratosis pilaris;Increased variability in muscle fiber diameter;0.905617967247963;1.0526658;0.5300875171392188;0.4832281922901065;0.9999296671401311;-0.09431169989216814;0.052736162518377205;-0.46984215000091234;-0.5167014748500246
Keratosis pilaris;Widened proximal tibial metaphyses;0.6893699169158936;0.9469284;0.6005400350902521;0.5169011621978159;0.9999506876445663;-0.31058077072867274;-0.053022305724705454;-0.3994106525543142;-0.4830495254467504
Keratosis pilaris;Wide anterior fontanel;0.9621913358569145;0.98527557;0.5120377407244665;0.5046871068484184;0.9999302980513178;-0.037738962194403314;-0.014654731473406457;-0.48789255732685133;-0.4952431912028994
Keratosis pilaris;Increased circulating oleate level;0.9563174098730087;1.0600508;0.5139090261467631;0.48087370462935697;0.9998710980331391;-0.04355368816013039;0.06017974711304008;-0.48596207188637597;-0.5189973934037821
Keratosis pilaris;Lozenge-shaped umbilicus;0.9059721678495407;0.85013235;0.5299742679466455;0.547884761033709;0.9999482333076865;-0.09397606545814574;-0.14981588715442717;-0.46997396536104097;-0.4520634722739775
Keratosis pilaris;Anti-myelin-associated glycoprotein antibody positivity;0.7798359990119934;0.89148664;0.5706592541141507;0.534609032352229;0.9998710980331391;-0.2200350990211457;-0.10838445328826607;-0.42921184391898837;-0.4652620656809101
Keratosis pilaris;Fractured radius;0.8348842114210129;0.8147548;0.5527997829239818;0.5593079456607049;0.9999506876445663;-0.16506647622355342;-0.18519590353735804;-0.4471509047205845;-0.44064274198386144
Keratosis pilaris;Abnormal manual kinetic perimetry test;0.716815710067749;0.98669493;0.5913908076875733;0.5042352682476027;0.9998710980331391;-0.2830553879653901;-0.013176166049191362;-0.40848029034556577;-0.49563582978553644
Keratosis pilaris;Small radial epiphyses;0.7958800494670868;0.8326928;0.5654332591497104;0.5535071700429613;0.9998710980331391;-0.20399104856605232;-0.16717829608077706;-0.4344378388834287;-0.44636392799017777
Keratosis pilaris;Generalized keratosis follicularis;0.5322674512863159;0.35485756;0.6549289541682447;0.7232019759599057;0.7882101819680228;-0.2559427306817069;-0.4333526179955497;-0.13328122779977813;-0.06500820600811719
Keratosis pilaris;Hypoplasia of the calcaneus;0.7636027336120605;0.9979823;0.5759666731196074;0.5006422392102785;0.9999482333076865;-0.2363454996956259;-0.0019659101379781996;-0.4239815601880791;-0.49930599409740795
Keratosis pilaris;2-hydroxyadipic aciduria;0.8599005043506622;0.90354484;0.5447422426142687;0.5307504426585519;0.9998710980331391;-0.13997059368247688;-0.09632625483627022;-0.4551288554188704;-0.46912065537458725
Keratosis pilaris;Potter facies;0.7481004595756531;0.6888682;0.581055253982627;0.6007080542498526;0.9999431163823408;-0.2518426568066877;-0.3110748917615217;-0.41888786239971376;-0.39923506213248816
Keratosis pilaris;Increased heart rate variability;0.916070818901062;1.0577006;0.5267469523839539;0.4816230918947849;0.9999506876445663;-0.08387986874350428;0.05774994635811925;-0.47320373526061243;-0.5183275957497814
Keratosis pilaris;Aplastic zygomatic arch;0.7381278574466705;0.8627805;0.5843398750200918;0.5438165656304182;0.9999482333076865;-0.2618203758610159;-0.1371677219284445;-0.4156083582875947;-0.4561316676772682
Keratosis pilaris;Testicular torsion;0.9189326465129852;1.1059461;0.5258328881883936;0.4662129273533461;0.9999506876445663;-0.08101804113158106;0.10599537635079503;-0.4741177994561727;-0.5337377602912202
Keratosis pilaris;Abolished vibration sense;0.8934464901685715;0.9820479;0.5339815460879513;0.5057146311856118;0.9999482333076865;-0.10650174313911498;-0.017900317849007252;-0.4659666872197351;-0.4942336021220747
Keratosis pilaris;Fractured metatarsal bone of digit 5;0.7650274187326431;0.7838202;0.5755000363311129;0.5693597386311293;0.9998710980331391;-0.234843679300496;-0.2160508861457795;-0.4243710617020262;-0.4305113594020098
Keratosis pilaris;Prolonged G2 phase of cell cycle;0.9039404690265656;1.0112883;0.5306239187855581;0.4964067520763922;0.9999455218634979;-0.09600505283693239;0.011342763391934185;-0.4693216030779398;-0.5035387697871058
Keratosis pilaris;Single naris;0.8782935738563538;0.7693511;0.5388366417943331;0.5740848805494471;0.9999455218634979;-0.12165194800714418;-0.23059439710000917;-0.46110888006916484;-0.4258606413140509
Keratosis pilaris;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7969229221343994;0.8968742;0.5650942006910589;0.5328844289237592;0.9998710980331391;-0.2029481758987397;-0.10299690865630806;-0.43477689734208025;-0.4669866691093799
Keratosis pilaris;Asymmetry of the thorax;0.81993667781353;0.9269815;0.5576302675793637;0.5232632062804152;0.9999455218634979;-0.18000884404996798;-0.0729640131316559;-0.4423152542841342;-0.4766823155830827
Keratosis pilaris;Type 2 muscle fiber predominance;0.9006708562374115;0.9992089;0.5316696717355309;0.5002517974401861;0.999943799935066;-0.09927294369765449;-0.0007348727805249755;-0.46827412819953507;-0.4996920024948799
Keratosis pilaris;Dependency on parenteral nutrition;0.7781356126070023;0.8666702;0.5712142281768029;0.5425669549751051;0.9999482333076865;-0.2218126207006842;-0.13327804201969207;-0.42873400513088356;-0.45738127833258135
Keratosis pilaris;Limited shoulder flexion;0.8906366676092148;1.1749209;0.5348811987964284;0.4440330271813169;0.9998710980331391;-0.10923443042392433;0.1750498185241729;-0.46498989923671075;-0.5558380708518222
Keratosis pilaris;Paroxysmal vertigo;0.7426155805587769;1.0201192;0.5828606626007953;0.4935954188667532;0.9999482333076865;-0.2573326527489096;0.020170956908378;-0.4170875707068912;-0.5063528144409333
Keratosis pilaris;Long hallux;0.8744314610958099;0.9224623;0.5400754964508441;0.5247058216857201;0.9999388341437339;-0.12550737304792392;-0.07747654957876193;-0.4598633376928898;-0.47523301245801375
Keratosis pilaris;Broad medial eyebrow;0.8003306090831757;0.78589725;0.5639868143603299;0.5686827370165974;0.8435749988201247;-0.043244389736948996;-0.057677743876277;-0.2795881844597947;-0.2748922618035272
Keratosis pilaris;Myxoid subcutaneous tumors;0.7944288551807404;0.72515285;0.5659051964415316;0.5886272429219468;0.8066897472845033;-0.01226089210376291;-0.08153689713344126;-0.24078455084297168;-0.21806250436255648
Keratosis pilaris;Bulbous tips of toes;0.896159790456295;0.8851595;0.5331130566193666;0.5366356920311572;0.9999482333076865;-0.10378844285139144;-0.11478874081501067;-0.46683517668831986;-0.4633125412765292
Keratosis pilaris;Absent internal genitalia;0.9089085683226585;0.8411813;0.5290355525276759;0.5507685499812797;0.9998710980331391;-0.09096252971048058;-0.15868981980437935;-0.47083554550546325;-0.44910254805185945
Keratosis pilaris;Hyperphalangy of the 2nd finger;0.7174551486968994;0.7528683;0.5911786015155192;0.5794880428884502;0.9999506876445663;-0.2824955389476669;-0.24708239292868495;-0.40877208612904714;-0.42046264475611606
Keratosis pilaris;Renal interstitial hemosiderin;0.850102961063385;0.91852176;0.5478942214648714;0.5259641204422377;0.9998710980331391;-0.1497681369697541;-0.08134933613891304;-0.4519768765682677;-0.4739069775909014
Keratosis pilaris;Abnormality of depressor anguli oris muscle;0.9325931295752525;1.0798199;0.5214725549942414;0.4745654906709206;0.9998710980331391;-0.06727796845788658;0.07994881964569389;-0.47839854303889773;-0.5253056073622185
Keratosis pilaris;Paroxysmal dyspnea;0.6202362775802612;0.81867;0.6239947102861907;0.5580402199799366;0.9998710980331391;-0.3796348204528779;-0.18120112322921456;-0.3758763877469484;-0.44183087805320254
Keratosis pilaris;Phenylpyruvic acidemia;0.4936862587928772;0.789077;0.6689922240207455;0.567646937886565;0.9999506876445663;-0.5062644288516891;-0.21087370371588587;-0.33095846362382075;-0.43230374975800134
Keratosis pilaris;Lateral ventricle dilatation;0.79509337246418;1.0192878;0.5656890731639386;0.4938601092592714;0.999932424164295;-0.20483905170011496;0.019355400466442352;-0.4342433510003564;-0.5060723149050236
Keratosis pilaris;Neonatal unconjugated hyperbilirubinemia;0.8178408443927765;0.88847125;0.5583086102282184;0.5355747122053465;0.9999506876445663;-0.1821098432517898;-0.11147944187888026;-0.44164207741634787;-0.4643759754392198
Keratosis pilaris;High maternal circulating alpha-fetoprotein concentration;0.7334704399108887;0.8775269;0.5858769963126956;0.5390825324908882;0.9998710980331391;-0.26640065812225044;-0.1223442187225312;-0.4139941017204435;-0.4607885655422509
Keratosis pilaris;Prominent nasolabial fold;0.8188194632530212;0.75685114;0.557991834881765;0.5781803536469305;0.9999419656013786;-0.18112250234835736;-0.24309082891696088;-0.44195013071961364;-0.42176161195444806
Keratosis pilaris;Abnormality of inferior alveolar nerve;0.9374297335743904;0.8549708;0.5199297531296143;0.5463276171340223;0.9998710980331391;-0.062441364458748705;-0.14490028523559273;-0.4799413449035248;-0.4535434808991168
Keratosis pilaris;Unilateral conductive hearing impairment;0.84427510201931;1.1141332;0.5497713353781055;0.46359093106988203;0.9999506876445663;-0.1556755856252563;0.11418255114785314;-0.4501793522664608;-0.5363597565746843
Keratosis pilaris;Macular hypopigmented whorls, streaks, and patches;0.5960835814476013;0.6682137;0.6323513453314706;0.6076512834296717;0.7882101819680228;-0.19212660052042152;-0.11999645687799598;-0.1558588366365522;-0.18055889853835116
Keratosis pilaris;Delayed ossification of pubic rami;0.9382918775081635;1.0712208;0.5196547928208184;0.47731052246507955;0.9999482333076865;-0.061656355799523;0.07127252226940095;-0.48029344048686806;-0.5226377108426069
Keratosis pilaris;Hyperphenylalaninemia;0.7043084502220154;0.96917754;0.595550057489254;0.509812640618589;0.9999445874977825;-0.2956361372757671;-0.0307670433808086;-0.40439453000852843;-0.4901319468791935
Keratosis pilaris;Ureteropelvic junction obstruction;0.7436051368713379;0.86705124;0.5825347392829249;0.5424445726698899;0.9999391471417843;-0.25633401027044644;-0.13288790335974088;-0.41740440785885946;-0.45749457447189446
Keratosis pilaris;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7197616100311279;0.8143934;0.5904135170942393;0.5594249930069894;0.9998710980331391;-0.2801094880020112;-0.18547769688720406;-0.40945758093889983;-0.44044610502614967
Keratosis pilaris;Difficulty walking;0.7943725883960724;0.89863044;0.5659234976985861;0.5323224443465692;0.9999275220014686;-0.20555493360539623;-0.10129708176633068;-0.43400402430288254;-0.46760507765489945
Keratosis pilaris;Bilobate gallbladder;0.7978626787662506;0.9297606;0.5647887314467632;0.5223763306680989;0.9999482333076865;-0.20208555454143584;-0.07018765801319182;-0.4351595018609232;-0.4775719026395876
Keratosis pilaris;Histidinuria;0.7755286693572998;0.8799021;0.5720655136666846;0.5383208404970933;0.9999466809608285;-0.2244180116035287;-0.12004455655592128;-0.42788116729414394;-0.4616258404637352
Keratosis pilaris;Widened interpedicular distance;0.8572602570056915;1.0866839;0.5455911918697015;0.4723729948146421;0.9998710980331391;-0.1426108410274476;0.08681277132873833;-0.4542799061634376;-0.527498103218497
Lamina lucida cleavage;Abnormal central response of multifocal electroretinogram;0.8763534873723984;0.8115618;0.5394588906272948;0.5603425015398469;0.9998962300503706;-0.12354274267797227;-0.1883344071591353;-0.46043733942307585;-0.43955372851052377
Lamina lucida cleavage;Atypical or prolonged hepatitis;0.8640561401844025;1.0814717;0.5434066792190033;0.47403797828063665;0.9999548690865008;-0.1358987289020983;0.08151681250834786;-0.45654818986749746;-0.5259168908058641
Lamina lucida cleavage;Cubitus varus;0.9071407839655876;1.0395743;0.5296006511320113;0.4873998463111563;0.9998962300503706;-0.09275544608478303;0.039678035429670855;-0.4702955789183594;-0.5124963837392144
Lamina lucida cleavage;Nasal regurgitation;0.9408893585205078;0.9621948;0.5188264759324833;0.512036633584581;0.9999528219730685;-0.05906346345256064;-0.03775802159617636;-0.48112634604058513;-0.4879161883884875
Lamina lucida cleavage;Moon facies;0.9727030731737614;0.8630834;0.5086899610796558;0.5437192274126857;0.9999528219730685;-0.027249748799307083;-0.13686939978907797;-0.49126286089341265;-0.4562335945603827
Lamina lucida cleavage;Intestinal pseudo-obstruction;0.7770924866199493;0.9172691;0.5715547937090835;0.5263641834863977;0.9999468979947994;-0.22285441137485007;-0.08267778731517295;-0.42839210428571595;-0.4735827145084017
Lamina lucida cleavage;Bilateral renal atrophy;0.9184287488460541;0.9321897;0.5259938167783493;0.5216012617858503;0.9999548690865008;-0.0815261202404467;-0.06776516609882988;-0.47396105230815144;-0.47835360730065046
Lamina lucida cleavage;Fractured left clavicle;0.7298062443733215;0.8899766;0.5870877597860611;0.535092564268482;0.9998962300503706;-0.2700899856770491;-0.10991960937623735;-0.41280847026430956;-0.4648036657818887
Lamina lucida cleavage;Positive urine norcotinine test;1.0173760056495667;1.0499178;0.49446876725877476;0.48410407334223426;0.9998962300503706;0.017479775599196;0.05002158706541304;-0.5054274627915959;-0.5157921567081364
Lamina lucida cleavage;Long fibula;0.7527837753295898;0.99752766;0.5795157979674435;0.500786978518146;0.9999505803237132;-0.24716680499412336;-0.0024229213843516284;-0.42043478235626974;-0.4991636018055672
Lamina lucida cleavage;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7898067533969879;1.023093;0.5674093179224757;0.492648619841505;0.9998962300503706;-0.21008947665338273;0.023196755102827593;-0.4324869121278949;-0.5072476102088657
Lamina lucida cleavage;Type II cryptotia;0.8672545254230499;0.76109374;0.5423792874610198;0.5767888579846338;0.9998962300503706;-0.13264170462732072;-0.2388024943554854;-0.45751694258935083;-0.4231073720657369
Lamina lucida cleavage;Increased variability in muscle fiber diameter;0.8649353086948395;0.86037314;0.5431242260478759;0.5445902952084181;0.999937876518323;-0.13500256782348352;-0.1395647371369143;-0.4568136504704471;-0.45534758130990494
Lamina lucida cleavage;Widened proximal tibial metaphyses;0.8928878381848335;1.0044103;0.5341603940875109;0.4985961713129917;0.9999548690865008;-0.10706703090166725;0.004455397789719928;-0.46579447499898985;-0.501358697773509
Lamina lucida cleavage;Wide anterior fontanel;0.9355160370469093;0.85851514;0.5205401346497024;0.5451876629834873;0.9999383692587659;-0.06442233221185656;-0.14142322586429568;-0.4793982346090635;-0.4547507062752786
Lamina lucida cleavage;Increased circulating oleate level;0.7916762232780457;0.87873304;0.5668007741312752;0.5386957023079882;0.9998962300503706;-0.208220006772325;-0.12116319114808793;-0.4330954559190955;-0.4612005277423824
Lamina lucida cleavage;Lozenge-shaped umbilicus;0.5753500461578369;0.77999157;0.6396028258097171;0.5706084905413127;0.9999528219730685;-0.42460277581523154;-0.21996125483821127;-0.3603499961633514;-0.42934433143175577
Lamina lucida cleavage;Anti-myelin-associated glycoprotein antibody positivity;0.8147183656692505;0.7656462;0.5593197373943216;0.5752974128385009;0.9998962300503706;-0.18517786438112016;-0.2342500107968306;-0.44057649265604903;-0.42459881721186976
Lamina lucida cleavage;Fractured radius;0.8326277732849121;0.94605315;0.5535281653594561;0.5171801589232041;0.9999548690865008;-0.16732709580158867;-0.05390172177052177;-0.4464267037270446;-0.48277471016329665
Lamina lucida cleavage;Abnormal manual kinetic perimetry test;0.9300813004374504;0.94506437;0.5222739866935069;0.5174953605561354;0.9998962300503706;-0.06981492961292024;-0.0548318641865706;-0.47762224335686376;-0.4824008694942352
Lamina lucida cleavage;Small radial epiphyses;0.906121551990509;0.9847161;0.5299265062294943;0.5048651920636475;0.9998962300503706;-0.09377467805986162;-0.015180112668321089;-0.4699697238208763;-0.4950310379867231
Lamina lucida cleavage;Generalized keratosis follicularis;0.7397271990776062;0.7199123;0.5838124988716538;0.5903635530493617;0.8061689028324591;-0.06644170375485292;-0.086256612259339;-0.22235640396080536;-0.2158053497830974
Lamina lucida cleavage;Hypoplasia of the calcaneus;0.8052355796098709;0.9368501;0.5623942334419475;0.5201146406047006;0.9999528219730685;-0.19471724236319754;-0.06310275101969931;-0.43755858853112095;-0.47983818136836787
Lamina lucida cleavage;2-hydroxyadipic aciduria;0.99442686047405;1.0602971;0.5017739945916168;0.48079517998516896;0.9998962300503706;-0.005469369576320604;0.060400901488020464;-0.4981222354587539;-0.5191010500652017
Lamina lucida cleavage;Potter facies;1.0699009001255035;0.9317157;0.4777316929395361;0.521752478840054;0.9999486088983908;0.06995229122711277;-0.06823288204597378;-0.5222169159588547;-0.4781961300583367
Lamina lucida cleavage;Increased heart rate variability;0.9601465314626694;1.0344845;0.5126891135646354;0.4890210511546803;0.9999548690865008;-0.0398083376238314;0.03452963656688057;-0.48726575552186535;-0.5109338179318205
Lamina lucida cleavage;Aplastic zygomatic arch;0.8971699774265289;0.8589653;0.5327897734405811;0.5450429199025173;0.9999528219730685;-0.10278284454653952;-0.14098754430125449;-0.46716304853248736;-0.45490990207055115
Lamina lucida cleavage;Testicular torsion;0.8893402218818665;1.0303358;0.535296390403736;0.4903423568031988;0.9999548690865008;-0.11061464720463432;0.030380914871934284;-0.4646584786827648;-0.509612512283302
Lamina lucida cleavage;Abolished vibration sense;0.82693712413311;0.9436606;0.5553663840156435;0.517942888093971;0.9999528219730685;-0.1730156978399584;-0.05629220509837363;-0.4445864379574249;-0.4820099338790974
Lamina lucida cleavage;Fractured metatarsal bone of digit 5;0.845771312713623;0.9856185;0.5492892521978694;0.5045779450701158;0.9998962300503706;-0.1541249173367476;-0.01427775795106645;-0.45060697785250126;-0.4953182849802549
Lamina lucida cleavage;Prolonged G2 phase of cell cycle;0.8696356266736984;0.9591951;0.5416147142056682;0.5129922245161176;0.9999505803237132;-0.13031495365001478;-0.040755502904432195;-0.458335866118045;-0.4869583558075956
Lamina lucida cleavage;Single naris;0.9482614323496819;0.8344711;0.5164762539870954;0.5529331177821367;0.9999505803237132;-0.051689147974031346;-0.16547947379447736;-0.4834743263366178;-0.4470174625415765
Lamina lucida cleavage;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8573232293128967;0.7392969;0.5455709398785182;0.5839543606174717;0.9998962300503706;-0.14257300073747392;-0.260599316903398;-0.4543252901718524;-0.4159418694328989
Lamina lucida cleavage;Asymmetry of the thorax;0.8867804855108261;1.0042796;0.5361163333661009;0.49863774188496535;0.9999505803237132;-0.11317009481288709;0.004329033171159846;-0.46383424695761233;-0.5013128384387479
Lamina lucida cleavage;Type 2 muscle fiber predominance;0.9137048423290253;0.9585489;0.5275028090177585;0.5131980727623592;0.9999491674684583;-0.08624432513943303;-0.041400264003187304;-0.4724463584506998;-0.4867510947060991
Lamina lucida cleavage;Dependency on parenteral nutrition;0.925724096596241;1.0086018;0.5236645476636914;0.4972619452781296;0.9999528219730685;-0.07422872537682745;0.008648962733047272;-0.47628827430937704;-0.5026908766949388
Lamina lucida cleavage;Limited shoulder flexion;0.9830595571547747;1.2089937;0.5053925683802326;0.43298117250017365;0.9998962300503706;-0.016836672895595983;0.2090974432742143;-0.49450366167013804;-0.566915057550197
Lamina lucida cleavage;Paroxysmal vertigo;0.8638434708118439;1.0814614;0.5434750093199252;0.47404127151243625;0.9999528219730685;-0.13610935116122458;0.08150860762287881;-0.45647781265314324;-0.5259115504606322
Lamina lucida cleavage;Long hallux;0.8320115804672241;1.0105493;0.5537271225799256;0.49664198726597375;0.9999451389191131;-0.16793355845188895;0.010604167950393761;-0.44621801633918745;-0.5033031516531393
Lamina lucida cleavage;Broad medial eyebrow;1.0451798141002655;0.9139209;0.48561392150112936;0.5274337949762558;0.8568390591914515;0.18834075490881397;0.05708182017256214;-0.37122513769032217;-0.3294052642151958
Lamina lucida cleavage;Myxoid subcutaneous tumors;0.7949346005916595;0.84718;0.5657407082977762;0.5488354801958197;0.8230814931248395;-0.028146892533179924;0.02409851576340516;-0.25734078482706324;-0.27424601292901973
Lamina lucida cleavage;Bulbous tips of toes;0.975630147382617;1.0221654;0.507757933034982;0.4929439458194623;0.9999528219730685;-0.024322674590451454;0.022212595698135162;-0.4921948889380865;-0.5070088761536061
Lamina lucida cleavage;Absent internal genitalia;0.8965575844049454;0.8790995;0.5329857492887278;0.5385782123710973;0.9998962300503706;-0.10333864564542528;-0.12079674179200883;-0.4669104807616429;-0.4613180176792734
Lamina lucida cleavage;Hyperphalangy of the 2nd finger;0.979767756536603;1.0685669;0.5064405625656415;0.4781573410280273;0.9999548690865008;-0.0201871125498978;0.06861204928660714;-0.49351430652085926;-0.5217975280584735
Lamina lucida cleavage;Renal interstitial hemosiderin;0.9316370636224747;0.84453404;0.5217775839037977;0.5496878968091297;0.9998962300503706;-0.06825916642789598;-0.15536219055299516;-0.47811864614657296;-0.450208333241241
Lamina lucida cleavage;Abnormality of depressor anguli oris muscle;0.8810364753007889;0.9372339;0.5379571579518612;0.5199922084817906;0.9998962300503706;-0.11885975474958177;-0.06266230518464799;-0.4619390720985095;-0.47990402156858003
Lamina lucida cleavage;Paroxysmal dyspnea;0.8531419783830643;0.98959357;0.5469160441518426;0.5033125307823632;0.9998962300503706;-0.14675425166730638;-0.010302664586350874;-0.45298018589852806;-0.4965836992680075
Lamina lucida cleavage;Phenylpyruvic acidemia;0.886880487203598;1.0756439;0.5360842960209576;0.47589876594327096;0.9999548690865008;-0.11307438188290275;0.07568902797007881;-0.46387057306554313;-0.5240561031432298
Lamina lucida cleavage;Lateral ventricle dilatation;0.62290358543396;0.8116839;0.6230774636474317;0.5603029563381808;0.9999400373813975;-0.3770364519474375;-0.18825614417766212;-0.3768625737339658;-0.43963708104321664
Lamina lucida cleavage;Neonatal unconjugated hyperbilirubinemia;0.7947385013103485;1.0331105;0.5658044853201852;0.48945866334855204;0.9999548690865008;-0.20521636777615226;0.03315563029551827;-0.43415038376631554;-0.5104962057379487
Lamina lucida cleavage;High maternal circulating alpha-fetoprotein concentration;0.9277812987565994;0.92978156;0.5230079560293573;0.5223696285980516;0.9998962300503706;-0.07211493129377122;-0.07011467392091508;-0.4768882740210133;-0.47752660145231907
Lamina lucida cleavage;Prominent nasolabial fold;0.8289864212274551;0.7949776;0.5547041993709214;0.5657267174505094;0.9999476714516888;-0.1709612502242337;-0.20497006610882385;-0.4452434720807674;-0.43422095400117944
Lamina lucida cleavage;Abnormality of inferior alveolar nerve;0.7728685438632965;0.7556814;0.5729347065491;0.5785642622020225;0.9998962300503706;-0.22702768618707414;-0.24421483451966997;-0.4269615235012707;-0.42133196784834814
Lamina lucida cleavage;Unilateral conductive hearing impairment;0.8644317090511322;1.0528371;0.5432860148595478;0.48317358977437164;0.9999548690865008;-0.13552316003536857;0.052882264321092;-0.456668854226953;-0.5167812793121291
Lamina lucida cleavage;Macular hypopigmented whorls, streaks, and patches;0.8807324022054672;0.7322097;0.5380546414685412;0.5862934448959876;0.8061689028324591;0.0745634993730081;-0.07395922036785951;-0.2681142613639179;-0.21987545793647156
Lamina lucida cleavage;Delayed ossification of pubic rami;0.8398262709379196;0.97366935;0.5512054456521751;0.5083822796691666;0.9999528219730685;-0.16012655103514883;-0.026283471825821136;-0.44874737632089334;-0.49157054230390185
Lamina lucida cleavage;Hyperphenylalaninemia;0.9191566556692123;1.1412212;0.5257613490483797;0.45489713335758175;0.9999498126421364;-0.08079315697292411;0.141271353014907;-0.47418846359375677;-0.5450526792845547
Lamina lucida cleavage;Ureteropelvic junction obstruction;0.7390101850032806;0.9617918;0.584048902015228;0.5121650034533773;0.9999453908499725;-0.26093520584669183;-0.0381535774764068;-0.4158964888347445;-0.4877803873965951
Lamina lucida cleavage;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9118052273988724;1.0427167;0.5281097898093574;0.48639868604488334;0.9998962300503706;-0.08809100265149827;0.042820511511519;-0.47178644024101324;-0.5134975440054873
Lamina lucida cleavage;Difficulty walking;0.9301408976316452;0.91510993;0.5222549698169794;0.5270539027814796;0.99993620886009;-0.06979531122844485;-0.08482627643745211;-0.47768123904311066;-0.4728823060786105
Lamina lucida cleavage;Bilobate gallbladder;0.7611226886510849;0.96616775;0.5767793769467311;0.510771195781714;0.9999528219730685;-0.23883013332198355;-0.0337850739986727;-0.42317344502633736;-0.4891816261913544
Lamina lucida cleavage;Histidinuria;0.9413662329316139;0.9515064;0.5186744183518226;0.5154420562265356;0.9999515360511232;-0.05858530311950927;-0.0484451597846437;-0.4812771176993006;-0.4845094798245876
Lamina lucida cleavage;Widened interpedicular distance;0.9138292297720909;1.0720404;0.5274630672267218;0.4770489253902994;0.9998962300503706;-0.08606700027827974;0.07214420860166793;-0.4724331628236489;-0.5228473046600712
Abnormal central response of multifocal electroretinogram;Atypical or prolonged hepatitis;0.808879941701889;1.0130074;0.561211981845062;0.49585948718752915;0.9999201345566091;-0.19104019285472007;0.013087267863434837;-0.43870815271154706;-0.50406064736908
Abnormal central response of multifocal electroretinogram;Cubitus varus;0.8122687041759491;1.0413623;0.5601134151710521;0.4868302019080517;1.0;-0.1877312958240509;0.04136228561401367;-0.43988658482894794;-0.5131697980919483
Abnormal central response of multifocal electroretinogram;Nasal regurgitation;0.8094623386859894;1.0600162;0.561023128629579;0.4808847774119793;0.9999134918687169;-0.19045115318272754;0.060102663374203;-0.4388903632391379;-0.5190287144567376
Abnormal central response of multifocal electroretinogram;Moon facies;0.9016558974981308;0.8572408;0.5313545805616446;0.5455974409835276;0.9999134918687169;-0.09825759437058612;-0.14267269577954456;-0.4685589113070723;-0.45431605088518934
Abnormal central response of multifocal electroretinogram;Intestinal pseudo-obstruction;0.7948374003171921;1.0015038;0.5657723202363117;0.49952133251417086;0.9998912449978579;-0.2050538446806658;0.0016125801898252412;-0.4341189247615461;-0.500369912483687
Abnormal central response of multifocal electroretinogram;Bilateral renal atrophy;0.74729785323143;0.8059951;0.5813192728409288;0.5621477672052135;0.9999201345566091;-0.25262228132517905;-0.1939250278595266;-0.41860086171568034;-0.4377723673513956
Abnormal central response of multifocal electroretinogram;Fractured left clavicle;0.876145176589489;1.1213078;0.5395257116391702;0.4612911664722147;1.0;-0.12385482341051102;0.1213078498840332;-0.4604742883608298;-0.5387088335277853
Abnormal central response of multifocal electroretinogram;Positive urine norcotinine test;0.7494093477725983;0.88894784;0.5806248149125767;0.5354220625852979;1.0;-0.25059065222740173;-0.11105215549468994;-0.41937518508742333;-0.4645779374147021
Abnormal central response of multifocal electroretinogram;Long fibula;0.8466006219387054;1.0963014;0.54902209565205;0.4692987073759698;0.9999056439461368;-0.15330502200743135;0.09639579247811858;-0.45088354829408683;-0.530606936570167
Abnormal central response of multifocal electroretinogram;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8713360726833344;1.1040933;0.5410688478409897;0.4668059485359076;1.0;-0.12866392731666565;0.10409331321716309;-0.45893115215901026;-0.5331940514640924
Abnormal central response of multifocal electroretinogram;Type II cryptotia;0.8653650730848312;0.9066994;0.5429861667660991;0.529741759302568;1.0;-0.13463492691516876;-0.09330058097839355;-0.4570138332339009;-0.47025824069743205
Abnormal central response of multifocal electroretinogram;Increased variability in muscle fiber diameter;0.733126163482666;0.8831923;0.585990701401776;0.537266125915889;0.9998452077479463;-0.26671904426528026;-0.11665290695143749;-0.41385450634617027;-0.4625790818320573
Abnormal central response of multifocal electroretinogram;Widened proximal tibial metaphyses;0.7990851104259491;1.1289406;0.5643914687542715;0.4588423695910089;0.9999201345566091;-0.20083502413066;0.12902044771878152;-0.4355286658023376;-0.5410777649656002
Abnormal central response of multifocal electroretinogram;Wide anterior fontanel;0.8621249347925186;0.8618369;0.5440272446040879;0.5441198163592095;0.999848231156753;-0.13772329636423442;-0.1380113209089503;-0.4558209865526651;-0.45572841479754356
Abnormal central response of multifocal electroretinogram;Increased circulating oleate level;0.7788775116205215;0.9368653;0.570972059357094;0.5201097619882069;1.0;-0.22112248837947845;-0.06313467025756836;-0.42902794064290595;-0.4798902380117931
Abnormal central response of multifocal electroretinogram;Lozenge-shaped umbilicus;0.9547430202364922;1.0601633;0.5144106662425453;0.4808378536488652;0.9999134918687169;-0.04517047163222476;0.06024976763750867;-0.48550282562617164;-0.5190756382198517
Abnormal central response of multifocal electroretinogram;Anti-myelin-associated glycoprotein antibody positivity;0.660962700843811;0.71284556;0.6101012888462908;0.5927092928809907;1.0;-0.33903729915618896;-0.2871544361114502;-0.3898987111537092;-0.4072907071190093
Abnormal central response of multifocal electroretinogram;Fractured radius;0.8145073801279068;1.0138953;0.5593880808737006;0.49557686312427063;0.9999201345566091;-0.1854127544287023;0.013975138652009056;-0.4405320536829085;-0.5043432714323385
Abnormal central response of multifocal electroretinogram;Abnormal manual kinetic perimetry test;0.4153902530670166;0.26323795;0.6987523622516107;0.7636462067016068;1.0;-0.5846097469329834;-0.7367620468139648;-0.30124763774838925;-0.23635379329839323
Abnormal central response of multifocal electroretinogram;Small radial epiphyses;0.8666765093803406;1.011856;0.5425649257472052;0.49622605064010117;1.0;-0.13332349061965942;0.01185595989227295;-0.45743507425279484;-0.5037739493598988
Abnormal central response of multifocal electroretinogram;Generalized keratosis follicularis;0.7423494458198547;0.8428128;0.5829483327135115;0.5502426022746432;0.9999201345566091;-0.25757068873675437;-0.15710735799105735;-0.41697180184309757;-0.44967753228196594
Abnormal central response of multifocal electroretinogram;Hypoplasia of the calcaneus;0.8529016077518463;1.1071075;0.5469933965683893;0.4658411062760741;0.9999134918687169;-0.1470118841168706;0.10719402823473767;-0.4529200953003276;-0.5340723855926428
Abnormal central response of multifocal electroretinogram;2-hydroxyadipic aciduria;0.8872216492891312;1.0018225;0.5359750013567701;0.499419898876427;1.0;-0.11277835071086884;0.0018224716186523438;-0.4640249986432299;-0.500580101123573
Abnormal central response of multifocal electroretinogram;Potter facies;0.9791507106274366;1.0331005;0.5066370158303359;0.4894618620098453;0.9998981869165328;-0.020747476289096123;0.03320229888516402;-0.4932611710861968;-0.5104363249066874
Abnormal central response of multifocal electroretinogram;Increased heart rate variability;0.7074145972728729;0.87959623;0.5945155771156655;0.5384189179620389;0.9999201345566091;-0.2925055372837362;-0.12032390118868919;-0.4054045574409436;-0.4615012165945702
Abnormal central response of multifocal electroretinogram;Aplastic zygomatic arch;0.8310308754444122;0.99687266;0.5540438177664384;0.5009954720493008;0.9999134918687169;-0.1688826164243047;-0.0030408283707921147;-0.4458696741022785;-0.4989180198194161
Abnormal central response of multifocal electroretinogram;Testicular torsion;0.8562372922897339;1.0571709;0.5459202049910907;0.48179203614460564;0.9999201345566091;-0.14368284226687522;0.05725073336331277;-0.4539999295655184;-0.5181280984120035
Abnormal central response of multifocal electroretinogram;Abolished vibration sense;0.8012245893478394;0.9296977;0.5636964306489107;0.5223963870108745;0.9999134918687169;-0.19868890252087756;-0.07021579947446033;-0.4362170612198062;-0.4775171048578424
Abnormal central response of multifocal electroretinogram;Fractured metatarsal bone of digit 5;0.8826173543930054;1.0772336;0.5374503975887804;0.4753912993471342;1.0;-0.11738264560699463;0.07723355293273926;-0.46254960241121956;-0.5246087006528658
Abnormal central response of multifocal electroretinogram;Prolonged G2 phase of cell cycle;0.7673195749521255;0.8890783;0.5747496172842721;0.5353802682866899;0.9999056439461368;-0.23258606899401124;-0.1108273248734134;-0.4251560266618647;-0.46452537565944685
Abnormal central response of multifocal electroretinogram;Single naris;0.8745958358049393;0.8874046;0.5400227574724509;0.5359163792592407;0.9999056439461368;-0.12530980814119752;-0.11250102329870637;-0.4598828864736859;-0.46398926468689605
Abnormal central response of multifocal electroretinogram;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.5005021691322327;0.24485213;0.6664821239730494;0.7724349576787483;1.0;-0.49949783086776733;-0.7551478743553162;-0.3335178760269506;-0.22756504232125174
Abnormal central response of multifocal electroretinogram;Asymmetry of the thorax;0.8644740581512451;1.0150654;0.5432724091539121;0.4952043605515307;0.9999056439461368;-0.13543158579489167;0.015159787648711842;-0.45663323479222473;-0.5047012833946061
Abnormal central response of multifocal electroretinogram;Type 2 muscle fiber predominance;0.8670968413352966;1.0350891;0.5424299285656927;0.4888284904680521;0.9999003561294039;-0.13280351479410724;0.035188779040579043;-0.45747042756371115;-0.5110718656613518
Abnormal central response of multifocal electroretinogram;Dependency on parenteral nutrition;0.85174959897995;1.0416456;0.5473641573812609;0.4867399620972114;0.9999134918687169;-0.14816389288876697;0.04173215422655896;-0.45254933448745605;-0.5131735297715055
Abnormal central response of multifocal electroretinogram;Limited shoulder flexion;0.8080492317676544;0.99000114;0.5614813929965099;0.5031827919374201;1.0;-0.19195076823234558;-0.009998857975006104;-0.4385186070034901;-0.4968172080625799
Abnormal central response of multifocal electroretinogram;Paroxysmal vertigo;0.6688580214977264;0.8829632;0.6074339088497415;0.537339553679388;0.9999134918687169;-0.3310554703709905;-0.11695031132672473;-0.39247958301897545;-0.4625739381893289
Abnormal central response of multifocal electroretinogram;Long hallux;0.8874639049172401;1.0994318;0.535897394945883;0.4682975041840013;0.9998836012415208;-0.11241969632428062;0.09954815191704858;-0.4639862062956378;-0.5315860970575195
Abnormal central response of multifocal electroretinogram;Broad medial eyebrow;0.7060402035713196;0.6757299;0.5949731816598821;0.60511867699652;0.9999201345566091;-0.29387993098528953;-0.3241902637604055;-0.404946952896727;-0.3948014575600891
Abnormal central response of multifocal electroretinogram;Myxoid subcutaneous tumors;0.7984630465507507;1.0569663;0.5645936127229505;0.48185724978113387;0.9999201345566091;-0.20145708800585838;0.057046170222443626;-0.4353265218336586;-0.5180628847754752
Abnormal central response of multifocal electroretinogram;Bulbous tips of toes;0.9277581796050072;1.0623711;0.5230153343561816;0.4801337517436157;0.9999134918687169;-0.07215531226370975;0.062457642889278686;-0.4768981575125353;-0.5197797401251012
Abnormal central response of multifocal electroretinogram;Absent internal genitalia;0.8932132720947266;1.0282549;0.5340562076909601;0.49100501493807436;1.0;-0.10678672790527344;0.02825486660003662;-0.46594379230903993;-0.5089949850619256
Abnormal central response of multifocal electroretinogram;Hyperphalangy of the 2nd finger;0.8655752539634705;1.0450071;0.5429186503594411;0.4856689533891786;0.9999201345566091;-0.13434488059313865;0.0450869750854197;-0.457001484197168;-0.5142511811674305
Abnormal central response of multifocal electroretinogram;Renal interstitial hemosiderin;0.772613987326622;0.81377625;0.573017911518287;0.5596249224492071;1.0;-0.227386012673378;-0.18622374534606934;-0.42698208848171304;-0.44037507755079286
Abnormal central response of multifocal electroretinogram;Abnormality of depressor anguli oris muscle;0.7897979021072388;0.9808523;0.5674121997588835;0.5060952751997418;1.0;-0.21020209789276123;-0.01914769411087036;-0.43258780024111654;-0.49390472480025815
Abnormal central response of multifocal electroretinogram;Paroxysmal dyspnea;0.7585909068584442;0.9904703;0.5776095616945334;0.5030334503195533;1.0;-0.2414090931415558;-0.009529709815979004;-0.42239043830546663;-0.49696654968044673
Abnormal central response of multifocal electroretinogram;Phenylpyruvic acidemia;0.7924964129924774;0.94952255;0.5665338669527495;0.5160742925820486;0.9999201345566091;-0.2074237215641317;-0.05039757968218894;-0.43338626760385957;-0.4838458419745605
Abnormal central response of multifocal electroretinogram;Lateral ventricle dilatation;0.6984013915061951;0.7581479;0.5975202476716602;0.5777548827520034;0.9998579617208769;-0.30145657021468186;-0.2417100663847258;-0.4023377140492167;-0.42210307896887356
Abnormal central response of multifocal electroretinogram;Neonatal unconjugated hyperbilirubinemia;0.8666943609714508;1.074352;0.5425591922306094;0.4763111688490985;0.9999201345566091;-0.1332257735851583;0.07443189142910867;-0.45736094232599966;-0.5236089657075106
Abnormal central response of multifocal electroretinogram;High maternal circulating alpha-fetoprotein concentration;0.8149700462818146;0.8880166;0.5592382153845205;0.5357203581872801;1.0;-0.18502995371818542;-0.11198341846466064;-0.44076178461547955;-0.46427964181271986
Abnormal central response of multifocal electroretinogram;Prominent nasolabial fold;0.8359948396682739;0.985388;0.5524413727452688;0.5046513168384126;0.9998944404568447;-0.1638996007885708;-0.01450645951888696;-0.4474530677115759;-0.49524312361843215
Abnormal central response of multifocal electroretinogram;Abnormality of inferior alveolar nerve;0.7805306017398834;0.9515053;0.570432611792633;0.5154423933894907;1.0;-0.21946939826011658;-0.048494696617126465;-0.42956738820736695;-0.4845576066105093
Abnormal central response of multifocal electroretinogram;Unilateral conductive hearing impairment;0.6043743193149567;0.8631116;0.6294722326411628;0.5437101584279145;0.9999201345566091;-0.39554581524165244;-0.13680851937563987;-0.3704479019154463;-0.4562099761286946
Abnormal central response of multifocal electroretinogram;Macular hypopigmented whorls, streaks, and patches;0.566218912601471;0.43364346;0.6428208772747512;0.6916474720553898;0.9999201345566091;-0.43370122195513816;-0.5662766742828664;-0.3570992572818579;-0.3082726625012193
Abnormal central response of multifocal electroretinogram;Delayed ossification of pubic rami;0.8740411251783371;1.1222595;0.5402007386278538;0.4609859998296113;0.9999134918687169;-0.12587236669037982;0.12234600577380017;-0.45971275324086314;-0.5389274920391056
Abnormal central response of multifocal electroretinogram;Hyperphenylalaninemia;0.814047560095787;0.91834795;0.5595370376530948;0.526019625172554;0.9999028053808913;-0.18585524528510422;-0.08155485063083023;-0.44036576772779645;-0.4738831802083373
Abnormal central response of multifocal electroretinogram;Ureteropelvic junction obstruction;0.7642928659915924;0.89791524;0.5757406086583687;0.5325512926536826;0.9998847295244674;-0.23559186353287498;-0.10196948542198936;-0.42414412086609865;-0.46733343687078477
Abnormal central response of multifocal electroretinogram;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7958286106586456;1.0659385;0.5654499848658248;0.47899588813488536;1.0;-0.20417138934135437;0.06593847274780273;-0.43455001513417524;-0.5210041118651146
Abnormal central response of multifocal electroretinogram;Difficulty walking;0.793298214673996;0.8954245;0.5662729895137872;0.5333483832952248;0.9998344221996177;-0.20653620752562174;-0.10440993699301371;-0.4335614326858305;-0.4664860389043929
Abnormal central response of multifocal electroretinogram;Bilobate gallbladder;0.8338828086853027;1.0582045;0.5531230029221017;0.48146245001488;0.9999134918687169;-0.16603068318341418;0.05829103980089978;-0.4467904889466152;-0.518451041853837
Abnormal central response of multifocal electroretinogram;Histidinuria;0.8532086610794067;0.9905459;0.5468945858365339;0.5030093751897526;0.9999090677057578;-0.1467004066263511;-0.009363139227516859;-0.4530144818692239;-0.4968996925160052
Abnormal central response of multifocal electroretinogram;Widened interpedicular distance;0.7384255528450012;0.97419816;0.5842416933065268;0.5082138831877783;1.0;-0.2615744471549988;-0.02580183744430542;-0.41575830669347325;-0.49178611681222173
Atypical or prolonged hepatitis;Cubitus varus;0.9660980924963951;1.0423366;0.5107933805353677;0.4865198038019679;0.9999201345566091;-0.033822042060214;0.0424164485809031;-0.4891267540212414;-0.5134003307546412
Atypical or prolonged hepatitis;Nasal regurgitation;0.9401508793234825;1.0821908;0.5190619580871392;0.473808335100248;0.8584874194359269;0.08166345988755563;0.22370333259349207;-0.3394254613487877;-0.3846790843356789
Atypical or prolonged hepatitis;Moon facies;0.898432195186615;1.0334934;0.5323858822400644;0.48933673138650036;0.9999584729108851;-0.10152627772427014;0.03353492670917102;-0.4675725906708207;-0.5106217415243848
Atypical or prolonged hepatitis;Intestinal pseudo-obstruction;0.6408992111682892;0.9318393;0.6169165703308541;0.5217130612394625;0.8430783222418983;-0.20217911107360909;0.0887609650391381;-0.22616175191104415;-0.3213652610024358
Atypical or prolonged hepatitis;Bilateral renal atrophy;0.772646114230156;1.0141721;0.5730074101604892;0.49548871950894147;0.9999600672783046;-0.2273139530481486;0.014212009900650524;-0.4269526571178154;-0.5044713477693631
Atypical or prolonged hepatitis;Fractured left clavicle;0.8723992556333542;0.905783;0.5407276134118495;0.5300347464478705;0.9999201345566091;-0.12752087892325492;-0.0941371369484243;-0.4591925211447596;-0.4698853881087386
Atypical or prolonged hepatitis;Positive urine norcotinine test;0.9050055891275406;0.99741125;0.5302833229120892;0.5008240335988574;0.9999201345566091;-0.09491454542906852;-0.0025088834884938738;-0.46963681164451987;-0.4990961009577517
Atypical or prolonged hepatitis;Long fibula;0.8525667786598206;1.0561328;0.547101150828888;0.48212299824491345;0.9999567459343585;-0.1473899672745379;0.05617604749215521;-0.45285559510547047;-0.517833747689445
Atypical or prolonged hepatitis;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.938346516340971;1.1163456;0.5196373675611892;0.4628819557488796;0.9999201345566091;-0.061573618215638115;0.11642550944058327;-0.48028276699541994;-0.5370381788077295
Atypical or prolonged hepatitis;Type II cryptotia;0.7663866579532623;1.0265555;0.5750549895947854;0.4915461283134278;0.9999201345566091;-0.23353347660334678;0.026635403620881126;-0.4248651449618237;-0.5083740062431813
Atypical or prolonged hepatitis;Increased variability in muscle fiber diameter;0.8009133636951447;1.0660414;0.5637975172188284;0.47896307676786465;0.9999473166570552;-0.1990339529619105;0.0660940337076299;-0.43614979943822674;-0.5209842398891905
Atypical or prolonged hepatitis;Widened proximal tibial metaphyses;0.8444974571466446;1.1158674;0.5496996846928954;0.46303523925653334;0.9999600672783046;-0.15546261013165996;0.1159073090492101;-0.4502603825854091;-0.5369248280217712
Atypical or prolonged hepatitis;Wide anterior fontanel;0.8475548177957535;1.124834;0.5487147507410199;0.46016020203750496;0.9999476714516888;-0.15239285365593536;0.12488627000796693;-0.4512329207106689;-0.5397874694141839
Atypical or prolonged hepatitis;Increased circulating oleate level;0.6817445456981659;0.81451505;0.6030969717585264;0.5593855901664688;0.9999201345566091;-0.3181755888584432;-0.18540508033068748;-0.3968231627980827;-0.4405345443901403
Atypical or prolonged hepatitis;Lozenge-shaped umbilicus;0.8332217335700989;0.93187225;0.5533364065926327;0.5217025401102366;0.8584874194359269;-0.025265685865828003;0.07338482921367029;-0.30515101284329416;-0.33678487932569023
Atypical or prolonged hepatitis;Anti-myelin-associated glycoprotein antibody positivity;0.7809114754199982;1.0369706;0.5703083517176721;0.4882292087058274;0.5829152011936182;0.19799627422638;0.4540554141933447;-0.012606849475946036;-0.09468599248779075
Atypical or prolonged hepatitis;Fractured radius;0.9006048664450645;1.0767388;0.531690781403436;0.47554921811660433;0.9999600672783046;-0.09935520083324001;0.07677876710279896;-0.4682692858748686;-0.5244108491617002
Atypical or prolonged hepatitis;Abnormal manual kinetic perimetry test;0.8464095294475555;1.0885278;0.5490836517557963;0.471783783674116;0.9999201345566091;-0.15351060510905357;0.08860766409603982;-0.4508364828008128;-0.5281363508824931
Atypical or prolonged hepatitis;Small radial epiphyses;0.9386213272809982;1.1362667;0.5195497265378868;0.45648959918530707;0.9999201345566091;-0.06129880727561088;0.13634657381741433;-0.48037040801872233;-0.543430535371302
Atypical or prolonged hepatitis;Generalized keratosis follicularis;0.7284351587295532;0.9512765;0.5875411403401976;0.5155153147841338;0.9999600672783046;-0.27152490854875133;-0.048683586126723744;-0.412418926938107;-0.48444475249417074
Atypical or prolonged hepatitis;Hypoplasia of the calcaneus;0.9732763450592756;1.1255336;0.508507416368092;0.45993572938024674;0.9999584729108851;-0.026682127851609505;0.12557510786914416;-0.4914510565427931;-0.5400227435306384
Atypical or prolonged hepatitis;2-hydroxyadipic aciduria;0.7863156646490097;0.9870028;0.5685463977674213;0.5041372486310358;0.9999201345566091;-0.2136044699075994;-0.012917344582396462;-0.4313737367891878;-0.4957828859255733
Atypical or prolonged hepatitis;Potter facies;0.8462009131908417;1.0463618;0.549150854855157;0.48523727106231684;0.9999552432134126;-0.15375433002257088;0.04640656079507133;-0.45080438835825554;-0.5147179721510957
Atypical or prolonged hepatitis;Increased heart rate variability;0.654132604598999;0.93472016;0.6124152988551339;0.5207939984305133;0.9999600672783046;-0.34582746267930553;-0.06523990870133922;-0.38754476842317065;-0.4791660688477912
Atypical or prolonged hepatitis;Aplastic zygomatic arch;0.7957238256931305;1.1586022;0.565484057053909;0.4493012532696474;0.9999584729108851;-0.20423464721775464;0.15864376479053088;-0.4344744158569761;-0.5506572196412377
Atypical or prolonged hepatitis;Testicular torsion;0.8058328330516815;0.9900858;0.5622004217629857;0.5031558546365497;0.9999600672783046;-0.19412723422662304;-0.009874286657729603;-0.4377596455153189;-0.4968042126417549
Atypical or prolonged hepatitis;Abolished vibration sense;0.9646320343017578;1.0535616;0.5112603215447509;0.48294265373845513;0.9999584729108851;-0.03532643860912732;0.05360309534930774;-0.48869815136613426;-0.51701581917243
Atypical or prolonged hepatitis;Fractured metatarsal bone of digit 5;0.9182327911257744;1.0696286;0.5260564011217832;0.4778185792670835;0.9999201345566091;-0.08168734343083472;0.06970846174923806;-0.4738637334348259;-0.5221015552895256
Atypical or prolonged hepatitis;Prolonged G2 phase of cell cycle;0.7177577018737793;0.88397306;0.5910782097663818;0.5370158861237694;0.9999567459343585;-0.28219904406057916;-0.11598368389593683;-0.40887853616797665;-0.4629408598105891
Atypical or prolonged hepatitis;Single naris;1.0807407796382904;1.1509318;0.4742714053821808;0.45177261170470284;0.9999567459343585;0.08078403370393195;0.1509750892402021;-0.5256853405521776;-0.5481841342296556
Atypical or prolonged hepatitis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7469469904899597;1.003528;0.5814347077536643;0.49887700547755187;0.9999201345566091;-0.2529731440666494;0.003607864367646263;-0.41848542680294476;-0.5010431290790572
Atypical or prolonged hepatitis;Asymmetry of the thorax;0.7812467217445374;1.0186081;0.5701989865848669;0.4940765151079538;0.9999567459343585;-0.2187100241898211;0.01865134732736029;-0.42975775934949156;-0.5058802308264047
Atypical or prolonged hepatitis;Type 2 muscle fiber predominance;0.8926398903131485;1.0240272;0.5342397760965591;0.4923511530769502;0.9999556674707869;-0.1073157771576384;0.024071560884620813;-0.46571589137422775;-0.5076045143938367
Atypical or prolonged hepatitis;Dependency on parenteral nutrition;0.7861821204423904;0.91959643;0.5685899119006449;0.5256209061781101;0.8584874194359269;-0.07230529899353644;0.06110901420359949;-0.289897507535282;-0.3328665132578168
Atypical or prolonged hepatitis;Limited shoulder flexion;0.8744997084140778;0.94914174;0.5400535994332353;0.516195680799099;0.9999201345566091;-0.12542042614253135;-0.05077839375765891;-0.45986653512337383;-0.48372445375751005
Atypical or prolonged hepatitis;Paroxysmal vertigo;0.7537822425365448;1.0467141;0.579187837927214;0.485125034746831;0.9999584729108851;-0.24617623037434033;0.04675559454822131;-0.4207706349836712;-0.5148334381640541
Atypical or prolonged hepatitis;Long hallux;0.8413669019937515;1.0339539;0.5507086958252073;0.4891900656983601;0.9999526340597648;-0.15858573206601323;0.034001271045826065;-0.44924393823455744;-0.5107625683614047
Atypical or prolonged hepatitis;Broad medial eyebrow;0.8746258765459061;1.0205226;0.5400131191383775;0.4934669841959278;0.9999600672783046;-0.1253341907323985;0.020562527173599743;-0.4599469481399271;-0.5064930830823767
Atypical or prolonged hepatitis;Myxoid subcutaneous tumors;0.8466221690177917;1.019675;0.5490151548661197;0.4937368329649514;0.9999600672783046;-0.1533378982605128;0.019714949124893688;-0.4509449124121848;-0.5062232343133531
Atypical or prolonged hepatitis;Bulbous tips of toes;0.8607397079467773;1.0594031;0.5444724711571807;0.4810802965459836;0.9999584729108851;-0.1392187649641078;0.05944458895587512;-0.45548600175370446;-0.5188781763649015
Atypical or prolonged hepatitis;Absent internal genitalia;1.0004671197384596;1.2028841;0.4998513111638093;0.43496854882373737;0.9999201345566091;0.000546985181850479;0.20296394346920876;-0.5000688233927998;-0.5649515857328717
Atypical or prolonged hepatitis;Hyperphalangy of the 2nd finger;0.7866316735744476;1.0087111;0.5684434343892721;0.49722713164975285;0.9999600672783046;-0.21332839370385692;0.008751032346329235;-0.4315166328890324;-0.5027329356285517
Atypical or prolonged hepatitis;Renal interstitial hemosiderin;0.7650711983442307;0.9243655;0.5754856995217899;0.524098211101435;0.9999201345566091;-0.23484893621237846;-0.07555461407931419;-0.42443443503481926;-0.47582192345517416
Atypical or prolonged hepatitis;Abnormality of depressor anguli oris muscle;0.8744706809520721;1.1238315;0.5400629128139376;0.46048175230614685;0.9999201345566091;-0.12544945360453696;0.12391137598721413;-0.4598572217426715;-0.5394383822504623
Atypical or prolonged hepatitis;Paroxysmal dyspnea;0.7089471220970154;1.009318;0.5940055599952083;0.49703396047493686;0.9999201345566091;-0.2909730124595937;0.009397859561127708;-0.4059145745614008;-0.5028861740816722
Atypical or prolonged hepatitis;Phenylpyruvic acidemia;0.7186945676803589;0.885284;0.5907674024530094;0.5365957990572963;0.9999600672783046;-0.28126549959794567;-0.11467606068269298;-0.40919266482529515;-0.4633642682210083
Atypical or prolonged hepatitis;Lateral ventricle dilatation;0.758762925863266;1.0052058;0.5775531387550701;0.49834293644775374;0.9999488789551968;-0.2411859530919308;0.00525687151019627;-0.4223957402001267;-0.5016059425074431
Atypical or prolonged hepatitis;Neonatal unconjugated hyperbilirubinemia;0.6537268757820129;0.61228067;0.6125529521393911;0.626737021587112;0.9999600672783046;-0.3462331914962916;-0.38767940045014904;-0.38740711513891346;-0.3732230456911926
Atypical or prolonged hepatitis;High maternal circulating alpha-fetoprotein concentration;0.694984495639801;0.85625386;0.5986616482673651;0.5459148847948014;0.9999201345566091;-0.3049356389168081;-0.14366627217562766;-0.401258486289244;-0.45400524976180767
Atypical or prolonged hepatitis;Prominent nasolabial fold;0.9285342246294022;1.164179;0.5227676713810663;0.4475025328781973;0.9999545338528789;-0.07142030922347675;0.1642244336230122;-0.47718686247181263;-0.5524520009746816
Atypical or prolonged hepatitis;Abnormality of inferior alveolar nerve;0.8308482319116592;1.0507077;0.5541028040761994;0.4838523264633333;0.9999201345566091;-0.16907190264494987;0.05078756331173806;-0.4458173304804097;-0.5160678080932758
Atypical or prolonged hepatitis;Unilateral conductive hearing impairment;0.8880594372749329;1.0335002;0.5357066256953069;0.4893345732111344;0.9999600672783046;-0.11190063000337169;0.03354012727125599;-0.46425344158299764;-0.5106254940671702
Atypical or prolonged hepatitis;Macular hypopigmented whorls, streaks, and patches;0.7311807870864868;0.98628235;0.5866334179085844;0.5043666063360541;0.9999600672783046;-0.26877928019181774;-0.013677718645492054;-0.4133266493697202;-0.49559346094225043
Atypical or prolonged hepatitis;Delayed ossification of pubic rami;0.7901990562677383;1.1083956;0.5672815960994289;0.46542867070563454;0.9999584729108851;-0.2097594166431468;0.10843710356616565;-0.4326768768114563;-0.5345298022052506
Atypical or prolonged hepatitis;Hyperphenylalaninemia;0.540426641702652;0.9535606;0.6519976695583893;0.5147874402845647;0.9999561589935034;-0.45952951729085145;-0.046395568249484875;-0.3479584894351141;-0.48516871870893874
Atypical or prolonged hepatitis;Ureteropelvic junction obstruction;0.859200045466423;0.9713528;0.5449674377838607;0.5091199314618782;0.9999528219730685;-0.14075277650664542;-0.028600006345016693;-0.45498538418920775;-0.4908328905111903
Atypical or prolonged hepatitis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9570867232978344;1.1351733;0.5136639162090479;0.4568408665099939;0.9999201345566091;-0.04283341125877471;0.13525318621365456;-0.48625621834756116;-0.5430792680466152
Atypical or prolonged hepatitis;Difficulty walking;0.9542758837342262;1.1170769;0.5145595145030855;0.462647613152097;0.9999461221900431;-0.04567023845581686;0.11713075158925379;-0.4853866076869576;-0.5372985090379461
Atypical or prolonged hepatitis;Bilobate gallbladder;0.6671428978443146;0.8567654;0.6080126778046697;0.5457503389315532;0.7152708671182011;-0.04812796927388652;0.14149452232424276;-0.10725818931353137;-0.16952052818664787
Atypical or prolonged hepatitis;Histidinuria;0.7277666330337524;0.97171265;0.5877622695578459;0.5090053495107089;0.9999574798349273;-0.2721908468011749;-0.02824483096636654;-0.4121952102770814;-0.49095213032421847
Atypical or prolonged hepatitis;Widened interpedicular distance;0.7736389487981796;1.0505022;0.5726829209946724;0.48391782485986223;0.9999201345566091;-0.22628118575842948;0.05058204649655251;-0.42723721356193667;-0.5160023096967469
Cubitus varus;Nasal regurgitation;0.7891297936439514;0.9159821;0.5676297412518115;0.5267752791398315;0.9999134918687169;-0.2107836982247655;-0.08393136467908069;-0.4322837506169054;-0.47313821272888545
Cubitus varus;Moon facies;0.9270202964544296;0.99367005;0.5232508314921951;0.5020148973236169;0.9999134918687169;-0.07289319541428729;-0.006243445539218628;-0.47666266037652183;-0.4978985945451
Cubitus varus;Intestinal pseudo-obstruction;0.8746548146009445;0.9737468;0.5400038346272354;0.5083576302919675;0.9998912449978579;-0.12523643039691335;-0.026144468417047317;-0.4598874103706224;-0.4915336147058904
Cubitus varus;Bilateral renal atrophy;0.8287356048822403;0.90136445;0.5547852321788538;0.5314478058108161;0.9999201345566091;-0.1711845296743688;-0.09855568887026878;-0.4451349023777553;-0.46847232874579303
Cubitus varus;Fractured left clavicle;0.7280104756355286;0.8630285;0.5876816083563028;0.5437368770810046;1.0;-0.27198952436447144;-0.13697147369384766;-0.4123183916436972;-0.4562631229189954
Cubitus varus;Positive urine norcotinine test;0.8057137131690979;0.92378044;0.5622390748836048;0.5242849938816092;1.0;-0.1942862868309021;-0.07621955871582031;-0.4377609251163952;-0.4757150061183908
Cubitus varus;Long fibula;0.8882121741771698;0.97215384;0.5356577009533339;0.5088648614433149;0.7078919860199948;0.180320188157175;0.2642618564291934;-0.17223428506666094;-0.19902712457667993
Cubitus varus;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7866666615009308;0.9985911;0.5684320349210376;0.5004484607643112;1.0;-0.2133333384990692;-0.0014088749885559082;-0.43156796507896245;-0.49955153923568885
Cubitus varus;Type II cryptotia;0.7552283406257629;0.88101757;0.578712999520321;0.5379632105583672;1.0;-0.24477165937423706;-0.11898243427276611;-0.42128700047967904;-0.46203678944163284
Cubitus varus;Increased variability in muscle fiber diameter;0.7714638710021973;0.82016903;0.5733939047482135;0.5575550845417451;0.7712186293488323;0.00024524165336492487;0.048950402271193294;-0.19782472460061884;-0.21366354480708727
Cubitus varus;Widened proximal tibial metaphyses;0.8339636474847794;0.95163876;0.5530969087588509;0.5153998658805067;0.7527521012230838;0.08121154626169558;0.19888665695944185;-0.1996551924642329;-0.2373522353425771
Cubitus varus;Wide anterior fontanel;0.9731480628252029;0.9726814;0.5085482645301124;0.5086968673637611;0.6617971500655027;0.3113509127597003;0.31088425309459256;-0.1532488855353903;-0.15310028270174159
Cubitus varus;Increased circulating oleate level;0.879011295735836;1.0051178;0.5386064829637285;0.4983709631268701;1.0;-0.12098870426416397;0.00511777400970459;-0.4613935170362715;-0.5016290368731299
Cubitus varus;Lozenge-shaped umbilicus;0.968350924551487;0.944951;0.5100758961918501;0.5175315025990062;0.9999134918687169;-0.03156256731722995;-0.054962494039279663;-0.4898375956768668;-0.48238198926971076
Cubitus varus;Anti-myelin-associated glycoprotein antibody positivity;1.0709886997938156;1.1016717;0.47738457317664806;0.4675808952510453;1.0;0.07098869979381561;0.10167169570922852;-0.5226154268233519;-0.5324191047489547
Cubitus varus;Fractured radius;0.7860001027584076;0.8679563;0.5686492227609494;0.542153937562112;0.660589513309896;0.12541058944851158;0.20736676739841697;-0.09194029054894659;-0.11843557574778396
Cubitus varus;Abnormal manual kinetic perimetry test;0.7910569608211517;0.86281353;0.5670023268838537;0.5438059495886184;1.0;-0.20894303917884827;-0.1371864676475525;-0.43299767311614634;-0.4561940504113816
Cubitus varus;Small radial epiphyses;0.8172634392976761;0.75676775;0.5584955415239012;0.5782077131501699;1.0;-0.1827365607023239;-0.24323225021362305;-0.44150445847609876;-0.42179228684983006
Cubitus varus;Generalized keratosis follicularis;0.9520491808652878;1.1451519;0.515269074913398;0.4536329193634392;0.9999201345566091;-0.04787095369132133;0.14523171900479226;-0.4846510596432111;-0.5462872151931699
Cubitus varus;Hypoplasia of the calcaneus;0.5351278781890869;0.73845595;0.6538997017078406;0.584231668205595;0.7321876298591573;-0.1970597516700704;0.006268321354679363;-0.07828792815131669;-0.14795596165356228
Cubitus varus;2-hydroxyadipic aciduria;0.8289395272731781;0.84887207;0.554719349422208;0.5482905425515656;1.0;-0.1710604727268219;-0.15112793445587158;-0.445280650577792;-0.4517094574484344
Cubitus varus;Potter facies;0.8835482448339462;0.8933884;0.5371520397091127;0.5340001385643904;0.9998981869165328;-0.11634994208258653;-0.1065097963754561;-0.46274614720742;-0.4658980483521423
Cubitus varus;Increased heart rate variability;0.8051973134279251;0.971415;0.5624066518041664;0.5091001365582227;0.9999201345566091;-0.194722821128684;-0.028505151284056618;-0.43751348275244273;-0.4908199979983864
Cubitus varus;Aplastic zygomatic arch;0.9290944784879684;1.0406047;0.522588883466768;0.48707155305825;0.8072246192530101;0.1218698592349583;0.2333800913259083;-0.28463573578624213;-0.32015306619476014
Cubitus varus;Testicular torsion;0.7569263279438019;0.8375209;0.5781556792546569;0.5519490136895975;0.9999201345566091;-0.24299380661280723;-0.16239923716815086;-0.42176445530195217;-0.44797112086701163
Cubitus varus;Abolished vibration sense;0.8689446747303009;0.77880836;0.5418365542851367;0.5709946265486097;0.9999134918687169;-0.13096881713841602;-0.22110513653729602;-0.45807693758358026;-0.42891886532010726
Cubitus varus;Fractured metatarsal bone of digit 5;0.8729465305805206;1.047981;0.5405519808715862;0.4847212805728479;1.0;-0.12705346941947937;0.04798102378845215;-0.4594480191284138;-0.5152787194271521
Cubitus varus;Prolonged G2 phase of cell cycle;0.8989309668540955;0.9752267;0.5322262970681002;0.5078864001313833;0.9999056439461368;-0.10097467709204133;-0.02467894364019807;-0.4676793468780366;-0.4920192438147535
Cubitus varus;Single naris;0.9783151391893625;1.052931;0.5069030466555823;0.48314366107310125;0.9999056439461368;-0.021590504756774265;0.05302530717233245;-0.4930025972905545;-0.5167619828730355
Cubitus varus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.92275320738554;1.0664829;0.5246129371171887;0.47882221470065445;1.0;-0.07724679261445999;0.06648290157318115;-0.4753870628828113;-0.5211777852993456
Cubitus varus;Asymmetry of the thorax;0.7451375126838684;0.6733367;0.5820302057446869;0.6059243163093306;0.789736248610815;-0.04459873592694663;-0.11639956390698813;-0.20770604286612815;-0.1838119323014844
Cubitus varus;Type 2 muscle fiber predominance;0.920063205063343;0.8729814;0.5254718484294697;0.5405407815924204;0.8527273749847077;0.0673358300786353;0.02025405411532888;-0.32725552655523804;-0.3121865933922874
Cubitus varus;Dependency on parenteral nutrition;0.9705879166722298;1.0920231;0.5093635072434075;0.47066663356769267;0.9999134918687169;-0.029325575196487152;0.09210964236285046;-0.4905499846253094;-0.5292468583010242
Cubitus varus;Limited shoulder flexion;0.7909766733646393;0.5633732;0.5670284602190518;0.6438269690661539;1.0;-0.20902332663536072;-0.4366267919540405;-0.43297153978094816;-0.3561730309338461
Cubitus varus;Paroxysmal vertigo;0.7495976686477661;0.79133177;0.5805628963995728;0.5669128813977307;0.9999134918687169;-0.2503158232209508;-0.20858172383282825;-0.4193505954691441;-0.43300061047098626
Cubitus varus;Long hallux;0.7514086067676544;0.9674312;0.5799676319138232;0.510368802657951;0.6396520543512125;0.11175655241644189;0.3277791332784872;-0.05968442243738936;-0.1292832516932615
Cubitus varus;Broad medial eyebrow;0.9360752403736115;1.0100719;0.5203617666862098;0.4967939646833146;0.9999201345566091;-0.06384489418299766;0.010151739108246849;-0.4795583678703993;-0.5031261698732945
Cubitus varus;Myxoid subcutaneous tumors;0.9873780319467187;1.1265088;0.5040178039013917;0.4596227833493327;0.9999201345566091;-0.012542102609890415;0.12658869742123513;-0.4959023306552174;-0.5402973512072764
Cubitus varus;Bulbous tips of toes;0.8577760607004166;1.0359808;0.5454253140702027;0.4885444859002147;0.7321876298591573;0.12558843084125926;0.30379319079666545;-0.18676231578895464;-0.2436431439589426
Cubitus varus;Absent internal genitalia;0.9456202760338783;0.9699622;0.5173181463140981;0.5095627682376709;1.0;-0.054379723966121674;-0.03003782033920288;-0.4826818536859019;-0.4904372317623291
Cubitus varus;Hyperphalangy of the 2nd finger;0.8892744481563568;0.8994658;0.5353174562873216;0.5320551830393836;0.660589513309896;0.2286849348464608;0.23887628602176902;-0.12527205702257438;-0.12853433027051242
Cubitus varus;Renal interstitial hemosiderin;0.9579039886593819;1.048505;0.513403537245064;0.4845543204579824;1.0;-0.042096011340618134;0.04850494861602783;-0.48659646275493595;-0.5154456795420176
Cubitus varus;Abnormality of depressor anguli oris muscle;0.7832955121994019;0.7056835;0.5695308060654543;0.5950919694060127;1.0;-0.21670448780059814;-0.29431647062301636;-0.43046919393454575;-0.4049080305939873
Cubitus varus;Paroxysmal dyspnea;0.8469446003437042;0.9249394;0.5489112954805114;0.5239150302483726;1.0;-0.15305539965629578;-0.07506060600280762;-0.45108870451948857;-0.4760849697516274
Cubitus varus;Phenylpyruvic acidemia;0.8237238079309464;0.87418914;0.5564051841833824;0.5401532419662582;0.9999201345566091;-0.17619632662566276;-0.12573099614413352;-0.44351495037322675;-0.45976689259035086
Cubitus varus;Lateral ventricle dilatation;0.7430521249771118;0.869796;0.5827168700496922;0.5415632292053973;0.9998579617208769;-0.2568058367437651;-0.1300619836515715;-0.41714109167118474;-0.4582947325154796
Cubitus varus;Neonatal unconjugated hyperbilirubinemia;0.9278053641319275;0.9107772;0.5230002757345378;0.5284383103329084;0.9999201345566091;-0.07211477042468162;-0.08914292336733909;-0.47691985882207133;-0.47148182422370066
Cubitus varus;High maternal circulating alpha-fetoprotein concentration;1.046384297311306;1.1026648;0.4852301201297663;0.4672630845385938;1.0;0.046384297311306;0.10266482830047607;-0.5147698798702337;-0.5327369154614062
Cubitus varus;Prominent nasolabial fold;0.9139592126011848;1.0698719;0.5274215381682559;0.47774093391793016;0.9998944404568447;-0.08593522785565988;0.06997746200897559;-0.47247290228858885;-0.5221535065389146
Cubitus varus;Abnormality of inferior alveolar nerve;0.9257736578583717;1.0796323;0.5236487281554222;0.4746253766786722;1.0;-0.07422634214162827;0.07963228225708008;-0.4763512718445778;-0.5253746233213278
Cubitus varus;Unilateral conductive hearing impairment;0.8992099389433861;1.0000513;0.5321370417181016;0.4999836792866871;0.9999201345566091;-0.10071019561322303;0.0001311254378977278;-0.4677830928385075;-0.49993645526992203
Cubitus varus;Macular hypopigmented whorls, streaks, and patches;0.9811846278607845;1.1517757;0.5059894723966615;0.451500855321898;0.9999201345566091;-0.018735506695824578;0.15185558317868142;-0.49393066215994763;-0.5484192792347111
Cubitus varus;Delayed ossification of pubic rami;0.7788305431604385;0.89340824;0.5709873894442233;0.5339937844323439;0.8072246192530101;-0.028394076092571607;0.08618361963477672;-0.2362372298087868;-0.27323083482066624
Cubitus varus;Hyperphenylalaninemia;0.9526230506598949;0.9565344;0.5150861986303807;0.5138399032492857;0.9999028053808913;-0.047279754720996325;-0.043368419699738925;-0.4848166067505105;-0.4860629021316055
Cubitus varus;Ureteropelvic junction obstruction;0.7661173790693283;0.9220564;0.5751431459008872;0.5248354183078197;0.9998847295244674;-0.23376735045513908;-0.07782835259041587;-0.42474158362358017;-0.47504931121664773
Cubitus varus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.74639493227005;0.9923381;0.5816163587705163;0.5024388674140818;1.0;-0.25360506772994995;-0.007661879062652588;-0.4183836412294837;-0.49756113258591816
Cubitus varus;Difficulty walking;0.8801597580313683;0.9770832;0.5382382365705118;0.5072952783116367;0.7552776988623575;0.12488205916901074;0.2218055073144003;-0.21703946229184568;-0.24798242055072084
Cubitus varus;Bilobate gallbladder;0.8697137534618378;0.87652314;0.5415896317556113;0.5394044676518832;0.9999134918687169;-0.13019973840687915;-0.12339035477612659;-0.45832386011310566;-0.4605090242168337
Cubitus varus;Histidinuria;1.003885630518198;1.0218115;0.4987631622796652;0.4930566522181875;0.9999090677057578;0.0039765628124401875;0.021902417584769518;-0.5011459054260926;-0.5068524154875703
Cubitus varus;Widened interpedicular distance;0.7478605806827545;0.56531346;0.5811341566123003;0.6431408211903968;1.0;-0.2521394193172455;-0.434686541557312;-0.4188658433876997;-0.35685917880960316
Nasal regurgitation;Moon facies;0.9609622918069363;0.8457285;0.5124292467258695;0.5493030492423973;0.9999567459343585;-0.038994454127422196;-0.15422822935568414;-0.4875274992084889;-0.4506536966919612
Nasal regurgitation;Intestinal pseudo-obstruction;0.7554076313972473;0.75664115;0.5786541403760417;0.5782492596468704;0.7763545580080901;-0.020946926610842742;-0.019713408487216033;-0.19770041763204838;-0.1981052983612197
Nasal regurgitation;Bilateral renal atrophy;0.6874585449695587;0.887866;0.60118031837451;0.5357685823403948;0.9999584729108851;-0.3124999279413264;-0.11209245270824841;-0.3987781545363751;-0.4641898905704903
Nasal regurgitation;Fractured left clavicle;0.8281870186328888;0.8711418;0.5549624798825121;0.5411312134084967;0.9999134918687169;-0.17172647323582813;-0.12877170052502795;-0.4449510119862048;-0.45878227846022024
Nasal regurgitation;Positive urine norcotinine test;0.7175281643867493;0.80769503;0.5911543729449196;0.5615962885526888;0.9999134918687169;-0.28238532748196765;-0.19221846070264026;-0.40875911892379735;-0.4383172033160281
Nasal regurgitation;Long fibula;0.9144602864980698;1.1540312;0.5272614511860128;0.45077438390199476;0.9999548690865008;-0.08549458258843101;0.15407628840709053;-0.472693417900488;-0.549180485184506
Nasal regurgitation;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9377492591738701;1.1540892;0.5198278463111888;0.45075566196035477;0.9999134918687169;-0.06216423269484683;0.15417572054888562;-0.4800856455575281;-0.5491578299083621
Nasal regurgitation;Type II cryptotia;0.9214946925640106;0.9757504;0.5250147551556174;0.5077196424219568;0.9999134918687169;-0.0784187993047063;-0.024163105153781617;-0.47489873671309957;-0.49219384944676015
Nasal regurgitation;Increased variability in muscle fiber diameter;0.938579086214304;1.0535938;0.5195631977037041;0.48293238303054176;0.9999445057306702;-0.061365419516366204;0.05364924903770141;-0.4803813080269661;-0.5170121227001284
Nasal regurgitation;Widened proximal tibial metaphyses;0.9473551586270332;1.1547153;0.5167651235875201;0.4505539581381083;0.9999584729108851;-0.0526033142838519;0.1547568266954381;-0.483193349323365;-0.5494045147727769
Nasal regurgitation;Wide anterior fontanel;0.9000273793935776;0.7206889;0.5318755214044941;0.590106080780034;0.9999448992541466;-0.09991751986056907;-0.27925601976424796;-0.4680693778496525;-0.40983881847411263
Nasal regurgitation;Increased circulating oleate level;0.9572862647473812;1.1759655;0.5136003419003867;0.44369525759962036;0.9999134918687169;-0.04262722712133571;0.1760520556929286;-0.4863131499683302;-0.5562182342690966
Nasal regurgitation;Lozenge-shaped umbilicus;0.907449409365654;0.9275937;0.529501987734349;0.5230678295001259;0.8526023716255289;0.054847037740125115;0.0749913364128012;-0.3231003838911799;-0.329534542125403
Nasal regurgitation;Anti-myelin-associated glycoprotein antibody positivity;0.8831801265478134;1.0152297;0.5372700206488159;0.4951520537996835;0.9999134918687169;-0.1167333653209035;0.01531621012713269;-0.462643471219901;-0.5047614380690334
Nasal regurgitation;Fractured radius;0.8278721868991852;1.0927303;0.5550642094920398;0.4704405480842012;0.9999584729108851;-0.17208628601169995;0.09277181082629748;-0.4448942634188453;-0.5295179248266839
Nasal regurgitation;Abnormal manual kinetic perimetry test;0.8600610792636871;1.0947596;0.5446906215013663;0.46979176606853945;0.9999134918687169;-0.13985241260502979;0.09484609160448865;-0.45522287036735065;-0.5301217258001775
Nasal regurgitation;Small radial epiphyses;0.9027584940195084;1.0805861;0.5310019228095127;0.47432079348406553;0.9999134918687169;-0.09715499784920856;0.08067258391405896;-0.46891156905920417;-0.5255926983846514
Nasal regurgitation;Generalized keratosis follicularis;0.9250525534152985;1.0176178;0.5238789039843044;0.49439177473437146;0.9999584729108851;-0.07490591949558667;0.017659348782535278;-0.47607956892658077;-0.5055666981765137
Nasal regurgitation;Hypoplasia of the calcaneus;0.8555844128131866;1.0034727;0.546130214496821;0.4988946223746098;0.9999567459343585;-0.14437233312117181;0.003515939879545349;-0.4538265314375375;-0.5010621235597487
Nasal regurgitation;2-hydroxyadipic aciduria;0.8792865872383118;0.9209291;0.5385182079583053;0.5251953584735802;0.9999134918687169;-0.12062690463040515;-0.07898441758130237;-0.4613952839104116;-0.4747181333951367
Nasal regurgitation;Potter facies;0.9649856984615326;0.8399168;0.5111476769736945;0.5511762493041137;0.9999532306564473;-0.03496753219491466;-0.16003640536195263;-0.4888055536827528;-0.44877698135233357
Nasal regurgitation;Increased heart rate variability;0.8192020654678345;0.87672716;0.5578680037518869;0.5393390263456399;0.9999584729108851;-0.18075640744305066;-0.12323130911922864;-0.4420904691589982;-0.4606194465652452
Nasal regurgitation;Aplastic zygomatic arch;0.7706775367259979;0.65133065;0.5736510312243137;0.6133663789371187;0.9999567459343585;-0.22927920920836053;-0.3486260960816058;-0.42630571471004475;-0.3865903669972398
Nasal regurgitation;Testicular torsion;0.8493302017450333;1.0762875;0.5481430240643533;0.4756933021360087;0.9999584729108851;-0.15062827116585187;0.07632903509997913;-0.4518154488465318;-0.5242651707748764
Nasal regurgitation;Abolished vibration sense;0.7642599940299988;0.81655264;0.5757513755378001;0.5587256770610385;0.9999567459343585;-0.23569675190435968;-0.1834041069267901;-0.42420537039655837;-0.44123106887332
Nasal regurgitation;Fractured metatarsal bone of digit 5;0.995889451354742;1.1584195;0.5013084319561201;0.4493601733703746;0.9999134918687169;-0.004024040513974869;0.15850599799181775;-0.49860505991259685;-0.5505533184983423
Nasal regurgitation;Prolonged G2 phase of cell cycle;0.9910484068095684;1.069202;0.5028494186649448;0.4779547359705052;0.9999548690865008;-0.00890646227693237;0.06924707717204415;-0.49710545042155596;-0.5220001331159956
Nasal regurgitation;Single naris;0.8222922384738922;0.7339581;0.5568681765252472;0.5857159464453567;0.9999548690865008;-0.17766263061260856;-0.26599674397205986;-0.44308669256125355;-0.41423892264114404
Nasal regurgitation;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8854065164923668;1.0433202;0.5365565464624701;0.4862064540783412;0.9999134918687169;-0.11450697537635013;0.043406687116878784;-0.46335694540624683;-0.5137070377903757
Nasal regurgitation;Asymmetry of the thorax;0.7687200903892517;0.7215757;0.5742913171382387;0.5898121435992728;0.9999548690865008;-0.23123477869724907;-0.27837919169163383;-0.4256635519482621;-0.41014272548722797
Nasal regurgitation;Type 2 muscle fiber predominance;0.9766794014722109;1.0612217;0.5074238500773716;0.4805003097627032;0.9999536937290383;-0.023274292256827422;0.061268025059108666;-0.49252984365166674;-0.5194533839663351
Nasal regurgitation;Dependency on parenteral nutrition;0.8499597907066345;0.9251646;0.5479403152911866;0.5238431419025172;0.7017107679063793;0.1482490228002552;0.2234538124387745;-0.15377045261519273;-0.17786762600386208
Nasal regurgitation;Limited shoulder flexion;0.826345682144165;0.99586546;0.555557540190526;0.501316062326475;0.9999134918687169;-0.17356780972455188;-0.0040480276582066654;-0.444355951678191;-0.49859742954224195
Nasal regurgitation;Paroxysmal vertigo;0.5927596688270569;0.82185495;0.6335088567199317;0.5570096367447321;0.9999567459343585;-0.4071970771073016;-0.1781017969368609;-0.3664478892144267;-0.4429471091896263
Nasal regurgitation;Long hallux;0.9485758990049362;1.1579875;0.5163760227132559;0.44949943691457495;0.9999503740898522;-0.051374475084915994;0.15803710130535042;-0.4835743513765963;-0.5504509371752773
Nasal regurgitation;Broad medial eyebrow;0.9753031060099602;1.0156566;0.5078620648800427;0.4950161429139833;0.9999584729108851;-0.024655366900924958;0.015698117550845825;-0.4920964080308424;-0.5049423299969018
Nasal regurgitation;Myxoid subcutaneous tumors;0.9499163590371609;1.011213;0.515948790380145;0.49643074522728137;0.9999584729108851;-0.05004211387372426;0.011254472073550903;-0.48400968253074017;-0.5035277276836038
Nasal regurgitation;Bulbous tips of toes;0.9806615523993969;1.163743;0.5061560027944778;0.44764323212262425;0.9999567459343585;-0.019295193534961563;0.16378627316964545;-0.49380074313988065;-0.5523135138117342
Nasal regurgitation;Absent internal genitalia;0.762420117855072;0.7856806;0.5763541496973397;0.5687533370213618;0.9999134918687169;-0.2374933740136449;-0.2142328998086278;-0.42355934217137725;-0.43116015484735515
Nasal regurgitation;Hyperphalangy of the 2nd finger;0.9501711279153824;1.0950975;0.515867593545472;0.4696837049657794;0.9999584729108851;-0.04978734499550275;0.0951390688981969;-0.4840908793654132;-0.5302747679451058
Nasal regurgitation;Renal interstitial hemosiderin;0.7541157603263855;0.96310264;0.5790783086453869;0.5117474578670379;0.9999134918687169;-0.24579773154233142;-0.036810853147250855;-0.42083518322333;-0.488166034001679
Nasal regurgitation;Abnormality of depressor anguli oris muscle;0.7694046795368195;0.7144548;0.5740673515262457;0.5921746599106142;0.9999134918687169;-0.23050881233189746;-0.28545866217587634;-0.42584614034247126;-0.4077388319581027
Nasal regurgitation;Paroxysmal dyspnea;0.6023762822151184;0.47820187;0.6301650522735653;0.6747385790471458;0.9999134918687169;-0.3975372096535985;-0.5217116257188146;-0.3697484395951516;-0.32517491282157107
Nasal regurgitation;Phenylpyruvic acidemia;0.8517637848854065;0.8711451;0.5473595914176106;0.5411301420025754;0.9999584729108851;-0.14819468802547864;-0.12881334370708875;-0.45259888149327454;-0.45882833090830977
Nasal regurgitation;Lateral ventricle dilatation;0.7306296825408936;0.7772826;0.5868155584257003;0.5714927245366953;0.9999462364511621;-0.26931655391026854;-0.22266364081670165;-0.4131306780254618;-0.4284535119144668
Nasal regurgitation;Neonatal unconjugated hyperbilirubinemia;0.8195666074752808;0.87288105;0.5577500261370856;0.5405729832425578;0.9999584729108851;-0.18039186543560437;-0.12707741803265027;-0.44220844677379956;-0.4593854896683274
Nasal regurgitation;High maternal circulating alpha-fetoprotein concentration;0.9761197827756405;0.9494494;0.5076020318720056;0.5160976161490083;0.9999134918687169;-0.02379370909307643;-0.05046407189343616;-0.49231145999671133;-0.48381587571970863
Nasal regurgitation;Prominent nasolabial fold;0.6185770630836487;0.48852193;0.6245658362767819;0.6709018513823607;0.9999524555142131;-0.3813753924305644;-0.51143052195861;-0.3753866192374312;-0.3290506041318524
Nasal regurgitation;Abnormality of inferior alveolar nerve;0.7587745934724808;0.7874274;0.5775493118214221;0.568184201033124;0.9999134918687169;-0.24113889839623615;-0.21248606648419543;-0.4223641800472948;-0.43172929083559297
Nasal regurgitation;Unilateral conductive hearing impairment;0.7209732532501221;1.00778;0.5900118139397212;0.4975235538638553;0.9999584729108851;-0.27898521966076306;0.007821482953067505;-0.4099466589711639;-0.5024349190470299
Nasal regurgitation;Macular hypopigmented whorls, streaks, and patches;0.8948554843664169;1.0054802;0.5335305154726999;0.49825558882058996;0.9999584729108851;-0.1051029885444682;0.005521697339053833;-0.4664279574381852;-0.5017028840902952
Nasal regurgitation;Delayed ossification of pubic rami;0.8486350327730179;0.98284227;0.5483668704963011;0.5054617501092881;0.9999567459343585;-0.15132171316134058;-0.01711447937475763;-0.4515898754380574;-0.4944949958250704
Nasal regurgitation;Hyperphenylalaninemia;0.8379695117473602;0.9355785;0.551804292848286;0.5205201955223756;0.9999542297279059;-0.1619847179805457;-0.0643757046615302;-0.4481499368796199;-0.4794340342055303
Nasal regurgitation;Ureteropelvic junction obstruction;0.540306031703949;0.87643296;0.6520408977793135;0.5394333997287966;0.9999505803237132;-0.4596445486197642;-0.12351762505866803;-0.3479096825443997;-0.46051718059491664
Nasal regurgitation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9737408794462681;1.1678662;0.5083594985659119;0.44631235107588885;0.9999134918687169;-0.026172612422448838;0.1679527381422694;-0.491553993302805;-0.5536011407928281
Nasal regurgitation;Difficulty walking;0.7960612028837204;0.90878356;0.565374357210152;0.5290755213785991;0.9999431787962207;-0.20388197591250035;-0.09115962376539799;-0.4345688215860688;-0.4708676574176216
Nasal regurgitation;Bilobate gallbladder;0.7710219621658325;0.81665885;0.573538400209585;0.5586912891295105;0.8526023716255289;-0.08158040945969636;-0.03594351714097077;-0.27906397141594386;-0.2939110824960184
Nasal regurgitation;Histidinuria;0.8445148169994354;1.0345699;0.5496940908413198;0.4889938790225812;0.9999556674707869;-0.15544085047135148;0.034614192033912805;-0.4502615766294671;-0.5109617884482057
Nasal regurgitation;Widened interpedicular distance;0.9425254166126251;1.0088404;0.5183048153454946;0.4971859728389566;0.9999134918687169;-0.0573880752560918;0.008926949835079467;-0.48160867652322237;-0.5027275190297603
Moon facies;Intestinal pseudo-obstruction;0.8780510276556015;0.9802762;0.5389144260424175;0.5062786713714623;0.9999518178785828;-0.12190079022298128;-0.019675590881207294;-0.4610373918361653;-0.49367314650712046
Moon facies;Bilateral renal atrophy;0.888859435915947;0.9301114;0.5354503792034099;0.5222643819603214;0.9999584729108851;-0.11109903699493817;-0.06984706467724255;-0.46450809370747526;-0.4776940909505637
Moon facies;Fractured left clavicle;0.9421754255890846;1.011189;0.5184164065384795;0.49643834369650874;0.9999134918687169;-0.057738066279632294;0.011275492048519409;-0.4814970853302374;-0.5034751481722082
Moon facies;Positive urine norcotinine test;0.8205980062484741;0.7907502;0.5574162754397025;0.5671021821718735;0.9999134918687169;-0.1793154856202428;-0.20916328635190173;-0.4424972164290144;-0.43281130969684345
Moon facies;Long fibula;0.9227656126022339;1.1526115;0.5246089765819083;0.45123167418646015;0.9999548690865008;-0.07718925648426689;0.15265662497783028;-0.47534589250459247;-0.5487231949000406
Moon facies;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9788572061806917;1.0764718;0.5067304617970487;0.4756344784225016;0.9999134918687169;-0.0210562856880252;0.07655831370379285;-0.4931830300716682;-0.5242790134462153
Moon facies;Type II cryptotia;0.8267284631729126;0.6502483;0.5554338216808343;0.6137340420956272;0.9999134918687169;-0.17318502869580432;-0.34966520276044055;-0.4444796701878826;-0.3861794497730897
Moon facies;Increased variability in muscle fiber diameter;0.9227092564105988;0.9270663;0.5246269690984413;0.523236150149982;0.9999445057306702;-0.07723524932007142;-0.07287817958931275;-0.47531753663222887;-0.47670835558068814
Moon facies;Widened proximal tibial metaphyses;0.7843048274517059;1.0802513;0.5692017485306291;0.4744277144504332;0.9999584729108851;-0.2156536454591792;0.08029286318683215;-0.43075672438025603;-0.5255307584604519
Moon facies;Wide anterior fontanel;0.8198949992656708;0.7542659;0.5576437547725348;0.579029008419347;0.8751074957066792;-0.05521249644100845;-0.12084159128010452;-0.3174637409341444;-0.2960784872873322
Moon facies;Increased circulating oleate level;0.8545058071613312;0.94010925;0.5464772102342877;0.5190752224872841;0.9999134918687169;-0.14540768470738574;-0.05980423893902942;-0.4534362816344292;-0.4808382693814328
Moon facies;Lozenge-shaped umbilicus;0.9709804281592369;1.0446345;0.5092385135993857;0.48578769270782574;0.9999567459343585;-0.02897631777512155;0.04467771546853461;-0.4907182323349728;-0.5141690532265327
Moon facies;Anti-myelin-associated glycoprotein antibody positivity;1.0053621707484126;0.99894917;0.4982931598598812;0.500334490640986;0.9999134918687169;0.00544867887969569;-0.0009643217561070561;-0.5016203320088357;-0.4995790012277309
Moon facies;Fractured radius;0.9670461639761925;1.0953571;0.5104914312495525;0.46960070620913674;0.9999584729108851;-0.03291230893469266;0.09539858752154895;-0.4894670416613326;-0.5303577667017484
Moon facies;Abnormal manual kinetic perimetry test;0.9777669813483953;0.92176306;0.507077572800634;0.5249290596665521;0.9999134918687169;-0.022146510520321572;-0.0781504293916051;-0.4928359190680829;-0.4749844322021648
Moon facies;Small radial epiphyses;0.8480687141418457;1.0020367;0.5485492445573412;0.4993516963163295;0.9999134918687169;-0.15184477772687122;0.0021231988432581783;-0.4513642473113757;-0.5005617955523874
Moon facies;Generalized keratosis follicularis;0.8688384890556335;0.7636919;0.5418706485355149;0.5759374671491994;0.9999584729108851;-0.1311199838552516;-0.2362665707502406;-0.4580878243753702;-0.4240210057616858
Moon facies;Hypoplasia of the calcaneus;0.9624407291412354;1.0406516;0.5119582999500896;0.48705662103492364;0.9999567459343585;-0.03751601679312311;0.040694813895353454;-0.4879984459842689;-0.5129001248994348
Moon facies;2-hydroxyadipic aciduria;0.8561698943376541;0.87149227;0.5459418837263041;0.5410187087771947;0.9999134918687169;-0.1437435975310628;-0.12842122521374866;-0.4539716081424128;-0.4588947830915222
Moon facies;Potter facies;0.6369671821594238;0.406084;0.6182587166342892;0.702418859123393;0.7002474829854209;-0.06328030082599712;-0.2941634819211204;-0.08198876635113173;0.0021713761379720253
Moon facies;Increased heart rate variability;0.901738241314888;0.92251813;0.5313282421415432;0.5246879786841281;0.9999584729108851;-0.09822023159599713;-0.07744033879375867;-0.46863023076934196;-0.47527049422675705
Moon facies;Aplastic zygomatic arch;0.8367892503738403;0.74084675;0.5521850501211525;0.5834434708412357;0.8846475303342614;-0.047858279960421024;-0.143800777213839;-0.33246248021310887;-0.30120405949302564
Moon facies;Testicular torsion;0.816670373082161;0.96689314;0.5586875642541527;0.5105401751196459;0.9999584729108851;-0.18328809982872418;-0.033065336409572876;-0.44127090865673246;-0.48941829779123924
Moon facies;Abolished vibration sense;0.9101852923631668;0.852122;0.5286274858351137;0.5472442944944464;0.9999567459343585;-0.08977145357119165;-0.14783473713385187;-0.4713292600992448;-0.452712451439912
Moon facies;Fractured metatarsal bone of digit 5;1.0032154428772628;1.0445538;0.49897649098001373;0.4858134168852738;0.9999134918687169;0.0033019510085459114;0.04464026484515027;-0.5009370008887032;-0.5141000749834431
Moon facies;Prolonged G2 phase of cell cycle;0.8976615518331528;0.9611495;0.5326324705660322;0.5123696092695447;0.9999548690865008;-0.102293317253348;-0.03880535536503471;-0.46732239852046853;-0.4875852598169561
Moon facies;Single naris;0.8452888578176498;0.620265;0.5494446879816739;0.6239848249018771;0.8796422427997362;-0.0343533849820864;-0.25937723578069327;-0.33019755481806234;-0.2556574178978591
Moon facies;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8079661428928375;0.71244794;0.5615083423612104;0.5928414331401728;0.9999134918687169;-0.1919473489758794;-0.28746555056546375;-0.43840514950750653;-0.40707205872854413
Moon facies;Asymmetry of the thorax;0.8308020085096359;0.806254;0.5541177326213558;0.5620637555651272;0.9999548690865008;-0.16915286057686485;-0.19370083981251396;-0.445837136465145;-0.43789111352137355
Moon facies;Type 2 muscle fiber predominance;0.8907213509082794;0.93554616;0.5348540807330053;0.5205305215561945;0.9999536937290383;-0.10923234282075889;-0.06440753398477561;-0.465099612996033;-0.4794231721728438
Moon facies;Dependency on parenteral nutrition;0.8174386918544769;0.94861186;0.5584388024488596;0.5163645527516183;0.9999567459343585;-0.18251805407988153;-0.05134489042746149;-0.4415179434854989;-0.48359219318274016
Moon facies;Limited shoulder flexion;0.9480075240135193;0.9540551;0.5165571844469806;0.5146298694294338;0.9999134918687169;-0.05190596785519763;-0.045858420991641724;-0.4833563074217363;-0.48528362243928314
Moon facies;Paroxysmal vertigo;0.9353922009468079;1.0145382;0.5205796352737094;0.4953721786621811;0.9999567459343585;-0.0645645449875506;0.014581422972807068;-0.47937711066064903;-0.5045845672721774
Moon facies;Long hallux;0.8624395877122879;0.9806483;0.5439261239419739;0.50616022502096;0.9999503740898522;-0.1375107863775643;-0.019302094899788735;-0.4560242501478783;-0.4937901490688922
Moon facies;Broad medial eyebrow;0.7823008000850677;0.64234936;0.5698551765714055;0.6164221308670441;0.8892531322460213;-0.10695233216095357;-0.24690376987266927;-0.3193979556746158;-0.2728310013789772
Moon facies;Myxoid subcutaneous tumors;0.8758306503295898;0.90961176;0.539626607300727;0.5288107895588777;0.9999584729108851;-0.12412782258129529;-0.09034671134090833;-0.46033186561015815;-0.4711476833520074
Moon facies;Bulbous tips of toes;0.790025532245636;0.87184536;0.5673380888592849;0.5409053819043661;0.9999567459343585;-0.20993121368872247;-0.12811138136374078;-0.4326186570750735;-0.45905136402999236
Moon facies;Absent internal genitalia;0.8910910487174988;0.7633911;0.5347356956787537;0.5760360124527026;0.9999134918687169;-0.10882244315121814;-0.23652241435025378;-0.46517779618996324;-0.4238774794160143
Moon facies;Hyperphalangy of the 2nd finger;0.944869838654995;0.9919064;0.5175573768446038;0.5025762966271751;0.9999584729108851;-0.05508863425589017;-0.008052068415645874;-0.48240109606628134;-0.49738217628371006
Moon facies;Renal interstitial hemosiderin;0.9602613262832165;0.96075726;0.5126525442689824;0.5124945594679953;0.9999134918687169;-0.03965216558550044;-0.0391562363145177;-0.4872609475997345;-0.48741893240072165
Moon facies;Abnormality of depressor anguli oris muscle;0.9659211784601212;0.827194;0.5108497265811568;0.5552833846652011;0.7692950606685226;0.19662611779159855;0.0578989147800858;-0.2584453340873658;-0.2140116760033215
Moon facies;Paroxysmal dyspnea;1.0095136789605021;0.9830123;0.4969716562491122;0.5054076064467602;0.9999134918687169;0.009600187091785228;-0.0169011732575719;-0.5029418356196047;-0.4945058854219567
Moon facies;Phenylpyruvic acidemia;0.9999863104894757;1.0349133;0.500004357506537;0.4888844896430311;0.9999584729108851;2.783757859059488e-05;0.034954828557010376;-0.4999541154043481;-0.511073983267854
Moon facies;Lateral ventricle dilatation;0.9469606354832649;0.96724284;0.5168908799019821;0.510428795666454;0.9999462364511621;-0.05298560096789717;-0.03270339949895262;-0.48305535654917997;-0.48951744078470805
Moon facies;Neonatal unconjugated hyperbilirubinemia;0.9509825371205807;1.1511878;0.5156089979442551;0.451690201784809;0.9999584729108851;-0.04897593579030446;0.15122930460834094;-0.48434947496663006;-0.5482682711260761
Moon facies;High maternal circulating alpha-fetoprotein concentration;0.867686927318573;0.8762538;0.5422404247666133;0.5394908753012604;0.9999134918687169;-0.13222656455014392;-0.12365970816586658;-0.45767306710210365;-0.46042261656745653
Moon facies;Prominent nasolabial fold;0.6617944836616516;0.61033756;0.6098199004773757;0.6274083186197885;0.8732055871936235;-0.2114111035319719;-0.26286803178514573;-0.26338568671624785;-0.245797268573835
Moon facies;Abnormality of inferior alveolar nerve;0.9418290853500366;0.7964385;0.518526835945375;0.5652516815972082;0.9999134918687169;-0.0580844065186803;-0.2034749766824071;-0.48138665592334196;-0.43466181027150874
Moon facies;Unilateral conductive hearing impairment;1.079707145690918;1.1884006;0.4746014851936068;0.439669669286993;0.9999584729108851;0.07974867278003284;0.18844215327167102;-0.5253569877172783;-0.5602888036238921
Moon facies;Macular hypopigmented whorls, streaks, and patches;0.8222928643226624;0.62404287;0.5568679740892966;0.6226860097528881;0.9999584729108851;-0.17766560858822278;-0.37591560429668835;-0.4430904988215886;-0.377272463157997
Moon facies;Delayed ossification of pubic rami;0.8290472477674484;0.874686;0.5546845482992373;0.5399938186764941;0.9999567459343585;-0.17090949816691003;-0.12527074320303522;-0.44527219763512116;-0.45996292725786436
Moon facies;Hyperphenylalaninemia;0.8814725205302238;0.9475128;0.5378173714148891;0.5167148806929042;0.9999542297279059;-0.11848170919768208;-0.052441424266022385;-0.4621368583130169;-0.48323934903500176
Moon facies;Ureteropelvic junction obstruction;1.0042352080345154;1.0737847;0.49865188738236843;0.4764922393479719;0.9999505803237132;0.00428462771080218;0.0738341286530324;-0.5012986929413448;-0.5234583409757413
Moon facies;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8729165494441986;1.0336843;0.5405616021542832;0.48927594872247004;0.9999134918687169;-0.1269969424245183;0.033770761823910034;-0.45935188971443375;-0.5106375431462469
Moon facies;Difficulty walking;1.0141816241666675;0.91532326;0.49548569749871907;0.5269857587013425;0.9999431787962207;0.014238445370446717;-0.08461992134993168;-0.5044574812975017;-0.4729574200948783
Moon facies;Bilobate gallbladder;0.9744038786739111;1.0892341;0.5081483883829;0.4715580561219297;0.9999567459343585;-0.025552867260447365;0.08927736775887885;-0.49180835755145846;-0.5283986898124288
Moon facies;Histidinuria;0.8740155547857285;0.96078956;0.5402089432963117;0.5124842659446533;0.9999556674707869;-0.12594011268505845;-0.03916610619911942;-0.45974672417447515;-0.48747140152613355
Moon facies;Widened interpedicular distance;0.8166607767343521;0.8827635;0.5586906715330341;0.5374035601319971;0.9999134918687169;-0.1832527151343648;-0.11714998688672229;-0.44122282033568283;-0.46250993173671984
Intestinal pseudo-obstruction;Bilateral renal atrophy;0.6965478658676147;0.92033684;0.5981392489005461;0.5253844777683259;0.9999539510871024;-0.30340608521948764;-0.07961710855017612;-0.40181470218655624;-0.4745694733187765
Intestinal pseudo-obstruction;Fractured left clavicle;0.8862470984458923;1.0161114;0.5362872197433333;0.49487137384905877;0.9998912449978579;-0.11364414655196553;0.016220128903509323;-0.4636040252545246;-0.5050198711487991
Intestinal pseudo-obstruction;Positive urine norcotinine test;0.7953661680221558;0.9960355;0.5656003598108625;0.5012619391553486;0.9998912449978579;-0.2045250769757021;-0.003855728735803421;-0.4342908851869953;-0.4986293058425093
Intestinal pseudo-obstruction;Long fibula;0.8150946497917175;0.95452607;0.5591978564461995;0.5144797958445457;0.9999494774285466;-0.18485482763682903;-0.04542341064845623;-0.4407516209823471;-0.48546968158400083
Intestinal pseudo-obstruction;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.8142853081226349;1.0595096;0.5594600185275707;0.4810463048380811;0.9998912449978579;-0.18560593687522298;0.05961838997376079;-0.4404312264702872;-0.5188449401597768
Intestinal pseudo-obstruction;Type II cryptotia;0.7734235525131226;0.9806543;0.5727533126473371;0.5061583196818249;0.9998912449978579;-0.2264676924847353;-0.019236945738672073;-0.4271379323505208;-0.49373292531603297
Intestinal pseudo-obstruction;Increased variability in muscle fiber diameter;0.7950134426355362;0.99435824;0.5657150673940277;0.5017958316781885;0.9999361236687703;-0.20492268103323408;-0.00557788211069532;-0.4342210562747426;-0.49814029199058174
Intestinal pseudo-obstruction;Widened proximal tibial metaphyses;0.8422233164310455;0.9874188;0.5504326137405668;0.5040048424103842;0.9999539510871024;-0.15773063465605686;-0.01253518029700229;-0.44952133734653554;-0.49594910867671815
Intestinal pseudo-obstruction;Wide anterior fontanel;0.9224504455924034;0.9118678;0.5247095991502385;0.5280898024518155;0.999936644490842;-0.07748619889843855;-0.08806884711611662;-0.47522704534060345;-0.4718468420390265
Intestinal pseudo-obstruction;Increased circulating oleate level;0.830765426158905;1.0599927;0.5541295475287259;0.48089227329609163;0.9998912449978579;-0.16912581883895283;0.060101426015020554;-0.44576169746913197;-0.5189989717017662
Intestinal pseudo-obstruction;Lozenge-shaped umbilicus;0.7547097951173782;0.65452677;0.578883247654262;0.6122815897105438;0.8358089506358302;-0.08109915551845193;-0.18128218052093148;-0.25692570298156814;-0.22352736092528636
Intestinal pseudo-obstruction;Anti-myelin-associated glycoprotein antibody positivity;0.7375518083572388;0.8615098;0.5845298827835514;0.5442249446902101;0.9998912449978579;-0.2623394366406191;-0.13838144504058247;-0.4153613622143064;-0.45566630030764776
Intestinal pseudo-obstruction;Fractured radius;0.84052374958992;0.95150506;0.5509805402197319;0.5154424788674257;0.9999539510871024;-0.15943020149718234;-0.048448886122807955;-0.4489734108673705;-0.4845114722196767
Intestinal pseudo-obstruction;Abnormal manual kinetic perimetry test;0.8522716462612152;1.0728198;0.5471961344598123;0.4768001891692918;0.9998912449978579;-0.14761959873664265;0.07292858398926372;-0.45269511053804556;-0.5230910558285661
Intestinal pseudo-obstruction;Small radial epiphyses;0.7805986553430557;0.953846;0.5704104084978943;0.5146965024443773;0.9998912449978579;-0.21929258965480214;-0.04604526721465474;-0.4294808364999636;-0.4851947425534806
Intestinal pseudo-obstruction;Generalized keratosis follicularis;0.8589565753936768;0.9867375;0.5450457178923022;0.5042217166562013;0.9999539510871024;-0.14099737569342563;-0.013216461386785006;-0.4549082331948002;-0.4957322344309011
Intestinal pseudo-obstruction;Hypoplasia of the calcaneus;0.8224313855171204;0.99577326;0.5568231688374314;0.5013454208349593;0.9999518178785828;-0.17752043236146242;-0.004178562053540058;-0.44312864904115135;-0.49860639704362353
Intestinal pseudo-obstruction;2-hydroxyadipic aciduria;0.6531588733196259;0.8602858;0.6127456975964356;0.5446183750073632;0.9998912449978579;-0.346732371678232;-0.13960542642104512;-0.38714554740142226;-0.45527286999049466
Intestinal pseudo-obstruction;Potter facies;0.8776758909225464;0.97318566;0.5390347365013821;0.5085363026487159;0.9999474151931498;-0.1222715242706034;-0.02676175673825476;-0.46091267869176766;-0.4914111125444339
Intestinal pseudo-obstruction;Increased heart rate variability;0.8841579854488373;1.1705631;0.5369566307215607;0.44544133969814503;0.9999539510871024;-0.11579596563826511;0.17060915068139126;-0.46299732036554164;-0.5545126113889574
Intestinal pseudo-obstruction;Aplastic zygomatic arch;0.7873284220695496;0.97067255;0.5682164424976412;0.5093365555009027;0.9999518178785828;-0.21262339580903322;-0.029279270061352558;-0.43173537538094153;-0.49061526237768005
Intestinal pseudo-obstruction;Testicular torsion;0.6467793583869934;0.9333572;0.6149135053439572;0.5212288047021931;0.9999539510871024;-0.353174592700109;-0.06659677192221591;-0.3850404457431452;-0.47872514638490926
Intestinal pseudo-obstruction;Abolished vibration sense;0.8889511376619339;1.0729138;0.5354210078169965;0.47677022268804226;0.9999518178785828;-0.11100068021664888;0.07296194802870481;-0.46453081006158625;-0.5231815951905405
Intestinal pseudo-obstruction;Fractured metatarsal bone of digit 5;0.8451470583677292;1.0014741;0.5494903747359055;0.49953077205951124;0.9998912449978579;-0.15474418663012868;0.0015828970767270967;-0.4504008702619524;-0.5003604729383466
Intestinal pseudo-obstruction;Prolonged G2 phase of cell cycle;0.8346950560808182;1.0336543;0.5528608318518295;0.4892854748854779;0.9999494774285466;-0.1652544213477284;0.033704854732403144;-0.447088645576717;-0.5106640025430687
Intestinal pseudo-obstruction;Single naris;0.9546945244073868;0.954839;0.5144261187943941;0.5143800936029433;0.9999494774285466;-0.04525495302115978;-0.04511048626338543;-0.4855233586341524;-0.4855693838256032
Intestinal pseudo-obstruction;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7434389591217041;1.0746796;0.5825894659046087;0.47620658013718975;0.9998912449978579;-0.25645228587615376;0.07478836811554546;-0.41730177909324917;-0.5236846648606681
Intestinal pseudo-obstruction;Asymmetry of the thorax;0.7391822040081024;0.88796914;0.5839921821620458;0.5357355609022489;0.9999494774285466;-0.26076727342044415;-0.11198034119044842;-0.4159572952665007;-0.4642139165262976
Intestinal pseudo-obstruction;Type 2 muscle fiber predominance;0.8420738577842712;0.9585929;0.5504807919212862;0.5131840659637472;0.999947999865749;-0.15787414208147776;-0.04135510817263377;-0.4494672079444628;-0.4867639339020018
Intestinal pseudo-obstruction;Dependency on parenteral nutrition;0.7808790057897568;0.6084301;0.5703189445127068;0.6280678847914011;0.7763545580080901;0.004524447781666718;-0.16792447044171432;-0.20603561349538324;-0.14828667321668898
Intestinal pseudo-obstruction;Limited shoulder flexion;0.7854559123516083;0.9887719;0.5688265628447425;0.5035740907562214;0.9998912449978579;-0.2144353326462496;-0.011119329562066849;-0.43106468215311533;-0.49631715424163647
Intestinal pseudo-obstruction;Paroxysmal vertigo;0.7020536065101624;1.013642;0.596301669051917;0.49565751443360306;0.9999518178785828;-0.29789821136842043;0.013690135589739971;-0.40365014882666583;-0.5042943034449797
Intestinal pseudo-obstruction;Long hallux;0.970897926017642;1.0799053;0.5092647859429473;0.4745382156037261;0.9999437764344117;-0.02904585041676966;0.07996149509573969;-0.49067899049146435;-0.5254055608306856
Intestinal pseudo-obstruction;Broad medial eyebrow;1.0782294422388077;1.1189483;0.47507332635463484;0.4620477123083184;0.9999539510871024;0.07827549115170529;0.1189943893288522;-0.5248806247324675;-0.537906238778784
Intestinal pseudo-obstruction;Myxoid subcutaneous tumors;0.6989238262176514;0.84014606;0.5973458448713223;0.5511023281679159;0.9999539510871024;-0.301030124869451;-0.1598078863288016;-0.40260810621578014;-0.44885162291918645
Intestinal pseudo-obstruction;Bulbous tips of toes;0.9397259950637817;1.069436;0.51919744755107;0.4778800479602894;0.9999518178785828;-0.060225822814801044;0.06948413621535032;-0.4807543703275128;-0.5220717699182934
Intestinal pseudo-obstruction;Absent internal genitalia;0.7979378551244736;0.86793745;0.5647642978807791;0.5421599763478493;0.9998912449978579;-0.2019533898733843;-0.1319537993572939;-0.4351269471170788;-0.45773126865000857
Intestinal pseudo-obstruction;Hyperphalangy of the 2nd finger;0.8464575409889221;1.0164188;0.5490681857547832;0.4947735018406536;0.9999539510871024;-0.15349641009818027;0.016464863572016264;-0.45088576533231917;-0.5051804492464488
Intestinal pseudo-obstruction;Renal interstitial hemosiderin;0.7263550460338593;0.85366404;0.5882293252026412;0.5467480612451994;0.9998912449978579;-0.2735361989639986;-0.14622720443236714;-0.4116619197952167;-0.4531431837526585
Intestinal pseudo-obstruction;Abnormality of depressor anguli oris muscle;0.6295453906059265;0.88293296;0.6207980941575776;0.537349239444398;0.9998912449978579;-0.37034585439193135;-0.1169582840107668;-0.3790931508402803;-0.4625420055534598
Intestinal pseudo-obstruction;Paroxysmal dyspnea;0.602763831615448;0.9126032;0.6300306184949473;0.5278547980041364;0.9998912449978579;-0.39712741338240987;-0.08728804551589375;-0.3698606265029105;-0.4720364469937215
Intestinal pseudo-obstruction;Phenylpyruvic acidemia;0.6912398338317871;1.0098095;0.5999140457263841;0.49687747913768143;0.9999539510871024;-0.3087141172553153;0.009855542931452299;-0.4000399053607183;-0.503076471949421
Intestinal pseudo-obstruction;Lateral ventricle dilatation;0.7637946009635925;0.9375749;0.5759038198283857;0.5198834473650937;0.9999384059522154;-0.23614380498862286;-0.062363482913732726;-0.4240345861238297;-0.48005495858712166
Intestinal pseudo-obstruction;Neonatal unconjugated hyperbilirubinemia;0.6656731367111206;0.8494611;0.608508944752896;0.5481008840090007;0.9999539510871024;-0.3342808143759818;-0.15049287244330356;-0.3914450063342064;-0.4518530670781017
Intestinal pseudo-obstruction;High maternal circulating alpha-fetoprotein concentration;0.8676315546035767;0.9894258;0.5422582068555095;0.5033659372626866;0.9998912449978579;-0.1322596903942812;-0.010465466608880813;-0.45763303814234835;-0.49652530773517123
Intestinal pseudo-obstruction;Prominent nasolabial fold;0.904527559876442;0.98544943;0.5304361790862;0.5046317553381446;0.9999464332748575;-0.0954188733984156;-0.014496999948136358;-0.46951025418865755;-0.4953146779367129
Intestinal pseudo-obstruction;Abnormality of inferior alveolar nerve;0.6564505100250244;0.9108729;0.6116293131594223;0.528407744412298;0.9998912449978579;-0.34344073497283345;-0.08901836835372334;-0.3882619318384356;-0.4714835005855599
Intestinal pseudo-obstruction;Unilateral conductive hearing impairment;0.851225882768631;1.0838046;0.5475327308148094;0.47329283133180755;0.9999539510871024;-0.1487280683184714;0.08385065630425503;-0.45242122027229303;-0.5266611197552948
Intestinal pseudo-obstruction;Macular hypopigmented whorls, streaks, and patches;0.7821425348520279;1.0395528;0.5699067928401972;0.48740668303887824;0.9999539510871024;-0.2178114162350745;0.039598856720819975;-0.4300471582469052;-0.5125472680482241
Intestinal pseudo-obstruction;Delayed ossification of pubic rami;0.6876720786094666;0.8948484;0.6011087665681203;0.533532776275885;0.9999518178785828;-0.31227973926911623;-0.10510341156373293;-0.3988430513104625;-0.46641904160269776
Intestinal pseudo-obstruction;Hyperphenylalaninemia;0.7849185764789581;1.0912843;0.5690016904782603;0.4709027876529692;0.9999486748218075;-0.21503009834284936;0.09133560023312415;-0.43094698434354717;-0.5290458871688383
Intestinal pseudo-obstruction;Ureteropelvic junction obstruction;0.5198923349380493;0.8192074;0.659402411245221;0.5578662917073165;0.9999440410039805;-0.48005170606593117;-0.180736670722761;-0.34054162975875946;-0.442077749296664
Intestinal pseudo-obstruction;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8602181971073151;1.0541396;0.5446401129013445;0.4827583767852661;0.9998912449978579;-0.1396730478905428;0.054248369107366745;-0.45525113209651336;-0.5171328682125917
Intestinal pseudo-obstruction;Difficulty walking;1.0007468541152775;1.1098741;0.4997622689294694;0.4649552094154501;0.999934359238598;0.0008124948766795592;0.10993977005675115;-0.5001720903091286;-0.5349791498231479
Intestinal pseudo-obstruction;Bilobate gallbladder;0.612615555524826;0.5201915;0.6266213860414853;0.6592938678131868;0.8358089506358302;-0.2231933951110041;-0.31561745998565316;-0.20918756459434484;-0.1765150828226434
Intestinal pseudo-obstruction;Histidinuria;0.7751596868038177;0.9241339;0.5721860454747909;0.5241721468867182;0.9999504758588345;-0.2247907890550167;-0.0758165790311367;-0.42776443038404355;-0.47577832897211625
Intestinal pseudo-obstruction;Widened interpedicular distance;0.803496927022934;0.98309267;0.5629585684587459;0.5053820340320467;0.9998912449978579;-0.1963943179749239;-0.016798579325555618;-0.43693267653911194;-0.49450921096581113
Bilateral renal atrophy;Fractured left clavicle;0.7992429435253143;1.0924733;0.5643401839851585;0.47052272113838345;0.9999201345566091;-0.20067719103129478;0.09255313395230202;-0.4355799505714506;-0.5293974134182257
Bilateral renal atrophy;Positive urine norcotinine test;0.8013157248497009;0.77477646;0.5636668309308586;0.5723112321339638;0.9999201345566091;-0.19860440970690818;-0.22514367581637473;-0.43625330362575054;-0.42760890242264527
Bilateral renal atrophy;Long fibula;0.7631704062223434;0.9069647;0.5761083091170266;0.5296569331568979;0.9999567459343585;-0.23678633971201501;-0.09299202663885675;-0.42384843681733186;-0.4702998127774606
Bilateral renal atrophy;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7643336355686188;0.9371679;0.5757272551173789;0.5200132718613943;0.9999201345566091;-0.23558649898799033;-0.06275225163729758;-0.42419287943923023;-0.47990686269521476
Bilateral renal atrophy;Type II cryptotia;0.8698956370353699;0.8834203;0.5415312394016708;0.5371930487743122;0.9999201345566091;-0.13002449752123924;-0.11649984599383445;-0.4583888951549383;-0.46272708578229693
Bilateral renal atrophy;Increased variability in muscle fiber diameter;0.7548803389072418;0.77483034;0.578827252416263;0.5722936431986987;0.9999473166570552;-0.24506697774981334;-0.22511697531794383;-0.4211200642407922;-0.4276536734583565
Bilateral renal atrophy;Widened proximal tibial metaphyses;0.7456891536712646;0.9267501;0.581848630035384;0.5233370562491431;0.9999600672783046;-0.2542709136070399;-0.07320994377748058;-0.41811143724292055;-0.4766230110291615
Bilateral renal atrophy;Wide anterior fontanel;0.8819683194160461;0.94748735;0.5376584380670244;0.5167229920565342;0.9999476714516888;-0.11797935203564269;-0.05246031717312438;-0.46228923338466443;-0.4832246793951547
Bilateral renal atrophy;Increased circulating oleate level;0.8120167851448059;0.9683933;0.5601950570129677;0.5100623915114544;0.9999201345566091;-0.1879033494118032;-0.031526808750945046;-0.43972507754364143;-0.4898577430451547
Bilateral renal atrophy;Lozenge-shaped umbilicus;0.9505569413304329;0.96178627;0.5157446337572579;0.5121667727684436;0.9999584729108851;-0.04940153158045224;-0.03817220276928357;-0.48421383915362726;-0.48779170014244155
Bilateral renal atrophy;Anti-myelin-associated glycoprotein antibody positivity;0.7756599187850952;0.7715029;0.5720226422760316;0.5733811447112429;0.9999201345566091;-0.2242602157715139;-0.22841722251208396;-0.4278974922805775;-0.4265389898453662
Bilateral renal atrophy;Fractured radius;0.6760774850845337;0.85472333;0.6050017147892524;0.5464072160233071;0.9999600672783046;-0.32388258219377086;-0.1452367329658656;-0.3949583524890522;-0.45355285125499745
Bilateral renal atrophy;Abnormal manual kinetic perimetry test;0.7048764824867249;0.7680044;0.5953608009329808;0.5745254919864529;0.9999201345566091;-0.29504365206988425;-0.23191571713717551;-0.4045593336236283;-0.42539464257015625
Bilateral renal atrophy;Small radial epiphyses;0.6958996057510376;0.802302;0.5983558314658831;0.5633465401190769;0.9999201345566091;-0.3040205288055715;-0.1976181316498098;-0.401564303090726;-0.4365735944375322
Bilateral renal atrophy;Generalized keratosis follicularis;0.7864766269922256;0.98129344;0.5684939514194756;0.5059548285838433;0.9999600672783046;-0.2134834402860789;-0.01866662741319225;-0.431466115858829;-0.4940052386944612
Bilateral renal atrophy;Hypoplasia of the calcaneus;0.7370118796825409;0.87631357;0.5847080043660091;0.5394716863607633;0.9999584729108851;-0.26294659322834424;-0.12364490574932507;-0.415250468544876;-0.4604867865501219
Bilateral renal atrophy;2-hydroxyadipic aciduria;0.5711618661880493;0.59884477;0.6410769320615005;0.6313912087794842;0.6288651353633673;-0.057703269175317984;-0.03002036874654601;0.012211796698133215;0.0025260734161168807
Bilateral renal atrophy;Potter facies;0.9019790664315224;0.94191885;0.531251213267891;0.5184982074690614;0.9999552432134126;-0.09797617678189019;-0.0580363932683442;-0.4687040299455215;-0.48145703574435117
Bilateral renal atrophy;Increased heart rate variability;0.8069141805171967;0.97586215;0.5618495785590618;0.5076840622555961;0.9999600672783046;-0.1930458867611079;-0.024097921854415394;-0.43811048871924274;-0.4922760050227084
Bilateral renal atrophy;Aplastic zygomatic arch;0.7375122904777527;0.9025057;0.5845429187468856;0.5310827703833763;0.9999584729108851;-0.26244618243313245;-0.0974527770910304;-0.41541555416399956;-0.4688757025275089
Bilateral renal atrophy;Testicular torsion;0.6793385446071625;0.97847176;0.6039051756218446;0.506853180562397;0.8586132879499475;-0.17927474334278504;0.1198584680314978;-0.25470811232810286;-0.3517601073875505
Bilateral renal atrophy;Abolished vibration sense;0.8205298185348511;0.98172784;0.5574383383522413;0.505816535114669;0.9999584729108851;-0.17942865437603406;-0.01823063439464978;-0.4425201345586438;-0.4941419377962162
Bilateral renal atrophy;Fractured metatarsal bone of digit 5;0.8254912197589874;0.93293655;0.5558337412725716;0.5213629955920285;0.9999201345566091;-0.17442891479762168;-0.06698358536990257;-0.44408639328403754;-0.47855713896458063
Bilateral renal atrophy;Prolonged G2 phase of cell cycle;0.8311465382575989;0.9207394;0.5540064644290137;0.5252559293470107;0.9999567459343585;-0.16881020767675958;-0.0792173336266192;-0.44595028150534477;-0.47470081658734775
Bilateral renal atrophy;Single naris;0.9253830760717392;0.8871325;0.5237733999319294;0.5360035598151509;0.9999567459343585;-0.07457366986261926;-0.1128242204903277;-0.47618334600242906;-0.46395318611920755
Bilateral renal atrophy;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.709644615650177;0.8200289;0.5937735197732759;0.5576004148183862;0.9999201345566091;-0.2902755189064321;-0.17989123345645042;-0.40614661478333325;-0.4423197197382229
Bilateral renal atrophy;Asymmetry of the thorax;0.6571880578994751;0.8447394;0.6113793648594981;0.5496217274825866;0.9999567459343585;-0.34276868803488336;-0.15521736843573175;-0.3885773810748604;-0.4503350184517718
Bilateral renal atrophy;Type 2 muscle fiber predominance;0.7359632849693298;0.82835436;0.5850540117329882;0.5549084202794685;0.9999556674707869;-0.26399238250145707;-0.1716013087976912;-0.4149016557377987;-0.4450472471913184
Bilateral renal atrophy;Dependency on parenteral nutrition;0.7328191697597504;0.7564131;0.5860921025197785;0.5783241015437801;0.9999584729108851;-0.26713930315113477;-0.24354537076092175;-0.41386637039110663;-0.421634371367105
Bilateral renal atrophy;Limited shoulder flexion;0.6820214688777924;0.9311438;0.6030039943311105;0.5219349565990623;0.9999201345566091;-0.31789866567881675;-0.06877631427081199;-0.3969161402254986;-0.4779851779575468
Bilateral renal atrophy;Paroxysmal vertigo;0.8159070909023285;1.0198494;0.5589347312453194;0.4936813203148175;0.9999584729108851;-0.18405138200855664;0.019890946682925903;-0.4410237416655657;-0.5062771525960676
Bilateral renal atrophy;Long hallux;0.8374970555305481;0.9390515;0.5519567001990403;0.5194125291201539;0.9999526340597648;-0.16245557852921666;-0.06090112515626134;-0.44799593386072445;-0.48054010493961086
Bilateral renal atrophy;Broad medial eyebrow;0.8898257985711098;0.93962;0.5351408756229561;0.5192312462124618;0.9999600672783046;-0.11013426870719478;-0.06034004927293346;-0.46481919165534846;-0.4807288210658428
Bilateral renal atrophy;Myxoid subcutaneous tumors;0.8745517432689667;1.0491115;0.5400369042805937;0.4843610328943886;0.9999600672783046;-0.12540832400933788;0.04915141820295765;-0.45992316299771085;-0.515599034383916
Bilateral renal atrophy;Bulbous tips of toes;0.7801569253206253;0.90528953;0.5705545343660448;0.5301925392874325;0.9999584729108851;-0.21980154759025983;-0.09466894215679578;-0.4294039385448404;-0.46976593362345265
Bilateral renal atrophy;Absent internal genitalia;0.8370747268199921;0.9703639;0.5520929473343086;0.5094348414835788;0.717226575899895;0.11984815092009704;0.2531373390666882;-0.16513362856558644;-0.20779173441631626
Bilateral renal atrophy;Hyperphalangy of the 2nd finger;0.6804389357566833;0.8523925;0.6035354555262098;0.5471572360270804;0.9999600672783046;-0.3195211315216212;-0.14756757259980724;-0.39642461175209476;-0.4528028312512241
Bilateral renal atrophy;Renal interstitial hemosiderin;0.5501275062561035;0.5135369;0.6485305754244594;0.661713206776597;0.4693866352828394;0.0807408709732641;0.044150235196744325;0.17914394014161994;0.19232657149375754
Bilateral renal atrophy;Abnormality of depressor anguli oris muscle;0.7057448327541351;0.9982121;0.5950715517910846;0.5005691146989599;0.9999201345566091;-0.294175301802474;-0.0017080354812917253;-0.4048485827655245;-0.4993510198576492
Bilateral renal atrophy;Paroxysmal dyspnea;0.6728419065475464;0.78862166;0.6060909655968412;0.567795204101468;0.9999201345566091;-0.3270782280090627;-0.2112984705093679;-0.39382916895976794;-0.4321249304551411
Bilateral renal atrophy;Phenylpyruvic acidemia;0.6754878461360931;0.7571105;0.605200120030978;0.5780952617792168;0.9999600672783046;-0.3244722211422114;-0.2428495907844691;-0.39475994724732655;-0.4218648054990878
Bilateral renal atrophy;Lateral ventricle dilatation;0.6952677667140961;0.7765277;0.5985669730557447;0.5717392173283249;0.9999488789551968;-0.3046811122411007;-0.22342117614681667;-0.4013819058994521;-0.4282096616268719
Bilateral renal atrophy;Neonatal unconjugated hyperbilirubinemia;0.7401105463504791;0.84978294;0.5836861267715262;0.5479972575334024;0.9999600672783046;-0.25984952092782543;-0.15017712355271862;-0.41627394050677835;-0.4519628097449021
Bilateral renal atrophy;High maternal circulating alpha-fetoprotein concentration;0.8237230479717255;0.88192916;0.5564054299342069;0.537670993326481;0.9999201345566091;-0.17619708658488364;-0.1179909753921804;-0.44351470462240217;-0.46224914123012806
Bilateral renal atrophy;Prominent nasolabial fold;0.7952716797590256;0.9871232;0.5656310868908672;0.5040989296638159;0.9999545338528789;-0.20468285409385334;-0.012831342496219977;-0.43432344696201175;-0.49585560418906305
Bilateral renal atrophy;Abnormality of inferior alveolar nerve;0.8435067981481552;1.0057342;0.5500189296513017;0.4981747311828836;0.9999201345566091;-0.1564133364084539;0.0058140706893625715;-0.4499012049053074;-0.5017454033737255
Bilateral renal atrophy;Unilateral conductive hearing impairment;0.7895688414573669;1.0081099;0.5674867801437796;0.4974184839172112;0.9999600672783046;-0.2103912258209376;0.008149859899124645;-0.43247328713452493;-0.5025415833610933
Bilateral renal atrophy;Macular hypopigmented whorls, streaks, and patches;0.7261733710765839;0.8320224;0.5882894506329558;0.5537236293875734;0.9999600672783046;-0.2737866962017207;-0.1679376387657313;-0.41167061664534876;-0.4462364378907312
Bilateral renal atrophy;Delayed ossification of pubic rami;0.7026718556880951;0.95559436;0.5960955318863481;0.5141394081198045;0.9999584729108851;-0.29728661722279004;-0.044364112082485474;-0.403862941024537;-0.4858190647910806
Bilateral renal atrophy;Hyperphenylalaninemia;0.6806357502937317;0.83252823;0.6034693431496677;0.553560308278183;0.9999561589935034;-0.31932040869977174;-0.16742792546536622;-0.3964868158438357;-0.4463958507153204
Bilateral renal atrophy;Ureteropelvic junction obstruction;0.5335907340049744;0.593688;0.6544525861730996;0.6331853848503435;0.7198694509471423;-0.1862787169421679;-0.12618143977770868;-0.06541686477404263;-0.0866840660967988
Bilateral renal atrophy;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7625651359558105;0.8877801;0.5763066292392047;0.5357961148208144;0.9999201345566091;-0.23735499860079856;-0.1121400642517385;-0.4236135053174044;-0.46412401973579476
Bilateral renal atrophy;Difficulty walking;0.7595654129981995;0.781971;0.577289952498662;0.5699627559091901;0.9999461221900431;-0.24038070919184362;-0.21797514440683996;-0.4226561696913811;-0.429983366280853
Bilateral renal atrophy;Bilobate gallbladder;0.6905953884124756;0.907211;0.600129740517742;0.5295782090853531;0.9999584729108851;-0.30936308449840955;-0.09274746722317151;-0.3998287323931431;-0.470380263825532
Bilateral renal atrophy;Histidinuria;0.6682798266410828;0.6967843;0.6076289794960885;0.5980602625133771;0.8024087134738423;-0.1341288868327596;-0.10562439598040363;-0.19477973397775383;-0.20434845096046528
Bilateral renal atrophy;Widened interpedicular distance;0.7809968143701553;0.97468793;0.5702805113712415;0.5080579480074245;0.9999201345566091;-0.21892332018645377;-0.025232200634795143;-0.42963962318536764;-0.49186218654918457
Fractured left clavicle;Positive urine norcotinine test;0.9118826761841774;1.057365;0.5280850407391815;0.4817301391370753;1.0;-0.0881173238158226;0.05736494064331055;-0.4719149592608185;-0.5182698608629247
Fractured left clavicle;Long fibula;0.7518447935581207;1.0095743;0.5798242978858472;0.4969523574176975;0.6263392562858507;0.12550553727226998;0.38323503780442025;-0.046514958400003525;-0.12938689886815324
Fractured left clavicle;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.6276745498180389;0.92507535;0.6214394749346348;0.5238716240680827;1.0;-0.37232545018196106;-0.07492464780807495;-0.3785605250653652;-0.47612837593191726
Fractured left clavicle;Type II cryptotia;0.7920321524143219;0.90456414;0.5666849413764034;0.530424476382563;1.0;-0.2079678475856781;-0.09543585777282715;-0.43331505862359665;-0.46957552361743704
Fractured left clavicle;Increased variability in muscle fiber diameter;0.9353878274559975;1.1059827;0.5205810303138796;0.466201209743743;0.7712186293488323;0.16416919810716513;0.3347640318984211;-0.25063759903495275;-0.3050174196050893
Fractured left clavicle;Widened proximal tibial metaphyses;0.7259335517883301;0.9267947;0.5883688239146744;0.5233228311864169;0.4693866352828394;0.25654691650549066;0.45740807249227655;0.11898218863183496;0.053936195903577455
Fractured left clavicle;Wide anterior fontanel;0.9075410440564156;0.78516924;0.5294726939014565;0.5689199907514286;0.558799737971173;0.34874130608524256;0.22636950584138804;-0.029327044069716535;0.010120252780255634
Fractured left clavicle;Increased circulating oleate level;0.8311058133840561;0.8905202;0.5540196164524782;0.5349185002678464;1.0;-0.1688941866159439;-0.10947978496551514;-0.4459803835475218;-0.4650814997321536
Fractured left clavicle;Lozenge-shaped umbilicus;0.8216905295848846;0.83861613;0.5570628150014691;0.5515957171383633;0.9999134918687169;-0.17822296228383228;-0.16129735913251086;-0.4428506768672478;-0.4483177747303536
Fractured left clavicle;Anti-myelin-associated glycoprotein antibody positivity;0.9557088613510132;1.1860152;0.5141029208293753;0.44044261480646196;1.0;-0.044291138648986816;0.18601524829864502;-0.48589707917062475;-0.559557385193538
Fractured left clavicle;Fractured radius;0.39567631483078003;0.6573247;0.7065566136836273;0.6113330654318536;0.0;0.39567631483078003;0.6573246717453003;0.7065566136836273;0.6113330654318536
Fractured left clavicle;Abnormal manual kinetic perimetry test;0.8914883732795715;1.1607434;0.5346084693315825;0.44861086589712806;1.0;-0.10851162672042847;0.1607433557510376;-0.46539153066841754;-0.5513891341028719
Fractured left clavicle;Small radial epiphyses;0.7042737007141113;0.79468846;0.5955616364336536;0.5658207498589205;1.0;-0.29572629928588867;-0.20531153678894043;-0.40443836356634644;-0.4341792501410795
Fractured left clavicle;Generalized keratosis follicularis;0.8078093230724335;0.9847818;0.5615592071206147;0.5048442920406553;0.9999201345566091;-0.19211081148417564;-0.015138332856017067;-0.4383609274359944;-0.4950758425159538
Fractured left clavicle;Hypoplasia of the calcaneus;0.5945224463939667;0.783684;0.6328947587027873;0.5694041371524912;0.6574179255159834;-0.06289547912201676;0.12626608975806441;-0.024523166813196107;-0.08801378836349227
Fractured left clavicle;2-hydroxyadipic aciduria;0.9418678320944309;1.1069863;0.5185144815670931;0.4658799150981472;1.0;-0.05813216790556908;0.10698628425598145;-0.4814855184329069;-0.5341200849018528
Fractured left clavicle;Potter facies;1.012491861358285;0.98545945;0.4960236136113183;0.5046285607602392;0.9998981869165328;0.01259367444175219;-0.014438740009489304;-0.5038745733052145;-0.49526962615629355
Fractured left clavicle;Increased heart rate variability;0.9466418214142323;1.0202687;0.5169925054800817;0.4935478367776832;0.9999201345566091;-0.053278313142376854;0.020348544108552025;-0.4829276290765274;-0.5063722977789259
Fractured left clavicle;Aplastic zygomatic arch;0.7787488102912903;0.7281289;0.5710140667241335;0.5876424234120982;0.7485161685812178;0.03023264171007245;-0.020387258516520568;-0.17750210185708437;-0.16087374516911968
Fractured left clavicle;Testicular torsion;0.8076331615447998;0.9301485;0.5616163472922057;0.5222525401130228;0.9999201345566091;-0.1922869730118093;-0.06977165223391624;-0.43830378726440344;-0.4776675944435863
Fractured left clavicle;Abolished vibration sense;0.7425472736358643;0.89236873;0.5828831636553324;0.534326588527887;0.9999134918687169;-0.25736621823285266;-0.10754475798581287;-0.4170303282133845;-0.46558690334082997
Fractured left clavicle;Fractured metatarsal bone of digit 5;0.571731448173523;0.89656436;0.6408762676732936;0.5329835890370185;1.0;-0.42826855182647705;-0.10343563556671143;-0.35912373232670636;-0.4670164109629815
Fractured left clavicle;Prolonged G2 phase of cell cycle;0.8852246105670929;0.97361165;0.5366148334963454;0.5084006445554416;0.9999056439461368;-0.1146810333790439;-0.026293991095032054;-0.46329081044979137;-0.49150499939069514
Fractured left clavicle;Single naris;0.9348834156990051;0.9650264;0.5207419284016577;0.511134726070251;0.9999056439461368;-0.06502222824713166;-0.034879265314544994;-0.4791637155444791;-0.4887709178758858
Fractured left clavicle;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9162301421165466;1.1025218;0.5266960590046275;0.4673088797494387;1.0;-0.08376985788345337;0.10252177715301514;-0.47330394099537254;-0.5326911202505613
Fractured left clavicle;Asymmetry of the thorax;0.7069008648395538;0.8596836;0.5946866007773275;0.5448119828180027;0.3872114577231953;0.3196894071163585;0.4724721155228069;0.20747514305413217;0.15760052509480738
Fractured left clavicle;Type 2 muscle fiber predominance;1.003465835005045;1.1707144;0.49889678824537265;0.4453924701269216;0.8527273749847077;0.1507384600203372;0.31798700337222585;-0.3538305867393351;-0.4073349048577861
Fractured left clavicle;Dependency on parenteral nutrition;0.953712847083807;1.0323175;0.5147389246005409;0.48971120484804986;0.9999134918687169;-0.04620064478490993;0.03240402731921033;-0.485174567268176;-0.5102022870206671
Fractured left clavicle;Limited shoulder flexion;0.6205873787403107;1.0949218;0.6238739100926783;0.4697398717322835;1.0;-0.37941262125968933;0.09492182731628418;-0.37612608990732166;-0.5302601282677165
Fractured left clavicle;Paroxysmal vertigo;0.8483017086982727;1.024037;0.5484742103619746;0.492348063184066;0.9999134918687169;-0.15161178317044421;0.02412351164843396;-0.4514392815067423;-0.5075654286846509
Fractured left clavicle;Long hallux;0.8581221997737885;1.0263828;0.5453140058437822;0.4916011181522044;0.5390476299078587;0.31907456986592975;0.48733517400907245;0.006266375935923496;-0.047446511755654286
Fractured left clavicle;Broad medial eyebrow;0.9441209957003593;0.9881637;0.517796108987632;0.503767696511438;0.9999201345566091;-0.055799138856249764;-0.011756424916106178;-0.48212402556897715;-0.49615243804517106
Fractured left clavicle;Myxoid subcutaneous tumors;0.9310659319162369;0.9949064;0.5219598106642499;0.5016213474740044;0.9999201345566091;-0.06885420264037223;-0.005013709080534889;-0.4779603238923592;-0.49829878708260467
Fractured left clavicle;Bulbous tips of toes;0.9125557690858841;0.94449955;0.5278699583527175;0.5176754210302743;0.6574179255159834;0.25513784356990066;0.287081626733925;-0.1295479671632659;-0.13974250448570913
Fractured left clavicle;Absent internal genitalia;0.8537142425775528;0.9526722;0.5467318980241768;0.5150705451553449;1.0;-0.1462857574224472;-0.04732781648635864;-0.45326810197582323;-0.4849294548446551
Fractured left clavicle;Hyperphalangy of the 2nd finger;0.7285772562026978;0.9227618;0.5874941441413759;0.5246101944758342;0.683723727808895;0.044853528393802744;0.23903807009607325;-0.0962295836675191;-0.15911353333306077
Fractured left clavicle;Renal interstitial hemosiderin;0.9334432184696198;1.1608343;0.5212013542228692;0.4485815125905296;1.0;-0.06655678153038025;0.16083431243896484;-0.4787986457771308;-0.5514184874094704
Fractured left clavicle;Abnormality of depressor anguli oris muscle;0.9008893966674805;0.98875654;0.5315997631946379;0.503578980697711;1.0;-0.09911060333251953;-0.011243462562561035;-0.46840023680536214;-0.496421019302289
Fractured left clavicle;Paroxysmal dyspnea;0.831098660826683;0.9479431;0.5540219263674195;0.5165777229863562;1.0;-0.16890133917331696;-0.05205690860748291;-0.44597807363258046;-0.4834222770136438
Fractured left clavicle;Phenylpyruvic acidemia;0.8388170599937439;0.9863126;0.5515309163862273;0.5043569690541327;0.9999201345566091;-0.1611030745628652;-0.01360750676425071;-0.4483892181703818;-0.49556316550247637
Fractured left clavicle;Lateral ventricle dilatation;0.7452588081359863;0.9389152;0.5819902783305098;0.5194560102968708;0.9998579617208769;-0.2545991535848906;-0.06094276863997483;-0.4178676833903672;-0.4804019514240061
Fractured left clavicle;Neonatal unconjugated hyperbilirubinemia;0.8607551604509354;0.85514873;0.5444675040775747;0.5462703694840232;0.9999201345566091;-0.13916497410567374;-0.14477140189440818;-0.4554526304790344;-0.4536497650725859
Fractured left clavicle;High maternal circulating alpha-fetoprotein concentration;0.8663214594125748;0.9579441;0.5426789624420385;0.5133907525207204;1.0;-0.13367854058742523;-0.04205590486526489;-0.4573210375579615;-0.4866092474792796
Fractured left clavicle;Prominent nasolabial fold;0.8708843737840652;0.8783498;0.5412138374364616;0.5388186165583138;0.9998944404568447;-0.12901006667277948;-0.12154465942046777;-0.45868060302038316;-0.46107582389853097
Fractured left clavicle;Abnormality of inferior alveolar nerve;0.833408921957016;0.8664688;0.5532759772877456;0.5426316470988248;1.0;-0.166591078042984;-0.13353121280670166;-0.4467240227122544;-0.45736835290117517
Fractured left clavicle;Unilateral conductive hearing impairment;0.8322645127773285;0.82008564;0.5536454528734849;0.5575820530450826;0.9999201345566091;-0.16765562177928062;-0.17983448983462424;-0.44627468168312423;-0.44233808151152654
Fractured left clavicle;Macular hypopigmented whorls, streaks, and patches;1.0078534577041864;1.1432997;0.49750014107436646;0.45422872687196425;0.9999201345566091;0.007933323147577331;0.14337956427304177;-0.5024199934822426;-0.5456914076846449
Fractured left clavicle;Delayed ossification of pubic rami;0.7542357891798019;0.9101231;0.5790388927759853;0.5286473500046484;0.6574179255159834;0.0968178636638185;0.25270518430152145;-0.07837903273999813;-0.12877057551133508
Fractured left clavicle;Hyperphenylalaninemia;0.8829227834939957;1.0574435;0.5373525014726825;0.4817050881896363;0.9999028053808913;-0.1169800218868956;0.05754069418423324;-0.4625503039082087;-0.518197717191255
Fractured left clavicle;Ureteropelvic junction obstruction;0.7185357511043549;0.9238583;0.5908200839343635;0.5242601408795082;0.9998847295244674;-0.2813489784201125;-0.07602644457421104;-0.4090646455901039;-0.47562458864495916
Fractured left clavicle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6166200041770935;0.8576083;0.6252400287925837;0.5454792523415546;1.0;-0.3833799958229065;-0.14239168167114258;-0.37475997120741633;-0.4545207476584454
Fractured left clavicle;Difficulty walking;0.8955650180578232;1.037407;0.5333034135464783;0.4880901786575119;0.7552776988623575;0.14028731919546567;0.2821293417336508;-0.22197428531587926;-0.2671875202048456
Fractured left clavicle;Bilobate gallbladder;0.8105352967977524;0.9165299;0.5606752585873758;0.5266003073350303;0.9999134918687169;-0.18937819507096454;-0.08338359799359485;-0.43923823328134115;-0.47331318453368665
Fractured left clavicle;Histidinuria;0.9879988450556993;1.146745;0.5038201779700573;0.4531203413520608;0.9999090677057578;-0.011910222650058477;0.14683589880120018;-0.49608888973570053;-0.546788726353697
Fractured left clavicle;Widened interpedicular distance;0.8070065379142761;0.95895594;0.561819616733273;0.5130683975082211;1.0;-0.19299346208572388;-0.04104405641555786;-0.43818038326672704;-0.4869316024917789
Positive urine norcotinine test;Long fibula;0.9377489201724529;1.035497;0.5198279544283813;0.48869859563220885;0.9999056439461368;-0.062156723773683864;0.03559130620339934;-0.48007768951775553;-0.5112070483139279
Positive urine norcotinine test;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.9720736220479012;1.0722765;0.5088903980206705;0.47697361120832127;1.0;-0.027926377952098846;0.07227647304534912;-0.4911096019793295;-0.5230263887916787
Positive urine norcotinine test;Type II cryptotia;0.8923347145318985;0.8741547;0.5343374829019873;0.5401642912905595;1.0;-0.1076652854681015;-0.1258453130722046;-0.46566251709801265;-0.45983570870944046
Positive urine norcotinine test;Increased variability in muscle fiber diameter;0.8992043659090996;0.89431393;0.5321388247502201;0.53370385342007;0.9998452077479463;-0.1006408418388467;-0.10553127628279735;-0.46770638299772616;-0.4661413543278763
Positive urine norcotinine test;Widened proximal tibial metaphyses;0.8216964304447174;1.0298704;0.5570609061094374;0.4904905614060183;0.9999201345566091;-0.1782237041118917;0.0299502563354197;-0.44285922844717174;-0.5094295731505908
Positive urine norcotinine test;Wide anterior fontanel;0.8841153606772423;0.92881954;0.5369702906048065;0.5226766217011738;0.999848231156753;-0.11573287047951075;-0.07102869399397227;-0.46287794055194653;-0.47717160945557924
Positive urine norcotinine test;Increased circulating oleate level;0.8727088570594788;0.91360044;0.5406282539921112;0.5275361619840089;1.0;-0.12729114294052124;-0.08639955520629883;-0.45937174600788877;-0.4724638380159911
Positive urine norcotinine test;Lozenge-shaped umbilicus;0.8942450433969498;1.0029341;0.5337259142912524;0.4990660635242825;0.9999134918687169;-0.10566844847176715;0.0030206063749964596;-0.46618757757746454;-0.5008474283444344
Positive urine norcotinine test;Anti-myelin-associated glycoprotein antibody positivity;0.7433832883834839;0.89713746;0.5826078002738981;0.5328001806326609;1.0;-0.2566167116165161;-0.10286253690719604;-0.41739219972610186;-0.4671998193673391
Positive urine norcotinine test;Fractured radius;0.8496248573064804;1.0134512;0.5480481513619707;0.49571821026556406;0.9999201345566091;-0.1502952772501287;0.013531084048432396;-0.4518719831946384;-0.504201924291045
Positive urine norcotinine test;Abnormal manual kinetic perimetry test;0.8072352707386017;0.8929756;0.5617454155024666;0.534132292809528;1.0;-0.19276472926139832;-0.10702437162399292;-0.4382545844975334;-0.465867707190472
Positive urine norcotinine test;Small radial epiphyses;0.9374706298112869;1.037384;0.5199167099124336;0.48809752506357595;1.0;-0.06252937018871307;0.037384033203125;-0.48008329008756645;-0.511902474936424
Positive urine norcotinine test;Generalized keratosis follicularis;0.9437356777489185;1.0260214;0.5179189527660446;0.49171622620216904;0.9999201345566091;-0.056184456807690575;0.026101226794404075;-0.4820011817905645;-0.5082039083544401
Positive urine norcotinine test;Hypoplasia of the calcaneus;0.8632803857326508;1.0536081;0.5436559367947771;0.48292784676586376;0.9999134918687169;-0.13663310613606616;0.053694568014400756;-0.45625755507393984;-0.5169856451028532
Positive urine norcotinine test;2-hydroxyadipic aciduria;0.7970518171787262;0.68810844;0.5650522995803917;0.6009625736538347;1.0;-0.2029481828212738;-0.3118915557861328;-0.4349477004196083;-0.39903742634616535
Positive urine norcotinine test;Potter facies;0.815308541059494;0.8073526;0.5591285795467726;0.5617073542485462;0.9998981869165328;-0.18458964585703874;-0.19254558443469072;-0.4407696073697601;-0.43819083266798653
Positive urine norcotinine test;Increased heart rate variability;0.8544076681137085;0.8178129;0.5465087850758215;0.5583176405838228;0.9999201345566091;-0.1455124664429006;-0.1821072149399099;-0.45341134948078765;-0.4416024939727863
Positive urine norcotinine test;Aplastic zygomatic arch;0.9647145457565784;0.99394166;0.5112340409290363;0.5019284310725984;0.9999134918687169;-0.035198946112138474;-0.005971827172977173;-0.48867945093968057;-0.4979850607961185
Positive urine norcotinine test;Testicular torsion;0.8147896230220795;0.9996655;0.5592966559855408;0.5001064667614694;0.9999201345566091;-0.18513051153452964;-0.00025463582308860033;-0.4406234785710683;-0.4998136677951397
Positive urine norcotinine test;Abolished vibration sense;0.8213624358177185;0.96665543;0.5571689545929988;0.5106158695583791;0.9999134918687169;-0.1785510560509984;-0.03325805869076892;-0.44274453727571816;-0.4892976223103378
Positive urine norcotinine test;Fractured metatarsal bone of digit 5;1.0181319508701563;1.0946366;0.494228104484018;0.46983109068514317;1.0;0.018131950870156288;0.09463655948638916;-0.505771895515982;-0.5301689093148568
Positive urine norcotinine test;Prolonged G2 phase of cell cycle;0.9387065172195435;0.9069287;0.5195225585856076;0.5296684426346114;0.6766288643064248;0.2620776529131187;0.2302998537836326;-0.15710630572081719;-0.14696042167181333
Positive urine norcotinine test;Single naris;0.713018000125885;0.7818557;0.5926519929769336;0.5700003542170465;0.9999056439461368;-0.2868876438202518;-0.21804994154592927;-0.4072536509692032;-0.42990528972909026
Positive urine norcotinine test;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8497001975774765;0.8807113;0.5480238941189461;0.5380614013375604;1.0;-0.1502998024225235;-0.11928868293762207;-0.45197610588105386;-0.4619385986624396
Positive urine norcotinine test;Asymmetry of the thorax;0.8997347876429558;1.0077214;0.5319691265728715;0.4975421536442648;0.9999056439461368;-0.10017085630318101;0.007815780156646412;-0.46793651737326525;-0.502363490301872
Positive urine norcotinine test;Type 2 muscle fiber predominance;0.9104442074894905;0.95821;0.5285447371262744;0.5133060524866446;0.9999003561294039;-0.08945614863991336;-0.04169036467432574;-0.4713556190031295;-0.48659430364275924
Positive urine norcotinine test;Dependency on parenteral nutrition;0.7415457963943481;0.89310986;0.5832131100420745;0.5340893149008312;0.9999134918687169;-0.2583676954743688;-0.10680363383267566;-0.4167003818266424;-0.4658241769678857
Positive urine norcotinine test;Limited shoulder flexion;0.8709942996501923;1.0197345;0.5411785518425065;0.49371792354336574;1.0;-0.12900570034980774;0.019734501838684082;-0.4588214481574935;-0.5062820764566343
Positive urine norcotinine test;Paroxysmal vertigo;0.7010984718799591;0.8302947;0.5966202128159296;0.5542815647058381;0.9999134918687169;-0.2988150199887578;-0.16961876358960315;-0.40329327905278733;-0.4456319271628788
Positive urine norcotinine test;Long hallux;0.9164937138557434;1.0329849;0.5266118665202897;0.4894986928095372;0.9998836012415208;-0.08338988738577735;0.03310125154931176;-0.4732717347212311;-0.5103849084319836
Positive urine norcotinine test;Broad medial eyebrow;0.9493526890873909;0.9520382;0.5161284401018176;0.5152725663587188;0.9999201345566091;-0.05056744546921821;-0.047881906044798805;-0.48379169445479153;-0.48464756819789034
Positive urine norcotinine test;Myxoid subcutaneous tumors;0.8489782363176346;0.98008376;0.5482563549505957;0.5063399618288471;0.9999201345566091;-0.15094189823897453;-0.019836370957213356;-0.45166377960601345;-0.493580172727762
Positive urine norcotinine test;Bulbous tips of toes;0.8728604763746262;1.0044357;0.5405795967308351;0.49858808736115656;0.9999134918687169;-0.12705301549409076;0.0045221665861781;-0.4593338951378818;-0.5013254045075604
Positive urine norcotinine test;Absent internal genitalia;0.8445590734481812;0.92931795;0.5496798301909941;0.5225175780999126;1.0;-0.15544092655181885;-0.07068204879760742;-0.4503201698090059;-0.4774824219000874
Positive urine norcotinine test;Hyperphalangy of the 2nd finger;0.9739698767662048;1.1023003;0.5082865815297455;0.467379750362347;0.9999201345566091;-0.025950257790404274;0.10238015173642068;-0.4916335530268636;-0.5325403841942621
Positive urine norcotinine test;Renal interstitial hemosiderin;0.8427009582519531;0.83441496;0.5502786531108834;0.5529512257669376;1.0;-0.15729904174804688;-0.16558504104614258;-0.4497213468891166;-0.44704877423306244
Positive urine norcotinine test;Abnormality of depressor anguli oris muscle;0.8746272772550583;1.0265383;0.5400126697328276;0.4915516139637214;1.0;-0.1253727227449417;0.02653825283050537;-0.4599873302671724;-0.5084483860362786
Positive urine norcotinine test;Paroxysmal dyspnea;0.7257260978221893;0.8255745;0.5884374897563895;0.5558068042380097;1.0;-0.27427390217781067;-0.17442548274993896;-0.41156251024361046;-0.44419319576199034
Positive urine norcotinine test;Phenylpyruvic acidemia;0.7204160094261169;0.68637127;0.5901965419039341;0.6015447305714012;0.726290173501319;-0.005874164075202026;-0.03991890665943054;-0.13609363159738486;-0.12474544292991774
Positive urine norcotinine test;Lateral ventricle dilatation;0.9161808863282204;0.88972926;0.5267117929443643;0.5351718022838519;0.9998579617208769;-0.08367707539265656;-0.1101287003225615;-0.4731461687765126;-0.46468615943702507
Positive urine norcotinine test;Neonatal unconjugated hyperbilirubinemia;0.6979155540466309;1.0000188;0.5976824604503168;0.4999939863801035;0.726290173501319;-0.02837461945468811;0.27372866156643005;-0.12860771305100216;-0.22629618712121546
Positive urine norcotinine test;High maternal circulating alpha-fetoprotein concentration;0.8328575938940048;0.8983942;0.5534539659609932;0.5323980259604957;1.0;-0.16714240610599518;-0.10160577297210693;-0.44654603403900683;-0.4676019740395043
Positive urine norcotinine test;Prominent nasolabial fold;0.7606027126312256;0.90755975;0.5769498362019899;0.5294667155989783;0.9998944404568447;-0.23929172782561914;-0.09233468799255029;-0.4229446042548548;-0.47042772485786644
Positive urine norcotinine test;Abnormality of inferior alveolar nerve;0.8468248248100281;0.977215;0.5489498761474181;0.5072533144587482;1.0;-0.15317517518997192;-0.0227850079536438;-0.4510501238525819;-0.4927466855412518
Positive urine norcotinine test;Unilateral conductive hearing impairment;0.692725658416748;1.0028177;0.5994169232995343;0.4991030953682257;0.9999201345566091;-0.30719447613986106;0.0028976154205027083;-0.4005032112570748;-0.5008170391883834
Positive urine norcotinine test;Macular hypopigmented whorls, streaks, and patches;0.9308394491672516;0.9248806;0.5220320748290856;0.5239337950984719;0.9999201345566091;-0.06908068538935752;-0.07503951073916526;-0.47788805972752346;-0.4759863394581372
Positive urine norcotinine test;Delayed ossification of pubic rami;0.9554364532232285;1.0852352;0.5141897167304936;0.4728358097092399;0.9999134918687169;-0.044477038645488465;0.08532174620653943;-0.4857237751382233;-0.527077682159477
Positive urine norcotinine test;Hyperphenylalaninemia;0.6777139902114868;0.59862924;0.6044512752196197;0.6314661086002803;0.6669007119557334;0.0108132782557534;-0.06827147573441994;-0.062449436736113695;-0.03543460335545312
Positive urine norcotinine test;Ureteropelvic junction obstruction;0.7039962112903595;0.8950759;0.5956541038502825;0.533459954464082;0.9998847295244674;-0.2958885182341079;-0.10480881228050987;-0.4042306256741849;-0.4664247750603854
Positive urine norcotinine test;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8857054337859154;1.0651246;0.5364607688445491;0.47925550482918067;1.0;-0.11429456621408463;0.06512463092803955;-0.4635392311554509;-0.5207444951708193
Positive urine norcotinine test;Difficulty walking;0.870698094367981;0.8752141;0.5412736332599465;0.5398243973635175;0.9998344221996177;-0.12913632783163675;-0.12462032231558451;-0.4585607889396712;-0.4600100248361002
Positive urine norcotinine test;Bilobate gallbladder;0.8182008415460587;0.894589;0.558192073692782;0.5336158166589218;0.9999134918687169;-0.18171265032265826;-0.10532448496792957;-0.4417214181759349;-0.46629767520979515
Positive urine norcotinine test;Histidinuria;0.7514205873012543;0.76594335;0.5799636948056401;0.5752001230440988;0.6883625580296748;0.06305802927157944;0.07758079037807053;-0.10839886322403469;-0.11316243498557599
Positive urine norcotinine test;Widened interpedicular distance;0.8893704935908318;1.019939;0.5352866950905875;0.4936528128627061;1.0;-0.11062950640916824;0.019938945770263672;-0.46471330490941254;-0.5063471871372939
Long fibula;Fragmentation of the epiphysis of the distal phalanx of the hallux;0.7568126916885376;0.5753464;0.5781929697521151;0.6396041041318697;0.6109530888848884;0.14585960280364918;-0.0356066786103828;-0.032760119132773324;0.028651015246981326
Long fibula;Type II cryptotia;1.0026943013072014;1.115258;0.49914237621993873;0.463230513072201;0.9999056439461368;0.002788657361064595;0.11535233449319426;-0.5007632677261981;-0.5366751308739358
Long fibula;Increased variability in muscle fiber diameter;0.6971137523651123;0.79901385;0.5979502255778173;0.5644146181462726;0.9133571980246588;-0.21624344565954645;-0.11434334495153864;-0.31540697244684146;-0.34894257987838617
Long fibula;Widened proximal tibial metaphyses;0.4422001838684082;0.20626312;0.6883543140022601;0.7918672921828832;0.8216557397003772;-0.379455555831969;-0.6153926147575977;-0.1333014256981171;-0.029788447517493988
Long fibula;Wide anterior fontanel;0.7903048396110535;1.1702607;0.5672471581595747;0.44553902199757656;0.870344338586674;-0.08003949897562057;0.2999163292142293;-0.3030971804270993;-0.4248053165890975
Long fibula;Increased circulating oleate level;0.7306000590324402;0.8915218;0.5868253498453246;0.5345977528745751;0.9999056439461368;-0.2693055849136966;-0.10838383246084626;-0.41308029410081215;-0.4653078910715617
Long fibula;Lozenge-shaped umbilicus;0.851279079914093;1.0807263;0.5475156071401598;0.4742760475142329;0.9999548690865008;-0.14867578917240776;0.08077139682078682;-0.452439261946341;-0.5256788215722679
Long fibula;Anti-myelin-associated glycoprotein antibody positivity;0.842451274394989;0.99317646;0.5503591334505803;0.5021720107858121;0.9999056439461368;-0.15745436955114778;-0.006729183680023509;-0.4495465104955565;-0.4977336331603247
Long fibula;Fractured radius;0.6754912734031677;0.78076315;0.6051989666811304;0.5703567467066558;0.8216557397003772;-0.14616446629720947;-0.04089259043890259;-0.21645677301924682;-0.2512989929937214
Long fibula;Abnormal manual kinetic perimetry test;0.8683688044548035;1.0371579;0.5420214613488841;0.48816955415714036;0.9999056439461368;-0.13153683949133332;0.03725224923471038;-0.4578841825972527;-0.5117360897889964
Long fibula;Small radial epiphyses;0.8586843907833099;0.77594304;0.5451332335002177;0.5719301773770034;0.6109530888848884;0.24773130189842152;0.1649899519628899;-0.06581985538467072;-0.03902291150788506
Long fibula;Generalized keratosis follicularis;0.7271090149879456;1.0561835;0.5879798332474115;0.4821068245411224;0.9999567459343585;-0.2728477309464129;0.056226711440214294;-0.4119769126869469;-0.517849921393236
Long fibula;Hypoplasia of the calcaneus;0.8273154497146606;0.6428771;0.5552441184108488;0.6162422673340986;0.6986638889529599;0.1286515607617007;-0.055786787054766585;-0.1434197705421112;-0.08242162161886135
Long fibula;2-hydroxyadipic aciduria;0.8862058073282242;0.9771333;0.5363004490158214;0.507279330502562;0.9999056439461368;-0.11369983661791261;-0.02277236986776765;-0.4636051949303154;-0.49262631344357477
Long fibula;Potter facies;0.9177041798830032;1.0890725;0.5262252323140111;0.47160972307071614;0.9999510285821799;-0.08224684869917664;0.08912143731442657;-0.4737257962681688;-0.5283413055114637
Long fibula;Increased heart rate variability;0.7475926280021667;0.98230416;0.581222299493253;0.505633047860907;0.9999567459343585;-0.2523641179321917;-0.017652590107789856;-0.41873444644110547;-0.49432369807345145
Long fibula;Aplastic zygomatic arch;0.8931456431746483;1.1069111;0.5340778585240198;0.465903992054852;0.8994299275196795;-0.006284284345031255;0.20748113567459536;-0.36535206899565975;-0.43352593546482754
Long fibula;Testicular torsion;0.8508852571249008;0.9622734;0.5476423783816302;0.51201159422504;0.9999567459343585;-0.14907148880945764;-0.03768332703100763;-0.45231436755272825;-0.4879451517093185
Long fibula;Abolished vibration sense;0.929057389497757;1.0483843;0.5226007190643993;0.4845927878093851;0.9999548690865008;-0.07089747958874382;0.048429439728501666;-0.47735415002210146;-0.5153620812771157
Long fibula;Fractured metatarsal bone of digit 5;0.6198644042015076;0.56209564;0.6241226779154798;0.6442791510620808;0.36999089714112543;0.24987350706038214;0.19210474494871832;0.2541317807743544;0.27428825392095535
Long fibula;Prolonged G2 phase of cell cycle;0.9037755653262138;1.0452325;0.5306766535506462;0.4855971110621341;0.9999528219730685;-0.09617725664685461;0.045279712435500885;-0.46927616842242226;-0.5143557109109343
Long fibula;Single naris;0.8523541241884232;1.0140538;0.5471695898353592;0.49552636874739187;0.9999528219730685;-0.1475986977846453;0.014100999590652252;-0.4527832321377092;-0.5044264532256766
Long fibula;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8160807937383652;1.1148198;0.5588784794215356;0.46337094728840955;0.9999056439461368;-0.18382485020777162;0.11491412114480559;-0.4410271645246012;-0.5365346966577272
Long fibula;Asymmetry of the thorax;0.7098932862281799;1.056135;0.5936908051512146;0.482122242887181;0.8948681243054075;-0.1849748380772276;0.16126693409760762;-0.3011773191541929;-0.41274588141822655
Long fibula;Type 2 muscle fiber predominance;0.8046675473451614;0.76656544;0.5625785844474235;0.574996472384742;0.9283707775802553;-0.12370323023509389;-0.1618053354949892;-0.36579219313283184;-0.35337430519551327
Long fibula;Dependency on parenteral nutrition;0.9272749722003937;0.8964142;0.523169549697062;0.5330316251929132;0.9999548690865008;-0.0726798968861071;-0.10354064875340141;-0.4767853193894388;-0.4669232438935875
Long fibula;Limited shoulder flexion;0.7825723737478256;0.9836307;0.5697666104942484;0.5052107302798469;0.8029485097445463;-0.020376135996720723;0.18068220705614335;-0.23318189925029797;-0.2977377794646995
Long fibula;Paroxysmal vertigo;0.9496814236044884;1.1157187;0.5160236670609553;0.46308287296095774;0.9999548690865008;-0.0502734454820124;0.11576385325694405;-0.4839312020255455;-0.536871996125543
Long fibula;Long hallux;0.5549420714378357;0.5325004;0.6468169170980496;0.6548450726865163;0.7851314665573785;-0.23018939511954284;-0.2526310803192804;-0.13831454945932897;-0.13028639387086227
Long fibula;Broad medial eyebrow;0.7897834181785583;1.0895165;0.5674169155032871;0.47146783062143593;0.9999567459343585;-0.2101733277558001;0.08955977456582465;-0.43253983043107136;-0.5284889153129225
Long fibula;Myxoid subcutaneous tumors;0.9255641400814056;0.9609108;0.523715604741519;0.5124456576347929;0.9999567459343585;-0.07439260585295282;-0.039045948815217835;-0.47624114119283945;-0.4875110882995656
Long fibula;Bulbous tips of toes;0.7995269298553467;0.7567893;0.5642479124618818;0.578200632385721;0.8139171598024477;-0.01439022994710104;-0.057127833134662076;-0.24966924734056595;-0.23571652741672677
Long fibula;Absent internal genitalia;0.8593383729457855;1.0206181;0.5449229641738011;0.49343657986338463;0.9999056439461368;-0.14056727100035127;0.020712437146697682;-0.45498267977233564;-0.5064690640827522
Long fibula;Hyperphalangy of the 2nd finger;0.8530698418617249;0.91543293;0.5469392577354522;0.5269507184175883;0.8216557397003772;0.03141410216134766;0.09377719029229858;-0.27471648196492504;-0.29470502128278886
Long fibula;Renal interstitial hemosiderin;0.909462220966816;1.0341123;0.5288585881659438;0.48913960453150196;0.9999056439461368;-0.09044342297932084;0.03420669030526702;-0.471047055780193;-0.5107660394146348
Long fibula;Abnormality of depressor anguli oris muscle;0.8506418466567993;1.0846338;0.5477207358230265;0.4730279413698095;0.8605427142144324;-0.009900867557633086;0.22409111299504025;-0.3128219783914059;-0.3875147728446229
Long fibula;Paroxysmal dyspnea;0.8922109752893448;1.0731667;0.534377100883199;0.4766894914564127;0.9999056439461368;-0.107694668656792;0.07326108407357756;-0.4655285430629378;-0.5232161524897241
Long fibula;Phenylpyruvic acidemia;0.8762030452489853;0.99569494;0.5395071486109433;0.5013703423587212;0.9999567459343585;-0.12375370068537317;-0.004261810612550598;-0.46044959732341517;-0.4985864035756372
Long fibula;Lateral ventricle dilatation;0.733404278755188;1.0875762;0.5858988466607601;0.47208786945217596;0.9999433058680118;-0.26653902711282385;0.0876328450261532;-0.41404445920725175;-0.5278554364158359
Long fibula;Neonatal unconjugated hyperbilirubinemia;0.8669793605804443;1.0095651;0.542467658852994;0.49695528765559704;0.9999567459343585;-0.13297738535391412;0.009608369040617126;-0.4574890870813645;-0.5030014582787614
Long fibula;High maternal circulating alpha-fetoprotein concentration;0.6386575698852539;0.9789846;0.6176814564439239;0.5066898943849194;0.9999056439461368;-0.3612480740608829;-0.020921049601044017;-0.3822241875022129;-0.4932157495612174
Long fibula;Prominent nasolabial fold;0.6808589100837708;1.0491384;0.6033943866826311;0.48435244922043874;0.9999501780647019;-0.3190912679809311;0.049188248715998806;-0.39655579138207075;-0.5155977288442631
Long fibula;Abnormality of inferior alveolar nerve;0.8853899464011192;1.0070964;0.5365618558672725;0.49774111534479615;0.9999056439461368;-0.11451569754501756;0.007190765851531666;-0.46334378807886434;-0.5021645286013406
Long fibula;Unilateral conductive hearing impairment;0.8499916195869446;0.9553692;0.5479300678667487;0.5142111535480081;0.9999567459343585;-0.14996512634741388;-0.04458757145392023;-0.45202667806760977;-0.4857455923863504
Long fibula;Macular hypopigmented whorls, streaks, and patches;0.9607781916856766;1.1803982;0.512487892529205;0.44226136418060236;0.9999567459343585;-0.039178554248681885;0.1804414798499433;-0.48746885340515345;-0.5576953817537561
Long fibula;Delayed ossification of pubic rami;0.7408801317214966;0.6854538;0.5834324703327822;0.6018523552183619;0.8212764310058089;-0.08039629928431236;-0.1358226584609481;-0.2378439606730267;-0.21942407578744705
Long fibula;Hyperphenylalaninemia;0.7972675561904907;0.9839964;0.5649821698511965;0.5050943338242448;0.9999521228478421;-0.20268456665735135;-0.015955731551455354;-0.43496995299664554;-0.4948577890235972
Long fibula;Ureteropelvic junction obstruction;0.8287598341703415;0.86158895;0.5547774041145703;0.5441995038693108;0.9999481150251853;-0.17118828085484383;-0.13835916009964822;-0.445170710910615;-0.4557486111558745
Long fibula;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8287055194377899;0.6199339;0.5547949523126302;0.6240987605770336;0.6109530888848884;0.2177524305529015;0.008980814332427256;-0.05615813657225821;0.0131456716921452
Long fibula;Difficulty walking;0.8072913438081741;0.8505832;0.5617272258432734;0.5477396072820406;0.9111657437054939;-0.10387439989731972;-0.060582548019153526;-0.34943851786222047;-0.3634261364234532
Long fibula;Bilobate gallbladder;0.7755297869443893;0.931588;0.5720651486117638;0.5217932374943581;0.9999548690865008;-0.22442508214211143;-0.06836687498783744;-0.42788972047473695;-0.47816163159214264
Long fibula;Histidinuria;0.9069332480430603;0.95024747;0.5296669991839075;0.5158432557114406;0.9999536937290383;-0.093020445685978;-0.04970622716485984;-0.47028669454513083;-0.4841104380175977
Long fibula;Widened interpedicular distance;0.6707972884178162;0.7784903;0.6067799471306563;0.5710984403056113;0.789736248610815;-0.11893896019299888;-0.011245943663915625;-0.18295630148015873;-0.21863780830520374
Fragmentation of the epiphysis of the distal phalanx of the hallux;Type II cryptotia;0.7865058481693268;1.0015275;0.5684844304881806;0.49951377868386937;1.0;-0.21349415183067322;0.001527547836303711;-0.43151556951181935;-0.5004862213161306
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased variability in muscle fiber diameter;0.8137630969285965;0.93348724;0.5596291949115874;0.5211873069783239;0.7712186293488323;0.042544467579764156;0.16226860715095404;-0.21158943443724498;-0.2500313223705084
Fragmentation of the epiphysis of the distal phalanx of the hallux;Widened proximal tibial metaphyses;0.580928772687912;0.35715914;0.637644244822406;0.722244350598301;0.4693866352828394;0.11154213740507257;-0.11222749755700934;0.1682576095395666;0.25285771531546164
Fragmentation of the epiphysis of the distal phalanx of the hallux;Wide anterior fontanel;0.9668676555156708;1.1573042;0.5105482833026944;0.4497196994665965;0.6617971500655027;0.3050705054501681;0.4955070176819949;-0.15124886676280824;-0.21207745059890615
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased circulating oleate level;0.9557983800768852;0.96546674;0.5140743982002679;0.5109944552585584;1.0;-0.04420161992311478;-0.03453326225280762;-0.4859256017997321;-0.48900554474144164
Fragmentation of the epiphysis of the distal phalanx of the hallux;Lozenge-shaped umbilicus;0.8920188322663307;1.0359186;0.5344386209771173;0.48856428964878984;0.9999134918687169;-0.1078946596023862;0.03600510153796033;-0.46547487089159967;-0.5113492022199271
Fragmentation of the epiphysis of the distal phalanx of the hallux;Anti-myelin-associated glycoprotein antibody positivity;0.9053220301866531;1.0030938;0.5301821405542775;0.4990151918722924;1.0;-0.09467796981334686;0.0030938386917114258;-0.4698178594457225;-0.5009848081277076
Fragmentation of the epiphysis of the distal phalanx of the hallux;Fractured radius;0.5948663353919983;0.67294866;0.6327750195717372;0.606055007269697;0.4693866352828394;0.12547970010915888;0.2035620231834997;0.1633883842888978;0.13666837198685755
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormal manual kinetic perimetry test;0.7501577138900757;0.9713428;0.5803787760557263;0.5091231267172129;1.0;-0.24984228610992432;-0.028657197952270508;-0.4196212239442737;-0.49087687328278706
Fragmentation of the epiphysis of the distal phalanx of the hallux;Small radial epiphyses;0.568231999874115;0.6163933;0.6421100794368544;0.6253181554303557;1.0;-0.431768000125885;-0.3836066722869873;-0.3578899205631456;-0.37468184456964426
Fragmentation of the epiphysis of the distal phalanx of the hallux;Generalized keratosis follicularis;0.8388685137033463;0.8981925;0.5515143212424636;0.5324625667909157;0.9999201345566091;-0.16105162085326286;-0.10172760964663596;-0.44840581331414553;-0.46745756776569336
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hypoplasia of the calcaneus;0.4842498302459717;0.56080693;0.672486725377238;0.6447355953167316;0.5863259809806012;-0.1020761507346295;-0.02551905091544615;0.08616074439663679;0.058409614336130455
Fragmentation of the epiphysis of the distal phalanx of the hallux;2-hydroxyadipic aciduria;0.7877119779586792;0.9963937;0.5680914998575152;0.5011479254644411;1.0;-0.2122880220413208;-0.0036063194274902344;-0.43190850014248483;-0.4988520745355589
Fragmentation of the epiphysis of the distal phalanx of the hallux;Potter facies;0.9188941791653633;0.97043025;0.5258451731791633;0.5094137179293217;0.9998981869165328;-0.08100400775116945;-0.0294679319803145;-0.4740530137373694;-0.4904844689872111
Fragmentation of the epiphysis of the distal phalanx of the hallux;Increased heart rate variability;0.9656113013625145;1.03736;0.5109484213748756;0.48810518473234155;0.9999201345566091;-0.03430883319409461;0.037439818370026634;-0.4889717131817335;-0.5118149498242676
Fragmentation of the epiphysis of the distal phalanx of the hallux;Aplastic zygomatic arch;0.7340008318424225;0.97278035;0.5857018443354636;0.5086653620724271;0.8072246192530101;-0.07322378741058766;0.16555572761741222;-0.22152277491754657;-0.29855925718058307
Fragmentation of the epiphysis of the distal phalanx of the hallux;Testicular torsion;0.8562713414430618;0.99448746;0.5459092530695592;0.5017547099795838;0.9999201345566091;-0.14364879311354728;-0.00543267012866111;-0.45401088148704993;-0.4981654245770253
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abolished vibration sense;0.7880225479602814;1.0385759;0.5679903400450204;0.48771787799250665;0.9999134918687169;-0.21189094390843555;0.03866239581133679;-0.43192315182369656;-0.5121956138762103
Fragmentation of the epiphysis of the distal phalanx of the hallux;Fractured metatarsal bone of digit 5;0.4252515435218811;0.16326594;0.6949001019581541;0.8155379672829725;1.0;-0.5747484564781189;-0.8367340564727783;-0.3050998980418459;-0.18446203271702755
Fragmentation of the epiphysis of the distal phalanx of the hallux;Prolonged G2 phase of cell cycle;0.9399682655930519;1.0641985;0.5191201905474907;0.4795509216266681;0.9999056439461368;-0.05993737835308488;0.06429285001138274;-0.4807854533986461;-0.5203547223194687
Fragmentation of the epiphysis of the distal phalanx of the hallux;Single naris;1.00543849542737;1.0628079;0.49826886460573216;0.4799944368134287;0.9999056439461368;0.005532851481233281;0.06290227364877288;-0.5016367793404046;-0.5199112071327081
Fragmentation of the epiphysis of the distal phalanx of the hallux;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8146254271268845;1.0600963;0.5593498421651952;0.4808592176740679;1.0;-0.18537457287311554;0.06009626388549805;-0.44065015783480477;-0.5191407823259321
Fragmentation of the epiphysis of the distal phalanx of the hallux;Asymmetry of the thorax;0.7651133239269257;1.1473783;0.5754719045159749;0.4529165016763844;0.789736248610815;-0.02462292468388938;0.35764207685152627;-0.2142643440948402;-0.3368197469344306
Fragmentation of the epiphysis of the distal phalanx of the hallux;Type 2 muscle fiber predominance;0.9341689050197601;0.9852322;0.5209698532811449;0.5047009116162593;0.8527273749847077;0.08144153003505239;0.13250479941180715;-0.3317575217035629;-0.34802646336844845
Fragmentation of the epiphysis of the distal phalanx of the hallux;Dependency on parenteral nutrition;0.8797283843159676;0.9112293;0.5383765474747126;0.5282938287255328;0.9999134918687169;-0.12018510755274936;-0.08868417944882556;-0.4615369443940043;-0.47161966314318415
Fragmentation of the epiphysis of the distal phalanx of the hallux;Limited shoulder flexion;0.8589594960212708;1.2342817;0.5450447788405454;0.42472619185291427;1.0;-0.14104050397872925;0.23428165912628174;-0.45495522115945464;-0.5752738081470857
Fragmentation of the epiphysis of the distal phalanx of the hallux;Paroxysmal vertigo;0.8975530713796616;1.1611602;0.5326671834156402;0.44847642240459007;0.9999134918687169;-0.10236042048905536;0.16124673876787976;-0.4672463084530767;-0.5514370694641268
Fragmentation of the epiphysis of the distal phalanx of the hallux;Long hallux;0.44284361600875854;0.15785629;0.6881076109372772;0.8187065984769629;0.0;0.44284361600875854;0.157856285572052;0.6881076109372772;0.8187065984769629
Fragmentation of the epiphysis of the distal phalanx of the hallux;Broad medial eyebrow;0.9372976794838905;0.99732083;0.5199718699519316;0.5008528159498626;0.9999201345566091;-0.06262245507271857;-0.0025993037346181413;-0.47994826460467754;-0.49906731860674647
Fragmentation of the epiphysis of the distal phalanx of the hallux;Myxoid subcutaneous tumors;0.8821840956807137;0.9150826;0.5375892717508926;0.5270626523523654;0.9999201345566091;-0.11773603887589545;-0.08483756066592307;-0.46233086280571656;-0.47285748220424373
Fragmentation of the epiphysis of the distal phalanx of the hallux;Bulbous tips of toes;0.6807785034179688;0.32592237;0.6034213935492163;0.7354586876671954;0.36317310279071235;0.3176054006272564;-0.03725073283374214;0.24024829075850396;0.372285584876483
Fragmentation of the epiphysis of the distal phalanx of the hallux;Absent internal genitalia;0.8040836751461029;0.9400331;0.5627680983616286;0.519099526385152;1.0;-0.1959163248538971;-0.05996692180633545;-0.43723190163837145;-0.480900473614848
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hyperphalangy of the 2nd finger;0.5983763933181763;0.4558015;0.6315539848843668;0.6831661656670863;0.6245600766986774;-0.026183683380501144;-0.16875858972968327;0.006993908185689346;0.05860608896840891
Fragmentation of the epiphysis of the distal phalanx of the hallux;Renal interstitial hemosiderin;0.8564570546150208;1.0779546;0.5458495193287498;0.47516106815813874;1.0;-0.14354294538497925;0.07795464992523193;-0.4541504806712502;-0.5248389318418613
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormality of depressor anguli oris muscle;0.757508397102356;1.1709816;0.5779646865173409;0.44530611722725943;1.0;-0.24249160289764404;0.17098164558410645;-0.4220353134826591;-0.5546938827727406
Fragmentation of the epiphysis of the distal phalanx of the hallux;Paroxysmal dyspnea;0.7333151698112488;1.0085301;0.5859282763888839;0.4972847561009368;1.0;-0.2666848301887512;0.008530139923095703;-0.4140717236111161;-0.5027152438990632
Fragmentation of the epiphysis of the distal phalanx of the hallux;Phenylpyruvic acidemia;0.8319763839244843;1.0137957;0.5537384875291734;0.4956085607305162;0.9999201345566091;-0.16794375063212486;0.013875598895234154;-0.4461816470274357;-0.5043115738260929
Fragmentation of the epiphysis of the distal phalanx of the hallux;Lateral ventricle dilatation;0.7293057441711426;1.0776618;0.587253240471573;0.47525459326252273;0.9998579617208769;-0.27055221754973435;0.07780379097992873;-0.4126047212493039;-0.5246033684583542
Fragmentation of the epiphysis of the distal phalanx of the hallux;Neonatal unconjugated hyperbilirubinemia;0.8850905299186707;1.0750575;0.5366577969505353;0.47608596388204716;0.9999201345566091;-0.11482960463793845;0.07513737200467019;-0.4632623376060738;-0.523834170674562
Fragmentation of the epiphysis of the distal phalanx of the hallux;High maternal circulating alpha-fetoprotein concentration;0.9614997282624245;1.095245;0.5122580466786436;0.4696365642703286;1.0;-0.03850027173757553;0.09524500370025635;-0.4877419533213564;-0.5303634357296714
Fragmentation of the epiphysis of the distal phalanx of the hallux;Prominent nasolabial fold;0.8708822727203369;1.0702027;0.5412145118712357;0.4776353783339261;0.9998944404568447;-0.1290121677365078;0.070308267787479;-0.458679928585609;-0.5222590621229186
Fragmentation of the epiphysis of the distal phalanx of the hallux;Abnormality of inferior alveolar nerve;0.8093733489513397;0.9589983;0.5610519838215164;0.5130549060139455;1.0;-0.19062665104866028;-0.04100167751312256;-0.43894801617848356;-0.48694509398605446
Fragmentation of the epiphysis of the distal phalanx of the hallux;Unilateral conductive hearing impairment;0.8791034817695618;1.0019246;0.5385769222474037;0.49938737567594516;0.9999201345566091;-0.12081665278704734;0.002004499423188255;-0.4613432123092054;-0.500532758880664
Fragmentation of the epiphysis of the distal phalanx of the hallux;Macular hypopigmented whorls, streaks, and patches;0.7775802910327911;1.0111008;0.5713955222844878;0.49646645475389406;0.9999201345566091;-0.22233984352381797;0.011180634486359642;-0.42852461227212135;-0.503453679802715
Fragmentation of the epiphysis of the distal phalanx of the hallux;Delayed ossification of pubic rami;0.6166566014289856;0.7688165;0.6252274158772522;0.5742597884809196;0.6574179255159834;-0.04076132408699784;0.11139854558387008;-0.03219050963873127;-0.0831581370350638
Fragmentation of the epiphysis of the distal phalanx of the hallux;Hyperphenylalaninemia;0.8349598348140717;0.9563123;0.5527753764055647;0.5139106569883573;0.9999028053808913;-0.1649429705668196;-0.04359050660617203;-0.44712742897532654;-0.485992148392534
Fragmentation of the epiphysis of the distal phalanx of the hallux;Ureteropelvic junction obstruction;0.8182319551706314;0.894643;0.5581820021114294;0.5335985310966177;0.9998847295244674;-0.18165277435383598;-0.10524172081551353;-0.44170272741303795;-0.4662861984278497
Fragmentation of the epiphysis of the distal phalanx of the hallux;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.3719269037246704;0.10410291;0.716156120670156;0.8534660651227854;1.0;-0.6280730962753296;-0.8958970904350281;-0.283843879329844;-0.14653393487721456
Fragmentation of the epiphysis of the distal phalanx of the hallux;Difficulty walking;0.8206049501895905;0.8164402;0.5574140286639944;0.5587620777820588;0.7552776988623575;0.06532725132723294;0.06116252578516446;-0.19786367019836315;-0.19651562108029874
Fragmentation of the epiphysis of the distal phalanx of the hallux;Bilobate gallbladder;0.8888369426131248;1.12505;0.5354575836870954;0.46009088742480087;0.9999134918687169;-0.11107654925559207;0.12513645682360486;-0.4644559081816215;-0.539822604443916
Fragmentation of the epiphysis of the distal phalanx of the hallux;Histidinuria;0.7941032946109772;0.98297274;0.566011090887518;0.5054202103245129;0.9999090677057578;-0.20580577309478065;-0.016936326578743666;-0.43389797681823983;-0.49448885738124493
Fragmentation of the epiphysis of the distal phalanx of the hallux;Widened interpedicular distance;0.7370180189609528;0.9016073;0.5847059788755467;0.5313701401583826;1.0;-0.26298198103904724;-0.09839272499084473;-0.41529402112445335;-0.4686298598416174
Type II cryptotia;Increased variability in muscle fiber diameter;0.8980237245559692;0.9065794;0.532516581102626;0.5297801237489213;0.9998452077479463;-0.10182148319197704;-0.09326583248091747;-0.46732862664532027;-0.470065083999025
Type II cryptotia;Widened proximal tibial metaphyses;0.9045823216438293;1.0446012;0.5304186679305632;0.4857982936155604;0.9999201345566091;-0.09533781291277976;0.04468106745449929;-0.46950146662604586;-0.5141218409410487
Type II cryptotia;Wide anterior fontanel;0.9799837060272694;0.81071556;0.506371809784339;0.5606168131947803;0.999848231156753;-0.019864525129483668;-0.18913267501203868;-0.493476421372414;-0.43923141796197274
Type II cryptotia;Increased circulating oleate level;0.8883908987045288;0.97723156;0.5356004529194691;0.5072480422245411;1.0;-0.11160910129547119;-0.02276843786239624;-0.4643995470805309;-0.4927519577754589
Type II cryptotia;Lozenge-shaped umbilicus;0.9198671579360962;0.9902128;0.525534452999505;0.5031154057403713;0.9999134918687169;-0.08004633393262073;-0.00970069375012561;-0.47437903886921196;-0.49679808612834564
Type II cryptotia;Anti-myelin-associated glycoprotein antibody positivity;0.9100293666124344;0.8656911;0.5286773203000312;0.5428814298094012;1.0;-0.08997063338756561;-0.13430887460708618;-0.47132267969996877;-0.45711857019059876
Type II cryptotia;Fractured radius;0.8036738187074661;0.92284465;0.562901143501939;0.5245837505593716;0.9999201345566091;-0.19624631584914298;-0.07707548619540305;-0.4370189910546701;-0.47533638399723754
Type II cryptotia;Abnormal manual kinetic perimetry test;0.8260627835988998;0.883098;0.5556489811692461;0.5372963359133602;1.0;-0.17393721640110016;-0.11690199375152588;-0.4443510188307539;-0.46270366408663977
Type II cryptotia;Small radial epiphyses;0.7112970352172852;0.865172;0.5932240019101624;0.543048180181775;1.0;-0.28870296478271484;-0.13482797145843506;-0.40677599808983755;-0.45695181981822497
Type II cryptotia;Generalized keratosis follicularis;0.8309841752052307;0.8142034;0.5540588998344955;0.5594865681257873;0.9999201345566091;-0.1689359593513784;-0.185716753018218;-0.4458612347221136;-0.44043356643082177
Type II cryptotia;Hypoplasia of the calcaneus;0.7569200396537781;0.88543516;0.5781577427704825;0.5365473600703754;0.9999134918687169;-0.24299345221493884;-0.11447832789395496;-0.42175574909823443;-0.4633661317983415
Type II cryptotia;2-hydroxyadipic aciduria;0.7051737010478973;0.77892685;0.595261787733733;0.5709559561368373;1.0;-0.29482629895210266;-0.22107315063476562;-0.40473821226626705;-0.42904404386316275
Type II cryptotia;Potter facies;0.8409931659698486;0.59413785;0.5508291890502108;0.6330286963618885;0.9998981869165328;-0.15890502094668413;-0.4057603394929793;-0.44906899786632193;-0.36686949055464424
Type II cryptotia;Increased heart rate variability;0.9508755058050156;1.0112854;0.5156431081629365;0.49640765215344473;0.9999201345566091;-0.049044628751593544;0.011365289675873802;-0.48427702639367265;-0.5035124824031644
Type II cryptotia;Aplastic zygomatic arch;0.8037828058004379;0.7991829;0.5628657636793725;0.5643597060842963;0.9999134918687169;-0.196130686068279;-0.2007306000230138;-0.43704772818934445;-0.4355537857844206
Type II cryptotia;Testicular torsion;0.8320774734020233;0.9550367;0.5537058459641369;0.5143170875098189;0.9999201345566091;-0.1678426611545858;-0.044883434784728005;-0.44621428859247225;-0.48560304704679025
Type II cryptotia;Abolished vibration sense;0.8520111739635468;0.9240997;0.5472799668097361;0.5241830830054236;0.9999134918687169;-0.14790231790517017;-0.07581380810712024;-0.4526335250589808;-0.4757304088632933
Type II cryptotia;Fractured metatarsal bone of digit 5;0.913988433778286;0.9707641;0.5274122021690015;0.5093074014520724;1.0;-0.08601156622171402;-0.029235899448394775;-0.47258779783099847;-0.49069259854792757
Type II cryptotia;Prolonged G2 phase of cell cycle;0.7507618963718414;0.8894433;0.5801801759703176;0.5352633887708291;0.9999056439461368;-0.24914374757429536;-0.11046236563345369;-0.4197254679758192;-0.46464225517530766
Type II cryptotia;Single naris;0.9640839472413063;0.72933674;0.5114348939963179;0.5872430019212578;0.9999056439461368;-0.035821696704830486;-0.270568905359711;-0.48847074994981887;-0.412662642024879
Type II cryptotia;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7778551578521729;0.77183264;0.5713057844282093;0.5732733347408784;1.0;-0.22214484214782715;-0.2281673550605774;-0.42869421557179066;-0.4267266652591216
Type II cryptotia;Asymmetry of the thorax;0.7831401526927948;0.8102129;0.5695814631579503;0.5607797737161192;0.9999056439461368;-0.216765491253342;-0.1896927337708133;-0.43032418078818646;-0.4391258702300176
Type II cryptotia;Type 2 muscle fiber predominance;0.8146899938583374;0.90589017;0.5593289275704665;0.5300004907272846;0.9999003561294039;-0.18521036227106646;-0.0940101893699129;-0.4405714285589374;-0.46989986540211925
Type II cryptotia;Dependency on parenteral nutrition;0.9598921239376068;1.0537921;0.5127701587946497;0.4828691588252365;0.9999134918687169;-0.04002136793111011;0.05387862715746716;-0.4871433330740672;-0.5170443330434804
Type II cryptotia;Limited shoulder flexion;0.8987579345703125;1.0402685;0.5322816589266188;0.48717865525476756;1.0;-0.1012420654296875;0.040268540382385254;-0.46771834107338117;-0.5128213447452324
Type II cryptotia;Paroxysmal vertigo;0.740590512752533;0.90523124;0.5835279227859198;0.5302111641782588;0.6634698588464949;0.07712065390603806;0.24176137856500413;-0.07994193606057509;-0.13325869466823614
Type II cryptotia;Long hallux;0.9400313124060631;1.0273404;0.519100085902369;0.4912962097406762;0.9998836012415208;-0.05985228883545768;0.02745681089837182;-0.48078351533915176;-0.5085873915008445
Type II cryptotia;Broad medial eyebrow;0.9728724751621485;0.83654475;0.5086360187759704;0.5522639356869344;0.9999201345566091;-0.027047659394460632;-0.16337538243563743;-0.4912841157806387;-0.44765619886967467
Type II cryptotia;Myxoid subcutaneous tumors;0.7691395282745361;0.8554834;0.5741540922044763;0.5461627094410446;0.9999201345566091;-0.23078060628207298;-0.14443672181399436;-0.4257660423521328;-0.4537574251155645
Type II cryptotia;Bulbous tips of toes;0.874828577041626;0.8794454;0.539948085251517;0.5384672951160274;0.9999134918687169;-0.12508491482709094;-0.12046811785672351;-0.45996540661719987;-0.4614461967526895
Type II cryptotia;Absent internal genitalia;0.8793987259268761;0.8412423;0.5384822504069705;0.5507488722293897;1.0;-0.12060127407312393;-0.15875768661499023;-0.4615177495930295;-0.44925112777061027
Type II cryptotia;Hyperphalangy of the 2nd finger;0.7703810632228851;0.90083486;0.5737479889330109;0.531617216352953;0.9999201345566091;-0.22953907133372398;-0.09908527613909812;-0.4261721456235982;-0.4683029182036561
Type II cryptotia;Renal interstitial hemosiderin;0.7622706741094589;0.84457546;0.5764031221945408;0.549674548494165;1.0;-0.23772932589054108;-0.15542453527450562;-0.4235968778054592;-0.45032545150583503
Type II cryptotia;Abnormality of depressor anguli oris muscle;0.927951380610466;0.9236549;0.5229536758926011;0.5243250601161309;1.0;-0.072048619389534;-0.07634508609771729;-0.4770463241073989;-0.4756749398838691
Type II cryptotia;Paroxysmal dyspnea;0.8065382242202759;0.9347221;0.561971548934286;0.5207933781215388;1.0;-0.19346177577972412;-0.06527787446975708;-0.438028451065714;-0.4792066218784612
Type II cryptotia;Phenylpyruvic acidemia;0.8227072060108185;0.87299556;0.5567339569485668;0.5405362531193991;0.9999201345566091;-0.17721292854579063;-0.12692457915576072;-0.44318617760804235;-0.45938388143721
Type II cryptotia;Lateral ventricle dilatation;0.8779840171337128;0.93927354;0.5389359166403447;0.5193417363623827;0.9998579617208769;-0.12187394458716416;-0.06058442551558518;-0.46092204508053225;-0.48051622535849425
Type II cryptotia;Neonatal unconjugated hyperbilirubinemia;0.8838156834244728;1.0819677;0.5370663295626812;0.4738795762465984;0.9999201345566091;-0.1161044511321363;0.08204757689206033;-0.4628538049939279;-0.5260405583100107
Type II cryptotia;High maternal circulating alpha-fetoprotein concentration;0.9281681925058365;0.94945514;0.5228844832408318;0.5160957912465618;1.0;-0.07183180749416351;-0.0505448579788208;-0.4771155167591682;-0.4839042087534382
Type II cryptotia;Prominent nasolabial fold;0.9407905861735344;0.84041715;0.5188579713108059;0.5510149131883381;0.9998944404568447;-0.05910385428331033;-0.15947729377410547;-0.4810364691460388;-0.44887952726850666
Type II cryptotia;Abnormality of inferior alveolar nerve;0.789578378200531;0.8728239;0.5674836749785821;0.5405913413347756;1.0;-0.210421621799469;-0.12717610597610474;-0.4325163250214179;-0.4594086586652244
Type II cryptotia;Unilateral conductive hearing impairment;0.8893152177333832;0.9893577;0.5353043986665151;0.5033876029880716;0.5881001503332186;0.30121506740016457;0.40125755955142495;-0.05279575166670347;-0.084712547345147
Type II cryptotia;Macular hypopigmented whorls, streaks, and patches;0.8557620346546173;0.7843909;0.5460730774887776;0.5691736819982665;0.9999201345566091;-0.1441580999019918;-0.21552920819552512;-0.45384705706783146;-0.43074645255834265
Type II cryptotia;Delayed ossification of pubic rami;0.9372627586126328;0.9411454;0.5199830075384307;0.5187448232943965;0.9999134918687169;-0.06265073325608417;-0.05876807179425403;-0.4799304843302862;-0.4811686685743204
Type II cryptotia;Hyperphenylalaninemia;0.8445397466421127;0.8833761;0.549686057809426;0.537207213689237;0.9999028053808913;-0.15536305873877854;-0.11652668385989517;-0.45021674757146524;-0.4626955916916543
Type II cryptotia;Ureteropelvic junction obstruction;0.8789033740758896;1.0444392;0.5386410899496334;0.48584988779858795;0.9998847295244674;-0.1209813554485778;0.0445544670621415;-0.46124363957483394;-0.5140348417258794
Type II cryptotia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6154969930648804;0.9276534;0.6256271655235544;0.5230487830850694;1.0;-0.38450300693511963;-0.07234662771224976;-0.37437283447644565;-0.4769512169149306
Type II cryptotia;Difficulty walking;0.9206164106726646;0.8738768;0.5252951962255783;0.5402534717819718;0.9998344221996177;-0.07921801152695307;-0.12595761212576517;-0.4745392259740394;-0.4595809504176459
Type II cryptotia;Bilobate gallbladder;0.8635440468788147;1.0316036;0.543571216847302;0.48993858725981043;0.9999134918687169;-0.13636944498990222;0.0316900828840907;-0.4563422750214149;-0.5099749046089065
Type II cryptotia;Histidinuria;0.7989296764135361;0.87246305;0.5644419756434249;0.5407071453418832;0.9999090677057578;-0.20097939129222175;-0.12744602020133278;-0.4354670920623329;-0.4592019223638746
Type II cryptotia;Widened interpedicular distance;0.8598814308643341;0.9694538;0.5447483743767388;0.5097246759277418;1.0;-0.1401185691356659;-0.030546188354492188;-0.45525162562326116;-0.49027532407225816
Increased variability in muscle fiber diameter;Widened proximal tibial metaphyses;0.6166289448738098;0.7888787;0.6252369474423273;0.5677115143989431;0.922134556158444;-0.30550561128463416;-0.13325587688293128;-0.2968976087161167;-0.3544230417595009
Increased variability in muscle fiber diameter;Wide anterior fontanel;0.8384900242090225;0.9900581;0.5516363971372242;0.5031646578324434;0.8867374741530093;-0.048247449943986775;0.10332064991238987;-0.33510107701578506;-0.38357281632056595
Increased variability in muscle fiber diameter;Increased circulating oleate level;0.7139804363250732;0.84516233;0.5923322357846855;0.5494854536143261;0.9998452077479463;-0.28586477142287303;-0.1546828756899934;-0.40751297196326075;-0.45035975413362017
Increased variability in muscle fiber diameter;Lozenge-shaped umbilicus;0.9281880185008049;1.0216674;0.5228781560905935;0.49310251366591684;0.9999445057306702;-0.07175648722986527;0.021722855528790275;-0.47706634964007666;-0.5068419920647533
Increased variability in muscle fiber diameter;Anti-myelin-associated glycoprotein antibody positivity;0.7109850645065308;0.7761897;0.5933277268954691;0.5718496126706676;0.9998452077479463;-0.2888601432414155;-0.2236555228800874;-0.4065174808524772;-0.4279955950772787
Increased variability in muscle fiber diameter;Fractured radius;0.7955432236194611;0.9316176;0.5655427839428204;0.5217837906590567;0.922134556158444;-0.12659133253898291;0.009483061448672725;-0.35659177221562355;-0.4003507654993873
Increased variability in muscle fiber diameter;Abnormal manual kinetic perimetry test;0.7018961608409882;0.82127005;0.5963541713740438;0.55719883854435;0.9998452077479463;-0.2979490469069581;-0.17857515912962962;-0.4034910363739025;-0.44264636920359623
Increased variability in muscle fiber diameter;Small radial epiphyses;0.7503085285425186;0.84184456;0.5803291989643952;0.5505547186361657;0.7712186293488323;-0.020910100806313725;0.07062592936698797;-0.19088943038443718;-0.22066391071266667
Increased variability in muscle fiber diameter;Generalized keratosis follicularis;0.7108006477355957;0.9587234;0.5933890471514346;0.5131424753456097;0.9999473166570552;-0.28914666892145946;-0.04122389079188182;-0.4065582695056206;-0.4868048413114454
Increased variability in muscle fiber diameter;Hypoplasia of the calcaneus;0.8368507921695709;0.89934874;0.5521651946223612;0.5320926426375103;0.91798003561481;-0.08112924344523909;-0.018631299805483836;-0.36581484099244876;-0.3858873929772997
Increased variability in muscle fiber diameter;2-hydroxyadipic aciduria;0.6931062340736389;0.769715;0.5992896318885279;0.5739658378258381;0.9998452077479463;-0.30673897367430736;-0.23013019662810374;-0.40055557585941837;-0.4258793699221082
Increased variability in muscle fiber diameter;Potter facies;0.9461091384291649;0.98074776;0.5171623080594514;0.5061285583487146;0.9999385832081533;-0.05382944477898843;-0.019190823865959716;-0.4827762751487019;-0.4938100248594387
Increased variability in muscle fiber diameter;Increased heart rate variability;0.5241801142692566;0.71778613;0.6578485896499287;0.5910687762689206;0.9999473166570552;-0.47576720238779857;-0.282161183367718;-0.3420987270071265;-0.40887854038813454
Increased variability in muscle fiber diameter;Aplastic zygomatic arch;0.8676382750272751;1.0203794;0.5422560486885633;0.4935125941411834;0.91798003561481;-0.05034176058753492;0.1023993884803438;-0.37572398692624676;-0.4244674414736266
Increased variability in muscle fiber diameter;Testicular torsion;0.8190630376338959;1.0558878;0.5579129997838157;0.4822010691496107;0.9999473166570552;-0.1808842790231593;0.05594050167943165;-0.44203431687323946;-0.5177462475074445
Increased variability in muscle fiber diameter;Abolished vibration sense;0.877720445394516;0.8571665;0.5390204471012823;0.5456213449656903;0.9999445057306702;-0.12222406033615418;-0.14277797702888795;-0.4609240586293879;-0.4543231607649799
Increased variability in muscle fiber diameter;Fractured metatarsal bone of digit 5;0.8433111906051636;0.9427117;0.5500819711757627;0.5182454134044108;0.7712186293488323;0.07209256125633123;0.17149308158103826;-0.2211366581730696;-0.25297321594442157
Increased variability in muscle fiber diameter;Prolonged G2 phase of cell cycle;0.6736197173595428;0.8466786;0.6058289998923019;0.5489969678144008;0.9999413779434757;-0.32632166058393286;-0.15326276332708166;-0.39411237805117383;-0.45094441012907494
Increased variability in muscle fiber diameter;Single naris;1.0071885054931045;1.0245982;0.49771180792746383;0.49216935642107096;0.9999413779434757;0.007247127549628751;0.02465686290888025;-0.5022295700160119;-0.5077720215224047
Increased variability in muscle fiber diameter;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.805535614490509;0.8944057;0.562296867723399;0.533674470976941;0.9998452077479463;-0.19430959325743724;-0.10543948512984325;-0.43754834002454723;-0.4661707367710053
Increased variability in muscle fiber diameter;Asymmetry of the thorax;0.7538624703884125;0.8483578;0.5791614897359811;0.5484561576435121;0.9133571980246588;-0.15949472763624628;-0.06499940135565241;-0.3341957082886776;-0.3649010403811467
Increased variability in muscle fiber diameter;Type 2 muscle fiber predominance;0.4689498543739319;0.3815049;0.6782024246079423;0.7122573460155001;0.37463062526818536;0.09431922910574653;0.006874268034732123;0.303571799339757;0.3376267207473147
Increased variability in muscle fiber diameter;Dependency on parenteral nutrition;0.8237012624740601;0.98734117;0.5564124748056223;0.5040295421516894;0.9999445057306702;-0.17624324325661012;-0.012603340188067635;-0.4435320309250479;-0.4959149635789808
Increased variability in muscle fiber diameter;Limited shoulder flexion;0.7913973033428192;0.8793432;0.5668915514639801;0.5385000511369049;0.7712186293488323;0.020178673993986873;0.10812458230201605;-0.20432707788485227;-0.23271857821192743
Increased variability in muscle fiber diameter;Paroxysmal vertigo;0.872308537364006;0.95174676;0.5407567280984475;0.5153654435170081;0.9999445057306702;-0.12763596836666413;-0.04819774393181153;-0.4591877776322226;-0.4845790622136621
Increased variability in muscle fiber diameter;Long hallux;0.8651853054761887;0.88852686;0.5430439150613566;0.535556901944405;0.9018040183019268;-0.03661871282573814;-0.013277161402665327;-0.35876010324057017;-0.36624711635752183
Increased variability in muscle fiber diameter;Broad medial eyebrow;0.7697174251079559;0.85013974;0.5739650482073899;0.5478823767431273;0.9999473166570552;-0.23022989154909923;-0.14980757952784374;-0.42598226844966525;-0.4520649399139278
Increased variability in muscle fiber diameter;Myxoid subcutaneous tumors;0.7081937789916992;0.88883585;0.594256237914565;0.5354579273263886;0.9999473166570552;-0.29175353766535594;-0.11111146927927806;-0.4056910787424901;-0.4644893893306665
Increased variability in muscle fiber diameter;Bulbous tips of toes;0.8174900859594345;0.92158496;0.5584221636527819;0.5249859320748442;0.91798003561481;-0.1004899496553755;0.003604928183712941;-0.35955787196202815;-0.3929941035399658
Increased variability in muscle fiber diameter;Absent internal genitalia;0.9051662012934685;0.9977604;0.5302319666220507;0.5007128903255103;0.9998452077479463;-0.0946790064544778;-0.0020847926707368014;-0.46961324112589553;-0.499132317422436
Increased variability in muscle fiber diameter;Hyperphalangy of the 2nd finger;0.7665939927101135;0.94150895;0.5749871165048146;0.5186289076280468;0.922134556158444;-0.15554056344833045;0.019374392644504024;-0.3471474396536294;-0.40350564853039717
Increased variability in muscle fiber diameter;Renal interstitial hemosiderin;0.8189251720905304;0.8995978;0.5579576207987065;0.5320129470722434;0.9998452077479463;-0.18092003565741588;-0.10024738412810374;-0.4418875869492398;-0.4678322606757028
Increased variability in muscle fiber diameter;Abnormality of depressor anguli oris muscle;0.5973922312259674;0.84638906;0.6318961346839098;0.5490902423621711;0.3068593097210791;0.2905329215048883;0.5395297455309961;0.3250368249628307;0.24223093264109197
Increased variability in muscle fiber diameter;Paroxysmal dyspnea;0.8197801411151886;0.8857329;0.5576809234531888;0.5364519718892469;0.9998452077479463;-0.18006506663275768;-0.11411231857253124;-0.4421642842947575;-0.4633932358586994
Increased variability in muscle fiber diameter;Phenylpyruvic acidemia;0.8097005784511566;0.95297205;0.5609458811598387;0.5149749927930354;0.9999473166570552;-0.19024673820589855;-0.046975262175548815;-0.4390014354972165;-0.4849723238640198
Increased variability in muscle fiber diameter;Lateral ventricle dilatation;0.7035554051399231;0.8443824;0.595801010193812;0.549736753353689;0.9999259293677907;-0.2963705242278676;-0.15554352408672378;-0.40412491917397864;-0.4501891760141017
Increased variability in muscle fiber diameter;Neonatal unconjugated hyperbilirubinemia;0.8333132863044739;1.0834433;0.553306850734244;0.4734082626702968;0.9999473166570552;-0.16663403035258129;0.08349596737767384;-0.44664046592281115;-0.5265390539867584
Increased variability in muscle fiber diameter;High maternal circulating alpha-fetoprotein concentration;0.8213620036840439;0.94123304;0.5571690943941339;0.5187168933132067;0.9998452077479463;-0.1784832040639024;-0.05861216884566356;-0.4426761133538124;-0.4811283144347396
Increased variability in muscle fiber diameter;Prominent nasolabial fold;0.8969690203666687;1.0288059;0.5328540816292598;0.4908295523153732;0.9999372395362296;-0.10296821916956089;0.028868612400110738;-0.46708315790696975;-0.5091076872208564
Increased variability in muscle fiber diameter;Abnormality of inferior alveolar nerve;0.7234106063842773;0.90495634;0.5892041892255402;0.5302990680126789;0.9998452077479463;-0.27643460136366893;-0.09488886695815135;-0.4106410185224061;-0.4695461397352674
Increased variability in muscle fiber diameter;Unilateral conductive hearing impairment;0.900207445025444;1.0547229;0.5318179166656061;0.4825724456921112;0.9999473166570552;-0.09973987163161113;0.05477558850194142;-0.4681293999914491;-0.517374870964944
Increased variability in muscle fiber diameter;Macular hypopigmented whorls, streaks, and patches;0.818278044462204;0.93117934;0.558167082966272;0.5219236195764214;0.9999473166570552;-0.18166927219485118;-0.06876797200297191;-0.4417802336907831;-0.47802369708063375
Increased variability in muscle fiber diameter;Delayed ossification of pubic rami;0.7883100211620331;0.938463;0.5678967096074661;0.519600223096839;0.91798003561481;-0.12967001445277693;0.020482937026181203;-0.35008332600734393;-0.39837981251797105
Increased variability in muscle fiber diameter;Hyperphenylalaninemia;0.8488956689834595;0.9841717;0.5482829420595519;0.5050385136730702;0.9999402946117394;-0.15104462562827992;-0.015768606055068246;-0.45165735255218753;-0.4949017809386692
Increased variability in muscle fiber diameter;Ureteropelvic junction obstruction;0.8675674349069595;1.0189241;0.542278798067689;0.4939758997306871;0.999933930251455;-0.13236649534449552;0.01899018683686282;-0.4576551321837661;-0.5059580305207679
Increased variability in muscle fiber diameter;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8333670049905777;0.9242769;0.5532895090118328;0.5241265047163062;0.7712186293488323;0.06214837564174536;0.15305825902168158;-0.21792912033699952;-0.24709212463252617
Increased variability in muscle fiber diameter;Difficulty walking;0.8243431597948074;0.8188464;0.5562049133632034;0.5579831197275242;0.7732092081591891;0.05113395163561829;0.045637196393270574;-0.2170042947959857;-0.2152260884316649
Increased variability in muscle fiber diameter;Bilobate gallbladder;0.9316937029361725;1.1214447;0.5217595128083545;0.46124729730088854;0.9999445057306702;-0.06825080279449769;0.12150019641776733;-0.47818499292231564;-0.5386972084297816
Increased variability in muscle fiber diameter;Histidinuria;0.8247483968734741;0.87459415;0.5560738899042861;0.5400232977174664;0.9999427179139311;-0.17519432104045696;-0.1253485659402067;-0.443868828009645;-0.4599194201964647
Increased variability in muscle fiber diameter;Widened interpedicular distance;0.619124710559845;0.803409;0.6243772813284758;0.5629871099811837;0.7712186293488323;-0.15209391878898737;0.03219035102073553;-0.14684134802035653;-0.2082315193676486
Widened proximal tibial metaphyses;Wide anterior fontanel;0.7520310431718826;1.139744;0.5797630999996544;0.4553720446332741;0.8833906631088758;-0.1313596199369932;0.2563533802413439;-0.30362756310922145;-0.42801861847560174
Widened proximal tibial metaphyses;Increased circulating oleate level;0.6212974488735199;0.8712395;0.6236296601190225;0.5410998558468452;0.9999201345566091;-0.3786226856830892;-0.12868065120013328;-0.37629047443758656;-0.45882027870976394
Widened proximal tibial metaphyses;Lozenge-shaped umbilicus;1.0001245364546776;1.0806389;0.4999603588151834;0.4743039477782799;0.9999584729108851;0.00016606354379244959;0.08068041258716174;-0.4999981140957017;-0.5256545251326052
Widened proximal tibial metaphyses;Anti-myelin-associated glycoprotein antibody positivity;0.8093539178371429;1.0079713;0.5610582844869108;0.4974626414504647;0.9999201345566091;-0.19056621671946616;0.008051152217072532;-0.43886185006969836;-0.5024574931061444
Widened proximal tibial metaphyses;Fractured radius;0.6283539533615112;0.7162916;0.6212064950641157;0.5915647695683459;0.7346933176414197;-0.10633936427990842;-0.01840171121518064;-0.11348682257730391;-0.14312854807307374
Widened proximal tibial metaphyses;Abnormal manual kinetic perimetry test;0.7535791397094727;1.0321003;0.5792545428276952;0.48978040946355994;0.9999201345566091;-0.24634099484713645;0.032180185305756615;-0.42066559172891393;-0.5101397250930492
Widened proximal tibial metaphyses;Small radial epiphyses;0.6570737957954407;0.6616645;0.6114180825599165;0.6098638722222569;0.4693866352828394;0.18768716051260126;0.19227785064855707;0.14203144727707706;0.1404772369394175
Widened proximal tibial metaphyses;Generalized keratosis follicularis;0.7470269203186035;0.99148095;0.5814084096335694;0.502711730552142;0.9999600672783046;-0.25293314695970104;-0.008479120737472035;-0.4185516576447351;-0.49724833672616253
Widened proximal tibial metaphyses;Hypoplasia of the calcaneus;0.728857159614563;0.5170473;0.5874015768140282;0.6604357036502395;0.8287763732556668;-0.09991921364110379;-0.3117290872220364;-0.24137479644163862;-0.16834066960542726
Widened proximal tibial metaphyses;2-hydroxyadipic aciduria;0.8742410391569138;1.0031581;0.540136593963251;0.49899476464510084;0.9999201345566091;-0.12567909539969535;0.0032379579421701887;-0.45978354059335813;-0.5009253699115083
Widened proximal tibial metaphyses;Potter facies;0.7486790716648102;1.0310911;0.580864953817289;0.49010178566369844;0.9999552432134126;-0.2512761715486024;0.03113585080361625;-0.4190902893961236;-0.5098534575497141
Widened proximal tibial metaphyses;Increased heart rate variability;0.6502010226249695;0.98968285;0.6137501120520032;0.5032841172708544;0.9999600672783046;-0.34975904465333507;-0.010277214056411244;-0.3862099552263013;-0.49667595000745013
Widened proximal tibial metaphyses;Aplastic zygomatic arch;0.7360364198684692;0.99047536;0.5850298758957615;0.5030318304477017;0.9074607173141833;-0.17142429744571408;0.08301463926464359;-0.3224308414184218;-0.4044288868664816
Widened proximal tibial metaphyses;Testicular torsion;0.713578075170517;0.9239447;0.5924659034803388;0.5242325551483042;0.9999600672783046;-0.2863819921077876;-0.07601535559312389;-0.40749416379796577;-0.4757275121300003
Widened proximal tibial metaphyses;Abolished vibration sense;0.8988746106624603;1.0322464;0.5322443281825235;0.4897338914773738;0.9999584729108851;-0.1010838622484248;0.0322878783311803;-0.4677141447283616;-0.5102245814335113
Widened proximal tibial metaphyses;Fractured metatarsal bone of digit 5;0.6089019775390625;0.38203466;0.6279046601749869;0.7120428034967844;0.4693866352828394;0.13951534225622308;-0.08735197589715826;0.1585180248921475;0.24265616821394498
Widened proximal tibial metaphyses;Prolonged G2 phase of cell cycle;0.8369278013706207;1.0786173;0.5521403490954058;0.47494947025273093;0.9999567459343585;-0.16302894456373773;0.07866058843148627;-0.4478163968389527;-0.5250072756816275
Widened proximal tibial metaphyses;Single naris;0.9325334206223488;0.99940115;0.5214916043090034;0.5001906230613198;0.9999567459343585;-0.06742332531200967;-0.0005555938004168093;-0.47846514162535503;-0.4997661228730387
Widened proximal tibial metaphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8369496166706085;1.1340265;0.5521333108697228;0.4572092593065147;0.9999201345566091;-0.1629705178860006;0.13410639284817605;-0.44778682368688627;-0.5427108752500944
Widened proximal tibial metaphyses;Asymmetry of the thorax;0.595889687538147;1.0149314;0.6324188152855681;0.4952470000763203;0.9036123096265051;-0.3077226220883581;0.11131913072688848;-0.271193494340937;-0.4083653095501848
Widened proximal tibial metaphyses;Type 2 muscle fiber predominance;0.8081774115562439;0.8129567;0.5614398195468476;0.5598904633965284;0.9344769737294281;-0.12629956217318417;-0.12152028294115902;-0.37303715418258043;-0.3745865103328997
Widened proximal tibial metaphyses;Dependency on parenteral nutrition;0.8115070909261703;0.85631835;0.5603602508223862;0.5458941313597546;0.9999584729108851;-0.18845138198471478;-0.14364011830425671;-0.43959822208849897;-0.4540643415511305
Widened proximal tibial metaphyses;Limited shoulder flexion;0.8146164417266846;1.1367885;0.5593527527559288;0.4563219226994967;0.8332104407109631;-0.018593998984278493;0.30357804672342414;-0.2738576879550343;-0.3768885180114664
Widened proximal tibial metaphyses;Paroxysmal vertigo;0.904904805123806;1.1169069;0.5303155493460618;0.4627021071319314;0.9999584729108851;-0.09505366778707913;0.11694840842151233;-0.4696429235648233;-0.5372563657789537
Widened proximal tibial metaphyses;Long hallux;0.6147715449333191;0.41084993;0.6258773542379108;0.7005373213541407;0.8047017442325175;-0.1899301992991984;-0.3938518153766215;-0.1788243899946067;-0.1041644228783768
Widened proximal tibial metaphyses;Broad medial eyebrow;0.6631276607513428;1.0472687;0.6093690789744228;0.48494827434284293;0.9999600672783046;-0.3368324065269618;0.047308681005081676;-0.3905909883038817;-0.5150117929354616
Widened proximal tibial metaphyses;Myxoid subcutaneous tumors;0.7740453481674194;0.9049613;0.572550119251948;0.5302974956434139;0.9999600672783046;-0.22591471911088512;-0.09499877930299327;-0.42740994802635657;-0.46966257163489067
Widened proximal tibial metaphyses;Bulbous tips of toes;0.6208842992782593;0.54839474;0.6237717660052566;0.6491484584548464;0.8287763732556668;-0.2078920739774075;-0.28038163362782864;-0.20500460725041014;-0.1796279148008204
Widened proximal tibial metaphyses;Absent internal genitalia;0.9040883183479309;0.9797162;0.530576638579003;0.5064569779539784;0.9999201345566091;-0.0958318162086782;-0.02020395280154319;-0.46934349597760616;-0.49346315660263074
Widened proximal tibial metaphyses;Hyperphalangy of the 2nd finger;0.7846124172210693;0.80407727;0.5691014828925756;0.562770187913959;0.8353502357086217;-0.05073781848755232;-0.03127296806183211;-0.2662487528160461;-0.2725800477946626
Widened proximal tibial metaphyses;Renal interstitial hemosiderin;0.8712228238582611;1.1094817;0.541105198465891;0.4650808984764022;0.9999201345566091;-0.128697310698348;0.10956155775753884;-0.4588149360907181;-0.5348392360802069
Widened proximal tibial metaphyses;Abnormality of depressor anguli oris muscle;0.9490293860435486;1.1548293;0.5162314837495088;0.45051723499340224;0.8819596887815145;0.06706969726203404;0.27286957490561925;-0.36572820503200576;-0.4314424537881123
Widened proximal tibial metaphyses;Paroxysmal dyspnea;0.8067369759082794;1.0244155;0.5619070673724934;0.4922275295147267;0.9999201345566091;-0.1931831586483297;0.0244953584548655;-0.4380130671841157;-0.5076926050418824
Widened proximal tibial metaphyses;Phenylpyruvic acidemia;0.7544278204441071;0.9971133;0.5789758348515461;0.5009188662694631;0.9999600672783046;-0.2455322468341975;-0.0028467798294214974;-0.4209842324267584;-0.4990412010088414
Widened proximal tibial metaphyses;Lateral ventricle dilatation;0.741572380065918;1.0918647;0.5832043506131136;0.4707172800315529;0.9999488789551968;-0.2583764988892788;0.0919158261305576;-0.4167445283420832;-0.5292315989236439
Widened proximal tibial metaphyses;Neonatal unconjugated hyperbilirubinemia;0.8825626075267792;1.0189991;0.5374679454267244;0.49395205144240006;0.9999600672783046;-0.11739745975152538;0.01903903245314076;-0.4624921218515802;-0.5060080158359045
Widened proximal tibial metaphyses;High maternal circulating alpha-fetoprotein concentration;0.6451382637023926;1.0146321;0.6154720597664858;0.49534227324498237;0.9999201345566091;-0.35478187085421653;0.014711971270722435;-0.38444807479012333;-0.5045778613116267
Widened proximal tibial metaphyses;Prominent nasolabial fold;0.7270305752754211;1.0239978;0.5880057867378377;0.49236054848194144;0.9999545338528789;-0.27292395857745777;0.02404324980800976;-0.41194874711504126;-0.5075939853709375
Widened proximal tibial metaphyses;Abnormality of inferior alveolar nerve;0.921484962105751;0.96154153;0.5250178620466801;0.5122447226851352;0.9999201345566091;-0.07843517245085807;-0.0383786010864553;-0.474902272509929;-0.4876754118714739
Widened proximal tibial metaphyses;Unilateral conductive hearing impairment;0.883606530725956;1.0091243;0.5371333597050614;0.4970956191903928;0.9999600672783046;-0.11635353655234859;0.009164211743912243;-0.4628267075732432;-0.5028644480879118
Widened proximal tibial metaphyses;Macular hypopigmented whorls, streaks, and patches;0.908009871840477;1.1345253;0.5293228226655611;0.4570490683768128;0.9999600672783046;-0.09195019543782756;0.13456523179396107;-0.4706372446127435;-0.5429109989014917
Widened proximal tibial metaphyses;Delayed ossification of pubic rami;0.5866434574127197;0.6093318;0.6356436816841019;0.6277560220915308;0.8355479869321181;-0.24890452951939834;-0.22621620029958023;-0.19990430524801617;-0.20779196484058726
Widened proximal tibial metaphyses;Hyperphenylalaninemia;0.6641598641872406;0.9374956;0.6090201903360725;0.5199087399980686;0.9999561589935034;-0.33579629480626283;-0.06246056973721681;-0.39093596865743097;-0.4800474189954348
Widened proximal tibial metaphyses;Ureteropelvic junction obstruction;0.8016285598278046;0.8658024;0.5635652301249845;0.5428456840854248;0.9999528219730685;-0.19832426214526389;-0.13415041470835898;-0.43638759184808396;-0.4571071378876437
Widened proximal tibial metaphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6351496577262878;0.40615493;0.6188798489115079;0.702390796878736;0.4693866352828394;0.16576302244344843;-0.06323170469125616;0.14949321362866852;0.23300416159589654
Widened proximal tibial metaphyses;Difficulty walking;0.7901397794485092;0.8289795;0.5673008941140527;0.5547064379311523;0.9203691460904122;-0.130229366641903;-0.0913896539029122;-0.3530682519763595;-0.36566270815925994
Widened proximal tibial metaphyses;Bilobate gallbladder;0.9596608951687813;1.0500776;0.5128438208119884;0.48405315914438873;0.9999584729108851;-0.04029757774210385;0.050119084652896606;-0.4871146520988967;-0.5159053137664964
Widened proximal tibial metaphyses;Histidinuria;0.8190656006336212;0.9869082;0.5579121702643894;0.5041673698379174;0.9999574798349273;-0.18089187920130612;-0.01304928243197323;-0.4420453095705379;-0.4957901099970099
Widened proximal tibial metaphyses;Widened interpedicular distance;0.4363110661506653;0.7434465;0.6906183221363826;0.582586972923155;0.822027235707794;-0.38571616955712873;-0.07858070679620344;-0.13140891357141138;-0.23944026278463904
Wide anterior fontanel;Increased circulating oleate level;0.7577405571937561;0.97982764;0.5778885164652203;0.5064214904689384;0.999848231156753;-0.24210767396299693;-0.020020588715957133;-0.4219597146915327;-0.49342674068781467
Wide anterior fontanel;Lozenge-shaped umbilicus;0.7630535662174225;0.6825531;0.576146590036993;0.6028255195982092;0.9999448992541466;-0.23689133303672416;-0.3173917867472802;-0.42379830921715367;-0.39711937965593747
Wide anterior fontanel;Anti-myelin-associated glycoprotein antibody positivity;0.8515145033597946;0.894363;0.547439828148333;0.5336881581035214;0.999848231156753;-0.14833372779695841;-0.10548524506895396;-0.45240840300842;-0.4661600730532316
Wide anterior fontanel;Fractured radius;0.9267434477806091;1.0707742;0.5233391916771665;0.47745302352249397;0.8833906631088758;0.04335278467173331;0.18738353446955436;-0.36005147143170935;-0.40593763958638185
Wide anterior fontanel;Abnormal manual kinetic perimetry test;0.8997986912727356;0.93781424;0.5319486824584893;0.5198071139907829;0.999848231156753;-0.10004953988401744;-0.06203399546949717;-0.4678995486982638;-0.4800411171659701
Wide anterior fontanel;Small radial epiphyses;0.939477913081646;1.0203835;0.5192765589267504;0.49351128356355867;0.6617971500655027;0.2776807630161433;0.3585863271454959;-0.14252059113875226;-0.168285866501944
Wide anterior fontanel;Generalized keratosis follicularis;0.888569250702858;1.0629255;0.5355433253647286;0.47995696741069216;0.9999476714516888;-0.11137842074883086;0.0629777865027179;-0.46440434608696024;-0.5199907040409967
Wide anterior fontanel;Hypoplasia of the calcaneus;0.9515142627060413;0.97888947;0.5154395429384342;0.5067201816094217;0.8772130769237713;0.07430118578227007;0.10167638840825999;-0.36177353398533707;-0.3704928953143496
Wide anterior fontanel;2-hydroxyadipic aciduria;0.8896933495998383;0.96409255;0.5351832939820027;0.5114321542244175;0.999848231156753;-0.11015488155691477;-0.03575567849485728;-0.4646649371747503;-0.4884160769323356
Wide anterior fontanel;Potter facies;0.8277097344398499;0.76732635;0.5551167039608423;0.5747473884761185;0.8618831027018246;-0.0341733682619747;-0.0945567477213558;-0.3067663987409822;-0.28713571422570605
Wide anterior fontanel;Increased heart rate variability;0.7334066033363342;0.87306905;0.5858980789387962;0.5405126640686038;0.9999476714516888;-0.2665410681153546;-0.1268786235238324;-0.41404959251289264;-0.45943500738308507
Wide anterior fontanel;Aplastic zygomatic arch;0.6455727219581604;0.52120316;0.6153241536917232;0.6589269401264528;0.8080353522002968;-0.16246263024213636;-0.28683219191434706;-0.19271119850857354;-0.14910841207384395
Wide anterior fontanel;Testicular torsion;0.8687904477119446;1.022449;0.5418860738785234;0.4928536492377742;0.9999476714516888;-0.13115722373974426;0.022501345119356086;-0.45806159757316545;-0.5070940222139146
Wide anterior fontanel;Abolished vibration sense;0.8517183512449265;0.8888074;0.5473742150059946;0.5354670385555669;0.9999448992541466;-0.1482265480092202;-0.11113748329192741;-0.45257068424815206;-0.46447786069857977
Wide anterior fontanel;Fractured metatarsal bone of digit 5;1.0701498240232468;1.1731024;0.47765226301809793;0.44462082984574636;0.6617971500655027;0.4083526739577441;0.5113052287797122;-0.18414488704740473;-0.2171763202197563
Wide anterior fontanel;Prolonged G2 phase of cell cycle;0.9078601002693176;1.091863;0.5293706997715368;0.4707177992343372;0.9999418169014338;-0.09208171663211617;0.09192121925426688;-0.47057111712989697;-0.5292240176670966
Wide anterior fontanel;Single naris;0.8331915140151978;0.6906569;0.5533461624368384;0.6001091405305883;0.8681209705070614;-0.03492945649186363;-0.1774640701011776;-0.31477480807022296;-0.2680118299764731
Wide anterior fontanel;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.87520582228899;0.91384107;0.5398270553524892;0.5274592894579706;0.999848231156753;-0.12464240886776301;-0.08600716241209361;-0.4600211758042638;-0.4723889416987824
Wide anterior fontanel;Asymmetry of the thorax;0.7278183698654175;0.6887796;0.5877451549405288;0.6007377306026742;0.830858575555589;-0.10304020569017147;-0.14207898304155087;-0.24311342061506014;-0.23012084495291474
Wide anterior fontanel;Type 2 muscle fiber predominance;0.9335173964500427;1.0535964;0.5211776902252627;0.48293154821560114;0.911096795389366;0.02242060106067667;0.14249958198337564;-0.38991910516410333;-0.4281652471737649
Wide anterior fontanel;Dependency on parenteral nutrition;0.8684296160936356;0.9367856;0.5420019345746951;0.5201352102156173;0.9999448992541466;-0.1315152831605111;-0.06315932052642448;-0.4579429646794515;-0.4798096890385294
Wide anterior fontanel;Limited shoulder flexion;0.8663728088140488;1.0307068;0.5426624694482076;0.49022419224709934;0.6830486703108347;0.18332413850321405;0.3476580929566824;-0.1403862008626271;-0.19282447806373537
Wide anterior fontanel;Paroxysmal vertigo;0.9175600185990334;0.9097619;0.5262712767352917;0.52876280586116;0.9999448992541466;-0.08238488065511329;-0.09018299358398063;-0.4736736225188549;-0.47118209339298667
Wide anterior fontanel;Long hallux;0.7408342361450195;1.1188104;0.5834475960582037;0.4620919096906325;0.8532022824788488;-0.11236804633382924;0.26560813278909556;-0.26975468642064504;-0.39111037278821625
Wide anterior fontanel;Broad medial eyebrow;0.6123173832893372;0.72564745;0.6267243426977274;0.5884635229187443;0.8813910167023682;-0.26907363341303103;-0.15574356720896;-0.2546666740046408;-0.2929274937836239
Wide anterior fontanel;Myxoid subcutaneous tumors;0.97777995839715;0.99834216;0.5070734410570166;0.5005277069861932;0.9999476714516888;-0.022167713054538796;-0.0016055150414715502;-0.49287423039467226;-0.49941996446549564
Wide anterior fontanel;Bulbous tips of toes;0.8572705090045929;1.0412896;0.5455878947983714;0.4868533969344434;0.8772130769237713;-0.019942567919178367;0.16407649102361643;-0.3316251821253998;-0.39035967998932786
Wide anterior fontanel;Absent internal genitalia;0.7371936142444611;0.7147113;0.5846480474021866;0.5920894669581898;0.999848231156753;-0.26265461691229197;-0.28513692267744395;-0.41520018375456647;-0.4077587641985633
Wide anterior fontanel;Hyperphalangy of the 2nd finger;0.9802258964627981;1.1051362;0.506294702912492;0.46647216505545863;0.8833906631088758;0.0968352333539223;0.2217454929732775;-0.3770959601963838;-0.4169184980534172
Wide anterior fontanel;Renal interstitial hemosiderin;0.9518963694572449;1.0066172;0.5153177724910367;0.49789367227491976;0.999848231156753;-0.04795186169950816;0.006768957296921285;-0.4845304586657163;-0.5019545588818333
Wide anterior fontanel;Abnormality of depressor anguli oris muscle;0.8273696899414062;0.7409153;0.5552265899671331;0.5834208904434505;0.6559975620430308;0.17137212789837541;0.08491773641888323;-0.10077097207589769;-0.07257667159958037
Wide anterior fontanel;Paroxysmal dyspnea;0.9303859025239944;0.8219116;0.5221767920087999;0.556991319733654;0.999848231156753;-0.06946232863275859;-0.17793665774671885;-0.4776714391479532;-0.442856911423099
Wide anterior fontanel;Phenylpyruvic acidemia;0.9456381946802139;0.99744225;0.5173124341825286;0.5008141546935845;0.9999476714516888;-0.05430947677147491;-0.002505425968290398;-0.48263523726916024;-0.49913351675810436
Wide anterior fontanel;Lateral ventricle dilatation;0.7431066632270813;0.61033154;0.5826989070114987;0.6274103993343109;0.9999266287857647;-0.25681996555868336;-0.3895950934464092;-0.4172277217742659;-0.3725162294514538
Wide anterior fontanel;Neonatal unconjugated hyperbilirubinemia;0.7876487970352173;0.94757986;0.5681120801960858;0.5166935021779966;0.9999476714516888;-0.21229887441647155;-0.052367810764432976;-0.431835591255603;-0.48325416927369225
Wide anterior fontanel;High maternal circulating alpha-fetoprotein concentration;0.7021791338920593;0.80505645;0.5962598122375731;0.5624523558812222;0.999848231156753;-0.2976690972646937;-0.19479177840559336;-0.40358841891917996;-0.4373958752755308
Wide anterior fontanel;Prominent nasolabial fold;0.5847854614257812;0.5959888;0.6362934873560593;0.6323843224787044;0.8588856025456406;-0.27410014111985936;-0.26289679248323217;-0.22259211518958133;-0.22650128006693626
Wide anterior fontanel;Abnormality of inferior alveolar nerve;0.7971751242876053;0.7683294;0.5650122160617714;0.5744191457373229;0.999848231156753;-0.20267310686914775;-0.231518849214004;-0.4348360150949816;-0.42542908541943014
Wide anterior fontanel;Unilateral conductive hearing impairment;0.7486186325550079;0.87297827;0.5808848302986954;0.5405417953594222;0.9999476714516888;-0.2513290388966809;-0.1269694013978253;-0.4190628411529934;-0.4594058760922667
Wide anterior fontanel;Macular hypopigmented whorls, streaks, and patches;1.0114343967288733;0.93340456;0.49636023916203187;0.5212136877852083;0.9999476714516888;0.011486725277184417;-0.06654310659420593;-0.503587432289657;-0.47873398366648057
Wide anterior fontanel;Delayed ossification of pubic rami;0.8546592146158218;0.97100157;0.5464278544921994;0.5092317789970899;0.8772130769237713;-0.022553862307949424;0.09378848853261912;-0.3307852224315718;-0.36798129792668133
Wide anterior fontanel;Hyperphenylalaninemia;0.6868804693222046;0.8665382;0.6013740491169643;0.5426093394350172;0.9999407498804347;-0.3130602805582301;-0.13340252327597302;-0.39856670076347034;-0.4573314104454175
Wide anterior fontanel;Ureteropelvic junction obstruction;0.9003421068191528;1.1201435;0.5317748377375248;0.46166452754728715;0.9999344873001771;-0.09959238048102426;0.12020904545281363;-0.4681596495626523;-0.5382699597528899
Wide anterior fontanel;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9632962495088577;1.1364504;0.511685791425656;0.4564305642779515;0.6617971500655027;0.30149909944335507;0.47465325982371853;-0.1501113586398467;-0.20536658578755118
Wide anterior fontanel;Difficulty walking;0.8695358037948608;0.8811864;0.5416467625207031;0.5379090887073215;0.8829632475843074;-0.013427443789446603;-0.001776821898424874;-0.34131648506360435;-0.345054158876986
Wide anterior fontanel;Bilobate gallbladder;0.8917241320014;1.0060008;0.5345329802206794;0.4980898982688835;0.9999448992541466;-0.10822076725274665;0.00605585796326058;-0.46541191903346724;-0.5018550009852631
Wide anterior fontanel;Histidinuria;0.9399647861719131;1.0890814;0.5191213000828347;0.47160685627595;0.9999431371057684;-0.059978350933855284;0.08913826948755432;-0.4808218370229337;-0.5283362808298184
Wide anterior fontanel;Widened interpedicular distance;0.648864209651947;0.85158;0.6142044492542071;0.5474187434698903;0.558799737971173;0.09006447168077403;0.29278028579439097;0.05540471128303415;-0.011380994501282715
Increased circulating oleate level;Lozenge-shaped umbilicus;0.8463283181190491;1.017622;0.5491098127000129;0.4943904410989096;0.9999134918687169;-0.15358517374966785;0.017708502149837768;-0.450803679168704;-0.5055230507698073
Increased circulating oleate level;Anti-myelin-associated glycoprotein antibody positivity;0.8595884442329407;1.0122638;0.5448425660987422;0.49609624033153843;1.0;-0.14041155576705933;0.012263774871826172;-0.45515743390125785;-0.5039037596684616
Increased circulating oleate level;Fractured radius;0.845292404294014;0.993097;0.5494435453458798;0.5021973017577082;0.9999201345566091;-0.15462773026259513;-0.006823127281981423;-0.4504765892107293;-0.49772283279890095
Increased circulating oleate level;Abnormal manual kinetic perimetry test;0.8313046395778656;0.9395087;0.5539554067786565;0.5192667581466319;1.0;-0.1686953604221344;-0.060491323471069336;-0.4460445932213435;-0.4807332418533681
Increased circulating oleate level;Small radial epiphyses;0.9017816334962845;0.99589115;0.5313143628435242;0.5013078977501815;1.0;-0.09821836650371552;-0.004108846187591553;-0.4686856371564758;-0.4986921022498185
Increased circulating oleate level;Generalized keratosis follicularis;0.869953528046608;0.97423226;0.5415126542226989;0.5082030402147582;0.9999201345566091;-0.12996660651000114;-0.025687878144103005;-0.4584074803339102;-0.49171709434185096
Increased circulating oleate level;Hypoplasia of the calcaneus;0.799452468752861;0.8678595;0.5642721054887581;0.542185016895657;0.9999134918687169;-0.2004610231158559;-0.13205400910351917;-0.43564138637995886;-0.4577284749730599
Increased circulating oleate level;2-hydroxyadipic aciduria;0.8046212494373322;0.8670101;0.5625936110547176;0.5424577859408088;1.0;-0.19537875056266785;-0.13298988342285156;-0.4374063889452824;-0.45754221405919115
Increased circulating oleate level;Potter facies;0.9358995482325554;0.9870979;0.5204178061636282;0.504106979817221;0.9998981869165328;-0.06399863868397737;-0.01280026792925859;-0.47948038075290456;-0.4957912070993118
Increased circulating oleate level;Increased heart rate variability;0.6325773000717163;0.8909453;0.6197597558975811;0.5347823667751712;0.9999201345566091;-0.3673428344848928;-0.10897481919558616;-0.38016037865902796;-0.4651377677814379
Increased circulating oleate level;Aplastic zygomatic arch;0.7710807770490646;0.948368;0.5735191680149692;0.51644228531244;0.9999134918687169;-0.22883271481965228;-0.05154547896359607;-0.42639432385374776;-0.48347120655627696
Increased circulating oleate level;Testicular torsion;0.8447119742631912;0.9598322;0.5496305620981174;0.5127892453443244;0.9999201345566091;-0.15520816029341789;-0.04008794308932395;-0.45028957245849166;-0.48713088921228476
Increased circulating oleate level;Abolished vibration sense;0.9318746328353882;1.1384356;0.5217017865643871;0.455792593797703;0.9999134918687169;-0.06803885903332874;0.13852211031939343;-0.47821170530432977;-0.5441208980710139
Increased circulating oleate level;Fractured metatarsal bone of digit 5;0.897338479757309;0.9658616;0.5327358521121721;0.5108687044424822;1.0;-0.10266152024269104;-0.034138381481170654;-0.4672641478878279;-0.4891312955575178
Increased circulating oleate level;Prolonged G2 phase of cell cycle;0.7539190649986267;0.9433699;0.5791429034364752;0.518035564961105;0.6766288643064248;0.07729020069220194;0.2667410607157005;-0.09748596086994954;-0.15859329934531974
Increased circulating oleate level;Single naris;1.0108156902715564;1.0599886;0.49655719173563606;0.48089356577075826;0.9999056439461368;0.010910046325419587;0.0600829739508969;-0.5033484522105007;-0.5190120781753785
Increased circulating oleate level;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8342442810535431;0.9059086;0.5530063251242197;0.5299945877252487;1.0;-0.1657557189464569;-0.09409141540527344;-0.44699367487578034;-0.47000541227475134
Increased circulating oleate level;Asymmetry of the thorax;0.8409600853919983;1.1023579;0.5508398546468392;0.4673613259711673;0.9999056439461368;-0.1589455585541385;0.10245222043374602;-0.44906578929929764;-0.5325443179749695
Increased circulating oleate level;Type 2 muscle fiber predominance;0.8748121857643127;0.92785764;0.5399533441229144;0.5229835931341635;0.9999003561294039;-0.12508817036509112;-0.07204271872400836;-0.45994701200648946;-0.47691676299524033
Increased circulating oleate level;Dependency on parenteral nutrition;0.8835239559412003;0.9687683;0.5371598240770017;0.5099429696598546;0.9999134918687169;-0.11638953592751666;-0.031145193242770874;-0.46275366779171523;-0.4899705222088623
Increased circulating oleate level;Limited shoulder flexion;0.9631075412034988;1.0861349;0.5117458998551598;0.4725484017530056;1.0;-0.03689245879650116;0.0861349105834961;-0.48825410014484016;-0.5274515982469944
Increased circulating oleate level;Paroxysmal vertigo;0.8421226590871811;1.0987055;0.5504650606324062;0.468529791890842;0.9999134918687169;-0.15779083278153583;0.09879203829790906;-0.44944843123631073;-0.5313836999778749
Increased circulating oleate level;Long hallux;0.8540074825286865;0.9206392;0.5466375438664359;0.5252879090441243;0.9998836012415208;-0.14587611871283424;-0.07924438434164893;-0.45324605737508483;-0.4745956921973965
Increased circulating oleate level;Broad medial eyebrow;0.7760230898857117;0.84096944;0.5719040227778251;0.5508368375262784;0.9999201345566091;-0.22389704467089744;-0.15895069123538108;-0.42801611177878396;-0.4490832970303307
Increased circulating oleate level;Myxoid subcutaneous tumors;0.9607968218624592;1.0913079;0.5124819577953168;0.47089526198887677;0.9999201345566091;-0.039123312694149925;0.09138774393765359;-0.4874381767612923;-0.5290248725677323
Increased circulating oleate level;Bulbous tips of toes;0.8239253908395767;0.9091572;0.5563399987718719;0.5289560710574157;0.9999134918687169;-0.1759881010291402;-0.09075627531979724;-0.443573493096845;-0.4709574208113012
Increased circulating oleate level;Absent internal genitalia;0.9651709757745266;1.0451971;0.5110886653792363;0.4856084125910385;1.0;-0.034829024225473404;0.045197129249572754;-0.48891133462076375;-0.5143915874089615
Increased circulating oleate level;Hyperphalangy of the 2nd finger;0.905853845179081;1.0152979;0.5300120990419424;0.49513035415602946;0.9999201345566091;-0.09406628937752815;0.015377755152863548;-0.46990803551466676;-0.5047897804005796
Increased circulating oleate level;Renal interstitial hemosiderin;0.8913899138569832;0.9918484;0.534639996269544;0.5025947642417912;1.0;-0.10861008614301682;-0.008151590824127197;-0.46536000373045605;-0.49740523575820883
Increased circulating oleate level;Abnormality of depressor anguli oris muscle;0.8805523216724396;1.0466719;0.5381123756051543;0.48513848805485904;1.0;-0.11944767832756042;0.04667186737060547;-0.46188762439484565;-0.514861511945141
Increased circulating oleate level;Paroxysmal dyspnea;0.86219921708107;1.0651802;0.5440033719479402;0.47923778933184524;1.0;-0.13780078291893005;0.06518018245697021;-0.45599662805205976;-0.5207622106681548
Increased circulating oleate level;Phenylpyruvic acidemia;0.7613458931446075;0.9272181;0.5767062126331008;0.5231876977916192;0.726290173501319;0.035055719643288574;0.2009279060656366;-0.14958396086821812;-0.20310247570969975
Increased circulating oleate level;Lateral ventricle dilatation;0.726252019405365;1.0003245;0.5882634215270988;0.4998967049485087;0.9998579617208769;-0.27360594231551194;0.00046652596528029555;-0.41159454019377817;-0.49996125677236825
Increased circulating oleate level;Neonatal unconjugated hyperbilirubinemia;0.7749228328466415;0.8501331;0.5722634217165198;0.5478845115705837;0.5415034547528017;0.23341937809383984;0.30862966626083965;0.030759966963718077;0.006381056817782005
Increased circulating oleate level;High maternal circulating alpha-fetoprotein concentration;0.664849579334259;0.77777797;0.6087871400231613;0.5713309840028118;1.0;-0.33515042066574097;-0.22222203016281128;-0.39121285997683874;-0.4286690159971882
Increased circulating oleate level;Prominent nasolabial fold;0.888354204595089;1.0906104;0.5356122064755144;0.47111820527030557;0.9998944404568447;-0.11154023586175577;0.09071594448425635;-0.4642822339813303;-0.5287762351865392
Increased circulating oleate level;Abnormality of inferior alveolar nerve;0.747056782245636;0.99569565;0.5813985847546166;0.5013701223913896;1.0;-0.252943217754364;-0.004304349422454834;-0.4186014152453834;-0.49862987760861044
Increased circulating oleate level;Unilateral conductive hearing impairment;0.8049384355545044;1.0510291;0.5624906668742635;0.4837498821072582;0.9999201345566091;-0.1949816990021047;0.051108951556366966;-0.4374294676823456;-0.5161702524493509
Increased circulating oleate level;Macular hypopigmented whorls, streaks, and patches;0.9075411409139633;0.91117245;0.52947266293811;0.5283120005134685;0.9999201345566091;-0.09237899364264579;-0.08874768496783347;-0.4704474716184991;-0.4716081340431406
Increased circulating oleate level;Delayed ossification of pubic rami;0.7273231744766235;0.9070885;0.5879089769636058;0.5296173648599511;0.9999134918687169;-0.2725903173920934;-0.09282497372601672;-0.41200451490511114;-0.4702961270087658
Increased circulating oleate level;Hyperphenylalaninemia;0.625102698802948;0.92084247;0.6223220309317936;0.525223012556133;0.4420190361951307;0.18308366260781728;0.4788234325434252;0.1803029947366629;0.0832039763610023
Increased circulating oleate level;Ureteropelvic junction obstruction;0.844382032752037;1.0406401;0.5497368781974776;0.48706029055084643;0.9998847295244674;-0.15550269677243034;0.04075538621344765;-0.45014785132698976;-0.512824438973621
Increased circulating oleate level;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8647883832454681;0.9384084;0.5431714268550587;0.5196176351623507;1.0;-0.13521161675453186;-0.06159162521362305;-0.4568285731449413;-0.4803823648376493
Increased circulating oleate level;Difficulty walking;0.9519686475396156;1.0160856;0.5152947390382618;0.4948795729172665;0.9998344221996177;-0.04786577466000208;0.016251202495206507;-0.48453968316135587;-0.5049548492823512
Increased circulating oleate level;Bilobate gallbladder;0.8131035566329956;0.9936204;0.5598428850187847;0.5020307028309368;0.9999134918687169;-0.1868099352357213;-0.006293096208316529;-0.44007060684993227;-0.49788278903778016
Increased circulating oleate level;Histidinuria;0.9068279713392258;0.9419711;0.5297006560402677;0.5184815390703932;0.6883625580296748;0.21846541330955094;0.25360856518886155;-0.1586619019894071;-0.16988101895928165
Increased circulating oleate level;Widened interpedicular distance;0.651159405708313;0.93633014;0.6134245393014777;0.5202804617306762;1.0;-0.348840594291687;-0.06366986036300659;-0.38657546069852233;-0.4797195382693238
Lozenge-shaped umbilicus;Anti-myelin-associated glycoprotein antibody positivity;0.9619228057563305;0.9859556;0.5121232781052798;0.5044706190316236;0.9999134918687169;-0.03799068611238643;-0.01395789589856311;-0.4877902137634371;-0.4954428728370933
Lozenge-shaped umbilicus;Fractured radius;0.8137754648923874;0.798954;0.5596251879691514;0.5644340637088114;0.9999584729108851;-0.18618300801849774;-0.2010044629011195;-0.44033328494173374;-0.4355244092020737
Lozenge-shaped umbilicus;Abnormal manual kinetic perimetry test;1.019606076180935;1.1478119;0.4937587922272485;0.45277698967028135;0.9999134918687169;0.019692584312217987;0.14789839777972058;-0.5061546996414684;-0.5471365021984356
Lozenge-shaped umbilicus;Small radial epiphyses;0.8519665896892548;0.8581662;0.5472943164765913;0.5452998561213671;0.9999134918687169;-0.14794690217946216;-0.14174727406476184;-0.4526191753921256;-0.4546136357473498
Lozenge-shaped umbilicus;Generalized keratosis follicularis;0.9048591703176498;0.9796387;0.5303301415168711;0.5064816600743197;0.9999584729108851;-0.09509930259323529;-0.020319777194027222;-0.46962833139401405;-0.4934768128365654
Lozenge-shaped umbilicus;Hypoplasia of the calcaneus;0.9058858528733253;0.9717074;0.5300018652373151;0.5090070174084749;0.9999567459343585;-0.09407089306103311;-0.028249342274537903;-0.4699548806970434;-0.4909497285258836
Lozenge-shaped umbilicus;2-hydroxyadipic aciduria;0.9557219259440899;1.0300779;0.5140987581564729;0.4904244525858025;0.9999134918687169;-0.04419156592462703;0.0301644423964198;-0.48581473371224404;-0.5094890392829144
Lozenge-shaped umbilicus;Potter facies;1.034636989235878;1.0059524;0.48897249816096255;0.4981052943357096;0.9999532306564473;0.034683758579430735;0.005999127589402353;-0.5109807324954847;-0.5018479363207377
Lozenge-shaped umbilicus;Increased heart rate variability;0.9231972545385361;1.0465227;0.5244711713566543;0.48518600711533055;0.9999584729108851;-0.07676121837234906;0.04656426363849231;-0.4754873015542308;-0.5147724657955546
Lozenge-shaped umbilicus;Aplastic zygomatic arch;0.8804707378149033;0.8946028;0.5381385319483791;0.5336114046337018;0.9999567459343585;-0.1194860081194552;-0.10535397036062799;-0.46181821398597933;-0.46634534130065664
Lozenge-shaped umbilicus;Testicular torsion;0.8548151552677155;0.95497066;0.5463776848973219;0.5143381282537267;0.9999584729108851;-0.14514331764316968;-0.04498781508541516;-0.4535807880135633;-0.4856203446571584
Lozenge-shaped umbilicus;Abolished vibration sense;0.8917269110679626;1.003184;0.5345320903850076;0.4989865242057391;0.9999567459343585;-0.10822983486639581;0.0032272149802533567;-0.46542465554935086;-0.5009702217286194
Lozenge-shaped umbilicus;Fractured metatarsal bone of digit 5;0.9515258520841599;1.0349113;0.5154358495819944;0.4888851517212225;0.9999134918687169;-0.04838763978455707;0.034997783041256225;-0.4844776422867225;-0.5110283401474944
Lozenge-shaped umbilicus;Prolonged G2 phase of cell cycle;0.961220245808363;1.0789554;0.5123470751939431;0.4748415141330986;0.9999548690865008;-0.038734623278137814;0.07900054282450997;-0.4876077938925577;-0.5251133549534022
Lozenge-shaped umbilicus;Single naris;0.8616496473550797;0.8635049;0.5441799971974297;0.5435838092504909;0.9999548690865008;-0.13830522173142112;-0.1364499824593035;-0.45577487188907106;-0.4563710598360099
Lozenge-shaped umbilicus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8995198756456375;1.0857862;0.5320378824094376;0.47265980706108224;0.9999134918687169;-0.10039361622307941;0.08587273154284314;-0.4678756094592793;-0.5272536848076347
Lozenge-shaped umbilicus;Asymmetry of the thorax;0.8688687086105347;0.8770547;0.5418609455478449;0.5392339791324849;0.9999548690865008;-0.1310861604759661;-0.12290017777180351;-0.45809392353865586;-0.46072088995401583
Lozenge-shaped umbilicus;Type 2 muscle fiber predominance;0.9393488503992558;1.0605342;0.5193177164632434;0.48071955877129036;0.9999536937290383;-0.060604843329782554;0.06058054508626931;-0.4806359772657949;-0.519234134957748
Lozenge-shaped umbilicus;Dependency on parenteral nutrition;0.909874215722084;0.7927554;0.5287269078161918;0.5664495936639771;0.8526023716255289;0.05727184409655517;-0.05984694664918;-0.32387546380933707;-0.2861527779615518
Lozenge-shaped umbilicus;Limited shoulder flexion;0.8810418024659157;1.0638312;0.5379554501352349;0.47966807910965625;0.9999134918687169;-0.11887168940280124;0.06391771826769665;-0.461958041733482;-0.5202454127590607
Lozenge-shaped umbilicus;Paroxysmal vertigo;0.8837577998638153;1.0291516;0.5370848801659054;0.4907194427910373;0.9999567459343585;-0.11619894607054315;0.029194812941679138;-0.4628718657684531;-0.5092373031433212
Lozenge-shaped umbilicus;Long hallux;0.8245372027158737;1.0544051;0.5561421731500042;0.4826737806887703;0.9999503740898522;-0.1754131713739785;0.05445471910320199;-0.44380820093984796;-0.5172765934010819
Lozenge-shaped umbilicus;Broad medial eyebrow;0.9127598702907562;0.96747077;0.5278047416873003;0.5103562123119215;0.9999584729108851;-0.0871986026201289;-0.032487707797054566;-0.47215373122358484;-0.4896022605989636
Lozenge-shaped umbilicus;Myxoid subcutaneous tumors;0.8692625463008881;0.88313746;0.5417344945043489;0.5372837035992493;0.9999584729108851;-0.13069592660999707;-0.1168210083875697;-0.4582239784065363;-0.46267476931163587
Lozenge-shaped umbilicus;Bulbous tips of toes;0.8249424993991852;0.96166587;0.5560111350204457;0.5122051258206894;0.9999567459343585;-0.17501424653517328;-0.038290877175203186;-0.4439456109139127;-0.487751620113669
Lozenge-shaped umbilicus;Absent internal genitalia;0.8143499940633774;0.79463947;0.5594390639493174;0.5658367043970548;0.9999134918687169;-0.18556349780533954;-0.20527402367566272;-0.4404744279193995;-0.4340767874716621
Lozenge-shaped umbilicus;Hyperphalangy of the 2nd finger;0.8549342602491379;0.94692385;0.5463393669429748;0.5169025978494872;0.9999584729108851;-0.14502421266174725;-0.05303462094402722;-0.45361910596791033;-0.4830558750613979
Lozenge-shaped umbilicus;Renal interstitial hemosiderin;0.8285129964351654;0.89680684;0.5548571546880576;0.5329059735867323;0.9999134918687169;-0.17140049543355151;-0.10310665574048206;-0.4450563371806593;-0.4670075182819846
Lozenge-shaped umbilicus;Abnormality of depressor anguli oris muscle;0.8143176883459091;0.92857265;0.5594495291380308;0.5227554168710804;0.9999134918687169;-0.1855958035228078;-0.07134083714459583;-0.4404639627306861;-0.4771580749976365
Lozenge-shaped umbilicus;Paroxysmal dyspnea;0.932665541768074;0.96154296;0.5214494529899931;0.5122442741221364;0.9999134918687169;-0.06724795010064288;-0.0383705278870885;-0.4784640388787238;-0.48766921774658056
Lozenge-shaped umbilicus;Phenylpyruvic acidemia;0.9059613794088364;0.9674053;0.529977717297848;0.5103770506959218;0.9999584729108851;-0.09399709350204877;-0.032553153697017945;-0.4699807556130371;-0.48958142221496337
Lozenge-shaped umbilicus;Lateral ventricle dilatation;0.6784577071666718;0.7433449;0.6042012327045905;0.5826204323070954;0.9999462364511621;-0.32148852928449034;-0.25660133345891356;-0.3957450037465716;-0.4173258041440667
Lozenge-shaped umbilicus;Neonatal unconjugated hyperbilirubinemia;0.5467052161693573;0.6314577;0.6497515066013242;0.6201430335767169;0.9999584729108851;-0.45325325674152783;-0.36850078648662976;-0.35020696630956094;-0.3798154393341683
Lozenge-shaped umbilicus;High maternal circulating alpha-fetoprotein concentration;0.9415374919772148;0.84822166;0.5186198112306476;0.5484999796661637;0.9999134918687169;-0.058375999891502106;-0.15169183220837756;-0.4812936806380693;-0.4514135122025532
Lozenge-shaped umbilicus;Prominent nasolabial fold;0.8253974914550781;0.96796596;0.5558640411021951;0.5101984914764797;0.9999524555142131;-0.17455496405913495;-0.03198649501158857;-0.44408841441201796;-0.4897539640377334
Lozenge-shaped umbilicus;Abnormality of inferior alveolar nerve;0.8556469678878784;0.9269416;0.5461100917456481;0.5232759520637518;0.9999134918687169;-0.1442665239808385;-0.07297191824887439;-0.45380340012306886;-0.47663753980496515
Lozenge-shaped umbilicus;Unilateral conductive hearing impairment;0.7871507406234741;0.9603144;0.5682743255253833;0.5126356297653787;0.9999584729108851;-0.212807732287411;-0.039644079867367066;-0.43168414738550187;-0.48732284314550645
Lozenge-shaped umbilicus;Macular hypopigmented whorls, streaks, and patches;0.9609171934425831;1.0636221;0.512443612944575;0.4797347473032292;0.9999584729108851;-0.03904127946830205;0.06366364413165637;-0.48751485996631017;-0.520223725607656
Lozenge-shaped umbilicus;Delayed ossification of pubic rami;0.8445627689361572;0.96508116;0.5496786394072322;0.5111172818316494;0.9999567459343585;-0.15539397699820123;-0.03487559063421808;-0.4502781065271263;-0.48883946410270906
Lozenge-shaped umbilicus;Hyperphenylalaninemia;0.8932481706142426;1.1254933;0.5340450352837296;0.4599486667537743;0.9999542297279059;-0.10670605911366338;0.1255390583122552;-0.46590919444417633;-0.5400055629741316
Lozenge-shaped umbilicus;Ureteropelvic junction obstruction;0.7045624554157257;0.87527686;0.5954654239318978;0.5398042593632907;0.9999505803237132;-0.2953881249079875;-0.12467371674873151;-0.40448515639181537;-0.4601463209604225
Lozenge-shaped umbilicus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8629412055015564;0.98407966;0.5437649272121419;0.5050678095082407;0.9999134918687169;-0.13697228636716052;-0.01583383288357898;-0.45614856465657505;-0.4948456823604762
Lozenge-shaped umbilicus;Difficulty walking;1.046256873756647;1.1055927;0.485270723890011;0.4663260155481017;0.9999431787962207;0.046313694960426366;0.10564954886491207;-0.5146724549062097;-0.533617163248119
Lozenge-shaped umbilicus;Bilobate gallbladder;0.7172990441322327;0.7516786;0.5912304030329216;0.5798789177942321;0.8526023716255289;-0.1353033274932962;-0.10092378561936433;-0.26137196859260725;-0.2727234538312968
Lozenge-shaped umbilicus;Histidinuria;0.8863706588745117;1.0228885;0.5362476325597493;0.4927136999317199;0.9999556674707869;-0.11358500859627518;0.02293287375083175;-0.4637080349110376;-0.507241967539067
Lozenge-shaped umbilicus;Widened interpedicular distance;0.9048990532755852;1.0573761;0.5303173885516623;0.4817265711270181;0.9999134918687169;-0.09501443859313174;0.0574626544478114;-0.4695961033170546;-0.5181869207416988
Anti-myelin-associated glycoprotein antibody positivity;Fractured radius;0.9545017443597317;1.0866451;0.5144875459329608;0.47238536891434235;0.9999201345566091;-0.045418390196877434;0.08672499178616433;-0.48543258862364835;-0.5275347656422668
Anti-myelin-associated glycoprotein antibody positivity;Abnormal manual kinetic perimetry test;0.7268778681755066;0.7692869;0.5880563149364391;0.5741059000803039;1.0;-0.2731221318244934;-0.2307131290435791;-0.41194368506356094;-0.42589409991969607
Anti-myelin-associated glycoprotein antibody positivity;Small radial epiphyses;0.9232550263404846;1.0369254;0.5244527275847402;0.4882435832625459;1.0;-0.07674497365951538;0.036925435066223145;-0.47554727241525985;-0.5117564167374541
Anti-myelin-associated glycoprotein antibody positivity;Generalized keratosis follicularis;0.6724991202354431;0.83312535;0.6062064392846086;0.5533675167516737;0.9999201345566091;-0.327421014321166;-0.16679478169711204;-0.3937136952720005;-0.4465526178049354
Anti-myelin-associated glycoprotein antibody positivity;Hypoplasia of the calcaneus;0.9149219244718552;1.0184784;0.5271139696173288;0.494117815801709;0.9999134918687169;-0.08499156739686176;0.01856490168597058;-0.4727995222513881;-0.5057956760670079
Anti-myelin-associated glycoprotein antibody positivity;2-hydroxyadipic aciduria;0.7837386876344681;0.8495023;0.5693863124801002;0.5480875939708137;1.0;-0.21626131236553192;-0.1504976749420166;-0.4306136875198998;-0.45191240602918625
Anti-myelin-associated glycoprotein antibody positivity;Potter facies;0.9235232546925545;0.959699;0.5243670961835182;0.5128316826124344;0.9998981869165328;-0.07637493222397829;-0.0401992118303206;-0.4755310907330146;-0.48706650430409837
Anti-myelin-associated glycoprotein antibody positivity;Increased heart rate variability;0.8722579926252365;1.0577116;0.5407729498333856;0.48161960458436726;0.9999201345566091;-0.1276621419313726;0.05779146670071511;-0.45914718472322347;-0.5183005299722419
Anti-myelin-associated glycoprotein antibody positivity;Aplastic zygomatic arch;0.79414401948452;0.9247081;0.5659978439826574;0.5239888391397555;0.9999134918687169;-0.20576947238419696;-0.07520536389325305;-0.4339156478860595;-0.47592465272896145
Anti-myelin-associated glycoprotein antibody positivity;Testicular torsion;0.91989865899086;1.0518535;0.5255243935658881;0.4834871173881736;0.9999201345566091;-0.08002147556574912;0.05193340300290017;-0.474395740990721;-0.5164330171684355
Anti-myelin-associated glycoprotein antibody positivity;Abolished vibration sense;0.9529444836080074;1.1031505;0.5149837691043084;0.4671076718609062;0.9999134918687169;-0.04696900826070949;0.10323699507738904;-0.4849297227644085;-0.5328058200078107
Anti-myelin-associated glycoprotein antibody positivity;Fractured metatarsal bone of digit 5;0.9028335213661194;0.9990656;0.5309779272317929;0.5002974352159918;1.0;-0.09716647863388062;-0.0009344220161437988;-0.46902207276820707;-0.4997025647840082
Anti-myelin-associated glycoprotein antibody positivity;Prolonged G2 phase of cell cycle;0.7424938082695007;0.8991743;0.5829007760329552;0.532148447896917;0.9999056439461368;-0.25741183567663606;-0.10073137093206819;-0.4170048679131816;-0.46775719604921984
Anti-myelin-associated glycoprotein antibody positivity;Single naris;0.9122732058167458;0.906887;0.5279602480178248;0.5296817838638964;0.9999056439461368;-0.08763243812939103;-0.09301864910742219;-0.471945395928312;-0.4702238600822404
Anti-myelin-associated glycoprotein antibody positivity;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7098298668861389;0.7605181;0.5937118995362982;0.576977574901056;1.0;-0.2901701331138611;-0.23948192596435547;-0.4062881004637018;-0.42302242509894405
Anti-myelin-associated glycoprotein antibody positivity;Asymmetry of the thorax;0.8937952965497971;0.9869452;0.5338698839571361;0.5041555920911656;0.9999056439461368;-0.10611034739633973;-0.012960432058777172;-0.4660357599890007;-0.49575005185497123
Anti-myelin-associated glycoprotein antibody positivity;Type 2 muscle fiber predominance;0.6681748628616333;0.78539723;0.6076643965489065;0.5688456918126662;0.9999003561294039;-0.33172549326777057;-0.21450312455057696;-0.3922359595804974;-0.43105466431673767
Anti-myelin-associated glycoprotein antibody positivity;Dependency on parenteral nutrition;0.8007418662309647;0.87370014;0.5638532226449882;0.5403101411988238;0.9999134918687169;-0.19917162563775226;-0.12621334996197864;-0.43606026922372876;-0.4596033506698931
Anti-myelin-associated glycoprotein antibody positivity;Limited shoulder flexion;0.8471890389919281;1.0209287;0.5488325620639446;0.4933376956867366;1.0;-0.1528109610080719;0.02092874050140381;-0.4511674379360554;-0.5066623043132634
Anti-myelin-associated glycoprotein antibody positivity;Paroxysmal vertigo;0.7945029735565186;0.979153;0.5658810891378122;0.5066362899649725;0.9999134918687169;-0.20541051831219836;-0.020760514402133667;-0.4340324027309047;-0.49327720190374447
Anti-myelin-associated glycoprotein antibody positivity;Long hallux;0.9297704175114632;1.0025287;0.522373187659908;0.4991950892147262;0.9998836012415208;-0.0701131837300576;0.0026450662084304133;-0.4775104135816127;-0.5006885120267945
Anti-myelin-associated glycoprotein antibody positivity;Broad medial eyebrow;0.7796483784914017;0.8646051;0.5707204791643876;0.5432302951638176;0.9999201345566091;-0.22027175606520744;-0.1353150057915029;-0.4291996553922215;-0.4566898393927915
Anti-myelin-associated glycoprotein antibody positivity;Myxoid subcutaneous tumors;0.6164636611938477;0.73265034;0.6252939133391224;0.5861478715371808;0.9999201345566091;-0.38345647336276145;-0.26726979495318504;-0.3746262212174867;-0.41377226301942827
Anti-myelin-associated glycoprotein antibody positivity;Bulbous tips of toes;1.0439332574605942;1.0461355;0.4860111072884652;0.48530938775346244;0.9999134918687169;0.04401976559187726;0.046222052908199585;-0.5139023845802517;-0.5146041041152545
Anti-myelin-associated glycoprotein antibody positivity;Absent internal genitalia;0.8040639758110046;0.9186329;0.5627744927873533;0.5259286017325235;1.0;-0.19593602418899536;-0.08136707544326782;-0.43722550721264675;-0.47407139826747646
Anti-myelin-associated glycoprotein antibody positivity;Hyperphalangy of the 2nd finger;0.8836429417133331;0.99657494;0.5371216904388258;0.5010902319465673;0.9999201345566091;-0.11627719284327598;-0.0033451962593373796;-0.46279844411778326;-0.4988299026100418
Anti-myelin-associated glycoprotein antibody positivity;Renal interstitial hemosiderin;0.7696755826473236;0.7228107;0.5739787349927794;0.5894029199467469;1.0;-0.2303244173526764;-0.27718931436538696;-0.4260212650072206;-0.4105970800532531
Anti-myelin-associated glycoprotein antibody positivity;Abnormality of depressor anguli oris muscle;0.7479788064956665;0.94328606;0.5810952683211363;0.5180623049639211;1.0;-0.2520211935043335;-0.05671393871307373;-0.41890473167886366;-0.48193769503607886
Anti-myelin-associated glycoprotein antibody positivity;Paroxysmal dyspnea;0.7282429337501526;0.9178414;0.5876047184316089;0.5261814110243298;1.0;-0.2717570662498474;-0.08215862512588501;-0.4123952815683911;-0.4738185889756702
Anti-myelin-associated glycoprotein antibody positivity;Phenylpyruvic acidemia;0.7116931676864624;0.8955465;0.5930923092476711;0.5333093369814168;0.9999201345566091;-0.2882269668701467;-0.10437363864214988;-0.406827825308938;-0.4666107975751923
Anti-myelin-associated glycoprotein antibody positivity;Lateral ventricle dilatation;0.8379474580287933;0.7533404;0.5518114067831112;0.5793329439819592;0.9998579617208769;-0.1619105036920836;-0.24651753861372971;-0.4480465549377657;-0.4205250177389177
Anti-myelin-associated glycoprotein antibody positivity;Neonatal unconjugated hyperbilirubinemia;0.8186375647783279;1.0912147;0.5580507103490244;0.47092504304202576;0.9999201345566091;-0.18128256977828117;0.09129452227322488;-0.4418694242075847;-0.5289950915145833
Anti-myelin-associated glycoprotein antibody positivity;High maternal circulating alpha-fetoprotein concentration;0.6684704720973969;0.8497183;0.6075646551330021;0.5480180697357457;1.0;-0.33152952790260315;-0.15028172731399536;-0.39243534486699794;-0.45198193026425426
Anti-myelin-associated glycoprotein antibody positivity;Prominent nasolabial fold;0.8470534086227417;0.92388654;0.548876248082726;0.5242511311379562;0.9998944404568447;-0.15284103183410302;-0.07600790290496484;-0.4510181923741188;-0.47564330931888854
Anti-myelin-associated glycoprotein antibody positivity;Abnormality of inferior alveolar nerve;0.6899063587188721;0.8281121;0.6003604102102978;0.5549866887809214;1.0;-0.31009364128112793;-0.17188787460327148;-0.39963958978970215;-0.4450133112190786
Anti-myelin-associated glycoprotein antibody positivity;Unilateral conductive hearing impairment;0.7598841041326523;0.91162187;0.5771854484936383;0.5281683882873665;0.9999201345566091;-0.24003603042395683;-0.08829826594622703;-0.4227346860629708;-0.47175174626924266
Anti-myelin-associated glycoprotein antibody positivity;Macular hypopigmented whorls, streaks, and patches;0.7042276859283447;0.7463232;0.595576969301679;0.5816399546065025;0.9999201345566091;-0.2956924486282644;-0.25359690667422385;-0.4043431652549301;-0.4182801799501066
Anti-myelin-associated glycoprotein antibody positivity;Delayed ossification of pubic rami;0.9223027899861336;1.0051377;0.5247567416299962;0.4983646024295817;0.9999134918687169;-0.07761070188258334;0.005224190092342651;-0.4751567502387207;-0.5015488894391352
Anti-myelin-associated glycoprotein antibody positivity;Hyperphenylalaninemia;0.7125054001808167;0.87986326;0.5928223370530388;0.5383333033348068;0.9999028053808913;-0.2873974052000746;-0.1200395432043776;-0.4070804683278525;-0.4615695020460845
Anti-myelin-associated glycoprotein antibody positivity;Ureteropelvic junction obstruction;0.8998101949691772;1.0835027;0.5319450021982441;0.4733893067731265;0.9998847295244674;-0.10007453455529014;0.0836179207364579;-0.46793972732622324;-0.5264954227513409
Anti-myelin-associated glycoprotein antibody positivity;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8973945081233978;0.99286366;0.5327179230502368;0.5022715937534865;1.0;-0.10260549187660217;-0.007136344909667969;-0.4672820769497632;-0.4977284062465135
Anti-myelin-associated glycoprotein antibody positivity;Difficulty walking;0.7963659763336182;0.81617707;0.5652752654028632;0.5588472973041072;0.9998344221996177;-0.20346844586599955;-0.1836573520587791;-0.4345591567967545;-0.4409871248955105
Anti-myelin-associated glycoprotein antibody positivity;Bilobate gallbladder;0.8799592405557632;1.0491644;0.5383025273755282;0.484344180151708;0.9999134918687169;-0.11995425131295367;0.049250922537105835;-0.4616109644931887;-0.5155693117170089
Anti-myelin-associated glycoprotein antibody positivity;Histidinuria;0.663042426109314;0.77251697;0.6093978947134358;0.5730496157836649;0.9999090677057578;-0.33686664159644386;-0.22739210183966896;-0.3905111729923221;-0.42685945192209296
Anti-myelin-associated glycoprotein antibody positivity;Widened interpedicular distance;0.7735842764377594;0.8842128;0.5727007876165784;0.5369390599287454;1.0;-0.2264157235622406;-0.11578720808029175;-0.4272992123834216;-0.46306094007125465
Fractured radius;Abnormal manual kinetic perimetry test;0.7594201564788818;0.95832884;0.577337587292235;0.5132681925911093;0.9999201345566091;-0.24049997807772727;-0.041591291439848854;-0.42258254726437405;-0.48665194196549977
Fractured radius;Small radial epiphyses;0.548593282699585;0.266545;0.6490776297167082;0.7620934807794758;0.1542140045508552;0.39437927814872975;0.11233099314125294;0.494863625165853;0.6078794762286206
Fractured radius;Generalized keratosis follicularis;0.7910212874412537;0.86837304;0.5670139384093715;0.5420200928905243;0.9999600672783046;-0.2089387798370509;-0.13158703089372203;-0.432946128868933;-0.4579399743877802
Fractured radius;Hypoplasia of the calcaneus;0.6969896554946899;0.79429674;0.5979916746553164;0.5659481727571938;0.8287763732556668;-0.13178671776097683;-0.03447963177007107;-0.23078469860035034;-0.262828200498473
Fractured radius;2-hydroxyadipic aciduria;0.8227448761463165;0.90752715;0.5567217732002541;0.5294771430990717;0.9999201345566091;-0.17717525841029258;-0.09239298583300681;-0.44319836135635504;-0.47044299145753743
Fractured radius;Potter facies;1.0638597086071968;1.0973362;0.47965898209012814;0.46896781677549115;0.9999552432134126;0.06390446539378425;0.0973809298441436;-0.5202962611232844;-0.5309874264379214
Fractured radius;Increased heart rate variability;0.8581486344337463;1.070313;0.5453055054579083;0.4776001965548624;0.9999600672783046;-0.14181143284455822;0.07035290955885365;-0.4546545618203962;-0.5223598707234421
Fractured radius;Aplastic zygomatic arch;0.7818416357040405;0.97797704;0.5700049325689619;0.5070106946835657;0.9074607173141833;-0.1256190816101428;0.07051632011562625;-0.3374557847452214;-0.4004500226306176
Fractured radius;Testicular torsion;0.749539315700531;0.93269193;0.5805820820844816;0.5214410432134802;0.9999600672783046;-0.25042075157777355;-0.06726813555375621;-0.41937798519382297;-0.4785190240648244
Fractured radius;Abolished vibration sense;0.7197014093399048;0.9486281;0.5904334796351234;0.5163593687158944;0.9999584729108851;-0.28025706357098035;-0.05133034533596448;-0.40952499327576175;-0.48359910419499075
Fractured radius;Fractured metatarsal bone of digit 5;0.48698103427886963;0.5583005;0.6714729532966031;0.6456242588871843;0.0;0.48698103427886963;0.5583004951477051;0.6714729532966031;0.6456242588871843
Fractured radius;Prolonged G2 phase of cell cycle;0.8956348448991776;0.9013715;0.5332810648454314;0.5314455632063656;0.9999567459343585;-0.10432190103518091;-0.09858526689993463;-0.4666756810889271;-0.46851118272799286
Fractured radius;Single naris;0.9117749705910683;1.044662;0.5281194585399969;0.485778931605339;0.9999567459343585;-0.08818177534329019;0.04470525281442084;-0.4718372873943616;-0.5141778143290194
Fractured radius;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7798600941896439;0.98893476;0.5706513914757001;0.503522244798555;0.9999201345566091;-0.22006004036696525;-0.010985379231291725;-0.429268743080909;-0.4963978897580541
Fractured radius;Asymmetry of the thorax;0.7566783428192139;1.0288403;0.5782370586454747;0.49081857083254776;0.9036123096265051;-0.1469339668072912;0.12522799379451544;-0.3253752509810304;-0.4127937387939573
Fractured radius;Type 2 muscle fiber predominance;0.9574553668498993;1.068302;0.5135464660541869;0.47824184691868943;0.9344769737294281;0.02297839312047123;0.133825061602298;-0.4209305076752412;-0.45623512681073863
Fractured radius;Dependency on parenteral nutrition;0.8463401794433594;0.84243935;0.5491059917412571;0.550362975992454;0.9999584729108851;-0.15361829346752576;-0.1575191194448512;-0.45085248116962806;-0.44959549691843115
Fractured radius;Limited shoulder flexion;0.6290110349655151;1.0790962;0.6209812347136059;0.47479656704886397;0.6115804491749721;0.01743058579054302;0.4675157489069981;0.009400785538633771;-0.13678388212610815
Fractured radius;Paroxysmal vertigo;0.8226517587900162;0.9780384;0.5567518905379086;0.506991174712761;0.9999584729108851;-0.17730671412086896;-0.021920102301601685;-0.4432065823729765;-0.4929672981981241
Fractured radius;Long hallux;0.8501610159873962;0.8839773;0.5478755309178092;0.5370145466132032;0.8047017442325175;0.04545927175487874;0.07927554973568318;-0.25682621331470834;-0.26768719761931425
Fractured radius;Broad medial eyebrow;0.9013839885592461;0.9948524;0.531441554644182;0.5016385232237084;0.9999600672783046;-0.09857607871905849;-0.005107643610396839;-0.4685185126341226;-0.49832154405459617
Fractured radius;Myxoid subcutaneous tumors;0.9326529651880264;0.91918087;0.5214534653476659;0.5257536208245316;0.9999600672783046;-0.06730710209027813;-0.08077919722215221;-0.47850660193063865;-0.47420644645377297
Fractured radius;Bulbous tips of toes;0.7455908358097076;0.7563768;0.5818809899118474;0.578336014840899;0.8287763732556668;-0.08318553744595913;-0.07239957033437161;-0.24689538334381933;-0.25044035841476775
Fractured radius;Absent internal genitalia;0.8602913618087769;0.9737694;0.5446165930650095;0.5083504157917305;0.9999201345566091;-0.13962877274783225;-0.026150708210783913;-0.4553035414915996;-0.49156971876487865
Fractured radius;Hyperphalangy of the 2nd finger;0.6707493662834167;0.6101017;0.6067961018294146;0.627489841611744;0.830294756654948;-0.15954539037153126;-0.22019305682584644;-0.22349865482553344;-0.20280491504320397
Fractured radius;Renal interstitial hemosiderin;0.8300470113754272;0.9832555;0.5543615873790918;0.5053301943323426;0.9999201345566091;-0.16987312318118186;-0.016664628994780495;-0.4455585471775173;-0.4945899402242665
Fractured radius;Abnormality of depressor anguli oris muscle;0.8641914278268814;1.1282737;0.5433632127087251;0.4590564142028527;0.8819596887815145;-0.01776826095463313;0.24631403672812902;-0.3385964760727894;-0.42290327457866184
Fractured radius;Paroxysmal dyspnea;0.786829262971878;1.0134817;0.5683790586640886;0.49570848733296513;0.9999201345566091;-0.21309087158473106;0.013561601626557396;-0.43154107589252055;-0.504211647223644
Fractured radius;Phenylpyruvic acidemia;0.8072774112224579;0.9739835;0.5617317454445532;0.5082822441951009;0.9999600672783046;-0.19268265605584667;-0.025976541048446156;-0.4382283218337514;-0.4916778230832036
Fractured radius;Lateral ventricle dilatation;0.8204293549060822;1.0217918;0.5574708450136426;0.49306289455008445;0.9999488789551968;-0.17951952404911464;0.02184293680255467;-0.44247803394155416;-0.5068859844051123
Fractured radius;Neonatal unconjugated hyperbilirubinemia;0.7816649079322815;0.90035963;0.5700625763485819;0.5317692413809769;0.9999600672783046;-0.21829515934602306;-0.09960043669358776;-0.4298974909297226;-0.46819082589732763
Fractured radius;High maternal circulating alpha-fetoprotein concentration;0.8500377237796783;1.0348549;0.5479152245420187;0.48890311324348756;0.9999201345566091;-0.14988241077693076;0.03493475435940652;-0.4520049100145904;-0.5110170213131215
Fractured radius;Prominent nasolabial fold;0.8424904048442841;1.0711775;0.5503465203588921;0.47732431508274764;0.9999545338528789;-0.15746412900859486;0.07122294875210156;-0.4496080134939868;-0.5226302187701313
Fractured radius;Abnormality of inferior alveolar nerve;0.8518322706222534;0.9522679;0.547337548311015;0.5151993829147319;0.9999201345566091;-0.1480878639343557;-0.047652249348479225;-0.4525825862455941;-0.4847207516418772
Fractured radius;Unilateral conductive hearing impairment;0.8813655376434326;1.0579705;0.5378516671025646;0.4815370463777988;0.9999600672783046;-0.11859452963487194;0.05801045655592396;-0.46210840017573995;-0.5184230209005057
Fractured radius;Macular hypopigmented whorls, streaks, and patches;0.9465651586651802;1.0270411;0.5170169428536451;0.4913914899417393;0.9999600672783046;-0.05339490861312435;0.027081010335526012;-0.4829431244246595;-0.5085685773365652
Fractured radius;Delayed ossification of pubic rami;0.6730885207653046;0.9138212;0.6060078981660484;0.5274656262090177;0.8355479869321181;-0.1624594661668135;0.07827323346583115;-0.22954008876606968;-0.30808236072310036
Fractured radius;Hyperphenylalaninemia;0.9020747765898705;1.0280728;0.5312206005022552;0.49106297833086043;0.9999561589935034;-0.09788138240363298;0.028116675021389148;-0.46873555849124826;-0.508893180662643
Fractured radius;Ureteropelvic junction obstruction;0.6592269539833069;0.732319;0.6106887733355655;0.5862573304242182;0.9999528219730685;-0.34072586798976157;-0.2676338245899508;-0.38926404863750297;-0.4136954915488502
Fractured radius;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6408605575561523;0.5657654;0.6169297535955349;0.6429811089277873;0.4693866352828394;0.17147392227331293;0.09637874557653558;0.1475431183126955;0.17359447364494784
Fractured radius;Difficulty walking;0.8558012694120407;1.0089445;0.5460604567388974;0.4971528368107344;0.9203691460904122;-0.0645678766783715;0.08857536532316201;-0.37430868935151485;-0.4232163092796778
Fractured radius;Bilobate gallbladder;0.8529795110225677;0.9339619;0.546968326618035;0.5210358822016248;0.9999584729108851;-0.14697896188831738;-0.06599654502010754;-0.45299014629285017;-0.47892259070926035
Fractured radius;Histidinuria;0.8777305632829666;0.92951953;0.539017202128125;0.5224532494619283;0.9999574798349273;-0.12222691655196072;-0.07043794572390438;-0.46094027770680235;-0.47750423037299905
Fractured radius;Widened interpedicular distance;0.7425869107246399;1.0301952;0.582870106709084;0.4903870788629183;0.822027235707794;-0.07944032498315412;0.20816800049826067;-0.23915712899871;-0.3316401568448757
Abnormal manual kinetic perimetry test;Small radial epiphyses;0.7762438356876373;0.90170544;0.5718319274124745;0.5313387398302316;1.0;-0.22375616431236267;-0.09829455614089966;-0.42816807258752554;-0.4686612601697684
Abnormal manual kinetic perimetry test;Generalized keratosis follicularis;0.8272595554590225;0.90879303;0.555262181552834;0.5290724754135289;0.9999201345566091;-0.1726605790975866;-0.09112710238726707;-0.4446579530037751;-0.47084765914308024
Abnormal manual kinetic perimetry test;Hypoplasia of the calcaneus;0.7936750054359436;1.0450251;0.566150410957388;0.4856632320489981;0.9999134918687169;-0.20623848643277332;0.04511161837603406;-0.43376308091132887;-0.5142502598197188
Abnormal manual kinetic perimetry test;2-hydroxyadipic aciduria;0.7189993858337402;0.82837516;0.5906662975471393;0.5549016894220289;1.0;-0.28100061416625977;-0.17162483930587769;-0.4093337024528607;-0.4450983105779711
Abnormal manual kinetic perimetry test;Potter facies;0.8553464710712433;0.9768991;0.5462067574254552;0.5073539077656191;0.9998981869165328;-0.14455171584528947;-0.02299909948748613;-0.45369142949107755;-0.4925442791509137
Abnormal manual kinetic perimetry test;Increased heart rate variability;0.8047274351119995;0.94701916;0.5625591472785851;0.5168722271807544;0.9999201345566091;-0.1951926994446096;-0.05290097476275535;-0.43736098727802397;-0.4830479073758547
Abnormal manual kinetic perimetry test;Aplastic zygomatic arch;0.7920265346765518;1.0054792;0.5666867695303399;0.49825591314086504;0.9999134918687169;-0.2078869571921651;0.005565724706905639;-0.433226722338377;-0.5016575787278519
Abnormal manual kinetic perimetry test;Testicular torsion;0.7243709564208984;0.99121153;0.5888861363978346;0.5027974941407451;0.9999201345566091;-0.27554917813571067;-0.008708601010161354;-0.4110339981587745;-0.49712264041586396
Abnormal manual kinetic perimetry test;Abolished vibration sense;0.7453432381153107;0.8510328;0.5819624868822137;0.5475948904391487;0.9999134918687169;-0.25457025375340625;-0.14888069834683582;-0.41795100498650317;-0.45231860142956826
Abnormal manual kinetic perimetry test;Fractured metatarsal bone of digit 5;0.7624141424894333;0.9604956;0.5763561077805575;0.5125779109072137;1.0;-0.2375858575105667;-0.039504408836364746;-0.42364389221944254;-0.4874220890927863
Abnormal manual kinetic perimetry test;Prolonged G2 phase of cell cycle;0.7434290647506714;0.91002625;0.5825927244551106;0.5286783228067683;0.9999056439461368;-0.2564765791954654;-0.08987939167639192;-0.4173129194910262;-0.4712273211393685
Abnormal manual kinetic perimetry test;Single naris;0.9193391501903534;0.9444408;0.5257030689077355;0.5176941523181456;0.9999056439461368;-0.0805664937557834;-0.05546486187597688;-0.47420257503840124;-0.48221149162799115
Abnormal manual kinetic perimetry test;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.6806517243385315;0.45152044;0.6034639774784523;0.6847931479734928;1.0;-0.3193482756614685;-0.5484795570373535;-0.39653602252154774;-0.3152068520265072
Abnormal manual kinetic perimetry test;Asymmetry of the thorax;0.7577763199806213;0.95904416;0.5778767833573508;0.5130402918373502;0.9999056439461368;-0.24212932396551545;-0.040861485487427074;-0.42202886058878597;-0.48686535210878656
Abnormal manual kinetic perimetry test;Type 2 muscle fiber predominance;0.8475685715675354;0.9564702;0.5487103210091617;0.5138603503221972;0.9999003561294039;-0.15233178456186847;-0.04343016465067462;-0.45119003512024214;-0.48604000580720663
Abnormal manual kinetic perimetry test;Dependency on parenteral nutrition;0.8158197700977325;1.0499507;0.5589630098662203;0.48409358255514856;0.9999134918687169;-0.18409372177098438;0.05003722701098279;-0.44095048200249665;-0.5158199093135684
Abnormal manual kinetic perimetry test;Limited shoulder flexion;0.7083484530448914;0.84842944;0.5942047645990403;0.5484330665164636;1.0;-0.29165154695510864;-0.15157055854797363;-0.40579523540095974;-0.4515669334835364
Abnormal manual kinetic perimetry test;Paroxysmal vertigo;0.6774203181266785;0.74993396;0.6045500281086438;0.5804523346726398;0.9999134918687169;-0.32249317374203845;-0.24997953381512805;-0.39536346376007314;-0.41946115719607713
Abnormal manual kinetic perimetry test;Long hallux;0.825875386595726;0.97880006;0.5557095558461922;0.5067486637063354;0.9998836012415208;-0.17400821464579475;-0.021083542876652595;-0.44417404539532857;-0.49313493753518534
Abnormal manual kinetic perimetry test;Broad medial eyebrow;0.760022908449173;0.73873794;0.5771399349548978;0.5841386747281052;0.9999201345566091;-0.23989722610743613;-0.26118219376834007;-0.4227801996017113;-0.4157814598285039
Abnormal manual kinetic perimetry test;Myxoid subcutaneous tumors;0.9113692492246628;1.1547978;0.5282491115681041;0.4505274132618503;0.9999201345566091;-0.08855088533194633;0.15487765787808327;-0.47167102298850505;-0.5493927212947588
Abnormal manual kinetic perimetry test;Bulbous tips of toes;0.861774668097496;0.981128;0.5441398157994668;0.5060075074169184;0.9999134918687169;-0.1381388237712209;-0.0187855144975011;-0.4557736760692501;-0.49390598445179856
Abnormal manual kinetic perimetry test;Absent internal genitalia;0.8627022802829742;1.0252264;0.543841705302561;0.4919693583456214;1.0;-0.13729771971702576;0.025226354598999023;-0.45615829469743896;-0.5080306416543786
Abnormal manual kinetic perimetry test;Hyperphalangy of the 2nd finger;0.6832318305969238;0.8525851;0.6025977200880566;0.5470952618486727;0.9999201345566091;-0.3166883039596853;-0.1473350572708425;-0.39732241446855254;-0.45282487270793637
Abnormal manual kinetic perimetry test;Renal interstitial hemosiderin;0.871321439743042;0.9485777;0.5410735446940554;0.5163754456525658;1.0;-0.128678560256958;-0.051422297954559326;-0.45892645530594456;-0.48362455434743423
Abnormal manual kinetic perimetry test;Abnormality of depressor anguli oris muscle;0.7261166572570801;0.9002154;0.5883082207658972;0.5318153758649824;1.0;-0.2738833427429199;-0.09978461265563965;-0.41169177923410283;-0.4681846241350176
Abnormal manual kinetic perimetry test;Paroxysmal dyspnea;0.6633826494216919;0.92651105;0.6092828791388545;0.5234133663519768;1.0;-0.3366173505783081;-0.07348895072937012;-0.3907171208611455;-0.47658663364802323
Abnormal manual kinetic perimetry test;Phenylpyruvic acidemia;0.6510948538780212;0.8447489;0.613446464335841;0.5496186545818705;0.9999201345566091;-0.34882528067858787;-0.15517122031481834;-0.38647367022076806;-0.45030147997473857
Abnormal manual kinetic perimetry test;Lateral ventricle dilatation;0.7770509123802185;0.8358079;0.5715683688203972;0.552501679315214;0.9998579617208769;-0.22280704934065843;-0.16405004221861863;-0.42828959290047974;-0.44735628240566294
Abnormal manual kinetic perimetry test;Neonatal unconjugated hyperbilirubinemia;0.8806259632110596;1.0912125;0.538088765845797;0.47092574559077693;0.9999201345566091;-0.11929417134554954;0.09129237650601296;-0.4618313687108121;-0.5289943889658322
Abnormal manual kinetic perimetry test;High maternal circulating alpha-fetoprotein concentration;0.8061436712741852;0.9626968;0.5620995624767515;0.5118767406126055;1.0;-0.19385632872581482;-0.03730320930480957;-0.4379004375232485;-0.48812325938739454
Abnormal manual kinetic perimetry test;Prominent nasolabial fold;0.9598314240574837;1.0696449;0.5127894957495283;0.4778133775930813;0.9998944404568447;-0.04006301639936105;0.0697504875216709;-0.48710494470731647;-0.5220810628637634
Abnormal manual kinetic perimetry test;Abnormality of inferior alveolar nerve;0.8064598739147186;1.0243268;0.5619969690490793;0.49225578951563964;1.0;-0.19354012608528137;0.024326801300048828;-0.43800303095092075;-0.5077442104843604
Abnormal manual kinetic perimetry test;Unilateral conductive hearing impairment;0.6998884081840515;0.8421928;0.5970239205989258;0.5504424414183946;0.9999201345566091;-0.3000317263725576;-0.1577273059013662;-0.40289621395768327;-0.4494776931382145
Abnormal manual kinetic perimetry test;Macular hypopigmented whorls, streaks, and patches;0.695769190788269;0.5967829;0.5983994085565203;0.6321080454712693;0.9999201345566091;-0.30415094376834007;-0.40313721181185813;-0.4015207260000888;-0.3678120890853398
Abnormal manual kinetic perimetry test;Delayed ossification of pubic rami;0.8557195961475372;1.1250321;0.5460867288795395;0.46009661471294183;0.9999134918687169;-0.1441938957211797;0.12511857543017224;-0.45382676298917746;-0.5398168771557751
Abnormal manual kinetic perimetry test;Hyperphenylalaninemia;0.7595829218626022;0.77675444;0.5772842108367995;0.5716651743952121;0.9999028053808913;-0.24031988351828903;-0.22314836650378556;-0.4226185945440918;-0.42823763098567913
Abnormal manual kinetic perimetry test;Ureteropelvic junction obstruction;0.8108427226543427;0.9129555;0.5605755997853616;0.5277422353471755;0.9998847295244674;-0.18904200687012473;-0.08692920698723594;-0.43930912973910574;-0.4721424941772919
Abnormal manual kinetic perimetry test;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6775376200675964;0.9198937;0.6045105818222656;0.525525990035317;1.0;-0.32246237993240356;-0.08010631799697876;-0.3954894181777344;-0.47447400996468303
Abnormal manual kinetic perimetry test;Difficulty walking;0.6643389463424683;0.7113148;0.6089596737854989;0.5932180965910967;0.9998344221996177;-0.33549547585714945;-0.2885196247981895;-0.39087474841411884;-0.406616325608521
Abnormal manual kinetic perimetry test;Bilobate gallbladder;0.9445593990385532;1.1125546;0.5176563442052795;0.46409667634845597;0.9999134918687169;-0.05535409283016368;0.11264105830218152;-0.4822571476634374;-0.535816815520261
Abnormal manual kinetic perimetry test;Histidinuria;0.7960549145936966;0.90980554;0.5653764018063427;0.5287488633265198;0.9999090677057578;-0.20385415311206123;-0.09010353143561622;-0.4345326658994151;-0.471160204379238
Abnormal manual kinetic perimetry test;Widened interpedicular distance;0.66782546043396;0.79535735;0.6077823024872774;0.5656032187938724;1.0;-0.33217453956604004;-0.204642653465271;-0.3922176975127226;-0.43439678120612757
Small radial epiphyses;Generalized keratosis follicularis;0.8450297266244888;0.8768376;0.5495281789495925;0.5393035998830282;0.9999201345566091;-0.15489040793212028;-0.12308252335818382;-0.4503919556070166;-0.4606165346735809
Small radial epiphyses;Hypoplasia of the calcaneus;0.6535455286502838;0.698455;0.6126144856307825;0.5975023583045207;0.6433114794007544;0.01023404924952942;0.05514349668109375;-0.030696993769971925;-0.045809121096233696
Small radial epiphyses;2-hydroxyadipic aciduria;0.7324855327606201;0.8273734;0.5862023141637829;0.5552254005431536;1.0;-0.2675144672393799;-0.17262661457061768;-0.4137976858362171;-0.4447745994568464
Small radial epiphyses;Potter facies;0.8352291733026505;0.9378207;0.5526884532693136;0.5198050752181465;0.9998981869165328;-0.1646690136138823;-0.06207751392764116;-0.44720973364721917;-0.4800931116983863
Small radial epiphyses;Increased heart rate variability;0.9333780705928802;1.0888546;0.5212221375654447;0.4716793588070135;0.9999201345566091;-0.06654206396372886;0.08893441675869851;-0.47869799699116444;-0.5282407757495956
Small radial epiphyses;Aplastic zygomatic arch;0.8355362564325333;0.98321134;0.5525893537085957;0.5053442408833334;0.8072246192530101;0.02831163717952312;0.1759867192670399;-0.2546352655444144;-0.30188037836967674
Small radial epiphyses;Testicular torsion;0.8032289147377014;0.92881286;0.5630455781667494;0.5226787449202825;0.9999201345566091;-0.1966912198189077;-0.07110727311404319;-0.4368745563898597;-0.47724138963632656
Small radial epiphyses;Abolished vibration sense;0.9572718478739262;1.0189371;0.5136049351271506;0.49397177479046683;0.9999134918687169;-0.04264164399479076;0.019023619032161987;-0.48630855674156637;-0.5059417170782501
Small radial epiphyses;Fractured metatarsal bone of digit 5;0.6115086078643799;0.59089637;0.6270036774131459;0.6341585384568711;1.0;-0.3884913921356201;-0.4091036319732666;-0.3729963225868541;-0.3658414615431289
Small radial epiphyses;Prolonged G2 phase of cell cycle;0.912297934293747;1.0098265;0.5279523462430094;0.49687208231664415;0.9999056439461368;-0.08760770965238984;0.009920897000823659;-0.47195329770312744;-0.5030335616294926
Small radial epiphyses;Single naris;0.8389874845743179;0.9851155;0.5514759506197036;0.5047380447720433;0.9999056439461368;-0.16091815937181886;-0.014790115839447338;-0.44842969332643323;-0.4951675991740935
Small radial epiphyses;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7481796145439148;0.96490735;0.5810292188986336;0.5111726248677818;1.0;-0.2518203854560852;-0.03509265184402466;-0.41897078110136643;-0.4888273751322182
Small radial epiphyses;Asymmetry of the thorax;0.7575217336416245;0.947694;0.5779603107716642;0.5166571242028482;0.789736248610815;-0.03221451496919059;0.1579577549711857;-0.21177593783915083;-0.2730791244079669
Small radial epiphyses;Type 2 muscle fiber predominance;0.8222154378890991;0.9672778;0.5568930184848315;0.5104176455713619;0.8527273749847077;-0.03051193709560862;0.11455044989398488;-0.2958343564998762;-0.3423097294133458
Small radial epiphyses;Dependency on parenteral nutrition;0.9126246422529221;0.8565769;0.5278479511086791;0.545810975801042;0.9999134918687169;-0.08728884961579486;-0.14333657231305286;-0.4720655407600378;-0.45410251606767493
Small radial epiphyses;Limited shoulder flexion;0.6758202910423279;0.9780026;0.6050882517680787;0.507002561112096;1.0;-0.3241797089576721;-0.021997392177581787;-0.3949117482319213;-0.49299743888790404
Small radial epiphyses;Paroxysmal vertigo;0.8926214501261711;1.0598453;0.5342456799191672;0.48093925359741185;0.9999134918687169;-0.10729204174254581;0.05993183646227673;-0.46566781194954976;-0.5189742382713051
Small radial epiphyses;Long hallux;0.9286607503890991;0.88387096;0.522727293920762;0.5370486171855666;0.5200670694678955;0.40859368092120363;0.3638038898140259;0.002660224452866511;0.01698154771767113
Small radial epiphyses;Broad medial eyebrow;0.9064532518386841;0.9719936;0.5298204561927604;0.5089158789009445;0.9999201345566091;-0.09346688271792503;-0.027926509392577126;-0.4700996783638487;-0.49100425565566463
Small radial epiphyses;Myxoid subcutaneous tumors;0.7901979386806488;0.9736094;0.5672819599359948;0.5084013657710265;0.9999201345566091;-0.2097221958759603;-0.026310746682005837;-0.43263817462061427;-0.49151876878558265
Small radial epiphyses;Bulbous tips of toes;0.6798780560493469;0.7492762;0.6037238872014027;0.5806685879594455;0.6433114794007544;0.03656657664859253;0.10596474139773804;-0.03958759219935171;-0.06264289144130886
Small radial epiphyses;Absent internal genitalia;0.7964742481708527;0.90344197;0.5652400642357136;0.5307833455721899;1.0;-0.20352575182914734;-0.09655803442001343;-0.4347599357642864;-0.46921665442781013
Small radial epiphyses;Hyperphalangy of the 2nd finger;0.7017523944377899;0.6195085;0.5964021145279303;0.6242451684218657;0.660589513309896;0.0411628811278939;-0.041081008442342304;-0.06418739878196567;-0.03634434488803029
Small radial epiphyses;Renal interstitial hemosiderin;0.7543242275714874;0.9628174;0.5790098515833337;0.5118383297245195;1.0;-0.24567577242851257;-0.037182629108428955;-0.42099014841666627;-0.4881616702754805
Small radial epiphyses;Abnormality of depressor anguli oris muscle;0.81914421916008;1.0308211;0.5578867254314397;0.4901878042665512;1.0;-0.18085578083992004;0.03082108497619629;-0.4421132745685603;-0.5098121957334488
Small radial epiphyses;Paroxysmal dyspnea;0.7958187460899353;1.0059198;0.5654531924256077;0.4981156512668339;1.0;-0.2041812539100647;0.005919814109802246;-0.43454680757439235;-0.5018843487331661
Small radial epiphyses;Phenylpyruvic acidemia;0.7898116111755371;0.9328257;0.5674077363109392;0.5213983694144735;0.9999201345566091;-0.210108523381072;-0.06709445000918479;-0.4325123982456699;-0.4785217651421356
Small radial epiphyses;Lateral ventricle dilatation;0.8114494383335114;0.9672142;0.5603789372791238;0.5104379157846081;0.9998579617208769;-0.18840852338736558;-0.032643734998159646;-0.43947902444175313;-0.48942004593626887
Small radial epiphyses;Neonatal unconjugated hyperbilirubinemia;0.812113493680954;0.9308724;0.5601637152667427;0.5220215672379956;0.9999201345566091;-0.18780664087565513;-0.06904775382311912;-0.4397564192898664;-0.47789856731861347
Small radial epiphyses;High maternal circulating alpha-fetoprotein concentration;0.9258456826210022;1.0593077;0.5236257386045182;0.48111069705453646;1.0;-0.0741543173789978;0.05930769443511963;-0.4763742613954818;-0.5188893029454635
Small radial epiphyses;Prominent nasolabial fold;0.8889217153191566;1.0738298;0.5354304315412977;0.47647785672249454;0.9998944404568447;-0.11097272513768808;0.07393532963135108;-0.46446400891554707;-0.5234165837343502
Small radial epiphyses;Abnormality of inferior alveolar nerve;0.9095511958003044;0.95652515;0.5288301499165257;0.5138428349384715;1.0;-0.09044880419969559;-0.04347485303878784;-0.47116985008347434;-0.4861571650615285
Small radial epiphyses;Unilateral conductive hearing impairment;0.9408473521471024;1.1111491;0.5188398704141747;0.4645469074837424;0.9999201345566091;-0.05907278240950675;0.11122893809048562;-0.48108026414243443;-0.5353732270728667
Small radial epiphyses;Macular hypopigmented whorls, streaks, and patches;0.8268526792526245;0.9975815;0.5553936756682529;0.5007698308826827;0.9999201345566091;-0.1730674553039846;-0.002338652623015358;-0.4445264588883562;-0.49915030367392643
Small radial epiphyses;Delayed ossification of pubic rami;0.637986958026886;0.78967017;0.6179104188631066;0.567453788096889;0.6574179255159834;-0.01943096748909745;0.13225224383750167;-0.039507506652876834;-0.08996413741909448
Small radial epiphyses;Hyperphenylalaninemia;0.8939901441335678;0.96329135;0.5338075099239314;0.5116873446803138;0.9999028053808913;-0.10591266124732346;-0.03661145835406632;-0.4660952954569598;-0.4882154607005774
Small radial epiphyses;Ureteropelvic junction obstruction;0.8157824575901031;0.8107853;0.5589750935706425;0.5605942210472974;0.9998847295244674;-0.18410227193436424;-0.18909943594536582;-0.44090963595382493;-0.43929050847717
Small radial epiphyses;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.5162697434425354;0.5046086;0.6607184206836485;0.664975360470162;1.0;-0.4837302565574646;-0.4953914284706116;-0.3392815793163515;-0.33502463952983796
Small radial epiphyses;Difficulty walking;0.9699513260275126;1.024686;0.5095662299551508;0.492141415308605;0.7552776988623575;0.21467362716515503;0.2694082800271078;-0.24571146890720674;-0.2631362835537525
Small radial epiphyses;Bilobate gallbladder;0.909509502351284;0.9859519;0.5288434760009741;0.5044717907143841;0.9999134918687169;-0.09040398951743289;-0.013961591386539185;-0.4710700158677428;-0.49544170115433284
Small radial epiphyses;Histidinuria;0.8101102560758591;0.86836547;0.5608130547346278;0.5420225283641613;0.9999090677057578;-0.18979881162989876;-0.13154360111106178;-0.43909601297113;-0.4578865393415965
Small radial epiphyses;Widened interpedicular distance;0.7894531488418579;0.88261867;0.5675244501985153;0.5374499796707899;1.0;-0.2105468511581421;-0.11738133430480957;-0.4324755498014847;-0.4625500203292101
Generalized keratosis follicularis;Hypoplasia of the calcaneus;0.9077699482440948;1.0617613;0.5293995187666147;0.4803282582745847;0.9999584729108851;-0.09218852466679028;0.061802787121768676;-0.4705589541442704;-0.5196302146363004
Generalized keratosis follicularis;2-hydroxyadipic aciduria;0.8411089479923248;0.99416554;0.5507918599151844;0.5018571700991468;0.9999201345566091;-0.15881118656428428;-0.005754594815092995;-0.4491282746414247;-0.49806296445746234
Generalized keratosis follicularis;Potter facies;0.8171397894620895;0.7560104;0.5585355750368632;0.5784562642327467;0.9999552432134126;-0.18281545375132302;-0.24394483004355172;-0.4414196681765493;-0.4214989789806659
Generalized keratosis follicularis;Increased heart rate variability;0.8326244056224823;1.0481488;0.5535292526576839;0.4846678342313655;0.9999600672783046;-0.16733566165582225;0.048188683980545544;-0.4464308146206206;-0.515292233046939
Generalized keratosis follicularis;Aplastic zygomatic arch;0.8749075829982758;0.993364;0.5399227376451035;0.5021123324351171;0.9999584729108851;-0.12505088991260938;-0.006594496432308472;-0.4600357352657817;-0.49784614047576803
Generalized keratosis follicularis;Testicular torsion;0.9046116471290588;0.9997666;0.5304092905660029;0.5000742937232558;0.9999600672783046;-0.09534842014924572;-0.00019347906724498376;-0.4695507767123016;-0.4998857735550487
Generalized keratosis follicularis;Abolished vibration sense;0.9092855602502823;1.0472889;0.5289150533736287;0.48494184369074234;0.9999584729108851;-0.09067291266060284;0.04733042174243518;-0.4710434195372565;-0.5150166292201428
Generalized keratosis follicularis;Fractured metatarsal bone of digit 5;0.9144137799739838;0.84800124;0.5272763091600845;0.5485709836750541;0.9999201345566091;-0.08550635458262534;-0.15191889287264915;-0.4726438253965246;-0.45134915088155503
Generalized keratosis follicularis;Prolonged G2 phase of cell cycle;0.7542997002601624;0.89578617;0.579017905737277;0.5332326241479277;0.9999567459343585;-0.2456570456741961;-0.10417057974325739;-0.4209388401970815;-0.46672412178643075
Generalized keratosis follicularis;Single naris;0.9408007115125656;0.77142096;0.5188547426518487;0.573407941414789;0.9999567459343585;-0.05915603442179285;-0.22853579027639948;-0.48110200328250974;-0.42654880451956945
Generalized keratosis follicularis;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.5915960669517517;0.67759436;0.633914509640026;0.6044915006797484;0.9999201345566091;-0.4083240676048574;-0.3223257708671865;-0.36600562491658306;-0.39542863387686067
Generalized keratosis follicularis;Asymmetry of the thorax;0.8878942131996155;1.0911442;0.535759551287121;0.4709475721617561;0.9999567459343585;-0.11206253273474298;0.09118745820535101;-0.4641971946472374;-0.5290091737726024
Generalized keratosis follicularis;Type 2 muscle fiber predominance;0.7231438159942627;0.93463343;0.5892925622289367;0.5208216628652217;0.9999556674707869;-0.2768118514765242;-0.06532223365196976;-0.41066310524185023;-0.4791340046055652
Generalized keratosis follicularis;Dependency on parenteral nutrition;0.8439061939716339;0.9591714;0.549890216207511;0.5129997653527174;0.9999584729108851;-0.15605227893925122;-0.040787058535579956;-0.45006825670337414;-0.4869587075581677
Generalized keratosis follicularis;Limited shoulder flexion;0.8065055310726166;1.1124235;0.5619821559095451;0.46413867823768984;0.9999201345566091;-0.19341460348399253;0.11250340460507302;-0.43793797864706396;-0.5357814563189193
Generalized keratosis follicularis;Paroxysmal vertigo;0.8492667376995087;1.0689399;0.5481634586748516;0.4780383089318676;0.9999584729108851;-0.15069173521137647;0.06898145132922717;-0.4517950142360335;-0.5219201639790175
Generalized keratosis follicularis;Long hallux;0.9191276803612709;0.9209993;0.5257706024743564;0.5251729384419284;0.9999526340597648;-0.08082495369849385;-0.0789533455008048;-0.4741820315854084;-0.4747796956178364
Generalized keratosis follicularis;Broad medial eyebrow;0.7447922825813293;0.65062094;0.5821438540453198;0.6136074574743535;0.8733283781844945;-0.12853609560316515;-0.22270744083708238;-0.2911845241391747;-0.25972092071014097
Generalized keratosis follicularis;Myxoid subcutaneous tumors;0.7150419652462006;0.6065716;0.5919796674394717;0.6287110692499761;0.8434590184411804;-0.12841705319497987;-0.23688740369890138;-0.2514793510017087;-0.21474794919120432
Generalized keratosis follicularis;Bulbous tips of toes;0.9103106930851936;0.8786117;0.528587407796359;0.5387346326491724;0.9999584729108851;-0.0896477798256915;-0.12134678906536511;-0.4713710651145261;-0.4612238402617127
Generalized keratosis follicularis;Absent internal genitalia;0.763323962688446;0.77357924;0.5760580002916562;0.5727024238192785;0.9999201345566091;-0.23659617186816306;-0.22634089471133323;-0.4238621342649529;-0.4272177107373306
Generalized keratosis follicularis;Hyperphalangy of the 2nd finger;0.7714343965053558;0.88954186;0.5734035418469428;0.535231804918073;0.9999600672783046;-0.22852567077294872;-0.11041820288316295;-0.4265565254313618;-0.46472826236023157
Generalized keratosis follicularis;Renal interstitial hemosiderin;0.738377183675766;0.8134738;0.5842576451876509;0.5597229263001762;0.9999201345566091;-0.2615429508808431;-0.18644631387026878;-0.4156624893689582;-0.44019720825643294
Generalized keratosis follicularis;Abnormality of depressor anguli oris muscle;0.8907074704766273;1.1193712;0.534858525634843;0.4619121370728303;0.9999201345566091;-0.10921266407998176;0.1194510412093821;-0.46506160892176607;-0.5380079974837788
Generalized keratosis follicularis;Paroxysmal dyspnea;0.8642095476388931;1.1101825;0.5433573910636771;0.46485644237751955;0.9999201345566091;-0.13571058691771598;0.11026238917080788;-0.456562743492932;-0.5350636921790896
Generalized keratosis follicularis;Phenylpyruvic acidemia;0.8098720908164978;1.0517715;0.560890271802471;0.4835132601889883;0.9999600672783046;-0.19008797646180675;0.051811454289993786;-0.4390697954758336;-0.5164468070893162
Generalized keratosis follicularis;Lateral ventricle dilatation;0.8342823386192322;1.0689572;0.5529940411377857;0.47803281272800224;0.9999488789551968;-0.16566654033596462;0.06900833063190037;-0.4469548378174111;-0.5219160662271946
Generalized keratosis follicularis;Neonatal unconjugated hyperbilirubinemia;0.823563426733017;1.0963418;0.5564570479979207;0.469285805205629;0.9999600672783046;-0.1763966405452876;0.09638178109510853;-0.4435030192803838;-0.5306742620726755
Generalized keratosis follicularis;High maternal circulating alpha-fetoprotein concentration;0.7059929668903351;0.8844092;0.5949889127093122;0.53687613645388;0.9999201345566091;-0.293927167666274;-0.11551094533236594;-0.4049312218472969;-0.4630439981027291
Generalized keratosis follicularis;Prominent nasolabial fold;0.8057974576950073;0.7646655;0.5622119005887114;0.575618567420144;0.9999545338528789;-0.1941570761578716;-0.23528904942447315;-0.4377426332641675;-0.42433596643273497
Generalized keratosis follicularis;Abnormality of inferior alveolar nerve;0.8522251546382904;0.84915864;0.54721109742906;0.548198273301767;0.9999201345566091;-0.1476949799183187;-0.1507614898804006;-0.45270903712754906;-0.45172186125484215
Generalized keratosis follicularis;Unilateral conductive hearing impairment;0.8516855537891388;1.1312219;0.5473847714864506;0.45810995015629696;0.9999600672783046;-0.14827451348916576;0.13126182317121937;-0.45257529579185396;-0.5418501171220076
Generalized keratosis follicularis;Macular hypopigmented whorls, streaks, and patches;0.6908828616142273;0.5104102;0.6000335178546432;0.662853480699679;0.8284944252404275;-0.1376115636262002;-0.3180842356118264;-0.22846090738578428;-0.1656409445407485
Generalized keratosis follicularis;Delayed ossification of pubic rami;0.9231037199497223;1.0142192;0.5245010326496856;0.49547376036164814;0.9999584729108851;-0.07685475296116284;0.014260691937442505;-0.4754574402611995;-0.504484712549237
Generalized keratosis follicularis;Hyperphenylalaninemia;0.8262896239757538;1.0157784;0.5555756594410433;0.4949773619774358;0.9999561589935034;-0.17366653501774965;0.015822263362148425;-0.4443804995524602;-0.5049787970160676
Generalized keratosis follicularis;Ureteropelvic junction obstruction;0.8829282373189926;0.971141;0.5373507534453226;0.5091873938361403;0.9999528219730685;-0.11702458465407584;-0.02881184125254843;-0.4626020685277459;-0.49076542813692814
Generalized keratosis follicularis;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8382154554128647;0.86867225;0.5517249598229108;0.5419240252367006;0.9999201345566091;-0.16170467914374442;-0.13124788285525413;-0.4481951747336983;-0.45799610931990853
Generalized keratosis follicularis;Difficulty walking;0.8395026624202728;0.99755895;0.5513098035663204;0.5007770118665459;0.9999461221900431;-0.16044345976977026;-0.002387170812174433;-0.44863631862372266;-0.4991691103234972
Generalized keratosis follicularis;Bilobate gallbladder;0.9336946308612823;1.1010201;0.5211211500030659;0.46778937399333653;0.9999584729108851;-0.06626384204960278;0.10106162482165881;-0.4788373229078192;-0.5321690989175486
Generalized keratosis follicularis;Histidinuria;0.7665016949176788;0.85962826;0.5750173306737975;0.5448297655270398;0.9999574798349273;-0.2334557849172485;-0.1403292196992767;-0.4249401491611299;-0.45512771430788757
Generalized keratosis follicularis;Widened interpedicular distance;0.8313619494438171;1.1436183;0.553936899328126;0.4541262144845911;0.9999201345566091;-0.16855818511279197;0.143698210704011;-0.44598323522848315;-0.545793920072018
Hypoplasia of the calcaneus;2-hydroxyadipic aciduria;0.7033304870128632;0.93595994;0.5958759761925605;0.5203985495770251;0.9999134918687169;-0.29658300485585376;-0.06395355668042346;-0.4040375156761564;-0.4795149422916918
Hypoplasia of the calcaneus;Potter facies;0.9725964814424515;0.99678195;0.508723902978767;0.5010243457521335;0.9999532306564473;-0.02735674921399578;-0.003171285427870596;-0.49122932767768024;-0.49892888490431375
Hypoplasia of the calcaneus;Increased heart rate variability;1.0006713662296534;1.0466963;0.4997862974757976;0.48513071260874185;0.9999584729108851;0.0007128933187682263;0.04673783236407825;-0.5001721754350875;-0.5148277603021433
Hypoplasia of the calcaneus;Aplastic zygomatic arch;0.6838218569755554;0.78468436;0.6023997325873122;0.5690780374181337;0.9036123096265051;-0.21979045265094965;-0.11892794959919184;-0.3012125770391929;-0.3345342722083714
Hypoplasia of the calcaneus;Testicular torsion;0.9075673818588257;1.0282569;0.5294642742633144;0.49100434469530896;0.9999584729108851;-0.09239109105205945;0.028298420247073852;-0.4704941986475707;-0.5089541282155762
Hypoplasia of the calcaneus;Abolished vibration sense;0.8166741728782654;0.9429364;0.5586863338890783;0.5181737713191068;0.9999567459343585;-0.18328257305609308;-0.05702032549368463;-0.44127041204528017;-0.48178297461525166
Hypoplasia of the calcaneus;Fractured metatarsal bone of digit 5;0.6601567268371582;0.6420529;0.6103740317508716;0.616523181514443;0.42239095481135847;0.23776577202579974;0.2196619340588808;0.1879830769395131;0.1941322267030845
Hypoplasia of the calcaneus;Prolonged G2 phase of cell cycle;0.969421599060297;1.1090919;0.5097349248133289;0.46520571362809926;0.9999548690865008;-0.030533270026203763;0.10913700885081612;-0.49021994427317184;-0.5347491554584015
Hypoplasia of the calcaneus;Single naris;0.8916830867528915;0.96905804;0.5345461226241259;0.5098507080281904;0.9999548690865008;-0.10827178233360923;-0.030896832282301556;-0.46540874646237484;-0.49010416105831034
Hypoplasia of the calcaneus;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8878900706768036;1.1142813;0.5357608782582532;0.46354348998343686;0.9999134918687169;-0.11202342119191333;0.11436780486132458;-0.46415261361046367;-0.5363700018852801
Hypoplasia of the calcaneus;Asymmetry of the thorax;0.7201117873191833;0.91935176;0.5902974055968464;0.5256990430558364;0.8994299275196795;-0.1793181402004962;0.01992182905304385;-0.30913252192283314;-0.37373088446384317
Hypoplasia of the calcaneus;Type 2 muscle fiber predominance;0.8757226765155792;0.90699625;0.5396612447248693;0.5296468481042942;0.9315598035443521;-0.05583712702877286;-0.024563553391764192;-0.39189855881948277;-0.4019129554400579
Hypoplasia of the calcaneus;Dependency on parenteral nutrition;0.9178266823291779;0.99584275;0.5261861060537201;0.5013233013812822;0.9999567459343585;-0.0821300636051806;-0.00411399109350763;-0.4737706398806384;-0.49863344455307623
Hypoplasia of the calcaneus;Limited shoulder flexion;0.7592454254627228;1.0399077;0.5773948901658196;0.4872936312235866;0.8193379704785829;-0.060092545015860144;0.22056972338433212;-0.24194308031276335;-0.3320443392549963
Hypoplasia of the calcaneus;Paroxysmal vertigo;0.9090592935681343;1.0266291;0.5289873752283516;0.4915226851222261;0.9999567459343585;-0.09089745236622415;0.026672344374784607;-0.47096937070600686;-0.5084340608121324
Hypoplasia of the calcaneus;Long hallux;0.6763679385185242;0.6717913;0.6049039968486452;0.6064449321019979;0.7626934093495967;-0.08632547083107256;-0.09090209427086138;-0.15778941250095158;-0.15624847724759883
Hypoplasia of the calcaneus;Broad medial eyebrow;0.9906032662838697;1.0000111;0.5029911172593621;0.4999964565429188;0.9999584729108851;-0.009355206627015389;5.2613553043090455e-05;-0.49696735565152306;-0.49996201636796633
Hypoplasia of the calcaneus;Myxoid subcutaneous tumors;0.8443597257137299;0.8819816;0.5497440663317066;0.5376541845294724;0.9999584729108851;-0.15559874719715527;-0.11797686165905408;-0.45021440657917855;-0.4623042883814127
Hypoplasia of the calcaneus;Bulbous tips of toes;0.7629304379224777;0.74047744;0.5761869324384247;0.5835652002444074;0.7931629904903006;-0.030232552567822868;-0.05268554774890655;-0.21697605805187592;-0.2095977902458932
Hypoplasia of the calcaneus;Absent internal genitalia;0.8222469389438629;0.94101965;0.5568828290938952;0.5187849266430664;0.9999134918687169;-0.177666552924854;-0.0588938375947301;-0.4430306627748217;-0.4811285652256505
Hypoplasia of the calcaneus;Hyperphalangy of the 2nd finger;0.6990017294883728;0.84811497;0.5973198412439591;0.5485343392367766;0.8287763732556668;-0.12977464376729397;0.01933859409052463;-0.23145653201170768;-0.28024203401889014
Hypoplasia of the calcaneus;Renal interstitial hemosiderin;0.9292101189494133;1.0819795;0.5225519812346453;0.47387578316099355;0.9999134918687169;-0.07070337291930362;0.08206602129961804;-0.4773615106340716;-0.5260377087077234
Hypoplasia of the calcaneus;Abnormality of depressor anguli oris muscle;0.6822527050971985;0.8240136;0.6029263633562836;0.5563114688593421;0.872141863789474;-0.18988915869227552;-0.0481282729767909;-0.2692155004331904;-0.3158303949301319
Hypoplasia of the calcaneus;Paroxysmal dyspnea;0.7755399346351624;1.0010755;0.5720618339174967;0.4996576447059756;0.9999134918687169;-0.22437355723355457;0.001162014341610229;-0.42785165795122027;-0.5002558471627413
Hypoplasia of the calcaneus;Phenylpyruvic acidemia;0.7399487495422363;1.0087289;0.5837394621468182;0.49722146866215755;0.9999584729108851;-0.2600097233686488;0.008770388897891723;-0.416219010764067;-0.5027370042487276
Hypoplasia of the calcaneus;Lateral ventricle dilatation;0.80251245200634;1.0360608;0.5632781999653416;0.48851899132668897;0.9999462364511621;-0.19743378444482207;0.03611457363794923;-0.43666803648582053;-0.5114272451244731
Hypoplasia of the calcaneus;Neonatal unconjugated hyperbilirubinemia;0.8392162919044495;0.91962475;0.5514021575358251;0.5256118719989133;0.9999584729108851;-0.16074218100643567;-0.08033372706509045;-0.44855631537506;-0.4743466009119718
Hypoplasia of the calcaneus;High maternal circulating alpha-fetoprotein concentration;0.8651300370693207;1.0259297;0.5430616696935073;0.4917454060547226;0.9999134918687169;-0.13478345479939624;0.026016197538631713;-0.4568518221752096;-0.5081680858139943
Hypoplasia of the calcaneus;Prominent nasolabial fold;0.8700390607118607;0.9473476;0.5414851952998188;0.5167675364729096;0.9999524555142131;-0.12991339480235242;-0.05260487412764692;-0.4584672602143943;-0.48318491904130345
Hypoplasia of the calcaneus;Abnormality of inferior alveolar nerve;0.7754465937614441;0.7927142;0.5720923235637116;0.5664630093874191;0.9999134918687169;-0.22446689810727283;-0.2071993133065526;-0.4278211683050053;-0.4334504824812978
Hypoplasia of the calcaneus;Unilateral conductive hearing impairment;0.8634237051010132;0.9066848;0.5436098848405131;0.5297464256118583;0.9999584729108851;-0.13653476780987195;-0.09327365702724866;-0.45634858807037204;-0.4702120472990269
Hypoplasia of the calcaneus;Macular hypopigmented whorls, streaks, and patches;0.8885146901011467;1.121184;0.5355608014345608;0.46133090636736584;0.9999584729108851;-0.11144378280973843;0.12122551852130481;-0.4643976714763244;-0.5386275665435193
Hypoplasia of the calcaneus;Delayed ossification of pubic rami;0.576131284236908;0.52472126;0.6393282099828337;0.6576527777568202;0.8287089627579918;-0.2525776785210838;-0.3039876979188194;-0.1893807527751581;-0.1710561850011716
Hypoplasia of the calcaneus;Hyperphenylalaninemia;0.8484348058700562;1.032181;0.5484313486083012;0.48975469759291945;0.9999542297279059;-0.15151942385784978;0.03222679482348567;-0.4515228811196047;-0.5101995321349865
Hypoplasia of the calcaneus;Ureteropelvic junction obstruction;0.7352142930030823;0.9162606;0.5853012214744333;0.5266863345058187;0.9999505803237132;-0.2647362873206309;-0.08368998023368635;-0.4146493588492799;-0.4732642458178945
Hypoplasia of the calcaneus;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.47903382778167725;0.5854635;0.674428237544399;0.6360562649740293;0.5863259809806012;-0.10729215319892393;-0.0008624571158550864;0.08810225656379778;0.04973028399342816
Hypoplasia of the calcaneus;Difficulty walking;0.8383940309286118;0.9250249;0.551667359492952;0.523887715529826;0.9160188400246831;-0.07762480909607139;0.009006086637761923;-0.36435148053173116;-0.3921311244948571
Hypoplasia of the calcaneus;Bilobate gallbladder;0.833636999130249;0.9061496;0.55320235063294;0.5299175304371169;0.9999567459343585;-0.16631974680410944;-0.09380712015616022;-0.44675439530141847;-0.4700392154972416
Hypoplasia of the calcaneus;Histidinuria;0.9611991308629513;1.066428;0.5123538013521046;0.47883974395269524;0.9999556674707869;-0.03875653660783562;0.06647227861991134;-0.4876018661186823;-0.5211159235180917
Hypoplasia of the calcaneus;Widened interpedicular distance;0.8550491631031036;0.7721931;0.5463024015203458;0.5731554984727454;0.8072246192530101;0.04782454385009349;-0.03503154502663075;-0.26092221773266433;-0.23406912078026476
2-hydroxyadipic aciduria;Potter facies;0.8040650188922882;0.7595945;0.5627741542013839;0.5772804140242793;0.9998981869165328;-0.19583316802424455;-0.2403036868516829;-0.4371240327151489;-0.42261777289225344
2-hydroxyadipic aciduria;Increased heart rate variability;0.9097737148404121;1.0600567;0.5287590291076285;0.4808718359984846;0.9999201345566091;-0.09014641971619697;0.06013655184475808;-0.4711611054489806;-0.5190482985581245
2-hydroxyadipic aciduria;Aplastic zygomatic arch;0.7893696874380112;0.90736324;0.5675516262166881;0.5295295430775189;0.9999134918687169;-0.21054380443070575;-0.09255025591824695;-0.43236186565202883;-0.47038394879119805
2-hydroxyadipic aciduria;Testicular torsion;0.7958999872207642;1.0068243;0.5654267762881692;0.4978277493812151;0.717226575899895;0.07867341132086914;0.289597679089729;-0.15179979961172585;-0.21939882651867992
2-hydroxyadipic aciduria;Abolished vibration sense;0.9618579372763634;1.058802;0.5121439413943105;0.48127191950713466;0.9999134918687169;-0.03805555459235355;0.058888516760128296;-0.4877695504744064;-0.5186415723615823
2-hydroxyadipic aciduria;Fractured metatarsal bone of digit 5;0.9093013852834702;0.9794116;0.5289099952578737;0.5065539613998796;1.0;-0.09069861471652985;-0.020588397979736328;-0.47109000474212626;-0.4934460386001204
2-hydroxyadipic aciduria;Prolonged G2 phase of cell cycle;0.6689120233058929;0.8782755;0.6074156919315342;0.5388424431561945;0.6766288643064248;-0.007716841000531827;0.20164664934256205;-0.06921317237489055;-0.13778642115023032
2-hydroxyadipic aciduria;Single naris;0.9860231000930071;0.93504894;0.5044491302856494;0.5206891269321359;0.9999056439461368;-0.013882543853129703;-0.0648567061485904;-0.4954565136604874;-0.4792165170140009
2-hydroxyadipic aciduria;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.734120786190033;0.95341307;0.5856622353535896;0.5148344510876279;1.0;-0.26587921380996704;-0.04658693075180054;-0.41433776464641037;-0.48516554891237207
2-hydroxyadipic aciduria;Asymmetry of the thorax;0.8084836006164551;0.996383;0.5613405153956662;0.501151329019706;0.9999056439461368;-0.1914220433296817;-0.00352263260504182;-0.4385651285504706;-0.49875431492643074
2-hydroxyadipic aciduria;Type 2 muscle fiber predominance;0.5690624117851257;0.74927616;0.6418170920507646;0.580668617357583;0.9999003561294039;-0.43083794434427813;-0.2506241949355562;-0.3580832640786392;-0.41923173877182085
2-hydroxyadipic aciduria;Dependency on parenteral nutrition;0.7747835665941238;0.7364827;0.5723089197092224;0.5848826128917475;0.9999134918687169;-0.22512992527459308;-0.26343081202481433;-0.42760457215949454;-0.41503087897696944
2-hydroxyadipic aciduria;Limited shoulder flexion;0.7348119616508484;0.91091967;0.5854340353503429;0.5283927794219292;1.0;-0.2651880383491516;-0.0890803337097168;-0.4145659646496571;-0.4716072205780708
2-hydroxyadipic aciduria;Paroxysmal vertigo;0.8327372223138809;0.91113853;0.5534928285102136;0.5283228317240476;0.9999134918687169;-0.167176269554836;-0.08877495732281848;-0.4464206633585033;-0.4715906601446693
2-hydroxyadipic aciduria;Long hallux;0.9286164864897728;1.0008627;0.5227414195704866;0.49972537892942803;0.9998836012415208;-0.07126711475174796;0.0009791163869582453;-0.47714218167103417;-0.5001582223120927
2-hydroxyadipic aciduria;Broad medial eyebrow;0.9600963965058327;0.99782985;0.5127050847215411;0.500690773976919;0.9999201345566091;-0.039823738050776436;-0.0020902800682363054;-0.487215049835068;-0.49922936057969014
2-hydroxyadipic aciduria;Myxoid subcutaneous tumors;0.8240199685096741;1.0098586;0.5563094162266209;0.49686184720927895;0.9999201345566091;-0.17590016604693504;0.009938473689240501;-0.4436107183299882;-0.5030582873473302
2-hydroxyadipic aciduria;Bulbous tips of toes;0.9019379168748856;0.97090745;0.5312643749874515;0.5092617573215247;0.9999134918687169;-0.09797557499383136;-0.02900604214642688;-0.4686491168812654;-0.49065173454719224
2-hydroxyadipic aciduria;Absent internal genitalia;0.8049531877040863;0.93437135;0.562485879159011;0.5209052631780898;1.0;-0.1950468122959137;-0.06562864780426025;-0.43751412084098895;-0.47909473682191017
2-hydroxyadipic aciduria;Hyperphalangy of the 2nd finger;0.6142328381538391;0.88255954;0.6260631936993192;0.5374689317198678;0.9999201345566091;-0.38568729640277;-0.11736059666903587;-0.37385694085728993;-0.46245120283674135
2-hydroxyadipic aciduria;Renal interstitial hemosiderin;0.7309591174125671;0.8736414;0.5867066764222475;0.5403289994130538;1.0;-0.26904088258743286;-0.12635862827301025;-0.4132933235777525;-0.4596710005869462
2-hydroxyadipic aciduria;Abnormality of depressor anguli oris muscle;0.6286870241165161;0.9110909;0.6210923039657024;0.5283380535710593;1.0;-0.3713129758834839;-0.0889090895652771;-0.37890769603429764;-0.47166194642894066
2-hydroxyadipic aciduria;Paroxysmal dyspnea;0.7079152762889862;0.89854956;0.5943489260400528;0.5323483261648315;1.0;-0.2920847237110138;-0.10145044326782227;-0.40565107395994715;-0.4676516738351685
2-hydroxyadipic aciduria;Phenylpyruvic acidemia;0.5621296763420105;0.4628629;0.6442671009183651;0.6804942226442221;0.726290173501319;-0.16416049715930847;-0.2634272646611395;-0.08202307258295383;-0.04579595085709687
2-hydroxyadipic aciduria;Lateral ventricle dilatation;0.8349241465330124;0.90669113;0.5527868943195623;0.5297444009235279;0.9998579617208769;-0.16493381518786454;-0.09316682774489426;-0.44707106740131464;-0.470113560797349
2-hydroxyadipic aciduria;Neonatal unconjugated hyperbilirubinemia;0.7223571836948395;0.8052312;0.5895531714907986;0.5623956600012521;0.726290173501319;-0.003932989806479492;0.07894104006832214;-0.13673700201052041;-0.1638945135000669
2-hydroxyadipic aciduria;High maternal circulating alpha-fetoprotein concentration;0.7945170998573303;0.89432156;0.565876494544416;0.5337014255416883;1.0;-0.20548290014266968;-0.10567843914031982;-0.434123505455584;-0.4662985744583117
2-hydroxyadipic aciduria;Prominent nasolabial fold;0.9281100928783417;1.0372983;0.5229030248629243;0.48812483522210026;0.9998944404568447;-0.07178434757850305;0.037403881267093264;-0.47699141559392044;-0.5117696052347445
2-hydroxyadipic aciduria;Abnormality of inferior alveolar nerve;0.7664805948734283;0.9691096;0.5750242379812384;0.5098342899390576;1.0;-0.23351940512657166;-0.03089040517807007;-0.42497576201876164;-0.49016571006094245
2-hydroxyadipic aciduria;Unilateral conductive hearing impairment;0.8758179321885109;1.036594;0.539630687188096;0.4883491442714085;0.9999201345566091;-0.12410220236809821;0.036673898684662865;-0.46028944736851307;-0.5115709902852006
2-hydroxyadipic aciduria;Macular hypopigmented whorls, streaks, and patches;0.7439130246639252;0.95499146;0.5824333504810093;0.5143315107276634;0.9999201345566091;-0.25600710989268394;-0.044928674710112526;-0.4174867840755998;-0.48558862382894574
2-hydroxyadipic aciduria;Delayed ossification of pubic rami;0.7936354577541351;0.9730847;0.5661632762448447;0.5085684481564623;0.9999134918687169;-0.2062780341145818;-0.02682880368207141;-0.43375021562387217;-0.4913450437122546
2-hydroxyadipic aciduria;Hyperphenylalaninemia;0.6239537298679352;0.55755967;0.622716630477287;0.6458871545328815;0.6669007119557334;-0.042946982087798236;-0.10934104293794167;-0.044184081478446435;-0.021013557422851936
2-hydroxyadipic aciduria;Ureteropelvic junction obstruction;0.7754966020584106;0.88480324;0.5720759883502959;0.5367498521587415;0.46433788485954575;0.3111587171988649;0.4204653506713075;0.10773810349075019;0.07241196729919575
2-hydroxyadipic aciduria;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6461199820041656;0.9303801;0.6151378826680229;0.5221786487280791;1.0;-0.35388001799583435;-0.06961989402770996;-0.38486211733197706;-0.47782135127192094
2-hydroxyadipic aciduria;Difficulty walking;0.8533147871494293;0.82891726;0.5468604351905488;0.5547265369545749;0.9998344221996177;-0.1465196350501884;-0.17091715726126322;-0.4529739870090689;-0.44510788524504286
2-hydroxyadipic aciduria;Bilobate gallbladder;0.7781500518321991;0.8862639;0.5712095145614906;0.536281834478301;0.9999134918687169;-0.22176344003651782;-0.11364958491299793;-0.4287039773072263;-0.4636316573904159
2-hydroxyadipic aciduria;Histidinuria;0.5638962984085083;0.4459157;0.6436419163217347;0.6869314824801902;0.250755027712249;0.3131412706962593;0.19516067129287795;0.39288688860948573;0.4361764547679412
2-hydroxyadipic aciduria;Widened interpedicular distance;0.7549122422933578;0.859368;0.5788167777426787;0.5449134304651893;1.0;-0.24508775770664215;-0.14063197374343872;-0.4211832222573213;-0.45508656953481075
Potter facies;Increased heart rate variability;0.9588761366903782;1.0374061;0.5130938246713961;0.48809049667360604;0.9999552432134126;-0.04107910652303437;0.037450843708279336;-0.4868614185420165;-0.5118647465398065
Potter facies;Aplastic zygomatic arch;0.9249175116419792;0.7839949;0.523922010572615;0.5693027692575405;0.875272781796774;0.04964472984520518;-0.09127786869557775;-0.35135077122415903;-0.3059700125392335
Potter facies;Testicular torsion;0.8490891456604004;0.93925655;0.5482206421020773;0.5193471476561267;0.9999552432134126;-0.15086609755301217;-0.0606986943318818;-0.45173460111133523;-0.4806080955572859
Potter facies;Abolished vibration sense;1.0064022447913885;0.94512445;0.49796208826706545;0.5174762083220754;0.9999532306564473;0.0064490141349412555;-0.054828783310713614;-0.5019911423893818;-0.48247702233437184
Potter facies;Fractured metatarsal bone of digit 5;1.0029179006814957;0.95133585;0.49907120204818767;0.5154963966716586;0.9998981869165328;0.0030197137649629058;-0.04856233953875566;-0.5008269848683451;-0.4844017902448742
Potter facies;Prolonged G2 phase of cell cycle;0.8974440768361092;1.0433567;0.5327020611624753;0.48619481284648103;0.9999510285821799;-0.10250695174607072;0.04340562844601836;-0.46724896741970456;-0.5137562157356989
Potter facies;Single naris;0.8979854136705399;0.68521297;0.5325288397667685;0.601933087146838;0.8694001614694122;0.02858525220112762;-0.18418719168944397;-0.3368713217026438;-0.2674670743225742
Potter facies;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.861889660358429;0.879273;0.5441028581589162;0.5385225608360441;0.9998981869165328;-0.1380085265581038;-0.12062518953722978;-0.4557953287576165;-0.46137562608048865
Potter facies;Asymmetry of the thorax;0.8295420408248901;0.81339043;0.5545247046092456;0.5597499338850882;0.9999510285821799;-0.17040898775728974;-0.18656059479388032;-0.44542632397293425;-0.4402010946970917
Potter facies;Type 2 muscle fiber predominance;0.8507199585437775;0.9252691;0.5476955901303392;0.5238097654999612;0.9999496416008017;-0.14922968305702422;-0.07468051470871184;-0.4522540514704625;-0.4761398761008405
Potter facies;Dependency on parenteral nutrition;0.8383753895759583;0.9539682;0.5516733722646627;0.5146575431881075;0.9999532306564473;-0.161577841080489;-0.045985003746809805;-0.4482798583917845;-0.48529568746833973
Potter facies;Limited shoulder flexion;0.9198983758687973;0.95816886;0.5255244839769564;0.5133191575137747;0.9998981869165328;-0.07999981104773546;-0.041729322666349655;-0.47437370293957637;-0.4865790294027581
Potter facies;Paroxysmal vertigo;0.8375613689422607;0.94964755;0.5519359529428269;0.5160344691327072;0.9999532306564473;-0.16239186171418651;-0.050305684841933096;-0.4480172777136203;-0.48391876152374
Potter facies;Long hallux;0.8428362607955933;0.9160358;0.5502350425361107;0.5267581573969286;0.9999456907727517;-0.1571094299771585;-0.08390991940281767;-0.4497106482366411;-0.4731875333758232
Potter facies;Broad medial eyebrow;0.8476262092590332;0.7173841;0.5486917575125319;0.5912021779195514;0.8806399863091361;-0.03301377705010289;-0.16325588634880894;-0.33194822879660424;-0.28943780838958466
Potter facies;Myxoid subcutaneous tumors;0.9246599972248077;0.91424257;0.5240042127853164;0.5273310142492919;0.9999552432134126;-0.07529524598860482;-0.0857126775815461;-0.47595103042809617;-0.4726242289641207
Potter facies;Bulbous tips of toes;0.736730545759201;0.7678273;0.5848008267290228;0.5745834618177563;0.9999532306564473;-0.2632226848972462;-0.23212595824128612;-0.4151524039274245;-0.42536976883869093
Potter facies;Absent internal genitalia;0.8820353299379349;0.68551147;0.5376369578908736;0.6018329877605748;0.9998981869165328;-0.11786285697859789;-0.31438671707552934;-0.46226122902565914;-0.39806519915595795
Potter facies;Hyperphalangy of the 2nd finger;0.8019121438264847;0.8183366;0.5634731349613211;0.5581481170749809;0.9999552432134126;-0.19804309938692788;-0.18161863718771676;-0.43648210825209144;-0.44180712613843165
Potter facies;Renal interstitial hemosiderin;0.9848454352468252;0.98915905;0.5048240324423159;0.5034508588139098;0.9998981869165328;-0.015052751669707543;-0.010739139312925583;-0.4950741544742169;-0.49644732810262293
Potter facies;Abnormality of depressor anguli oris muscle;1.0187114663422108;0.87785065;0.4940436076694661;0.5389786904860738;0.7284789198879239;0.29023254645428687;0.14937173185310393;-0.23443531221845781;-0.18950022940185007
Potter facies;Paroxysmal dyspnea;0.8202311098575592;0.9179364;0.5575349922416037;0.5261510612355854;0.9998981869165328;-0.17966707705897356;-0.0819618022386458;-0.442363194674929;-0.47374712568094735
Potter facies;Phenylpyruvic acidemia;0.6652959287166595;0.8028423;0.6086363537892423;0.5631710941871384;0.9999552432134126;-0.334659314496753;-0.19711292420172433;-0.39131888942417026;-0.43678414902627416
Potter facies;Lateral ventricle dilatation;0.9432866126298904;0.9689752;0.518062123244541;0.5098770851034574;0.9999406960247658;-0.05665408339487532;-0.030965509676804337;-0.4818785727802247;-0.49006361092130835
Potter facies;Neonatal unconjugated hyperbilirubinemia;0.9606508687138557;1.0936621;0.5125284520006793;0.4701426577329191;0.9999552432134126;-0.039304374499556816;0.09370689954018852;-0.48742679121273325;-0.5298125854804935
Potter facies;High maternal circulating alpha-fetoprotein concentration;0.8001700639724731;0.8992861;0.5640389685210114;0.5321126824541478;0.9998981869165328;-0.19972812294405962;-0.10061209558886552;-0.43585921839552133;-0.467785504462385
Potter facies;Prominent nasolabial fold;0.7835710346698761;0.61154234;0.5694409725946457;0.6269920235362114;0.8617867669399137;-0.07821573227003764;-0.250244422846591;-0.2923457943452681;-0.23479474340370232
Potter facies;Abnormality of inferior alveolar nerve;0.9857425903901458;0.81698716;0.5045384281962485;0.558584988625155;0.9998981869165328;-0.014155596526386982;-0.1829110300485518;-0.49535975872028426;-0.4413131982913777
Potter facies;Unilateral conductive hearing impairment;0.9484315738081932;1.1049054;0.5164220238851887;0.46654602649993404;0.9999552432134126;-0.05152366940521935;0.10495012368417045;-0.4835332193282239;-0.5334092167134785
Potter facies;Macular hypopigmented whorls, streaks, and patches;0.8258833885192871;0.7538614;0.5557069692427212;0.5791618371918081;0.9999552432134126;-0.17407185469412545;-0.24609381590628365;-0.44424827397069133;-0.4207934060216044
Potter facies;Delayed ossification of pubic rami;0.873839408159256;0.81892455;0.5402654634819899;0.5579578233610621;0.9999532306564473;-0.12611382249719127;-0.181028684414687;-0.45968776717445736;-0.4419954072953851
Potter facies;Hyperphenylalaninemia;0.698829710483551;0.77042747;0.5973772610127883;0.573732818120247;0.9999502748700689;-0.3011205643865179;-0.22952280943122616;-0.4025730138572806;-0.4262174567498219
Potter facies;Ureteropelvic junction obstruction;0.9531094990670681;1.0177441;0.5149311850077742;0.4943516108567445;0.9999459376721075;-0.04683643860503939;0.0177981266589472;-0.48501475266433325;-0.505594326815363
Potter facies;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8242666721343994;0.9171714;0.5562296448490018;0.5263953988129428;0.9998981869165328;-0.17563151478213335;-0.08272676824969316;-0.4436685420675309;-0.4735027881035899
Potter facies;Difficulty walking;0.9657453149557114;0.8852732;0.5109057383760099;0.5365992631101044;0.999936953772814;-0.03419163881710263;-0.11466373561790677;-0.48903121539680405;-0.4633376906627096
Potter facies;Bilobate gallbladder;0.9273787289857864;1.0032767;0.5231364353258352;0.49895697192185884;0.9999532306564473;-0.07257450167066082;0.003323475085435068;-0.47681679533061205;-0.5009962587345884
Potter facies;Histidinuria;0.8209471702575684;0.86406565;0.5573033038093385;0.5434036342865982;0.999951967215123;-0.17900479695755467;-0.1358863200898789;-0.44264866340578457;-0.4565483329285248
Potter facies;Widened interpedicular distance;0.7888500988483429;0.8521259;0.5677208216468134;0.5472430427609793;0.9998981869165328;-0.21104808806818987;-0.14777230381411577;-0.4321773652697194;-0.4526551441555534
Increased heart rate variability;Aplastic zygomatic arch;0.8107292354106903;0.8837508;0.5606123884522274;0.5370871222926916;0.9999584729108851;-0.18922923750019482;-0.11620767659283093;-0.43934608445865775;-0.4628713506181935
Increased heart rate variability;Testicular torsion;0.8102436363697052;1.0876205;0.5607698122472551;0.47207370877885513;0.9999600672783046;-0.18971643090859935;0.08766042947157338;-0.43919025503104947;-0.5278863584994494
Increased heart rate variability;Abolished vibration sense;0.861623153090477;0.8208555;0.5441885124881092;0.5573329538163263;0.9999584729108851;-0.13833531982040814;-0.17910297459698132;-0.45576996042277595;-0.44262551909455883
Increased heart rate variability;Fractured metatarsal bone of digit 5;0.9501166194677353;1.0245906;0.5158849657271107;0.4921717655029515;0.9999201345566091;-0.04980351508887382;0.0246704769012156;-0.4840351688294984;-0.5077483690536576
Increased heart rate variability;Prolonged G2 phase of cell cycle;0.696324348449707;0.8572789;0.5982139203702803;0.545585206347051;0.9999567459343585;-0.30363239748465143;-0.14267786247717462;-0.40174282556407814;-0.45437153958730747
Increased heart rate variability;Single naris;1.0256414413452148;0.99403274;0.49183718107064944;0.5018994518999983;0.9999567459343585;0.025684695410856384;-0.005924005341401917;-0.508119564863709;-0.49805729403436017
Increased heart rate variability;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.7623312771320343;0.9384931;0.5763832624503369;0.5195906343677712;0.9999201345566091;-0.2375888574245748;-0.061427061570006325;-0.4235368721062722;-0.4803295001888379
Increased heart rate variability;Asymmetry of the thorax;0.6512525081634521;0.77538794;0.6133929180350607;0.5721114821531255;0.9999567459343585;-0.3487042377709063;-0.22456880314337335;-0.3865638278992978;-0.427845263781233
Increased heart rate variability;Type 2 muscle fiber predominance;0.8291867822408676;0.9102272;0.5546394700558486;0.5286140962763616;0.9999556674707869;-0.1707688852299193;-0.08972848794350419;-0.44531619741493833;-0.4713415711944253
Increased heart rate variability;Dependency on parenteral nutrition;0.8928661122918129;1.1346192;0.5341673496780913;0.4570188832699257;0.9999584729108851;-0.10709236061907224;0.1346607630815465;-0.4657911232327938;-0.5429395896409595
Increased heart rate variability;Limited shoulder flexion;0.8970057666301727;1.0444105;0.5328423223716491;0.4858590630657935;0.9999201345566091;-0.10291436792643638;0.04449033259121804;-0.46707781218496003;-0.5140610714908156
Increased heart rate variability;Paroxysmal vertigo;0.7874002158641815;0.9484646;0.5681930549869318;0.5164115132366724;0.9999584729108851;-0.2125582570467036;-0.05149390048122815;-0.4317654179239533;-0.4835469596742127
Increased heart rate variability;Long hallux;0.8285901844501495;0.9653126;0.5548322157108265;0.5110435481965071;0.9999526340597648;-0.17136244960961522;-0.03464003392396153;-0.44512041834893823;-0.48890908586325765
Increased heart rate variability;Broad medial eyebrow;0.7634198516607285;0.87934214;0.5760265857194047;0.5385003879925767;0.9999600672783046;-0.2365402156175761;-0.12061792851106212;-0.42393348155889987;-0.46145967928572784
Increased heart rate variability;Myxoid subcutaneous tumors;0.8943598717451096;1.0328697;0.5336891573926118;0.48953537041810646;0.9999600672783046;-0.105600195533195;0.03290962933882191;-0.46627090988569275;-0.5104246968601981
Increased heart rate variability;Bulbous tips of toes;0.8130935430526733;0.9521401;0.5598461296144945;0.5152401046543984;0.9999584729108851;-0.1868649298582118;-0.04781838006115369;-0.4401123432963906;-0.48471836825648673
Increased heart rate variability;Absent internal genitalia;0.964575283229351;1.0445553;0.511278397299266;0.4858128934290993;0.9999201345566091;-0.035344851327258064;0.04463517187802224;-0.48864173725734306;-0.5141072411275098
Increased heart rate variability;Hyperphalangy of the 2nd finger;0.8388284146785736;1.0423119;0.5515272541963929;0.48652769048828837;0.9999600672783046;-0.16113165259973095;0.04235183953627064;-0.44843281308191163;-0.5134323767900162
Increased heart rate variability;Renal interstitial hemosiderin;0.8079856634140015;1.0097957;0.5615020109603055;0.49688188191603355;0.9999201345566091;-0.19193447114260764;0.009875531184357689;-0.4384181235963036;-0.5030382526405756
Increased heart rate variability;Abnormality of depressor anguli oris muscle;0.837243527173996;0.97317404;0.5520384896301245;0.5085399906174077;0.9999201345566091;-0.16267660738261314;-0.02674609900744529;-0.44788164492648463;-0.4913801439392014
Increased heart rate variability;Paroxysmal dyspnea;0.7592149376869202;0.6649915;0.5774048888655641;0.6087391941540008;0.9999201345566091;-0.24070519686968894;-0.33492863656313987;-0.42251524569104504;-0.3911809404026083
Increased heart rate variability;Phenylpyruvic acidemia;0.8529353439807892;0.9563445;0.546982539920339;0.5139003924252243;0.9999600672783046;-0.14702472329751537;-0.043615581995406605;-0.4529775273579656;-0.4860596748530802
Increased heart rate variability;Lateral ventricle dilatation;0.7167356610298157;0.92001534;0.5914173759603678;0.5254871253475417;0.9999488789551968;-0.2832132179253811;-0.07993354387218898;-0.408531502994829;-0.4744617536076551
Increased heart rate variability;Neonatal unconjugated hyperbilirubinemia;0.8245624601840973;1.005631;0.556134006773898;0.4982076089656783;0.9999600672783046;-0.17539760709420726;0.005670902722916149;-0.44382606050440654;-0.5017524583126263
Increased heart rate variability;High maternal circulating alpha-fetoprotein concentration;0.6688920855522156;0.83650225;0.6074224176716492;0.5522776477208953;0.9999201345566091;-0.33102804900439353;-0.16341788054736228;-0.39249771688495994;-0.44764248683571384
Increased heart rate variability;Prominent nasolabial fold;0.8119102418422699;0.92124987;0.5602295867392444;0.525092937251428;0.9999545338528789;-0.18804429201060902;-0.07870466736728321;-0.4397249471136345;-0.4748615966014509
Increased heart rate variability;Abnormality of inferior alveolar nerve;0.8654610216617584;1.0300832;0.5429553449621589;0.49042277807596346;0.9999201345566091;-0.13445911289485069;0.030163044917267845;-0.4569647895944502;-0.5094973564806456
Increased heart rate variability;Unilateral conductive hearing impairment;0.901087149977684;1.021302;0.5315365055295662;0.4932188446475889;0.9999600672783046;-0.09887291730062053;0.02134191750868275;-0.46842356174873834;-0.5067412226307156
Increased heart rate variability;Macular hypopigmented whorls, streaks, and patches;0.8647378534078598;0.98005;0.543187660132245;0.5063507013520228;0.9999600672783046;-0.13522221387044475;-0.019910039907851673;-0.4567724071460596;-0.4936093659262818
Increased heart rate variability;Delayed ossification of pubic rami;0.8091039061546326;1.0112727;0.5611393545657419;0.4964117232525871;0.9999584729108851;-0.19085456675625256;0.011314195927615844;-0.4388191183451432;-0.503546749658298
Increased heart rate variability;Hyperphenylalaninemia;0.690838634967804;0.8870585;0.6000483207256662;0.5360272589022517;0.9999561589935034;-0.3091175240256995;-0.1128976625182837;-0.39990783826783727;-0.46392890009125176
Increased heart rate variability;Ureteropelvic junction obstruction;0.8906887546181679;1.0612011;0.5348645189861829;0.48050691161478043;0.9999528219730685;-0.10926406735490057;0.06124827360798624;-0.4650883029868855;-0.519445910358288
Increased heart rate variability;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9999913559295237;1.0671848;0.5000027514930895;0.478598279067329;0.9999201345566091;7.122137291459829e-05;0.06726467131344704;-0.4999173830635196;-0.5213218554892801
Increased heart rate variability;Difficulty walking;0.8830967396497726;0.9061317;0.5372967466436565;0.5299232617922346;0.9999461221900431;-0.11684938254027044;-0.09381443740992224;-0.46264937554638663;-0.4700228603978085
Increased heart rate variability;Bilobate gallbladder;0.9092710912227631;1.1400534;0.5289196780790923;0.45527257893630646;0.9999584729108851;-0.09068738168812207;0.14009491854571887;-0.4710387948317928;-0.5446858939745787
Increased heart rate variability;Histidinuria;0.8297622799873352;1.0678296;0.5544535604630121;0.47839257448077943;0.9999574798349273;-0.17019519984759213;0.067872129082309;-0.44550391937191525;-0.5215649053541479
Increased heart rate variability;Widened interpedicular distance;0.6257606148719788;0.91706884;0.6220961666609246;0.5264281612578701;0.9999201345566091;-0.37415951968463035;-0.08285129548342796;-0.3778239678956845;-0.47349197329873904
Aplastic zygomatic arch;Testicular torsion;0.8381335139274597;0.9824667;0.5517513909867531;0.5055813082653537;0.9999584729108851;-0.16182495898342542;-0.01749177521801404;-0.44820708192413206;-0.4943771646455314
Aplastic zygomatic arch;Abolished vibration sense;0.8675612062215805;0.9357227;0.5422807983390101;0.5204742098804624;0.9999567459343585;-0.13239553971277795;-0.06423403723227106;-0.45767594759534835;-0.479482536053896
Aplastic zygomatic arch;Fractured metatarsal bone of digit 5;0.7279763221740723;0.90898913;0.587692905702828;0.5290098062864383;0.8072246192530101;-0.07924829707893788;0.10176451219764293;-0.2195317135501822;-0.2782148129665718
Aplastic zygomatic arch;Prolonged G2 phase of cell cycle;0.8649458587169647;1.0550216;0.5431208368177173;0.4824772012968004;0.9999548690865008;-0.13500901036953605;0.055066774552110065;-0.4568340322687835;-0.5174776677897004
Aplastic zygomatic arch;Single naris;0.9571457430720329;0.8126918;0.5136451123331527;0.5599763097271215;0.8796422427997362;0.07750350027229669;-0.06695043505284903;-0.36599713046658355;-0.3196659330726147
Aplastic zygomatic arch;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.816959023475647;0.998109;0.5585941024569663;0.5006019250089047;0.9999134918687169;-0.18295446839306995;-0.0018045088288609623;-0.44131938941175064;-0.49931156685981226
Aplastic zygomatic arch;Asymmetry of the thorax;0.6673649549484253;0.76815146;0.607937723681923;0.5744773693816847;0.8688019857338005;-0.20143703078537523;-0.10065052365570604;-0.2608642620518775;-0.2943246163521158
Aplastic zygomatic arch;Type 2 muscle fiber predominance;0.9828876312822104;1.0892887;0.5054473020194029;0.47154063362602916;0.9315598035443521;0.05132782773785827;0.15772890800349948;-0.42611250152494917;-0.4600191699183229
Aplastic zygomatic arch;Dependency on parenteral nutrition;0.8875359371304512;0.9974718;0.5358743198932963;0.5008047397335486;0.9999567459343585;-0.11242080880390726;-0.0024849365471514284;-0.4640824260410622;-0.4991520062008099
Aplastic zygomatic arch;Limited shoulder flexion;0.9812750611454248;1.2377534;0.5059606815158804;0.4235889963279621;0.8193379704785829;0.16193709066684192;0.4184154207872862;-0.31337728896270256;-0.3957489741506208
Aplastic zygomatic arch;Paroxysmal vertigo;0.7857811450958252;0.9159672;0.5687205738023736;0.5267800415400031;0.9999567459343585;-0.21417560083853326;-0.08398951990591608;-0.43123617213198484;-0.47317670439435533
Aplastic zygomatic arch;Long hallux;0.8296573758125305;1.0520492;0.5544874474536978;0.48342474088207477;0.8894132426424965;-0.05975586682996603;0.16263591736116556;-0.3349257951887987;-0.4059885017604218
Aplastic zygomatic arch;Broad medial eyebrow;0.7324782609939575;0.7639106;0.5862047163934648;0.5758658291226313;0.8892531322460213;-0.1567748712520638;-0.12534254064369588;-0.3030484158525565;-0.31338730312339
Aplastic zygomatic arch;Myxoid subcutaneous tumors;0.8727395236492157;1.0112473;0.5406184124759559;0.4964198082308001;0.9999584729108851;-0.12721894926166943;0.011288804348941528;-0.45934006043492925;-0.503538664680085
Aplastic zygomatic arch;Bulbous tips of toes;0.8556182086467743;0.94298255;0.5461193430112491;0.5181590719662201;0.9036123096265051;-0.04799410097973078;0.03937024480922491;-0.357492966615256;-0.38545323766028494
Aplastic zygomatic arch;Absent internal genitalia;0.7296115159988403;0.6828671;0.5871521400747826;0.6027201252909387;0.9999134918687169;-0.2703019758698766;-0.3170463820931737;-0.41276135179393436;-0.39719336657777826
Aplastic zygomatic arch;Hyperphalangy of the 2nd finger;0.7257888913154602;0.9364505;0.588416705094562;0.5202420851496145;0.9074607173141833;-0.1816718259987231;0.028989764100611604;-0.3190440122196213;-0.38721863216456887
Aplastic zygomatic arch;Renal interstitial hemosiderin;0.9888385497033596;1.0934114;0.503552873744475;0.470222796594853;0.9999134918687169;-0.011074942165357315;0.09349795374895886;-0.4963606181242419;-0.5296906952738639
Aplastic zygomatic arch;Abnormality of depressor anguli oris muscle;0.7360733449459076;0.5892491;0.5850176901437724;0.6347334194538328;0.7692950606685226;-0.03322171572261501;-0.18004598620944667;-0.18427737052475024;-0.13456164121468983
Aplastic zygomatic arch;Paroxysmal dyspnea;0.7413720488548279;0.7965195;0.5832703621585011;0.5652253367648463;0.9999134918687169;-0.25854144301388904;-0.20339397397015735;-0.4166431297102158;-0.4346881551038706
Aplastic zygomatic arch;Phenylpyruvic acidemia;0.7531771659851074;0.95570683;0.579386573221571;0.5141035712843267;0.9999584729108851;-0.2467813069257777;-0.04425163811779431;-0.4205718996893141;-0.4858549016265584
Aplastic zygomatic arch;Lateral ventricle dilatation;0.8395774066448212;0.8570876;0.5512856994074362;0.5456467156744149;0.9999462364511621;-0.16036882980634093;-0.1428586242990625;-0.4486605370437259;-0.4542995207767472
Aplastic zygomatic arch;Neonatal unconjugated hyperbilirubinemia;0.8491282612085342;1.0036573;0.5482080470273456;0.49883584027834715;0.9999584729108851;-0.1508302117023509;0.0036988680925328365;-0.45175042588353953;-0.501122632632538
Aplastic zygomatic arch;High maternal circulating alpha-fetoprotein concentration;0.7829557061195374;0.91505843;0.5696416068118778;0.5270703641783014;0.9999134918687169;-0.21695778574917957;-0.08485505785916492;-0.4302718850568391;-0.4728431276904155
Aplastic zygomatic arch;Prominent nasolabial fold;0.6878953576087952;0.52041614;0.6010339548981393;0.6592123708194582;0.8732055871936235;-0.18531022958482835;-0.35278944663728806;-0.27217163229548424;-0.21399321637416535
Aplastic zygomatic arch;Abnormality of inferior alveolar nerve;0.613782674074173;0.4732529;0.6262185230916879;0.6765885128056188;0.9999134918687169;-0.38613081779454395;-0.5266605993745153;-0.373694968777029;-0.3233249790630981
Aplastic zygomatic arch;Unilateral conductive hearing impairment;0.8203784823417664;0.9059101;0.5574873059006294;0.5299941232037358;0.9999584729108851;-0.17957999056911877;-0.09404839820003918;-0.4424711670102557;-0.4699643497071493
Aplastic zygomatic arch;Macular hypopigmented whorls, streaks, and patches;0.8306808024644852;0.92975557;0.5541568785134403;0.5223779211927437;0.9999584729108851;-0.16927767044639996;-0.07020290440655164;-0.4458015943974448;-0.4775805517181414
Aplastic zygomatic arch;Delayed ossification of pubic rami;0.6565333902835846;0.67878205;0.6116012222120752;0.6040922088092573;0.9036123096265051;-0.24707891934292048;-0.22483026378528803;-0.2920110874144298;-0.2995201008172478
Aplastic zygomatic arch;Hyperphenylalaninemia;0.7213922441005707;0.950695;0.5898729377594012;0.5157006439649566;0.9999542297279059;-0.27856198562733525;-0.04925925149075383;-0.41008129196850474;-0.4842535857629493
Aplastic zygomatic arch;Ureteropelvic junction obstruction;0.803898274898529;1.0338796;0.5628282805010563;0.4892137027401584;0.9999505803237132;-0.19605230542518415;0.03392905739448748;-0.43712229982265693;-0.5107368775835548
Aplastic zygomatic arch;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6727150082588196;0.92401296;0.6061337118588845;0.5242107683054915;0.8072246192530101;-0.13450961099419056;0.11678833975043834;-0.2010909073941256;-0.28301385094751863
Aplastic zygomatic arch;Difficulty walking;0.9363363906741142;0.93943727;0.5202784702951622;0.5192895292478918;0.9160188400246831;0.020317550649431082;0.0234184301398066;-0.395740369729521;-0.3967293107767913
Aplastic zygomatic arch;Bilobate gallbladder;0.8877038061618805;1.020415;0.5358205448717266;0.4935012834375426;0.9999567459343585;-0.11225293977247797;0.020458202529081482;-0.46413620106263187;-0.5064554624968158
Aplastic zygomatic arch;Histidinuria;0.9773389957845211;1.1122833;0.5072138391722805;0.464183553071686;0.9999556674707869;-0.0226166716862658;0.11232768156638351;-0.49274182829850643;-0.5357721143991009
Aplastic zygomatic arch;Widened interpedicular distance;0.7937946319580078;0.9147934;0.5661114958268003;0.5271550358391226;0.7485161685812178;0.04527846337678998;0.166277203573018;-0.18240467275441752;-0.22136113274209523
Testicular torsion;Abolished vibration sense;0.7862027287483215;0.9763789;0.5685831967915771;0.5075195245769775;0.9999584729108851;-0.2137557441625636;-0.023579555216793335;-0.43137527611930804;-0.49243894833390767
Testicular torsion;Fractured metatarsal bone of digit 5;0.8401069492101669;0.9256384;0.5511149364644917;0.5236919061337177;0.9999201345566091;-0.15981318534644218;-0.07428175689013572;-0.4488051980921174;-0.47622822842289136
Testicular torsion;Prolonged G2 phase of cell cycle;0.8778381049633026;0.94673973;0.5389827119951174;0.516961299554575;0.9999567459343585;-0.12211864097105585;-0.05321701271521173;-0.4609740339392411;-0.4829954463797834
Testicular torsion;Single naris;0.9994193613529205;1.0220852;0.5001848230320509;0.49296948464645596;0.9999567459343585;-0.0005373845814379274;0.022128443884977478;-0.49977192290230754;-0.5069872612879025
Testicular torsion;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9027558863162994;1.1004062;0.5310027568198601;0.4679857776810924;0.9999201345566091;-0.09716424824030967;0.10048603533474831;-0.468917377736749;-0.5319343568755167
Testicular torsion;Asymmetry of the thorax;0.5401157438755035;0.91775167;0.6521091056374801;0.5262100691158013;0.9999567459343585;-0.4598410020588549;-0.08220507605063043;-0.3478476402968783;-0.4737466768185572
Testicular torsion;Type 2 muscle fiber predominance;0.8615784347057343;1.0230527;0.5442028851066141;0.4926614684050449;0.9999556674707869;-0.13837723276505265;0.023097024942543176;-0.4557527823641728;-0.507294199065742
Testicular torsion;Dependency on parenteral nutrition;0.9148371517658234;1.0408754;0.5271410518983495;0.4869853357176238;0.9999584729108851;-0.08512132114506177;0.04091696196460315;-0.47281742101253565;-0.5129731371932613
Testicular torsion;Limited shoulder flexion;0.743626207113266;0.9232972;0.5825278004868005;0.5244392527891965;0.9999201345566091;-0.2562939274433431;-0.07662290812762351;-0.4173923340698086;-0.47548088176741266
Testicular torsion;Paroxysmal vertigo;0.7520547211170197;0.90616536;0.5797553201177705;0.5299124899017531;0.9999584729108851;-0.24790375179386548;-0.09379311150646619;-0.4202031527931146;-0.47004598300913203
Testicular torsion;Long hallux;0.9047122970223427;0.97397065;0.5303771061082925;0.5082863336142274;0.9999526340597648;-0.09524033703742207;-0.02598198243317784;-0.4695755279514723;-0.4916663004455374
Testicular torsion;Broad medial eyebrow;0.9654207415878773;1.063148;0.5110091145323539;0.4798859915007718;0.9999600672783046;-0.03453932569042728;0.06318795441969349;-0.4889509527459507;-0.5200740757775327
Testicular torsion;Myxoid subcutaneous tumors;0.8763863071799278;1.0110846;0.5394483629940078;0.4964715854191175;0.9999600672783046;-0.12357376009837673;0.01112448930128529;-0.4605117042842968;-0.503488481859187
Testicular torsion;Bulbous tips of toes;0.8376215249300003;0.9452359;0.5519165470569003;0.5174406734772257;0.9999584729108851;-0.16233694798088483;-0.05472256487942151;-0.44804192585398483;-0.48251779943365947
Testicular torsion;Absent internal genitalia;0.795068085193634;0.7274226;0.5656972968683824;0.5878760844443096;0.5291492300651881;0.26591885512844593;0.19827336495892078;0.036548066803194335;0.05872685437912151
Testicular torsion;Hyperphalangy of the 2nd finger;0.8503001481294632;0.9869681;0.5478307385663945;0.5041482928913583;0.9999600672783046;-0.14965991914884136;-0.012991967207351185;-0.45212932871191003;-0.49581177438694624
Testicular torsion;Renal interstitial hemosiderin;0.8174374103546143;1.0141947;0.5584392173353714;0.49548151032544063;0.717226575899895;0.10021083445471923;0.2969681510440747;-0.15878735856452364;-0.2217450655744544
Testicular torsion;Abnormality of depressor anguli oris muscle;0.7558245062828064;0.9332812;0.5785172956471165;0.521253053668251;0.9999201345566091;-0.2440956282738027;-0.06663895131381126;-0.4214028389094926;-0.4786670808883581
Testicular torsion;Paroxysmal dyspnea;0.8138135969638824;1.1184173;0.5596128340947546;0.4622179532316285;0.9999201345566091;-0.18610653759272666;0.11849712847439675;-0.4403073004618545;-0.5377021813249806
Testicular torsion;Phenylpyruvic acidemia;0.8168235570192337;1.0772461;0.5586379643568848;0.4753873055103076;0.9999600672783046;-0.18313651025907085;0.07728600262983754;-0.4413221029214197;-0.5245727617679969
Testicular torsion;Lateral ventricle dilatation;0.7634837329387665;1.013634;0.5760056577357235;0.4956600564253024;0.9999488789551968;-0.23646514601643032;0.013685087490726056;-0.42394322121947325;-0.5042888225298944
Testicular torsion;Neonatal unconjugated hyperbilirubinemia;0.8463726937770844;1.0494606;0.5490955177426466;0.48424977192395013;0.9999600672783046;-0.1535873735012202;0.04950058221205189;-0.4508645495356579;-0.5157102953543544
Testicular torsion;High maternal circulating alpha-fetoprotein concentration;0.9162326231598854;1.0588671;0.5266952664784594;0.4812511985750677;0.9999201345566091;-0.0836875113967237;0.05894696234433083;-0.4732248680781497;-0.5186689359815414
Testicular torsion;Prominent nasolabial fold;0.88960400223732;1.0194031;0.5352119088922869;0.4938233972368954;0.9999545338528789;-0.11035053161555897;0.019448566160853997;-0.46474262496059204;-0.5061311366159835
Testicular torsion;Abnormality of inferior alveolar nerve;0.8711785674095154;1.0098519;0.5411194040539322;0.49686397700364027;0.9999201345566091;-0.12874156714709373;0.009931797969025657;-0.4588007305026769;-0.5030561575529688
Testicular torsion;Unilateral conductive hearing impairment;0.9590191021561623;1.0118343;0.5130482789549802;0.49623293378367006;0.9999600672783046;-0.04094096512214229;0.011874196523270153;-0.4869117883233244;-0.5037271334946345
Testicular torsion;Macular hypopigmented whorls, streaks, and patches;0.8910008072853088;1.0693345;0.5347645924474586;0.4779124342308243;0.9999600672783046;-0.10895925999299572;0.06937443971022084;-0.465195474830846;-0.5220476330474803
Testicular torsion;Delayed ossification of pubic rami;0.6021641492843628;0.70979154;0.6302386477155526;0.5937246376573582;0.9999584729108851;-0.39779432362652234;-0.2901669318113368;-0.36971982519533253;-0.40623383525352696
Testicular torsion;Hyperphenylalaninemia;0.8438844233751297;1.0799023;0.5498972320137769;0.4745391791800343;0.9999561589935034;-0.15607173561837373;0.07994613230440917;-0.4500589269797265;-0.5254169798134691
Testicular torsion;Ureteropelvic junction obstruction;0.6639679074287415;0.9507428;0.6090850621078576;0.5156854021869648;0.832960393740828;-0.16899248631208652;0.11778238742143399;-0.22387533163297035;-0.3172749915538632
Testicular torsion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.863831028342247;1.0030961;0.543479007114539;0.49901447327603166;0.9999201345566091;-0.1360891062143621;0.0031759691116037825;-0.4564411274420701;-0.5009056612805775
Testicular torsion;Difficulty walking;1.0206452999264002;1.1704922;0.49342793000664764;0.44546424806593055;0.9999461221900431;0.0206991777363571;0.17054605005116785;-0.5065181921833954;-0.5544818741241125
Testicular torsion;Bilobate gallbladder;0.8252385556697845;0.94470155;0.5559154219188266;0.5176110211158811;0.9999584729108851;-0.1747199172411006;-0.055256920519832886;-0.44404305099205854;-0.48234745179500405
Testicular torsion;Histidinuria;0.8185403347015381;0.9739465;0.5580821818388944;0.5082940225562284;0.8494521264714628;-0.030911791769924757;0.12449438527399004;-0.2913699446325685;-0.3411581039152345
Testicular torsion;Widened interpedicular distance;0.7061696350574493;0.87375706;0.5949300788169287;0.5402918808069601;0.9999201345566091;-0.29375049949915977;-0.12616307021411033;-0.4049900557396804;-0.459628253749649
Abolished vibration sense;Fractured metatarsal bone of digit 5;0.8219618946313858;1.0240536;0.5569750322148248;0.4923427824902198;0.9999134918687169;-0.17795159723733112;0.024140081739681518;-0.4429384596538921;-0.5075707093784971
Abolished vibration sense;Prolonged G2 phase of cell cycle;1.0164097640663385;1.0975461;0.4947763754132698;0.4689006561876059;0.9999548690865008;0.016454894979837764;0.0975912315299543;-0.505178493673231;-0.5310542128988949
Abolished vibration sense;Single naris;0.8571518659591675;0.8870964;0.5456260510327916;0.5360151169438698;0.9999548690865008;-0.1428030031273333;-0.1128584640572039;-0.45432881805370917;-0.46393975214263095
Abolished vibration sense;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.8593436628580093;0.93725795;0.5449212634338649;0.5199845449882883;0.9999134918687169;-0.14056982901070758;-0.06265554633114978;-0.454992228434852;-0.47992894688042864
Abolished vibration sense;Asymmetry of the thorax;0.8239061832427979;0.7593249;0.5563462097862559;0.5773688137670153;0.9999548690865008;-0.17604868584370292;-0.24062996082997;-0.44360865930024485;-0.42258605531948545
Abolished vibration sense;Type 2 muscle fiber predominance;0.9891392216086388;0.9411929;0.5034571611016679;0.5187296840934609;0.9999536937290383;-0.010814472120399543;-0.05876076875268943;-0.49649653262737037;-0.48122400963557743
Abolished vibration sense;Dependency on parenteral nutrition;0.8941808491945267;1.1356573;0.5337464632446689;0.4566853947072841;0.9999567459343585;-0.10577589673983179;0.13570056455148138;-0.46621028268968956;-0.5432713512270744
Abolished vibration sense;Limited shoulder flexion;0.7012839317321777;0.6979815;0.5965583529182161;0.5976604583972356;0.9999134918687169;-0.2986295601365392;-0.3019320150849645;-0.4033551389505008;-0.40225303347148134
Abolished vibration sense;Paroxysmal vertigo;0.6958308219909668;0.6516482;0.5983788147580165;0.6132585305673053;0.9999567459343585;-0.30412592394339166;-0.3483085225342425;-0.401577931176342;-0.3866982153670532
Abolished vibration sense;Long hallux;0.8291026651859283;0.964654;0.5546666449215858;0.5112533197803655;0.9999503740898522;-0.17084770890392387;-0.03529634567417228;-0.4452837291682664;-0.48869705430948673
Abolished vibration sense;Broad medial eyebrow;0.9820433594286442;1.0310147;0.5057160834277994;0.490126139443799;0.9999584729108851;-0.017915113482240952;0.031056207951541626;-0.49424238948308574;-0.5098323334670861
Abolished vibration sense;Myxoid subcutaneous tumors;0.8947284370660782;0.9991344;0.5335711815717615;0.5002755187190324;0.9999584729108851;-0.10523003584480695;-0.0008240515623133549;-0.4663872913391236;-0.4996829541918527
Abolished vibration sense;Bulbous tips of toes;0.7967602163553238;0.9156155;0.5651470946052413;0.5268924059416364;0.9999567459343585;-0.20319652957903467;-0.08434124691473566;-0.4348096513291172;-0.473064339992722
Abolished vibration sense;Absent internal genitalia;0.6901996433734894;0.876568;0.6002622192780885;0.5393900782119432;0.9999134918687169;-0.30971384849522754;-0.12334547247861072;-0.3996512725906284;-0.46052341365677374
Abolished vibration sense;Hyperphalangy of the 2nd finger;0.8781314939260483;0.8958928;0.5388886203565053;0.533198501032841;0.9999584729108851;-0.12182697898483685;-0.10406567401028088;-0.4610698525543798;-0.4667599718780441
Abolished vibration sense;Renal interstitial hemosiderin;0.9735433403402567;1.1252438;0.5084223990698589;0.4600286991390251;0.9999134918687169;-0.02637015152846023;0.12533029112841443;-0.49149109279885805;-0.5398847927296918
Abolished vibration sense;Abnormality of depressor anguli oris muscle;0.7949734628200531;0.74791235;0.5657280695219168;0.5811171287408663;0.9999134918687169;-0.20494002904866382;-0.252001144551975;-0.43418542234680013;-0.4187963631278506
Abolished vibration sense;Paroxysmal dyspnea;0.7775428295135498;0.7473144;0.57140775307769;0.5813138313053745;0.9999134918687169;-0.22237066235516711;-0.2525990983483617;-0.42850573879102694;-0.4185996605633424
Abolished vibration sense;Phenylpyruvic acidemia;0.9301215931773186;0.97634405;0.5222611296691321;0.5075306243643858;0.9999584729108851;-0.06983687973356656;-0.02361442393398694;-0.47769734324175306;-0.49242784854649935
Abolished vibration sense;Lateral ventricle dilatation;0.8644975870847702;1.0261548;0.5432648499310071;0.49167371752260725;0.915698319803367;-0.05120073271859682;0.11045643674265349;-0.3724334698723599;-0.4240246022807598
Abolished vibration sense;Neonatal unconjugated hyperbilirubinemia;0.8638220429420471;1.0281276;0.5434818941489528;0.4910455230319626;0.9999584729108851;-0.136136429968838;0.028169078167911255;-0.4564765787619324;-0.5089129498789225
Abolished vibration sense;High maternal circulating alpha-fetoprotein concentration;1.0391799174249172;1.128637;0.48752545201230657;0.45893980926788325;0.9999134918687169;0.0392664255562003;0.12872346434618787;-0.5123880398564103;-0.5409736826008337
Abolished vibration sense;Prominent nasolabial fold;0.8001361191272736;0.86412454;0.5640499959557844;0.5433846993013463;0.9999524555142131;-0.19981633638693952;-0.13582791899993085;-0.43590245955842866;-0.4565677562128668
Abolished vibration sense;Abnormality of inferior alveolar nerve;0.7999919056892395;0.96731955;0.5640968464796122;0.5104043622868546;0.8643545492165687;-0.06436264352732923;0.10296499891346667;-0.3002577027369565;-0.35395018692971414
Abolished vibration sense;Unilateral conductive hearing impairment;0.6691286861896515;0.74964756;0.6073426067592058;0.5805464937580151;0.9999584729108851;-0.33082978672123364;-0.250310915175442;-0.3926158661516793;-0.41941197915287
Abolished vibration sense;Macular hypopigmented whorls, streaks, and patches;0.909746915102005;0.9949442;0.5287675946761733;0.5016093085176763;0.9999584729108851;-0.09021155780888013;-0.005014258090023316;-0.47119087823471184;-0.49834916439320887
Abolished vibration sense;Delayed ossification of pubic rami;0.8803767561912537;1.0652008;0.5381686634210412;0.4792312083908221;0.9999567459343585;-0.1195799897431048;0.06524405972970404;-0.46178808251331727;-0.5207255375435363
Abolished vibration sense;Hyperphenylalaninemia;0.967402920126915;1.0787824;0.510377811195746;0.47489675698681133;0.9999542297279059;-0.03255130960099095;0.07882820950396663;-0.48957641853215994;-0.5250574727410946
Abolished vibration sense;Ureteropelvic junction obstruction;0.7668041586875916;1.0068312;0.5749183201318933;0.49782555738486445;0.9999505803237132;-0.23314642163612165;0.006880588804704768;-0.42503226019181994;-0.5021250229388488
Abolished vibration sense;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8805034980177879;1.0614519;0.5381280287719863;0.4804269261119627;0.9999134918687169;-0.11940999385092899;0.06153842005755261;-0.46178546309673063;-0.5194865657567542
Abolished vibration sense;Difficulty walking;0.745587021112442;0.7755739;0.5818822454807215;0.5720507363205488;0.8934045521129487;-0.14781753100050665;-0.11783064283026434;-0.31152230663222713;-0.32135381579239986
Abolished vibration sense;Bilobate gallbladder;0.9610617086291313;1.1340343;0.5123975772895578;0.4572067703923858;0.9999567459343585;-0.03889503730522714;0.1340775300742475;-0.48755916864480064;-0.5427499755419727
Abolished vibration sense;Histidinuria;0.953775979578495;1.0750266;0.5147188073706106;0.47609582906790215;0.9999556674707869;-0.046179687892291876;0.07507096388449874;-0.4852368601001763;-0.5238598384028847
Abolished vibration sense;Widened interpedicular distance;0.7985508143901825;0.77398175;0.5645650903565183;0.5725709007826935;0.9999134918687169;-0.20136267747853442;-0.22593174185727283;-0.43534840151219867;-0.42734259108602346
Fractured metatarsal bone of digit 5;Prolonged G2 phase of cell cycle;0.9716234095394611;1.0500796;0.5090337619338496;0.48405251207327915;0.9999056439461368;-0.028282234406675655;0.05017394017556731;-0.49087188201228715;-0.5158531318728576
Fractured metatarsal bone of digit 5;Single naris;0.952355645596981;1.0201943;0.5151714125351685;0.4935715332535986;0.9999056439461368;-0.04754999834915574;0.020288648122344655;-0.4847342314109683;-0.5063341106925382
Fractured metatarsal bone of digit 5;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.92440165579319;1.0572932;0.5240866806043021;0.48175302589529356;1.0;-0.07559834420681;0.05729317665100098;-0.4759133193956979;-0.5182469741047064
Fractured metatarsal bone of digit 5;Asymmetry of the thorax;0.8271259367465973;1.1163452;0.5553053633516587;0.46288213005897483;0.789736248610815;0.03738968813578225;0.32660891854921914;-0.23443088525915634;-0.3268541185518402
Fractured metatarsal bone of digit 5;Type 2 muscle fiber predominance;1.0004315357655287;1.0165248;0.4998626378953269;0.49473976312504186;0.8527273749847077;0.14770416078082094;0.16379741673282155;-0.3528647370893808;-0.3579876118596659
Fractured metatarsal bone of digit 5;Dependency on parenteral nutrition;0.8787954598665237;0.8882482;0.5386756950053417;0.535646159610732;0.9999134918687169;-0.12111803200219318;-0.1116652866837804;-0.4612377968633752;-0.4642673322579849
Fractured metatarsal bone of digit 5;Limited shoulder flexion;0.7917080819606781;1.2003639;0.5667904057496713;0.4357875799691192;1.0;-0.2082919180393219;0.2003638744354248;-0.4332095942503287;-0.5642124200308808
Fractured metatarsal bone of digit 5;Paroxysmal vertigo;0.9042145609855652;1.0994843;0.5305362684322963;0.46828067015211683;0.9999134918687169;-0.09569893088315173;0.09957083258654431;-0.46937722343642063;-0.5316328217166001
Fractured metatarsal bone of digit 5;Long hallux;0.6931324601173401;0.28772575;0.5992808606497728;0.7523347632544618;0.44339171919682574;0.24974074092051435;-0.15566597256520343;0.15588914145294708;0.30894304405763606
Fractured metatarsal bone of digit 5;Broad medial eyebrow;0.904752217233181;0.9468041;0.5303643410510217;0.5169407680232074;0.9999201345566091;-0.09516791732342811;-0.05311602832110496;-0.4695557935055874;-0.4829793665334017
Fractured metatarsal bone of digit 5;Myxoid subcutaneous tumors;0.8413818180561066;0.82454085;0.550703887009723;0.5561409879391203;0.9999201345566091;-0.15853831650050254;-0.1753792810562429;-0.44921624754688616;-0.44377914661748885
Fractured metatarsal bone of digit 5;Bulbous tips of toes;0.6487732529640198;0.30186975;0.6142353711610548;0.7459843640074992;0.5863259809806012;0.062447271983418595;-0.284456230957713;0.027909390180453575;0.15965838302689805
Fractured metatarsal bone of digit 5;Absent internal genitalia;0.8482119739055634;0.8892735;0.5485031084749956;0.5353177474118573;1.0;-0.15178802609443665;-0.11072647571563721;-0.4514968915250044;-0.46468225258814266
Fractured metatarsal bone of digit 5;Hyperphalangy of the 2nd finger;0.5793047547340393;0.35896665;0.6382138278306266;0.7214939841000079;0.6707004714172433;-0.09139571668320401;-0.3117338228385995;-0.03248664358661668;0.05079351268276455
Fractured metatarsal bone of digit 5;Renal interstitial hemosiderin;1.014595054090023;1.0976757;0.49535408504173906;0.4688592091384918;1.0;0.01459505409002304;0.09767568111419678;-0.5046459149582609;-0.5311407908615082
Fractured metatarsal bone of digit 5;Abnormality of depressor anguli oris muscle;0.8603534400463104;1.1597099;0.5445966373228424;0.44894410176371236;1.0;-0.13964655995368958;0.15970993041992188;-0.45540336267715764;-0.5510558982362876
Fractured metatarsal bone of digit 5;Paroxysmal dyspnea;0.83080193400383;1.0198008;0.5541177566842271;0.49369681282945754;1.0;-0.16919806599617004;0.019800782203674316;-0.44588224331577286;-0.5063031871705425
Fractured metatarsal bone of digit 5;Phenylpyruvic acidemia;0.8784284293651581;1.0231;0.5387933948182106;0.4926463982515984;0.9999201345566091;-0.12149170519145103;0.02317988394467263;-0.46112673973839846;-0.5072737363050107
Fractured metatarsal bone of digit 5;Lateral ventricle dilatation;0.8354206681251526;1.1159719;0.5526266548945333;0.4630017519064704;0.9998579617208769;-0.16443729359572434;0.11611396115357375;-0.4472313068263436;-0.5368562098144065
Fractured metatarsal bone of digit 5;Neonatal unconjugated hyperbilirubinemia;0.9277671128511429;1.0697895;0.5230124833673262;0.47776724219347555;0.9999201345566091;-0.07215302170546622;0.06986939429013161;-0.4769076511892829;-0.5221528923631336
Fractured metatarsal bone of digit 5;High maternal circulating alpha-fetoprotein concentration;0.8955928385257721;1.0475094;0.5332945093387623;0.48487157146894844;1.0;-0.1044071614742279;0.04750943183898926;-0.4667054906612377;-0.5151284285310516
Fractured metatarsal bone of digit 5;Prominent nasolabial fold;0.8905956894159317;1.0305054;0.5348943213009114;0.49028832053207205;0.9998944404568447;-0.10929875104091302;0.030610978320621096;-0.4650001191559333;-0.5096061199247727
Fractured metatarsal bone of digit 5;Abnormality of inferior alveolar nerve;0.8100299090147018;0.8832841;0.5608391041592602;0.537236694715491;1.0;-0.18997009098529816;-0.11671590805053711;-0.4391608958407398;-0.46276330528450904
Fractured metatarsal bone of digit 5;Unilateral conductive hearing impairment;0.9637054651975632;1.0444243;0.5115554471750259;0.48585463804835594;0.9999201345566091;-0.03621466935904594;0.04450416086880593;-0.48836468738158323;-0.5140654965082532
Fractured metatarsal bone of digit 5;Macular hypopigmented whorls, streaks, and patches;0.845653772354126;0.96411365;0.5493271198839471;0.5114254252343158;0.9999201345566091;-0.15426636220248313;-0.03580648185046287;-0.450593014672662;-0.48849470932229333
Fractured metatarsal bone of digit 5;Delayed ossification of pubic rami;0.626799464225769;0.7275324;0.621739658606991;0.5878397519503842;0.6574179255159834;-0.030618461290214394;0.07011446126380172;-0.03567826690899245;-0.06957817356559926
Fractured metatarsal bone of digit 5;Hyperphenylalaninemia;0.881285771727562;0.98421824;0.5378772380864286;0.5050237000357718;0.9999028053808913;-0.11861703365332932;-0.015684565596650546;-0.46202556729446265;-0.4948791053451195
Fractured metatarsal bone of digit 5;Ureteropelvic junction obstruction;0.8405046463012695;0.86230606;0.5509866998269713;0.5439690311977854;0.9998847295244674;-0.15938008322319785;-0.13757867111763755;-0.44889802969749604;-0.455915698326682
Fractured metatarsal bone of digit 5;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.5239179730415344;0.15647942;0.6579434672148197;0.8195209622624788;1.0;-0.4760820269584656;-0.8435205817222595;-0.34205653278518033;-0.18047903773752116
Fractured metatarsal bone of digit 5;Difficulty walking;0.9102325960993767;0.874159;0.5286123675196759;0.5401629238682981;0.7552776988623575;0.15495489723701916;0.11888127959986172;-0.22666533134268163;-0.2151147749940594
Fractured metatarsal bone of digit 5;Bilobate gallbladder;0.941815584897995;1.1006726;0.5185311405636955;0.46790052329163223;0.9999134918687169;-0.058097906970721924;0.1007591107847865;-0.4813823513050214;-0.5320129685770847
Fractured metatarsal bone of digit 5;Histidinuria;0.9458408877253532;0.9818919;0.517247819793415;0.5057643087286854;0.9999090677057578;-0.054068179980404585;-0.0180171972071006;-0.4826612479123428;-0.49414475897707244
Fractured metatarsal bone of digit 5;Widened interpedicular distance;0.8509849607944489;0.9387866;0.5476102831310203;0.519497001736868;1.0;-0.14901503920555115;-0.06121337413787842;-0.45238971686897966;-0.48050299826313203
Prolonged G2 phase of cell cycle;Single naris;1.1395593285560608;1.0802535;0.4554314038851791;0.47442701732502246;0.9999528219730685;0.13960650658299234;0.08030065989186075;-0.5445214180878893;-0.525525804648046
Prolonged G2 phase of cell cycle;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.81649249792099;0.9080116;0.5587451608073739;0.5293222605862881;0.9999056439461368;-0.1834131460251468;-0.09189402866980012;-0.4411604831387629;-0.47058338335984873
Prolonged G2 phase of cell cycle;Asymmetry of the thorax;0.8452323377132416;0.9706723;0.5494628982262177;0.5093366320177053;0.9999528219730685;-0.15472048425982687;-0.029280512574417328;-0.4504899237468507;-0.49061618995536316
Prolonged G2 phase of cell cycle;Type 2 muscle fiber predominance;0.5743939280509949;0.8148595;0.6399390656665653;0.5592740189420429;0.9999515360511232;-0.4255576080001283;-0.18509202658304458;-0.36001247038455786;-0.4406775171090803
Prolonged G2 phase of cell cycle;Dependency on parenteral nutrition;0.8073425590991974;0.94331694;0.5617106121873001;0.5180524600577623;0.9999548690865008;-0.1926123099873034;-0.05663793259358085;-0.43824425689920066;-0.4819024090287385
Prolonged G2 phase of cell cycle;Limited shoulder flexion;0.839046835899353;1.0115373;0.5514568088439342;0.4963274930039102;0.9999056439461368;-0.16085880804678376;0.01163166951516692;-0.44844883510220257;-0.5035781509422266
Prolonged G2 phase of cell cycle;Paroxysmal vertigo;0.9134120792150497;1.0877591;0.5275963485370406;0.47202941941537635;0.9999548690865008;-0.08654278987145103;0.08780426806712471;-0.47235852054946015;-0.5279254496711244
Prolonged G2 phase of cell cycle;Long hallux;0.9650449119508266;1.0645769;0.5111288171896033;0.4794302345647745;0.9999478876548411;-0.03490297570401446;0.0646289765877126;-0.48881907046523776;-0.5205176530900666
Prolonged G2 phase of cell cycle;Broad medial eyebrow;0.8305417895317078;0.93864685;0.5542017765107734;0.5195415789885233;0.9999567459343585;-0.1694149564026507;-0.06130989296423517;-0.44575496942358506;-0.4804151669458352
Prolonged G2 phase of cell cycle;Myxoid subcutaneous tumors;0.834164172410965;0.9562964;0.5530321823584186;0.5139157275549493;0.9999567459343585;-0.1657925735233935;-0.04366036159979425;-0.4469245635759399;-0.48604101837940916
Prolonged G2 phase of cell cycle;Bulbous tips of toes;0.9549942873418331;1.0634623;0.5143306038600006;0.4797857590154335;0.9999548690865008;-0.04496058174466766;0.06350738829875313;-0.48562426522650015;-0.5201691100710673
Prolonged G2 phase of cell cycle;Absent internal genitalia;0.9905622880905867;1.1525652;0.5030041616018286;0.4512466002848944;0.9999056439461368;-0.009343355855550128;0.15265959691384856;-0.4969014823443082;-0.5486590436612424
Prolonged G2 phase of cell cycle;Hyperphalangy of the 2nd finger;0.6400627493858337;0.95599115;0.6172019023362485;0.5140129734463644;0.9999567459343585;-0.3598939965485247;-0.043965596985689026;-0.38275484359810996;-0.48594377248799403
Prolonged G2 phase of cell cycle;Renal interstitial hemosiderin;0.8166102170944214;0.8909911;0.5587070427401937;0.5347677011575921;0.9999056439461368;-0.1832954268517154;-0.10891455221792634;-0.4411986012059431;-0.4651379427885447
Prolonged G2 phase of cell cycle;Abnormality of depressor anguli oris muscle;0.8923228681087494;1.1009384;0.5343412757853012;0.46781549304958603;0.9999056439461368;-0.1075827758373874;0.10103279542306487;-0.4655643681608356;-0.5320901508965508
Prolonged G2 phase of cell cycle;Paroxysmal dyspnea;0.8385492265224457;0.9573692;0.5516173018475332;0.5135739065705041;0.9999056439461368;-0.1613564174236911;-0.042536435610260326;-0.4482883420986036;-0.48633173737563273
Prolonged G2 phase of cell cycle;Phenylpyruvic acidemia;0.7192961573600769;0.8038024;0.5905678706541244;0.5628594027474378;0.851762385589393;-0.13246622822931609;-0.04796001456430754;-0.2611945149352686;-0.28890298284195515
Prolonged G2 phase of cell cycle;Lateral ventricle dilatation;0.841381162405014;1.0443074;0.5507040983859826;0.485891923007858;0.9999433058680118;-0.1585621434629978;0.04436404524435389;-0.4492392074820293;-0.5140513828601538
Prolonged G2 phase of cell cycle;Neonatal unconjugated hyperbilirubinemia;0.9176190048456192;0.98705494;0.5262524367450694;0.5041206508236405;0.851762385589393;0.06585661925622621;0.13529255844899812;-0.3255099488443236;-0.34764173476575244
Prolonged G2 phase of cell cycle;High maternal circulating alpha-fetoprotein concentration;0.7697612643241882;0.79845977;0.573950708427075;0.5645946683995744;0.9999056439461368;-0.23014437962194856;-0.2014458756508487;-0.42595493551906183;-0.4353109755465624
Prolonged G2 phase of cell cycle;Prominent nasolabial fold;0.9938386529684067;1.0638822;0.5019612300812659;0.4796518147296921;0.9999501780647019;-0.006111525096295201;0.06393205364763943;-0.49798894798343596;-0.5202983633350098
Prolonged G2 phase of cell cycle;Abnormality of inferior alveolar nerve;0.872093141078949;1.0336736;0.5408258577238103;0.48927932185614176;0.9999056439461368;-0.12781250286718782;0.03376800011972014;-0.4590797862223265;-0.510626322089995
Prolonged G2 phase of cell cycle;Unilateral conductive hearing impairment;1.02098916657269;1.1197807;0.49331845012854725;0.46178086666713725;0.9999567459343585;0.02103242063833155;0.11982391374123968;-0.5066382958058112;-0.5381758792672212
Prolonged G2 phase of cell cycle;Macular hypopigmented whorls, streaks, and patches;0.8682836592197418;0.9854348;0.5420488019709169;0.5046364293548257;0.9999567459343585;-0.13167308671461664;-0.014521975350252014;-0.4579079439634416;-0.4953203165795328
Prolonged G2 phase of cell cycle;Delayed ossification of pubic rami;0.8886743187904358;1.0429983;0.5355096717640564;0.4863089965357167;0.9999548690865008;-0.11128055029606498;0.04304344481730782;-0.4644451973224444;-0.5136458725507841
Prolonged G2 phase of cell cycle;Hyperphenylalaninemia;0.8137481510639191;0.9990337;0.5596340370487591;0.5003075909766804;0.8359184341309926;-0.022170283067073582;0.16311525536790872;-0.2762843970822335;-0.3356108431543122
Prolonged G2 phase of cell cycle;Ureteropelvic junction obstruction;0.875740185379982;0.95462567;0.5396556279424156;0.5144480548766563;0.9999481150251853;-0.12420792964520333;-0.045322448883675315;-0.4602924870827697;-0.485500060148529
Prolonged G2 phase of cell cycle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6949655413627625;0.99884534;0.5986679835113007;0.5003675472647926;0.9999056439461368;-0.30494010258337434;-0.0010603051247256579;-0.4012376604348361;-0.4995380966813442
Prolonged G2 phase of cell cycle;Difficulty walking;0.8721882700920105;0.99036807;0.5407953266289413;0.5030659948187549;0.9999398952172014;-0.1277516251251909;-0.00957182699897019;-0.45914456858826014;-0.4968739003984465
Prolonged G2 phase of cell cycle;Bilobate gallbladder;0.8522130399942398;0.99598944;0.547214996450806;0.501276601055594;0.9999548690865008;-0.14774182909226097;-0.0039654272148577085;-0.4527398726356948;-0.49867826803090676
Prolonged G2 phase of cell cycle;Histidinuria;0.8695904910564423;0.93855125;0.5416292050243111;0.5195720818730003;0.8413020594063172;0.028288431650125068;0.09724918771358637;-0.2996728543820061;-0.3217299775333169
Prolonged G2 phase of cell cycle;Widened interpedicular distance;0.6504647731781006;0.9743398;0.6136605008473955;0.5081688056152925;0.9999056439461368;-0.3494408707680362;-0.025565860754455882;-0.38624514309874125;-0.49173683833084425
Single naris;Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;0.9304492324590683;0.88428766;0.5221565844854802;0.5369150712873418;0.9999056439461368;-0.06945641148706849;-0.11561798859259065;-0.4777490594606566;-0.46299057265879495
Single naris;Asymmetry of the thorax;0.955846942961216;0.8763938;0.5140589250477179;0.5394459659021846;0.9999528219730685;-0.04410587901185248;-0.12355902695964072;-0.48589389692535057;-0.4605068560708838
Single naris;Type 2 muscle fiber predominance;0.9828607365489006;1.0212814;0.5054558641346008;0.49322543620718273;0.9999515360511232;-0.017090799502222587;0.02132982552877183;-0.49449567191652244;-0.5067260998439405
Single naris;Dependency on parenteral nutrition;0.9591817110776901;0.9371304;0.5129964755817453;0.5200252293605174;0.9999548690865008;-0.04077315800881065;-0.06282447748875297;-0.48695839350475545;-0.47992963972598335
Single naris;Limited shoulder flexion;0.8400803208351135;0.9903778;0.5511235230298425;0.5030628855156372;0.9999056439461368;-0.15982532311102327;-0.0095278601708072;-0.4487821209162943;-0.49684275843049963
Single naris;Paroxysmal vertigo;0.9540486484766006;0.9855981;0.514631921839682;0.504584434421906;0.9999548690865008;-0.04590622060990013;-0.01435678177570976;-0.4853229472468188;-0.49537043466459474
Single naris;Long hallux;0.9001285582780838;0.99898684;0.5318431531710051;0.5003224911128019;0.9999478876548411;-0.0998193293767573;-0.0009610474067331953;-0.46810473448383605;-0.4996253965420392
Single naris;Broad medial eyebrow;0.8488596975803375;0.67957807;0.5482945251436863;0.6038246765687245;0.8846475303342614;-0.03578783275392383;-0.20506946446206897;-0.3363530051905751;-0.28082285376553684
Single naris;Myxoid subcutaneous tumors;0.8883709013462067;0.8499316;0.5356068583031557;0.5479494017665314;0.9999567459343585;-0.1115858445881518;-0.1500251482247027;-0.4643498876312028;-0.45200734416782706
Single naris;Bulbous tips of toes;0.8431205451488495;0.94502664;0.5501434153964744;0.5175073884813037;0.9999548690865008;-0.1568343239376513;-0.05492823296284355;-0.4498114536900264;-0.48244748060519704
Single naris;Absent internal genitalia;0.7371888160705566;0.5981148;0.5846496303523385;0.6316449175863341;0.9999056439461368;-0.26271682787558015;-0.4017908554138797;-0.41525601359379827;-0.36826072635980267
Single naris;Hyperphalangy of the 2nd finger;1.0533847287297249;1.0820863;0.4829990312842062;0.473841697574907;0.9999567459343585;0.053427982795366424;0.082129578757414;-0.5169577146501523;-0.5261150483594514
Single naris;Renal interstitial hemosiderin;0.9271325021982193;0.88066554;0.5232150199474725;0.5380760772397818;0.9999056439461368;-0.07277314174791749;-0.11924010325094636;-0.47669062399866424;-0.461829566706355
Single naris;Abnormality of depressor anguli oris muscle;0.9424314796924591;0.88949895;0.5183347659862022;0.535245544662513;0.7483657621638067;0.19406571752865243;0.14113318688709664;-0.23003099617760447;-0.21312021750129373
Single naris;Paroxysmal dyspnea;0.9838728420436382;0.92665243;0.5051336563613188;0.5233682364563941;0.9999056439461368;-0.01603280190249856;-0.07325321245809968;-0.494771987584818;-0.4765374074897427
Single naris;Phenylpyruvic acidemia;0.9515830725431442;0.99496466;0.5154176143328424;0.5016028117511397;0.9999567459343585;-0.048373673391214234;-0.004992086720338684;-0.48453913160151607;-0.4983539341832187
Single naris;Lateral ventricle dilatation;1.0424499958753586;1.0029902;0.4864836851651594;0.49904815954556525;0.9999433058680118;0.04250669000734675;0.0030469399510799633;-0.5134596207028524;-0.5008951463224466
Single naris;Neonatal unconjugated hyperbilirubinemia;0.7738723456859589;0.99509084;0.5726066508161105;0.5015626426867417;0.9999567459343585;-0.2260844002483996;-0.004865903687349182;-0.42735009511824795;-0.4983941032476168
Single naris;High maternal circulating alpha-fetoprotein concentration;0.8996849358081818;0.8666627;0.5319850753145436;0.5425693622925359;0.9999056439461368;-0.10022070813795503;-0.1332429628433841;-0.46792056863159315;-0.45733628165360085
Single naris;Prominent nasolabial fold;0.6233381927013397;0.43344504;0.6229281109548437;0.6917241143058853;0.7703267171239124;-0.1469885244225727;-0.33688168071262703;-0.14739860616906875;-0.07860260281802711
Single naris;Abnormality of inferior alveolar nerve;0.8004351258277893;0.7541168;0.5639528623276592;0.5790779758929532;0.9999056439461368;-0.19947051811834748;-0.2457888703407901;-0.4359527816184776;-0.4208276680531836
Single naris;Unilateral conductive hearing impairment;0.6642819344997406;0.88560826;0.6089789391354012;0.5364919129171211;0.9999567459343585;-0.33567481143461786;-0.11434849007116876;-0.3909778067989572;-0.4634648330172374
Single naris;Macular hypopigmented whorls, streaks, and patches;0.9779849480837584;0.788555;0.5070081748474823;0.5678169255741845;0.9999567459343585;-0.021971797850600105;-0.21140171987997614;-0.4929485710868762;-0.43213982036017395
Single naris;Delayed ossification of pubic rami;0.9508459381759167;0.91311264;0.5156525312152406;0.5276920186981522;0.9999548690865008;-0.0491089309105841;-0.0868422287056414;-0.4843023378712602;-0.4722628503883486
Single naris;Hyperphenylalaninemia;0.9427443742752075;0.9389445;0.5182350039960117;0.5194466534971383;0.9999521228478421;-0.057207748572634554;-0.06100760428171048;-0.48171711885183033;-0.4805054693507038
Single naris;Ureteropelvic junction obstruction;0.8663243353366852;0.94046104;0.5426780387164701;0.5189630546500659;0.9999481150251853;-0.13362377968850014;-0.05948707548203347;-0.4572700763087152;-0.48098506037511946
Single naris;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9464519955217838;1.0286324;0.5170530154457658;0.4908847709653147;0.9999056439461368;-0.05345364842435296;0.028726758473907155;-0.48285262850037103;-0.5090208729808221
Single naris;Difficulty walking;0.9275191575288773;0.88419086;0.5230916174235973;0.5369460891873643;0.9999398952172014;-0.07242073768832413;-0.11574903780677048;-0.47684827779360406;-0.4629938060298371
Single naris;Bilobate gallbladder;0.930954284965992;0.988372;0.5219954338696057;0.5037013747823899;0.9999548690865008;-0.0690005841205088;-0.011582841212507855;-0.4779594352168951;-0.4962534943041109
Single naris;Histidinuria;0.8881579786539078;0.8788557;0.5356750607868423;0.5386563831104663;0.9999536937290383;-0.11179571507513053;-0.12109798846780784;-0.46427863294219596;-0.46129731061857204
Single naris;Widened interpedicular distance;1.0738455951213837;1.041959;0.47647280091381805;0.48664009593795743;0.9999056439461368;0.07393995117524688;0.04205340337136809;-0.5234328430323187;-0.5132655480081794
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Asymmetry of the thorax;0.8191127181053162;1.0030228;0.5578969206816042;0.4990378323951611;0.9999056439461368;-0.18079292584082063;0.0031171460090023695;-0.44200872326453255;-0.5008678115509757
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Type 2 muscle fiber predominance;0.829499214887619;1.0024343;0.5545385390474125;0.4992251451041162;0.9999003561294039;-0.17040114124178485;0.0025338975632230865;-0.4453618170819914;-0.5006752110252877
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Dependency on parenteral nutrition;0.9628867320716381;1.0964059;0.5118162337524322;0.46926532126814013;0.9999134918687169;-0.03702675979707881;0.09649237189318494;-0.4880972581162847;-0.5306481706005768
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Limited shoulder flexion;0.7415189146995544;0.9766725;0.5832219677364916;0.5074260639692441;1.0;-0.25848108530044556;-0.023327529430389404;-0.4167780322635084;-0.49257393603075594
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Paroxysmal vertigo;0.7914552092552185;0.9835177;0.566872704941287;0.5052467080562273;0.9999134918687169;-0.2084582826134984;-0.016395785474521363;-0.43304078692742987;-0.49466678381248963
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Long hallux;0.8644745945930481;1.0597861;0.5432722368091012;0.48095814396139946;0.9998836012415208;-0.13540900664847266;0.059902480072566155;-0.45661136443241956;-0.5189254572801213
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Broad medial eyebrow;0.7895441204309464;0.6237408;0.5674948293445479;0.6227897831190601;0.9999201345566091;-0.21037601412566276;-0.376179342282134;-0.43242530521206124;-0.377130351437549
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Myxoid subcutaneous tumors;0.8621761798858643;1.0349011;0.5440107755574763;0.4888883766820473;0.9999201345566091;-0.13774395467074485;0.03498100756375222;-0.45590935899913276;-0.5110317578745618
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Bulbous tips of toes;0.83699831366539;0.9809487;0.5521175999505238;0.5060645954135201;0.9999134918687169;-0.1629151782033269;-0.018964805268985474;-0.44779589191819313;-0.4938488964551968
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Absent internal genitalia;0.8477927893400192;0.995117;0.5486381076416601;0.5015543128095397;1.0;-0.15220721065998077;-0.004882991313934326;-0.4513618923583399;-0.49844568719046034
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Hyperphalangy of the 2nd finger;0.7063091397285461;0.9644031;0.5948836234443748;0.5113332465328699;0.9999201345566091;-0.29361099482806297;-0.03551704169543357;-0.40503651111223427;-0.4885868880237392
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Renal interstitial hemosiderin;0.6266209483146667;0.69333005;0.6218009095217586;0.5992147898108614;1.0;-0.37337905168533325;-0.3066699504852295;-0.3781990904782414;-0.4007852101891386
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Abnormality of depressor anguli oris muscle;0.8712456226348877;1.0442816;0.5410978804678187;0.4859001272872038;1.0;-0.1287543773651123;0.044281601905822754;-0.4589021195321813;-0.5140998727127962
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Paroxysmal dyspnea;0.8060848414897919;1.024249;0.5621186507964475;0.4922805687119466;1.0;-0.19391515851020813;0.024248957633972168;-0.4378813492035525;-0.5077194312880534
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Phenylpyruvic acidemia;0.7227283120155334;0.95184284;0.5894302099586762;0.5153348345355292;0.9999201345566091;-0.27719182254107566;-0.048077290070372536;-0.4104899245979329;-0.4845853000210799
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Lateral ventricle dilatation;0.8146886378526688;0.8292662;0.559329366808079;0.5546138071462314;0.9998579617208769;-0.18516932386820817;-0.1705917711920073;-0.44052859491279794;-0.4452441545746455
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Neonatal unconjugated hyperbilirubinemia;0.7831507921218872;1.1240133;0.5695779939694358;0.4604234622078369;0.9999201345566091;-0.2167693424347219;0.12409317015377908;-0.43034214058717335;-0.5394966723487722
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;High maternal circulating alpha-fetoprotein concentration;0.7366373538970947;0.8377526;0.5848315757651171;0.5518742604934792;1.0;-0.2633626461029053;-0.1622474193572998;-0.41516842423488287;-0.4481257395065208
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Prominent nasolabial fold;0.8609601706266403;0.9393826;0.5444016062838642;0.5193069450253818;0.9998944404568447;-0.1389342698302044;-0.06051182775161401;-0.4554928341729805;-0.48058749543146295
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Abnormality of inferior alveolar nerve;0.8560450524091721;0.97413236;0.5459820400402511;0.5082348473635683;1.0;-0.14395494759082794;-0.02586764097213745;-0.4540179599597489;-0.4917651526364317
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Unilateral conductive hearing impairment;0.8073573410511017;1.0209525;0.5617058171224458;0.493330145842132;0.9999201345566091;-0.19256279350550742;0.021032328593415306;-0.4382143174341633;-0.5065899887144771
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Macular hypopigmented whorls, streaks, and patches;0.5320813059806824;0.27469164;0.654995994785476;0.7583028093554955;0.9999201345566091;-0.46783882857592674;-0.7252284932258901;-0.3449241397711331;-0.24161732520111356
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Delayed ossification of pubic rami;0.8800432980060577;1.122435;0.5382755763109062;0.4609297212598328;0.9999134918687169;-0.11987019386265918;0.12252148184801892;-0.46163791555781075;-0.5389837706088841
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Hyperphenylalaninemia;0.6647001206874847;0.9141557;0.608837635982947;0.5273587455777393;0.9999028053808913;-0.3352026846934065;-0.08574708371646256;-0.3910651693979442;-0.47254405980315195
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Ureteropelvic junction obstruction;0.8669561296701431;0.9515549;0.5424751197964468;0.5154266013601091;0.9998847295244674;-0.13292859985432426;-0.048329835077140726;-0.4574096097280206;-0.4844581281643583
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7662928998470306;0.9994487;0.5750856833827654;0.5001754727268808;1.0;-0.23370710015296936;-0.0005512833595275879;-0.42491431661723456;-0.4998245272731192
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Difficulty walking;0.922847181558609;0.8936093;0.5245829346707972;0.5339294209891858;0.9998344221996177;-0.0769872406410087;-0.10622513684500345;-0.4752514875288205;-0.4659050012104319
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Bilobate gallbladder;0.8780954778194427;1.1340694;0.5389001707585996;0.4571954984502493;0.9999134918687169;-0.12181801404927417;0.13415595088030652;-0.4610133211101173;-0.5427179934184676
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Histidinuria;0.7426543235778809;0.9670275;0.582847900410869;0.5104973753213785;0.9999090677057578;-0.25725474412787697;-0.03288158233512184;-0.41706116729488885;-0.4894116923843793
Perifoveal ring of hyperautofluorescence surrounded by normal autofluorescence;Widened interpedicular distance;0.784154623746872;1.039298;0.5692507132604379;0.4874878048029292;1.0;-0.21584537625312805;0.039298057556152344;-0.43074928673956214;-0.5125121951970708
Asymmetry of the thorax;Type 2 muscle fiber predominance;0.8025418668985367;0.87826645;0.5632686488369554;0.5388453366738967;0.9283707775802553;-0.12582891068171864;-0.05010432383727437;-0.36510212874329995;-0.38952544090635866
Asymmetry of the thorax;Dependency on parenteral nutrition;0.921839639544487;1.0839074;0.5249046166944074;0.47326000432255033;0.9999548690865008;-0.07811522954201378;0.08395249671244942;-0.4750502523920934;-0.5266948647639504
Asymmetry of the thorax;Limited shoulder flexion;0.652675986289978;0.70099103;0.6129095940041733;0.5966560600783096;0.8029485097445463;-0.15027252345456832;-0.10195747523679488;-0.19003891574037302;-0.20629244966623672
Asymmetry of the thorax;Paroxysmal vertigo;0.7722717225551605;0.8709911;0.573129793021031;0.5411795754380362;0.9999548690865008;-0.22768314653134025;-0.128963758284804;-0.4268250760654698;-0.4587752936484646
Asymmetry of the thorax;Long hallux;0.7450861930847168;1.1278098;0.5820470992642186;0.4592053189963389;0.8838724518653985;-0.13878625878068174;0.24393731108931338;-0.30182535260117993;-0.42466713286905966
Asymmetry of the thorax;Broad medial eyebrow;0.798701599240303;0.8476217;0.5645160902548949;0.5486932164783013;0.9999567459343585;-0.20125514669405542;-0.1523350666283282;-0.43544065567946355;-0.4512635294560572
Asymmetry of the thorax;Myxoid subcutaneous tumors;0.8417388796806335;0.8951148;0.5505887767677495;0.5334475155984817;0.9999567459343585;-0.15821786625372491;-0.10484196646200739;-0.4493679691666089;-0.46650923033587677
Asymmetry of the thorax;Bulbous tips of toes;0.8524002730846405;1.0953836;0.5471547374588734;0.4695922222939396;0.8994299275196795;-0.04702965443503904;0.19595371658432437;-0.3522751900608061;-0.42983770522573994
Asymmetry of the thorax;Absent internal genitalia;0.8204679489135742;0.8415056;0.5574583572153384;0.5506639805366191;0.9999056439461368;-0.17943769503256257;-0.15840005684515412;-0.44244728673079836;-0.44924166340951766
Asymmetry of the thorax;Hyperphalangy of the 2nd finger;0.7362280189990997;0.9474658;0.5849666470974823;0.5167298578100883;0.9036123096265051;-0.16738429062740534;0.04385346777065069;-0.3186456625290228;-0.3868824518164168
Asymmetry of the thorax;Renal interstitial hemosiderin;0.8483999669551849;0.9625186;0.5484425678219212;0.5119335135749703;0.9999056439461368;-0.15150567699095185;-0.03738707113882478;-0.45146307612421555;-0.4879721303711665
Asymmetry of the thorax;Abnormality of depressor anguli oris muscle;0.7120150327682495;0.70214546;0.5929853185620438;0.5962710315238398;0.8605427142144324;-0.1485276814461829;-0.15839725694667117;-0.26755739565238856;-0.26427168269059265
Asymmetry of the thorax;Paroxysmal dyspnea;0.6637257039546967;0.56406933;0.6091669214848536;0.6435807144767691;0.9999056439461368;-0.33617993999144014;-0.43583631325384553;-0.39073872246128316;-0.35632492946936767
Asymmetry of the thorax;Phenylpyruvic acidemia;0.7783189564943314;0.9692707;0.57115437762958;0.5097829828375267;0.9999567459343585;-0.2216377894400271;-0.030686039757600647;-0.42880236830477847;-0.4901737630968318
Asymmetry of the thorax;Lateral ventricle dilatation;0.6885762214660645;0.7819715;0.6008058608751332;0.5699625760851279;0.9999433058680118;-0.3113670844019474;-0.21797179164300573;-0.3991374449928786;-0.42998072978288393
Asymmetry of the thorax;Neonatal unconjugated hyperbilirubinemia;0.7883210480213165;0.8661429;0.5678931182623006;0.5427363059276872;0.9999567459343585;-0.21163569791304193;-0.13381381733404718;-0.43206362767205786;-0.4572204400066713
Asymmetry of the thorax;High maternal circulating alpha-fetoprotein concentration;0.7441981434822083;0.8204067;0.5823394672317979;0.5574781882665224;0.9999056439461368;-0.25570750046392854;-0.17949896860739167;-0.41756617671433893;-0.4424274556796144
Asymmetry of the thorax;Prominent nasolabial fold;0.6838608980178833;0.76152825;0.6023866335395072;0.5766464445737886;0.9999501780647019;-0.3160892800468186;-0.23842192450940403;-0.3975635445251947;-0.4233037334909133
Asymmetry of the thorax;Abnormality of inferior alveolar nerve;0.7900950014591217;0.9285021;0.567315472091999;0.5227779286744341;0.9999056439461368;-0.2098106424870151;-0.07140356112142976;-0.43259017185413784;-0.4771277152717027
Asymmetry of the thorax;Unilateral conductive hearing impairment;0.8592669814825058;0.9899096;0.5449459171030204;0.5032119290259329;0.9999567459343585;-0.14068976445185266;-0.010047156643739563;-0.45501082883133803;-0.49674481690842553
Asymmetry of the thorax;Macular hypopigmented whorls, streaks, and patches;0.8803854808211327;1.0085558;0.5381658662007327;0.49727659277835057;0.9999567459343585;-0.1195712651132258;0.008599023985990661;-0.46179087973362576;-0.5026801531560079
Asymmetry of the thorax;Delayed ossification of pubic rami;0.640808641910553;0.9088209;0.6169474603618322;0.5290635685411484;0.8994299275196795;-0.25862128560912656;0.009390999623417384;-0.2824824671578473;-0.3703663589785311
Asymmetry of the thorax;Hyperphenylalaninemia;0.7062594592571259;0.9806809;0.5949001669154006;0.5061498544756048;0.9999521228478421;-0.2936926635907162;-0.019271239917086458;-0.4050519559324415;-0.4938022683722373
Asymmetry of the thorax;Ureteropelvic junction obstruction;0.7537340223789215;0.9991868;0.5792036745137756;0.5002588369247437;0.9999481150251853;-0.24621409264626382;-0.0007613011938559788;-0.4207444405114097;-0.4996892781004416
Asymmetry of the thorax;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8165100067853928;1.1153972;0.5587394912940835;0.46318592128286395;0.789736248610815;0.026773758174577722;0.32566096627871133;-0.23099675731673153;-0.3265503273279511
Asymmetry of the thorax;Difficulty walking;0.8892703801393509;0.9788761;0.5353187591891629;0.5067244407552411;0.9111657437054939;-0.021895363566142967;0.0677103701861077;-0.3758469845163309;-0.4044413029502527
Asymmetry of the thorax;Bilobate gallbladder;0.7815333008766174;0.89140105;0.5701055044982499;0.5346364344122451;0.9999548690865008;-0.21842156820988334;-0.10855381661152519;-0.42984936458825085;-0.4653184346742557
Asymmetry of the thorax;Histidinuria;0.8370528072118759;1.1273347;0.5521000190646216;0.45935774879883995;0.9999536937290383;-0.1629008865171624;0.12738102020681374;-0.4478536746644167;-0.5405959449301984
Asymmetry of the thorax;Widened interpedicular distance;0.6049524545669556;0.6831932;0.6292718854497242;0.602610672010931;0.7257018318265508;-0.12074937725959523;-0.04250862503944142;-0.09642994637682656;-0.1230911598156198
Type 2 muscle fiber predominance;Dependency on parenteral nutrition;0.8478893339633942;0.94526416;0.5486070144860407;0.5174316656982221;0.9999536937290383;-0.15206435976564414;-0.05468953309595115;-0.45134667924299765;-0.48252202803081623
Type 2 muscle fiber predominance;Limited shoulder flexion;0.7187309265136719;0.758137;0.5907553421244383;0.5777584609965978;0.8527273749847077;-0.13399644847103587;-0.09459038729855052;-0.2619720328602695;-0.27496891398810996
Type 2 muscle fiber predominance;Paroxysmal vertigo;0.8998402431607246;1.0093745;0.5319353892070773;0.4970159785643664;0.9999536937290383;-0.10011345056831367;0.00942080559194558;-0.468018304521961;-0.5029377151646719
Type 2 muscle fiber predominance;Long hallux;0.9974022284150124;0.93748087;0.500826897307592;0.519913442578706;0.920652924919851;0.0767493034951614;0.016827941989176143;-0.41982602761225896;-0.400739482341145
Type 2 muscle fiber predominance;Broad medial eyebrow;0.8849847540259361;0.9565252;0.5366916911868453;0.5138428135739306;0.9999556674707869;-0.11497091344485078;-0.04343046090492997;-0.46326397628394156;-0.4861128538968563
Type 2 muscle fiber predominance;Myxoid subcutaneous tumors;0.6365072131156921;0.8310231;0.6184158646258175;0.5540463250194207;0.9999556674707869;-0.36344845435509476;-0.16893257043251786;-0.38153980284496936;-0.44590934245136615
Type 2 muscle fiber predominance;Bulbous tips of toes;1.0065018823370337;1.0363936;0.49793037199107115;0.4884129992720023;0.9315598035443521;0.07494207879268167;0.10483383888118503;-0.43362943155328093;-0.44314680427234976
Type 2 muscle fiber predominance;Absent internal genitalia;0.9196988642215729;1.0289071;0.525588195742714;0.4907973219821856;0.9999003561294039;-0.08020149190783099;0.02900670449376508;-0.4743121603866899;-0.5091030341472182
Type 2 muscle fiber predominance;Hyperphalangy of the 2nd finger;0.6917276084423065;0.9503045;0.5997508199363984;0.5158250869892951;0.9344769737294281;-0.24274936528712154;0.015827534479800454;-0.3347261537930296;-0.418651886740133
Type 2 muscle fiber predominance;Renal interstitial hemosiderin;0.758703351020813;0.91681707;0.5775726792663548;0.5265085847673514;0.9999003561294039;-0.24119700510859088;-0.08308328707575396;-0.42232767686304906;-0.47339177136205246
Type 2 muscle fiber predominance;Abnormality of depressor anguli oris muscle;0.709200382232666;0.8643399;0.5939213001719561;0.5433155101195981;0.5538069875543539;0.15539339467831215;0.31053290054150184;0.04011431261760223;-0.010491477434755758
Type 2 muscle fiber predominance;Paroxysmal dyspnea;0.837545782327652;0.92018485;0.5519409811035709;0.525433005684623;0.9999003561294039;-0.1623545738017519;-0.07971550543665484;-0.44795937502583294;-0.47446735044478083
Type 2 muscle fiber predominance;Phenylpyruvic acidemia;0.7575284242630005;0.9238352;0.5779581155708371;0.5242675070950299;0.9999556674707869;-0.2424272432077864;-0.07612044951805863;-0.4219975518999498;-0.475688160375757
Type 2 muscle fiber predominance;Lateral ventricle dilatation;0.8760360106825829;1.0577676;0.5395607300951064;0.48160173564714326;0.9999414386047084;-0.12390542792212556;0.057826191018704676;-0.460380708509602;-0.5183397029575652
Type 2 muscle fiber predominance;Neonatal unconjugated hyperbilirubinemia;0.9352404102683067;1.0892979;0.5206280531432315;0.4715376715313041;0.9999556674707869;-0.06471525720248017;0.08934222319236007;-0.47932761432755544;-0.5284179959394828
Type 2 muscle fiber predominance;High maternal circulating alpha-fetoprotein concentration;0.8678328096866608;0.9915042;0.5421935775406391;0.5027043315056766;0.9999003561294039;-0.1320675464427431;-0.008396163777108945;-0.45770677858876474;-0.49719602462372725
Type 2 muscle fiber predominance;Prominent nasolabial fold;0.8759676888585091;1.0210321;0.5395826467500564;0.4933047689431592;0.9999487417813083;-0.12398105292279926;0.02108335317413601;-0.4603660950312519;-0.5066439728381491
Type 2 muscle fiber predominance;Abnormality of inferior alveolar nerve;0.8521221578121185;0.9420245;0.5472442465352962;0.5184645274498121;0.9999003561294039;-0.14777819831728534;-0.05787582714914874;-0.4526561095941076;-0.4814358286795918
Type 2 muscle fiber predominance;Unilateral conductive hearing impairment;0.9335158243775368;1.0717688;0.5211781917410709;0.4771356442462722;0.9999556674707869;-0.06643984309325013;0.07181309321036544;-0.47877747572971596;-0.5228200232245147
Type 2 muscle fiber predominance;Macular hypopigmented whorls, streaks, and patches;0.8476703763008118;1.0036159;0.5486775326503052;0.49884905162353355;0.9999556674707869;-0.15228529116997513;0.003660188699867395;-0.45127813482048174;-0.5011066158472534
Type 2 muscle fiber predominance;Delayed ossification of pubic rami;0.9284930899739265;0.9706765;0.5227807985333567;0.509335306912845;0.9315598035443521;-0.003066713570425539;0.03911667817943332;-0.4087790050109954;-0.4222244966315071
Type 2 muscle fiber predominance;Hyperphenylalaninemia;0.9082032516598701;1.0087094;0.529261006403076;0.4972276587563955;0.9999507979965523;-0.09174754633668214;0.00875863269802779;-0.47068979159347624;-0.5027231392401568
Type 2 muscle fiber predominance;Ureteropelvic junction obstruction;0.9196848049759865;1.0590217;0.5255926854409286;0.4812018904191202;0.9999465554694025;-0.080261750493416;0.05907515588008483;-0.47435387002847385;-0.5187446650502823
Type 2 muscle fiber predominance;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7278257608413696;0.9274147;0.5877427100164472;0.5231249573526615;0.8527273749847077;-0.12490161414333811;0.07468734030536184;-0.26498466496826056;-0.32960241763204623
Type 2 muscle fiber predominance;Difficulty walking;0.8976121544837952;0.89974755;0.5326482772617315;0.5319650434600568;0.8236523433548952;0.07395981112889993;0.07609520713262308;-0.29100406609316376;-0.29168729989483844
Type 2 muscle fiber predominance;Bilobate gallbladder;0.892607256770134;1.0530301;0.5342502240815926;0.4831120662058599;0.9999536937290383;-0.10734643695890433;0.05307643951833718;-0.4657034696474457;-0.5168416275231784
Type 2 muscle fiber predominance;Histidinuria;0.849359542131424;0.92073166;0.5481335769029986;0.5252583845564787;0.9999524555142131;-0.15059291338278913;-0.07922079181029462;-0.4518188786112145;-0.4746940709577344
Type 2 muscle fiber predominance;Widened interpedicular distance;0.7819194048643112;0.7920606;0.569979567129193;0.5666756842598388;0.8527273749847077;-0.07080797012039652;-0.060666761352505594;-0.2827478078555148;-0.2860516907248689
Dependency on parenteral nutrition;Limited shoulder flexion;0.9037036746740341;1.1291895;0.5306996438184661;0.45876244722047765;0.9999134918687169;-0.0962098171946828;0.12927599940325574;-0.4692138480502508;-0.5411510446482393
Dependency on parenteral nutrition;Paroxysmal vertigo;0.8013845086097717;1.0678124;0.563644491159994;0.47839805599647056;0.9999567459343585;-0.19857223732458673;0.06785569684518256;-0.4363122547743644;-0.5215586899378879
Dependency on parenteral nutrition;Long hallux;0.9696638025343418;0.95101815;0.5096577932691571;0.5155976516556802;0.9999503740898522;-0.0302865715555104;-0.048932219468727944;-0.49029258082069516;-0.48435272243417204
Dependency on parenteral nutrition;Broad medial eyebrow;0.9204138368368149;1.0618299;0.5253598821419061;0.4803063764504444;0.9999584729108851;-0.07954463607407025;0.061871451672549926;-0.47459859076897903;-0.5196520964604407
Dependency on parenteral nutrition;Myxoid subcutaneous tumors;0.8895878940820694;0.970318;0.5352170678149446;0.5094494569290191;0.9999584729108851;-0.11037057882881574;-0.02964045352077893;-0.46474140509594053;-0.490509015981866
Dependency on parenteral nutrition;Bulbous tips of toes;0.8978465646505356;0.9256344;0.5325732688900235;0.5236931927281132;0.9999567459343585;-0.10211018128382288;-0.07432236177908502;-0.4673834770443349;-0.47626355320624525
Dependency on parenteral nutrition;Absent internal genitalia;0.952442292124033;1.0487818;0.5151438007891053;0.48446613627090906;0.9999134918687169;-0.047471199744683945;0.04886826071764783;-0.48476969107961165;-0.5154473555978079
Dependency on parenteral nutrition;Hyperphalangy of the 2nd finger;0.8092796206474304;0.9177526;0.5610823760581928;0.5262097550012145;0.9999584729108851;-0.1906788522634547;-0.0822058493528407;-0.43887609685269235;-0.47374871790967066
Dependency on parenteral nutrition;Renal interstitial hemosiderin;0.7646434456110001;0.8752535;0.575625785332008;0.5398117552221664;0.9999134918687169;-0.23527004625771686;-0.12465999331448718;-0.4242877065367089;-0.4601017366465505
Dependency on parenteral nutrition;Abnormality of depressor anguli oris muscle;0.9289764016866684;1.205718;0.5226265634774033;0.43404702886415303;0.9999134918687169;-0.07093709018204852;0.20580454859759167;-0.4772869283913136;-0.5658664630045639
Dependency on parenteral nutrition;Paroxysmal dyspnea;0.736970067024231;0.9278182;0.5847217994260565;0.5229961764123912;0.9999134918687169;-0.26294342484448596;-0.07209531273816272;-0.4151916924426604;-0.47691731545632576
Dependency on parenteral nutrition;Phenylpyruvic acidemia;0.697202742099762;0.80041796;0.5979205035442343;0.5639584386587841;0.9999584729108851;-0.30275573081112317;-0.19954051322079114;-0.4020379693666508;-0.436000034252101
Dependency on parenteral nutrition;Lateral ventricle dilatation;0.8386617004871368;0.92766434;0.5515810246776565;0.5230452781732541;0.9999462364511621;-0.16128453596402526;-0.07228189690877318;-0.44836521177350563;-0.476900958277908
Dependency on parenteral nutrition;Neonatal unconjugated hyperbilirubinemia;0.6813920736312866;0.72885686;0.6032153280434316;0.587401675369755;0.9999584729108851;-0.3185663992795985;-0.271101611319546;-0.39674314486745355;-0.41255679754113017
Dependency on parenteral nutrition;High maternal circulating alpha-fetoprotein concentration;0.7774404585361481;0.92025465;0.571441176675296;0.5254107104155812;0.9999134918687169;-0.22247303333256885;-0.07965884413693591;-0.4284723151934209;-0.47450278145313574
Dependency on parenteral nutrition;Prominent nasolabial fold;0.8789349496364594;1.0257787;0.5386309646411034;0.49179349254963656;0.9999524555142131;-0.12101750587775373;0.025826195723274714;-0.4613214908731097;-0.5081589629645765
Dependency on parenteral nutrition;Abnormality of inferior alveolar nerve;0.8630645424127579;0.99071425;0.5437252941716422;0.5029557807537179;0.9999134918687169;-0.13684894945595905;-0.00919923987363025;-0.45618819769707475;-0.496957711114999
Dependency on parenteral nutrition;Unilateral conductive hearing impairment;0.9328192323446274;1.1193461;0.5214004207334852;0.46192016061398533;0.9999584729108851;-0.06713924056625775;0.11938766890430041;-0.4785580521773999;-0.5380383122968998
Dependency on parenteral nutrition;Macular hypopigmented whorls, streaks, and patches;0.9194906875491142;1.0905907;0.5256546756806082;0.47112450165848363;0.9999584729108851;-0.0804677853617709;0.09063224249744006;-0.47430379723027694;-0.5288339712524015
Dependency on parenteral nutrition;Delayed ossification of pubic rami;0.8071913123130798;0.94979167;0.5617596754099665;0.5159885301792457;0.9999567459343585;-0.19276543362127863;-0.050165076088777405;-0.43819707052439194;-0.48396821575511273
Dependency on parenteral nutrition;Hyperphenylalaninemia;0.73813796043396;0.8974236;0.5843365428601234;0.5327085961645297;0.9999542297279059;-0.26181626929394597;-0.10253060473553532;-0.41561768686778255;-0.46724563356337623
Dependency on parenteral nutrition;Ureteropelvic junction obstruction;0.7314739525318146;0.8594527;0.586536538336859;0.5448862093153645;0.9999505803237132;-0.2684766277918986;-0.1404978558669261;-0.41341404198685416;-0.45506437100834873
Dependency on parenteral nutrition;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8816810995340347;0.88231057;0.5377505081534617;0.5375487295261685;0.9999134918687169;-0.11823239233468219;-0.11760292258237048;-0.4621629837152552;-0.4623647623425484
Dependency on parenteral nutrition;Difficulty walking;0.7359625697135925;0.88971674;0.5850542477827696;0.5351757919213485;0.9999431787962207;-0.2639806090826282;-0.11022643437330815;-0.41488893101345115;-0.4647673868748723
Dependency on parenteral nutrition;Bilobate gallbladder;0.8680026680231094;0.84637934;0.542139032066756;0.5490933720676012;0.8526023716255289;0.01540029639758056;-0.00622303193055207;-0.3104633395587729;-0.30350899955792765
Dependency on parenteral nutrition;Histidinuria;0.751505970954895;0.7896336;0.5799356359263612;0.5674657088148076;0.9999556674707869;-0.24844969651589188;-0.21032209536919388;-0.4200200315444257;-0.4324899586559793
Dependency on parenteral nutrition;Widened interpedicular distance;0.8473301082849503;1.0256075;0.5487871251723379;0.4918480038337857;0.9999134918687169;-0.15258338358376666;0.025693974828975952;-0.45112636669637907;-0.5080654880349312
Limited shoulder flexion;Paroxysmal vertigo;0.8097879886627197;0.808124;0.5609175399611014;0.5614571457160152;0.9999134918687169;-0.1901255032059972;-0.19178948607419177;-0.43899595190761553;-0.4384563461527017
Limited shoulder flexion;Long hallux;0.8718653917312622;1.11058;0.5408989540667822;0.4647291614361302;0.7569149208434753;0.11495047088778687;0.35366504665530396;-0.2160159667766931;-0.29218575940734515
Limited shoulder flexion;Broad medial eyebrow;0.8290651142597198;0.9524869;0.5546787762581596;0.5151295954870809;0.9999201345566091;-0.17085502029688926;-0.04743326188357444;-0.44524135829844946;-0.4847905390695282
Limited shoulder flexion;Myxoid subcutaneous tumors;0.8385869264602661;1.0661578;0.551605142095488;0.4789259275178165;0.9999201345566091;-0.161333208096343;0.06623768328396706;-0.44831499246112105;-0.5209942070387926
Limited shoulder flexion;Bulbous tips of toes;0.8613298535346985;1.1543902;0.5442827814700463;0.4506587083568545;0.8193379704785829;0.041991883056115564;0.33505224539513534;-0.27505518900853665;-0.3686792621217284
Limited shoulder flexion;Absent internal genitalia;0.8081056326627731;0.9930565;0.5614630999679031;0.5022102088715579;1.0;-0.19189436733722687;-0.00694352388381958;-0.4385369000320969;-0.4977897911284421
Limited shoulder flexion;Hyperphalangy of the 2nd finger;0.5937902927398682;0.88186115;0.633149754776002;0.5376927866454062;0.8332104407109631;-0.2394201479710949;0.04865070955377693;-0.20006068593496107;-0.29551765406555686
Limited shoulder flexion;Renal interstitial hemosiderin;0.7754345387220383;0.9840905;0.5720962613720028;0.5050643566237508;1.0;-0.22456546127796173;-0.01590949296951294;-0.42790373862799724;-0.4949356433762492
Limited shoulder flexion;Abnormality of depressor anguli oris muscle;0.6408734917640686;0.6693928;0.6169253422098702;0.6072535050939851;1.0;-0.3591265082359314;-0.33060717582702637;-0.38307465779012984;-0.3927464949060149
Limited shoulder flexion;Paroxysmal dyspnea;0.7618338167667389;0.97757405;0.576546290287351;0.5071389975642089;1.0;-0.2381661832332611;-0.022425949573516846;-0.42345370971264895;-0.4928610024357911
Limited shoulder flexion;Phenylpyruvic acidemia;0.7731136977672577;1.0165848;0.5728545797420852;0.49472065732145043;0.9999201345566091;-0.22680643678935142;0.01666461943356423;-0.4270655548145239;-0.5051994772351587
Limited shoulder flexion;Lateral ventricle dilatation;0.8101702034473419;1.0445436;0.5607936193883529;0.48581662409210835;0.9998579617208769;-0.189687758273535;0.04468566220337844;-0.439064342332524;-0.5140413376287686
Limited shoulder flexion;Neonatal unconjugated hyperbilirubinemia;0.8642575293779373;1.0691833;0.5433419752648685;0.4779606482933997;0.9999201345566091;-0.1356626051786718;0.06926321505276589;-0.4565781592917406;-0.5219594862632094
Limited shoulder flexion;High maternal circulating alpha-fetoprotein concentration;0.8302052915096283;1.0263357;0.5543104621845738;0.491616122508547;1.0;-0.1697947084903717;0.026335716247558594;-0.4456895378154262;-0.508383877491453
Limited shoulder flexion;Prominent nasolabial fold;0.8492608219385147;1.046697;0.5481653634843768;0.4851304561969324;0.9998944404568447;-0.15063361851833001;0.04680258007385596;-0.4517290769724679;-0.5147639842599123
Limited shoulder flexion;Abnormality of inferior alveolar nerve;0.8605652898550034;1.1236534;0.5445285371658146;0.4605389106333755;1.0;-0.13943471014499664;0.12365341186523438;-0.4554714628341854;-0.5394610893666245
Limited shoulder flexion;Unilateral conductive hearing impairment;0.7627793848514557;0.9381365;0.576236425964572;0.5197043375747419;0.9999201345566091;-0.23714074970515342;-0.06178361655505271;-0.4236837085920371;-0.4802157969818672
Limited shoulder flexion;Macular hypopigmented whorls, streaks, and patches;0.8886826485395432;1.063044;0.5355070037393073;0.4799191674213136;0.9999201345566091;-0.11123748601706596;0.0631238174316111;-0.46441313081730184;-0.5200009671352955
Limited shoulder flexion;Delayed ossification of pubic rami;0.8423795253038406;1.0299668;0.5503822608612753;0.4904598414475423;0.8193379704785829;0.023041554825257715;0.21062886072869247;-0.26895570961730764;-0.32887812903104063
Limited shoulder flexion;Hyperphenylalaninemia;0.8584413826465607;0.98994035;0.5452113708889932;0.50320213681243;0.9999028053808913;-0.1414614227343306;-0.00996246009356827;-0.4546914344918981;-0.4967006685684613
Limited shoulder flexion;Ureteropelvic junction obstruction;0.7182937264442444;1.0265534;0.5909003715163941;0.491546806235316;0.9998847295244674;-0.281591003080223;0.026668662885810934;-0.4089843580080733;-0.5083379232891514
Limited shoulder flexion;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7321456670761108;1.1676002;0.5863145942484077;0.44639825295591695;1.0;-0.26785433292388916;0.16760015487670898;-0.4136854057515923;-0.553601747044083
Limited shoulder flexion;Difficulty walking;0.8069100081920624;1.0048356;0.5618509321235048;0.49846079189932657;0.7552776988623575;0.05163230932970486;0.24955790675898037;-0.19342676673885273;-0.25681690696303094
Limited shoulder flexion;Bilobate gallbladder;0.9245096743106842;1.0361099;0.524052198708324;0.4885033713253959;0.9999134918687169;-0.07540381755803272;0.03619643244768933;-0.47586129316039294;-0.511410120543321
Limited shoulder flexion;Histidinuria;0.8829594552516937;0.9691247;0.5373407476820733;0.5098294798318417;0.9999090677057578;-0.1169496124540641;-0.03078439290869972;-0.46256832002368453;-0.49007958787391614
Limited shoulder flexion;Widened interpedicular distance;0.6733600199222565;0.56366205;0.6059164573752405;0.6437247682076156;1.0;-0.32663998007774353;-0.436337947845459;-0.39408354262475953;-0.3562752317923844
Paroxysmal vertigo;Long hallux;0.9671831801533699;1.1348284;0.5104477940437584;0.4569516570637563;0.9999503740898522;-0.03276719393648231;0.13487807420574105;-0.4895025800460938;-0.5429987170260959
Paroxysmal vertigo;Broad medial eyebrow;1.0482788644731045;1.0585152;0.4846263839333155;0.48136340235266073;0.9999584729108851;0.048320391562219345;0.0585567181673009;-0.5153320889775697;-0.5185950705582244
Paroxysmal vertigo;Myxoid subcutaneous tumors;0.8296859562397003;1.0498422;0.5544782151123413;0.48412813702444357;0.9999584729108851;-0.17027251667118481;0.049883765515323364;-0.44548025779854383;-0.5158303358864416
Paroxysmal vertigo;Bulbous tips of toes;0.894744411110878;1.0725081;0.5335660684688058;0.4768996677560381;0.9999567459343585;-0.10521233482348047;0.07255135076058783;-0.4663906774655526;-0.5230570781783204
Paroxysmal vertigo;Absent internal genitalia;0.850792720913887;0.9605488;0.5476721668180276;0.5125609538388207;0.9999134918687169;-0.1491207709548299;-0.03936467375729724;-0.45224132505068937;-0.4873525380298962
Paroxysmal vertigo;Hyperphalangy of the 2nd finger;0.8075255453586578;0.9545382;0.5616512549232596;0.5144759213970717;0.9999584729108851;-0.1924329275522273;-0.04542024678326062;-0.4383072179876255;-0.4854825515138135
Paroxysmal vertigo;Renal interstitial hemosiderin;0.909278504550457;1.1274555;0.5289173085716663;0.45931901815253506;0.9999134918687169;-0.09063498731825992;0.12754198107745007;-0.4709961832970506;-0.5405944737161819
Paroxysmal vertigo;Abnormality of depressor anguli oris muscle;0.829171746969223;0.7499411;0.5546443273229624;0.5804499832371184;0.9999134918687169;-0.1707417448994939;-0.249972381257755;-0.4452691645457545;-0.41946350863159854
Paroxysmal vertigo;Paroxysmal dyspnea;0.33609676361083984;0.73242205;0.7311013311022702;0.5862232846173097;0.9999134918687169;-0.6638167282578771;-0.2674914380547826;-0.26881216076644676;-0.41369020725140726
Paroxysmal vertigo;Phenylpyruvic acidemia;0.6206269264221191;0.88269144;0.6238603044586317;0.5374266503973396;0.9999584729108851;-0.379331546488766;-0.11726702994442395;-0.3760981684522534;-0.4625318225135455
Paroxysmal vertigo;Lateral ventricle dilatation;0.6733717620372772;0.9074415;0.6059125028411743;0.5295045100786937;0.9999462364511621;-0.3265744744138849;-0.09250473960210204;-0.39403373360998784;-0.4704417263724684
Paroxysmal vertigo;Neonatal unconjugated hyperbilirubinemia;0.8039639294147491;1.0134313;0.5628069683532775;0.49572454062038673;0.9999584729108851;-0.195994543496136;0.013472837742801391;-0.43715150455760765;-0.5042339322904984
Paroxysmal vertigo;High maternal circulating alpha-fetoprotein concentration;0.8863939493894577;1.0700295;0.5362401706392483;0.47769063965970393;0.9999134918687169;-0.11351954247925922;0.07011600527788953;-0.4636733212294686;-0.522222852209013
Paroxysmal vertigo;Prominent nasolabial fold;0.8281561136245728;0.94685686;0.5549724657734469;0.5169239569196074;0.9999524555142131;-0.17179634188964032;-0.05309559916808271;-0.44497998974076614;-0.4830284985946057
Paroxysmal vertigo;Abnormality of inferior alveolar nerve;0.7013894617557526;0.914574;0.5965231551929879;0.5272251086704469;0.9999134918687169;-0.29852403011296436;-0.08533946480725452;-0.403390336675729;-0.47268838319827
Paroxysmal vertigo;Unilateral conductive hearing impairment;0.5536277294158936;0.7287353;0.6472842762011739;0.5874418671117572;0.7730659511922591;-0.21943822177636552;-0.04433062347161698;-0.12578167499108517;-0.1856240840805019
Paroxysmal vertigo;Macular hypopigmented whorls, streaks, and patches;0.8360588848590851;1.0346658;0.5524207068103941;0.488963315765664;0.9999584729108851;-0.16389958805180005;0.034707350071902954;-0.447537766100491;-0.5109951571452211
Paroxysmal vertigo;Delayed ossification of pubic rami;0.8328396677970886;1.0787437;0.5534597534374509;0.4749091277041294;0.9999567459343585;-0.16711707813726984;0.0787869502784101;-0.44649699249690755;-0.525047618230229
Paroxysmal vertigo;Hyperphenylalaninemia;0.762920156121254;0.8992686;0.5761903012782306;0.5321182651164237;0.9999542297279059;-0.23703407360665196;-0.10068560256115788;-0.42376392844967536;-0.46783596461148225
Paroxysmal vertigo;Ureteropelvic junction obstruction;0.7064035534858704;0.97117835;0.5948521846305485;0.5091754906003592;0.9999505803237132;-0.29354702683784284;-0.02877222749091901;-0.40509839569316475;-0.49077508972335404
Paroxysmal vertigo;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.873178094625473;1.1325203;0.5404776706282697;0.4576930161360332;0.9999134918687169;-0.1267353972432439;0.13260682616259412;-0.45943582124044724;-0.5422204757326837
Paroxysmal vertigo;Difficulty walking;0.8107096254825592;0.89762497;0.5606187454004876;0.5326441718044949;0.9999431787962207;-0.18923355331366154;-0.10231820931379887;-0.4393244333957331;-0.4672990069917259
Paroxysmal vertigo;Bilobate gallbladder;0.8300050050020218;0.97830963;0.5543751558641807;0.5069047949311647;0.9999567459343585;-0.16995174093233667;-0.02164711458670221;-0.4455815900701777;-0.49305195100319377
Paroxysmal vertigo;Histidinuria;0.8593713641166687;0.98970014;0.5449123573266593;0.5032786128064027;0.9999556674707869;-0.1405843033541182;-0.010255528901908728;-0.4550433101441276;-0.49667705466438417
Paroxysmal vertigo;Widened interpedicular distance;0.8791732862591743;0.92222494;0.5385545387026767;0.5247815976251172;0.9999134918687169;-0.12074020560954257;-0.0776885529992406;-0.46135895316604025;-0.4751318942435997
Long hallux;Broad medial eyebrow;0.717082679271698;0.93987525;0.5913022053503596;0.5191498534728791;0.9999526340597648;-0.28286995478806676;-0.06007738896546544;-0.40865042870940516;-0.48080278058688564
Long hallux;Myxoid subcutaneous tumors;1.0156484320759773;0.94221395;0.49501874605671403;0.5184041296149096;0.9999526340597648;0.01569579801621257;-0.05773868151841344;-0.5049338880030507;-0.4815485044448552
Long hallux;Bulbous tips of toes;0.6024332940578461;0.2989871;0.6301452743681222;0.7472684803353895;0.6346804177612032;-0.03224712370335714;-0.33569332717358724;-0.004535143393081031;0.1125880625741863
Long hallux;Absent internal genitalia;0.8611479252576828;0.9258343;0.5443412567358565;0.5236293628929531;0.9998836012415208;-0.13873567598383796;-0.07404930310767066;-0.4555423445056642;-0.4762542383485676
Long hallux;Hyperphalangy of the 2nd finger;0.7676524817943573;0.5713327;0.5746406636587147;0.6410167432440189;0.7773371784594012;-0.009684696665043901;-0.20600448535942562;-0.2026965148006865;-0.13632043521538229
Long hallux;Renal interstitial hemosiderin;0.9451067857444286;1.0767205;0.5174818398584959;0.47555507424397825;0.9998836012415208;-0.054776815497092124;0.07683687490899194;-0.4824017613830248;-0.5243285269975425
Long hallux;Abnormality of depressor anguli oris muscle;0.8282501995563507;1.1451359;0.5549420653092427;0.453638058480208;0.8279638214854832;0.0002863780708675101;0.31717205803111836;-0.27302175617624047;-0.3743257630052752
Long hallux;Paroxysmal dyspnea;0.93447445333004;1.0385828;0.5208723837814375;0.4877156636473169;0.9998836012415208;-0.06540914791148078;0.0386992005773269;-0.47901121746008324;-0.5121679375942039
Long hallux;Phenylpyruvic acidemia;0.9834308996796608;1.068897;0.5052743497882546;0.47805200424523875;0.9999526340597648;-0.01652173438010396;0.06894437483610927;-0.49467828427151017;-0.521900629814526
Long hallux;Lateral ventricle dilatation;0.7120530605316162;1.0919678;0.5929726785252389;0.4706842938228727;0.9999360266643673;-0.2878829661327511;0.0920317944568485;-0.4069633481391284;-0.5292517328414946
Long hallux;Neonatal unconjugated hyperbilirubinemia;0.8964208886027336;1.0938094;0.5330294959062458;0.47009557112782474;0.9999526340597648;-0.10353174545703114;0.09385673216643153;-0.46692313815351894;-0.52985706293194
Long hallux;High maternal circulating alpha-fetoprotein concentration;0.8703925460577011;1.0665346;0.541371717655087;0.4788057003037548;0.9998836012415208;-0.12949105518381965;0.06665103716332543;-0.4585118835864338;-0.521077900937766
Long hallux;Prominent nasolabial fold;0.6607517898082733;1.0144446;0.6101726533363292;0.49540199805929563;0.9999446427564167;-0.3391928529481434;0.014499946858451462;-0.3897719894200875;-0.5045426446971211
Long hallux;Abnormality of inferior alveolar nerve;0.8648707568645477;1.0036936;0.543144963648027;0.4988242800161572;0.9998836012415208;-0.13501284437697303;0.0038099793859206477;-0.45673863759349376;-0.5010593212253636
Long hallux;Unilateral conductive hearing impairment;0.7954434901475906;0.96356934;0.5655752155287745;0.5115987989287649;0.9999526340597648;-0.20450914391217412;-0.03638329096970738;-0.4343774185309902;-0.48835383513099984
Long hallux;Macular hypopigmented whorls, streaks, and patches;0.9084873497486115;0.99142927;0.5291701929248789;0.502728179635574;0.9999526340597648;-0.0914652843111533;-0.0085233647459525;-0.4707824411348859;-0.4972244544241907
Long hallux;Delayed ossification of pubic rami;0.7398197054862976;0.8654299;0.5837820024934175;0.5429653396260317;0.803475731189364;-0.06365602570306639;0.061954147045499286;-0.2196937286959465;-0.26051039156333233
Long hallux;Hyperphenylalaninemia;0.7309150695800781;0.9500733;0.5867212341332536;0.5158987784974515;0.9999470333157194;-0.2690319637356413;-0.04987373152357466;-0.4132257991824658;-0.48404825481826796
Long hallux;Ureteropelvic junction obstruction;0.951876774430275;0.9609296;0.5153240170137581;0.5124396671567208;0.999942084065247;-0.04806530963497202;-0.03901251148300211;-0.4846180670514889;-0.48750241690852614
Long hallux;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.6753571629524231;0.31212038;0.6052440988319188;0.7414583114519997;0.1431341874814257;0.5322229754709974;0.16898619053599984;0.46210991135049306;0.598324123970574
Long hallux;Difficulty walking;0.7408924698829651;0.69675195;0.5834284040992264;0.5980710737425967;0.8989796451888926;-0.15808717530592753;-0.20222769301756693;-0.31555124108966626;-0.3009085714462959
Long hallux;Bilobate gallbladder;0.8813265636563301;1.1291158;0.537864161170209;0.4587861051648414;0.9999503740898522;-0.1186238104335221;0.12916544584117806;-0.46208621291964325;-0.5411642689250108
Long hallux;Histidinuria;0.8491484373807907;0.97351867;0.5482015503975817;0.5084302488300069;0.9999489492479948;-0.1508005118672041;-0.026430279642739696;-0.45174739885041315;-0.49151870041798795
Long hallux;Widened interpedicular distance;0.6230619549751282;0.84726596;0.6230230366869316;0.548807777307986;0.7406161172192745;-0.11755416224414628;0.10664984156673629;-0.11759308053234285;-0.19180833991128843
Broad medial eyebrow;Myxoid subcutaneous tumors;0.927467368543148;0.88363683;0.5231081458739123;0.5371236556094745;0.8733283781844945;0.05413899035865355;0.01030845405274916;-0.3502202323105822;-0.33620472257502
Broad medial eyebrow;Bulbous tips of toes;0.8172822296619415;0.8772086;0.5584894579399038;0.5391846174834718;0.9999584729108851;-0.1826762432489436;-0.12274988240337781;-0.44146901497098134;-0.46077385542741334
Broad medial eyebrow;Absent internal genitalia;0.9016439765691757;0.8329018;0.5313583935972361;0.5534397018079793;0.9999201345566091;-0.09827615798743339;-0.16701835871966453;-0.468561740959373;-0.4464804327486298
Broad medial eyebrow;Hyperphalangy of the 2nd finger;0.7858513295650482;0.87425315;0.5686977026294393;0.5401326973328835;0.9999600672783046;-0.21410873771325634;-0.1257069134773402;-0.43126236464886525;-0.45982736994542106
Broad medial eyebrow;Renal interstitial hemosiderin;0.933343730866909;0.9086397;0.5212330925911478;0.5291214850538208;0.9999201345566091;-0.06657640368970008;-0.09128040553362937;-0.4786870419654613;-0.47079864950278827
Broad medial eyebrow;Abnormality of depressor anguli oris muscle;0.8375781178474426;0.79477555;0.5519305498477685;0.5657924372670998;0.7870101688836642;0.050567948963778475;0.007765376713412264;-0.2350796190358957;-0.22121773161656433
Broad medial eyebrow;Paroxysmal dyspnea;1.0234067849814892;1.0333638;0.49254870843169496;0.4893780047647406;0.9999201345566091;0.023486650424880073;0.033443684565705345;-0.5073714261249141;-0.5105421297918685
Broad medial eyebrow;Phenylpyruvic acidemia;1.000134363770485;1.0986458;0.49995723068338105;0.4685489053509193;0.9999600672783046;0.00017429649218037024;0.09868573903425648;-0.5000028365949235;-0.5314111619273852
Broad medial eyebrow;Lateral ventricle dilatation;0.807890996336937;0.92182714;0.5615327160681838;0.5249086013051277;0.9999488789551968;-0.19205788261825985;-0.07812174148495143;-0.438416162887013;-0.47504027765006906
Broad medial eyebrow;Neonatal unconjugated hyperbilirubinemia;0.956121139228344;1.1184247;0.5139715609940692;0.4622156030465445;0.9999600672783046;-0.04383892804996059;0.11846458672865345;-0.4859885062842354;-0.53774446423176
Broad medial eyebrow;High maternal circulating alpha-fetoprotein concentration;0.7741082012653351;0.8434347;0.5725295814878792;0.5500421731916678;0.9999201345566091;-0.22581193329127403;-0.15648544312747092;-0.42739055306872986;-0.4498779613649413
Broad medial eyebrow;Prominent nasolabial fold;0.6600697636604309;0.6372964;0.6104034652742487;0.618146265533414;0.8787482221886792;-0.2186784585282483;-0.2414518435761609;-0.2683447569144305;-0.2606019566552652
Broad medial eyebrow;Abnormality of inferior alveolar nerve;0.9102771133184433;0.79030555;0.5285981398366657;0.567246930160664;0.9999201345566091;-0.08964302123816581;-0.20961457968981834;-0.4713219947199434;-0.43267320439594514
Broad medial eyebrow;Unilateral conductive hearing impairment;0.8577631562948227;1.0028899;0.5454294638585708;0.4990801210559047;0.9999600672783046;-0.14219691098348186;0.002929804318985485;-0.4545306034197337;-0.5008799462223998
Broad medial eyebrow;Macular hypopigmented whorls, streaks, and patches;0.7962120920419693;0.55092824;0.5653252974118106;0.648245249645703;0.8733283781844945;-0.07711628614252519;-0.3224001431304784;-0.3080030807726839;-0.22508312853879153
Broad medial eyebrow;Delayed ossification of pubic rami;0.9784244708716869;0.95916635;0.5068682371561762;0.5130013698879812;0.9999584729108851;-0.021534002039198197;-0.040792124930385865;-0.4930902357547089;-0.48695710302290396
Broad medial eyebrow;Hyperphenylalaninemia;0.764910414814949;0.9070815;0.5755383531717668;0.5296195990797521;0.9999561589935034;-0.2350457441785544;-0.09287467419888673;-0.4244178058217366;-0.47033655991375134
Broad medial eyebrow;Ureteropelvic junction obstruction;1.063307374715805;1.0945784;0.4798351519067138;0.4698497177231158;0.9999528219730685;0.0633545527427366;0.09462556338001993;-0.5201176700663547;-0.5301031042499527
Broad medial eyebrow;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8409796953201294;0.9341969;0.5508335321510796;0.5209609190893536;0.9999201345566091;-0.1589404392364797;-0.06572324515612693;-0.44908660240552956;-0.4789592154672555
Broad medial eyebrow;Difficulty walking;0.8638031482696533;0.89590436;0.5434879650721989;0.5331948002120758;0.9999461221900431;-0.13614297392038976;-0.10404175998835241;-0.4564581571178442;-0.4667513219779673
Broad medial eyebrow;Bilobate gallbladder;0.9650773219764233;1.1597117;0.5111184944555074;0.4489435347898889;0.9999584729108851;-0.03488115093446187;0.15975324564838;-0.48883997845537774;-0.5510149381209962
Broad medial eyebrow;Histidinuria;0.8819838687777519;1.0058426;0.5376534537146045;0.4981402294042986;0.9999574798349273;-0.11797361105717541;0.005885086655246008;-0.46230402612032284;-0.5018172504306287
Broad medial eyebrow;Widened interpedicular distance;0.6407103538513184;0.90122354;0.6169809843136361;0.5314928870206904;0.9999201345566091;-0.35920978070529075;-0.0986965942505178;-0.382939150242973;-0.4684272475359187
Myxoid subcutaneous tumors;Bulbous tips of toes;0.9216179624199867;0.9123746;0.524975395857958;0.5279278363282272;0.9999584729108851;-0.07834051049089841;-0.08758385724163464;-0.4749830770529271;-0.472030636582658
Myxoid subcutaneous tumors;Absent internal genitalia;0.9329982399940491;0.8549173;0.521343312154288;0.5463448319920605;0.9999201345566091;-0.06692189456256004;-0.14500284673007102;-0.47857682240232113;-0.4535753025645486
Myxoid subcutaneous tumors;Hyperphalangy of the 2nd finger;0.9096996933221817;0.968594;0.5287826874635745;0.5099984773540415;0.9999600672783046;-0.09026037395612285;-0.03136605263368175;-0.47117737981473007;-0.4899615899242631
Myxoid subcutaneous tumors;Renal interstitial hemosiderin;0.7394353747367859;0.7921756;0.5839087091041915;0.5666382587427847;0.9999201345566091;-0.2604847598198232;-0.20774454356463523;-0.41601142545241765;-0.4332818758138244
Myxoid subcutaneous tumors;Abnormality of depressor anguli oris muscle;0.7790374904870987;0.99194354;0.5709198449354911;0.5025644845208206;0.9999201345566091;-0.22088264406951041;-0.007976596367674782;-0.429000289621118;-0.4973556500357885
Myxoid subcutaneous tumors;Paroxysmal dyspnea;0.7817244380712509;0.9523725;0.5700431589799331;0.5151660418938168;0.9999201345566091;-0.2181956964853582;-0.047547643196898415;-0.42987697557667603;-0.48475409266279235
Myxoid subcutaneous tumors;Phenylpyruvic acidemia;0.8922270834445953;1.1154797;0.5343719434543783;0.46315946717190193;0.9999600672783046;-0.10773298383370922;0.11551964043959095;-0.4655881238239262;-0.5368006001064026
Myxoid subcutaneous tumors;Lateral ventricle dilatation;0.914079375565052;1.0934023;0.5273831469385655;0.47022573837417225;0.9999488789551968;-0.08586950339014476;0.09345338754718358;-0.4725657320166313;-0.5297231405810245
Myxoid subcutaneous tumors;Neonatal unconjugated hyperbilirubinemia;0.9208290427923203;1.1253073;0.5252272996221374;0.4600083135923664;0.9999600672783046;-0.0791310244859843;0.12534725427015736;-0.4747327676561671;-0.5399517536859382
Myxoid subcutaneous tumors;High maternal circulating alpha-fetoprotein concentration;0.9117940738797188;0.92614746;0.5281133539751974;0.5235294059509115;0.9999201345566091;-0.08812606067689033;-0.07377267361910911;-0.4718067805814117;-0.47639072860569764
Myxoid subcutaneous tumors;Prominent nasolabial fold;0.8575637936592102;0.8343545;0.5454935757227937;0.5529707479554582;0.9999545338528789;-0.1423907401936687;-0.16560001400882374;-0.45446095813008525;-0.4469837858974207
Myxoid subcutaneous tumors;Abnormality of inferior alveolar nerve;0.7824518531560898;0.84250075;0.5698059142021814;0.550343186980881;0.9999201345566091;-0.21746828140051933;-0.15741938830645652;-0.4301142203544277;-0.4495769475757281
Myxoid subcutaneous tumors;Unilateral conductive hearing impairment;0.8491535186767578;1.026775;0.548199914248076;0.49147622326920193;0.9999600672783046;-0.15080654860154674;0.02681493520124867;-0.45176015303022854;-0.5084838440091026
Myxoid subcutaneous tumors;Macular hypopigmented whorls, streaks, and patches;0.7121778130531311;0.8209747;0.5929312131317384;0.5572943944420462;0.8434590184411804;-0.13128120538804933;-0.02248431083772584;-0.2505278053094421;-0.2861646239991342
Myxoid subcutaneous tumors;Delayed ossification of pubic rami;0.8735999315977097;0.9276544;0.5403423063978297;0.5230484692122553;0.9999584729108851;-0.12635854131317548;-0.0723040873441737;-0.4596161665130555;-0.4769100036986298
Myxoid subcutaneous tumors;Hyperphenylalaninemia;0.9763792064040899;1.0762175;0.5075194314659548;0.47571566020925415;0.9999561589935034;-0.023576952589413502;0.07626137316439452;-0.49243672752754863;-0.5242404987842493
Myxoid subcutaneous tumors;Ureteropelvic junction obstruction;0.8849959373474121;1.0598855;0.5366881076460223;0.4809264251701706;0.9999528219730685;-0.11495688462565634;0.059932679888503815;-0.4632647143270462;-0.5190263968028979
Myxoid subcutaneous tumors;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8513370156288147;0.9005393;0.547496958320995;0.5317117625069518;0.9999201345566091;-0.1485831189277944;-0.09938085557253928;-0.4524231762356141;-0.46820837204965726
Myxoid subcutaneous tumors;Difficulty walking;0.9092012569308281;1.0386245;0.528941999156074;0.48770238349709516;0.9999461221900431;-0.09074486525921499;0.038678402880147345;-0.4710041230339691;-0.5122437386929479
Myxoid subcutaneous tumors;Bilobate gallbladder;0.98167909309268;1.0470648;0.5058320520836723;0.4850132595543942;0.9999584729108851;-0.018279379818205155;0.04710630827807971;-0.4941264208272128;-0.5149452133564909
Myxoid subcutaneous tumors;Histidinuria;0.7980106472969055;0.9246652;0.5647406395835435;0.5240025503169177;0.9999574798349273;-0.20194683253802181;-0.07529226720370175;-0.43521684025138385;-0.47595492951800966
Myxoid subcutaneous tumors;Widened interpedicular distance;0.9373721778392792;1.092972;0.5199481096907941;0.470363298848128;0.9999201345566091;-0.06254795671732993;0.0930519056197825;-0.47997202486581503;-0.5295568357084811
Bulbous tips of toes;Absent internal genitalia;0.8315433859825134;0.88089347;0.5538783080515484;0.5380030090588663;0.9999134918687169;-0.1683701058862035;-0.1190200230119054;-0.44603518381716856;-0.4619104828098506
Bulbous tips of toes;Hyperphalangy of the 2nd finger;0.6145636439323425;0.43069392;0.625949069163745;0.6927880580977981;0.8047850673551408;-0.19022142342279824;-0.3740911429281083;-0.17883599819139573;-0.11199700925734268
Bulbous tips of toes;Renal interstitial hemosiderin;0.9113124385476112;1.0650163;0.5282672664618031;0.47929005628083854;0.9999134918687169;-0.08860105332110568;0.06510277781512097;-0.4716462254069138;-0.5206234355878784
Bulbous tips of toes;Abnormality of depressor anguli oris muscle;0.9443956390023232;1.169456;0.5177085511763585;0.4457989261568047;0.872141863789474;0.07225377521284915;0.29731414130696154;-0.3544333126131155;-0.4263429376326693
Bulbous tips of toes;Paroxysmal dyspnea;0.8947633728384972;1.0138074;0.5335599990551727;0.49560481503477893;0.9999134918687169;-0.10515011903021976;0.013893924093502319;-0.4663534928135442;-0.504308676833938
Bulbous tips of toes;Phenylpyruvic acidemia;0.9122636020183563;0.98952746;0.5279633168346954;0.5033335685556797;0.9999584729108851;-0.08769487089252881;-0.010431008997921265;-0.4719951560761897;-0.49662490435520545
Bulbous tips of toes;Lateral ventricle dilatation;0.8077932298183441;1.0872729;0.5615644270833392;0.4721848095361032;0.9999462364511621;-0.19215300663281798;0.08732664601038576;-0.4383818093678229;-0.5277614269150589
Bulbous tips of toes;Neonatal unconjugated hyperbilirubinemia;0.7923634052276611;1.0155122;0.5665771472783662;0.4950621182793289;0.9999584729108851;-0.207595067683224;0.015553755101199829;-0.43338132563251897;-0.5048963546315562
Bulbous tips of toes;High maternal circulating alpha-fetoprotein concentration;0.9469368867576122;1.0347345;0.5168984500164413;0.4889414376840565;0.9999134918687169;-0.05297660511110469;0.03482099566485242;-0.4830150418522756;-0.5109720541846604
Bulbous tips of toes;Prominent nasolabial fold;0.8127118051052094;0.99949044;0.559969824865141;0.5001621925427486;0.9999524555142131;-0.18724065040900373;-0.0004620156223978933;-0.43998263064907206;-0.49979026297146445
Bulbous tips of toes;Abnormality of inferior alveolar nerve;0.9285938441753387;0.9663596;0.5227486452820738;0.5107100841627481;0.9999134918687169;-0.07131964769337817;-0.033553876542789185;-0.47716484658664315;-0.4892034077059688
Bulbous tips of toes;Unilateral conductive hearing impairment;0.8735067844390869;0.9564509;0.5403721959706381;0.513866505701144;0.9999584729108851;-0.12645168847179822;-0.04350759333706311;-0.459586276940247;-0.4860919672097411
Bulbous tips of toes;Macular hypopigmented whorls, streaks, and patches;0.8395485579967499;0.923983;0.551295002731844;0.5242203297661769;0.9999584729108851;-0.16040991491413525;-0.07597549504375867;-0.4486634701790412;-0.4757381431447082
Bulbous tips of toes;Delayed ossification of pubic rami;0.6910547018051147;0.81205493;0.5999760042404916;0.5601826892672295;0.8287089627579918;-0.13765426095287703;-0.016654030640529616;-0.2287329585175002;-0.2685262734907623
Bulbous tips of toes;Hyperphenylalaninemia;0.7539108246564865;0.9252882;0.5791456096393526;0.5238036938482662;0.9999542297279059;-0.24604340507141942;-0.07466602934948796;-0.42080862008855335;-0.47615053587963974
Bulbous tips of toes;Ureteropelvic junction obstruction;0.8287502229213715;0.8716897;0.5547805093390181;0.5409553416961737;0.9999505803237132;-0.17120035740234174;-0.12826090308524885;-0.4451700709846951;-0.45899523862753955
Bulbous tips of toes;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.5953764319419861;0.2978912;0.63259744517675;0.7477579953506941;0.36317310279071235;0.23220332915127373;-0.06528190320193672;0.26942434238603763;0.38458489255998174
Bulbous tips of toes;Difficulty walking;0.8414451628923416;0.78128755;0.5506834652869632;0.5701856580120248;0.9160188400246831;-0.07457367713234153;-0.13473128909847465;-0.36533537473771993;-0.34583318201265834
Bulbous tips of toes;Bilobate gallbladder;0.9078104794025421;1.1431286;0.529386562097617;0.4542837314306366;0.9999567459343585;-0.09214626653181635;0.14317188756478705;-0.47057018383674143;-0.5456730145037219
Bulbous tips of toes;Histidinuria;0.8709852397441864;0.96329427;0.5411814600028884;0.5116864203217024;0.9999556674707869;-0.1289704277266005;-0.03666139981636796;-0.45877420746789854;-0.4882692471490845
Bulbous tips of toes;Widened interpedicular distance;0.7224552035331726;0.8998572;0.5895206944104194;0.5319299618009707;0.8072246192530101;-0.08476941571983754;0.09263260378089488;-0.2177039248425907;-0.2752946574520394
Absent internal genitalia;Hyperphalangy of the 2nd finger;0.9171307757496834;0.98638105;0.5264083781049349;0.5043351720785462;0.9999201345566091;-0.08278935880692573;-0.013539080632048561;-0.4735117564516742;-0.49558496247806294
Absent internal genitalia;Renal interstitial hemosiderin;0.8635439872741699;0.92727;0.543571235999194;0.5231711333721192;1.0;-0.13645601272583008;-0.07273000478744507;-0.456428764000806;-0.4768288666278808
Absent internal genitalia;Abnormality of depressor anguli oris muscle;0.7856868505477905;0.81375754;0.5687513023490449;0.5596310004526291;1.0;-0.21431314945220947;-0.1862424612045288;-0.4312486976509551;-0.44036899954737085
Absent internal genitalia;Paroxysmal dyspnea;0.8958951383829117;0.98214316;0.5331977570530473;0.505684304909066;1.0;-0.10410486161708832;-0.017856836318969727;-0.4668022429469527;-0.494315695090934
Absent internal genitalia;Phenylpyruvic acidemia;0.9323497787117958;1.1017509;0.521550193201523;0.4675555537908338;0.9999201345566091;-0.0675703558448133;0.10183071612088113;-0.47836994135508615;-0.5323645807657753
Absent internal genitalia;Lateral ventricle dilatation;0.9029944837093353;0.9604721;0.5309264481391699;0.5125854003201227;0.9998579617208769;-0.0968634780115416;-0.03938585478728318;-0.46893151358170704;-0.48727256140075426
Absent internal genitalia;Neonatal unconjugated hyperbilirubinemia;0.8022206425666809;1.1044328;0.5633729547392732;0.4666972660739399;0.9999201345566091;-0.1976994919899282;0.1045126867171946;-0.43654717981733593;-0.5332228684826692
Absent internal genitalia;High maternal circulating alpha-fetoprotein concentration;0.9385357685387135;0.96242994;0.5195770122490142;0.5119617316963647;1.0;-0.061464231461286545;-0.037570059299468994;-0.4804229877509858;-0.4880382683036353
Absent internal genitalia;Prominent nasolabial fold;0.7201015949249268;0.6188891;0.5903007850080091;0.6244583986398782;0.9998944404568447;-0.27979284553191797;-0.3810053470577969;-0.40959365544883564;-0.37543604181696655
Absent internal genitalia;Abnormality of inferior alveolar nerve;0.7552976906299591;0.76460874;0.5786902323680043;0.5756371515494312;1.0;-0.2447023093700409;-0.2353912591934204;-0.4213097676319957;-0.4243628484505688
Absent internal genitalia;Unilateral conductive hearing impairment;0.7663471698760986;0.97145134;0.5750679168027725;0.5090885519323822;0.9999201345566091;-0.23357296468051048;-0.02846879245074363;-0.42485221775383664;-0.4908315826242269
Absent internal genitalia;Macular hypopigmented whorls, streaks, and patches;0.8678824156522751;0.86055857;0.5421776477792257;0.5445306974473535;0.9999201345566091;-0.13203771890433402;-0.13936156512530418;-0.4577424867773834;-0.4553894371092556
Absent internal genitalia;Delayed ossification of pubic rami;0.7533815205097198;0.7716929;0.579319450156542;0.5733190319881002;0.9999134918687169;-0.24653197135899707;-0.2282206198212926;-0.42059404171217496;-0.4265944598806167
Absent internal genitalia;Hyperphenylalaninemia;0.8700531274080276;1.0326467;0.54148067943701;0.4896063950721933;0.9999028053808913;-0.12984967797286362;0.032743850655485685;-0.4584221259438813;-0.510296410308698
Absent internal genitalia;Ureteropelvic junction obstruction;0.7372106611728668;1.0093554;0.5846424235220931;0.4970220367690792;0.5918707055256804;0.14533995564718638;0.4174847203089753;-0.007228282003587383;-0.09484866875660125
Absent internal genitalia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8288811147212982;0.946017;0.5547382209671989;0.5171916660613535;1.0;-0.17111888527870178;-0.05398297309875488;-0.44526177903280106;-0.48280833393864653
Absent internal genitalia;Difficulty walking;0.910639613866806;0.9722889;0.5284822869559517;0.5088218520067159;0.9998344221996177;-0.08919480833281168;-0.027545515625368444;-0.47135213524366604;-0.4910125701929018
Absent internal genitalia;Bilobate gallbladder;0.9271467626094818;0.9791343;0.5232104686208492;0.5066422398084676;0.9999134918687169;-0.07276672925923511;-0.020779170655948365;-0.47670302324786773;-0.49327125206024935
Absent internal genitalia;Histidinuria;0.8493106961250305;0.9604757;0.5481493046030914;0.5125842634384243;0.6780430294702215;0.17126766665480897;0.2824326537420587;-0.12989372486713013;-0.1654587660317972
Absent internal genitalia;Widened interpedicular distance;0.862864226102829;0.95021504;0.5437896640916093;0.515853602752331;1.0;-0.13713577389717102;-0.049784958362579346;-0.45621033590839066;-0.48414639724766895
Hyperphalangy of the 2nd finger;Renal interstitial hemosiderin;0.8295622766017914;1.0388672;0.5545181677049209;0.48762505535859446;0.9999201345566091;-0.17035785795481773;0.03894710062710671;-0.4454019668516882;-0.5122950791980146
Hyperphalangy of the 2nd finger;Abnormality of depressor anguli oris muscle;0.7455316483974457;0.99983025;0.581900470994389;0.5000540342374687;0.8819596887815145;-0.13642804038406886;0.11787055719016515;-0.3000592177871255;-0.3819056545440458
Hyperphalangy of the 2nd finger;Paroxysmal dyspnea;0.6948392391204834;0.9246861;0.5987101995800674;0.5239958838014438;0.9999201345566091;-0.3050808954361257;-0.07523406029971214;-0.40120993497654167;-0.4759242507551653
Hyperphalangy of the 2nd finger;Phenylpyruvic acidemia;0.678785502910614;0.88374364;0.6040910468108054;0.5370894217281528;0.9999600672783046;-0.32117456436769054;-0.1162164235176234;-0.39586902046749917;-0.4628706455501518
Hyperphalangy of the 2nd finger;Lateral ventricle dilatation;0.8398981690406799;1.0770187;0.5511822605640959;0.4754598528683668;0.9999488789551968;-0.16005070991451686;0.07706985883777195;-0.4487666183911009;-0.52448902608683
Hyperphalangy of the 2nd finger;Neonatal unconjugated hyperbilirubinemia;0.8681976944208145;0.9591049;0.5420764060761565;0.5130209471436913;0.9999600672783046;-0.13176237285749004;-0.040855171686568714;-0.4578836612021481;-0.48693912013461327
Hyperphalangy of the 2nd finger;High maternal circulating alpha-fetoprotein concentration;0.8184174299240112;1.0202342;0.5581219645530362;0.4935588224728632;0.9999201345566091;-0.18150270463259788;0.02031409262387185;-0.4417981700035729;-0.5063613120837459
Hyperphalangy of the 2nd finger;Prominent nasolabial fold;0.881148561835289;1.0093019;0.5379212247660052;0.4970390566572489;0.9999545338528789;-0.11880597201758991;0.009347367010768548;-0.4620333090868737;-0.50291547719563
Hyperphalangy of the 2nd finger;Abnormality of inferior alveolar nerve;0.8101673424243927;0.89966995;0.5607945469462716;0.5319898711557717;0.9999201345566091;-0.1897527921322164;-0.10025018931658836;-0.4391255876103375;-0.46793026340083743
Hyperphalangy of the 2nd finger;Unilateral conductive hearing impairment;0.9308039098978043;1.0440027;0.5220434144962225;0.4859890051935367;0.9999600672783046;-0.0691561573805003;0.04404258488996937;-0.47791665278208206;-0.5139710620847678
Hyperphalangy of the 2nd finger;Macular hypopigmented whorls, streaks, and patches;0.8005668818950653;0.95261735;0.5639100627122902;0.5150880161263208;0.9999600672783046;-0.19939318538323925;-0.047342720037856556;-0.4360500045660144;-0.48487205115198373
Hyperphalangy of the 2nd finger;Delayed ossification of pubic rami;0.7942090034484863;0.9306586;0.5659767063698666;0.5220897790495467;0.8355479869321181;-0.04133898348363174;0.0951105919405626;-0.26957128056225144;-0.3134582078825714
Hyperphalangy of the 2nd finger;Hyperphenylalaninemia;0.6764743030071259;0.921669;0.6048682149575186;0.5249590884460529;0.9999561589935034;-0.3234818559863776;-0.07828715264584718;-0.3950879440359848;-0.47499707054745055
Hyperphalangy of the 2nd finger;Ureteropelvic junction obstruction;0.8022493124008179;0.8607829;0.5633636449747167;0.5444585806051394;0.9999528219730685;-0.19770350957225058;-0.13916990065882895;-0.43658917699835176;-0.45549424136792904
Hyperphalangy of the 2nd finger;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.3429986238479614;0.30938387;0.7281754426143038;0.7426605598286068;0.6245600766986774;-0.281561452850716;-0.31517620752753484;0.10361536591562637;0.11810048312992938
Hyperphalangy of the 2nd finger;Difficulty walking;0.8705025911331177;0.87082547;0.5413363915111377;0.5412327503800531;0.9203691460904122;-0.04986655495729453;-0.04954367659654624;-0.37903275457927454;-0.37913639571035906
Hyperphalangy of the 2nd finger;Bilobate gallbladder;0.8627086877822876;1.0690901;0.5438396462333546;0.4779903928437912;0.9999584729108851;-0.13724978512859753;0.06913165503406116;-0.45611882667753056;-0.5219680800670939
Hyperphalangy of the 2nd finger;Histidinuria;0.8213528096675873;0.95961463;0.557172068786443;0.5128585639787988;0.9999574798349273;-0.17860467016734005;-0.04034284532107235;-0.44278541104848435;-0.4870989158561285
Hyperphalangy of the 2nd finger;Widened interpedicular distance;0.7265675663948059;0.8554058;0.5881589955686428;0.5461876693768317;0.822027235707794;-0.0954596693129881;0.033378571787323175;-0.2338682401391512;-0.2758395663309623
Renal interstitial hemosiderin;Abnormality of depressor anguli oris muscle;0.9006942510604858;1.1339203;0.5316621879306315;0.4572433906692229;1.0;-0.09930574893951416;0.1339203119277954;-0.46833781206936853;-0.5427566093307771
Renal interstitial hemosiderin;Paroxysmal dyspnea;0.883928194642067;0.9943333;0.5370302721744855;0.5018037736787485;1.0;-0.11607180535793304;-0.005666673183441162;-0.4629697278255145;-0.4981962263212515
Renal interstitial hemosiderin;Phenylpyruvic acidemia;0.8211157023906708;0.9638474;0.5572487780352369;0.511510245769126;0.9999201345566091;-0.17880443216593833;-0.03607273579867454;-0.44267135652137224;-0.48840988878748315
Renal interstitial hemosiderin;Lateral ventricle dilatation;0.8062337934970856;0.86882675;0.5620703212341523;0.5418744091714356;0.9998579617208769;-0.19362416822379136;-0.13103121478026414;-0.4377876404867246;-0.45798355254944134
Renal interstitial hemosiderin;Neonatal unconjugated hyperbilirubinemia;0.7578105032444;0.9758109;0.5778655685626717;0.5077003806187488;0.9999201345566091;-0.24210963131220908;-0.024109249127226784;-0.4220545659939374;-0.4922197539378603
Renal interstitial hemosiderin;High maternal circulating alpha-fetoprotein concentration;0.8466253727674484;0.8303318;0.5490141228702179;0.5542695948132541;1.0;-0.15337462723255157;-0.16966819763183594;-0.4509858771297821;-0.4457304051867459
Renal interstitial hemosiderin;Prominent nasolabial fold;0.9241687208414078;1.051834;0.5241610395487876;0.483493341705036;0.9998944404568447;-0.07572571961543695;0.051939546779178225;-0.47573340090805716;-0.5164010987518087
Renal interstitial hemosiderin;Abnormality of inferior alveolar nerve;0.8965650275349617;1.0373641;0.5329833672894129;0.48810387707132996;1.0;-0.1034349724650383;0.03736412525177002;-0.46701663271058713;-0.51189612292867
Renal interstitial hemosiderin;Unilateral conductive hearing impairment;0.8570401966571808;1.134336;0.5456619650773031;0.4571098538569881;0.9999201345566091;-0.14287993789942832;0.13441586016384988;-0.454258169479306;-0.542810280699621
Renal interstitial hemosiderin;Macular hypopigmented whorls, streaks, and patches;0.7328484058380127;0.70796126;0.5860824453535125;0.59433362126907;0.9999201345566091;-0.2670717287185964;-0.2919588732841787;-0.4138376892030966;-0.40558651328753914
Renal interstitial hemosiderin;Delayed ossification of pubic rami;0.8519458472728729;1.056411;0.5473009925578094;0.48203428577721064;0.9999134918687169;-0.147967644595844;0.056497536039608276;-0.4526124993109075;-0.5178792060915063
Renal interstitial hemosiderin;Hyperphenylalaninemia;0.7760523855686188;0.9695154;0.571894454620244;0.5097050501526292;0.9999028053808913;-0.2238504198122725;-0.030387422137330478;-0.42800835076064725;-0.49019775522826203
Renal interstitial hemosiderin;Ureteropelvic junction obstruction;0.6056632399559021;0.61669666;0.6290256439173434;0.6252136117516404;0.31555464056675586;0.29010859938914624;0.3011420151835188;0.31347100335058753;0.3096589711848845
Renal interstitial hemosiderin;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8475574851036072;1.0510021;0.5487138916698513;0.4837584760946001;1.0;-0.15244251489639282;0.0510021448135376;-0.4512861083301487;-0.5162415239053999
Renal interstitial hemosiderin;Difficulty walking;0.8787328153848648;0.95110804;0.5386957835416772;0.5155690016826144;0.9998344221996177;-0.1211016068147529;-0.048726383774172155;-0.46113863865794047;-0.4842654205170033
Renal interstitial hemosiderin;Bilobate gallbladder;0.7566148191690445;0.891878;0.5782579055577713;0.5344837104510043;0.9999134918687169;-0.24329867269967242;-0.10803548302624866;-0.4216555863109456;-0.46542978141771263
Renal interstitial hemosiderin;Histidinuria;0.5230764150619507;0.6721661;0.6582481583952673;0.6063186439822872;0.5774374587829405;-0.05436104372098982;0.0947286503021425;0.08081069961232679;0.02888118519934668
Renal interstitial hemosiderin;Widened interpedicular distance;0.867178350687027;1.1244136;0.5424037512580877;0.46029504433270263;1.0;-0.13282164931297302;0.12441360950469971;-0.4575962487419123;-0.5397049556672974
Abnormality of depressor anguli oris muscle;Paroxysmal dyspnea;0.7746188938617706;0.8801696;0.5723627198854205;0.538235090510728;1.0;-0.22538110613822937;-0.1198304295539856;-0.42763728011457947;-0.46176490948927196
Abnormality of depressor anguli oris muscle;Phenylpyruvic acidemia;0.8708384037017822;1.1038548;0.5412285937291685;0.4668822960177771;0.9999201345566091;-0.12908173085482688;0.10393464087216286;-0.45869154082744057;-0.533037838538832
Abnormality of depressor anguli oris muscle;Lateral ventricle dilatation;0.7470777332782745;0.9267475;0.5813916916982463;0.5233378980547193;0.9998579617208769;-0.2527802284426024;-0.07311046082442307;-0.4184662700226306;-0.4765200636661576
Abnormality of depressor anguli oris muscle;Neonatal unconjugated hyperbilirubinemia;0.8374160379171371;1.053754;0.5519828364826906;0.48288132253983496;0.9999201345566091;-0.16250409663947196;0.053833837496918724;-0.44793729807391847;-0.5170388120167742
Abnormality of depressor anguli oris muscle;High maternal circulating alpha-fetoprotein concentration;0.9113400429487228;1.0890383;0.5282584449576809;0.4716206759198245;1.0;-0.08865995705127716;0.08903825283050537;-0.47174155504231907;-0.5283793240801755
Abnormality of depressor anguli oris muscle;Prominent nasolabial fold;0.786774069070816;0.63289124;0.5683970408581445;0.6196523182699196;0.7184876422794455;0.06828642679137054;-0.08559640454369721;-0.15009060142130104;-0.09883532400952588
Abnormality of depressor anguli oris muscle;Abnormality of inferior alveolar nerve;0.520372599363327;0.5884846;0.6592281655117478;0.6350003688490664;1.0;-0.479627400636673;-0.41151541471481323;-0.3407718344882522;-0.3649996311509336
Abnormality of depressor anguli oris muscle;Unilateral conductive hearing impairment;0.7910741865634918;0.85675955;0.5669967200142092;0.5457522320111801;0.9999201345566091;-0.2088459479931173;-0.14316058636935325;-0.4329234145423999;-0.45416790254542905
Abnormality of depressor anguli oris muscle;Macular hypopigmented whorls, streaks, and patches;0.8337699472904205;1.0475764;0.5531594343437838;0.4848502457011975;0.9999201345566091;-0.16615018726618858;0.04765629290310769;-0.4467607002128253;-0.5150698888554116
Abnormality of depressor anguli oris muscle;Delayed ossification of pubic rami;0.704887717962265;0.75942934;0.5953570578565781;0.5773345770806495;0.872141863789474;-0.167254145827209;-0.11271252819529676;-0.2767848059328959;-0.2948072867088245
Abnormality of depressor anguli oris muscle;Hyperphenylalaninemia;0.9141811802983284;1.1010661;0.5273506213481216;0.46777463022992816;0.9999028053808913;-0.08572162508256287;0.10116330713741928;-0.47255218403276966;-0.5321281751509631
Abnormality of depressor anguli oris muscle;Ureteropelvic junction obstruction;0.7735755741596222;1.1504204;0.5727036314939541;0.4519372682492716;0.9998847295244674;-0.2263091553648452;0.1505356977979203;-0.4271810980305133;-0.5479474612751958
Abnormality of depressor anguli oris muscle;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8803945928812027;1.1820662;0.5381629447688497;0.44172150026202217;1.0;-0.1196054071187973;0.1820662021636963;-0.46183705523115026;-0.5582784997379778
Abnormality of depressor anguli oris muscle;Difficulty walking;0.8870808631181717;1.0281808;0.5360201030886818;0.4910285736493869;0.5306161845308115;0.3564646785873602;0.4975646531004141;0.0054039185578702575;-0.039587610881424595
Abnormality of depressor anguli oris muscle;Bilobate gallbladder;0.8193448930978775;0.97355694;0.5578217791424576;0.5084180622797478;0.9999134918687169;-0.18056859877083942;-0.02635655608151599;-0.44209171272625936;-0.4914954295889691
Abnormality of depressor anguli oris muscle;Histidinuria;0.827420249581337;1.062746;0.555210251105867;0.48001418370428983;0.9999090677057578;-0.17248881812442085;0.06283698026787499;-0.44469881659989086;-0.519894884001468
Abnormality of depressor anguli oris muscle;Widened interpedicular distance;0.7907353639602661;0.62317747;0.5671070084945995;0.6229833403742089;1.0;-0.2092646360397339;-0.3768225312232971;-0.4328929915054005;-0.3770166596257911
Paroxysmal dyspnea;Phenylpyruvic acidemia;0.46342289447784424;0.7121235;0.6802829453707544;0.5929492710812987;0.9999201345566091;-0.5364972400787649;-0.2877966213348684;-0.3196371891858547;-0.4069708634753104
Paroxysmal dyspnea;Lateral ventricle dilatation;0.7284750044345856;0.80115354;0.5875279618881364;0.5637195164934118;0.9998579617208769;-0.27138295728629136;-0.19870442110960984;-0.41232999983274055;-0.43613844522746514
Paroxysmal dyspnea;Neonatal unconjugated hyperbilirubinemia;0.7502249777317047;0.80540156;0.5803566642603777;0.5623403684584634;0.9999201345566091;-0.2496951568249044;-0.19451857091219993;-0.4195634702962314;-0.43757976609814575
Paroxysmal dyspnea;High maternal circulating alpha-fetoprotein concentration;0.8196253031492233;0.86328876;0.5577310310638117;0.5436532362805101;1.0;-0.18037469685077667;-0.1367112398147583;-0.4422689689361883;-0.4563467637194899
Paroxysmal dyspnea;Prominent nasolabial fold;0.8593421876430511;0.8020032;0.5449217377245906;0.5634435636407502;0.9998944404568447;-0.14055225281379358;-0.19789123563430444;-0.4549727027322541;-0.4364508768160945
Paroxysmal dyspnea;Abnormality of inferior alveolar nerve;0.8044895529747009;0.959374;0.5626363556818675;0.5129352080045775;1.0;-0.19551044702529907;-0.04062598943710327;-0.43736364431813246;-0.4870647919954225
Paroxysmal dyspnea;Unilateral conductive hearing impairment;0.7038242518901825;0.9276638;0.595711409820477;0.5230454517543025;0.9999201345566091;-0.2960958826664266;-0.07225633145602317;-0.4042087247361321;-0.4768746828023066
Paroxysmal dyspnea;Macular hypopigmented whorls, streaks, and patches;0.7165083289146423;0.98842186;0.5914928310533425;0.503685515165728;0.9999201345566091;-0.2834118056419668;-0.011498277199583962;-0.4084273035032666;-0.4962346193908811
Paroxysmal dyspnea;Delayed ossification of pubic rami;0.8387846499681473;1.0612379;0.5515413695249862;0.4804951454144014;0.9999134918687169;-0.16112884190056964;0.06132443938280896;-0.4483721223437307;-0.5194183464543155
Paroxysmal dyspnea;Hyperphenylalaninemia;0.6841763854026794;0.90270245;0.6022807878221863;0.5310198564619413;0.9999028053808913;-0.3157264199782118;-0.09720035462863297;-0.39762201755870497;-0.46888294891895
Paroxysmal dyspnea;Ureteropelvic junction obstruction;0.6459894776344299;0.95026934;0.6151822987219275;0.5158362888320738;0.9998847295244674;-0.35389525189003745;-0.04961538805565635;-0.38470243080253985;-0.4840484406923936
Paroxysmal dyspnea;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7617272883653641;1.0085839;0.5765812044625039;0.4972676387948818;1.0;-0.23827271163463593;0.008583903312683105;-0.42341879553749606;-0.5027323612051182
Paroxysmal dyspnea;Difficulty walking;0.7331041097640991;0.7801493;0.5859979855250759;0.5705570237828514;0.9998344221996177;-0.2667303124355186;-0.21968514117468485;-0.41383643667454184;-0.42927739841676626
Paroxysmal dyspnea;Bilobate gallbladder;0.7416697442531586;0.9410058;0.5831722692640691;0.5187893478770392;0.9999134918687169;-0.25824374761555835;-0.058907665872317994;-0.41674122260464785;-0.4811241439916777
Paroxysmal dyspnea;Histidinuria;0.8850703984498978;1.0904;0.5366642477337755;0.4711854598266795;0.9999090677057578;-0.11483866925586006;0.09049091283928612;-0.4632448199719823;-0.5287236078790784
Paroxysmal dyspnea;Widened interpedicular distance;0.8193777501583099;0.9101164;0.5578111454865993;0.528649514543905;1.0;-0.18062224984169006;-0.08988362550735474;-0.44218885451340073;-0.47135048545609504
Phenylpyruvic acidemia;Lateral ventricle dilatation;0.8364722430706024;0.8742594;0.5522873308220817;0.5401306988180592;0.9999488789551968;-0.16347663588459438;-0.12568946666653102;-0.4476615481331151;-0.4598181801371376
Phenylpyruvic acidemia;Neonatal unconjugated hyperbilirubinemia;0.7025335431098938;0.6727607;0.596141644570501;0.606118311731739;0.8631450867506595;-0.16061154364076569;-0.19038436172929718;-0.2670034421801585;-0.25702677501892046
Phenylpyruvic acidemia;High maternal circulating alpha-fetoprotein concentration;0.6417698860168457;0.80052656;0.6166196721305721;0.5639231609546751;0.9999201345566091;-0.3581502485397634;-0.19939357520373435;-0.383300462426037;-0.435996973601934
Phenylpyruvic acidemia;Prominent nasolabial fold;0.9288743659853935;1.089727;0.5226591247974048;0.47140051478655687;0.9999545338528789;-0.07108016786748539;0.08977251025265087;-0.4772954090554741;-0.528554019066322
Phenylpyruvic acidemia;Abnormality of inferior alveolar nerve;0.9036834314465523;1.1226734;0.5307061175294524;0.46085325384445575;0.9999201345566091;-0.09623670311005683;0.1227532577392283;-0.4692140170271567;-0.5390668807121534
Phenylpyruvic acidemia;Unilateral conductive hearing impairment;0.802599310874939;0.98442525;0.563249996723789;0.5049578066986324;0.9999600672783046;-0.1973607564033656;-0.0155348205627589;-0.4367100705545156;-0.4950022605796721
Phenylpyruvic acidemia;Macular hypopigmented whorls, streaks, and patches;0.7737699449062347;1.0284511;0.572640113146535;0.49094251255223764;0.9999600672783046;-0.2261901223720698;0.028491017812332653;-0.4273199541317696;-0.5090175547260669
Phenylpyruvic acidemia;Delayed ossification of pubic rami;0.8376196771860123;1.0525638;0.5519171431228287;0.48326072106192564;0.9999584729108851;-0.16233879572487286;0.0526053135957677;-0.44804132978805644;-0.5166977518489595
Phenylpyruvic acidemia;Hyperphenylalaninemia;0.4674069881439209;0.46929407;0.6787823454853732;0.6780731333838212;0.8497508587917271;-0.38234387064780617;-0.3804567875942173;-0.17096851330635388;-0.17167772540790582
Phenylpyruvic acidemia;Ureteropelvic junction obstruction;0.6347019076347351;0.8250884;0.6190329386930162;0.5559639619086083;0.9999528219730685;-0.36525091433833334;-0.1748644402057955;-0.3809198832800522;-0.44398886006446014
Phenylpyruvic acidemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.704628974199295;0.95613843;0.5954432612780893;0.5139660440994138;0.9999201345566091;-0.29529116035731406;-0.043781702530699684;-0.4044768732785198;-0.4859540904571953
Phenylpyruvic acidemia;Difficulty walking;0.852960854768753;0.8595215;0.546974330336109;0.5448640857872623;0.9999461221900431;-0.14698526742129003;-0.14042461397318518;-0.4529717918539341;-0.4550820364027808
Phenylpyruvic acidemia;Bilobate gallbladder;0.7403504550457001;0.839039;0.5836070466942886;0.5514593319143563;0.9999584729108851;-0.25960801786518506;-0.16091944521999768;-0.4163514262165965;-0.4484991409965289
Phenylpyruvic acidemia;Histidinuria;0.7419312596321106;0.7180937;0.5830861046301443;0.5909667336264941;0.8542775634790427;-0.11234630384693212;-0.13618387022266454;-0.2711914588488984;-0.2633108298525486
Phenylpyruvic acidemia;Widened interpedicular distance;0.7572005838155746;0.8881303;0.5780656848634198;0.5356839245097643;0.9999201345566091;-0.24271955074103446;-0.11178982735903831;-0.4218544496931893;-0.4642362100468448
Lateral ventricle dilatation;Neonatal unconjugated hyperbilirubinemia;0.7362044453620911;0.7958258;0.5849744263458687;0.5654509103091185;0.9999488789551968;-0.26374443359310573;-0.204123099517178;-0.4149744526093281;-0.43449796864607826
Lateral ventricle dilatation;High maternal circulating alpha-fetoprotein concentration;0.8189471065998077;0.8194351;0.5579505214854257;0.5577925885871847;0.9998579617208769;-0.1809108551210692;-0.18042284209197068;-0.44190744023545125;-0.4420653731336922
Lateral ventricle dilatation;Prominent nasolabial fold;0.8240416049957275;0.9366835;0.5563024199469541;0.5201677615118098;0.9999394441529541;-0.17589783915722657;-0.06325596818173218;-0.44363702420600004;-0.47977168264114434
Lateral ventricle dilatation;Abnormality of inferior alveolar nerve;0.8027144372463226;0.9665401;0.5632126157451721;0.5106525963901305;0.596292991364175;0.20642144588214761;0.3702471068261326;-0.0330803756190029;-0.08564039497404452
Lateral ventricle dilatation;Unilateral conductive hearing impairment;0.7361322641372681;1.0120647;0.5849982463147348;0.49615961192243174;0.9999488789551968;-0.26381661481792873;0.012115816403079571;-0.41495063264046195;-0.503789267032765
Lateral ventricle dilatation;Macular hypopigmented whorls, streaks, and patches;0.7869245707988739;0.9221625;0.5683480078594102;0.5248015415247298;0.9999488789551968;-0.2130243081563229;-0.07778640575344509;-0.4316008710957866;-0.475147337430467
Lateral ventricle dilatation;Delayed ossification of pubic rami;0.7476409673690796;1.0164418;0.5812063978156807;0.49476615246624167;0.9999462364511621;-0.2523052690820825;0.016495585600839857;-0.41873983863548137;-0.5051800839849204
Lateral ventricle dilatation;Hyperphenylalaninemia;0.7055315971374512;0.83342326;0.5951425734786524;0.5532713448712948;0.9999422932358373;-0.2944106960983861;-0.1665190363617528;-0.4047997197571849;-0.44667094836454246
Lateral ventricle dilatation;Ureteropelvic junction obstruction;0.741634726524353;0.94488543;0.5831838074519464;0.5175524067287534;0.9999363689743077;-0.2583016424499547;-0.055050936254123384;-0.4167525615223613;-0.48238396224555435
Lateral ventricle dilatation;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8447921276092529;1.0891286;0.5496047353602906;0.4715917865169784;0.9998579617208769;-0.155065834111624;0.08927065175110793;-0.4502532263605863;-0.5282661752038985
Lateral ventricle dilatation;Difficulty walking;0.8147861808538437;0.92350495;0.5592977709522388;0.5243729307938123;0.8801199872450469;-0.06533380639120323;0.04338496137098091;-0.32082221629280816;-0.3557470564512346
Lateral ventricle dilatation;Bilobate gallbladder;0.8052384257316589;0.9928997;0.5623933098059224;0.502260109614088;0.9999462364511621;-0.19470781071950316;-0.007046520550740953;-0.4375529266452397;-0.49768612683707414
Lateral ventricle dilatation;Histidinuria;0.8223702907562256;1.0099413;0.5568429300495875;0.49683551648829083;0.9999445600944175;-0.17757426933819187;0.009996779398380395;-0.44310163004482994;-0.5031090436061266
Lateral ventricle dilatation;Widened interpedicular distance;0.6894491314888;0.9218915;0.6005135083998158;0.5248880502712194;0.9998579617208769;-0.3104088302320769;-0.07796645123427415;-0.39934445332106117;-0.4749699114496575
Neonatal unconjugated hyperbilirubinemia;High maternal circulating alpha-fetoprotein concentration;0.7627013027667999;0.8292513;0.5762620108067342;0.554618630648305;0.9999201345566091;-0.23721883178980918;-0.17066884518893333;-0.4236581237498749;-0.44530150390830414
Neonatal unconjugated hyperbilirubinemia;Prominent nasolabial fold;0.7912460416555405;1.0525118;0.566940783429044;0.4832772822409641;0.9999545338528789;-0.20870849219733845;0.05255727740352978;-0.43301375042383494;-0.5166772516119148
Neonatal unconjugated hyperbilirubinemia;Abnormality of inferior alveolar nerve;0.821517750620842;1.0306758;0.5571187088585494;0.49023406628483324;0.9999201345566091;-0.17840238393576713;0.03075563429562478;-0.4428014256980597;-0.5096860682717759
Neonatal unconjugated hyperbilirubinemia;Unilateral conductive hearing impairment;0.6800230145454407;0.9655256;0.6036751837162457;0.5109756990157485;0.9999600672783046;-0.3199370527328639;-0.034434440142074085;-0.3962848835620588;-0.4889843682625561
Neonatal unconjugated hyperbilirubinemia;Macular hypopigmented whorls, streaks, and patches;0.8595633506774902;1.138234;0.5448506335624212;0.4558574064866291;0.9999600672783046;-0.14039671660081432;0.13827395200117543;-0.4551094337158833;-0.5441026607916755
Neonatal unconjugated hyperbilirubinemia;Delayed ossification of pubic rami;0.7626246511936188;0.99975723;0.57628712740759;0.5000772807453058;0.9999584729108851;-0.23733382171726636;-0.00020124262905529822;-0.4236713455032951;-0.49988119216557936
Neonatal unconjugated hyperbilirubinemia;Hyperphenylalaninemia;0.6314531564712524;0.90948516;0.6201445846881579;0.5288512535425922;0.5721925110198667;0.05926064545138576;0.3372926502846072;0.04795207366829124;-0.043341257477274464
Neonatal unconjugated hyperbilirubinemia;Ureteropelvic junction obstruction;0.706465870141983;0.7908361;0.5948314343450407;0.5670742092107268;0.9999528219730685;-0.2934869518310854;-0.20911672616313193;-0.40512138762802774;-0.43287861276234163
Neonatal unconjugated hyperbilirubinemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9455157406628132;1.0663394;0.5173514703597364;0.4788680116674411;0.9999201345566091;-0.05440439389379592;0.0664192390319529;-0.4825686641968727;-0.521052122889168
Neonatal unconjugated hyperbilirubinemia;Difficulty walking;0.9596887715160847;1.0538528;0.5128349402717052;0.4828498402822009;0.9999461221900431;-0.040257350673958414;0.053906674364522345;-0.4871111819183379;-0.5170962819078422
Neonatal unconjugated hyperbilirubinemia;Bilobate gallbladder;0.5977679491043091;0.57983774;0.6317654950666787;0.6380268449854298;0.9999584729108851;-0.40219052380657605;-0.4201207334432643;-0.36819297784420646;-0.3619316279254553
Neonatal unconjugated hyperbilirubinemia;Histidinuria;0.6749521493911743;0.9101127;0.6053804112655621;0.5286506980164255;0.8542775634790427;-0.1793254140878684;0.05583511552562648;-0.24889715221348063;-0.3256268654626172
Neonatal unconjugated hyperbilirubinemia;Widened interpedicular distance;0.8565920442342758;1.0034008;0.5458061015931142;0.49891749830734267;0.9999201345566091;-0.1433280903223333;0.0034806680556955794;-0.45411403296349495;-0.5010026362492664
High maternal circulating alpha-fetoprotein concentration;Prominent nasolabial fold;0.8246018588542938;0.97405744;0.5561212682652961;0.5082587029274053;0.9998944404568447;-0.1752925816025509;-0.02583700446746484;-0.44377317219154866;-0.49163573752943945
High maternal circulating alpha-fetoprotein concentration;Abnormality of inferior alveolar nerve;0.8484312295913696;0.96659756;0.5484325002784206;0.5106343130425203;1.0;-0.15156877040863037;-0.033402442932128906;-0.4515674997215794;-0.48936568695747973
High maternal circulating alpha-fetoprotein concentration;Unilateral conductive hearing impairment;0.896575927734375;1.049309;0.5329798789394067;0.48429809755978737;0.9999201345566091;-0.10334420682223411;0.04938888071743874;-0.4669402556172024;-0.5156220369968217
High maternal circulating alpha-fetoprotein concentration;Macular hypopigmented whorls, streaks, and patches;0.8926044553518295;0.8907391;0.5342511209879701;0.5348484118825912;0.9999201345566091;-0.10731567920477958;-0.10918105126650901;-0.465669013568639;-0.46507172267401786
High maternal circulating alpha-fetoprotein concentration;Delayed ossification of pubic rami;0.8982434868812561;1.0059468;0.5324462627921311;0.49810708610628196;0.9999134918687169;-0.10167000498746082;0.006033263540523803;-0.4674672290765858;-0.501806405762435
High maternal circulating alpha-fetoprotein concentration;Hyperphenylalaninemia;0.5411916971206665;0.8817818;0.6517235342490464;0.5377182247482877;0.9999028053808913;-0.45871110826022476;-0.11812098889834732;-0.3481792711318449;-0.4621845806326036
High maternal circulating alpha-fetoprotein concentration;Ureteropelvic junction obstruction;0.900737851858139;0.95342666;0.5316482404531968;0.5148301265360777;0.9998847295244674;-0.09914687766632835;-0.046458070417259134;-0.4682364890712706;-0.48505460298838965
High maternal circulating alpha-fetoprotein concentration;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8798599541187286;1.0276977;0.5383343616156762;0.4911824256182218;1.0;-0.12014004588127136;0.02769768238067627;-0.46166563838432384;-0.5088175743817782
High maternal circulating alpha-fetoprotein concentration;Difficulty walking;0.8906054943799973;0.9896737;0.5348911814380568;0.5032870312250998;0.9998344221996177;-0.10922892781962046;-0.010160748093019811;-0.4649432407615609;-0.49654739097451794
High maternal circulating alpha-fetoprotein concentration;Bilobate gallbladder;0.9576486647129059;1.0196842;0.5134848819261956;0.4937339390604887;0.9999134918687169;-0.042264827155811036;0.019770703649776733;-0.48642860994252135;-0.5061795528082282
High maternal circulating alpha-fetoprotein concentration;Histidinuria;0.8522207736968994;1.0538087;0.5472125074065799;0.4828639040642855;0.9999090677057578;-0.1476882940088584;0.053899621411673815;-0.45269656029917793;-0.5170451636414723
High maternal circulating alpha-fetoprotein concentration;Widened interpedicular distance;0.7959363907575607;1.0299952;0.5654149395649034;0.4904508057649217;1.0;-0.20406360924243927;0.029995203018188477;-0.4345850604350966;-0.5095491942350783
Prominent nasolabial fold;Abnormality of inferior alveolar nerve;0.6644997894763947;0.4795274;0.608905324172451;0.6742442054561992;0.9998944404568447;-0.33539465098045007;-0.5203670266117825;-0.3909891162843937;-0.3256502350006455
Prominent nasolabial fold;Unilateral conductive hearing impairment;0.7549401223659515;0.91888225;0.5788076240941393;0.5258489755141651;0.9999545338528789;-0.24501441148692737;-0.08107228306705128;-0.4211469097587396;-0.4741055583387138
Prominent nasolabial fold;Macular hypopigmented whorls, streaks, and patches;0.8857394158840179;0.8204323;0.5364498806768494;0.5574698999879408;0.9999545338528789;-0.11421511796886097;-0.17952222851688038;-0.4635046531760295;-0.4424846338649381
Prominent nasolabial fold;Delayed ossification of pubic rami;0.7509656548500061;0.8180548;0.5801132059641895;0.5582393501358787;0.9999524555142131;-0.24898680066420698;-0.18189766024901532;-0.4198392495500236;-0.4417131053783344
Prominent nasolabial fold;Hyperphenylalaninemia;0.7500089108943939;0.96669984;0.5804276938106974;0.5106017305667316;0.9999493977362748;-0.24994048684188086;-0.03324955909796912;-0.4195217039255774;-0.48934766716954314
Prominent nasolabial fold;Ureteropelvic junction obstruction;0.7899483144283295;1.0333863;0.5673632287083362;0.4893708017799774;0.9999448992541466;-0.20999658482581718;0.033441450423892904;-0.4325816705458104;-0.5105740974741693
Prominent nasolabial fold;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.9013542085886002;1.0629765;0.5314510803497765;0.47994067545277164;0.9998944404568447;-0.09854023186824457;0.06308203907348975;-0.4684433601070682;-0.5199537650040731
Prominent nasolabial fold;Difficulty walking;0.8788035213947296;0.940961;0.5386731098838176;0.5188036296041645;0.9999355370354486;-0.12113201564071896;-0.05897453373192074;-0.461262427151631;-0.4811319074312841
Prominent nasolabial fold;Bilobate gallbladder;0.8212760239839554;1.0150216;0.5571969102210921;0.4952183154007842;0.9999524555142131;-0.1786764315302577;0.015069107062080866;-0.442755545293121;-0.5047341401134289
Prominent nasolabial fold;Histidinuria;0.8896597474813461;1.0661446;0.5351940555600183;0.47893015822105667;0.9999511492611326;-0.11029140177978647;0.06619343634830344;-0.4647570937011143;-0.5210209910400759
Prominent nasolabial fold;Widened interpedicular distance;0.7657323032617569;0.9272195;0.5752692219186593;0.523187245990655;0.9998944404568447;-0.23416213719508783;-0.07267493037841455;-0.42462521853818547;-0.4767071944661897
Abnormality of inferior alveolar nerve;Unilateral conductive hearing impairment;0.6227784156799316;0.90390104;0.6231204834970094;0.5306365323556663;0.9999201345566091;-0.37714171887667747;-0.09601909400256248;-0.37679965105959967;-0.4692836022009428
Abnormality of inferior alveolar nerve;Macular hypopigmented whorls, streaks, and patches;0.8838932886719704;0.86953473;0.5370414587245242;0.5416470974060688;0.9999201345566091;-0.11602684588463874;-0.13038540364535423;-0.46287867583208486;-0.45827303715054035
Abnormality of inferior alveolar nerve;Delayed ossification of pubic rami;0.684678465127945;0.66010594;0.6021123647011879;0.6103912196793069;0.9999134918687169;-0.315235026740772;-0.33980754818890735;-0.397801127167529;-0.38952227218941005
Abnormality of inferior alveolar nerve;Hyperphenylalaninemia;0.8252250850200653;1.0695703;0.5559197767828631;0.47783718685216514;0.9999028053808913;-0.17467772036082596;0.06966749758236557;-0.4439830285980282;-0.5220656185287261
Abnormality of inferior alveolar nerve;Ureteropelvic junction obstruction;0.7588759511709213;1.0184745;0.5775160673438422;0.49411904924086203;0.9998847295244674;-0.24100877835354606;0.018589730123664938;-0.4223686621806252;-0.5057656802836054
Abnormality of inferior alveolar nerve;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8384695202112198;0.9351946;0.5516430106011698;0.5206426572623397;1.0;-0.1615304797887802;-0.06480538845062256;-0.4483569893988302;-0.4793573427376603
Abnormality of inferior alveolar nerve;Difficulty walking;0.8863544836640358;0.9705583;0.5362528148585994;0.5093729520543016;0.7403726674076037;0.14598181625643214;0.23018561830559214;-0.20411985254900422;-0.2309997153533021
Abnormality of inferior alveolar nerve;Bilobate gallbladder;0.8303094208240509;0.99291223;0.5542768287197716;0.5022561335375992;0.9999134918687169;-0.16960407104466602;-0.007001258992892945;-0.44563666314894534;-0.4976573583311177
Abnormality of inferior alveolar nerve;Histidinuria;0.8730571269989014;1.0607169;0.5405164895633637;0.4806613417168084;0.9999090677057578;-0.12685194070685646;0.06080779974114159;-0.4593925781423941;-0.5192477259889494
Abnormality of inferior alveolar nerve;Widened interpedicular distance;0.8268840312957764;0.9319436;0.5553835429862133;0.5216797887843208;1.0;-0.17311596870422363;-0.06805640459060669;-0.4446164570137867;-0.47832021121567925
Unilateral conductive hearing impairment;Macular hypopigmented whorls, streaks, and patches;0.8499219417572021;1.085355;0.5479525009640637;0.4727975278619905;0.9999600672783046;-0.1500381255211024;0.08539497613295033;-0.4520075663142409;-0.5271625394163141
Unilateral conductive hearing impairment;Delayed ossification of pubic rami;0.8973058685660362;1.0430174;0.532746287732508;0.4863029279419784;0.9999584729108851;-0.10265260434484891;0.04305891447925159;-0.46721218517837715;-0.5136555449689068
Unilateral conductive hearing impairment;Hyperphenylalaninemia;0.7778407335281372;0.9338317;0.5713104935033654;0.5210774332794371;0.9999561589935034;-0.22211542546536622;-0.06612446725156007;-0.42864566549013805;-0.4788787257140663
Unilateral conductive hearing impairment;Ureteropelvic junction obstruction;0.7634831666946411;1.0164828;0.5760058432400558;0.4947531306535067;0.9999528219730685;-0.23646965527842734;0.01653000807453897;-0.4239469787330127;-0.5051996913195618
Unilateral conductive hearing impairment;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8758016228675842;1.004893;0.5396359191094782;0.4984425265597412;0.9999201345566091;-0.12411851168902488;0.004972810733002708;-0.46028421544713094;-0.5014776079968679
Unilateral conductive hearing impairment;Difficulty walking;0.6733606457710266;0.82035726;0.6059162466001538;0.55749417188185;0.9999461221900431;-0.3265854764190165;-0.17958885910181677;-0.39402987558988933;-0.44245195030819306
Unilateral conductive hearing impairment;Bilobate gallbladder;0.7931936234235764;1.0253718;0.5663070171805736;0.4919230340057922;0.9999584729108851;-0.20676484948730878;0.025413317021365844;-0.4336514557303115;-0.508035438905093
Unilateral conductive hearing impairment;Histidinuria;0.7950880825519562;0.9944876;0.5656907934991383;0.5017546696618824;0.9999574798349273;-0.20486939728297116;-0.005469896197689783;-0.434266686335789;-0.4982028101730449
Unilateral conductive hearing impairment;Widened interpedicular distance;0.8520352393388748;0.88697135;0.5472722212911502;0.5360551758201075;0.9999201345566091;-0.1478848952177343;-0.112948780072051;-0.45264791326545895;-0.4638649587365016
Macular hypopigmented whorls, streaks, and patches;Delayed ossification of pubic rami;0.9049488380551338;1.0899826;0.5303014694508059;0.4713188601715862;0.9999584729108851;-0.09500963485575131;0.09002415591144153;-0.4696570034600792;-0.5286396127392989
Macular hypopigmented whorls, streaks, and patches;Hyperphenylalaninemia;0.7769298255443573;0.944339;0.571607907694837;0.5177266174954973;0.9999561589935034;-0.22302633344914613;-0.055617181656619885;-0.4283482512986664;-0.4822295414980061
Macular hypopigmented whorls, streaks, and patches;Ureteropelvic junction obstruction;0.8910112231969833;1.0358822;0.5347612570890987;0.4885758586246155;0.9999528219730685;-0.10894159877608511;0.03592941260029581;-0.46519156488396973;-0.511376963348453
Macular hypopigmented whorls, streaks, and patches;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.8425920903682709;0.9952213;0.5503137439845548;0.5015211029987687;0.9999201345566091;-0.15732804418833823;-0.004698817742186501;-0.4496063905720543;-0.4983990315578404
Macular hypopigmented whorls, streaks, and patches;Difficulty walking;0.8083939254283905;0.90870464;0.5613695984942783;0.5291007370231192;0.9999461221900431;-0.19155219676165258;-0.09124148370890295;-0.43857652369576483;-0.47084538516692387
Macular hypopigmented whorls, streaks, and patches;Bilobate gallbladder;0.8134048879146576;1.1033158;0.5597452507367451;0.4670547730598553;0.9999584729108851;-0.18655358499622754;0.10335735731982776;-0.44021322217414005;-0.5329036998510298
Macular hypopigmented whorls, streaks, and patches;Histidinuria;0.7702729105949402;0.944103;0.5737833605429193;0.5178018501021395;0.9999574798349273;-0.22968456923998715;-0.05585447728670956;-0.426174119292008;-0.4821556297327878
Macular hypopigmented whorls, streaks, and patches;Widened interpedicular distance;0.9340047687292099;1.146164;0.521022213349313;0.4533072892517862;0.9999201345566091;-0.06591536582739921;0.1462438058730784;-0.47889792120729613;-0.5466128453048229
Delayed ossification of pubic rami;Hyperphenylalaninemia;0.8046473264694214;1.0374805;0.5625851473866248;0.4880668139350547;0.9999542297279059;-0.19530690325848454;0.03752624379046565;-0.43736908234128113;-0.5118874157928512
Delayed ossification of pubic rami;Ureteropelvic junction obstruction;0.6545263528823853;0.93384814;0.6122817312335579;0.5210721734188635;0.9999505803237132;-0.34542422744132795;-0.06610243769981183;-0.3876688490901553;-0.47887840690484973
Delayed ossification of pubic rami;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7208456099033356;0.77802;0.5900541253312449;0.5712519668584668;0.6574179255159834;0.06342768438735213;0.12060209878363815;-0.06736380018473853;-0.08616595865751664
Delayed ossification of pubic rami;Difficulty walking;0.9914679583162069;1.1135395;0.5027158661685422;0.46378116709663253;0.9160188400246831;0.07544911829152379;0.19752061729648385;-0.4133029738561409;-0.4522376729280506
Delayed ossification of pubic rami;Bilobate gallbladder;0.7973454296588898;0.9382068;0.5649568565077282;0.5196819329554114;0.9999567459343585;-0.2026113162754687;-0.06174995405661188;-0.43499988942663026;-0.48027481297894703
Delayed ossification of pubic rami;Histidinuria;0.8671307861804962;1.011098;0.5424190269023406;0.496467299093178;0.9999556674707869;-0.1328248812902907;0.01114235975852218;-0.45753664056844634;-0.5034883683776089
Delayed ossification of pubic rami;Widened interpedicular distance;0.6508203148841858;0.68818754;0.6135397178097317;0.6009360653818556;0.8072246192530101;-0.15640430436882435;-0.11903707967552601;-0.19368490144327843;-0.20628855387115452
Hyperphenylalaninemia;Ureteropelvic junction obstruction;0.7779064476490021;0.9092703;0.5712890400973759;0.5289199305091239;0.999947268185474;-0.2220408205364719;-0.09067698162541538;-0.42865822808809806;-0.4710273376763501
Hyperphenylalaninemia;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7726233154535294;0.93070173;0.5730148624144145;0.5220760262989361;0.9999028053808913;-0.2272794899273619;-0.06920107274539322;-0.4268879429664768;-0.47782677908195514
Hyperphenylalaninemia;Difficulty walking;0.8646432459354401;0.7820519;0.5432180541480209;0.5699363560356998;0.9999387558585022;-0.13529550992306216;-0.21788683496769412;-0.4567207017104813;-0.4300023998228024
Hyperphenylalaninemia;Bilobate gallbladder;0.6700477600097656;0.936297;0.6070326482220759;0.5202910415422276;0.9999542297279059;-0.3299064697181403;-0.06365723027340764;-0.39292158150583;-0.4796631881856783
Hyperphenylalaninemia;Histidinuria;0.6043126583099365;0.62564796;0.6294936038717291;0.6221348360556679;0.8389944217294671;-0.23468176341953062;-0.21334645963611387;-0.209500817857738;-0.21685958567379926
Hyperphenylalaninemia;Widened interpedicular distance;0.6823132634162903;0.8425328;0.6029060336739641;0.5503328506625602;0.9999028053808913;-0.317589541964601;-0.15736999183184952;-0.39699677170692715;-0.44956995471833106
Ureteropelvic junction obstruction;Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;0.7524425387382507;0.82523245;0.5796279014856327;0.5559173970217803;0.9998847295244674;-0.24744219078621665;-0.17465228333077232;-0.4202568280388347;-0.44396733250268705
Ureteropelvic junction obstruction;Difficulty walking;0.8417870402336121;0.9600277;0.5505732511831634;0.5127269670860519;0.999932040772814;-0.15814500053920189;-0.03990434607066551;-0.4493587895896506;-0.487205073686762
Ureteropelvic junction obstruction;Bilobate gallbladder;0.6537752449512482;0.7009498;0.6125365405793728;0.5966698088231841;0.9999505803237132;-0.34617533537246503;-0.2990007922301463;-0.3874140397443404;-0.4032807715005291
Ureteropelvic junction obstruction;Histidinuria;0.8149047046899796;0.77935433;0.5592593798385224;0.5708164334242393;0.7637811309637142;0.0511235737262653;0.015573202913849227;-0.2045217511251919;-0.19296469753947498
Ureteropelvic junction obstruction;Widened interpedicular distance;0.7770520150661469;0.9905721;0.5715680087619721;0.5030010445964459;0.9998847295244674;-0.22283271445832054;-0.009312634607170023;-0.4283167207624953;-0.4968836849280215
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Difficulty walking;0.8481449484825134;0.83179015;0.5485246935456036;0.553798623793224;0.7552776988623575;0.09286724962015591;0.07651245034952603;-0.2067530053167539;-0.20147907506913354
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Bilobate gallbladder;0.9467322528362274;1.1420343;0.5169636792693124;0.4546356620050025;0.9999134918687169;-0.0531812390324895;0.14212080035235242;-0.4829498125994045;-0.5452778298637144
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Histidinuria;0.8965003490447998;0.97648895;0.5330040661862478;0.5074844816662927;0.9999090677057578;-0.10340871866095802;-0.023420119837410658;-0.46690500151951;-0.49242458603946515
Cone-shaped epiphysis of the proximal phalanx of the 2nd toe;Widened interpedicular distance;0.696305513381958;0.88535565;0.5982202129411331;0.5365728399696246;1.0;-0.303694486618042;-0.11464434862136841;-0.40177978705886686;-0.46342716003037543
Difficulty walking;Bilobate gallbladder;0.9895275346934795;1.1428899;0.5033335501748224;0.4543605399755273;0.9999431787962207;-0.010415644102741206;0.14294667849595455;-0.49660962862139835;-0.5455826388206935
Difficulty walking;Histidinuria;0.8770837783813477;0.88809186;0.5392246448905156;0.5356962440329529;0.9999413030146577;-0.12285752463331001;-0.111849440812967;-0.4607166581241421;-0.46424505898170476
Difficulty walking;Widened interpedicular distance;0.7710300832986832;0.8426573;0.5735357446204645;0.5502927210862716;0.7552776988623575;0.01575238443632565;0.08737962878962002;-0.181741954241893;-0.20498497777608593
Bilobate gallbladder;Histidinuria;0.8085122406482697;0.9064166;0.5613312270842594;0.5298321734627132;0.9999556674707869;-0.19144342682251725;-0.09353907248863969;-0.4386244403865275;-0.47012349400807374
Bilobate gallbladder;Widened interpedicular distance;0.9203304573893547;1.0470808;0.5253865071878885;0.48500818583475147;0.9999134918687169;-0.07958303447936221;0.04716726336504773;-0.47452698468082843;-0.5149053060339654
Histidinuria;Widened interpedicular distance;0.8292232155799866;0.9439463;0.5546277000218321;0.5178518101573408;0.9999090677057578;-0.17068585212577125;-0.055962765768654554;-0.4452813676839257;-0.482057257548417
